Citrus Sinensis ID: 003737
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 799 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGE0 | 1014 | Probable LRR receptor-lik | yes | no | 0.928 | 0.731 | 0.616 | 0.0 | |
| C0LGN2 | 1020 | Probable leucine-rich rep | no | no | 0.931 | 0.729 | 0.498 | 0.0 | |
| C0LGG8 | 1038 | Probable LRR receptor-lik | no | no | 0.926 | 0.712 | 0.498 | 0.0 | |
| C0LGG9 | 1035 | Probable LRR receptor-lik | no | no | 0.917 | 0.708 | 0.496 | 0.0 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.858 | 0.719 | 0.465 | 1e-180 | |
| Q9FXF2 | 1021 | Probable LRR receptor-lik | no | no | 0.907 | 0.710 | 0.455 | 1e-176 | |
| Q9ASQ6 | 1019 | Probable LRR receptor-lik | no | no | 0.927 | 0.727 | 0.455 | 1e-169 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.908 | 0.703 | 0.389 | 1e-140 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.933 | 0.722 | 0.387 | 1e-138 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.762 | 0.522 | 0.281 | 5e-47 |
| >sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 895 bits (2314), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 465/754 (61%), Positives = 570/754 (75%), Gaps = 12/754 (1%)
Query: 22 VTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFES 81
+ F G + NKLH EV+ALK+IG+KLGKKDW+F DPCS +G W +++ KGFES
Sbjct: 16 LIFHGRLGFSDNNKLHEAEVRALKEIGKKLGKKDWDFNKDPCSGEGTWIVTTYTTKGFES 75
Query: 82 NVTCDCS----SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWA 137
N+TCDCS +++CHV+ IALK+QNLTG +P E SKLR+LK LDLSRN LTGS +WA
Sbjct: 76 NITCDCSFLPQNSSCHVIRIALKSQNLTGIVPPEFSKLRHLKVLDLSRNSLTGSIPKEWA 135
Query: 138 SLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN 197
S++L +LS MGNRLSGPFPKVLT +T L+NLS+EGN F+G IPPDI +L++L+KL L SN
Sbjct: 136 SMRLEDLSFMGNRLSGPFPKVLTRLTMLRNLSLEGNQFSGPIPPDIGQLVHLEKLHLPSN 195
Query: 198 SFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISA 257
+FTG L +L L NL D+RISDNNF+G IP+FI W +I KL + G L+GPIP+SIS+
Sbjct: 196 AFTGPLTEKLGLLKNLTDMRISDNNFTGPIPDFISNWTRILKLQMHGCGLDGPIPSSISS 255
Query: 258 LTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN 316
LTSLTDLRISDL G S+FP L + ++KTLIL KC I G IP YIGD+ KLK +DLSFN
Sbjct: 256 LTSLTDLRISDLGGKPSSFPPLKNLESIKTLILRKCKIIGPIPKYIGDLKKLKTLDLSFN 315
Query: 317 NLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPI-ECP 375
L+G IP++FE + K +F+YLTGNKLTG VP Y NKNVD+S NNFT ESS P +C
Sbjct: 316 LLSGEIPSSFENMKKADFIYLTGNKLTGGVPNYFVERNKNVDVSFNNFTDESSIPSHDCN 375
Query: 376 RGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTG-HTKYEA 434
R + NLVES++ NK K C Q PC P + Y L+INCGG ++ Y+A
Sbjct: 376 RVTSNLVESFALG-NKSHKGSTCFLQRMPCVHPKRYHLYKLYINCGGGEVKVDKEITYQA 434
Query: 435 DMEARGASMFY-SSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLS-KVSAVDLELYRTAR 492
D E +GASM+ + + WA SSTG FMD+D D D Y NTS LS S+ LYRTAR
Sbjct: 435 DDEPKGASMYVLGANKRWALSSTGNFMDNDDDADEYTVQNTSRLSVNASSPSFGLYRTAR 494
Query: 493 VSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIED 552
VSPLSLTYYG+CLGNGNYTV LHFAEIIF +D+T SLGKR+FDIY+Q++LV K+FNI++
Sbjct: 495 VSPLSLTYYGICLGNGNYTVNLHFAEIIFTDDNTLYSLGKRLFDIYVQDQLVIKNFNIQE 554
Query: 553 EAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVV 612
A G+G PI+K+F VT HTLKI L WAG+GTTGIP+RG YGP+ISAISV+ NFKPPV
Sbjct: 555 AARGSGKPIIKSFLVNVTDHTLKIGLRWAGKGTTGIPIRGVYGPMISAISVEPNFKPPVY 614
Query: 613 HSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIK 672
+ K+ ++ + V A+ LL+ +I+ + WK K DKELRGLDLQTG +TLRQIK
Sbjct: 615 YDTKDIILKVGVPVAAATLLLFIIVGVF-WKK-RRDKNDIDKELRGLDLQTGTFTLRQIK 672
Query: 673 AATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHP 732
AAT+NFD K+GEGGFGSVYKG LS+G +IAVKQLS+KSRQGNREFVNEIGMISA QHP
Sbjct: 673 AATDNFDVTRKIGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNREFVNEIGMISALQHP 732
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK 766
NLVKLYGCCVEGNQL+LVYEY++NNCLSRA+FGK
Sbjct: 733 NLVKLYGCCVEGNQLILVYEYLENNCLSRALFGK 766
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 742 bits (1915), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/768 (49%), Positives = 515/768 (67%), Gaps = 24/768 (3%)
Query: 9 KLLLASHLLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQ--- 65
+ LL ++ +SL+ F + +AT L EEV AL+ + L K +WNF VDPC +
Sbjct: 5 RQLLFTYYFIVSLILFSDFVSSAT---LPKEEVDALQSVATALKKSNWNFSVDPCDETLS 61
Query: 66 KGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSR 125
+G W + + KGFE VTC+CSS CHV I LKAQ+L G+LPT+LS L +L++LDL+R
Sbjct: 62 EGGWR-NPNAAKGFEDAVTCNCSSVICHVTNIVLKAQDLQGSLPTDLSGLPFLQELDLTR 120
Query: 126 NCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRK 185
N L GS P+W + L+ +S++GNR+SG PK L N+TTL L +E N +G IPP++
Sbjct: 121 NYLNGSIPPEWGASSLLNISLLGNRISGSIPKELGNLTTLSGLVLEYNQLSGKIPPELGN 180
Query: 186 LINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGS 245
L NL++L+LSSN+ +GE+P+ KLT L DLRISDN F+G IP+FI WK ++KL IQ S
Sbjct: 181 LPNLKRLLLSSNNLSGEIPSTFAKLTTLTDLRISDNQFTGAIPDFIQNWKGLEKLVIQAS 240
Query: 246 SLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGD 304
L GPIP++I L +LTDLRI+DL G ES FP L M ++K LIL C + G++P Y+G
Sbjct: 241 GLVGPIPSAIGLLGTLTDLRITDLSGPESPFPPLRNMTSMKYLILRNCNLTGDLPAYLGQ 300
Query: 305 MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNF 364
KLKN+DLSFN L+G IP T+ L+ +F+Y T N L G VP ++ + +DI+ NNF
Sbjct: 301 NRKLKNLDLSFNKLSGPIPATYSGLSDVDFIYFTSNMLNGQVPSWMVDQGDTIDITYNNF 360
Query: 365 TWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAK 424
+ + ++ EC + SVN S S CL + + C + Y LHINCGG +
Sbjct: 361 SKDKTE--ECQQKSVNTFSSTSPLVANNSSNVSCLSK-YTCP----KTFYGLHINCGGNE 413
Query: 425 INTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKV--SA 482
I + TKY+AD +Y S W S+TG F+DDD + + + S+ K+ S+
Sbjct: 414 ITSNETKYDAD--TWDTPGYYDSKNGWVSSNTGNFLDDDRTNNGKSKWSNSSELKITNSS 471
Query: 483 VDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEK 542
+D LY AR+S +SLTY LCLG GNYTV LHFAEI+F + +++LG+R FDIY+Q K
Sbjct: 472 IDFRLYTQARLSAISLTYQALCLGKGNYTVNLHFAEIMFNEKNMYSNLGRRYFDIYVQGK 531
Query: 543 LVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAIS 602
KDFNI DEA G G +VK FP VT+ L+I L WAG+GT IP+RG YGPLISA+S
Sbjct: 532 REVKDFNIVDEAKGVGKAVVKKFPVMVTNGKLEIRLQWAGKGTQAIPVRGVYGPLISAVS 591
Query: 603 VKSNFKPP-----VVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELR 657
V +F PP + ++ +++ ++V LVLLI I+ W+GCL K +K+ +
Sbjct: 592 VDPDFIPPKEPGTGTGGGSSVGTVVGSVIASTVFLVLLIGGILWWRGCLRPKSQMEKDFK 651
Query: 658 GLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR 717
LD Q ++LRQIK AT+NFDPANK+GEGGFG V+KGI++DGTVIAVKQLS+KS+QGNR
Sbjct: 652 NLDFQISSFSLRQIKVATDNFDPANKIGEGGFGPVHKGIMTDGTVIAVKQLSAKSKQGNR 711
Query: 718 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG 765
EF+NEI MISA QHP+LVKLYGCCVEG+QLLLVYEY++NN L+RA+FG
Sbjct: 712 EFLNEIAMISALQHPHLVKLYGCCVEGDQLLLVYEYLENNSLARALFG 759
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 725 bits (1871), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/765 (49%), Positives = 511/765 (66%), Gaps = 25/765 (3%)
Query: 9 KLLLASHLLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGN 68
K++ L+F+ L F + A L +EV+ L+ I RKL + N CS + N
Sbjct: 9 KVVYVLLLIFVCLENF-----GSNAQLLPEDEVQTLRTIFRKLQNQTVNIERTSCSDQ-N 62
Query: 69 WELSSDDKKGFE-SNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLS 124
W + SN+TCDC+ S+ C V I LK+ +L G P E L L+++DLS
Sbjct: 63 WNFVVESASNSPTSNITCDCTFNASSVCRVTNIQLKSFSLPGIFPPEFGNLTRLREIDLS 122
Query: 125 RNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIR 184
RN L G+ + + L LSV+GNRLSGPFP L +ITTL ++++E NLFTG +P ++
Sbjct: 123 RNFLNGTIPTTLSQIPLEILSVIGNRLSGPFPPQLGDITTLTDVNLETNLFTGPLPRNLG 182
Query: 185 KLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQG 244
L +L++L+LS+N+FTG++P L+ L NL + RI N+ SGKIP+FIG W +++L +QG
Sbjct: 183 NLRSLKELLLSANNFTGQIPESLSNLKNLTEFRIDGNSLSGKIPDFIGNWTLLERLDLQG 242
Query: 245 SSLEGPIPASISALTSLTDLRISDLKGSES-AFPKL-DKMNLKTLILTKCLIHGEIPDYI 302
+S+EGPIP SIS LT+LT+LRI+DL+G + +FP L + M +K L+L CLI G IP+YI
Sbjct: 243 TSMEGPIPPSISNLTNLTELRITDLRGQAAFSFPDLRNLMKMKRLVLRNCLIRGPIPEYI 302
Query: 303 GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLN 362
G M++LK +DLS N LTG IP TF L NFM+L N LTGPVP++I NS +N+D+S N
Sbjct: 303 GSMSELKTLDLSSNMLTGVIPDTFRNLDAFNFMFLNNNSLTGPVPQFIINSKENLDLSDN 362
Query: 363 NFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGG 422
NFT + + C + VNL+ SY S + + V CLR+ PC P D +L INCGG
Sbjct: 363 NFTQPPT--LSCNQLDVNLISSYPSVTD--NSVQWCLREGLPC--PEDAKQSSLFINCGG 416
Query: 423 AKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSA 482
+++ G Y D+ +RG S F S + W +SS+G ++ + Y+ T+ L ++
Sbjct: 417 SRLKIGKDTYTDDLNSRGQSTFSSVSERWGYSSSGVWLGKEDA--GYLATDRFNL--ING 472
Query: 483 VDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEK 542
E Y+TAR+SP SL YYGLCL G+Y ++LHFAEI+F ND TFNSLG+RIFDIY+Q
Sbjct: 473 STPEYYKTARLSPQSLKYYGLCLRRGSYKLQLHFAEIMFSNDQTFNSLGRRIFDIYVQGN 532
Query: 543 LVKKDFNIEDEAGGTGIPIVKNFPA-EVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAI 601
L+++DFNI + AGG G P ++ +V TL+IHL W G+GT IP RG YGPLISAI
Sbjct: 533 LLERDFNIAERAGGVGKPFIRQIDGVQVNGSTLEIHLQWTGKGTNVIPTRGVYGPLISAI 592
Query: 602 SVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGK-VSADKELRGLD 660
++ NFK N + ++ A + LL+L I+R G LGGK V ++ELRGLD
Sbjct: 593 TITPNFKVDTGKPLSNGA-VAGIVIAACAVFGLLVLVILRLTGYLGGKEVDENEELRGLD 651
Query: 661 LQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFV 720
LQTG +TL+QIK ATNNFDP NK+GEGGFG VYKG+L+DG IAVKQLSSKS+QGNREFV
Sbjct: 652 LQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFV 711
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG 765
EIGMISA QHPNLVKLYGCC+EG +LLLVYEY++NN L+RA+FG
Sbjct: 712 TEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFG 756
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 712 bits (1839), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/758 (49%), Positives = 500/758 (65%), Gaps = 25/758 (3%)
Query: 16 LLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDD 75
++FI L F + A L +EV+ L+ I RKL + N C + W ++
Sbjct: 14 IIFICLDIF-----GSNAQLLPEDEVQTLRTIFRKLQNQTVNIERTSCLDR-KWNFVAES 67
Query: 76 KKGF-ESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGS 131
SN+TCDC+ S+ C V I L+ NL G +P E L L ++DL N L+G+
Sbjct: 68 TSKLPTSNITCDCTFNASSVCRVTNIQLRGFNLRGIIPPEFGNLTRLTEIDLVLNFLSGT 127
Query: 132 FSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191
+ + L L+V GNRLSGPFP L ITTL ++ +E NLFTG +PP++ L +L++
Sbjct: 128 IPTTLSQIPLEILAVTGNRLSGPFPPQLGQITTLTDVIMESNLFTGQLPPNLGNLRSLKR 187
Query: 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251
L++SSN+ TG +P L+ L NL + RI N+ SGKIP+FIG W ++ +L +QG+S+EGPI
Sbjct: 188 LLISSNNITGRIPESLSNLKNLTNFRIDGNSLSGKIPDFIGNWTRLVRLDLQGTSMEGPI 247
Query: 252 PASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIG-DMTKLK 309
PASIS L +LT+LRI+DL+G S FP L M N++ L+L CLI IP+YIG MT LK
Sbjct: 248 PASISNLKNLTELRITDLRGPTSPFPDLQNMTNMERLVLRNCLIREPIPEYIGTSMTMLK 307
Query: 310 NIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESS 369
+DLS N L G IP TF L NFMYL N LTGPVP++I +S +N+D+S NNFT +
Sbjct: 308 LLDLSSNMLNGTIPDTFRSLNAFNFMYLNNNSLTGPVPQFILDSKQNIDLSYNNFTQPPT 367
Query: 370 DPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGH 429
+ C + VNL+ SY S N + V CLR++ PC P D +H +L INCGG ++
Sbjct: 368 --LSCNQLDVNLISSYPSVTN--NSVQWCLRKDLPC--PGDAHHSSLFINCGGNRLKVDK 421
Query: 430 TKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYR 489
+Y D+ RGAS F S + W +SS+G ++ +D Y+ T+T L ++ E Y+
Sbjct: 422 DEYADDLNKRGASTFSSVSERWGYSSSGAWLGNDGA--TYLATDTFNL--INESTPEYYK 477
Query: 490 TARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFN 549
TAR++ SL YYGLC+ G+Y V+L+FAEI+F ND T++SLG+R+FDIY+Q L+++DFN
Sbjct: 478 TARLASQSLKYYGLCMRRGSYKVQLYFAEIMFSNDQTYSSLGRRLFDIYVQGILLERDFN 537
Query: 550 IEDEAGGTGIPIVKNF-PAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFK 608
I AGG G P ++ +V TL+IHL W G+GT IP RG YGPLISAI+V NFK
Sbjct: 538 IAQRAGGVGKPFLRQVDEVQVNGSTLEIHLKWTGKGTNVIPTRGVYGPLISAITVTPNFK 597
Query: 609 PPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGK-VSADKELRGLDLQTGLYT 667
N V + ++ A V LL+L I+R G LGGK V ++ELRGLDLQTG +T
Sbjct: 598 VDTGKPLSNGV-VAGIVIAACVAFGLLVLVILRLTGYLGGKEVDENEELRGLDLQTGSFT 656
Query: 668 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMIS 727
L+QIK ATNNFDP NK+GEGGFG VYKG+L+DG IAVKQLSSKS+QGNREFV EIGMIS
Sbjct: 657 LKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMIS 716
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG 765
A QHPNLVKLYGCC+EG +LLLVYEY++NN L+RA+FG
Sbjct: 717 ALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFG 754
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 632 bits (1629), Expect = e-180, Method: Compositional matrix adjust.
Identities = 344/739 (46%), Positives = 461/739 (62%), Gaps = 53/739 (7%)
Query: 31 ATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSA 90
A++ L +E +A K + L K + + VDPC E+SS +
Sbjct: 22 ASSATLPTQEGEAFKVVLTTLKKTNIDLNVDPC------EVSS--------------TGN 61
Query: 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNR 150
++ LK +NL G+LP EL L L+++DLSRN L GS P+W L LV + ++GNR
Sbjct: 62 EWSTISRNLKRENLQGSLPKELVGLPLLQEIDLSRNYLNGSIPPEWGVLPLVNIWLLGNR 121
Query: 151 LSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKL 210
L+GP PK NITTL +L +E N +G +P ++ L N+Q++ILSSN+F GE+P+ KL
Sbjct: 122 LTGPIPKEFGNITTLTSLVLEANQLSGELPLELGNLPNIQQMILSSNNFNGEIPSTFAKL 181
Query: 211 TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK 270
T L D R+SDN SG IP+FI KW K+++L IQ S L GPIP +I++L L DLRISDL
Sbjct: 182 TTLRDFRVSDNQLSGTIPDFIQKWTKLERLFIQASGLVGPIPIAIASLVELKDLRISDLN 241
Query: 271 GSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL 329
G ES FP+L + ++TLIL C + G++PDY+G +T K +DLSFN L+G IP T+ L
Sbjct: 242 GPESPFPQLRNIKKMETLILRNCNLTGDLPDYLGKITSFKFLDLSFNKLSGAIPNTYINL 301
Query: 330 AKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPR 389
++Y TGN L G VP ++ N +D+S NNF+ + ++ + C
Sbjct: 302 RDGGYIYFTGNMLNGSVPDWMVNKGYKIDLSYNNFSVDPTNAV-C--------------- 345
Query: 390 NKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQ 449
K + V C+R N+ C + LHINCGG +++ T YE+D R S +Y S
Sbjct: 346 -KYNNVLSCMR-NYQCPKTFN----ALHINCGGDEMSINGTIYESDKYDRLES-WYESRN 398
Query: 450 YWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGN 509
W ++ G F+DD + T S S+++ VD LY AR+S +SLTYY LCL NGN
Sbjct: 399 GWFSNNVGVFVDDKHVPERV--TIESNSSELNVVDFGLYTQARISAISLTYYALCLENGN 456
Query: 510 YTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEV 569
Y V LHFAEI+F ++ + SLG+R FDIYIQ KL KDFNI EA G ++K FP E+
Sbjct: 457 YNVNLHFAEIMFNGNNNYQSLGRRFFDIYIQRKLEVKDFNIAKEAKDVGNVVIKTFPVEI 516
Query: 570 TSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHV---MIMAAIV 626
L+I LYWAGRGTT IP YGPLISAISV S+ P S +N + + +V
Sbjct: 517 KDGKLEIRLYWAGRGTTVIPKERVYGPLISAISVDSSVNP----SPRNGMSTGTLHTLVV 572
Query: 627 GASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGE 686
S+ +V L+ + KG L K +K+ + L+L ++LRQIK ATNNFD AN++GE
Sbjct: 573 ILSIFIVFLVFGTLWKKGYLRSKSQMEKDFKSLELMIASFSLRQIKIATNNFDSANRIGE 632
Query: 687 GGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746
GGFG VYKG L DGT+IAVKQLS+ S+QGNREF+NEIGMISA HPNLVKLYGCCVEG Q
Sbjct: 633 GGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQ 692
Query: 747 LLLVYEYMKNNCLSRAIFG 765
LLLVYE+++NN L+RA+FG
Sbjct: 693 LLLVYEFVENNSLARALFG 711
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FXF2|RKF1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RFK1 OS=Arabidopsis thaliana GN=RKF1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 619 bits (1595), Expect = e-176, Method: Compositional matrix adjust.
Identities = 346/760 (45%), Positives = 468/760 (61%), Gaps = 35/760 (4%)
Query: 20 SLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGF 79
+++ F Y++ A KL +EV AL+QI LG K W F + C + L+
Sbjct: 28 AIICFKFYSVNAI--KLPQQEVDALQQIATTLGSKFWKFDAENCKIE-MVGLTETPPPTA 84
Query: 80 ESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQW 136
+ + C+CS CHVV A K NL GTLP ++ KL YL+++DL+ N + G+ +W
Sbjct: 85 KQEIECECSPTNDTDCHVVKFAFKDHNLPGTLP-QIVKLPYLREIDLAYNYINGTLPREW 143
Query: 137 ASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSS 196
AS L +S++ NRLSG PK N ++L L +E N F+G+IP ++ L++L+KL+LSS
Sbjct: 144 ASSNLTFISLLVNRLSGEIPKEFGN-SSLTYLDLESNAFSGTIPQELGNLVHLKKLLLSS 202
Query: 197 NSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASIS 256
N TG LPA L +L N+ D RI+D SG IP +I WK++++L + S L GPIP+ IS
Sbjct: 203 NKLTGTLPASLARLQNMTDFRINDLQLSGTIPSYIQNWKQLERLEMIASGLTGPIPSVIS 262
Query: 257 ALTSLTDLRISDLKGSESAFPKLDKMN-LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSF 315
L++L +LRISD++G FP L + L +IL C I G+IP Y+ + +L+ +DLSF
Sbjct: 263 VLSNLVNLRISDIRGPVQPFPSLKNVTGLTKIILKNCNISGQIPTYLSHLKELETLDLSF 322
Query: 316 NNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIEC- 374
N L GGIP+ F + F+ L GN L G P + VD+S NN W+S + C
Sbjct: 323 NKLVGGIPS-FAQAENLRFIILAGNMLEGDAPDELLRDGITVDLSYNNLKWQSPESRACR 381
Query: 375 PRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTK--- 431
P ++NL S+ K K PC++ +F C +Y LH+NCGG+ + K
Sbjct: 382 PNMNLNLNLFQSTSTKKSSKFLPCIK-DFKCP----RYSSCLHVNCGGSDMYVKEKKTKE 436
Query: 432 -YEAD--MEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELY 488
YE D +E A F W FSSTG FMDD N + T+ ++ +LY
Sbjct: 437 LYEGDGNVEGGAAKYFLKPDANWGFSSTGDFMDD-----NNFQNTRFTMFVPASNQSDLY 491
Query: 489 RTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDF 548
++AR++P+SLTY+ CL NGNYT+ L FAEI F ND +N LG+R+FDIYIQEKLV KDF
Sbjct: 492 KSARIAPVSLTYFHACLENGNYTINLDFAEIRFTNDENYNRLGRRLFDIYIQEKLVAKDF 551
Query: 549 NIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFK 608
NI DEA G PI+K A VT+H L I L WAG+GTT IP RG YGP+ISAIS+ S+ K
Sbjct: 552 NIMDEAKGAQTPIIKPLTAYVTNHFLTIRLSWAGKGTTRIPTRGVYGPIISAISIVSDSK 611
Query: 609 PPVVHSKKNHVMIMAAI---VGASVLLVLLILFIMRW-KGCLGGKVSADKELRGLDLQTG 664
P K + A I +GA L++ ++ F+ W GCL K+ +L +G
Sbjct: 612 P--CERPKTGMSPGAYIAIGIGAPCLIIFILGFL--WICGCLPRCGRQRKDPYEEELPSG 667
Query: 665 LYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIG 724
+TLRQIK AT++F+P NK+GEGGFG+V+KG+L+DG V+AVKQLSSKSRQGNREF+NEIG
Sbjct: 668 TFTLRQIKFATDDFNPTNKIGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEIG 727
Query: 725 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF 764
IS QHPNLVKL+G CVE QLLL YEYM+NN LS A+F
Sbjct: 728 AISCLQHPNLVKLHGFCVERAQLLLAYEYMENNSLSSALF 767
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 595 bits (1534), Expect = e-169, Method: Compositional matrix adjust.
Identities = 355/779 (45%), Positives = 466/779 (59%), Gaps = 38/779 (4%)
Query: 8 LKLLLASHLLFISLV--TFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNF-GVDPCS 64
+ ++L S LF +++ + A+ + LHA+E+ ALK+I LG K N DPCS
Sbjct: 1 MSIILWSFFLFFTIILSSLTNITTLASFSSLHADELNALKEIATTLGIKRLNLRDEDPCS 60
Query: 65 QKGNWELSSDD---KKGFESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYL 118
K + D + + CDCS + C + +ALK +L G LP EL+KL YL
Sbjct: 61 SKTLKIIQEVDFVPNLDINNTIGCDCSFNNNTICRITELALKTMSLRGKLPPELTKLPYL 120
Query: 119 KQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG 177
K ++L RN L+G+ +WA + L +SV N LSG P L N L L +EGN F+G
Sbjct: 121 KSIELCRNYLSGTIPMEWAKMAYLTSISVCANNLSGNLPAGLQNFKNLTFLGVEGNQFSG 180
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
IP ++ L +L L L+SN FTG LP L +L NL +RI DNNF+G IP +IG W ++
Sbjct: 181 PIPDELGNLTSLTGLELASNKFTGILPGTLARLVNLERVRICDNNFTGIIPAYIGNWTRL 240
Query: 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGE 297
QKLH+ S L GPIP ++ L +L +L +SD G +S FP L LK LIL + G
Sbjct: 241 QKLHLYASGLTGPIPDAVVRLENLLELSLSDTTGIKS-FPNLSSKGLKRLILRNVGLSGP 299
Query: 298 IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY-IFNSNKN 356
IP YI ++T LK +DLSFN L G I + K +YLTGN L+G + + NS
Sbjct: 300 IPSYIWNLTDLKILDLSFNKLNG-IVQGVQNPPKN--IYLTGNLLSGNIESGGLLNSQSY 356
Query: 357 VDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPAD--QYHY 414
+D+S NNF+W SS C +GS S +N L + PC + PA+ +Y
Sbjct: 357 IDLSYNNFSWSSS----CQKGSTINTYQSSYSKNNLTGLPPC-------AVPANCKKYQR 405
Query: 415 TLHINCGGAKINT----GHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYI 470
LHINCGG +++ G Y+ D + + YW S+TG F DD++D D Y
Sbjct: 406 FLHINCGGEEVSIRNSLGKITYQTDNSRQTNAASNQQFDYWGVSNTGDFTDDNSDHDEYY 465
Query: 471 RTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSL 530
TST +S +LY+TAR S LSL YY CL NGNY V+LHF EI F + ++ L
Sbjct: 466 ---TSTNLTLSGDYPDLYKTARRSALSLVYYAFCLENGNYNVKLHFMEIQFSDKEVYSRL 522
Query: 531 GKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPL 590
G+RIFD+Y+Q KL +DFNI EA G P++K A VT+H L+I LYWAG+GTT IP
Sbjct: 523 GRRIFDVYVQGKLFLRDFNINKEANGNMKPVIKEINATVTNHMLEIRLYWAGKGTTLIPK 582
Query: 591 RGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGAS---VLLVLLILFIMRWKGCLG 647
RG YGPLISAIS+ + +P K H + I+GAS V +VLL + I
Sbjct: 583 RGNYGPLISAISLCHSQEPLCGVEKTKHHIKYPLILGASGALVTIVLLAVGIYARGIYRR 642
Query: 648 GKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQ 707
+++LR LQT ++ RQ++ ATNNFD ANK+GEGGFGSV+KG LSDGT+IAVKQ
Sbjct: 643 DNNRRERDLRAQGLQTVCFSWRQLQTATNNFDQANKLGEGGFGSVFKGELSDGTIIAVKQ 702
Query: 708 LSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK 766
LSSKS QGNREFVNEIGMIS HPNLVKLYGCCVE +QLLLVYEYM+NN L+ A+FG+
Sbjct: 703 LSSKSSQGNREFVNEIGMISGLNHPNLVKLYGCCVERDQLLLVYEYMENNSLALALFGQ 761
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 499 bits (1284), Expect = e-140, Method: Compositional matrix adjust.
Identities = 295/757 (38%), Positives = 429/757 (56%), Gaps = 31/757 (4%)
Query: 32 TANKLHAEEVKALKQI---GRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCS 88
T H +E +AL I + ++WN + CS D + + CDCS
Sbjct: 33 TGATTHPDEARALNSIFAAWKIQAPREWNISGELCSGAAIDASVLDSNPAYNPLIKCDCS 92
Query: 89 ---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELS 145
S C + I + A ++ G +P EL L YL L+L +N LTGS P +L ++
Sbjct: 93 FQNSTICRITNIKVYAIDVVGPIPPELWTLTYLTNLNLGQNVLTGSLPPAIGNLTRMQWM 152
Query: 146 VMG-NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELP 204
G N LSGP PK + +T L+ L I N F+GSIP +I + LQ++ + S+ +G +P
Sbjct: 153 TFGINALSGPVPKEIGLLTDLRLLGISSNNFSGSIPDEIGRCTKLQQMYIDSSGLSGRIP 212
Query: 205 AELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL 264
L L I+D + +IP+FIG W K+ L I G+ L GPIP+S S LTSLT+L
Sbjct: 213 LSFANLVQLEQAWIADLEVTDQIPDFIGDWTKLTTLRIIGTGLSGPIPSSFSNLTSLTEL 272
Query: 265 RISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323
R+ D+ S+ + M +L L+L + G IP IG+ + L+ +DLSFN L G IP
Sbjct: 273 RLGDISSGSSSLDFIKDMKSLSVLVLRNNNLTGTIPSTIGEHSSLRQVDLSFNKLHGPIP 332
Query: 324 TTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVE 383
+ L++ ++L N L G P S +NVD+S N+ + + P +NLV
Sbjct: 333 ASLFNLSQLTHLFLGNNTLNGSFPTQKTQSLRNVDVSYNDLSGSLPSWVSLPSLKLNLVA 392
Query: 384 SYSSPRNKLDKVHP---CLRQNFPCSAPADQYHYTLHINCGGAKIN--TGHTKYEADMEA 438
+ + ++V P CL++NFPC+ Y INCGG + TG D +
Sbjct: 393 NNFTLEGLDNRVLPGLNCLQKNFPCNRGKGIYS-DFSINCGGPEKRSVTGALFEREDEDF 451
Query: 439 RGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSL 498
AS F S+GQ WA SS G F ++ YI T+ S V+ +D EL+++AR+S S+
Sbjct: 452 GPASFFVSAGQRWAASSVGLFAGSSNNI--YIATSQSQF--VNTLDSELFQSARLSASSV 507
Query: 499 TYYGLCLGNGNYTVRLHFAEI--IFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGG 556
YYGL L NG YTV L FAEI + +T+ LG+R FDIY+Q +LV+KDF++ AG
Sbjct: 508 RYYGLGLENGGYTVTLQFAEIQILGSTSTTWKGLGRRRFDIYVQGRLVEKDFDVRRTAGD 567
Query: 557 TGIPIVKN-FPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVH-- 613
+ + V+ + A V+ + L++HL+WAG+GT IP++G YGPLISA+S +F P V +
Sbjct: 568 STVRAVQRVYKANVSENHLEVHLFWAGKGTCCIPIQGAYGPLISAVSATPDFTPTVANKP 627
Query: 614 ---SKKNHVMIMAAIVGASVLLVL--LILFIMRWKGCLGGKVSADKELRGLDLQTGLYTL 668
K I+ IVG +L +L +++F +R + + + D+EL G+D++ ++T
Sbjct: 628 PSKGKNRTGTIVGVIVGVGLLSILAGVVMFTIRKRR---KRYTDDEELLGMDVKPYIFTY 684
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA 728
++K+AT +FDP+NK+GEGGFG VYKG L+DG V+AVK LS SRQG +FV EI IS+
Sbjct: 685 SELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISS 744
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG 765
H NLVKLYGCC EG +LVYEY+ N L +A+FG
Sbjct: 745 VLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFG 781
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 492 bits (1267), Expect = e-138, Method: Compositional matrix adjust.
Identities = 305/787 (38%), Positives = 437/787 (55%), Gaps = 41/787 (5%)
Query: 16 LLFISLVTFFG--YAIAA---TANKLHAEEVKALKQI---GRKLGKKDWNFGVDPCSQKG 67
LL + + FG Y + A T H +E AL I R ++WN + CS
Sbjct: 11 LLTVWFLCNFGPVYVVRAQNRTGATTHPDEALALNSIFAAWRIRAPREWNISGELCSGAA 70
Query: 68 NWELSSDDKKGFESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLS 124
D + + CDCS S C + I + A + G++P +L L YL L+L
Sbjct: 71 IDASVLDSNPAYNPLIKCDCSFENSTICRITNIKVYAMEVVGSIPQQLWTLEYLTNLNLG 130
Query: 125 RNCLTGSFSPQWASLQLVELSVMG-NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI 183
+N LTGS P +L + G N LSGP PK + +T L+ LSI N F+GSIP +I
Sbjct: 131 QNVLTGSLPPALGNLTRMRWMTFGINALSGPIPKEIGLLTDLRLLSISSNNFSGSIPDEI 190
Query: 184 RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQ 243
+ LQ++ + S+ +G LP L L I+D +G+IP+FIG W K+ L I
Sbjct: 191 GRCTKLQQIYIDSSGLSGGLPVSFANLVELEQAWIADMELTGQIPDFIGDWTKLTTLRIL 250
Query: 244 GSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYI 302
G+ L GPIPAS S LTSLT+LR+ D+ S+ + M +L L+L + G IP I
Sbjct: 251 GTGLSGPIPASFSNLTSLTELRLGDISNGNSSLEFIKDMKSLSILVLRNNNLTGTIPSNI 310
Query: 303 GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLN 362
G+ + L+ +DLSFN L G IP + L + ++L N L G +P S NVD+S N
Sbjct: 311 GEYSSLRQLDLSFNKLHGTIPASLFNLRQLTHLFLGNNTLNGSLPTQKGQSLSNVDVSYN 370
Query: 363 NFT-----WESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLH 417
+ + W S + + N + N++ CL++NFPC+ Y
Sbjct: 371 DLSGSLPSWVSLPNLNLNLVANNF--TLEGLDNRVLSGLNCLQKNFPCNRGKGIYS-DFS 427
Query: 418 INCGGAKINT-GHTKYEADMEARG-ASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTS 475
INCGG +I + +E + E G AS S+GQ WA SS G F ++ YI T+ S
Sbjct: 428 INCGGPEIRSVTEAVFEREDEDLGPASFVVSAGQRWAASSVGLFAGSSNNI--YISTSQS 485
Query: 476 TLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEI--IFKNDSTFNSLGKR 533
V+ +D EL+++AR+S SL YYGL L NG YTV L FAEI + +T+ LG+R
Sbjct: 486 QF--VNTLDSELFQSARLSASSLRYYGLGLENGGYTVTLQFAEIQILGSTSNTWRGLGRR 543
Query: 534 IFDIYIQEKLVKKDFNIEDEAGGTGIPIV-KNFPAEVTSHTLKIHLYWAGRGTTGIPLRG 592
FDIY+Q +LV+KDF++ AG + + V + + A V+ + L+IHL+WAG+GT IP++G
Sbjct: 544 RFDIYVQGRLVEKDFDVRRTAGDSTVRAVQREYKANVSQNHLEIHLFWAGKGTCCIPIQG 603
Query: 593 TYGPLISAISVKSNFKP-----PVVHSKKNHVMIMAAIVGASVLLVL--LILFIMRWKGC 645
YGPLISA+ +F P P K I+ IVG +L ++ +++FI+R +
Sbjct: 604 AYGPLISAVGATPDFTPTVGNRPPSKGKSMTGTIVGVIVGVGLLSIISGVVIFIIRKRR- 662
Query: 646 LGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAV 705
+ + D+E+ +D++ +T ++K+AT +FDP+NK+GEGGFG VYKG L+DG +AV
Sbjct: 663 --KRYTDDEEILSMDVKPYTFTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAV 720
Query: 706 KQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG 765
K LS SRQG +FV EI ISA QH NLVKLYGCC EG LLVYEY+ N L +A+FG
Sbjct: 721 KLLSVGSRQGKGQFVAEIVAISAVQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFG 780
Query: 766 KLRIFHI 772
+ + H+
Sbjct: 781 E-KTLHL 786
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 190 bits (482), Expect = 5e-47, Method: Compositional matrix adjust.
Identities = 205/727 (28%), Positives = 318/727 (43%), Gaps = 118/727 (16%)
Query: 97 IALKAQNLTGTLPTELSKL-RYLKQLDLSRNCLTGSFSPQW-ASLQLVELSVMGNRLSGP 154
++L L+G +P ELS L + L LDLS N +G Q+ A + L L++ N LSG
Sbjct: 282 LSLAHNRLSGEIPPELSLLCKTLVILDLSGNTFSGELPSQFTACVWLQNLNLGNNYLSGD 341
Query: 155 F-PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN- 212
F V++ IT + L + N +GS+P + NL+ L LSSN FTG +P+ L +
Sbjct: 342 FLNTVVSKITGITYLYVAYNNISGSVPISLTNCSNLRVLDLSSNGFTGNVPSGFCSLQSS 401
Query: 213 --LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRI--SD 268
L + I++N SG +P +GK K ++ + + + L GPIP I L +L+DL + ++
Sbjct: 402 PVLEKILIANNYLSGTVPMELGKCKSLKTIDLSFNELTGPIPKEIWMLPNLSDLVMWANN 461
Query: 269 LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328
L G+ + NL+TLIL L+ G IP+ I T + I LS N LTG IP+
Sbjct: 462 LTGTIPEGVCVKGGNLETLILNNNLLTGSIPESISRCTNMIWISLSSNRLTGKIPSGIGN 521
Query: 329 LAKTNFMYLTGNKLTGPVPKYIFNSNKNV--DISLNNFTWESSDPIECPRGSVNLVESYS 386
L+K + L N L+G VP+ + N + D++ NN T + + G V
Sbjct: 522 LSKLAILQLGNNSLSGNVPRQLGNCKSLIWLDLNSNNLTGDLPGELASQAGLV------- 574
Query: 387 SPRNKLDKVHPCLRQNFPCSAPADQYHYTLH---INCGGAKINTGHTKYEADMEAR---- 439
P S Q+ + + +C GA G ++E R
Sbjct: 575 ----------------MPGSVSGKQFAFVRNEGGTDCRGAG---GLVEFEGIRAERLERL 615
Query: 440 ------GASMFYSSGQYWAFSSTGKFMDDDTD---LDNYIRTNTSTLSKVSAVDLELYRT 490
A+ YS + FS+ G + D + +I + + ++L R
Sbjct: 616 PMVHSCPATRIYSGMTMYTFSANGSMIYFDISYNAVSGFIPPGYGNMGYLQVLNLGHNRI 675
Query: 491 ARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTF--NSLGKRIFDIYIQEKLVKKDF 548
P S + GL + ++ N + SLG F D
Sbjct: 676 TGTIPDS--FGGL--------KAIGVLDLSHNNLQGYLPGSLGSLSF---------LSDL 716
Query: 549 NIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFK 608
++ + IP F ++T+ + Y G G+PLR P SA +
Sbjct: 717 DVSNNNLTGPIP----FGGQLTT--FPVSRYANNSGLCGVPLR----PCGSAP------R 760
Query: 609 PPV---VHSKKNHV--MIMAAIVGASVLLVLLILFIMRWK-------------------G 644
P+ +H+KK V ++A I + + V+L++ + R + G
Sbjct: 761 RPITSRIHAKKQTVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIESLPTSG 820
Query: 645 CLGGKVSADKELRGLDLQTGLYTLRQIK-----AATNNFDPANKVGEGGFGSVYKGILSD 699
K+S+ E +++ T LR++ ATN F VG GGFG VYK L D
Sbjct: 821 SCSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRD 880
Query: 700 GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759
G+V+A+K+L + QG+REF+ E+ I +H NLV L G C G + LLVYEYMK L
Sbjct: 881 GSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSL 940
Query: 760 SRAIFGK 766
+ K
Sbjct: 941 ETVLHEK 947
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 799 | ||||||
| 302143484 | 1011 | unnamed protein product [Vitis vinifera] | 0.951 | 0.751 | 0.695 | 0.0 | |
| 449444971 | 1028 | PREDICTED: probable LRR receptor-like se | 0.932 | 0.724 | 0.692 | 0.0 | |
| 224080095 | 977 | predicted protein [Populus trichocarpa] | 0.916 | 0.749 | 0.687 | 0.0 | |
| 359485473 | 999 | PREDICTED: probable LRR receptor-like se | 0.918 | 0.734 | 0.684 | 0.0 | |
| 255584521 | 941 | conserved hypothetical protein [Ricinus | 0.832 | 0.706 | 0.749 | 0.0 | |
| 356501491 | 1025 | PREDICTED: probable LRR receptor-like se | 0.946 | 0.737 | 0.650 | 0.0 | |
| 357494365 | 1039 | BED finger-nbs resistance protein [Medic | 0.933 | 0.717 | 0.647 | 0.0 | |
| 317106662 | 927 | JHL10I11.12 [Jatropha curcas] | 0.812 | 0.700 | 0.738 | 0.0 | |
| 345651730 | 1027 | rfls6 protein [Glycine max] | 0.941 | 0.732 | 0.638 | 0.0 | |
| 297849060 | 1012 | hypothetical protein ARALYDRAFT_470791 [ | 0.924 | 0.730 | 0.630 | 0.0 |
| >gi|302143484|emb|CBI22045.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1067 bits (2760), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 534/768 (69%), Positives = 630/768 (82%), Gaps = 8/768 (1%)
Query: 12 LASHLLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWEL 71
+ + + + V F + + + KL A+E+KALK IG +LGK+DW+FG DPCS +GNW
Sbjct: 1 MGAEPIIVFSVLFIFFTVPGFSAKLPADELKALKVIGTRLGKRDWDFGKDPCSGEGNWS- 59
Query: 72 SSDDKKGFESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCL 128
S ++KKG ES+VTCDC+ +A+CHVVTIALKAQNL+G+LP ELSKL +LK LDLSRN
Sbjct: 60 SVNEKKGVESSVTCDCTFHHNASCHVVTIALKAQNLSGSLPPELSKLYHLKHLDLSRNLF 119
Query: 129 TGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLIN 188
+GS QWA+++LVELS+MGNRLSGPFPKVLTNITTL+NLSIEGNLF+G IPP+I KLI
Sbjct: 120 SGSIPSQWATMRLVELSLMGNRLSGPFPKVLTNITTLRNLSIEGNLFSGPIPPEIGKLIR 179
Query: 189 LQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248
++K++LSSN+FTGELP L KLTNL D+RI+DN+FSG+IPEFIG W +QKLHIQGSSLE
Sbjct: 180 IEKMVLSSNAFTGELPVALAKLTNLTDMRINDNHFSGRIPEFIGNWTHVQKLHIQGSSLE 239
Query: 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTK 307
GPIP+SISALTSL+DLRISDLKG S FP L + +LKTL+L KCLIHGEIP+YIGDM K
Sbjct: 240 GPIPSSISALTSLSDLRISDLKGRGSTFPPLSTIESLKTLVLRKCLIHGEIPEYIGDMKK 299
Query: 308 LKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWE 367
LK++DLSFN L G IPT+F++LAKT+FMYLTGN LTG +P +I +NKN D+S NNFTW+
Sbjct: 300 LKHLDLSFNELAGEIPTSFQELAKTDFMYLTGNMLTGHIPDWILGTNKNFDLSYNNFTWD 359
Query: 368 SSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKIN- 426
SS P+ECPRGSVNLVESYSS + CL+QNFPCSA ++QYHY+LHINCGG + +
Sbjct: 360 SSSPVECPRGSVNLVESYSSSSVRRSIHS-CLKQNFPCSASSNQYHYSLHINCGGKETSI 418
Query: 427 TGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLE 486
G TKYEAD+E GASMFY GQ WAFSSTG FMD+D D D YI NTS+LS VS +D+E
Sbjct: 419 NGSTKYEADLEPTGASMFYL-GQNWAFSSTGNFMDNDVDGDAYIEANTSSLSNVSVLDVE 477
Query: 487 LYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKK 546
LY+ ARVSPLSLTYYGLCLGNGNYTV+LHFAEIIF ND +FNSLG+RIFD+YIQ KLV K
Sbjct: 478 LYKKARVSPLSLTYYGLCLGNGNYTVKLHFAEIIFINDKSFNSLGERIFDVYIQGKLVLK 537
Query: 547 DFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSN 606
DFNIE EAGGTG PI+KNF AEVTSHTLK+ YWAGRGTTGIPLRG YGPLISAISV N
Sbjct: 538 DFNIEKEAGGTGKPIIKNFTAEVTSHTLKVQFYWAGRGTTGIPLRGFYGPLISAISVDPN 597
Query: 607 FKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLY 666
F+PP K + I+ +V+LVLL L I+ KG LGGK S DKELRGLDLQTGL+
Sbjct: 598 FEPPSPPGKNWDIKIVVGAAAVAVVLVLLTLGILWRKGWLGGKTSEDKELRGLDLQTGLF 657
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMI 726
TLRQIKAAT NFD NK+GEGGFG+V+KG LSDGTVIAVKQLSSKS+QGNREFVNE+GMI
Sbjct: 658 TLRQIKAATKNFDAENKLGEGGFGAVFKGTLSDGTVIAVKQLSSKSKQGNREFVNEVGMI 717
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISI 774
SA QHPNLVKLYGCC+EGNQL LVYEYM+NN LSRA+FG+ + + +
Sbjct: 718 SALQHPNLVKLYGCCIEGNQLSLVYEYMENNSLSRALFGRDATYKLKL 765
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449444971|ref|XP_004140247.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g07650-like [Cucumis sativus] gi|449481221|ref|XP_004156118.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g07650-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1060 bits (2741), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 523/755 (69%), Positives = 616/755 (81%), Gaps = 10/755 (1%)
Query: 15 HLLF-ISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSS 73
H + I L+ F + +AA A KLH EEVKALK+I +KLGK DW+F +DPCS +G W +
Sbjct: 17 HFFYAILLLQFATFGLAAAA-KLHREEVKALKEIEKKLGKNDWDFNIDPCSGEGKWHVV- 74
Query: 74 DDKKGFESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTG 130
+ +KGFES+VTCDCS ++TCH+V IALK+QNL+G +P E SKLR+LKQLDLSRNCLTG
Sbjct: 75 NGRKGFESSVTCDCSFNHNSTCHIVAIALKSQNLSGIVPPEFSKLRFLKQLDLSRNCLTG 134
Query: 131 SFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQ 190
QWA+++LVELS MGN+LSGPFPKVLTNITTL+NLSIEGN F+G IPP+I KL+NL+
Sbjct: 135 FVPSQWATMRLVELSFMGNKLSGPFPKVLTNITTLRNLSIEGNQFSGRIPPEIGKLVNLE 194
Query: 191 KLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP 250
KL+LSSN TGELP L KL+NL D+RISDNNFSGKIPEFI W +I+KLHIQG SLEGP
Sbjct: 195 KLVLSSNGLTGELPKGLAKLSNLTDMRISDNNFSGKIPEFISNWAQIEKLHIQGCSLEGP 254
Query: 251 IPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLK 309
IP SIS +TSLTDLRISDLKG S FP L + ++KTLIL KC I GEIP YIGDM KLK
Sbjct: 255 IPLSISTMTSLTDLRISDLKGGRSPFPPLSNIKSMKTLILRKCFIFGEIPKYIGDMKKLK 314
Query: 310 NIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESS 369
N+DLS+N+LTG +P TFE+L K ++++LT NKL G +P +I SNKNVD+S NNFTWE+S
Sbjct: 315 NLDLSYNDLTGEVPATFERLDKIDYIFLTANKLNGIIPGWILGSNKNVDLSNNNFTWENS 374
Query: 370 DPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGH 429
P ECPRGSVNLVE+YS KL ++HPCL++NFPCSA +++HY+L INCGG + +
Sbjct: 375 SPAECPRGSVNLVETYSPSAEKLTRIHPCLKRNFPCSASREEHHYSLRINCGGKETSIRG 434
Query: 430 TKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYR 489
+YEAD E GASMFY+ GQ WAFSSTG FMD+D D DNYI TNTS LS VSA ELY
Sbjct: 435 ERYEADRE--GASMFYT-GQNWAFSSTGSFMDNDVDADNYIVTNTSALSNVSATYSELYT 491
Query: 490 TARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFN 549
AR SP SLTYYGLCL NGNYTV+LHFAEI+F NDS+FNSLG+R+FD+YIQEKLV KDF+
Sbjct: 492 KARNSPQSLTYYGLCLINGNYTVKLHFAEIVFINDSSFNSLGRRVFDVYIQEKLVLKDFD 551
Query: 550 IEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKP 609
IE EAGGTG PI+K VTSHTLKIH YWAGRGTTGIPLRG YGPLISAISV NF P
Sbjct: 552 IEHEAGGTGKPIIKKITVAVTSHTLKIHFYWAGRGTTGIPLRGNYGPLISAISVDPNFTP 611
Query: 610 PVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLR 669
P H KK+ +I+ A+ +L+LL+L IMR KG LGGK S KELRG+DLQTGL+T+R
Sbjct: 612 PKNHGKKDFTIIIIGTAAAAFVLLLLVLCIMRRKGWLGGKASVYKELRGIDLQTGLFTIR 671
Query: 670 QIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ 729
QIKAAT NFD ANKVGEGGFG+VYKG+LSDGT+IAVKQLSSKS+QGNREFVNEIGMISA
Sbjct: 672 QIKAATKNFDAANKVGEGGFGAVYKGLLSDGTIIAVKQLSSKSKQGNREFVNEIGMISAL 731
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF 764
QHPNLVKLYGCC++GNQL+L+YEYM+NNCLSRA+F
Sbjct: 732 QHPNLVKLYGCCIDGNQLMLIYEYMENNCLSRALF 766
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224080095|ref|XP_002306015.1| predicted protein [Populus trichocarpa] gi|222848979|gb|EEE86526.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1048 bits (2709), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 509/740 (68%), Positives = 600/740 (81%), Gaps = 8/740 (1%)
Query: 41 VKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCS---SATCHVVTI 97
V+ L++IG+KLGKKDW+F DPCS +GNW + D++KGFE++VTCDCS +++CH+V+I
Sbjct: 1 VRVLREIGKKLGKKDWDFNKDPCSGEGNWSIL-DERKGFENSVTCDCSFNNNSSCHLVSI 59
Query: 98 ALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPK 157
ALK+QNL+G +P E SK RYLKQLDLSRN TG PQW +L+L E SVMGNRLSGPFPK
Sbjct: 60 ALKSQNLSGIIPPEFSKFRYLKQLDLSRNLFTGVIPPQWGTLRLEEFSVMGNRLSGPFPK 119
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
VLTN+TTL+NLSIEGN F+G IPP+I +LINLQKL+ SSN+ TG LPAEL KL NL D+R
Sbjct: 120 VLTNMTTLRNLSIEGNHFSGPIPPEIGRLINLQKLVFSSNALTGNLPAELGKLVNLTDVR 179
Query: 218 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 277
I+DNNFSGK+P FI KW K+QKLH+QG+SL+GPIP+SI++LT L+DLRISDL G S FP
Sbjct: 180 INDNNFSGKLPTFISKWTKVQKLHLQGTSLKGPIPSSIASLTKLSDLRISDLTGRGSPFP 239
Query: 278 KLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 336
L M ++KTLIL CLI+GEIP+Y+G M KLK++D+SFNNL G IP+TF +LA+ +F+Y
Sbjct: 240 PLSDMESMKTLILRNCLIYGEIPEYVGQMEKLKHLDVSFNNLRGEIPSTFIQLARIDFLY 299
Query: 337 LTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVH 396
LTGNKLTG VP ++ NKNVD+S NNFTW+SS P EC RGSVN+VES+S P K H
Sbjct: 300 LTGNKLTGSVPPWLLERNKNVDLSYNNFTWQSSSPDECARGSVNIVESFS-PSTIKSKAH 358
Query: 397 PCLRQNFPCSAPADQYHYTLHINCGGAKINT-GHTKYEADMEARGASMFYSS-GQYWAFS 454
CL+QNFPCSA +Q HYTLHINCGG +I G+T Y+ D E RGASMFYS Q WAFS
Sbjct: 359 SCLKQNFPCSASRNQQHYTLHINCGGNEITVDGNTTYQDDKEPRGASMFYSHPSQEWAFS 418
Query: 455 STGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRL 514
STG FMDDD++ D Y +TN S +S VSA +LY TARVSPLSLTYYGLCL NGNYTV+L
Sbjct: 419 STGNFMDDDSEADAYTKTNKSAISNVSATIAQLYTTARVSPLSLTYYGLCLMNGNYTVKL 478
Query: 515 HFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTL 574
HFAEIIF NDS+ SLGKRIFD+YIQ KLV KDFNIEDEAGG IP+VK F A VT +TL
Sbjct: 479 HFAEIIFTNDSSLTSLGKRIFDVYIQGKLVLKDFNIEDEAGGVAIPLVKTFIAAVTHNTL 538
Query: 575 KIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVL 634
KI LYWAGRGTTGIPLRG YGPLISAISV NFKPP SK+N V+I+ V ++ L
Sbjct: 539 KIRLYWAGRGTTGIPLRGIYGPLISAISVDPNFKPPSNGSKRNVVIIVTGAVAGAIFLAF 598
Query: 635 LILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYK 694
L+L +M G L GK +ADKEL+GLDLQTGL+TLRQ+KAATNNFD NKVGEGGFGSVYK
Sbjct: 599 LVLGVMWRNGWLCGKAAADKELKGLDLQTGLFTLRQMKAATNNFDAENKVGEGGFGSVYK 658
Query: 695 GILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754
G LSDGTVIAVK LSSKS+QGNREFVNEIGMISA QHPNLVKLYGCCVEGNQL++VYEYM
Sbjct: 659 GSLSDGTVIAVKLLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCVEGNQLMIVYEYM 718
Query: 755 KNNCLSRAIFGKLRIFHISI 774
+NNCLSRA+ GK F + +
Sbjct: 719 ENNCLSRALLGKESKFRMKL 738
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485473|ref|XP_002278131.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g07650 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1038 bits (2685), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 524/766 (68%), Positives = 616/766 (80%), Gaps = 32/766 (4%)
Query: 12 LASHLLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWEL 71
+ + + + V F + + + KL A+E+KALK IG +LGK+DW+FG DPCS +GNW
Sbjct: 1 MGAEPIIVFSVLFIFFTVPGFSAKLPADELKALKVIGTRLGKRDWDFGKDPCSGEGNWS- 59
Query: 72 SSDDKKGFESNVTCDCS---SATCHVVTI------ALKAQNLTGTLPTELSKLRYLKQLD 122
S ++KKG ES+VTCDC+ +A+CHVVT+ ALKAQNL+G+LP ELSKL +LK LD
Sbjct: 60 SVNEKKGVESSVTCDCTFHHNASCHVVTMVYVNCRALKAQNLSGSLPPELSKLYHLKHLD 119
Query: 123 LSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPD 182
LSRN +GS QWA+++LVELS+MGNRLSGPFPKVLTNITTL+NLSIEGNLF+G IPP+
Sbjct: 120 LSRNLFSGSIPSQWATMRLVELSLMGNRLSGPFPKVLTNITTLRNLSIEGNLFSGPIPPE 179
Query: 183 IRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHI 242
I KLI ++K++LSSN+FTGELP L KLTNL D+RI+DN+FSG+IPEFIG W +QKLHI
Sbjct: 180 IGKLIRIEKMVLSSNAFTGELPVALAKLTNLTDMRINDNHFSGRIPEFIGNWTHVQKLHI 239
Query: 243 QGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDY 301
QGSSLEGPIP+SISALTSL+DLRISDLKG S FP L + +LKTL+L KCLIHGEIP+Y
Sbjct: 240 QGSSLEGPIPSSISALTSLSDLRISDLKGRGSTFPPLSTIESLKTLVLRKCLIHGEIPEY 299
Query: 302 IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISL 361
IGDM KLK++DLSFN L G IPT+F++LAKT+FMYLTGN LTG +P +I +NKN D+S
Sbjct: 300 IGDMKKLKHLDLSFNELAGEIPTSFQELAKTDFMYLTGNMLTGHIPDWILGTNKNFDLSY 359
Query: 362 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCG 421
NNFTW+SS P+ECPRGSVNLVESYSS +R+N HY+LHINCG
Sbjct: 360 NNFTWDSSSPVECPRGSVNLVESYSSS---------SVRRN----------HYSLHINCG 400
Query: 422 GAKIN-TGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKV 480
G + + G TKYEAD+E GASMFY GQ WAFSSTG FMD+D D D YI NTS+LS V
Sbjct: 401 GKETSINGSTKYEADLEPTGASMFYL-GQNWAFSSTGNFMDNDVDGDAYIEANTSSLSNV 459
Query: 481 SAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQ 540
S +D+ELY+ ARVSPLSLTYYGLCLGNGNYTV+LHFAEIIF ND +FNSLG+RIFD+YIQ
Sbjct: 460 SVLDVELYKKARVSPLSLTYYGLCLGNGNYTVKLHFAEIIFINDKSFNSLGERIFDVYIQ 519
Query: 541 EKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISA 600
KLV KDFNIE EAGGTG PI+KNF AEVTSHTLK+ YWAGRGTTGIPLRG YGPLISA
Sbjct: 520 GKLVLKDFNIEKEAGGTGKPIIKNFTAEVTSHTLKVQFYWAGRGTTGIPLRGFYGPLISA 579
Query: 601 ISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLD 660
ISV NF+PP K + I+ +V+LVLL L I+ KG LGGK S DKELRGLD
Sbjct: 580 ISVDPNFEPPSPPGKNWDIKIVVGAAAVAVVLVLLTLGILWRKGWLGGKTSEDKELRGLD 639
Query: 661 LQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFV 720
LQTGL+TLRQIKAAT NFD NK+GEGGFG+V+KG LSDGTVIAVKQLSSKS+QGNREFV
Sbjct: 640 LQTGLFTLRQIKAATKNFDAENKLGEGGFGAVFKGTLSDGTVIAVKQLSSKSKQGNREFV 699
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK 766
NE+GMISA QHPNLVKLYGCC+EGNQL LVYEYM+NN LSRA+FG+
Sbjct: 700 NEVGMISALQHPNLVKLYGCCIEGNQLSLVYEYMENNSLSRALFGR 745
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255584521|ref|XP_002532988.1| conserved hypothetical protein [Ricinus communis] gi|223527234|gb|EEF29396.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1029 bits (2660), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/671 (74%), Positives = 574/671 (85%), Gaps = 6/671 (0%)
Query: 98 ALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPK 157
ALK+QNL+G +P + SKL Y++ LDLSRNCLTGS QWA+++LV+LS MGN+LSGPFPK
Sbjct: 6 ALKSQNLSGIVPPDFSKLHYIELLDLSRNCLTGSIPSQWATMRLVDLSFMGNQLSGPFPK 65
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
LTNITTLKNLSIEGN F+G IPP+I KLINL+KL LSSN+FTG+LP EL KL NL D+R
Sbjct: 66 ALTNITTLKNLSIEGNNFSGPIPPEIGKLINLEKLTLSSNAFTGKLPRELAKLVNLTDMR 125
Query: 218 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 277
ISD NFSG+IP+FI +WK+IQKLHIQGSSLEGPIP+SIS LT L+DLRISDLKG S+FP
Sbjct: 126 ISDANFSGQIPDFISRWKQIQKLHIQGSSLEGPIPSSISGLTRLSDLRISDLKGQSSSFP 185
Query: 278 KLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 336
LD M ++KTLIL KCL+ G+IP+YIG M KLKN+DLSFNNLTG IP TF LAK +FMY
Sbjct: 186 HLDNMESMKTLILRKCLLSGKIPEYIGHMKKLKNLDLSFNNLTGEIPATFSHLAKVDFMY 245
Query: 337 LTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVH 396
LTGNKLTGP+P+++ NKNVDIS NNFTW+SS IECPRGSVNLVESYSS NKL KVH
Sbjct: 246 LTGNKLTGPIPEWVLERNKNVDISDNNFTWDSSSQIECPRGSVNLVESYSSSTNKLSKVH 305
Query: 397 PCLRQNFPCSAPADQYHYTLHINCGGAKINTG-HTKYEADMEARGASMFYSSGQYWAFSS 455
CL+QNFPCS+ + +Y LHINCGG +I G + Y AD+EARGASM+YSS Q WAFSS
Sbjct: 306 SCLKQNFPCSSKPN--NYALHINCGGKEIIAGSNITYNADLEARGASMYYSS-QNWAFSS 362
Query: 456 TGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLH 515
TG FMD+D D D YI+ NTS +S VSA+D +LY+TARVSPLSL+YYGLCL NGNYTV+LH
Sbjct: 363 TGNFMDNDIDADPYIQINTSAISNVSALDAQLYKTARVSPLSLSYYGLCLINGNYTVKLH 422
Query: 516 FAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLK 575
FAEI+F +D+TFNSLGKRIFD+YIQEKLV KDFNI +EAGGTG PIVK F VTSHTLK
Sbjct: 423 FAEIVFTDDNTFNSLGKRIFDVYIQEKLVLKDFNIAEEAGGTGRPIVKMFTVAVTSHTLK 482
Query: 576 IHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLL 635
IH YWAGRGTTGIP+RG YGPLISAISV NFKPP + KKN V+I+A V A+V LVLL
Sbjct: 483 IHFYWAGRGTTGIPVRGIYGPLISAISVDPNFKPPSDNDKKN-VIIVATTVSAAVFLVLL 541
Query: 636 ILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKG 695
IL IM KGCLG VSADKELRGLDLQTG++TLRQIKAAT NFDPANK+GEGGFGSVYKG
Sbjct: 542 ILGIMWRKGCLGDNVSADKELRGLDLQTGIFTLRQIKAATKNFDPANKLGEGGFGSVYKG 601
Query: 696 ILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755
+LSDGT+IAVKQLSSKS+QGNREFVNEIGMIS QHPNLVKLYGCCVEGNQLLL+YEYM+
Sbjct: 602 LLSDGTIIAVKQLSSKSKQGNREFVNEIGMISGLQHPNLVKLYGCCVEGNQLLLIYEYME 661
Query: 756 NNCLSRAIFGK 766
NNCLSRA+FGK
Sbjct: 662 NNCLSRALFGK 672
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501491|ref|XP_003519558.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g07650-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1008 bits (2607), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/763 (65%), Positives = 610/763 (79%), Gaps = 7/763 (0%)
Query: 9 KLLLASHLLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGN 68
K+L L SL+ FF +A KL+ +EVKALK+IG K+GKKDW+FGVDPCS KGN
Sbjct: 9 KMLFLLLLGSTSLIFFFPQLASAATPKLNTQEVKALKEIGSKIGKKDWDFGVDPCSGKGN 68
Query: 69 WELSSDDKKGFESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSR 125
W +S D +KGFES+V CDCS +++CHVV+I+LKAQNL+G+L + SKL +L++LDLSR
Sbjct: 69 WNVS-DARKGFESSVICDCSFDHNSSCHVVSISLKAQNLSGSLSPDFSKLHHLQELDLSR 127
Query: 126 NCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRK 185
N +TG+ PQW +++LVELS MGN+LSGPFPKVLTNITTL+NLSIEGN F+G IP +I K
Sbjct: 128 NIITGAIPPQWGTMRLVELSFMGNKLSGPFPKVLTNITTLRNLSIEGNQFSGHIPTEIGK 187
Query: 186 LINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGS 245
L NL+KLILSSN FTG LP L+KLT L DLRISDNNF GKIP+FI W I+KLH+ G
Sbjct: 188 LTNLEKLILSSNGFTGALPPTLSKLTKLIDLRISDNNFFGKIPDFISNWTLIEKLHMHGC 247
Query: 246 SLEGPIPASISALTSLTDLRISDLKGSES-AFPKLDKM-NLKTLILTKCLIHGEIPDYIG 303
SLEGPIP+SISALT L+DLRI+DLKGS+S AFP L+ + ++KTL+L KC+I GEIP YIG
Sbjct: 248 SLEGPIPSSISALTRLSDLRIADLKGSKSSAFPPLNNLKSMKTLVLRKCMIKGEIPAYIG 307
Query: 304 DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNN 363
M KLK +DLS+N L+G IP +F +L K +FMYLTGNKL+G +P ++ +NKN+DIS NN
Sbjct: 308 RMEKLKILDLSYNGLSGEIPESFAQLDKVDFMYLTGNKLSGIIPGWVLANNKNIDISDNN 367
Query: 364 FTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGA 423
F+W+SS P ECPRGS+NLVESYSS N +K+H CL++NFPC++ ++YHY+++INCGG
Sbjct: 368 FSWDSSSPTECPRGSINLVESYSSSVNTQNKIHSCLKRNFPCTSSVNKYHYSMNINCGGN 427
Query: 424 KINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAV 483
+ N YEAD E +GA+M Y +GQ WA SSTG FMD+D D D Y+ NTS L+ VSA+
Sbjct: 428 EANISGQIYEADREQKGAAMLYYTGQDWALSSTGNFMDNDIDSDPYVVANTSRLN-VSAL 486
Query: 484 DLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKL 543
+ +LY TARVSPL+LTYYGLCL NGNYTV+LHFAEIIF ND + SLG+R+FD+YIQ L
Sbjct: 487 NSQLYTTARVSPLALTYYGLCLINGNYTVKLHFAEIIFINDRSLYSLGRRVFDVYIQGNL 546
Query: 544 VKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISV 603
V KDF+I+ EAGGTG PIVK A VT HTL+IH YWAG+GTTGIP RG YGPLISAISV
Sbjct: 547 VLKDFDIQREAGGTGKPIVKTLNASVTQHTLEIHFYWAGKGTTGIPTRGVYGPLISAISV 606
Query: 604 KSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQT 663
NFKPP K+ + M+ IV +++VLL+L +MR G LGGK KELRG+DLQT
Sbjct: 607 NPNFKPPSGDGKRTYFMLAIGIVAGVLVVVLLVLVLMRRMGWLGGKDPVYKELRGIDLQT 666
Query: 664 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEI 723
GL+TLRQIKAAT NFD NK+GEGGFG V+KG+LSDGT+IAVKQLSSKS+QGNREFVNE+
Sbjct: 667 GLFTLRQIKAATKNFDAENKIGEGGFGCVFKGLLSDGTIIAVKQLSSKSKQGNREFVNEM 726
Query: 724 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK 766
G+IS QHPNLVKLYGCCVEGNQL+L+YEYM+NNCLSR +FG+
Sbjct: 727 GLISGLQHPNLVKLYGCCVEGNQLILIYEYMENNCLSRILFGR 769
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357494365|ref|XP_003617471.1| BED finger-nbs resistance protein [Medicago truncatula] gi|355518806|gb|AET00430.1| BED finger-nbs resistance protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 999 bits (2583), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 500/772 (64%), Positives = 595/772 (77%), Gaps = 26/772 (3%)
Query: 18 FISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKK 77
F SL+ +A AAT KL+ +EVKALK+IG K+GKKDW+FGVDPCS KG W +S D +K
Sbjct: 14 FTSLIFISHFASAATL-KLNTQEVKALKEIGNKIGKKDWDFGVDPCSGKGKWNVS-DSRK 71
Query: 78 GFESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSP 134
GFES V C+CS +++CHVV+I LKAQNL+GTL E SKL +LK LDLSRN +TGS
Sbjct: 72 GFESAVICNCSFNHNSSCHVVSIFLKAQNLSGTLSPEFSKLPHLKILDLSRNIITGSIPQ 131
Query: 135 QWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLIL 194
QWA + LV+LS MGNR SGPFP VLTNITTLKNLSIEGN F+G IP DI KLINL+KL+L
Sbjct: 132 QWAKMNLVDLSFMGNRFSGPFPTVLTNITTLKNLSIEGNQFSGFIPEDIGKLINLEKLVL 191
Query: 195 SSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPAS 254
SN FTG LP+ +KLT LNDLRISDN+FSGKIP+FI KW I+KLHI+G SLEGPIP+S
Sbjct: 192 QSNRFTGALPSAFSKLTKLNDLRISDNDFSGKIPDFISKWTLIEKLHIEGCSLEGPIPSS 251
Query: 255 ISALTSLTDLRISDLKGSESA-FPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNID 312
ISALT L+DLRI+DL+GS S+ FP L M ++KTL+L KCLI GEIP+YIG+M KLK +D
Sbjct: 252 ISALTVLSDLRITDLRGSRSSTFPPLSNMKSMKTLVLRKCLIKGEIPEYIGEMAKLKVLD 311
Query: 313 LSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPI 372
LSFN+L+G IP +F L K +FMYLT N L+G +P ++ +NKN+D+S NNF WESS P
Sbjct: 312 LSFNSLSGKIPESFRDLDKVDFMYLTRNNLSGTIPDWVLKNNKNIDVSYNNFEWESSSPT 371
Query: 373 ECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKY 432
EC RGSVNLVESYS K +H CL++NFPC++ + HY+L INCGG + N Y
Sbjct: 372 ECQRGSVNLVESYSLSATKKSNIHSCLKRNFPCTS-KNPRHYSLRINCGGNEANVSGNIY 430
Query: 433 EADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTAR 492
AD+E +GASM Y S + WA SSTG FMD+D D D YI TNTS+L VS ++ +LY TAR
Sbjct: 431 TADIERKGASMLYISAEDWALSSTGSFMDNDIDSDPYIVTNTSSLQNVSVINSKLYTTAR 490
Query: 493 VSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIED 552
VSPLSLTYYGLC+ NGNYTV+LHFAEIIF ND + NSLG+RIFD+YIQ KLV +DF+IE
Sbjct: 491 VSPLSLTYYGLCMINGNYTVQLHFAEIIFINDRSLNSLGRRIFDVYIQGKLVLRDFDIER 550
Query: 553 EAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVV 612
EAGG PIVK F A VT +TLKI YWAG+GTTGIP RG YGPL+SAISV NFKPP
Sbjct: 551 EAGGAEKPIVKKFNATVTENTLKIQFYWAGKGTTGIPTRGVYGPLVSAISVDPNFKPPSE 610
Query: 613 HSKKNHVMIMA-AIVGASVLLVLLILFIMRWKGCLGGKVSADK----------------- 654
H + V+++A IV + +VL+++ +MR KG LGGK K
Sbjct: 611 HGNRTRVILLAVGIVCGFLAVVLIMVAVMRRKGLLGGKDPVYKGKVINFVIESKFPFFFS 670
Query: 655 ELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ 714
ELRG+DLQTGL+TLRQIK AT NFD ANK+GEGGFGSVYKG LSDGTVIAVKQLSSKS+Q
Sbjct: 671 ELRGIDLQTGLFTLRQIKVATKNFDAANKLGEGGFGSVYKGQLSDGTVIAVKQLSSKSKQ 730
Query: 715 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK 766
GNREFVNEIGMIS QHPNLVKL+GCCVEGNQL+L+YEYM+NNCLSR +FGK
Sbjct: 731 GNREFVNEIGMISGLQHPNLVKLHGCCVEGNQLILIYEYMENNCLSRILFGK 782
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|317106662|dbj|BAJ53166.1| JHL10I11.12 [Jatropha curcas] | Back alignment and taxonomy information |
|---|
Score = 983 bits (2540), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 484/655 (73%), Positives = 551/655 (84%), Gaps = 6/655 (0%)
Query: 114 KLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN 173
KLR+L+ LDLSRNC TGS QWA+L+LV LS MGNRLSG FPKVLTNITTL NLS+EGN
Sbjct: 1 KLRHLQLLDLSRNCFTGSIPSQWATLRLVNLSFMGNRLSGSFPKVLTNITTLTNLSVEGN 60
Query: 174 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGK 233
F+GSIP +I KLINLQK ILSSN+FTG+LP EL+KLTNL D+RISDNNFSG IP FI K
Sbjct: 61 RFSGSIPREIGKLINLQKFILSSNAFTGKLPTELSKLTNLTDMRISDNNFSGTIPTFINK 120
Query: 234 WKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKC 292
W IQKLHIQGS LEGPIP+SISAL +L+DLRISDLKG S FP L M ++K LIL C
Sbjct: 121 WTHIQKLHIQGSGLEGPIPSSISALKNLSDLRISDLKGKGSTFPPLSNMESIKALILRNC 180
Query: 293 LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN 352
L+ EIP+YIG M KLKN+DLSFNNLTG IPT+F L K +FMYLTGNKLTG VP+++
Sbjct: 181 LLSDEIPEYIGHMKKLKNLDLSFNNLTGEIPTSFSYLGKADFMYLTGNKLTGSVPEWVLE 240
Query: 353 SNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQY 412
NKNVDIS NNF+WESS PIECPRGSVNLVESYSS KL KVH CL+QNFPCS+ ++
Sbjct: 241 RNKNVDISDNNFSWESSSPIECPRGSVNLVESYSSSTEKLSKVHSCLKQNFPCSS--NKK 298
Query: 413 HYTLHINCGGAK-INTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIR 471
+Y+L+INCGG + I G+T Y+AD+E RGASMFY+S Q WAFSSTG FMD++ D D YI+
Sbjct: 299 YYSLYINCGGEEMIAGGNTTYQADLEPRGASMFYTS-QSWAFSSTGNFMDNNIDSDPYIQ 357
Query: 472 TNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLG 531
NTS +S VS+ D +LY TARVSP+SLTYYGLCL NGNYTV LHFAEI+F NDS+FNSLG
Sbjct: 358 INTSAISNVSSPDAQLYTTARVSPISLTYYGLCLINGNYTVNLHFAEIVFINDSSFNSLG 417
Query: 532 KRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLR 591
+RIFD+YIQEKLV KDFNI +EAGGTG PIVK F VTSHTLKIH YWAG+GTTGIP+R
Sbjct: 418 RRIFDVYIQEKLVLKDFNIVEEAGGTGRPIVKKFTVTVTSHTLKIHFYWAGKGTTGIPVR 477
Query: 592 GTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVS 651
GTYGPLISAISV NFKPP + +K +++ + + GA V LVLL+L IM KGCLGGKV
Sbjct: 478 GTYGPLISAISVDPNFKPPSDNDEKEKIIVSSTVAGA-VFLVLLVLCIMWRKGCLGGKVY 536
Query: 652 ADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK 711
ADKELRGLDLQTG++TL+QIKAAT NFD ANKVGEGGFGSVYKG LSDGT+IAVKQLSSK
Sbjct: 537 ADKELRGLDLQTGIFTLKQIKAATKNFDAANKVGEGGFGSVYKGQLSDGTIIAVKQLSSK 596
Query: 712 SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK 766
S+QGNREFVNEIGMISA QHPNLVKLYGCCVEGNQLLL+YEYM+NNCLSRA+FGK
Sbjct: 597 SKQGNREFVNEIGMISALQHPNLVKLYGCCVEGNQLLLIYEYMENNCLSRALFGK 651
|
Source: Jatropha curcas Species: Jatropha curcas Genus: Jatropha Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|345651730|gb|AEO14875.1| rfls6 protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 976 bits (2522), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 487/763 (63%), Positives = 596/763 (78%), Gaps = 11/763 (1%)
Query: 14 SHLLFISLV-----TFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGN 68
S +LF+ L+ F + +A KL+ +EVKALK+IG K+GKKDWNFGVDPCS KGN
Sbjct: 8 SKMLFLLLLGSTSLIFLSHLASAATPKLNTQEVKALKEIGSKIGKKDWNFGVDPCSGKGN 67
Query: 69 WELSSDDKKGFESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSR 125
W + K S+V CDCS +++CHVV+I KAQNL+G+L E SKL YL++LDLSR
Sbjct: 68 WNVPDARKAFVMSSVICDCSFNHNSSCHVVSIYWKAQNLSGSLSPEFSKLHYLQKLDLSR 127
Query: 126 NCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRK 185
N +TGS PQW +++LVELS+MGN+LSGPFPKVLTNITTL+NLSIEGN F+G IP +I K
Sbjct: 128 NIITGSIPPQWGTMRLVELSLMGNKLSGPFPKVLTNITTLRNLSIEGNQFSGHIPTEIGK 187
Query: 186 LINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGS 245
L NL+KL+LSSN FTG LP L+KLT L DLRISDNNF GKIP+FI W I+KLH+ G
Sbjct: 188 LTNLEKLVLSSNGFTGALPPVLSKLTKLIDLRISDNNFLGKIPDFISNWTLIEKLHMHGC 247
Query: 246 SLEGPIPASISALTSLTDLRISDLKGSES-AFPKLDKM-NLKTLILTKCLIHGEIPDYIG 303
SLEGPIP+SISALT L+DLRI+DLKGS+S AFP L+ + ++KTL+L KC+I GEIP+YIG
Sbjct: 248 SLEGPIPSSISALTRLSDLRITDLKGSKSSAFPPLNNLKSMKTLVLRKCMIKGEIPEYIG 307
Query: 304 DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNN 363
M KLK +DLS+N L+G IP +F +L K +FMYLTGNKL+G +P+++ +N+N+DIS NN
Sbjct: 308 RMEKLKILDLSYNGLSGEIPESFAQLDKVDFMYLTGNKLSGIIPRWVLANNENIDISDNN 367
Query: 364 FTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGA 423
F+W+SS P EC RGSVNLVESYSS N K++ CL++NF C+A QY Y+L+INCGG
Sbjct: 368 FSWDSSSPTECQRGSVNLVESYSSSVNTQTKINSCLKKNFLCTASPSQYRYSLNINCGGN 427
Query: 424 KINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAV 483
+ N YEAD E +GA+M Y + Q WA SSTG F D+D D D YI NTS L+ VSA+
Sbjct: 428 EANVSGNIYEADREQKGAAMLYYTSQDWALSSTGNFTDNDIDSDPYIVANTSRLN-VSAL 486
Query: 484 DLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKL 543
+ +LY TARVSPL+LTYYGLCL NGNYTV+LHFAEIIF ND + NSLG+R+FD+YIQ L
Sbjct: 487 NSKLYTTARVSPLALTYYGLCLINGNYTVKLHFAEIIFINDRSLNSLGRRVFDVYIQGNL 546
Query: 544 VKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISV 603
V KDF+I EAGGTG I K F A VT HTLKIH YWAG+GTTGIP RG YGPL+SAISV
Sbjct: 547 VLKDFDIRREAGGTGKSIEKTFNASVTQHTLKIHFYWAGKGTTGIPTRGVYGPLVSAISV 606
Query: 604 KSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQT 663
NFKPP K+ ++++ IV +++VLL+L ++R G LGGK KELRG+DLQT
Sbjct: 607 NPNFKPPSGEGKRTYLILAIIIVAGVLVVVLLVLVLLRRMGWLGGKDPVYKELRGIDLQT 666
Query: 664 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEI 723
GL+TLRQIKAAT NFD NK+GEGGFG VYKG SDGT+IAVKQLSSKS+QGNREFVNE+
Sbjct: 667 GLFTLRQIKAATKNFDALNKIGEGGFGCVYKGQQSDGTMIAVKQLSSKSKQGNREFVNEM 726
Query: 724 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK 766
G+IS QHPNLVKLYGCCVEGNQL+L+YEYM+NNCLSR +FG+
Sbjct: 727 GLISGLQHPNLVKLYGCCVEGNQLILIYEYMENNCLSRILFGR 769
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297849060|ref|XP_002892411.1| hypothetical protein ARALYDRAFT_470791 [Arabidopsis lyrata subsp. lyrata] gi|297338253|gb|EFH68670.1| hypothetical protein ARALYDRAFT_470791 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 927 bits (2396), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 476/755 (63%), Positives = 581/755 (76%), Gaps = 16/755 (2%)
Query: 22 VTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFES 81
+TF G + KLH EV+ALK+IG KLGKKDWNF DPCS +GNW +++ K FES
Sbjct: 16 LTFHGRLGFSDNTKLHEAEVRALKEIGEKLGKKDWNFNKDPCSGEGNWVVTTYTTKEFES 75
Query: 82 NVTCDCS----SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWA 137
N+TCDCS +++CHV+ IALK+QNLTG +P+E SKLR+LK LDLSRN LTGS +WA
Sbjct: 76 NITCDCSFLPPNSSCHVIRIALKSQNLTGIVPSEFSKLRHLKVLDLSRNSLTGSIPKEWA 135
Query: 138 SLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN 197
S++L +LS MGNRLSGPFPKVLT ITTL+NLS+EGN F+G IPPDI KL++L+KL L SN
Sbjct: 136 SMRLEDLSFMGNRLSGPFPKVLTRITTLRNLSLEGNQFSGPIPPDIGKLVHLEKLHLPSN 195
Query: 198 SFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISA 257
+FTG L +L L NL D+RISDNNF+G IP+FIG W ++ KL + G L+GPIP+SIS
Sbjct: 196 AFTGPLTEKLGLLKNLTDMRISDNNFTGPIPDFIGNWTRVMKLQMHGCGLDGPIPSSIST 255
Query: 258 LTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN 316
LTSLTDLRISDL G S+FP+L + ++KTLIL KC ++G IP YIGD+ KLK +DLSFN
Sbjct: 256 LTSLTDLRISDLGGKPSSFPQLKNLESIKTLILRKCNLNGPIPKYIGDLMKLKTLDLSFN 315
Query: 317 NLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPI--EC 374
L+G IP++FEK+ K +F+YLTGNKLTG VP Y NKNVD+S NNFT ESS P +C
Sbjct: 316 LLSGEIPSSFEKMKKADFIYLTGNKLTGGVPNYFVERNKNVDVSYNNFTDESSIPKNGDC 375
Query: 375 PRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGA--KINTGHTKY 432
R S N+VE ++ NK K C Q+FPC+ P + Y L+INCGG K++ G T Y
Sbjct: 376 NRVSFNMVEGFA--LNKSHKNSTCFLQHFPCAHPKRHHTYKLYINCGGGEVKVDKGIT-Y 432
Query: 433 EADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLS-KVSAVDLELYRTA 491
+ D E +GASM Y G++WA SSTG FMD+D D D+Y NTS LS S+ ELYRTA
Sbjct: 433 QTDDEPKGASM-YVLGKHWALSSTGNFMDNDDDADDYTVQNTSRLSVNASSPSFELYRTA 491
Query: 492 RVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIE 551
RVSPLSLTYYGLCLGNGNYTV LHFAEIIF +D+T SLGKR+FDIY+Q++LV K+FNI+
Sbjct: 492 RVSPLSLTYYGLCLGNGNYTVNLHFAEIIFTDDNTLYSLGKRLFDIYVQDQLVIKNFNIQ 551
Query: 552 DEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPV 611
+ A G+G PI+K+F VT HTLKI L WAG+GTTGIP+RG YGP+ISAISV+ NFKPPV
Sbjct: 552 EAARGSGKPIIKSFMVNVTDHTLKIGLRWAGKGTTGIPIRGVYGPMISAISVEPNFKPPV 611
Query: 612 VHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQI 671
+ K ++ V A+ LL+ +I+ + WK K + DKELRGLDLQTG +TLRQI
Sbjct: 612 YYDIKGIILKAGVPVAAATLLLFIIVGVF-WKK-RRDKNAIDKELRGLDLQTGTFTLRQI 669
Query: 672 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH 731
KAAT+NFD A K+GEGGFGSVYKG LS+G +IAVKQLS+KSRQGNREFVNEIGMISA QH
Sbjct: 670 KAATDNFDVAKKIGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNREFVNEIGMISALQH 729
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK 766
PNLVKLYGCCVEGNQL+LVYEY++NNCLSRA+FGK
Sbjct: 730 PNLVKLYGCCVEGNQLILVYEYLENNCLSRALFGK 764
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 799 | ||||||
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.904 | 0.698 | 0.506 | 2.3e-188 | |
| TAIR|locus:2203847 | 1021 | RKF1 "receptor-like kinase in | 0.904 | 0.708 | 0.460 | 9e-164 | |
| TAIR|locus:2019367 | 1078 | AT1G29740 [Arabidopsis thalian | 0.889 | 0.659 | 0.453 | 3.8e-156 | |
| TAIR|locus:2019317 | 969 | AT1G29730 [Arabidopsis thalian | 0.689 | 0.568 | 0.438 | 9e-156 | |
| TAIR|locus:2205250 | 1032 | AT1G56130 [Arabidopsis thalian | 0.916 | 0.709 | 0.393 | 3e-133 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.841 | 0.705 | 0.406 | 6.9e-118 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.811 | 0.618 | 0.347 | 2.2e-89 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.335 | 0.207 | 0.361 | 5.3e-51 | |
| TAIR|locus:2181017 | 951 | AT5G01950 [Arabidopsis thalian | 0.382 | 0.321 | 0.330 | 2.4e-49 | |
| TAIR|locus:2092810 | 1164 | BRL3 "BRI1-like 3" [Arabidopsi | 0.330 | 0.226 | 0.379 | 6.9e-48 |
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1826 (647.8 bits), Expect = 2.3e-188, P = 2.3e-188
Identities = 376/743 (50%), Positives = 495/743 (66%)
Query: 31 ATANKLHAEEVKALKQIGRKLGKKDWNFGVDPC-SQKGNWELSSDDKKGFESNVTCDCS- 88
+ A L +EV+ L+ I RKL + N C +K N+ S K SN+TCDC+
Sbjct: 24 SNAQLLPEDEVQTLRTIFRKLQNQTVNIERTSCLDRKWNFVAESTSKLP-TSNITCDCTF 82
Query: 89 --SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSV 146
S+ C V I L+ NL G +P E L L ++DL N L+G+ + + L L+V
Sbjct: 83 NASSVCRVTNIQLRGFNLRGIIPPEFGNLTRLTEIDLVLNFLSGTIPTTLSQIPLEILAV 142
Query: 147 MGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE 206
GNRLSGPFP L ITTL ++ +E NLFTG +PP++ L +L++L++SSN+ TG +P
Sbjct: 143 TGNRLSGPFPPQLGQITTLTDVIMESNLFTGQLPPNLGNLRSLKRLLISSNNITGRIPES 202
Query: 207 LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRI 266
L+ L NL + RI N+ SGKIP+FIG W ++ +L +QG+S+EGPIPASIS L +LT+LRI
Sbjct: 203 LSNLKNLTNFRIDGNSLSGKIPDFIGNWTRLVRLDLQGTSMEGPIPASISNLKNLTELRI 262
Query: 267 SDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIG-DMTKLKNIDLSFNNLTGGIPT 324
+DL+G S FP L M N++ L+L CLI IP+YIG MT LK +DLS N L G IP
Sbjct: 263 TDLRGPTSPFPDLQNMTNMERLVLRNCLIREPIPEYIGTSMTMLKLLDLSSNMLNGTIPD 322
Query: 325 TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVES 384
TF L NFMYL N LTGPVP++I +S +N+D+S NNFT + + C + VNL+ S
Sbjct: 323 TFRSLNAFNFMYLNNNSLTGPVPQFILDSKQNIDLSYNNFTQPPT--LSCNQLDVNLISS 380
Query: 385 YSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMF 444
Y S N + V CLR++ PC P D +H +L INCGG ++ +Y D+ RGAS F
Sbjct: 381 YPSVTN--NSVQWCLRKDLPC--PGDAHHSSLFINCGGNRLKVDKDEYADDLNKRGASTF 436
Query: 445 YSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLC 504
S + W +SS+G ++ +D Y+ T+T L S E Y+TAR++ SL YYGLC
Sbjct: 437 SSVSERWGYSSSGAWLGNDGA--TYLATDTFNLINESTP--EYYKTARLASQSLKYYGLC 492
Query: 505 LGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKN 564
+ G+Y V+L+FAEI+F ND T++SLG+R+FDIY+Q L+++DFNI AGG G P ++
Sbjct: 493 MRRGSYKVQLYFAEIMFSNDQTYSSLGRRLFDIYVQGILLERDFNIAQRAGGVGKPFLRQ 552
Query: 565 FP-AEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMA 623
+V TL+IHL W G+GT IP RG YGPLISAI+V NFK N V +
Sbjct: 553 VDEVQVNGSTLEIHLKWTGKGTNVIPTRGVYGPLISAITVTPNFKVDTGKPLSNGV-VAG 611
Query: 624 AIVGASVLLVLLILFIMRWKGCLGGK-VSADKELRGLDLQTGLYTLRQIKAATNNFDPAN 682
++ A V LL+L I+R G LGGK V ++ELRGLDLQTG +TL+QIK ATNNFDP N
Sbjct: 612 IVIAACVAFGLLVLVILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNNFDPEN 671
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
K+GEGGFG VYKG+L+DG IAVKQLSSKS+QGNREFV EIGMISA QHPNLVKLYGCC+
Sbjct: 672 KIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCI 731
Query: 743 EGNQLLLVYEYMKNNCLSRAIFG 765
EG +LLLVYEY++NN L+RA+FG
Sbjct: 732 EGKELLLVYEYLENNSLARALFG 754
|
|
| TAIR|locus:2203847 RKF1 "receptor-like kinase in flowers 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1594 (566.2 bits), Expect = 9.0e-164, P = 9.0e-164
Identities = 349/758 (46%), Positives = 470/758 (62%)
Query: 22 VTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFES 81
+ F Y++ A KL +EV AL+QI LG K W F + C + L+ +
Sbjct: 30 ICFKFYSVNAI--KLPQQEVDALQQIATTLGSKFWKFDAENCKIE-MVGLTETPPPTAKQ 86
Query: 82 NVTCDCSSAT---CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWAS 138
+ C+CS CHVV A K NL GTLP ++ KL YL+++DL+ N + G+ +WAS
Sbjct: 87 EIECECSPTNDTDCHVVKFAFKDHNLPGTLP-QIVKLPYLREIDLAYNYINGTLPREWAS 145
Query: 139 LQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS 198
L +S++ NRLSG PK N ++L L +E N F+G+IP ++ L++L+KL+LSSN
Sbjct: 146 SNLTFISLLVNRLSGEIPKEFGN-SSLTYLDLESNAFSGTIPQELGNLVHLKKLLLSSNK 204
Query: 199 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 258
TG LPA L +L N+ D RI+D SG IP +I WK++++L + S L GPIP+ IS L
Sbjct: 205 LTGTLPASLARLQNMTDFRINDLQLSGTIPSYIQNWKQLERLEMIASGLTGPIPSVISVL 264
Query: 259 TSLTDLRISDLKGSESAFPKLDKMN-LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNN 317
++L +LRISD++G FP L + L +IL C I G+IP Y+ + +L+ +DLSFN
Sbjct: 265 SNLVNLRISDIRGPVQPFPSLKNVTGLTKIILKNCNISGQIPTYLSHLKELETLDLSFNK 324
Query: 318 LTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIEC-PR 376
L GGIP+ F + F+ L GN L G P + VD+S NN W+S + C P
Sbjct: 325 LVGGIPS-FAQAENLRFIILAGNMLEGDAPDELLRDGITVDLSYNNLKWQSPESRACRPN 383
Query: 377 GSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAK--INTGHTK--Y 432
++NL S+ K K PC++ +F C P +Y LH+NCGG+ + TK Y
Sbjct: 384 MNLNLNLFQSTSTKKSSKFLPCIK-DFKC--P--RYSSCLHVNCGGSDMYVKEKKTKELY 438
Query: 433 EAD--MEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRT 490
E D +E A F W FSSTG FMDD+ N+ T T+ ++ +LY++
Sbjct: 439 EGDGNVEGGAAKYFLKPDANWGFSSTGDFMDDN----NFQNTRF-TMFVPASNQSDLYKS 493
Query: 491 ARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNI 550
AR++P+SLTY+ CL NGNYT+ L FAEI F ND +N LG+R+FDIYIQEKLV KDFNI
Sbjct: 494 ARIAPVSLTYFHACLENGNYTINLDFAEIRFTNDENYNRLGRRLFDIYIQEKLVAKDFNI 553
Query: 551 EDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPP 610
DEA G PI+K A VT+H L I L WAG+GTT IP RG YGP+ISAIS+ S+ KP
Sbjct: 554 MDEAKGAQTPIIKPLTAYVTNHFLTIRLSWAGKGTTRIPTRGVYGPIISAISIVSDSKP- 612
Query: 611 VVHSKKNHVMIMAAI---VGASVLLVLLILFIMRWK-GCLGGKVSADKELRGLDLQTGLY 666
K + A I +GA L++ ++ F+ W GCL K+ +L +G +
Sbjct: 613 -CERPKTGMSPGAYIAIGIGAPCLIIFILGFL--WICGCLPRCGRQRKDPYEEELPSGTF 669
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMI 726
TLRQIK AT++F+P NK+GEGGFG+V+KG+L+DG V+AVKQLSSKSRQGNREF+NEIG I
Sbjct: 670 TLRQIKFATDDFNPTNKIGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEIGAI 729
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF 764
S QHPNLVKL+G CVE QLLL YEYM+NN LS A+F
Sbjct: 730 SCLQHPNLVKLHGFCVERAQLLLAYEYMENNSLSSALF 767
|
|
| TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1522 (540.8 bits), Expect = 3.8e-156, P = 3.8e-156
Identities = 345/761 (45%), Positives = 457/761 (60%)
Query: 29 IAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDD-KKGFESNVTCDC 87
+ + + LH +EV+ALK I LG K N DPC K ++ D K+G S + CDC
Sbjct: 32 VLSASPSLHPDEVEALKDIALTLGVKHLNLSEDPCLTK-TLVITQDVLKEGQNSTIRCDC 90
Query: 88 ---SSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVE 143
++ TCH+ LK +L G LP E SKLRYL+ +DL RN L GS +WASL L
Sbjct: 91 HFNNNNTCHITHFVLKTFSLPGRLPPEFSKLRYLEFIDLCRNYLYGSIPMEWASLPYLKS 150
Query: 144 LSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGEL 203
+SV NRL+G PK L L L +E N F+G+IP ++ L+NL+ L SSN G +
Sbjct: 151 ISVCANRLTGDIPKGLGKFINLTQLGLEANQFSGTIPKELGNLVNLEGLAFSSNQLVGGV 210
Query: 204 PAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTD 263
P L +L L +LR SDN +G IPEFIG K+Q+L + S L+ PIP SI L +L D
Sbjct: 211 PKTLARLKKLTNLRFSDNRLNGSIPEFIGNLSKLQRLELYASGLKDPIPYSIFRLENLID 270
Query: 264 LRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323
LRISD P + +LK L+L + G IP + D+ L +DLSFN LTG +P
Sbjct: 271 LRISDTAAGLGQVPLITSKSLKFLVLRNMNLTGPIPTSLWDLPNLMTLDLSFNRLTGEVP 330
Query: 324 TTFEKLAKTNFMYLTGNKLTGPVPKYIF-NSNKNVDISLNNFTWESSDPIECPRGSVNLV 382
+ + YL GN L+G V F ++ N+D+S NNFTW S C N +
Sbjct: 331 AD---ASAPKYTYLAGNMLSGKVESGPFLTASTNIDLSYNNFTWSQS----CKER--NNI 381
Query: 383 ESYSSPR--NKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKI----NTGHTKYEADM 436
+Y+S R N L ++ PC N C Y+ +LHINCGG + + G YE D
Sbjct: 382 NTYASSRSTNSLTRLLPCSAINL-CQ----NYNRSLHINCGGPDVTIENSRGRFLYEGDN 436
Query: 437 EARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPL 496
S G+ W FS+TG FMDD D Y S+ S VSA +LY+ AR SPL
Sbjct: 437 YGLTGSATNYYGKNWGFSNTGDFMDDAITEDTY---TVSSESAVSAKYPDLYQNARRSPL 493
Query: 497 SLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGG 556
SL Y+ +C NG+Y V+LHFAEI F ++ F+ L KR+F+IY+Q KL+ +DF+I +EA G
Sbjct: 494 SLAYFAICFENGSYNVKLHFAEIQFSDEEPFSRLAKRVFNIYVQGKLIWEDFSIREEANG 553
Query: 557 TGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISV----KSNFKPPV- 611
T ++K VT +TL+I LYWAG+GTT IP RG YG LISAISV +S PV
Sbjct: 554 THKEVIKEVNTTVTDNTLEIRLYWAGKGTTIIPKRGNYGSLISAISVCPSSESECGVPVQ 613
Query: 612 VH--SKKNHVMIMA-AIVGASVLLV---LLILFIMRWKGCLGGKVSADKELRGLDLQTGL 665
+H +K+ H I+G + L+V LIL + W+ C+ +AD E RG
Sbjct: 614 IHPVTKQQHKQRKYHLILGIAALIVSLSFLILGALYWRICVS---NADGEKRGS------ 664
Query: 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGM 725
++LRQ+K AT++F+P NK+GEGGFGSVYKG L +GT+IAVK+LSSKS QGN+EF+NEIG+
Sbjct: 665 FSLRQLKVATDDFNPLNKIGEGGFGSVYKGRLPNGTLIAVKKLSSKSCQGNKEFINEIGI 724
Query: 726 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK 766
I+ QHPNLVKLYGCCVE QLLLVYEY++NNCL+ A+FG+
Sbjct: 725 IACLQHPNLVKLYGCCVEKTQLLLVYEYLENNCLADALFGR 765
|
|
| TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1082 (385.9 bits), Expect = 9.0e-156, Sum P(2) = 9.0e-156
Identities = 254/579 (43%), Positives = 330/579 (56%)
Query: 36 LHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDC---SSATC 92
LH +EV+ALK I LG K N DPC K K+G S + CDC + +TC
Sbjct: 39 LHPDEVEALKDITETLGVKHLNLSEDPCLTKTLVISQGVLKEGQNSTIRCDCHFNNYSTC 98
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRL 151
H+ L+ NL G LP L K R+L+ +DL N L GS +WASL L +SV NRL
Sbjct: 99 HIKHFVLQKFNLPGRLPPMLYKFRHLESIDLYNNYLYGSIPMEWASLPYLKSISVCANRL 158
Query: 152 SGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLT 211
SG PK L L L +E N F+G+IP ++ L+NLQ L LSSN G LP L KLT
Sbjct: 159 SGDIPKGLGKFINLTLLVLEANQFSGTIPKELGNLVNLQGLGLSSNQLVGGLPKTLAKLT 218
Query: 212 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG 271
L +L +SDN +G IPEFIGK K+Q+L + S L GPIP SI L +L D+RISD
Sbjct: 219 KLTNLHLSDNRLNGSIPEFIGKLPKLQRLELYASGLRGPIPDSIFHLENLIDVRISDTVA 278
Query: 272 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331
P++ +LK L+L + G IP I D+ L +DLSFN LTG IP + K
Sbjct: 279 GLGHVPQITSTSLKYLVLRNINLSGPIPTSIWDLPSLMTLDLSFNRLTGEIPA-YATAPK 337
Query: 332 TNFMYLTGNKLTGPVPKYIF-NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRN 390
+ YL GN L+G V F ++ N+D+S NNFTW P+ R ++N ES S +N
Sbjct: 338 --YTYLAGNMLSGKVETGAFLTASTNIDLSYNNFTWS---PMCKERKNINTYES-SHSKN 391
Query: 391 KLDKVHPC--LRQNFPCSAPADQYHYTLHINCGGAKI---NT-GHTKYEADMEARGASMF 444
+L ++ PC ++Q C Y +LHINCGG + N+ G YE D S
Sbjct: 392 RLTRLLPCSAIKQ---CQ----NYSRSLHINCGGPDVTIENSRGRFLYEGDNYGLTGSAT 444
Query: 445 YSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLC 504
+ W +S+TG FMDD D Y S+ S VSA +LY+ AR SPLSL YY C
Sbjct: 445 NYYRKNWGYSNTGDFMDDAITEDTY---TVSSESAVSAKYPDLYQNARRSPLSLAYYAFC 501
Query: 505 LGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKN 564
NG+Y V+LHFAEI F + + L KR+F+IYIQ KL+ +DF+I +EA GT +++
Sbjct: 502 FENGSYNVKLHFAEIQFSDVEPYTKLAKRVFNIYIQGKLIWEDFSIREEANGTHKEVIRE 561
Query: 565 FPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISV 603
VT +TL+I LYWAG+GT IP RG YG LISA+SV
Sbjct: 562 VNTTVTDNTLEIRLYWAGKGTMIIPQRGYYGSLISAVSV 600
|
|
| TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1306 (464.8 bits), Expect = 3.0e-133, P = 3.0e-133
Identities = 301/764 (39%), Positives = 438/764 (57%)
Query: 32 TANKLHAEEVKALKQI--GRKL-GKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCS 88
T H +E +AL I K+ ++WN + CS D + + CDCS
Sbjct: 33 TGATTHPDEARALNSIFAAWKIQAPREWNISGELCSGAAIDASVLDSNPAYNPLIKCDCS 92
Query: 89 ---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELS 145
S C + I + A ++ G +P EL L YL L+L +N LTGS P +L ++
Sbjct: 93 FQNSTICRITNIKVYAIDVVGPIPPELWTLTYLTNLNLGQNVLTGSLPPAIGNLTRMQWM 152
Query: 146 VMG-NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELP 204
G N LSGP PK + +T L+ L I N F+GSIP +I + LQ++ + S+ +G +P
Sbjct: 153 TFGINALSGPVPKEIGLLTDLRLLGISSNNFSGSIPDEIGRCTKLQQMYIDSSGLSGRIP 212
Query: 205 AELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL 264
L L I+D + +IP+FIG W K+ L I G+ L GPIP+S S LTSLT+L
Sbjct: 213 LSFANLVQLEQAWIADLEVTDQIPDFIGDWTKLTTLRIIGTGLSGPIPSSFSNLTSLTEL 272
Query: 265 RISDLKGSESAFPKL-DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323
R+ D+ S+ + D +L L+L + G IP IG+ + L+ +DLSFN L G IP
Sbjct: 273 RLGDISSGSSSLDFIKDMKSLSVLVLRNNNLTGTIPSTIGEHSSLRQVDLSFNKLHGPIP 332
Query: 324 TTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVE 383
+ L++ ++L N L G P S +NVD+S N+ + + P +NLV
Sbjct: 333 ASLFNLSQLTHLFLGNNTLNGSFPTQKTQSLRNVDVSYNDLSGSLPSWVSLPSLKLNLVA 392
Query: 384 SYSSPRNKLDKVHP---CLRQNFPCSAPADQYHYTLHINCGGA-KINTGHTKYEADMEAR 439
+ + ++V P CL++NFPC+ Y INCGG K + +E + E
Sbjct: 393 NNFTLEGLDNRVLPGLNCLQKNFPCNRGKGIYS-DFSINCGGPEKRSVTGALFEREDEDF 451
Query: 440 G-ASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSL 498
G AS F S+GQ WA SS G F ++ YI T+ S V+ +D EL+++AR+S S+
Sbjct: 452 GPASFFVSAGQRWAASSVGLFAGSSNNI--YIATSQSQF--VNTLDSELFQSARLSASSV 507
Query: 499 TYYGLCLGNGNYTVRLHFAEI--IFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGG 556
YYGL L NG YTV L FAEI + +T+ LG+R FDIY+Q +LV+KDF++ AG
Sbjct: 508 RYYGLGLENGGYTVTLQFAEIQILGSTSTTWKGLGRRRFDIYVQGRLVEKDFDVRRTAGD 567
Query: 557 TGIPIVKN-FPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVH-- 613
+ + V+ + A V+ + L++HL+WAG+GT IP++G YGPLISA+S +F P V +
Sbjct: 568 STVRAVQRVYKANVSENHLEVHLFWAGKGTCCIPIQGAYGPLISAVSATPDFTPTVANKP 627
Query: 614 -SK-KNHV-MIMAAIVGASVLLVL--LILFIMRWKGCLGGKVSADKELRGLDLQTGLYTL 668
SK KN I+ IVG +L +L +++F +R + + + D+EL G+D++ ++T
Sbjct: 628 PSKGKNRTGTIVGVIVGVGLLSILAGVVMFTIRKRR---KRYTDDEELLGMDVKPYIFTY 684
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA 728
++K+AT +FDP+NK+GEGGFG VYKG L+DG V+AVK LS SRQG +FV EI IS+
Sbjct: 685 SELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISS 744
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHI 772
H NLVKLYGCC EG +LVYEY+ N L +A+FG + H+
Sbjct: 745 VLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGD-KTLHL 787
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1161 (413.8 bits), Expect = 6.9e-118, P = 6.9e-118
Identities = 287/706 (40%), Positives = 388/706 (54%)
Query: 79 FESNVTCDCSSATCH-VVTIALKAQNLTGTL-PTELSKLRYLKQLDLSRNC----LTGSF 132
F S+ T VV LK N+ + P E+S + +SRN L GS
Sbjct: 21 FASSATLPTQEGEAFKVVLTTLKKTNIDLNVDPCEVSSTGN-EWSTISRNLKRENLQGSL 79
Query: 133 SPQWASLQLV-ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191
+ L L+ E+ + N L+G P + L N+ + GN TG IP + + L
Sbjct: 80 PKELVGLPLLQEIDLSRNYLNGSIPPEW-GVLPLVNIWLLGNRLTGPIPKEFGNITTLTS 138
Query: 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251
L+L +N +GELP EL L N+ + +S NNF+G+IP K ++ + + L G I
Sbjct: 139 LVLEANQLSGELPLELGNLPNIQQMILSSNNFNGEIPSTFAKLTTLRDFRVSDNQLSGTI 198
Query: 252 PASISALTSLTDLRI--SDLKGS-ESAFPKLDKMNLKTLILTKCLIHG-EIP-DYIGDMT 306
P I T L L I S L G A L + LK L ++ ++G E P + ++
Sbjct: 199 PDFIQKWTKLERLFIQASGLVGPIPIAIASL--VELKDLRISD--LNGPESPFPQLRNIK 254
Query: 307 KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTW 366
K++ + L NLTG +P K+ F+ L+ NKL+G +P N I
Sbjct: 255 KMETLILRNCNLTGDLPDYLGKITSFKFLDLSFNKLSGAIPNTYINLRDGGYIYFTGNML 314
Query: 367 ESSDPIECPRGSVNLVESYSS----PRN---KLDKVHPCLRQNFPCSAPADQYHYTLHIN 419
S P + SY++ P N K + V C+R N+ C + LHIN
Sbjct: 315 NGSVPDWMVNKGYKIDLSYNNFSVDPTNAVCKYNNVLSCMR-NYQCPKTFN----ALHIN 369
Query: 420 CGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSK 479
CGG +++ T YE+D R S +Y S W ++ G F+DD + T S S+
Sbjct: 370 CGGDEMSINGTIYESDKYDRLES-WYESRNGWFSNNVGVFVDDKHVPERV--TIESNSSE 426
Query: 480 VSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYI 539
++ VD LY AR+S +SLTYY LCL NGNY V LHFAEI+F ++ + SLG+R FDIYI
Sbjct: 427 LNVVDFGLYTQARISAISLTYYALCLENGNYNVNLHFAEIMFNGNNNYQSLGRRFFDIYI 486
Query: 540 QEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLIS 599
Q KL KDFNI EA G ++K FP E+ L+I LYWAGRGTT IP YGPLIS
Sbjct: 487 QRKLEVKDFNIAKEAKDVGNVVIKTFPVEIKDGKLEIRLYWAGRGTTVIPKERVYGPLIS 546
Query: 600 AISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGL 659
AISV S+ P + + ++ S+ +V L+ + KG L K +K+ + L
Sbjct: 547 AISVDSSVNPSPRNGMSTGTLHTLVVI-LSIFIVFLVFGTLWKKGYLRSKSQMEKDFKSL 605
Query: 660 DLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREF 719
+L ++LRQIK ATNNFD AN++GEGGFG VYKG L DGT+IAVKQLS+ S+QGNREF
Sbjct: 606 ELMIASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREF 665
Query: 720 VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG 765
+NEIGMISA HPNLVKLYGCCVEG QLLLVYE+++NN L+RA+FG
Sbjct: 666 LNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFG 711
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 892 (319.1 bits), Expect = 2.2e-89, P = 2.2e-89
Identities = 241/694 (34%), Positives = 371/694 (53%)
Query: 95 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSG 153
+T + A L+G +P E+ L L+ L +S N +GS + S +L ++ + + LSG
Sbjct: 127 MTFGINA--LSGPIPKEIGLLTDLRLLGISSNNFSGSLPAEIGSCTKLQQMYIDSSGLSG 184
Query: 154 PFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNL 213
P N L+ I TG IP I L L + +G +P+ + L L
Sbjct: 185 GIPLSFANFVELEVAWIMDVELTGRIPDFIGFWTKLTTLRILGTGLSGPIPSSFSNLIAL 244
Query: 214 NDLRISD-NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSL--TDLRISDLK 270
+LR+ D +N S + +FI K + L ++ ++L G IP++I TSL DL + L
Sbjct: 245 TELRLGDISNGSSSL-DFIKDMKSLSVLVLRNNNLTGTIPSTIGGYTSLQQVDLSFNKLH 303
Query: 271 GSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE--- 327
G A + L L L ++G +P G L N+D+S+N+L+G +P+
Sbjct: 304 GPIPA-SLFNLSRLTHLFLGNNTLNGSLPTLKGQ--SLSNLDVSYNDLSGSLPSWVSLPD 360
Query: 328 ---KLAKTNFMY--LTGNKLTG-PVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNL 381
L NF L L+G + F N+ I N P + +N
Sbjct: 361 LKLNLVANNFTLEGLDNRVLSGLHCLQKNFPCNRGEGICKCN----KKIPSQIMFSMLN- 415
Query: 382 VESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINT--GHTKYEADMEAR 439
V++Y N L + + C + F D Y INCGG +I + G + D +
Sbjct: 416 VQTYGQGSNVLLEKN-CFK-TFAIDWCLD---YNFSINCGGPEIRSVSGALFEKEDADLG 470
Query: 440 GASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLT 499
AS S+ + WA SS G F ++ YI T+ + ++ +D EL+++AR+S SL
Sbjct: 471 PASFVVSAAKRWAASSVGNFAGSSNNI--YIATSLAQF--INTMDSELFQSARLSASSLR 526
Query: 500 YYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGI 559
YYGL L NG YTV L FAE+ + +++ +G+R F+IY+Q +LV+KDF+I AGG+ +
Sbjct: 527 YYGLGLENGGYTVTLQFAEVQIEGSNSWKGIGRRRFNIYVQGRLVEKDFDIRRTAGGSSV 586
Query: 560 PIV-KNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVH---SK 615
V + + V+ + L++HL+WAG+GT IP++G YGPLI+A+S +F P V + SK
Sbjct: 587 RAVQREYKTNVSENHLEVHLFWAGKGTCCIPIQGAYGPLIAAVSATPDFTPTVANRPPSK 646
Query: 616 -KNHV-MIMAAIVGASVLLVL--LILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQI 671
K+ I+ IVG +L + +++ ++R + + D+E+ +D++ +T ++
Sbjct: 647 GKSRTGTIVGVIVGVGLLSIFAGVVILVIRKRR---KPYTDDEEILSMDVKPYTFTYSEL 703
Query: 672 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH 731
K AT +FD +NK+GEGGFG+VYKG L+DG +AVKQLS SRQG +FV EI IS+ H
Sbjct: 704 KNATQDFDLSNKLGEGGFGAVYKGNLNDGREVAVKQLSIGSRQGKGQFVAEIIAISSVLH 763
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG 765
NLVKLYGCC EG+ LLVYEY+ N L +A+FG
Sbjct: 764 RNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFG 797
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 406 (148.0 bits), Expect = 5.3e-51, Sum P(2) = 5.3e-51
Identities = 99/274 (36%), Positives = 154/274 (56%)
Query: 97 IALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVEL-SVMGNRLSGPF 155
+ L +L+G L +++L++L +L +S N ++GS P SL+ +EL + N +G
Sbjct: 142 MVLDYNSLSGQLSPAIAQLQHLTKLSISMNSISGSLPPDLGSLKNLELLDIKMNTFNGSI 201
Query: 156 PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLND 215
P N++ L + N TGSI P I L NL L LSSNSF G +P E+ +L NL
Sbjct: 202 PATFGNLSCLLHFDASQNNLTGSIFPGITSLTNLLTLDLSSNSFEGTIPREIGQLENLEL 261
Query: 216 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA 275
L + N+ +G+IP+ IG K+++ LH++ G IP SIS L+SLT+L ISD ++
Sbjct: 262 LILGKNDLTGRIPQEIGSLKQLKLLHLEECQFTGKIPWSISGLSSLTELDISD-NNFDAE 320
Query: 276 FPK-LDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN 333
P + ++ NL LI + G +P +G+ KL I+LSFN L G IP F L
Sbjct: 321 LPSSMGELGNLTQLIAKNAGLSGNMPKELGNCKKLTVINLSFNALIGPIPEEFADLEAIV 380
Query: 334 FMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFT 365
++ GNKL+G VP +I + + +++ + N F+
Sbjct: 381 SFFVEGNKLSGRVPDWIQKWKNARSIRLGQNKFS 414
|
|
| TAIR|locus:2181017 AT5G01950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 365 (133.5 bits), Expect = 2.4e-49, Sum P(2) = 2.4e-49
Identities = 112/339 (33%), Positives = 166/339 (48%)
Query: 29 IAATANKLHAEEVKALKQIGRKL-GKKD----WNFGVDPCSQKGNWELSSDDKKGFESNV 83
+ A A + H EV AL+ + R L KD WN G DPC + NW + V
Sbjct: 21 LLADAQRTHPSEVTALRSVKRSLLDPKDYLRNWNRG-DPC--RSNW-----------TGV 66
Query: 84 TCDCSSAT---CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ 140
C T HV + L NL+GTL EL KL +L+ LD N ++GS + +
Sbjct: 67 ICFNEIGTDDYLHVRELLLMNMNLSGTLSPELQKLAHLEILDFMWNNISGSIPNEIGQIS 126
Query: 141 -LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSF 199
LV L + GN+LSG P L ++ L I+ N TG IP L ++ L ++NS
Sbjct: 127 SLVLLLLNGNKLSGTLPSELGYLSNLNRFQIDENNITGPIPKSFSNLKKVKHLHFNNNSL 186
Query: 200 TGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP-IPASISAL 258
TG++P EL+ LTN+ + + +N SG +P + +Q L + ++ G IPAS
Sbjct: 187 TGQIPVELSNLTNIFHVLLDNNKLSGNLPPQLSALPNLQILQLDNNNFSGSDIPASYGNF 246
Query: 259 TSLT--DLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIP--DYIGDMTKLKNIDLS 314
+++ LR LKG+ F K+ +LK L L+ + G IP ++ D+T I+LS
Sbjct: 247 SNILKLSLRNCSLKGALPDFSKI--RHLKYLDLSWNELTGPIPSSNFSKDVT---TINLS 301
Query: 315 FNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNS 353
N L G IP +F L + L N L+G VP ++ +
Sbjct: 302 NNILNGSIPQSFSDLPLLQMLLLKNNMLSGSVPDSLWKN 340
|
|
| TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 371 (135.7 bits), Expect = 6.9e-48, Sum P(2) = 6.9e-48
Identities = 105/277 (37%), Positives = 151/277 (54%)
Query: 101 AQNL-TGTLPTELSKL-RYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPF-P 156
A NL +G +P ELS L R L+ LDLS N LTG + S L L++ N+LSG F
Sbjct: 285 AHNLYSGEIPPELSLLCRTLEVLDLSGNSLTGQLPQSFTSCGSLQSLNLGNNKLSGDFLS 344
Query: 157 KVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN---L 213
V++ ++ + NL + N +GS+P + NL+ L LSSN FTGE+P+ L + L
Sbjct: 345 TVVSKLSRITNLYLPFNNISGSVPISLTNCSNLRVLDLSSNEFTGEVPSGFCSLQSSSVL 404
Query: 214 NDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRI--SDLKG 271
L I++N SG +P +GK K ++ + + ++L G IP I L L+DL + ++L G
Sbjct: 405 EKLLIANNYLSGTVPVELGKCKSLKTIDLSFNALTGLIPKEIWTLPKLSDLVMWANNLTG 464
Query: 272 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331
+D NL+TLIL L+ G +P+ I T + I LS N LTG IP KL K
Sbjct: 465 GIPESICVDGGNLETLILNNNLLTGSLPESISKCTNMLWISLSSNLLTGEIPVGIGKLEK 524
Query: 332 TNFMYLTGNKLTGPVPKYIFNSNKNV---DISLNNFT 365
+ L N LTG +P + N KN+ D++ NN T
Sbjct: 525 LAILQLGNNSLTGNIPSELGNC-KNLIWLDLNSNNLT 560
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGE0 | Y1765_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6167 | 0.9286 | 0.7317 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00018818001 | SubName- Full=Chromosome chr12 scaffold_18, whole genome shotgun sequence; (1010 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 799 | |||
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 1e-58 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-36 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-34 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-28 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-19 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-18 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-17 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-15 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-15 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-14 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-13 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-12 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-12 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-11 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-11 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-10 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-10 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-10 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-10 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-09 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-09 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-09 | |
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 8e-09 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-08 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-08 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-08 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-08 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-07 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-07 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-07 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-07 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-07 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-06 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-06 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-05 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-05 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-05 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-05 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-05 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-05 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-05 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-05 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-05 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-05 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-05 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-04 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-04 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-04 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-04 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-04 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-04 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-04 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-04 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-04 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-04 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 0.001 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.001 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.001 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 0.001 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 0.001 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 0.001 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 0.001 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 0.001 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.001 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 0.001 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 0.001 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 0.002 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.002 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 0.002 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 0.002 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 0.003 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 0.003 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 0.003 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 0.003 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 0.004 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 1e-58
Identities = 86/192 (44%), Positives = 101/192 (52%), Gaps = 32/192 (16%)
Query: 414 YTLHINCGGAKINTGH-TKYEAD-MEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIR 471
L INCGG + YEAD G++ +Y S + S G D
Sbjct: 1 VVLAINCGGPEHTDSDGITYEADTYFTGGSADYYVSDTNGSSSIAG--TTDP-------- 50
Query: 472 TNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLG 531
ELY+T R SP S +YY CL NGNYTV LHFAEI F D LG
Sbjct: 51 --------------ELYQTERYSPSSFSYYIPCLENGNYTVILHFAEIYFGED----GLG 92
Query: 532 KRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNF-PAEVTSHTLKIHLYWAGRGTTGIPL 590
+R+FD+Y+Q KLV KDF+I EAGG G K + P VT TL+IH YWAG+GT IP
Sbjct: 93 RRVFDVYVQGKLVLKDFDIVAEAGGKGKTAHKEYIPVTVTDGTLEIHFYWAGKGTLLIPF 152
Query: 591 RGTYG-PLISAI 601
RG YG P ISAI
Sbjct: 153 RGVYGNPKISAI 164
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 3e-36
Identities = 101/293 (34%), Positives = 150/293 (51%), Gaps = 29/293 (9%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTN 161
NLTG +P+ L L+ L+ L L +N L+G P SLQ L+ L + N LSG P+++
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
+ L+ L + N FTG IP + L LQ L L SN F+GE+P L K NL L +S N
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGS-ESAFPK 278
N +G+IPE + + KL + +SLEG IP S+ A SL +R+ D G S F K
Sbjct: 367 NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK 426
Query: 279 L----------------------DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN 316
L D +L+ L L + G +PD G +L+N+DLS N
Sbjct: 427 LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRN 485
Query: 317 NLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK--NVDISLNNFTWE 367
+G +P L++ + L+ NKL+G +P + + K ++D+S N + +
Sbjct: 486 QFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQ 538
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 8e-34
Identities = 118/396 (29%), Positives = 183/396 (46%), Gaps = 76/396 (19%)
Query: 14 SHLLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGK-----KDWNFGVDPCSQKG- 67
+L+F+ F +++ LHAEE++ L + +WN D C +G
Sbjct: 10 PYLIFMLFFLFLNFSM------LHAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGI 63
Query: 68 ----NWELSSDDKKGFESNVTCDCSSATCH---VVTIALKAQNLTGTLPTEL----SKLR 116
+ + S D G N++ SSA + TI L L+G +P ++ S LR
Sbjct: 64 TCNNSSRVVSIDLSG--KNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLR 121
Query: 117 YL-------------------KQLDLSRNCLTGSFSPQ----WASLQLVELSVMGNRLSG 153
YL + LDLS N L+G P ++SL++++L GN L G
Sbjct: 122 YLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEI-PNDIGSFSSLKVLDLG--GNVLVG 178
Query: 154 PFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNL 213
P LTN+T+L+ L++ N G IP ++ ++ +L+ + L N+ +GE+P E+ LT+L
Sbjct: 179 KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSL 238
Query: 214 NDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE 273
N L + NN +G IP +G K +Q L + + L GPIP SI +L L L +SD S
Sbjct: 239 NHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS- 297
Query: 274 SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN 333
GEIP+ + + L+ + L NN TG IP L +
Sbjct: 298 ----------------------GEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQ 335
Query: 334 FMYLTGNKLTGPVPKYIFNSNK--NVDISLNNFTWE 367
+ L NK +G +PK + N +D+S NN T E
Sbjct: 336 VLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGE 371
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-28
Identities = 88/272 (32%), Positives = 141/272 (51%), Gaps = 9/272 (3%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWA---SLQLVELSVMGNRLSGPF 155
L + N TG +P L+ L L+ L L N +G +L +++LS N L+G
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLST--NNLTGEI 372
Query: 156 PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLND 215
P+ L + L L + N G IP + +L+++ L NSF+GELP+E TKL +
Sbjct: 373 PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYF 432
Query: 216 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA 275
L IS+NN G+I +Q L + + G +P S + L +L +S + S +
Sbjct: 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAV 491
Query: 276 FPKLDKMN-LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNF 334
KL ++ L L L++ + GEIPD + KL ++DLS N L+G IP +F ++ +
Sbjct: 492 PRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQ 551
Query: 335 MYLTGNKLTGPVPKYIFN--SNKNVDISLNNF 364
+ L+ N+L+G +PK + N S V+IS N+
Sbjct: 552 LDLSQNQLSGEIPKNLGNVESLVQVNISHNHL 583
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-22
Identities = 74/245 (30%), Positives = 121/245 (49%), Gaps = 27/245 (11%)
Query: 87 CSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVE-LS 145
CSS ++ + L + +L G +P L R L+++ L N +G ++ L LV L
Sbjct: 377 CSSG--NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLD 434
Query: 146 VMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPA 205
+ N L G ++ +L+ LS+ N F G + PD L+ L LS N F+G +P
Sbjct: 435 ISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL-PDSFGSKRLENLDLSRNQFSGAVPR 493
Query: 206 ELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLR 265
+L L+ L L++S+N SG+IP+ + KK+ L + + L G IPAS S + L+ L
Sbjct: 494 KLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQL- 552
Query: 266 ISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTT 325
DL ++ + GEIP +G++ L +++S N+L G +P+T
Sbjct: 553 --DLSQNQ--------------------LSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590
Query: 326 FEKLA 330
LA
Sbjct: 591 GAFLA 595
|
Length = 968 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 8e-19
Identities = 34/83 (40%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 682 NKVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
K+GEG FG VYKG L T +AVK L S + ++F+ E ++ HPN+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 737 LYGCCVEGNQLLLVYEYMKNNCL 759
L G C E L LV EYM+ L
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDL 83
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (212), Expect = 2e-18
Identities = 34/83 (40%), Positives = 45/83 (54%), Gaps = 6/83 (7%)
Query: 683 KVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVK 736
K+GEG FG VYKG L T +AVK L + + R EF+ E ++ HPN+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 737 LYGCCVEGNQLLLVYEYMKNNCL 759
L G C +G L +V EYM L
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDL 88
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 35/83 (42%), Positives = 43/83 (51%), Gaps = 6/83 (7%)
Query: 683 KVGEGGFGSVYKGILSDG-----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
K+GEG FG VYKG L +AVK L S Q EF+ E ++ HPN+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 737 LYGCCVEGNQLLLVYEYMKNNCL 759
L G C E L++V EYM L
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDL 88
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 35/83 (42%), Positives = 43/83 (51%), Gaps = 6/83 (7%)
Query: 683 KVGEGGFGSVYKGILSD-----GTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
K+GEG FG VYKG L +AVK L S Q EF+ E ++ HPN+VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 737 LYGCCVEGNQLLLVYEYMKNNCL 759
L G C E L +V EYM+ L
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDL 88
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 30/85 (35%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 684 VGEGGFGSVYKGILS------DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVK 736
+GEG FG V+ G D ++AVK L + S ++F E +++ QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSR 761
YG C EG+ ++V+EYM++ L++
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNK 97
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 41/112 (36%), Positives = 54/112 (48%), Gaps = 13/112 (11%)
Query: 682 NKVGEGGFGSVYKGILSD-GTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
+G G FGSVY + D G ++AVK LS S + EI ++S+ QHPN+V+ Y
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 739 GCCV--EGNQLLLVYEYMKNNCLSRAI--FGKLRIFHISIYATFPQGNIQIL 786
G E N L + EY+ LS + FGKL I Y QIL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTR------QIL 111
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 27/78 (34%), Positives = 48/78 (61%), Gaps = 1/78 (1%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
F+ K+G+GGFG VYK G +A+K + +S++ + +NEI ++ +HPN+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 737 LYGCCVEGNQLLLVYEYM 754
YG ++ ++L +V E+
Sbjct: 62 YYGSYLKKDELWIVMEFC 79
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 1e-13
Identities = 28/88 (31%), Positives = 48/88 (54%), Gaps = 2/88 (2%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLV 735
++ K+GEG FG VY G ++A+K + K + +RE + EI ++ +HPN+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAI 763
+LY + ++L LV EY + L +
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL 88
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 28/75 (37%), Positives = 40/75 (53%), Gaps = 2/75 (2%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLYGCC 741
+GEGGFG+VY G +A+K + + E + EI ++ HPN+VKLYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 742 VEGNQLLLVYEYMKN 756
+ N L LV EY +
Sbjct: 61 EDENHLYLVMEYCEG 75
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-13
Identities = 54/175 (30%), Positives = 80/175 (45%), Gaps = 42/175 (24%)
Query: 39 EEVKALKQIGRKLG---KKDWNFGVDPCS-QKGNWELSSDDKKGFESNVTC--DCSSATC 92
EEV AL+ + LG + WN DPC Q+ W S C D +
Sbjct: 372 EEVSALQTLKSSLGLPLRFGWNG--DPCVPQQHPW-----------SGADCQFDSTKGKW 418
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 152
+ + L Q L G +P ++SKLR+L+ ++LS GN +
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLS-----------------------GNSIR 455
Query: 153 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAEL 207
G P L +IT+L+ L + N F GSIP + +L +L+ L L+ NS +G +PA L
Sbjct: 456 GNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-13
Identities = 34/82 (41%), Positives = 52/82 (63%)
Query: 177 GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 236
G IP DI KL +LQ + LS NS G +P L +T+L L +S N+F+G IPE +G+
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 237 IQKLHIQGSSLEGPIPASISAL 258
++ L++ G+SL G +PA++
Sbjct: 492 LRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-12
Identities = 62/251 (24%), Positives = 112/251 (44%), Gaps = 32/251 (12%)
Query: 118 LKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNIT-TLKNLSIEGNLFT 176
L LDL+ N L + S L L + N ++ P ++ + LK L + N
Sbjct: 95 LPSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE 153
Query: 177 GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 236
S+P +R L NL+ L LS N + +LP L+ L+NLN+L +S N S +P I
Sbjct: 154 -SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSA 210
Query: 237 IQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHG 296
+++L + +S+ + +S+S L +L+ L +S+ K
Sbjct: 211 LEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE------------------------ 245
Query: 297 EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN 356
++P+ IG+++ L+ +DLS N ++ ++ L + L+GN L+ +P
Sbjct: 246 DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLL 303
Query: 357 VDISLNNFTWE 367
+ T +
Sbjct: 304 ELLLNLLLTLK 314
|
Length = 394 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 8e-12
Identities = 26/77 (33%), Positives = 41/77 (53%), Gaps = 3/77 (3%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYG 739
K+G G FG+VYK G ++AVK L +S + ++ EI ++ HPN+V+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 740 CCVEGNQLLLVYEYMKN 756
+ + L LV EY +
Sbjct: 66 AFEDKDHLYLVMEYCEG 82
|
Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 8e-12
Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 5/96 (5%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQHPN 733
N+ + +G G FG VYKG+ L G +A+KQ+S + + + EI ++ +HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKL 767
+VK G + L ++ EY +N L + I FG
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPF 96
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 31/85 (36%), Positives = 50/85 (58%), Gaps = 6/85 (7%)
Query: 683 KVGEGGFGSVY----KGIL--SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
++GEG FG V+ +L D ++AVK L S ++F E +++ QH ++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSR 761
YG C EG LL+V+EYM++ L+R
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNR 96
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQH 731
+ K+GEG G VYK + G +A+K+ L ++++ +NEI ++ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKH 74
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCL 759
PN+V Y + G++L +V EYM L
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSL 102
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 28/77 (36%), Positives = 41/77 (53%), Gaps = 3/77 (3%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
FD K+GEG +GSVYK I G V+A+K + + +E + EI ++ P +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 737 LYGCCVEGNQLLLVYEY 753
YG + L +V EY
Sbjct: 63 YYGSYFKNTDLWIVMEY 79
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 31/85 (36%), Positives = 50/85 (58%), Gaps = 6/85 (7%)
Query: 683 KVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
++GEG FG V+ D ++AVK L S ++F E +++ QH ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSR 761
YG CVEG+ L++V+EYMK+ L++
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNK 96
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 10/91 (10%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYG 739
++G G FG V+ G + +A+K + R+G +F+ E ++ HP LV+LYG
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 740 CCVEGNQLLLVYEYMKNNCLS---RAIFGKL 767
C E + + LV+E+M++ CLS RA GK
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKF 97
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 30/87 (34%), Positives = 42/87 (48%), Gaps = 8/87 (9%)
Query: 682 NKVGEGGFGSVYKG---ILSDGT--VIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLV 735
++GEG FG V L D T +AVK L+ S Q +F EI ++ H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 736 KLYGCCVE--GNQLLLVYEYMKNNCLS 760
K G C + G L L+ EY+ + L
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLR 96
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 26/75 (34%), Positives = 42/75 (56%), Gaps = 3/75 (4%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGN-REFVNEIGMISAQQHPNLVKLY 738
NK+G G FG VY + L G ++AVK++ + +E +E+ ++ +HPNLVK Y
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 739 GCCVEGNQLLLVYEY 753
G V ++ + EY
Sbjct: 66 GVEVHREKVYIFMEY 80
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 7/86 (8%)
Query: 676 NNFDPANKVGEGGFGSVYK----GILS--DGTVIAVKQLSSK-SRQGNREFVNEIGMISA 728
NN + +G+G FG V++ G+L T++AVK L + S +F E +++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYM 754
HPN+VKL G C G + L++EYM
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYM 90
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 28/73 (38%), Positives = 41/73 (56%), Gaps = 1/73 (1%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLYGCC 741
K+G+G FG VYKG+L T +AVK S + F+ E ++ HPN+VKL G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 742 VEGNQLLLVYEYM 754
V+ + +V E +
Sbjct: 62 VQKQPIYIVMELV 74
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 8/100 (8%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLS-----SKSRQGNREFVNEIGMISAQQHPNLVKL 737
+G G FGSVY+G+ L DG AVK++S ++ ++ EI ++S QHPN+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAI--FGKLRIFHISIY 775
G E + L + E + L++ + +G I +Y
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLY 107
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 30/78 (38%), Positives = 42/78 (53%), Gaps = 6/78 (7%)
Query: 684 VGEGGFGSVYKGILSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
+G+G FG V G V AVK L S + Q F+ E +++ +HPNLV+L G
Sbjct: 14 IGKGEFGDVMLGDYRGQKV-AVKCLKDDSTAAQ---AFLAEASVMTTLRHPNLVQLLGVV 69
Query: 742 VEGNQLLLVYEYMKNNCL 759
++GN L +V EYM L
Sbjct: 70 LQGNPLYIVTEYMAKGSL 87
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 28/85 (32%), Positives = 49/85 (57%), Gaps = 6/85 (7%)
Query: 683 KVGEGGFGSVYKG------ILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
++GEG FG V+ D ++AVK L + ++F E +++ QH ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSR 761
YG C +G+ L++V+EYMK+ L++
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNK 96
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 10/96 (10%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ------LSSKSRQGNREFVNEIGMIS 727
NF K+G+G F VYK I L DG V+A+K+ + +K+RQ + + EI ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI 763
HPN++K +E N+L +V E LSR I
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMI 93
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 36/117 (30%), Positives = 49/117 (41%), Gaps = 24/117 (20%)
Query: 231 IGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILT 290
GKW I L + L G IP IS L L + +S
Sbjct: 415 KGKWF-IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNS-------------------- 453
Query: 291 KCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 347
I G IP +G +T L+ +DLS+N+ G IP + +L + L GN L+G VP
Sbjct: 454 ---IRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 27/80 (33%), Positives = 39/80 (48%), Gaps = 7/80 (8%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPNLVKLYG 739
K+G G FG V+ G + T +AVK L + G F+ E ++ +H LV+LY
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 740 CCVEGNQLLLVYEYMKNNCL 759
C E + +V EYM L
Sbjct: 69 VCSEEEPIYIVTEYMSKGSL 88
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 24/81 (29%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 684 VGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 738
+G G FG V +G L +A+K L + S R +F+ E ++ HPN+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 739 GCCVEGNQLLLVYEYMKNNCL 759
G + ++++ EYM+N L
Sbjct: 72 GVVTKSRPVMIITEYMENGSL 92
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 25/77 (32%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
K+G G FG V++G+ ++ T +AVK L + +F+ E ++ +HP L++LY C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 743 EGNQLLLVYEYMKNNCL 759
+ +V E MK L
Sbjct: 72 LEEPIYIVTELMKYGSL 88
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 30/88 (34%), Positives = 44/88 (50%), Gaps = 4/88 (4%)
Query: 684 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743
+G G FG V+ G +A+K + + +F+ E ++ HPNLV+LYG C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 744 GNQLLLVYEYMKNNCLS---RAIFGKLR 768
+ +V EYM N CL R GKL
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLG 98
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 27/81 (33%), Positives = 47/81 (58%), Gaps = 7/81 (8%)
Query: 685 GEGGFGSVYKGI---LSDGTVI--AVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
G G FG+VYKG+ + I A+K L S + N+E ++E ++++ HP++V+L
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 739 GCCVEGNQLLLVYEYMKNNCL 759
G C+ +Q+ L+ + M CL
Sbjct: 76 GICL-SSQVQLITQLMPLGCL 95
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (140), Expect = 6e-09
Identities = 28/85 (32%), Positives = 44/85 (51%), Gaps = 3/85 (3%)
Query: 682 NKVGEGGFGSVYKG-ILSDGTVIAVKQLS-SKSRQGNREFV-NEIGMISAQQHPNLVKLY 738
++G+G FG VY SDG + +K++ S + RE NE+ ++ HPN++K Y
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAI 763
E +L +V EY LS+ I
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKI 90
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 8e-09
Identities = 43/177 (24%), Positives = 60/177 (33%), Gaps = 47/177 (26%)
Query: 451 WAFSSTGKFM--DDDT-------DLDNYIRTNTSTLSKVSAVD--------LELYRTARV 493
F + + DD + + ST V + +TA
Sbjct: 175 LNFGGSEGTIRYPDDVYDRIWEPFFSSPGWSQISTSLSVDISSNNAPYIPPSAVLQTAVT 234
Query: 494 -----SPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDF 548
+PL+ T+ L N Y V LHFAEI SL R FDIYI K V D
Sbjct: 235 PTNASAPLNFTW-DLVDPNFEYYVYLHFAEI--------QSLETREFDIYINGKTVYGDV 285
Query: 549 NIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLR----GTYGPLISAI 601
+ G + +FP + +G G I L T PL++A+
Sbjct: 286 SP-KYLGTDTGALYLDFP-----------VNVSGGGLLNISLVPTSGSTLPPLLNAL 330
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 34/90 (37%), Positives = 54/90 (60%), Gaps = 3/90 (3%)
Query: 677 NFDPANKVGEGGFGSVYK-GILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPN 733
+F K+G+G +GSVYK LSD A+K+ L S S++ + VNEI ++++ HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI 763
++ ++GN+L +V EY LS+AI
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAI 90
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 3e-08
Identities = 25/85 (29%), Positives = 44/85 (51%), Gaps = 17/85 (20%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF--------VNEIGMISA-QQHP 732
++G+G FGSVY G ++A+K++ ++F + E+ + +HP
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHP 58
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNN 757
N+VKL E ++L V+EYM+ N
Sbjct: 59 NIVKLKEVFRENDELYFVFEYMEGN 83
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 26/86 (30%), Positives = 49/86 (56%), Gaps = 3/86 (3%)
Query: 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPN 733
+F+ NK+G+G FG V+K + +D V A+KQ LS +R+ E ++E +++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCL 759
+++ Y ++ +L +V EY +N L
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDL 86
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 39/128 (30%), Positives = 62/128 (48%), Gaps = 27/128 (21%)
Query: 683 KVGEGGFGSVY----KGILS-----------DGTVIAVKQLSSKSRQGNR-EFVNEIGMI 726
K+GEG FG V+ +G+ ++AVK L + + R +F+ EI ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIF--HISIYATFPQGNIQ 784
S ++PN+++L G CV + L ++ EYM+N G L F I +TF N
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMEN--------GDLNQFLSQREIESTFTHAN-N 122
Query: 785 ILIISAAN 792
I +S AN
Sbjct: 123 IPSVSIAN 130
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 22/82 (26%), Positives = 41/82 (50%)
Query: 678 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL 737
F K+G G FG V++G+ + +A+K L S ++F E+ + +H +L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 738 YGCCVEGNQLLLVYEYMKNNCL 759
+ C G + ++ E M+ L
Sbjct: 68 FAVCSVGEPVYIITELMEKGSL 89
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 31/94 (32%), Positives = 46/94 (48%), Gaps = 15/94 (15%)
Query: 684 VGEGGFGSVYKGI------LSDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVK 736
+GEG FG V K + T +AVK L + R+ ++E ++ HP+++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIF 770
LYG C + LLL+ EY K +G LR F
Sbjct: 68 LYGACSQDGPLLLIVEYAK--------YGSLRSF 93
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 4e-08
Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLVKLYGC 740
+G+G FG VYK I V+A+K + + + E + EI +S + P + K YG
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 741 CVEGNQLLLVYEYMKN-NCLSRAIFGKLRIFHISI 774
++G++L ++ EY +CL GKL +I+
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF 102
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 29/83 (34%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 684 VGEGGFGSVYKGIL------SDGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVK 736
+GEG FG VYKG L T +A+K L + +EF E ++S QHPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 737 LYGCCVEGNQLLLVYEYMKNNCL 759
L G C + +++EY+ + L
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDL 95
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 21/77 (27%), Positives = 41/77 (53%), Gaps = 1/77 (1%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
++ ++G G +G VYK ++ G ++A+K + + EI M+ +HPN+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 737 LYGCCVEGNQLLLVYEY 753
+G + ++L +V EY
Sbjct: 65 YFGSYLRRDKLWIVMEY 81
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 42/120 (35%), Positives = 59/120 (49%), Gaps = 17/120 (14%)
Query: 487 LYRTARVS---PLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKL 543
LY++A VS L+Y N NY+V LHFAEI D++ + GKR+FD+ I
Sbjct: 254 LYQSALVSTDTQPDLSYTMDVDPNRNYSVWLHFAEI----DNSITAEGKRVFDVLINGDT 309
Query: 544 VKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISV 603
KD +I +G +V N V+ TL I L P +GT+ +I+AI V
Sbjct: 310 AFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQ---------PKKGTHA-IINAIEV 359
|
Length = 623 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 25/75 (33%), Positives = 41/75 (54%), Gaps = 3/75 (4%)
Query: 683 KVGEGGFGSVYK-GILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 739
++GEG G V+K G +A+K+++ + +G + + EI + A QHP +VKL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 740 CCVEGNQLLLVYEYM 754
G+ +LV EYM
Sbjct: 67 VFPHGSGFVLVMEYM 81
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 28/76 (36%), Positives = 42/76 (55%), Gaps = 6/76 (7%)
Query: 682 NKVGEGGFGSVYKGI--LSDGTVI--AVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVK 736
++G G FGSV KG+ + G + AVK L G +EF+ E +++ HP +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 737 LYGCCVEGNQLLLVYE 752
L G C +G L+LV E
Sbjct: 61 LIGVC-KGEPLMLVME 75
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 2e-07
Identities = 22/82 (26%), Positives = 45/82 (54%), Gaps = 5/82 (6%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS-RQG-NREFVNEIGMISAQQHPNL 734
++ ++GEG +G VYK G ++A+K++ ++ ++G + EI ++ +HPN+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 735 VKLYGCCVE--GNQLLLVYEYM 754
V+L + +V+EYM
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYM 82
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 26/94 (27%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQL---SSKSRQGNREFVN---EIGMISAQQHPNLV 735
+G+G +G+VY G+ + G +IAVKQ+ +S +E+ E+ ++ + +H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKL 767
+ G C++ N + + E++ +S + FG L
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPL 99
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ------LSSKSRQGNREFVNEIGMISAQ 729
NF K+G G F VY+ L DG +A+K+ + +K+R + + EI ++
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQL 59
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI 763
HPN++K Y +E N+L +V E LSR I
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMI 93
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 2/75 (2%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLVKLYG 739
+G G VY I L + +A+K++ + Q + + + E+ +S HPN+VK Y
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 740 CCVEGNQLLLVYEYM 754
V G++L LV Y+
Sbjct: 67 SFVVGDELWLVMPYL 81
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 26/70 (37%), Positives = 40/70 (57%), Gaps = 1/70 (1%)
Query: 684 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYGCCV 742
+G+G FG V+KG L D T +AVK Q + +F++E ++ HPN+VKL G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 743 EGNQLLLVYE 752
+ + +V E
Sbjct: 63 QRQPIYIVME 72
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 23/79 (29%), Positives = 39/79 (49%), Gaps = 7/79 (8%)
Query: 684 VGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVK 736
+G+G FG VY+G+ T +A+K ++ + R EF+NE ++ ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 737 LYGCCVEGNQLLLVYEYMK 755
L G G L+V E M
Sbjct: 74 LLGVVSTGQPTLVVMELMA 92
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 29/79 (36%), Positives = 42/79 (53%), Gaps = 8/79 (10%)
Query: 684 VGEGGFGSVYKG----ILSDGT---VIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLV 735
+G G FG VY+G IL G+ +AVK L + Q +EF+ E ++S HPN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 736 KLYGCCVEGNQLLLVYEYM 754
KL G C+ ++ E M
Sbjct: 63 KLLGVCLLNEPQYIIMELM 81
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 28/80 (35%), Positives = 43/80 (53%), Gaps = 8/80 (10%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKLYG 739
K+G G FG V+ G + T +A+K L +QG+ F+ E ++ QHP LV+LY
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 740 CCVEGNQLLLVYEYMKNNCL 759
V + ++ EYM+N L
Sbjct: 69 -VVTQEPIYIITEYMENGSL 87
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (123), Expect = 9e-07
Identities = 24/77 (31%), Positives = 39/77 (50%), Gaps = 7/77 (9%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF----VNEIGMISAQQHPNLVKL 737
K+GEG +G VYK G ++A+K++ + + EI ++ +HPN+VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 738 YGCCVEGNQLLLVYEYM 754
+L LV+EY
Sbjct: 64 LDVIHTERKLYLVFEYC 80
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 9e-07
Identities = 22/84 (26%), Positives = 44/84 (52%), Gaps = 6/84 (7%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIGMISAQQ 730
++ K+GEG + VYK G ++A+K++ R+ ++ +N EI ++ +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYM 754
HPN++ L + + LV+E+M
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFM 84
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 31/83 (37%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 684 VGEGGFGSVYK---GILSD--GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
+G+G FGSV L D G V+AVK+L + + R+F EI ++ + QH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 739 GCCVEG--NQLLLVYEYMKNNCL 759
G C L LV EY+ L
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSL 94
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 25/88 (28%), Positives = 48/88 (54%), Gaps = 11/88 (12%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREF-VNEIGM---ISAQQH 731
++ ++GEG +G+VYK L+ G +A+K++ S +G + EI + + + +H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 732 PNLVKLYGCCV-----EGNQLLLVYEYM 754
PN+V+L C +L LV+E++
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV 88
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 26/77 (33%), Positives = 39/77 (50%), Gaps = 1/77 (1%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
++G G FG V G +A+K + S + EF+ E ++ H LV+LYG C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 743 EGNQLLLVYEYMKNNCL 759
+ + +V EYM N CL
Sbjct: 70 KQRPIYIVTEYMSNGCL 86
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 25/79 (31%), Positives = 41/79 (51%), Gaps = 2/79 (2%)
Query: 682 NKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
+K+G G +G VY+G+ +AVK L + + EF+ E ++ +HPNLV+L G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 741 CVEGNQLLLVYEYMKNNCL 759
C ++ E+M L
Sbjct: 71 CTREPPFYIITEFMTYGNL 89
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 27/83 (32%), Positives = 49/83 (59%), Gaps = 2/83 (2%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQHPNL 734
NF K+GEG + +VYKG + G ++A+K++ + +G + EI ++ +H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 735 VKLYGCCVEGNQLLLVYEYMKNN 757
V+L+ N+L+LV+EYM +
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKD 83
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 23/78 (29%), Positives = 40/78 (51%), Gaps = 3/78 (3%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPNLVKLYG 739
K+GEG +G VYK G ++A+K++ + + + EI ++ HPN++KL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 740 CCVEGNQLLLVYEYMKNN 757
L LV+E+M +
Sbjct: 66 VFRHKGDLYLVFEFMDTD 83
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 29/82 (35%), Positives = 50/82 (60%), Gaps = 7/82 (8%)
Query: 684 VGEGGFGSVYKGI-LSDGTVI----AVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKL 737
+G G FG+VYKGI + +G + A+K L+ + + N EF++E ++++ HP+LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 738 YGCCVEGNQLLLVYEYMKNNCL 759
G C+ + LV + M + CL
Sbjct: 75 LGVCLSPT-IQLVTQLMPHGCL 95
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 30/85 (35%), Positives = 47/85 (55%), Gaps = 12/85 (14%)
Query: 684 VGEGGFGSVYKGILS--DGTV--IAVK--QLSSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+GEG FGSV +G LS DG+ +AVK +L + EF++E + HPN++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 738 YGCCVEGNQL------LLVYEYMKN 756
G C E + L +++ +MK+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKH 91
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 26/85 (30%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
D K+GEG G V S G +AVK++ + +Q NE+ ++ QHPN+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLS 760
++Y + G++L +V E+++ L+
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALT 104
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 27/97 (27%), Positives = 51/97 (52%), Gaps = 18/97 (18%)
Query: 683 KVGEGGFGSVY----KGIL-------------SDGTVIAVKQLSSKSRQGNR-EFVNEIG 724
K+GEG FG V+ +G+ + ++AVK L + + R +F+ EI
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 725 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSR 761
++S + PN+++L C+ + L ++ EYM+N L++
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 26/80 (32%), Positives = 42/80 (52%), Gaps = 7/80 (8%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYG 739
++G G FG V+ G +A+K + +G +F+ E ++ HP LV+LYG
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI----NEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 740 CCVEGNQLLLVYEYMKNNCL 759
C + L +V E+M+N CL
Sbjct: 67 VCTQQKPLYIVTEFMENGCL 86
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-06
Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 23/99 (23%)
Query: 225 GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNL 284
G IP I K + +Q +++ G+S+ G IP S+ ++TSL L DL +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL---DLSYNS----------- 477
Query: 285 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323
+G IP+ +G +T L+ ++L+ N+L+G +P
Sbjct: 478 ---------FNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 24/76 (31%), Positives = 37/76 (48%), Gaps = 4/76 (5%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIA---VKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+++G G FG V G G A VK+L +S + F+ E+ HPN+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 738 YGCCVEGNQLLLVYEY 753
G C+E LLV E+
Sbjct: 61 LGQCIESIPYLLVLEF 76
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 27/80 (33%), Positives = 39/80 (48%), Gaps = 7/80 (8%)
Query: 682 NKVGEGGFGSVYKGILS--DGTV----IAVKQL-SSKSRQGNREFVNEIGMISAQQHPNL 734
+G G FG VY+G+ DG +AVK L S S Q +F+ E ++S H N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 735 VKLYGCCVEGNQLLLVYEYM 754
V+L G E ++ E M
Sbjct: 72 VRLIGVSFERLPRFILLELM 91
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 28/81 (34%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPN 733
NF K+GEG +G VYK G V+A+K+ L +++ + EI ++ HPN
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 734 LVKLYGCCVEGNQLLLVYEYM 754
+VKL N+L LV+E++
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL 81
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 27/84 (32%), Positives = 38/84 (45%), Gaps = 7/84 (8%)
Query: 677 NFDPANKVGEGGFGSVY----KGILSDG--TVIAVKQLSSKSRQG-NREFVNEIGMISAQ 729
N +G G FG V+ KGI +G T++ VK L + EF E+ M
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEY 753
H N+V+L G C E ++ EY
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEY 89
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 27/79 (34%), Positives = 41/79 (51%), Gaps = 11/79 (13%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR-QGNREFV-----NEIGMISAQQHPNLV 735
K+GEG +G VYK G ++A+K K R + E V EI ++ HPN+V
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALK----KIRLETEDEGVPSTAIREISLLKELNHPNIV 61
Query: 736 KLYGCCVEGNQLLLVYEYM 754
+L N+L LV+E++
Sbjct: 62 RLLDVVHSENKLYLVFEFL 80
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 8e-06
Identities = 21/60 (35%), Positives = 28/60 (46%)
Query: 283 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 342
NLK+L L+ + + LK +DLS NNLT P F L + L+GN L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 25/75 (33%), Positives = 44/75 (58%), Gaps = 3/75 (4%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
K+GEG +G VYKG G ++A+K+ L S+ + EI ++ QHPN+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 740 CCVEGNQLLLVYEYM 754
++ ++L L++E++
Sbjct: 67 VLMQESRLYLIFEFL 81
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 23/83 (27%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 684 VGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 738
+G G FG V++GIL +A+K L + R +F++E ++ H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 739 GCCVEGNQLLLVYEYMKNNCLSR 761
G + +++ EYM+N L +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDK 95
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 30/82 (36%), Positives = 41/82 (50%), Gaps = 14/82 (17%)
Query: 684 VGEGGFGSVYKGIL------SDGT--VIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNL 734
+GEG FG V L +DGT ++AVK L + Q N + EI ++ H N+
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 735 VKLYGCCVEGNQ--LLLVYEYM 754
VK GCC E L L+ EY+
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYV 90
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 24/79 (30%), Positives = 46/79 (58%), Gaps = 1/79 (1%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+G+G G+VY I ++ G +A+KQ++ + + +NEI ++ +HPN+V
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 742 VEGNQLLLVYEYMKNNCLS 760
+ G++L +V EY+ L+
Sbjct: 86 LVGDELWVVMEYLAGGSLT 104
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 28/75 (37%), Positives = 41/75 (54%), Gaps = 6/75 (8%)
Query: 683 KVGEGGFGSVYKG--ILSDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKL 737
K+G+G FG V +G S G VI AVK L S +F+ E ++ + H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 738 YGCCVEGNQLLLVYE 752
YG V + L++V E
Sbjct: 62 YG-VVLTHPLMMVTE 75
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 24/79 (30%), Positives = 46/79 (58%), Gaps = 1/79 (1%)
Query: 683 KVGEGGFGSV-YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+GEG G V + S G ++AVK++ + +Q NE+ ++ QH N+V++Y
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 742 VEGNQLLLVYEYMKNNCLS 760
+ G++L +V E+++ L+
Sbjct: 87 LVGDELWVVMEFLEGGALT 105
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 23/81 (28%), Positives = 43/81 (53%), Gaps = 5/81 (6%)
Query: 684 VGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLY 738
+G G FG V +G L +A+K L S + + R+F++E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 739 GCCVEGNQLLLVYEYMKNNCL 759
G + ++++ E+M+N L
Sbjct: 72 GVVTKSRPVMIITEFMENGAL 92
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 47.0 bits (110), Expect = 2e-05
Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 6/85 (7%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISA-QQHPNLVKLY 738
K+GEG FG VY D ++A+K L+ K + F+ EI ++++ PN+VKLY
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAI 763
+ L LV EY+ L +
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLL 89
|
Length = 384 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 23/82 (28%), Positives = 47/82 (57%), Gaps = 1/82 (1%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+G+G G+VY I ++ G +A+KQ++ + + +NEI ++ ++PN+V
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 742 VEGNQLLLVYEYMKNNCLSRAI 763
+ G++L +V EY+ L+ +
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV 107
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 10/94 (10%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ------LSSKSRQGNREFVNEIGMISAQ 729
NF K+G G F VY+ L D +A+K+ + +K+RQ + V EI ++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQL 59
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI 763
HPN++K +E N+L +V E LS+ I
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMI 93
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 20/74 (27%), Positives = 38/74 (51%), Gaps = 2/74 (2%)
Query: 683 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYGC 740
+G+G G VYK G + A+K++ + R + + E+ + + + P +VK YG
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 741 CVEGNQLLLVYEYM 754
+ ++ +V EYM
Sbjct: 68 FYKEGEISIVLEYM 81
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 24/77 (31%), Positives = 39/77 (50%), Gaps = 1/77 (1%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
K+G G FG V+ G ++ T +AVK L + + F+ E ++ QH LV+LY
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 743 EGNQLLLVYEYMKNNCL 759
+ + ++ EYM L
Sbjct: 72 KEEPIYIITEYMAKGSL 88
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 26/89 (29%), Positives = 46/89 (51%), Gaps = 8/89 (8%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPN 733
F ++G G FG+VY + + V+A+K++S +Q N ++ + E+ + +HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRA 762
++ GC + + LV EY CL A
Sbjct: 77 TIQYRGCYLREHTAWLVMEY----CLGSA 101
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 27/84 (32%), Positives = 42/84 (50%), Gaps = 8/84 (9%)
Query: 684 VGEGGFGSVYKGI---LSDG-----TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
+G+G F ++KGI + D T + +K L R + F M+S H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCL 759
YG CV G++ ++V EY+K L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSL 86
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 25/81 (30%), Positives = 46/81 (56%), Gaps = 5/81 (6%)
Query: 677 NFDPANKVGEGGFGS--VYKGILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHP 732
++ P +G+G FG +Y+ D +++ K+ L+ S + R+ +NEI ++S QHP
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 733 NLVKLYGCCVEGNQLLLVYEY 753
N++ Y ++ N LL+ EY
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEY 80
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 5e-05
Identities = 21/87 (24%), Positives = 36/87 (41%), Gaps = 7/87 (8%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVN---EIGMISAQ 729
++F +GEG F +V A+K L + ++ ++V E+ +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV-LTRLN 59
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKN 756
HP ++KLY + L V EY N
Sbjct: 60 GHPGIIKLYYTFQDEENLYFVLEYAPN 86
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 27/85 (31%), Positives = 46/85 (54%), Gaps = 8/85 (9%)
Query: 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPNLVKL 737
+++G G FG+VY S V+AVK++S +Q N ++ + E+ + +HPN ++
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRA 762
GC ++ + LV EY CL A
Sbjct: 87 KGCYLKEHTAWLVMEY----CLGSA 107
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 30/99 (30%), Positives = 47/99 (47%), Gaps = 11/99 (11%)
Query: 684 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743
+G+G FG V G G +AVK + K+ + F+ E +++ +H NLV+L G VE
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 744 GN-QLLLVYEYMKNNCL-------SRAIFGKLRIFHISI 774
L +V EYM L R++ G + S+
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 109
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 23/89 (25%), Positives = 43/89 (48%), Gaps = 7/89 (7%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREF----VNEIGMISAQQ 730
N ++ VGEG +G V K G ++A+K+ K + + + + E+ ++ +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLR 58
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759
H N+V L +L LV+EY++ L
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLL 87
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 8e-05
Identities = 21/82 (25%), Positives = 47/82 (57%), Gaps = 1/82 (1%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+G+G G+VY + ++ G +A++Q++ + + +NEI ++ ++PN+V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 742 VEGNQLLLVYEYMKNNCLSRAI 763
+ G++L +V EY+ L+ +
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVV 108
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 9e-05
Identities = 26/89 (29%), Positives = 45/89 (50%), Gaps = 8/89 (8%)
Query: 678 FDPANKVGEGGFGSVY-KGILSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPN 733
F ++G G FG+VY + V+A+K++S +Q N ++ + E+ + +HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRA 762
++ GC + + LV EY CL A
Sbjct: 87 SIEYKGCYLREHTAWLVMEY----CLGSA 111
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 27/81 (33%), Positives = 45/81 (55%), Gaps = 10/81 (12%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQL-----SSKSRQGNREFVN----EIGMISAQQHPN 733
+G G FGSVY G+ S G ++AVKQ+ S+ S+ R ++ EI ++ QH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 734 LVKLYGCCVEGNQLLLVYEYM 754
+V+ G ++ + L + EY+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYV 88
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 29/100 (29%), Positives = 51/100 (51%), Gaps = 24/100 (24%)
Query: 683 KVGEGGFGSVY--------------------KGILSDGTVIAVKQLSSKSRQGNR-EFVN 721
K+GEG FG V+ KG ++AVK L + + R +F+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG---RPLLVAVKILRPDANKNARNDFLK 68
Query: 722 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSR 761
E+ ++S + PN+++L G CV+ + L ++ EYM+N L++
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 22/80 (27%), Positives = 40/80 (50%), Gaps = 3/80 (3%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHPN 733
++ K+GEG +G+V+K ++A+K +L + EI ++ +H N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 734 LVKLYGCCVEGNQLLLVYEY 753
+V+LY +L LV+EY
Sbjct: 61 IVRLYDVLHSDKKLTLVFEY 80
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 20/84 (23%), Positives = 37/84 (44%), Gaps = 8/84 (9%)
Query: 678 FDPANKVGEGGFGSVYKGIL---SDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQH 731
++ +G G +G VYK DG A+K+ Q ++ EI ++ +H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 732 PNLVKLYGCCVEGNQ--LLLVYEY 753
N+V L +E + L+++Y
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDY 85
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 22/78 (28%), Positives = 40/78 (51%), Gaps = 7/78 (8%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGN--REFVNEIGMISAQQHPNLVK 736
+G G F S Y+ + GT++AVKQ++ + S Q EI +++ HP++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 737 LYGCCVEGNQLLLVYEYM 754
+ G E + L E+M
Sbjct: 68 MLGATCEDSHFNLFVEWM 85
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 23/75 (30%), Positives = 40/75 (53%), Gaps = 2/75 (2%)
Query: 683 KVGEGGFGSVYKGIL-SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
++G G FG V+ G L +D T +AVK + +F+ E ++ HPN+V+L G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 741 CVEGNQLLLVYEYMK 755
C + + +V E ++
Sbjct: 62 CTQKQPIYIVMELVQ 76
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 25/105 (23%), Positives = 54/105 (51%), Gaps = 1/105 (0%)
Query: 660 DLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE 718
++ L T+ I + K+G+G G+V+ I ++ G +A+KQ++ + +
Sbjct: 3 EIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL 62
Query: 719 FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI 763
+NEI ++ ++PN+V + G++L +V EY+ L+ +
Sbjct: 63 IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV 107
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 27/86 (31%), Positives = 41/86 (47%), Gaps = 8/86 (9%)
Query: 676 NNFDPANKVGEGGFGSVYK----GILSDGTVI--AVKQLSSKSRQGNRE-FVNEIGMIS- 727
NN +G G FG V + G+ V+ AVK L + RE ++E+ ++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEY 753
H N+V L G C G +L++ EY
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEY 120
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 27/95 (28%), Positives = 42/95 (44%), Gaps = 16/95 (16%)
Query: 684 VGEGGFGSVYKGILSD------GTVIAVKQL-SSKSRQGNREFVNEIGMI-SAQQHPNLV 735
+GEG FG V K + +AVK L + + + V+E+ M+ +H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIF 770
L G C + L +V EY + G LR F
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAH--------GNLRDF 106
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 24/95 (25%)
Query: 683 KVGEGGFGSVY----------------KGILSDGTV-IAVKQL----SSKSRQGNREFVN 721
K+GEG FG V+ + +D V +AVK L S +R+ +F+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE---DFLK 68
Query: 722 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756
E+ ++S PN+ +L G C L ++ EYM+N
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMEN 103
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 24/82 (29%), Positives = 50/82 (60%), Gaps = 7/82 (8%)
Query: 684 VGEGGFGSVYKGI-LSDGTVI----AVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+G G FG+VYKG+ + +G + A+K+L + S + N+E ++E ++++ +P++ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 738 YGCCVEGNQLLLVYEYMKNNCL 759
G C+ + + L+ + M CL
Sbjct: 75 LGICLT-STVQLITQLMPFGCL 95
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 26/85 (30%), Positives = 40/85 (47%), Gaps = 6/85 (7%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQ-----LSSKSRQGNREFVNEIGMISAQ 729
N+ +G+G FG VY D G +AVKQ S ++++ EI ++
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYM 754
QH +V+ YGC + L + EYM
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYM 86
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 25/81 (30%), Positives = 39/81 (48%), Gaps = 5/81 (6%)
Query: 684 VGEGGFGSVYKGILS----DGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
+G G FG + +G L +A+ L + S + R F+ E + H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 739 GCCVEGNQLLLVYEYMKNNCL 759
G GN +++V EYM N L
Sbjct: 73 GVITRGNTMMIVTEYMSNGAL 93
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 21/78 (26%), Positives = 36/78 (46%), Gaps = 1/78 (1%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
+G+G +G VY LS IA+K++ + + + EI + S +H N+V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 743 EGNQLLLVYEYMKNNCLS 760
E + E + LS
Sbjct: 76 ENGFFKIFMEQVPGGSLS 93
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 26/75 (34%), Positives = 40/75 (53%), Gaps = 4/75 (5%)
Query: 683 KVGEGGFGSVYKGILSDGTVIA---VKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
++G G FG V + T +A VK+L ++ S + EF+ + QHPN+++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 739 GCCVEGNQLLLVYEY 753
G CVE LLV+EY
Sbjct: 62 GQCVEAIPYLLVFEY 76
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 24/93 (25%), Positives = 41/93 (44%), Gaps = 9/93 (9%)
Query: 677 NFDPANKVGEGGFGSVY--KGILSDGTVI----AVKQLSSKSRQGNREFVNEIGMISAQQ 730
++ VG G FG V+ + VI V+Q++ R + NE ++
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLS 57
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI 763
HPN+++ Y +E L++V EY L+ I
Sbjct: 58 HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYI 90
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 28/78 (35%), Positives = 39/78 (50%), Gaps = 7/78 (8%)
Query: 683 KVGEGGFGSVYKGILSDGT------VIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLV 735
++GE FG VYKG L +A+K L K+ RE F +E M S QHPN+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 736 KLYGCCVEGNQLLLVYEY 753
L G + L +++ Y
Sbjct: 72 CLLGVVTKEQPLSMIFSY 89
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 23/72 (31%), Positives = 42/72 (58%), Gaps = 1/72 (1%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAV-KQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
++G+G FG VYK + V+A K + +KS + +++ EI ++++ HPN+VKL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 742 VEGNQLLLVYEY 753
N L ++ E+
Sbjct: 72 YYENNLWILIEF 83
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 24/79 (30%), Positives = 44/79 (55%), Gaps = 2/79 (2%)
Query: 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLV 735
F ++G+G FG V+KGI + V+A+K + + + E + EI ++S P +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 736 KLYGCCVEGNQLLLVYEYM 754
K YG ++G +L ++ EY+
Sbjct: 66 KYYGSYLKGTKLWIIMEYL 84
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 22/66 (33%), Positives = 35/66 (53%), Gaps = 5/66 (7%)
Query: 683 KVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKL 737
+GEG FG VY+G+ ++ +AVK + + RE F+ E ++ HP++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 738 YGCCVE 743
G E
Sbjct: 73 IGVITE 78
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 26/75 (34%), Positives = 38/75 (50%), Gaps = 4/75 (5%)
Query: 683 KVGEGGFGSVYKGILSDG---TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
++G G FG V G ++ G + VK+L S S Q +F+ E + QH NL++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 739 GCCVEGNQLLLVYEY 753
G C E LLV E+
Sbjct: 62 GQCTEVTPYLLVMEF 76
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 24/81 (29%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 684 VGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLY 738
+G G FG V G L +A+K L + + + R+F++E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 739 GCCVEGNQLLLVYEYMKNNCL 759
G + +++V EYM+N L
Sbjct: 72 GVVTKSKPVMIVTEYMENGSL 92
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 24/79 (30%), Positives = 44/79 (55%), Gaps = 2/79 (2%)
Query: 678 FDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLV 735
F ++G+G FG VYKGI + V+A+K + + + E + EI ++S P +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 736 KLYGCCVEGNQLLLVYEYM 754
+ YG ++G +L ++ EY+
Sbjct: 66 RYYGSYLKGTKLWIIMEYL 84
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 24/89 (26%), Positives = 35/89 (39%), Gaps = 15/89 (16%)
Query: 679 DPANK------VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISA-QQ 730
DP +GEG +G VYK G ++A+K + + E E ++
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSN 61
Query: 731 HPNLVKLYGC------CVEGNQLLLVYEY 753
HPN+ YG +QL LV E
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMEL 90
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 19/87 (21%), Positives = 36/87 (41%), Gaps = 4/87 (4%)
Query: 676 NNFDPANKVGEGGFGSVYKG-ILSDGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHP 732
++ + ++G G G V K G ++AVK +L ++ + E+ ++ P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSP 59
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCL 759
+V YG + + EYM L
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSL 86
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 9e-04
Identities = 22/82 (26%), Positives = 44/82 (53%), Gaps = 13/82 (15%)
Query: 684 VGEGGFGSVYKGILSDG--TVIAVKQLS---------SKSRQGN-REFVNEIGMISAQ-Q 730
+G G FG VYK + ++A+K+++ + R + + V+E+ +I Q +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 731 HPNLVKLYGCCVEGNQLLLVYE 752
HPN+V+ Y +E ++L +V +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMD 89
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 22/80 (27%), Positives = 38/80 (47%), Gaps = 3/80 (3%)
Query: 677 NFDPANKVGEGGFGSVY--KG-ILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
++ K+GEG FG +Y K S+ VI L+ + E+ +++ +HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 734 LVKLYGCCVEGNQLLLVYEY 753
+V + E +L +V EY
Sbjct: 61 IVTFFASFQENGRLFIVMEY 80
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.001
Identities = 25/86 (29%), Positives = 46/86 (53%), Gaps = 11/86 (12%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREF----VNEIGMISAQQ 730
++ N++ EG +G VY+ G ++A+K+L K ++G F + EI ++ Q
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQ 62
Query: 731 HPNLVKLYGCCVEGN--QLLLVYEYM 754
HPN+V + V N ++ +V EY+
Sbjct: 63 HPNIVTVKEVVVGSNLDKIYMVMEYV 88
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 23/78 (29%), Positives = 40/78 (51%), Gaps = 6/78 (7%)
Query: 683 KVGEGGFGSVYKGIL-----SDGTVIAVKQLSS-KSRQGNREFVNEIGMISAQQHPNLVK 736
++GE FG +YKG L ++A+K L + Q EF E +++ HPN+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 737 LYGCCVEGNQLLLVYEYM 754
L G + + +++EY+
Sbjct: 72 LLGVVTQEQPVCMLFEYL 89
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 6/107 (5%)
Query: 113 SKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172
KLR L+ C+ +F P+ LV+L + G++L + V ++T L+N+ + G
Sbjct: 589 PKLRLLRWDKYPLRCMPSNFRPE----NLVKLQMQGSKLEKLWDGV-HSLTGLRNIDLRG 643
Query: 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219
+ IP D+ NL+ L LS S ELP+ + L L DL +S
Sbjct: 644 SKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 27/83 (32%), Positives = 44/83 (53%), Gaps = 7/83 (8%)
Query: 677 NFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLS-SKSRQG-NREFVNEIGMISAQQHPN 733
F+ N++GEG +G VY+ + G ++A+K++ R G + EI ++ +HPN
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 734 LVKLYGCCVEGNQL---LLVYEY 753
+V+L V G L LV EY
Sbjct: 68 IVELKE-VVVGKHLDSIFLVMEY 89
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 0.001
Identities = 23/70 (32%), Positives = 37/70 (52%), Gaps = 9/70 (12%)
Query: 674 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ-LSSKSRQGNREF----VNEIGMIS 727
+++ K+GEG FG VYK + G V+A+K+ L + G F + EI ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILK 62
Query: 728 AQQHPNLVKL 737
+HPN+V L
Sbjct: 63 KLKHPNVVPL 72
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 25/77 (32%), Positives = 43/77 (55%), Gaps = 2/77 (2%)
Query: 683 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGC 740
K+GEG + +VYKGI +G ++A+K +S K+ +G + E ++ +H N+V L+
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 741 CVEGNQLLLVYEYMKNN 757
L V+EYM +
Sbjct: 72 IHTKETLTFVFEYMHTD 88
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 21/75 (28%), Positives = 43/75 (57%), Gaps = 5/75 (6%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQH---PNLVKLY 738
+G G +G+VY+G + G V+A+K ++ + + + E+ ++S + PN+ K Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 739 GCCVEGNQLLLVYEY 753
G ++G +L ++ EY
Sbjct: 69 GSYLKGPRLWIIMEY 83
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 26/79 (32%), Positives = 42/79 (53%), Gaps = 7/79 (8%)
Query: 683 KVGEGGFGSVYKGILSD------GTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLV 735
++G+G FG VY+G D T +AVK ++ S S + EF+NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 736 KLYGCCVEGNQLLLVYEYM 754
+L G +G L+V E M
Sbjct: 73 RLLGVVSKGQPTLVVMELM 91
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 22/72 (30%), Positives = 41/72 (56%), Gaps = 1/72 (1%)
Query: 683 KVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
++G+G FG VYK + G + A K + +KS + +++ EI +++ HP +VKL G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 742 VEGNQLLLVYEY 753
+L ++ E+
Sbjct: 79 YWDGKLWIMIEF 90
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 24/75 (32%), Positives = 38/75 (50%), Gaps = 5/75 (6%)
Query: 684 VGEGGFGSVYKGILS-DGTVI--AVKQLSS-KSRQGNREFVNEIGMISA-QQHPNLVKLY 738
+GEG FG V + ++ DG + A+K L S +R+F E+ ++ HPN++ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 739 GCCVEGNQLLLVYEY 753
G C L + EY
Sbjct: 70 GACENRGYLYIAIEY 84
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.002
Identities = 23/77 (29%), Positives = 44/77 (57%), Gaps = 5/77 (6%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQHPNLVKLY 738
+G+G FG+V K SDG ++ K++ + + + ++ V+E+ ++ +HPN+V+ Y
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 739 GCCV-EGNQLL-LVYEY 753
+ NQ L +V EY
Sbjct: 66 DRIIDRSNQTLYIVMEY 82
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 27/82 (32%), Positives = 46/82 (56%), Gaps = 7/82 (8%)
Query: 684 VGEGGFGSVYKGI-LSDGTVI----AVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+G G FG+VYKGI + DG + A+K L + S + N+E ++E +++ P + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 738 YGCCVEGNQLLLVYEYMKNNCL 759
G C+ + + LV + M CL
Sbjct: 75 LGICLT-STVQLVTQLMPYGCL 95
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 25/84 (29%), Positives = 43/84 (51%), Gaps = 8/84 (9%)
Query: 683 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPNLVKLY 738
++G G FG+VY V+A+K++S +Q N ++ + E+ + +HPN ++
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRA 762
GC + + LV EY CL A
Sbjct: 82 GCYLREHTAWLVMEY----CLGSA 101
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 32/108 (29%), Positives = 49/108 (45%), Gaps = 8/108 (7%)
Query: 668 LRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMI 726
L + T+ ++ +G+G +G VYK DG++ AVK L + E E ++
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP-ISDVDEEIEAEYNIL 72
Query: 727 -SAQQHPNLVKLYGCCVE-----GNQLLLVYEYMKNNCLSRAIFGKLR 768
S HPN+VK YG + G QL LV E ++ + G L
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI 120
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.003
Identities = 26/80 (32%), Positives = 41/80 (51%), Gaps = 3/80 (3%)
Query: 683 KVGEGGFGSVYKGILSD-GTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
K+GEG +G V+K + G ++A+K+ S + + EI M+ +HPNLV L
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 740 CCVEGNQLLLVYEYMKNNCL 759
+L LV+EY + L
Sbjct: 68 VFRRKRKLHLVFEYCDHTVL 87
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 28/98 (28%), Positives = 45/98 (45%), Gaps = 7/98 (7%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
K+G+G FG V+ G + T +A+K L + F+ E ++ +H LV+LY
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQ 780
E + +V EYM L + G+ + Y PQ
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKGE-----MGKYLRLPQ 103
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.003
Identities = 24/79 (30%), Positives = 43/79 (54%), Gaps = 2/79 (2%)
Query: 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLV 735
F K+G+G FG V+KGI + V+A+K + + + E + EI ++S P +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 736 KLYGCCVEGNQLLLVYEYM 754
K YG ++ +L ++ EY+
Sbjct: 66 KYYGSYLKDTKLWIIMEYL 84
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 22/79 (27%), Positives = 41/79 (51%), Gaps = 1/79 (1%)
Query: 683 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+GEG G V G +AVK++ + +Q NE+ ++ H N+V +Y
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 742 VEGNQLLLVYEYMKNNCLS 760
+ G++L +V E+++ L+
Sbjct: 89 LVGDELWVVMEFLEGGALT 107
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 24/80 (30%), Positives = 40/80 (50%), Gaps = 3/80 (3%)
Query: 683 KVGEGGFGSVYKGILSD-GTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
VGEG +G V K + G ++A+K+ S + + + EI M+ +H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 740 CCVEGNQLLLVYEYMKNNCL 759
+L LV+E++ + L
Sbjct: 68 VFRRKKRLYLVFEFVDHTVL 87
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 799 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.93 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.93 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.89 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.89 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.83 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.81 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.81 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.8 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.79 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.79 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.78 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.77 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.76 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.75 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.73 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.73 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.72 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.71 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.71 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.7 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.69 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.69 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.69 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.69 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.67 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.66 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.65 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.65 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.65 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.64 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.64 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.62 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.62 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.62 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.61 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.6 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.6 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.59 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.58 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.57 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.57 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.57 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.56 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.55 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.55 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.55 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.55 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.55 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.55 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.55 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.54 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.54 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.54 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.54 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.54 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.53 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.53 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.53 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.53 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.52 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.52 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.52 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.51 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.51 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.51 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.51 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.51 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.51 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.51 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.51 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.5 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.5 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.5 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.5 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.5 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.5 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.5 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.49 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.49 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.49 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.49 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.49 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.49 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.48 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.48 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.48 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.48 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.48 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.48 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.48 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.48 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.48 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.47 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.47 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.47 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.47 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.46 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.46 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.46 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.46 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.45 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.45 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.45 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.45 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.45 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.45 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.45 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.45 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.44 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.44 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.44 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.44 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.44 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.44 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.44 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.44 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.44 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.44 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.44 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.44 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.44 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.43 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.43 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.43 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.43 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.43 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.43 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.43 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.43 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.43 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.43 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.43 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.43 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.43 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.43 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.43 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.43 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.43 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.43 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.43 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.42 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.42 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.42 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.42 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.42 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.42 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.42 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.42 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.42 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.41 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.41 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.41 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.41 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.41 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.41 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.41 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.41 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.41 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.41 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.41 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.41 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.41 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.41 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.41 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.41 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.41 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.41 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.4 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.4 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.4 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.4 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.4 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.4 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.4 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.4 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.4 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.4 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.4 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.4 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.4 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.4 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.4 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.4 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.39 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.39 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.39 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.39 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.39 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.39 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.39 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.39 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.39 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.39 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.39 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.39 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.39 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.39 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.39 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.39 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.39 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.39 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.39 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.38 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.38 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.38 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.38 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.38 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.38 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.38 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.38 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.38 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.38 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.38 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.38 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.38 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.37 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.37 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.37 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.37 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.37 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.37 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.37 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.37 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.37 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.37 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.37 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.37 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.37 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.37 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.36 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.36 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.36 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.36 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.36 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.36 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.36 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.36 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.36 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.36 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.36 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.36 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.36 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.36 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.36 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.35 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.35 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.35 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.35 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.35 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.35 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.35 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.35 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.35 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.35 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.35 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.35 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.34 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.34 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.34 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.34 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.34 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.34 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.34 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.34 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.34 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.34 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.34 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.34 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.34 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.34 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.34 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.34 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.34 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.34 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.34 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.34 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.34 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.33 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.33 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.33 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.33 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.33 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.33 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.33 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.32 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.32 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.32 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.32 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.32 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.32 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.32 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.32 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.32 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.32 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.32 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.31 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.31 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.31 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.31 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.31 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.31 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.31 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.31 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.31 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.31 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.3 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.3 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.3 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.3 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.3 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.29 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.29 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.29 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.29 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.29 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.29 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.29 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.29 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.29 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.29 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.29 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.29 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.29 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.28 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.28 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.28 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.28 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.27 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.27 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.27 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.27 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.27 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.27 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.27 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.27 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.27 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.27 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.27 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.27 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.26 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.26 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.26 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.26 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.26 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.25 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.25 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.25 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.25 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.25 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.25 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.25 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.25 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.24 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.24 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.23 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.23 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.23 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.23 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.23 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.23 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.22 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.22 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.22 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.21 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.21 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.21 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.21 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.21 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.2 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.2 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.19 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.19 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.19 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.18 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.18 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.18 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.18 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.17 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.17 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.17 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.17 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.17 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.17 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.16 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.16 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.16 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.15 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.15 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.14 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.14 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.14 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.11 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.1 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.09 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.08 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.08 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.08 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.07 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.07 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.06 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.05 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.03 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.03 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.02 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.02 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 98.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 98.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 98.96 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 98.95 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 98.94 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.94 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.91 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 98.91 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.88 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.87 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 98.86 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 98.83 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.83 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 98.82 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 98.81 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 98.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.79 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 98.78 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.74 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 98.72 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.7 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 98.69 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 98.69 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.69 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 98.67 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 98.67 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 98.66 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 98.64 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.63 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.62 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 98.62 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.62 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 98.59 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.58 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 98.51 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 98.49 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 98.48 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.44 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 98.43 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 98.38 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.36 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 98.26 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 98.21 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 98.16 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.15 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 98.14 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.12 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.12 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.1 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 98.09 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.06 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.01 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.92 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 97.91 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 97.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 97.82 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 97.81 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 97.76 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 97.75 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 97.69 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 97.65 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.61 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 97.6 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 97.59 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.58 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 97.55 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 97.5 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 97.42 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 97.37 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 97.33 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 97.33 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 97.2 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 97.08 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 97.05 | |
| KOG3665 | 699 | consensus ZYG-1-like serine/threonine protein kina | 96.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 96.8 | |
| KOG3665 | 699 | consensus ZYG-1-like serine/threonine protein kina | 96.77 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 96.75 | |
| KOG2739 | 260 | consensus Leucine-rich acidic nuclear protein [Cel | 96.67 | |
| PF13306 | 129 | LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ | 96.52 | |
| PF13306 | 129 | LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ | 96.49 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 96.32 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 96.2 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 96.15 | |
| KOG2739 | 260 | consensus Leucine-rich acidic nuclear protein [Cel | 96.05 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 95.93 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 95.77 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-58 Score=569.24 Aligned_cols=679 Identities=24% Similarity=0.383 Sum_probs=352.6
Q ss_pred CHHHHHHHHHHHHhcCC-----CCCCCCCCCCCCCCCCcccCCCCCCCCCCeEecCCCCcccEEEEEeCCCCCcccCCcc
Q 003737 37 HAEEVKALKQIGRKLGK-----KDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTE 111 (799)
Q Consensus 37 ~~~~~~aL~~~~~~~~~-----~~W~~~~d~C~~~~~W~~~~~~~~~~~~gv~c~~~~~~~~v~~L~L~~~~l~g~~p~~ 111 (799)
+++|++||++||+++.+ .+|+.+.||| .| .||+|+. .++|+.|+|++++++|.++..
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c----~w-----------~gv~c~~---~~~v~~L~L~~~~i~~~~~~~ 88 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSSADVC----LW-----------QGITCNN---SSRVVSIDLSGKNISGKISSA 88 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC----cC-----------cceecCC---CCcEEEEEecCCCccccCChH
Confidence 56899999999999853 5798778999 78 7899974 368999999999999999999
Q ss_pred ccCCCCCCEEEccCCcCCCcCccccc-ccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCC
Q 003737 112 LSKLRYLKQLDLSRNCLTGSFSPQWA-SLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINL 189 (799)
Q Consensus 112 ~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L 189 (799)
|..+++|++|+|++|++.+.+|..+. .++ |++|+|++|++++.+|. +.+++|++|+|++|.+++.+|..++++++|
T Consensus 89 ~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L 166 (968)
T PLN00113 89 IFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSL 166 (968)
T ss_pred HhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCC
Confidence 99999999999999999987776543 555 77777777777665553 335555555555555555555555555555
Q ss_pred CEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCC
Q 003737 190 QKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDL 269 (799)
Q Consensus 190 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n 269 (799)
++|+|++|.+.+.+|..+.++++|++|+|++|++.+.+|..++++++|++|+|++|++++.+|..++++++|++|++++|
T Consensus 167 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 246 (968)
T PLN00113 167 KVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYN 246 (968)
T ss_pred CEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCc
Confidence 55555555555555555555555555555555555555555555555555555555555555555555555555555553
Q ss_pred CCCCCCCCc-cCC-------------------------CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCc
Q 003737 270 KGSESAFPK-LDK-------------------------MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323 (799)
Q Consensus 270 ~~~~~~~~~-l~~-------------------------~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 323 (799)
+.. +.+|. +.. .+|+.|+|++|.+++.+|..+..+++|+.|++++|.+++.+|
T Consensus 247 ~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~ 325 (968)
T PLN00113 247 NLT-GPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325 (968)
T ss_pred eec-cccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCC
Confidence 322 12221 222 345555555555555555555555555555555555555555
Q ss_pred hhhhccCCCCEEeccCCcCCCcCChhhh--cCCCEEEeecCcCcccCCCCCcCCCCC---ccceecccCCCCCcCCcc--
Q 003737 324 TTFEKLAKTNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESSDPIECPRGS---VNLVESYSSPRNKLDKVH-- 396 (799)
Q Consensus 324 ~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~l~~l~ls~N~~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~-- 396 (799)
..+..+++|+.|++++|++++.+|..+. ..++.|++++|++++.+|..+ |.... +++..+.... ..+...
T Consensus 326 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~-~~~~~L~~L~l~~n~l~~--~~p~~~~~ 402 (968)
T PLN00113 326 VALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGL-CSSGNLFKLILFSNSLEG--EIPKSLGA 402 (968)
T ss_pred hhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhH-hCcCCCCEEECcCCEecc--cCCHHHhC
Confidence 5555555555555555555555554442 234555555555555555433 21111 1111110000 000000
Q ss_pred -----------cccccCCCCCCCCcccceeeeeecCC-ceeecCCccccccccc-ccccccccCCceeeEeeeCCccCCC
Q 003737 397 -----------PCLRQNFPCSAPADQYHYTLHINCGG-AKINTGHTKYEADMEA-RGASMFYSSGQYWAFSSTGKFMDDD 463 (799)
Q Consensus 397 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~n~~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (799)
+.+.+..|.. + ..+.. ..+++++|.+++.+.. ...... ...+.++. +...+.
T Consensus 403 ~~~L~~L~L~~n~l~~~~p~~---------~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~---L~~L~L~~--n~~~~~ 467 (968)
T PLN00113 403 CRSLRRVRLQDNSFSGELPSE---------F-TKLPLVYFLDISNNNLQGRINSRKWDMPS---LQMLSLAR--NKFFGG 467 (968)
T ss_pred CCCCCEEECcCCEeeeECChh---------H-hcCCCCCEEECcCCcccCccChhhccCCC---CcEEECcC--ceeeee
Confidence 0000000000 0 00001 2245555655554411 110000 01111111 111111
Q ss_pred CCCCcccccccccccccccCCHH--------HHhhhccCCcceeeeeee------ecCCceEEEeccccceecCCC--cc
Q 003737 464 TDLDNYIRTNTSTLSKVSAVDLE--------LYRTARVSPLSLTYYGLC------LGNGNYTVRLHFAEIIFKNDS--TF 527 (799)
Q Consensus 464 ~~~~~~~~~~~~~l~~~~~~~~~--------~~~~~~~~~~~l~~~~~~------~~~~~~~~~l~~~~~~~~~~~--~~ 527 (799)
+|.. . ....+..+++..+. +.....+..++++.+.+- ......+..++++.|.+.+.. .+
T Consensus 468 ~p~~--~--~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 543 (968)
T PLN00113 468 LPDS--F--GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASF 543 (968)
T ss_pred cCcc--c--ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhH
Confidence 1110 0 11122222222211 111111111111110000 000011233444444443211 11
Q ss_pred ccCCceEEEEEeCCeeeecccccchhcCCCCccEE---eeeeeeecCcccEEEEeecCCCccccCCCCCCCCceeccc--
Q 003737 528 NSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIV---KNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAIS-- 602 (799)
Q Consensus 528 ~~l~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~---~~~~~~~s~n~l~~~~~~~~~~~~~~p~~g~~~~~~~~~~-- 602 (799)
..+ ..+...+++.+...|.+|..+. .+..+++++|.+.+. +|..|.|.. ..+.+
T Consensus 544 ~~l----------~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~----------~p~~~~~~~-~~~~~~~ 602 (968)
T PLN00113 544 SEM----------PVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGS----------LPSTGAFLA-INASAVA 602 (968)
T ss_pred hCc----------ccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceee----------CCCcchhcc-cChhhhc
Confidence 111 0122223444444555654333 234578888888763 333333211 00000
Q ss_pred ----ccccc---CCCcccc--CcceeEeehhh-HHHHHHHHHHHHHHhhhhccCCCCccc-hhhc--ccCc-cc---ccc
Q 003737 603 ----VKSNF---KPPVVHS--KKNHVMIMAAI-VGASVLLVLLILFIMRWKGCLGGKVSA-DKEL--RGLD-LQ---TGL 665 (799)
Q Consensus 603 ----~~~~~---~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~-~~---~~~ 665 (799)
.|+.. ..+++.. +.....+++++ +++++++++++++++++|++++.+... .... .... .. ...
T Consensus 603 ~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 682 (968)
T PLN00113 603 GNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKS 682 (968)
T ss_pred CCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchh
Confidence 11110 0111111 11122223322 222233333333333333322111010 0000 0000 00 112
Q ss_pred ccHHHHHHhhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC
Q 003737 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG 744 (799)
Q Consensus 666 ~~~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 744 (799)
++++++ ...|...+.||+|+||.||+|+. .+|..||||+++..... ...|++.+++++|||||+++|+|.++
T Consensus 683 ~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 683 ITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred hhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 233333 34577889999999999999995 57899999998654322 23468899999999999999999999
Q ss_pred CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhc
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFF 798 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH 798 (799)
+..++|||||++|+|.+++++ +++.....++.|||+||+|||
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~~------------l~~~~~~~i~~~ia~~L~yLH 797 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLRN------------LSWERRRKIAIGIAKALRFLH 797 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHhc------------CCHHHHHHHHHHHHHHHHHhc
Confidence 999999999999999999963 234566777999999999999
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=339.57 Aligned_cols=281 Identities=32% Similarity=0.445 Sum_probs=250.5
Q ss_pred cccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEE
Q 003737 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 169 (799)
..++++|+|++|.+++.+|..++.+++|++|+|++|.+.+.+|..+..++ |++|+|++|.+++.+|..++++++|++|+
T Consensus 139 l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 218 (968)
T PLN00113 139 IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIY 218 (968)
T ss_pred cCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEE
Confidence 35789999999999999999999999999999999999999999999887 99999999999999999999999999999
Q ss_pred eeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCC
Q 003737 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (799)
Q Consensus 170 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 249 (799)
|++|++++.+|..++++++|++|++++|.+++.+|..+.++++|++|++++|.+.+.+|..+.++++|++|+|++|.+.+
T Consensus 219 L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~ 298 (968)
T PLN00113 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSG 298 (968)
T ss_pred CcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeecc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCchhhhcCCCCCeEEcCCCCCCCCCCCc-cCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhh
Q 003737 250 PIPASISALTSLTDLRISDLKGSESAFPK-LDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327 (799)
Q Consensus 250 ~~p~~~~~l~~L~~L~L~~n~~~~~~~~~-l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 327 (799)
.+|..+.++++|+.|++++|.... .+|. +.. ++|+.|++++|.+++.+|..++.+++|+.|++++|++++.+|..+.
T Consensus 299 ~~p~~~~~l~~L~~L~l~~n~~~~-~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~ 377 (968)
T PLN00113 299 EIPELVIQLQNLEILHLFSNNFTG-KIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLC 377 (968)
T ss_pred CCChhHcCCCCCcEEECCCCccCC-cCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHh
Confidence 999999999999999999855443 3343 555 7889999999999888888888889999999999999888888888
Q ss_pred ccCCCCEEeccCCcCCCcCChhhh--cCCCEEEeecCcCcccCCCCC
Q 003737 328 KLAKTNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESSDPI 372 (799)
Q Consensus 328 ~l~~L~~L~L~~N~l~g~~p~~~~--~~l~~l~ls~N~~~g~~p~~~ 372 (799)
.+++|+.|++++|++++.+|..+. ..++.|++++|++++.+|..+
T Consensus 378 ~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~ 424 (968)
T PLN00113 378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEF 424 (968)
T ss_pred CcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhH
Confidence 888888888888888888887664 467888888888888877654
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-27 Score=254.01 Aligned_cols=278 Identities=23% Similarity=0.274 Sum_probs=183.3
Q ss_pred cccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccc-cceeEEEccCCcCcCcCCcccCCCCCCCEEE
Q 003737 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWAS-LQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 169 (799)
.+|++.|+|.+|.++..-..++..++.|+.||||.|.++.+....|.. .++++|+|++|.|+..--+.|.++.+|..|.
T Consensus 124 sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlk 203 (873)
T KOG4194|consen 124 SGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLK 203 (873)
T ss_pred ccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeee
Confidence 467888888888888766777888888888888888888777666665 4588888888888877778888888888888
Q ss_pred eeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCC
Q 003737 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (799)
Q Consensus 170 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 249 (799)
|++|+++...+..|.+|++|+.|+|..|++.-.--.+|..|++|+.|.|..|.+...-...|..+.++++|+|+.|+++.
T Consensus 204 LsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~ 283 (873)
T KOG4194|consen 204 LSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQA 283 (873)
T ss_pred cccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhh
Confidence 88888886556677778888888888888774334556777777777777777665555666666666666666666665
Q ss_pred CCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCC-----------------------
Q 003737 250 PIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDM----------------------- 305 (799)
Q Consensus 250 ~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l----------------------- 305 (799)
.-..++.++++|+.|+++.|.+....+..+.. ++|+.|+|++|+|+...+..|..+
T Consensus 284 vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~ 363 (873)
T KOG4194|consen 284 VNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVG 363 (873)
T ss_pred hhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHH
Confidence 55566666666666666665554444444444 556666666666665555444444
Q ss_pred -CCCCeeccccccCCCCCch---hhhccCCCCEEeccCCcCCCcCChhhh---cCCCEEEeecCcCcccCC
Q 003737 306 -TKLKNIDLSFNNLTGGIPT---TFEKLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLNNFTWESS 369 (799)
Q Consensus 306 -~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~g~~p~~~~---~~l~~l~ls~N~~~g~~p 369 (799)
++|++|||++|.+++.+.+ .|..|+.|+.|.|.+|++. .||..-| +.++.|||.+|.+-..-|
T Consensus 364 lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaSIq~ 433 (873)
T KOG4194|consen 364 LSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIASIQP 433 (873)
T ss_pred hhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchhhhccCcccceecCCCCcceeecc
Confidence 4444444444444443332 2444555555555555555 3443332 244566666665554333
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=247.86 Aligned_cols=278 Identities=23% Similarity=0.260 Sum_probs=208.4
Q ss_pred cccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEE
Q 003737 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 169 (799)
+..++.||+++|.+..+-+..|.++++|+.++|.+|.++. +|....... |+.|+|.+|.|+.+-.+++..++.|+.||
T Consensus 77 p~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~-IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslD 155 (873)
T KOG4194|consen 77 PSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTR-IPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLD 155 (873)
T ss_pred ccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhh-cccccccccceeEEeeeccccccccHHHHHhHhhhhhhh
Confidence 3568889999999998778889999999999999999884 555444454 88999999998888888888888888888
Q ss_pred eeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCC
Q 003737 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (799)
Q Consensus 170 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 249 (799)
||.|.|+...-.+|..-.++++|+|++|+|+..-...|..+.+|.+|.|++|+++...+..|.++++|+.|+|.+|+|.-
T Consensus 156 LSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iri 235 (873)
T KOG4194|consen 156 LSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRI 235 (873)
T ss_pred hhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceee
Confidence 88888885444567777788888888888887777788888888888888888887777778888888888888888874
Q ss_pred CCchhhhcCCCCCeEEcCCCCCCC---CCC---------------------Cc-cCCCCccEEEccCCcCcccCCccccC
Q 003737 250 PIPASISALTSLTDLRISDLKGSE---SAF---------------------PK-LDKMNLKTLILTKCLIHGEIPDYIGD 304 (799)
Q Consensus 250 ~~p~~~~~l~~L~~L~L~~n~~~~---~~~---------------------~~-l~~~~L~~L~L~~N~l~~~~p~~l~~ 304 (799)
.---.|..+++|+.|.|..|++.. +.| .. ++...|+.|+|++|.|...-++.+.-
T Consensus 236 ve~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsf 315 (873)
T KOG4194|consen 236 VEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSF 315 (873)
T ss_pred ehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhh
Confidence 444566677777777666655432 211 11 12245677777777777666676667
Q ss_pred CCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhh---cCCCEEEeecCcCcccCCC
Q 003737 305 MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLNNFTWESSD 370 (799)
Q Consensus 305 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~---~~l~~l~ls~N~~~g~~p~ 370 (799)
.++|++|||++|+|+...+..|..|..|++|+|++|.++ .+.+..| .+++.|||+.|.++|.|.+
T Consensus 316 tqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~-~l~e~af~~lssL~~LdLr~N~ls~~IED 383 (873)
T KOG4194|consen 316 TQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID-HLAEGAFVGLSSLHKLDLRSNELSWCIED 383 (873)
T ss_pred cccceeEeccccccccCChhHHHHHHHhhhhcccccchH-HHHhhHHHHhhhhhhhcCcCCeEEEEEec
Confidence 777777777777777777777777777777777777776 3444333 4677889999999887754
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-25 Score=238.53 Aligned_cols=274 Identities=24% Similarity=0.348 Sum_probs=134.5
Q ss_pred cEEEEEeCCCCCcc-cCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 93 HVVTIALKAQNLTG-TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 93 ~v~~L~L~~~~l~g-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
+++++++..|++.. -||+.+..|..|+.||||+|+++. .|..+..-+ +..|+||+|+|..+....|.+|+.|-+|||
T Consensus 79 ~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~E-vP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDL 157 (1255)
T KOG0444|consen 79 RLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLRE-VPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDL 157 (1255)
T ss_pred hhHHHhhhccccccCCCCchhcccccceeeecchhhhhh-cchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhcc
Confidence 34444444444432 245555555555555555555543 233333333 455555555554332233445555555555
Q ss_pred eCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCC-CcCCccccCCCCCCEEEccCCCCCC
Q 003737 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS-GKIPEFIGKWKKIQKLHIQGSSLEG 249 (799)
Q Consensus 171 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~ 249 (799)
|+|++. .+|+.+..|..|++|+|++|.+.-.--..+-.+++|++|++++.+-+ ..+|.++..+.+|..+||+.|++.
T Consensus 158 S~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp- 235 (1255)
T KOG0444|consen 158 SNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP- 235 (1255)
T ss_pred ccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-
Confidence 555554 44445555555555555555443211112223344444444443321 234444444444444444444444
Q ss_pred CCchhhhcCCCCCeEEcCCCCCCCCC---------------------CCc-cCC-CCccEEEccCCcCcc-cCCccccCC
Q 003737 250 PIPASISALTSLTDLRISDLKGSESA---------------------FPK-LDK-MNLKTLILTKCLIHG-EIPDYIGDM 305 (799)
Q Consensus 250 ~~p~~~~~l~~L~~L~L~~n~~~~~~---------------------~~~-l~~-~~L~~L~L~~N~l~~-~~p~~l~~l 305 (799)
.+|+.+.++.+|+.|+|++|.+.... +|. +.. +.|+.|++.+|+++- -||+.++.+
T Consensus 236 ~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL 315 (1255)
T KOG0444|consen 236 IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKL 315 (1255)
T ss_pred cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhccchHHHhhhHHHHHHHhccCcccccCCccchhhh
Confidence 34444444444444444443332211 111 111 334444444444432 245555556
Q ss_pred CCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhh--hcCCCEEEeecCcCcccCCCC
Q 003737 306 TKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDP 371 (799)
Q Consensus 306 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~--~~~l~~l~ls~N~~~g~~p~~ 371 (799)
.+|+.+..++|++. .+|..++.+..|+.|.|+.|++. .+|+.+ ...++.||+..|.---..|++
T Consensus 316 ~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP 381 (1255)
T KOG0444|consen 316 IQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKP 381 (1255)
T ss_pred hhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCc
Confidence 66666666666655 56666666777777777777766 566654 456677788777655555544
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-23 Score=223.80 Aligned_cols=131 Identities=47% Similarity=0.809 Sum_probs=115.6
Q ss_pred ccccccHHHHHHhhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEE
Q 003737 662 QTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741 (799)
Q Consensus 662 ~~~~~~~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~ 741 (799)
....|++.+++.||++|+..+.||+|+||.||+|.+++|..||||++.....+..++|.+|++++++++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34579999999999999999999999999999999999999999998765443145699999999999999999999999
Q ss_pred EECC-EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 742 VEGN-QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 742 ~~~~-~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+.+ +.+||||||++|+|+++|+.+... .+.|.. ++++ |.++|+||+|||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-----~L~W~~-R~kI-a~g~A~gL~yLH~ 192 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-----PLDWET-RLKI-ALGAARGLAYLHE 192 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-----CCCHHH-HHHH-HHHHHHHHHHHcc
Confidence 9998 599999999999999999986532 235655 7776 9999999999996
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.8e-25 Score=235.57 Aligned_cols=266 Identities=24% Similarity=0.349 Sum_probs=129.5
Q ss_pred cEEEEEeCCCCCc-ccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 93 HVVTIALKAQNLT-GTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 93 ~v~~L~L~~~~l~-g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
-|+.+|+++|.++ +.+|..+..+++++.|.|...++. .+|..++.++ |++|.+++|++. .+...+..|+.|+.+++
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 3455555555555 344555555555555555544444 2344444444 555555555544 23334444445555555
Q ss_pred eCCcCC-CCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCC
Q 003737 171 EGNLFT-GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (799)
Q Consensus 171 s~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 249 (799)
..|++. .-+|..+..|..|..||||+|+++ +.|..+..-+++-+|+||+|+|..+....|-+++.|-.|||++|++.
T Consensus 86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe- 163 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE- 163 (1255)
T ss_pred hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-
Confidence 444443 124444444555555555555544 44444444444555555555544222233344444445555555444
Q ss_pred CCchhhhcCCCCCeEEcCCCCC------------------------CCCCCCc-cCC-CCccEEEccCCcCcccCCcccc
Q 003737 250 PIPASISALTSLTDLRISDLKG------------------------SESAFPK-LDK-MNLKTLILTKCLIHGEIPDYIG 303 (799)
Q Consensus 250 ~~p~~~~~l~~L~~L~L~~n~~------------------------~~~~~~~-l~~-~~L~~L~L~~N~l~~~~p~~l~ 303 (799)
.+|+.+..+..|+.|+|++|.. ....+|. +.. .+|..+||+.|.+. ..|+.+-
T Consensus 164 ~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly 242 (1255)
T KOG0444|consen 164 MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLY 242 (1255)
T ss_pred hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHh
Confidence 3344444444444444444333 2233333 333 45555555555555 4555555
Q ss_pred CCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhh--cCCCEEEeecCcCc
Q 003737 304 DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFT 365 (799)
Q Consensus 304 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~l~~l~ls~N~~~ 365 (799)
++++|+.|+||+|+|+ .+....+...+|+.|+|+.|+++ .+|+.+. ..++.|.+.+|+++
T Consensus 243 ~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~ 304 (1255)
T KOG0444|consen 243 KLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT 304 (1255)
T ss_pred hhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc
Confidence 5555555555555555 33334444555555555555555 4555543 23445555555555
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-23 Score=215.31 Aligned_cols=260 Identities=24% Similarity=0.356 Sum_probs=213.1
Q ss_pred EEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeC
Q 003737 94 VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (799)
Q Consensus 94 v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~ 172 (799)
+..+.+++|.++ .+.+.+.++..|.+|++++|++... |++++.+. ++.|+.++|+++ .+|+.++.+.+|+.|+.++
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~~l-p~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLSQL-PAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhhhC-CHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 567888999888 5666788999999999999999854 55566665 999999999998 8899999999999999999
Q ss_pred CcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCc
Q 003737 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252 (799)
Q Consensus 173 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 252 (799)
|.+. .+|++++.+..|+.|+..+|+++ ..|..++.+.+|..|++.+|.+....|+.+. |+.|++||...|-++ .+|
T Consensus 124 n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP 199 (565)
T KOG0472|consen 124 NELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLP 199 (565)
T ss_pred ccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCC
Confidence 9997 78888999999999999999998 7888899999999999999999865555554 999999999999887 688
Q ss_pred hhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCcccc-CCCCCCeeccccccCCCCCchhhhccC
Q 003737 253 ASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIG-DMTKLKNIDLSFNNLTGGIPTTFEKLA 330 (799)
Q Consensus 253 ~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 330 (799)
+.++.+.+|..|++..|++.. +|.|.. ..|++|+++.|+|+ .+|.+.. ++++|..|||..|+++ ..|+.+..+.
T Consensus 200 ~~lg~l~~L~~LyL~~Nki~~--lPef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLr 275 (565)
T KOG0472|consen 200 PELGGLESLELLYLRRNKIRF--LPEFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLR 275 (565)
T ss_pred hhhcchhhhHHHHhhhccccc--CCCCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhh
Confidence 889999999999888766543 456655 56888888888887 5666654 7888888888888888 7888888888
Q ss_pred CCCEEeccCCcCCCcCChhhhc-CCCEEEeecCcCc
Q 003737 331 KTNFMYLTGNKLTGPVPKYIFN-SNKNVDISLNNFT 365 (799)
Q Consensus 331 ~L~~L~L~~N~l~g~~p~~~~~-~l~~l~ls~N~~~ 365 (799)
+|..||+++|.++ .+|..+++ .++.|.+.+|.+-
T Consensus 276 sL~rLDlSNN~is-~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 276 SLERLDLSNNDIS-SLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred hhhhhcccCCccc-cCCcccccceeeehhhcCCchH
Confidence 8888888888888 45655554 4667777777664
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.6e-23 Score=212.20 Aligned_cols=248 Identities=24% Similarity=0.403 Sum_probs=214.5
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEee
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls 171 (799)
..++.+++.+|++. ++|++++.+..++.|+.++|++...++......+++.|+.++|.+. .+|+.++.+..|+.|+..
T Consensus 68 ~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~ 145 (565)
T KOG0472|consen 68 ACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDAT 145 (565)
T ss_pred cceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhcc
Confidence 35788999999998 8899999999999999999999965444444445999999999998 788889999999999999
Q ss_pred CCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCC
Q 003737 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251 (799)
Q Consensus 172 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 251 (799)
+|+++ ..|+.++++.+|..|++.+|.+.. .|+..-+++.|++||...|-+. .+|+.++.+.+|+.|+|.+|++. ..
T Consensus 146 ~N~i~-slp~~~~~~~~l~~l~~~~n~l~~-l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~l 221 (565)
T KOG0472|consen 146 NNQIS-SLPEDMVNLSKLSKLDLEGNKLKA-LPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FL 221 (565)
T ss_pred ccccc-cCchHHHHHHHHHHhhccccchhh-CCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cC
Confidence 99998 789999999999999999999994 5555555999999999999887 88999999999999999999998 45
Q ss_pred chhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccC
Q 003737 252 PASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLA 330 (799)
Q Consensus 252 p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 330 (799)
| +|..+..|++|+++.|.+...+...... .+|..|||..|+++ ..|+.+.-+.+|++||+|+|.++ .+|.+++++
T Consensus 222 P-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl- 297 (565)
T KOG0472|consen 222 P-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL- 297 (565)
T ss_pred C-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-
Confidence 6 8999999999999975544322222444 78999999999998 78999999999999999999999 678899999
Q ss_pred CCCEEeccCCcCCCcCChhh
Q 003737 331 KTNFMYLTGNKLTGPVPKYI 350 (799)
Q Consensus 331 ~L~~L~L~~N~l~g~~p~~~ 350 (799)
.|+.|-+.+|.+. .|-..+
T Consensus 298 hL~~L~leGNPlr-TiRr~i 316 (565)
T KOG0472|consen 298 HLKFLALEGNPLR-TIRREI 316 (565)
T ss_pred eeeehhhcCCchH-HHHHHH
Confidence 9999999999997 444433
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=188.43 Aligned_cols=116 Identities=26% Similarity=0.500 Sum_probs=105.5
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
..+|...+.||+|+||+||+|++ .++..||||.+.+. .....+....|+++|+.++|||||+++.++.+++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 45677778899999999999995 57899999999776 4455677899999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||.+|||.++|+.++ .++|+.++.|+.|+|.||++||+
T Consensus 89 EyC~gGDLs~yi~~~~---------~l~e~t~r~Fm~QLA~alq~L~~ 127 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---------RLPEATARHFMQQLASALQFLHE 127 (429)
T ss_pred EeCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999886 78899999999999999999995
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-21 Score=200.46 Aligned_cols=284 Identities=20% Similarity=0.220 Sum_probs=188.6
Q ss_pred cccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-ee-EEEccCCcCcCcCCcccCCCCCCCEE
Q 003737 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LV-ELSVMGNRLSGPFPKVLTNITTLKNL 168 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~-~L~Ls~N~l~~~~p~~~~~L~~L~~L 168 (799)
++..+.|+|..|+|+...|.+|..+++|++||||+|+|+.+-|.+|.++. +. -+++++|+|+...-+.|++|..|+.|
T Consensus 66 P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrL 145 (498)
T KOG4237|consen 66 PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRL 145 (498)
T ss_pred CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHH
Confidence 45667777777777766666777777777777777777777777777775 33 34455577776555677777777777
Q ss_pred EeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCCh-hccCCCCCCEEEccCCcCC------------CcCCccccCCC
Q 003737 169 SIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPA-ELTKLTNLNDLRISDNNFS------------GKIPEFIGKWK 235 (799)
Q Consensus 169 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~------------~~~p~~~~~l~ 235 (799)
.+.-|++.-...+.|..|++|..|.+.+|.+. .++. +|..+.+++.+.+..|.+. ...|-.++...
T Consensus 146 llNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgar 224 (498)
T KOG4237|consen 146 LLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGAR 224 (498)
T ss_pred hcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccce
Confidence 77777776555666777777777777777776 3443 6777777777777776632 12223333333
Q ss_pred CCCEEEccCCCCCCCCchhhhcCCCCCeE--EcCCCCCCCCCCCc--cCC-CCccEEEccCCcCcccCCccccCCCCCCe
Q 003737 236 KIQKLHIQGSSLEGPIPASISALTSLTDL--RISDLKGSESAFPK--LDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKN 310 (799)
Q Consensus 236 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L--~L~~n~~~~~~~~~--l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 310 (799)
-..-..|..+++....+..|.. +++.+ .++.........|. |.. ++|+.|+|++|++++.-+.+|.++..+++
T Consensus 225 c~~p~rl~~~Ri~q~~a~kf~c--~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~e 302 (498)
T KOG4237|consen 225 CVSPYRLYYKRINQEDARKFLC--SLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQE 302 (498)
T ss_pred ecchHHHHHHHhcccchhhhhh--hHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhh
Confidence 3333334444443333332221 12222 12222223334443 555 89999999999999999999999999999
Q ss_pred eccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhh--cCCCEEEeecCcCcccCCCCCcCCCCCccceecc
Q 003737 311 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESSDPIECPRGSVNLVESY 385 (799)
Q Consensus 311 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~l~~l~ls~N~~~g~~p~~~~~~~~~~~~~~~~ 385 (799)
|.|..|+|...-...|.++..|+.|+|.+|+|+-.-|..+- .++..|.|-.|.| .|++.-..+-+|.
T Consensus 303 L~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~--------~CnC~l~wl~~Wl 371 (498)
T KOG4237|consen 303 LYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF--------NCNCRLAWLGEWL 371 (498)
T ss_pred hhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc--------cCccchHHHHHHH
Confidence 99999999977778899999999999999999965565442 3567888888865 4877654444443
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.4e-19 Score=204.46 Aligned_cols=240 Identities=27% Similarity=0.357 Sum_probs=116.5
Q ss_pred EEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcC
Q 003737 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLF 175 (799)
Q Consensus 96 ~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l 175 (799)
.|+|+.++|+ .+|+.+. ++|+.|++++|+++.. |.. ..+|++|+|++|+|+. +|.. .++|+.|+|++|.+
T Consensus 205 ~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~L-P~l--p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L 274 (788)
T PRK15387 205 VLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSL-PAL--PPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPL 274 (788)
T ss_pred EEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCC-CCC--CCCCcEEEecCCccCc-ccCc---ccccceeeccCCch
Confidence 4566666666 4565554 3566666666666643 221 1126666666666663 3432 24555555555555
Q ss_pred CCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCcccc-----------------CCCCCC
Q 003737 176 TGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIG-----------------KWKKIQ 238 (799)
Q Consensus 176 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----------------~l~~L~ 238 (799)
+ .+|.. .++|+.|++++|+++ .+|.. +++|+.|++++|++++ +|.... -..+|+
T Consensus 275 ~-~Lp~l---p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq 345 (788)
T PRK15387 275 T-HLPAL---PSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPTLPSGLQ 345 (788)
T ss_pred h-hhhhc---hhhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCCcccccccccccCccccccccccccc
Confidence 4 23321 133445555555554 23321 2345555555555543 222111 012455
Q ss_pred EEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccC
Q 003737 239 KLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNL 318 (799)
Q Consensus 239 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 318 (799)
.|+|++|+|++ +|.. ..+|+.|++++|.+. .+|.+. .+|+.|+|++|.|++ +|.. .++|+.|++++|+|
T Consensus 346 ~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~--~LP~l~-~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~L 414 (788)
T PRK15387 346 ELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT--SLPALP-SGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRL 414 (788)
T ss_pred eEecCCCccCC-CCCC---Ccccceehhhccccc--cCcccc-cccceEEecCCcccC-CCCc---ccCCCEEEccCCcC
Confidence 55555555553 2322 234444555543322 133221 345666666666653 3332 24566666666666
Q ss_pred CCCCchhhhccCCCCEEeccCCcCCCcCChhhh--cCCCEEEeecCcCcccCCC
Q 003737 319 TGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESSD 370 (799)
Q Consensus 319 ~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~l~~l~ls~N~~~g~~p~ 370 (799)
++ +|..+ .+|+.|++++|+|+ .+|..+. ..++.++|++|+|++.+|.
T Consensus 415 ss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 415 TS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred CC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 53 44322 34555666666665 4555543 2455666666666655443
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=204.07 Aligned_cols=308 Identities=22% Similarity=0.255 Sum_probs=210.7
Q ss_pred cCCCCHHHHHHHHHHHHhcCC--------CCCCCCCCCCCCCCC-CcccCCCCCCCCCCeEecCCCCcccEEEEEeCCCC
Q 003737 33 ANKLHAEEVKALKQIGRKLGK--------KDWNFGVDPCSQKGN-WELSSDDKKGFESNVTCDCSSATCHVVTIALKAQN 103 (799)
Q Consensus 33 ~~~~~~~~~~aL~~~~~~~~~--------~~W~~~~d~C~~~~~-W~~~~~~~~~~~~gv~c~~~~~~~~v~~L~L~~~~ 103 (799)
.+.+.++|.+.+.++.+.+.. ..|+.++|+|....+ -+............|.|.. ..|+.+..-+..
T Consensus 57 ~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~----~~vt~l~~~g~~ 132 (754)
T PRK15370 57 PETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGG----KSVTYTRVTESE 132 (754)
T ss_pred CCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecCC----Cccccccccccc
Confidence 455779999999999998853 348877888843220 0000000011123455643 456666554432
Q ss_pred Cccc---------------------CC-------ccc-----cCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCc
Q 003737 104 LTGT---------------------LP-------TEL-----SKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNR 150 (799)
Q Consensus 104 l~g~---------------------~p-------~~~-----~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~ 150 (799)
.... .+ ..+ +-..+...|+++++.++.. |..+. -.++.|+|++|+
T Consensus 133 ~~~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~LtsL-P~~Ip-~~L~~L~Ls~N~ 210 (754)
T PRK15370 133 QASSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTTI-PACIP-EQITTLILDNNE 210 (754)
T ss_pred ccccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCcC-Ccccc-cCCcEEEecCCC
Confidence 2110 00 001 1124578899999888854 43332 148899999999
Q ss_pred CcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCcc
Q 003737 151 LSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEF 230 (799)
Q Consensus 151 l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 230 (799)
|+ .+|..+. ++|++|++++|+++ .+|..+. .+|+.|+|++|++. .+|..+. ++|+.|++++|+++ .+|+.
T Consensus 211 Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~ 280 (754)
T PRK15370 211 LK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPEN 280 (754)
T ss_pred CC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccc
Confidence 98 4565553 58999999999988 5676553 47999999999988 6777664 47999999999998 56776
Q ss_pred ccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCe
Q 003737 231 IGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKN 310 (799)
Q Consensus 231 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 310 (799)
+. ++|+.|+|++|++++ +|..+. ++|+.|++++|.... +|.....+|+.|++++|.+++ +|..+. ++|+.
T Consensus 281 l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~--LP~~l~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~ 350 (754)
T PRK15370 281 LP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA--LPETLPPGLKTLEAGENALTS-LPASLP--PELQV 350 (754)
T ss_pred cC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc--CCccccccceeccccCCcccc-CChhhc--CcccE
Confidence 54 589999999999885 454442 468888888866543 333222578999999999885 666553 68999
Q ss_pred eccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhhcCCCEEEeecCcCcccCCCC
Q 003737 311 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDP 371 (799)
Q Consensus 311 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~l~~l~ls~N~~~g~~p~~ 371 (799)
|++++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+...++.||+++|+++ .+|..
T Consensus 351 L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~~sL~~LdLs~N~L~-~LP~s 406 (754)
T PRK15370 351 LDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLPAALQIMQASRNNLV-RLPES 406 (754)
T ss_pred EECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHHHHHHHHhhccCCcc-cCchh
Confidence 999999998 5676653 68999999999998 578777777889999999887 44543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=204.77 Aligned_cols=245 Identities=24% Similarity=0.357 Sum_probs=192.4
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEee
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls 171 (799)
.+.+.|++++++++ .+|..+. ++|+.|+|++|+++..+.. +. .+|++|++++|+|+ .+|..+. .+|+.|+|+
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~LtsLP~~-l~-~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELKSLPEN-LQ-GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCcCChh-hc-cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 45788999999998 5776664 5899999999999965443 32 25999999999998 5676654 579999999
Q ss_pred CCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCC
Q 003737 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251 (799)
Q Consensus 172 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 251 (799)
+|++. .+|..+. .+|++|++++|+++ .+|..+. ++|++|++++|++++ +|..+. ++|+.|++++|+++. +
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-L 319 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-L 319 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-C
Confidence 99998 6787664 58999999999998 5787664 589999999999984 565543 579999999999985 5
Q ss_pred chhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCC
Q 003737 252 PASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331 (799)
Q Consensus 252 p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 331 (799)
|..+ .++|+.|++++|.... +|..-..+|+.|++++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ..
T Consensus 320 P~~l--~~sL~~L~Ls~N~Lt~--LP~~l~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~s 389 (754)
T PRK15370 320 PETL--PPGLKTLEAGENALTS--LPASLPPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AA 389 (754)
T ss_pred Cccc--cccceeccccCCcccc--CChhhcCcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HH
Confidence 5544 3689999999866543 34311268999999999998 5676553 68999999999999 5676654 36
Q ss_pred CCEEeccCCcCCCcCChhhh------cCCCEEEeecCcCc
Q 003737 332 TNFMYLTGNKLTGPVPKYIF------NSNKNVDISLNNFT 365 (799)
Q Consensus 332 L~~L~L~~N~l~g~~p~~~~------~~l~~l~ls~N~~~ 365 (799)
|+.|++++|+|+ .+|..+. ..+..+++.+|.++
T Consensus 390 L~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 390 LQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred HHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 899999999998 6776542 34578999999886
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.2e-18 Score=199.65 Aligned_cols=227 Identities=27% Similarity=0.394 Sum_probs=155.9
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccC-----------
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLT----------- 160 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~----------- 160 (799)
.+++.|++.+|+++. +|. ..++|++|+|++|+|+.. |... -+|++|++++|.++ .+|..+.
T Consensus 222 ~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~LtsL-P~lp--~sL~~L~Ls~N~L~-~Lp~lp~~L~~L~Ls~N~ 293 (788)
T PRK15387 222 AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSL-PVLP--PGLLELSIFSNPLT-HLPALPSGLCKLWIFGNQ 293 (788)
T ss_pred cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCcc-cCcc--cccceeeccCCchh-hhhhchhhcCEEECcCCc
Confidence 367888888888874 554 247788888888888854 3211 12556666666555 2232211
Q ss_pred ------CCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCC
Q 003737 161 ------NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKW 234 (799)
Q Consensus 161 ------~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 234 (799)
.+++|+.|+|++|++++ +|... .+|+.|++++|+++ .+|.. ..+|++|+|++|+|++ +|.. .
T Consensus 294 Lt~LP~~p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p 361 (788)
T PRK15387 294 LTSLPVLPPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLAS-LPTL---P 361 (788)
T ss_pred cccccccccccceeECCCCcccc-CCCCc---ccccccccccCccc-ccccc---ccccceEecCCCccCC-CCCC---C
Confidence 12345555555555542 33211 23445555555554 23321 1479999999999984 5653 3
Q ss_pred CCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccc
Q 003737 235 KKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLS 314 (799)
Q Consensus 235 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 314 (799)
.+|+.|++++|+++. +|.. ..+|+.|++++|.+.. +|... .+|+.|++++|+|++ +|.. ..+|+.|+++
T Consensus 362 ~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~--LP~l~-s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls 430 (788)
T PRK15387 362 SELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS--LPVLP-SELKELMVSGNRLTS-LPML---PSGLLSLSVY 430 (788)
T ss_pred cccceehhhcccccc-Cccc---ccccceEEecCCcccC--CCCcc-cCCCEEEccCCcCCC-CCcc---hhhhhhhhhc
Confidence 578899999999985 6653 3579999999976543 44322 579999999999985 6654 3578899999
Q ss_pred cccCCCCCchhhhccCCCCEEeccCCcCCCcCChhh
Q 003737 315 FNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI 350 (799)
Q Consensus 315 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~ 350 (799)
+|+|+ .+|..+.++++|+.|+|++|+|++.+|..+
T Consensus 431 ~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 431 RNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred cCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 99999 789999999999999999999999888765
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-17 Score=206.04 Aligned_cols=254 Identities=21% Similarity=0.315 Sum_probs=130.4
Q ss_pred cEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEee
Q 003737 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (799)
Q Consensus 93 ~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls 171 (799)
+++.|++.++.++ .+|..| ...+|+.|+|++|++.. ++..+..+. |++|+|+++...+.+|. ++.+++|++|+|+
T Consensus 590 ~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~-L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~ 665 (1153)
T PLN03210 590 KLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEK-LWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLS 665 (1153)
T ss_pred ccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccc-cccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEec
Confidence 3555555555543 445444 34566666666666553 333344444 66666665544344443 5556666666666
Q ss_pred CCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCC
Q 003737 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251 (799)
Q Consensus 172 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 251 (799)
+|.....+|..+.++++|+.|++++|...+.+|..+ ++++|++|++++|...+.+|.. .++|++|+|++|.++ .+
T Consensus 666 ~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~l 740 (1153)
T PLN03210 666 DCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EF 740 (1153)
T ss_pred CCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cc
Confidence 655445566666666666666666654434555443 4555555555555443333322 234444555554443 22
Q ss_pred chhh------------------------------hcCCCCCeEEcCCCCCCCCCCCc-cCC-CCccEEEccCCcCcccCC
Q 003737 252 PASI------------------------------SALTSLTDLRISDLKGSESAFPK-LDK-MNLKTLILTKCLIHGEIP 299 (799)
Q Consensus 252 p~~~------------------------------~~l~~L~~L~L~~n~~~~~~~~~-l~~-~~L~~L~L~~N~l~~~~p 299 (799)
|..+ ...++|+.|++++|.... .+|. +.. .+|+.|+|++|..-+.+|
T Consensus 741 P~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~-~lP~si~~L~~L~~L~Ls~C~~L~~LP 819 (1153)
T PLN03210 741 PSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLV-ELPSSIQNLHKLEHLEIENCINLETLP 819 (1153)
T ss_pred cccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCcc-ccChhhhCCCCCCEEECCCCCCcCeeC
Confidence 2211 112345555555433222 2332 333 566666666654444555
Q ss_pred ccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhh--hcCCCEEEeec
Q 003737 300 DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISL 361 (799)
Q Consensus 300 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~--~~~l~~l~ls~ 361 (799)
..+ ++++|+.|+|++|.....+|.. .++|+.|+|++|.++ .+|..+ +..++.|++++
T Consensus 820 ~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~ 878 (1153)
T PLN03210 820 TGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNG 878 (1153)
T ss_pred CCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCC
Confidence 544 4666666666665444444432 245666666666665 455544 23556666665
|
syringae 6; Provisional |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.2e-18 Score=195.04 Aligned_cols=126 Identities=25% Similarity=0.458 Sum_probs=106.2
Q ss_pred HHhhcCCCCCCeecccCCeeEEEEEeC------CCcEEEEEEccccChh-hHHHHHHHHHHHHhCCCCcccceeEEEEEC
Q 003737 672 KAATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEG 744 (799)
Q Consensus 672 ~~~t~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 744 (799)
+..+.+....+.||+|+||+||+|+.. +.+.||||.++..... .+++|.||+++++.++|||||+|+|+|..+
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 344556667789999999999999853 3468999999877554 778999999999999999999999999999
Q ss_pred CEEEEEEecCCCCcHHHHHhcCccccccc-cc----CCCChHHHHHHHHHHHHHHhhh
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFHIS-IY----ATFPQGNIQILIISAANNIDFF 797 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~-~~----~~~~~~~i~~~~~qi~~gL~yL 797 (799)
++.+||+|||..|||+++|+.+.+..... .. ..+...+...+|.|||.||+||
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YL 619 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYL 619 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999998665433322 22 2377888999999999999999
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-19 Score=203.47 Aligned_cols=266 Identities=24% Similarity=0.302 Sum_probs=197.9
Q ss_pred cEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCccc------------------ccccceeEEEccCCcCcCc
Q 003737 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQ------------------WASLQLVELSVMGNRLSGP 154 (799)
Q Consensus 93 ~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~------------------~~~l~L~~L~Ls~N~l~~~ 154 (799)
.++.++|..+.+.+.++.++..+++ .|||++|.+....-.. ....+|+.|+.++|.++..
T Consensus 157 ~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~ 234 (1081)
T KOG0618|consen 157 SIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEVLDLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTL 234 (1081)
T ss_pred cchhhhhhhhhcccchhcchhhhhe--eeecccchhhhhhhhhccchhhhhhhhcccceEEecCcchheeeeccCcceee
Confidence 3777888888888888888887777 7888888776221111 1122355666666766633
Q ss_pred CCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCC
Q 003737 155 FPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKW 234 (799)
Q Consensus 155 ~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 234 (799)
.+.. --.+|+++++++|+++ .+|++++.+.+|+.|+..+|+++ .+|..+..+++|+.|++..|.+. .+|+....+
T Consensus 235 ~~~p--~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~ 309 (1081)
T KOG0618|consen 235 DVHP--VPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGL 309 (1081)
T ss_pred cccc--ccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCccccc
Confidence 3222 2357888999999888 56788888999999999999986 78888888888888888888887 678888888
Q ss_pred CCCCEEEccCCCCCCCCchhhhc-------------------------CCCCCeEEcCCCCCCCCCCCccCC-CCccEEE
Q 003737 235 KKIQKLHIQGSSLEGPIPASISA-------------------------LTSLTDLRISDLKGSESAFPKLDK-MNLKTLI 288 (799)
Q Consensus 235 ~~L~~L~L~~N~l~~~~p~~~~~-------------------------l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~ 288 (799)
+.|++|+|..|++....+..+.. +..|+.|.+.+|...+..+|.+.. .+|+.|+
T Consensus 310 ~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLh 389 (1081)
T KOG0618|consen 310 KSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLH 389 (1081)
T ss_pred ceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeee
Confidence 89999999988887432222211 234556666676667777888777 8899999
Q ss_pred ccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhh-hcCCCEEEeecCcCccc
Q 003737 289 LTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI-FNSNKNVDISLNNFTWE 367 (799)
Q Consensus 289 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~-~~~l~~l~ls~N~~~g~ 367 (799)
|++|++.......+.++..|++|+||+|+++ .+|.++.+++.|++|...+|++. ..|... .+.++.+|+|.|+++-.
T Consensus 390 LsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fPe~~~l~qL~~lDlS~N~L~~~ 467 (1081)
T KOG0618|consen 390 LSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFPELAQLPQLKVLDLSCNNLSEV 467 (1081)
T ss_pred ecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-echhhhhcCcceEEecccchhhhh
Confidence 9999998555556888999999999999999 78888888888888888888888 667322 35678888888888743
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.3e-17 Score=202.06 Aligned_cols=260 Identities=21% Similarity=0.272 Sum_probs=207.3
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.+++.|++.++.+. .++..+..+++|+.|+|+++...+.+|. +..++ |++|+|++|.....+|..++++++|+.|++
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 57899999999987 6788899999999999999865556664 56665 999999998877789999999999999999
Q ss_pred eCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccc-------------------
Q 003737 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI------------------- 231 (799)
Q Consensus 171 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~------------------- 231 (799)
++|.....+|..+ ++++|++|++++|...+.+|.. .++|+.|++++|.+. .+|..+
T Consensus 689 ~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~ 763 (1153)
T PLN03210 689 SRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLW 763 (1153)
T ss_pred CCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccccccccccccccccchhhcc
Confidence 9986656788766 7899999999998766666643 457888888888876 444432
Q ss_pred -----------cCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCc-cCCCCccEEEccCCcCcccCC
Q 003737 232 -----------GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPK-LDKMNLKTLILTKCLIHGEIP 299 (799)
Q Consensus 232 -----------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~-l~~~~L~~L~L~~N~l~~~~p 299 (799)
...++|+.|+|++|...+.+|..++++++|+.|++++|+.... +|. ....+|+.|+|++|.....+|
T Consensus 764 ~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~-LP~~~~L~sL~~L~Ls~c~~L~~~p 842 (1153)
T PLN03210 764 ERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLET-LPTGINLESLESLDLSGCSRLRTFP 842 (1153)
T ss_pred ccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCe-eCCCCCccccCEEECCCCCcccccc
Confidence 1235788999999988888999999999999999998765443 444 333789999999987655666
Q ss_pred ccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhh--cCCCEEEeecCc
Q 003737 300 DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNN 363 (799)
Q Consensus 300 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~l~~l~ls~N~ 363 (799)
.. .++|+.|+|++|.++ .+|..+..+++|+.|+|++|+-...+|..+. ..++.++++++.
T Consensus 843 ~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 843 DI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred cc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 53 468999999999998 6899999999999999998544335666543 467788887763
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.2e-20 Score=188.01 Aligned_cols=273 Identities=21% Similarity=0.256 Sum_probs=202.7
Q ss_pred EEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeC-
Q 003737 95 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEG- 172 (799)
Q Consensus 95 ~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~- 172 (799)
..++.++.+++ ++|..+. ..-..++|..|+|+.+++..|+.++ |+.||||+|+|+.+-|+.|.+|++|..|-+.+
T Consensus 49 ~~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~ 125 (498)
T KOG4237|consen 49 GIVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGN 125 (498)
T ss_pred ceEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcC
Confidence 34566666776 6665544 4567899999999999999999998 99999999999999999999999988876655
Q ss_pred CcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCC---
Q 003737 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG--- 249 (799)
Q Consensus 173 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--- 249 (799)
|+|+......|++|..|+.|.+.-|++.....+.|..|++|..|.+.+|.+...--..|..+..++.+.+..|.+-.
T Consensus 126 NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCn 205 (498)
T KOG4237|consen 126 NKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCN 205 (498)
T ss_pred CchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccc
Confidence 99986555679999999999999999998888899999999999999999985444489999999999999998432
Q ss_pred ---------CCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEE---EccCCcCcccCC-ccccCCCCCCeeccccc
Q 003737 250 ---------PIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTL---ILTKCLIHGEIP-DYIGDMTKLKNIDLSFN 316 (799)
Q Consensus 250 ---------~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L---~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N 316 (799)
..|.+++...-..-..+.........-..+. ..++.+ ..+.+...+.-| ..|..+++|+.|+|++|
T Consensus 206 L~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~-c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN 284 (498)
T KOG4237|consen 206 LPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFL-CSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNN 284 (498)
T ss_pred cchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhh-hhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCC
Confidence 1222222222222111111111110000111 112222 122333333444 35889999999999999
Q ss_pred cCCCCCchhhhccCCCCEEeccCCcCCCcCChhhhc---CCCEEEeecCcCcccCCCCC
Q 003737 317 NLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN---SNKNVDISLNNFTWESSDPI 372 (799)
Q Consensus 317 ~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~---~l~~l~ls~N~~~g~~p~~~ 372 (799)
++++.-+.+|..+..+++|+|..|++. .+....|. .++.|+|.+|+++-.-|-.+
T Consensus 285 ~i~~i~~~aFe~~a~l~eL~L~~N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF 342 (498)
T KOG4237|consen 285 KITRIEDGAFEGAAELQELYLTRNKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPGAF 342 (498)
T ss_pred ccchhhhhhhcchhhhhhhhcCcchHH-HHHHHhhhccccceeeeecCCeeEEEecccc
Confidence 999999999999999999999999998 45555554 57899999999997776554
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.5e-19 Score=191.05 Aligned_cols=248 Identities=20% Similarity=0.246 Sum_probs=136.5
Q ss_pred EEeCCCCCc-ccCCccccCCCCCCEEEccCCcCCCc----Ccccccccc-eeEEEccCCcCcC------cCCcccCCCCC
Q 003737 97 IALKAQNLT-GTLPTELSKLRYLKQLDLSRNCLTGS----FSPQWASLQ-LVELSVMGNRLSG------PFPKVLTNITT 164 (799)
Q Consensus 97 L~L~~~~l~-g~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~-L~~L~Ls~N~l~~------~~p~~~~~L~~ 164 (799)
|+|..+.++ +.....+..++.|++|+++++.++.. ++..+...+ +++|+++++.+.+ .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 455556665 33444455666677777777776432 233333333 6677776666652 23345556667
Q ss_pred CCEEEeeCCcCCCCCCccccCCCC---CCEEEcccCcCCc----cCChhccCC-CCCCEEEccCCcCCCc----CCcccc
Q 003737 165 LKNLSIEGNLFTGSIPPDIRKLIN---LQKLILSSNSFTG----ELPAELTKL-TNLNDLRISDNNFSGK----IPEFIG 232 (799)
Q Consensus 165 L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~----~~p~~~~~l-~~L~~L~Ls~N~l~~~----~p~~~~ 232 (799)
|+.|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++. ++..+.
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~ 162 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR 162 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHH
Confidence 777777777776555555544444 7777777777662 233344555 6777777777776632 233455
Q ss_pred CCCCCCEEEccCCCCCCC----CchhhhcCCCCCeEEcCCCCCCCCCCCc----cCC-CCccEEEccCCcCcccCCcccc
Q 003737 233 KWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESAFPK----LDK-MNLKTLILTKCLIHGEIPDYIG 303 (799)
Q Consensus 233 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~n~~~~~~~~~----l~~-~~L~~L~L~~N~l~~~~p~~l~ 303 (799)
.+++|++|++++|.+++. ++..+..+++|+.|++++|......... +.. ++|+.|++++|.+++.....+.
T Consensus 163 ~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~ 242 (319)
T cd00116 163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALA 242 (319)
T ss_pred hCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHH
Confidence 556677777777776642 2233444456666666664433211111 122 4566666666666542221111
Q ss_pred -----CCCCCCeeccccccCCC----CCchhhhccCCCCEEeccCCcCCC
Q 003737 304 -----DMTKLKNIDLSFNNLTG----GIPTTFEKLAKTNFMYLTGNKLTG 344 (799)
Q Consensus 304 -----~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~g 344 (799)
..+.|++|++++|.++. .+...+..+++|+++++++|.++.
T Consensus 243 ~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~ 292 (319)
T cd00116 243 SALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGE 292 (319)
T ss_pred HHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcH
Confidence 12566666666666651 233344555666666666666663
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.6e-17 Score=176.86 Aligned_cols=115 Identities=25% Similarity=0.466 Sum_probs=100.7
Q ss_pred cCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEEC--CEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 750 (799)
+.|+..+.||+|.||.||||. ..+|+.||+|+++... .....-..|||.+|++++||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 346667889999999999999 6789999999997654 44556788999999999999999999998776 689999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|||++ ||..++...+ +.|.+.++++||.|+++||+|+|.
T Consensus 197 FeYMdh-DL~GLl~~p~--------vkft~~qIKc~mkQLl~Gl~~cH~ 236 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG--------VKFTEPQIKCYMKQLLEGLEYCHS 236 (560)
T ss_pred Eecccc-hhhhhhcCCC--------cccChHHHHHHHHHHHHHHHHHhh
Confidence 999998 9999987654 268899999999999999999995
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.7e-17 Score=176.26 Aligned_cols=112 Identities=29% Similarity=0.531 Sum_probs=95.7
Q ss_pred CCeecccCCeeEEEEEeCCCcEEEEEEccccChh--hHHHHHHHHHHHHhCCCCcccceeEEEEECC-EEEEEEecCCCC
Q 003737 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPNLVKLYGCCVEGN-QLLLVYEYMKNN 757 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~~~G 757 (799)
.+.+|+|+||+||+|.+.....||||++...... ..++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 4559999999999999964444999999765322 2569999999999999999999999999887 799999999999
Q ss_pred cHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 758 CLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 758 sL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|.++++++... .++...+..+|.|||+||+|||+
T Consensus 126 sL~~~l~~~~~~-------~l~~~~~l~~aldiArGm~YLH~ 160 (362)
T KOG0192|consen 126 SLSVLLHKKRKR-------KLPLKVRLRIALDIARGMEYLHS 160 (362)
T ss_pred cHHHHHhhcccC-------CCCHHHHHHHHHHHHHHHHHHhc
Confidence 999999984111 57777888889999999999996
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.8e-17 Score=169.98 Aligned_cols=115 Identities=18% Similarity=0.334 Sum_probs=100.2
Q ss_pred cCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccChh-------hHHHHHHHHHHHHhCCCCcccceeEEEEECCEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQ-------GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 747 (799)
+.|-..+.+|+|+||.|-+|. ..+|+.||||++.+.... ......+|+++|++++|||||++++++..+++.
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 445667899999999999998 678999999999764211 112357999999999999999999999999999
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||||||++|+|.+.+-..+ .+.|+..+.|++|++.|+.|||+
T Consensus 252 YmVlE~v~GGeLfd~vv~nk---------~l~ed~~K~~f~Qll~avkYLH~ 294 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANK---------YLREDLGKLLFKQLLTAVKYLHS 294 (475)
T ss_pred EEEEEEecCccHHHHHHhcc---------ccccchhHHHHHHHHHHHHHHHH
Confidence 99999999999999998776 56788889999999999999996
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=6e-17 Score=179.78 Aligned_cols=113 Identities=22% Similarity=0.436 Sum_probs=97.2
Q ss_pred CCCCCeecccCCeeEEEEEeC----CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 678 FDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
..+.++||.|.||.||+|.++ ....||||.++... +..+.+|..|+.+|+++.||||++|.|+....++.++|.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 345689999999999999964 34689999998874 4556899999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhc
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFF 798 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH 798 (799)
||+||+|+.+|+.+...+. .-++.-+.+.||.||.||-
T Consensus 711 yMENGsLDsFLR~~DGqft--------viQLVgMLrGIAsGMkYLs 748 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQFT--------VIQLVGMLRGIASGMKYLS 748 (996)
T ss_pred hhhCCcHHHHHhhcCCceE--------eehHHHHHHHHHHHhHHHh
Confidence 9999999999998765432 3356666999999999984
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.5e-17 Score=175.39 Aligned_cols=114 Identities=23% Similarity=0.390 Sum_probs=98.7
Q ss_pred CCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCC
Q 003737 678 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~G 757 (799)
+...+.||+|.||.||.|.+.....||||.++.. ....++|.+|+++|++++|+|||+++|+|..++++|||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3346789999999999999987779999999765 334578999999999999999999999999999999999999999
Q ss_pred cHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 758 CLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 758 sL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|.++|+.+.+. .+.-.++..|+.|||+||+||++
T Consensus 287 sLl~yLr~~~~~-------~l~~~~Ll~~a~qIaeGM~YLes 321 (468)
T KOG0197|consen 287 SLLDYLRTREGG-------LLNLPQLLDFAAQIAEGMAYLES 321 (468)
T ss_pred cHHHHhhhcCCC-------ccchHHHHHHHHHHHHHHHHHHh
Confidence 999999973322 45566788889999999999963
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=7.6e-19 Score=198.39 Aligned_cols=240 Identities=23% Similarity=0.322 Sum_probs=175.4
Q ss_pred CCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcc
Q 003737 116 RYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILS 195 (799)
Q Consensus 116 ~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 195 (799)
++|+.|+.++|.+.. .-..+....|+++++++|+++ .+|+.++.+.+|+.|+..+|+++ .+|..+..+++|+.|++.
T Consensus 219 ~~l~~L~a~~n~l~~-~~~~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~ 295 (1081)
T KOG0618|consen 219 PSLTALYADHNPLTT-LDVHPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAA 295 (1081)
T ss_pred cchheeeeccCccee-eccccccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhh
Confidence 456666666666662 222233334666666666666 34466666666666666666664 566666666666666666
Q ss_pred cCcCCccCChhccCCCCCCEEEccCCcCCCcCCcc------------------------c--cCCCCCCEEEccCCCCCC
Q 003737 196 SNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEF------------------------I--GKWKKIQKLHIQGSSLEG 249 (799)
Q Consensus 196 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~------------------------~--~~l~~L~~L~L~~N~l~~ 249 (799)
.|.++ .+|.....+++|++|+|..|++.. .|+. + ..++.|+.|++.+|.++.
T Consensus 296 ~nel~-yip~~le~~~sL~tLdL~~N~L~~-lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd 373 (1081)
T KOG0618|consen 296 YNELE-YIPPFLEGLKSLRTLDLQSNNLPS-LPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTD 373 (1081)
T ss_pred hhhhh-hCCCcccccceeeeeeehhccccc-cchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccc
Confidence 66665 555556666666666666666652 2221 1 123568899999999998
Q ss_pred CCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhc
Q 003737 250 PIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328 (799)
Q Consensus 250 ~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 328 (799)
..-+.+.+..+|+.|+|++|.+...+-..+.+ ..|+.|+||+|+++ .+|+.+.+++.|++|...+|++. ..| .+..
T Consensus 374 ~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~ 450 (1081)
T KOG0618|consen 374 SCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQ 450 (1081)
T ss_pred cchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhh
Confidence 88888999999999999997665433333555 68999999999999 78899999999999999999999 677 8999
Q ss_pred cCCCCEEeccCCcCCC-cCChhhh-cCCCEEEeecCc
Q 003737 329 LAKTNFMYLTGNKLTG-PVPKYIF-NSNKNVDISLNN 363 (799)
Q Consensus 329 l~~L~~L~L~~N~l~g-~~p~~~~-~~l~~l~ls~N~ 363 (799)
++.|+++|++.|+|+. .+|.... +.+++|||++|.
T Consensus 451 l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 451 LPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred cCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 9999999999999985 4455555 689999999996
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1e-16 Score=175.11 Aligned_cols=115 Identities=20% Similarity=0.415 Sum_probs=104.6
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
..|...+.||+|+|+.||+++. .+|+.||+|++.+. +....+...+||++.++++|||||+++++|++.+.+|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4588889999999999999995 89999999999764 3445678999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|++|+|.++++++. .+.|.+++.|++||+.||.|||+
T Consensus 98 ELC~~~sL~el~Krrk---------~ltEpEary~l~QIv~GlkYLH~ 136 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK---------PLTEPEARYFLRQIVEGLKYLHS 136 (592)
T ss_pred EecCCccHHHHHHhcC---------CCCcHHHHHHHHHHHHHHHHHHh
Confidence 9999999999998554 68899999999999999999995
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.1e-18 Score=182.90 Aligned_cols=250 Identities=20% Similarity=0.281 Sum_probs=191.3
Q ss_pred cEEEEEeCCCCCccc----CCccccCCCCCCEEEccCCcCCC------cCcccccccc-eeEEEccCCcCcCcCCcccCC
Q 003737 93 HVVTIALKAQNLTGT----LPTELSKLRYLKQLDLSRNCLTG------SFSPQWASLQ-LVELSVMGNRLSGPFPKVLTN 161 (799)
Q Consensus 93 ~v~~L~L~~~~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~ 161 (799)
.++.|+++++.++.. ++..+...+.|++|+++++.+.+ .++..+..+. |++|++++|.+.+..+..+..
T Consensus 24 ~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~ 103 (319)
T cd00116 24 CLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLES 103 (319)
T ss_pred hccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHH
Confidence 488999999998643 66677888899999999998873 2334555565 999999999998777777766
Q ss_pred CCC---CCEEEeeCCcCCC----CCCccccCC-CCCCEEEcccCcCCcc----CChhccCCCCCCEEEccCCcCCCc---
Q 003737 162 ITT---LKNLSIEGNLFTG----SIPPDIRKL-INLQKLILSSNSFTGE----LPAELTKLTNLNDLRISDNNFSGK--- 226 (799)
Q Consensus 162 L~~---L~~L~Ls~N~l~~----~~p~~~~~l-~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~--- 226 (799)
+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++. ++..+..+++|++|++++|.+++.
T Consensus 104 l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 183 (319)
T cd00116 104 LLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIR 183 (319)
T ss_pred HhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHH
Confidence 666 9999999999873 233455667 8999999999999843 445577788999999999999842
Q ss_pred -CCccccCCCCCCEEEccCCCCCCC----CchhhhcCCCCCeEEcCCCCCCCCCCCc----cC--CCCccEEEccCCcCc
Q 003737 227 -IPEFIGKWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESAFPK----LD--KMNLKTLILTKCLIH 295 (799)
Q Consensus 227 -~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~n~~~~~~~~~----l~--~~~L~~L~L~~N~l~ 295 (799)
++..+..+++|++|+|++|.+++. ++..+..+++|++|++++|......+.. +. ...|+.|++++|.++
T Consensus 184 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 184 ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 344556678999999999998754 3445667889999999997654322211 11 268999999999997
Q ss_pred c----cCCccccCCCCCCeeccccccCCCC----Cchhhhcc-CCCCEEeccCCcC
Q 003737 296 G----EIPDYIGDMTKLKNIDLSFNNLTGG----IPTTFEKL-AKTNFMYLTGNKL 342 (799)
Q Consensus 296 ~----~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~L~~N~l 342 (799)
. .+...+..+++|+++++++|.++.. +...+... +.|+.+++.+|.+
T Consensus 264 ~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 264 DDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred cHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 2 3345566779999999999999954 44455555 7899999988864
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.5e-16 Score=173.01 Aligned_cols=118 Identities=28% Similarity=0.535 Sum_probs=98.7
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeC--CC--cE-EEEEEcccc---ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECC
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILS--DG--TV-IAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN 745 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~--~g--~~-vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 745 (799)
..++....+.||+|+||.||+|.+. ++ .. ||||..+.. .....++|.+|+++|++++|||||+++|++....
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 3444455689999999999999964 22 23 899998752 3455689999999999999999999999999999
Q ss_pred EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+.|+|||+|+||+|.++|+.... .++..+-..|+.|+|.||+|||+
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~--------~v~~~ek~~~~~~AA~Gl~YLh~ 280 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKK--------SLPTLEKLRFCYDAARGLEYLHS 280 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHhHHHHHHH
Confidence 99999999999999999987653 35556666779999999999995
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.9e-18 Score=159.04 Aligned_cols=159 Identities=31% Similarity=0.522 Sum_probs=102.1
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.+++.|.|++|.++ .+|+.+..+.+|+.|++++|+++. .|..++.++ |+.|+++-|++. ..|..|+.++.|+.|||
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~-lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEE-LPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhh-cChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 46667777777776 666677777777777777777763 344455554 666666666665 56666666666666666
Q ss_pred eCCcCC-CCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCC
Q 003737 171 EGNLFT-GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (799)
Q Consensus 171 s~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 249 (799)
.+|++. ..+|..|..|+.|+.|.|++|.|. .+|..++++++|+.|.+..|.+- .+|..++.++.|++|++.+|+++
T Consensus 110 tynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~- 186 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT- 186 (264)
T ss_pred cccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-
Confidence 666665 345666666666666666666665 56666666666666666666665 45666666666666666666665
Q ss_pred CCchhhh
Q 003737 250 PIPASIS 256 (799)
Q Consensus 250 ~~p~~~~ 256 (799)
.+|..++
T Consensus 187 vlppel~ 193 (264)
T KOG0617|consen 187 VLPPELA 193 (264)
T ss_pred ecChhhh
Confidence 3344443
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.8e-16 Score=170.80 Aligned_cols=118 Identities=26% Similarity=0.421 Sum_probs=100.5
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChh-hHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
+.......++||+|.||.|..|+...+..||||+++..... .+.+|.+|+++|.+++|||||+++|+|..+++.++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 44556667899999999999999988899999999887544 45899999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhc
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFF 798 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH 798 (799)
||++|+|.+++.+.... +...+....++.||++||+||-
T Consensus 616 YmEnGDLnqFl~aheap-------t~~t~~~vsi~tqiasgmaYLe 654 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELP-------TAETAPGVSICTQIASGMAYLE 654 (807)
T ss_pred HHhcCcHHHHHHhccCc-------ccccchhHHHHHHHHHHHHHHH
Confidence 99999999999876432 2222344456999999999984
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.8e-16 Score=161.54 Aligned_cols=116 Identities=22% Similarity=0.373 Sum_probs=105.7
Q ss_pred hcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
.++|+..++||+|+||+||.++ .++++.+|+|++++.. ..+.+...+|..+|.+++||+||++...+.+.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4678999999999999999998 4679999999998753 33457789999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||+.||+|+.+|.+++ .|+|+.++.|+.+|+.||+|||+
T Consensus 104 ld~~~GGeLf~hL~~eg---------~F~E~~arfYlaEi~lAL~~LH~ 143 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG---------RFSEDRARFYLAEIVLALGYLHS 143 (357)
T ss_pred EeccCCccHHHHHHhcC---------CcchhHHHHHHHHHHHHHHHHHh
Confidence 99999999999999876 78999999999999999999996
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.8e-18 Score=157.99 Aligned_cols=161 Identities=27% Similarity=0.486 Sum_probs=93.3
Q ss_pred CCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEE
Q 003737 161 NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKL 240 (799)
Q Consensus 161 ~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 240 (799)
++..++.|.||+|+++ .+|+.+..+.+|+.|++++|+++ .+|.+++.+++|+.|+++-|++. ..|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 3455555666666665 55556666666666666666665 55666666666666666666665 556666666666666
Q ss_pred EccCCCCCC-CCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCC
Q 003737 241 HIQGSSLEG-PIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319 (799)
Q Consensus 241 ~L~~N~l~~-~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 319 (799)
||..|++.. .+|..|.-++.|+.| +|+.|.+. .+|..++++++|+.|.+..|.+-
T Consensus 108 dltynnl~e~~lpgnff~m~tlral-----------------------yl~dndfe-~lp~dvg~lt~lqil~lrdndll 163 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRAL-----------------------YLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL 163 (264)
T ss_pred hccccccccccCCcchhHHHHHHHH-----------------------HhcCCCcc-cCChhhhhhcceeEEeeccCchh
Confidence 666655542 234434333333333 33334443 45555666666666666666665
Q ss_pred CCCchhhhccCCCCEEeccCCcCCCcCChhh
Q 003737 320 GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI 350 (799)
Q Consensus 320 ~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~ 350 (799)
.+|..++.+.+|++|++.+|+++ .+|+.+
T Consensus 164 -~lpkeig~lt~lrelhiqgnrl~-vlppel 192 (264)
T KOG0617|consen 164 -SLPKEIGDLTRLRELHIQGNRLT-VLPPEL 192 (264)
T ss_pred -hCcHHHHHHHHHHHHhcccceee-ecChhh
Confidence 56666666666666666666666 455544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.2e-16 Score=159.17 Aligned_cols=112 Identities=18% Similarity=0.329 Sum_probs=99.9
Q ss_pred CCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECC-EEEEEEecCC
Q 003737 679 DPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-QLLLVYEYMK 755 (799)
Q Consensus 679 ~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~~ 755 (799)
+..+.||+|..|+|||+.+ ++++.+|+|.+.... ....++..+|++++.+.+||+||+++|.|.... +..++||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 3467899999999999995 578999999996553 344678999999999999999999999999888 5999999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|+++++..+ +++|..+..++.||++||.|||+
T Consensus 162 gGSLd~~~k~~g---------~i~E~~L~~ia~~VL~GL~YLh~ 196 (364)
T KOG0581|consen 162 GGSLDDILKRVG---------RIPEPVLGKIARAVLRGLSYLHE 196 (364)
T ss_pred CCCHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHhh
Confidence 999999998765 68999999999999999999994
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.3e-16 Score=151.61 Aligned_cols=114 Identities=25% Similarity=0.441 Sum_probs=100.9
Q ss_pred CCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccCh--hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
.|...+.+|+|.||.||+|. ..+|+.||||+++.... +-.....||++.|+.++|+||+.+++++-..+...||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 46677899999999999999 67899999999976532 2245789999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+. +|+..++.+.. .+...+++.|+.|+++|++|||+
T Consensus 83 m~t-dLe~vIkd~~i--------~l~pa~iK~y~~m~LkGl~y~H~ 119 (318)
T KOG0659|consen 83 MPT-DLEVVIKDKNI--------ILSPADIKSYMLMTLKGLAYCHS 119 (318)
T ss_pred ccc-cHHHHhccccc--------ccCHHHHHHHHHHHHHHHHHHHh
Confidence 997 99999987653 57788999999999999999995
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.8e-16 Score=151.86 Aligned_cols=118 Identities=24% Similarity=0.398 Sum_probs=103.2
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
.++|+..+.||+|.||.||.|.. +++-.||+|++.+.. .+-.+++.+|+++-++++||||.++++|+.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 45688899999999999999994 567899999996542 23356899999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||.+.|++...|..+... .+.|.....|+.|+|.|+.|+|.
T Consensus 101 lEya~~gel~k~L~~~~~~-------~f~e~~~a~Yi~q~A~Al~y~h~ 142 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMK-------RFDEQRAATYIKQLANALLYCHL 142 (281)
T ss_pred EEecCCchHHHHHHhcccc-------cccccchhHHHHHHHHHHHHhcc
Confidence 9999999999999854422 57788889999999999999995
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.3e-16 Score=160.88 Aligned_cols=114 Identities=17% Similarity=0.361 Sum_probs=102.5
Q ss_pred CCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
+|+..+.+|+|.||+|-++. ...|+.||||.+++.. +++.-...+|+++|+.++||||+.++.+|...+.+.+|||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 35556789999999999998 5689999999998764 3444568899999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|..+|+|.|++.+++ .++|.+++.|++||.+|+.|+|.
T Consensus 134 YaS~GeLYDYiSer~---------~LsErEaRhfFRQIvSAVhYCHk 171 (668)
T KOG0611|consen 134 YASGGELYDYISERG---------SLSEREARHFFRQIVSAVHYCHK 171 (668)
T ss_pred ecCCccHHHHHHHhc---------cccHHHHHHHHHHHHHHHHHHhh
Confidence 999999999998877 78899999999999999999995
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.6e-15 Score=151.83 Aligned_cols=115 Identities=23% Similarity=0.349 Sum_probs=103.3
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh---hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.+|.|+||+|...+. .+|..+|+|++++... ...+...+|..+|+.+.||+++++.+.|.+.+..||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 4577788999999999999984 5789999999977532 33467889999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|.|+.+|++.+ +++|..++.||.||+.|++|||+
T Consensus 124 eyv~GGElFS~Lrk~~---------rF~e~~arFYAAeivlAleylH~ 162 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG---------RFSEPHARFYAAEIVLALEYLHS 162 (355)
T ss_pred eccCCccHHHHHHhcC---------CCCchhHHHHHHHHHHHHHHHHh
Confidence 9999999999999876 78999999999999999999995
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.9e-16 Score=164.55 Aligned_cols=114 Identities=20% Similarity=0.381 Sum_probs=102.4
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
++|...+.||+|+||+||||.. .+.+.||+|.+.+.. +.+.+...+|++++++++|||||.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4577778999999999999995 478999999997653 3445789999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+.+ +|+.+|...+ .+||+.++.++.|++.||.|||+
T Consensus 82 ~a~g-~L~~il~~d~---------~lpEe~v~~~a~~LVsaL~yLhs 118 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---------KLPEEQVRAIAYDLVSALYYLHS 118 (808)
T ss_pred hhhh-hHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9987 9999998766 78999999999999999999996
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.1e-15 Score=157.27 Aligned_cols=111 Identities=24% Similarity=0.393 Sum_probs=93.7
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHh--CCCCcccceeEEEEECC----EE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA--QQHPNLVKLYGCCVEGN----QL 747 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~~----~~ 747 (799)
........+.||+|.||.||+|.++ |+.||||++... +.+.+.+|.|+... +||+||..+++.-..++ +.
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 3455677899999999999999995 789999999644 45678899998876 59999999998765443 68
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhc
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFF 798 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH 798 (799)
+||.||-++|||+|+|.+. ++..+.+..++..+|.||+|||
T Consensus 285 wLvTdYHe~GSL~DyL~r~----------tv~~~~ml~LalS~AsGLaHLH 325 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN----------TVTTEGMLKLALSIASGLAHLH 325 (513)
T ss_pred EEeeecccCCcHHHHHhhc----------cCCHHHHHHHHHHHhhhHHHHH
Confidence 9999999999999999874 5666777788999999999999
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.5e-15 Score=157.98 Aligned_cols=110 Identities=23% Similarity=0.368 Sum_probs=92.5
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHh--CCCCcccceeEEEEECC----EEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA--QQHPNLVKLYGCCVEGN----QLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~l 749 (799)
......+++|+|+||.||||.+. ++.||||++.. ++.+.|.+|-++.+- ++|+||++++++-.... +.+|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34556788999999999999985 58999999964 456789888887764 68999999999887655 8899
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+||.++|+|.++|+... .+......++..+++||+|||+
T Consensus 286 Vt~fh~kGsL~dyL~~nt----------isw~~~cria~SmarGLa~LHe 325 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT----------ISWNSLCRIAESMARGLAHLHE 325 (534)
T ss_pred EeeeccCCcHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHhcc
Confidence 999999999999999763 3444577779999999999996
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.3e-16 Score=164.23 Aligned_cols=115 Identities=23% Similarity=0.420 Sum_probs=99.0
Q ss_pred cCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCC-CCcccceeEEEEECC-EEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGN-QLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~lV~ 751 (799)
++|...+.+|.|.||.||+|+ ..+|..||||+++..- ..+.-.=.||++.|+++. |||||++.+++.+.+ ..|+||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 346667889999999999999 5689999999997642 222233469999999998 999999999999887 899999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+. +|.++++++++ .++|+.++.|+.||++||+|+|+
T Consensus 90 E~Md~-NLYqLmK~R~r--------~fse~~irnim~QilqGL~hiHk 128 (538)
T KOG0661|consen 90 EFMDC-NLYQLMKDRNR--------LFSESDIRNIMYQILQGLAHIHK 128 (538)
T ss_pred Hhhhh-hHHHHHhhcCC--------cCCHHHHHHHHHHHHHHHHHHHh
Confidence 99987 99999998754 78999999999999999999995
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.1e-14 Score=170.47 Aligned_cols=151 Identities=31% Similarity=0.586 Sum_probs=98.6
Q ss_pred CCCCHHHHHHHHHHHHhcCC---CCCCCCCCCCCCC-CCCcccCCCCCCCCCCeEecCCCC--cccEEEEEeCCCCCccc
Q 003737 34 NKLHAEEVKALKQIGRKLGK---KDWNFGVDPCSQK-GNWELSSDDKKGFESNVTCDCSSA--TCHVVTIALKAQNLTGT 107 (799)
Q Consensus 34 ~~~~~~~~~aL~~~~~~~~~---~~W~~~~d~C~~~-~~W~~~~~~~~~~~~gv~c~~~~~--~~~v~~L~L~~~~l~g~ 107 (799)
..+.++|.+||+++|++++. .+|+ .|+|... ..| .||.|..... ...|+.|+|++++++|.
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~~~W~--g~~C~p~~~~w-----------~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ 433 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLRFGWN--GDPCVPQQHPW-----------SGADCQFDSTKGKWFIDGLGLDNQGLRGF 433 (623)
T ss_pred cccCchHHHHHHHHHHhcCCcccCCCC--CCCCCCccccc-----------ccceeeccCCCCceEEEEEECCCCCcccc
Confidence 45678899999999999865 3785 4677432 257 7999953221 23588899999999999
Q ss_pred CCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCC
Q 003737 108 LPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKL 186 (799)
Q Consensus 108 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l 186 (799)
+|..+..+++|+.|+|++|.+.|.+|..++.++ |++|+|++|+++|.+|+.+++|++|++|+|++|+++|.+|..++.+
T Consensus 434 ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~ 513 (623)
T PLN03150 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513 (623)
T ss_pred CCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhc
Confidence 999999898888888888877766665555554 5555555555555555555555555555555555555555444432
Q ss_pred -CCCCEEEcccC
Q 003737 187 -INLQKLILSSN 197 (799)
Q Consensus 187 -~~L~~L~Ls~N 197 (799)
.++..+++.+|
T Consensus 514 ~~~~~~l~~~~N 525 (623)
T PLN03150 514 LLHRASFNFTDN 525 (623)
T ss_pred cccCceEEecCC
Confidence 23334444444
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=6e-15 Score=173.30 Aligned_cols=122 Identities=26% Similarity=0.438 Sum_probs=102.8
Q ss_pred cCCCCCCeecccCCeeEEEEEeC--CC----cEEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS--DG----TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~--~g----~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 748 (799)
...+..+.||+|+||.||+|.+. +| ..||||.+++. +.++..+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 34456789999999999999964 23 35999999776 4566789999999999999999999999999999999
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|||++|||..+|++.+.. ......+...++..++.|||+|+.||++
T Consensus 772 i~leyM~gGDL~sflr~~r~~--~~~~~~L~~~dLl~~a~dvA~G~~YLe~ 820 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPA--PFQPSNLSMRDLLAFALDVAKGMNYLES 820 (1025)
T ss_pred EEehhcccCcHHHHHHhcccc--cCCCCCCCHHHHHHHHHHHhhhhHHHHh
Confidence 999999999999999876422 1223467778899999999999999964
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.57 E-value=4.3e-15 Score=150.84 Aligned_cols=115 Identities=21% Similarity=0.407 Sum_probs=97.8
Q ss_pred cCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccCh--hhHHHHHHHHHHHHhCCCCcccceeEEEEE--CCEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 750 (799)
++|+..+.|++|+||.||+|+ .++++.||+|+++...+ +-.-...|||.+|.+++|||||.+..+... -+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 446678899999999999999 56789999999987542 223456899999999999999999998865 4679999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+. ||..+++.-.. .+.+.+++.++.|+++|++|||.
T Consensus 156 Me~~Eh-DLksl~d~m~q--------~F~~~evK~L~~QlL~glk~lH~ 195 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQ--------PFLPGEVKTLMLQLLRGLKHLHD 195 (419)
T ss_pred HHHHHh-hHHHHHHhccC--------CCchHHHHHHHHHHHHHHHHHhh
Confidence 999998 99999986542 67788999999999999999995
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.4e-15 Score=161.39 Aligned_cols=121 Identities=22% Similarity=0.435 Sum_probs=102.3
Q ss_pred HHHHHhhcCCCCCCeecccCCeeEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEE
Q 003737 669 RQIKAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (799)
Q Consensus 669 ~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 747 (799)
++++..+.+.....+||-|.||.||.|+++. ...||||.++.+ ....++|..|+.+|+.++|||+|+|+|+|..+.++
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4444455566678899999999999999753 568999999764 44678999999999999999999999999999999
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhh
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFF 797 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yL 797 (799)
|||+|||.+|+|.++|++..+. -.+.-.+..+|.||++||+||
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~-------ev~avvLlyMAtQIsSaMeYL 381 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRS-------EVPAVVLLYMATQISSAMEYL 381 (1157)
T ss_pred EEEEecccCccHHHHHHHhchh-------hcchhHHHHHHHHHHHHHHHH
Confidence 9999999999999999987654 334445666788999999998
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.5e-14 Score=159.97 Aligned_cols=115 Identities=23% Similarity=0.377 Sum_probs=101.2
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||.||+++. .+|+.||||++.... ......+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 3688889999999999999995 478999999996532 223456889999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.++++... .+++..++.++.||+.||+|||+
T Consensus 81 E~~~~g~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~ 119 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---------TFTEEETRFYIAETILAIDSIHK 119 (364)
T ss_pred CCCCCcHHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998654 57888999999999999999995
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.5e-14 Score=152.16 Aligned_cols=115 Identities=23% Similarity=0.404 Sum_probs=98.9
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECC--EEEEEEec
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--QLLLVYEY 753 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~Ey 753 (799)
++...+.||+|+||.||++.. ++|...|||..........+...+|+.+|.+++|||||+++|.....+ ..++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 455678999999999999995 458999999997653333667899999999999999999999865544 68999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++.+.+. .++|..++.|++||++||+|||+
T Consensus 98 ~~~GsL~~~~~~~g~--------~l~E~~v~~ytr~iL~GL~ylHs 135 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGG--------KLPEPLVRRYTRQILEGLAYLHS 135 (313)
T ss_pred cCCCcHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999987642 47899999999999999999995
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=2e-14 Score=157.18 Aligned_cols=117 Identities=18% Similarity=0.322 Sum_probs=102.4
Q ss_pred hhcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEcccc----Ch-hhHHHHHHHHHHHHhCC-CCcccceeEEEEECCE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK----SR-QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQ 746 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~----~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~ 746 (799)
..+.|...+.||+|.||+||.|. ..+|..||+|.++.. .. ...+...+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 45678889999999999999998 457899999977654 12 22456678999999999 9999999999999999
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++||||+.+|+|++++..++ .+.|..++.+++|+++|++|||.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g---------~l~E~~ar~~F~Qlisav~y~H~ 138 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKG---------RLKEDEARKYFRQLISAVAYCHS 138 (370)
T ss_pred EEEEEEecCCccHHHHHHHcC---------CCChHHHHHHHHHHHHHHHHHHh
Confidence 999999999999999999855 67889999999999999999995
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=6e-15 Score=160.57 Aligned_cols=120 Identities=18% Similarity=0.383 Sum_probs=102.3
Q ss_pred HHHHHhhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCE
Q 003737 669 RQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (799)
Q Consensus 669 ~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 746 (799)
++++...+.+...+.||+|+||+||||++.. .||||.+.... ....+.|.+|+.++++-||.||+=+.|||..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 5555566666778899999999999999753 59999997764 3345789999999999999999999999998877
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+.+|++-+|+.+||-... .+....+..||+|||+||.|||.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~et--------kfdm~~~idIAqQiaqGM~YLHA 506 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQET--------KFDMNTTIDIAQQIAQGMDYLHA 506 (678)
T ss_pred -eeeehhccCchhhhhccchhh--------hhhHHHHHHHHHHHHHhhhhhhh
Confidence 999999999999999996543 45666788889999999999993
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=9.8e-15 Score=152.47 Aligned_cols=114 Identities=20% Similarity=0.270 Sum_probs=99.9
Q ss_pred CCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChh---hHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ---GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
|...+.||+|.-|+||.+++. ++..+|+|++.+..-. ...+...|.++|+.++||.++.|++.+..++..++||||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 445678999999999999975 4689999999875322 234677888999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhc
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFF 798 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH 798 (799)
|+||+|+.+.+++... .++++.++.|+.+|+-||+|||
T Consensus 159 CpGGdL~~LrqkQp~~-------~fse~~aRFYaAEvl~ALEYLH 196 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQPGK-------RFSESAARFYAAEVLLALEYLH 196 (459)
T ss_pred CCCccHHHHHhhCCCC-------ccchhhHHHHHHHHHHHHHHHH
Confidence 9999999998876644 8999999999999999999999
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.5e-14 Score=159.23 Aligned_cols=114 Identities=20% Similarity=0.281 Sum_probs=100.5
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
.|+..+.||+|+||+||+|.. .+++.||+|++.... ....+.+.+|++++.+++|+|||++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 477789999999999999984 578999999996542 2334678999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++|+|.+++.+.. .+++..++.++.||+.||+|||+
T Consensus 82 ~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~aL~~LH~ 119 (381)
T cd05626 82 YIPGGDMMSLLIRME---------VFPEVLARFYIAELTLAIESVHK 119 (381)
T ss_pred cCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999997654 57788899999999999999995
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.5e-14 Score=159.05 Aligned_cols=115 Identities=19% Similarity=0.305 Sum_probs=100.6
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||.||++.. .+|+.||||++.... ....+.+.+|++++.+++|||||++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3678889999999999999984 578999999986532 223467889999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++.... .+++..++.++.|++.||+|||+
T Consensus 81 E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~ 119 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---------TFSEDVTRFYMAECVLAIEAVHK 119 (377)
T ss_pred eCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999997654 57788899999999999999995
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.7e-14 Score=150.67 Aligned_cols=116 Identities=22% Similarity=0.401 Sum_probs=99.6
Q ss_pred cCCCCCCeecccCCeeEEEEEeC----CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
++|+..+.||+|+||.||+|... .+..||+|.++... ....+.|.+|+.++.+++||||++++|++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45777899999999999999752 35789999997653 23346799999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.+++..... .+++..+..++.|++.||+|||+
T Consensus 85 ~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~i~~al~~lH~ 125 (266)
T cd05064 85 TEYMSNGALDSFLRKHEG--------QLVAGQLMGMLPGLASGMKYLSE 125 (266)
T ss_pred EEeCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999976431 46677888999999999999995
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.5e-15 Score=147.64 Aligned_cols=114 Identities=25% Similarity=0.367 Sum_probs=96.0
Q ss_pred CCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccCh-hh-HHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR-QG-NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~-~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
.|+....+|+|+||+||||+ ..+|+.||||++..... .. .+-..||+++|++++|+|+|.++.+|.+....+||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 46667789999999999999 45799999999965422 22 35578999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++.-=|+++=+... ..+++.++.|..|++.|+.|+|+
T Consensus 83 ~dhTvL~eLe~~p~---------G~~~~~vk~~l~Q~l~ai~~cHk 119 (396)
T KOG0593|consen 83 CDHTVLHELERYPN---------GVPSELVKKYLYQLLKAIHFCHK 119 (396)
T ss_pred cchHHHHHHHhccC---------CCCHHHHHHHHHHHHHHhhhhhh
Confidence 99865555544332 57788999999999999999995
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=9.4e-16 Score=152.12 Aligned_cols=118 Identities=25% Similarity=0.438 Sum_probs=99.3
Q ss_pred CCCCCCeecccCCeeEEEEE-eCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeE-EEEECCE-EEEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYG-CCVEGNQ-LLLVY 751 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lV~ 751 (799)
+|+..+.||+|.||+|||+. +.+|..||.|.++-+ +....+....|+.+|++++|||||+.++ -+.++++ .++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 45667889999999999998 679999999998743 4455678999999999999999999998 4555555 89999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+..|||...++.-+.. ...++|..+..|+.|+|+||+++|.
T Consensus 100 E~c~~GDLsqmIk~~K~q-----kr~ipE~~Vwk~f~QL~~AL~~cH~ 142 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQ-----KRLIPEKTVWKYFVQLCRALYHCHS 142 (375)
T ss_pred HhhcccCHHHHHHHHHhc-----cccCchHHHHHHHHHHHHHHHHHhc
Confidence 999999999999632211 1278999999999999999999995
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.4e-14 Score=154.21 Aligned_cols=117 Identities=21% Similarity=0.323 Sum_probs=106.5
Q ss_pred hhcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
..++|+...+||+|+||.||.|+ ..+|..+|+|++++.. ....+....|-.+|...+++.||+|+..|.+.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45789999999999999999998 5689999999998753 3445678899999999999999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+||||+..+|...+ +++|+.++.|+.+++.|++-+|.
T Consensus 219 iMEylPGGD~mTLL~~~~---------~L~e~~arfYiaE~vlAI~~iH~ 259 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD---------TLTEDWARFYIAETVLAIESIHQ 259 (550)
T ss_pred EEEecCCccHHHHHHhcC---------cCchHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999877 89999999999999999999984
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.4e-15 Score=164.34 Aligned_cols=113 Identities=27% Similarity=0.464 Sum_probs=96.2
Q ss_pred CCCCCeecccCCeeEEEEE-eCCC----cEEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 678 FDPANKVGEGGFGSVYKGI-LSDG----TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~-~~~g----~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
+...++||+|+||+||||. .+.| .+||+|++... ..+...++..|+-+|.+++|||++|++|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 3457899999999999998 4555 47899998665 3445679999999999999999999999998765 88999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|||.|+|.|+++.++. .+-.+++..|..|||+||.|||+
T Consensus 777 q~mP~G~LlDyvr~hr~--------~igsq~lLnw~~QIAkgM~YLe~ 816 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD--------NIGSQDLLNWCYQIAKGMKYLEE 816 (1177)
T ss_pred HhcccchHHHHHHHhhc--------cccHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999987654 45566888899999999999985
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.9e-14 Score=157.81 Aligned_cols=114 Identities=18% Similarity=0.281 Sum_probs=100.4
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
.|+..+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++.+++|+|||++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 477889999999999999984 578899999996542 2334678999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||++|+|.+++.+.+ .+++..++.++.||+.||+|||+
T Consensus 82 ~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~al~~lH~ 119 (382)
T cd05625 82 YIPGGDMMSLLIRMG---------IFPEDLARFYIAELTCAVESVHK 119 (382)
T ss_pred CCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999997654 56788999999999999999995
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.5e-14 Score=156.17 Aligned_cols=115 Identities=20% Similarity=0.287 Sum_probs=101.0
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||+||++.. .+++.||+|+++... ......+.+|++++.+++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4688889999999999999984 468999999996542 223457889999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++..++ .+++..++.++.|++.||+|||+
T Consensus 81 E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~ 119 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---------TLTEEETQFYIAETVLAIDSIHQ 119 (363)
T ss_pred cCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999998654 57788999999999999999995
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.6e-14 Score=153.02 Aligned_cols=115 Identities=16% Similarity=0.222 Sum_probs=100.3
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 3577889999999999999995 478999999986532 223467889999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++...+ .+++..+..++.||++||+|||+
T Consensus 81 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~ 119 (291)
T cd05612 81 EYVPGGELFSYLRNSG---------RFSNSTGLFYASEIVCALEYLHS 119 (291)
T ss_pred eCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999997654 56788888899999999999995
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=4e-14 Score=154.39 Aligned_cols=115 Identities=17% Similarity=0.301 Sum_probs=100.8
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|...+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+.+|++++.+++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 4577789999999999999995 468999999986532 223467899999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++.... .++++.++.++.||+.||+|||+
T Consensus 98 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~ 136 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---------RFPNDVAKFYHAELVLAFEYLHS 136 (329)
T ss_pred cCCCCChHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998654 56788899999999999999995
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.52 E-value=5e-14 Score=156.58 Aligned_cols=114 Identities=18% Similarity=0.251 Sum_probs=100.1
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
+|+..+.||+|+||.||+++. .+++.||||++.... ....+.+.+|++++.+++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 578889999999999999994 568999999986532 2234578899999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++|+|.+++.+.+ .+++..++.++.||+.||+|||+
T Consensus 82 ~~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~al~~lH~ 119 (376)
T cd05598 82 YIPGGDMMSLLIRLG---------IFEEDLARFYIAELTCAIESVHK 119 (376)
T ss_pred CCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999997654 56788889999999999999995
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.4e-14 Score=153.61 Aligned_cols=114 Identities=18% Similarity=0.329 Sum_probs=100.4
Q ss_pred CCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
+|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5788899999999999999954 68999999997542 2234678999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++|+|.+++.... .+++..++.++.|++.||+|||+
T Consensus 82 ~~~g~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~ 119 (333)
T cd05600 82 YVPGGDFRTLLNNLG---------VLSEDHARFYMAEMFEAVDALHE 119 (333)
T ss_pred CCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999997654 56788899999999999999995
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.52 E-value=4e-14 Score=148.80 Aligned_cols=112 Identities=32% Similarity=0.585 Sum_probs=93.8
Q ss_pred CCeecccCCeeEEEEEeC-----CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 681 ANKVGEGGFGSVYKGILS-----DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~~-----~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
.+.||+|.||.||+|.+. .+..|+||.++... ....+.|.+|++.+.+++||||++++|+|...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999975 35789999996543 334689999999999999999999999999888899999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.++|+..... .+++.....++.||++||+|||+
T Consensus 84 ~~g~L~~~L~~~~~~-------~~~~~~~~~i~~~i~~~l~~Lh~ 121 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKE-------PLSEQQRLSIAIQIAEALSYLHS 121 (259)
T ss_dssp TTEBHHHHHHHTCTT-------TSBHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccc-------ccccccccccccccccccccccc
Confidence 999999999976211 56777888889999999999994
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.6e-14 Score=145.47 Aligned_cols=119 Identities=21% Similarity=0.353 Sum_probs=107.6
Q ss_pred cHHHHHHhhcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhCC-CCcccceeEEEEEC
Q 003737 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEG 744 (799)
Q Consensus 667 ~~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~ 744 (799)
.++++.+.|+ +.||+|+|+.|..++ +.+|..+|||++.+.....+....+|++++.+.+ |+||++|+.++.++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4677777774 679999999999998 7889999999998876666788999999999985 99999999999999
Q ss_pred CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..+|||||-|.+|.|-.+|+++. .+.|.++..+.++|+.||+|||.
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~---------~F~E~EAs~vvkdia~aLdFlH~ 194 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK---------HFNEREASRVVKDIASALDFLHT 194 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh---------hccHHHHHHHHHHHHHHHHHHhh
Confidence 99999999999999999999876 78899999999999999999994
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.51 E-value=8.6e-14 Score=146.84 Aligned_cols=123 Identities=18% Similarity=0.214 Sum_probs=105.1
Q ss_pred HHHhhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 671 IKAATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 671 ~~~~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
++.+++++.....||+|+||.||+|.. .++..||+|.+........+.+.+|++++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 456778888888999999999999994 5678899999877666666789999999999999999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+||+++++|.++++.+... ...++..+..++.||++|++|||+
T Consensus 83 v~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~ 126 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGP------LKDNEQTIIFYTKQILEGLKYLHD 126 (268)
T ss_pred EEecCCCCCHHHHHHHhccc------CCCcHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999864211 012566788889999999999995
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-13 Score=151.04 Aligned_cols=116 Identities=16% Similarity=0.304 Sum_probs=102.0
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
.++|+..+.||+|+||.||++.. .+|..||+|.+.... ....+.+.+|++++.+++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 35788899999999999999995 478899999987643 2345679999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++|+|.+++.... .+++..+..++.|++.||+|||+
T Consensus 84 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~ 121 (331)
T cd06649 84 HMDGGSLDQVLKEAK---------RIPEEILGKVSIAVLRGLAYLRE 121 (331)
T ss_pred cCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhh
Confidence 999999999997654 56788888999999999999994
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.2e-13 Score=150.94 Aligned_cols=116 Identities=16% Similarity=0.320 Sum_probs=101.6
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
.++|+..+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|++++.+++|+|||+++++|.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367888999999999999999954 68899999987542 3344679999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++|+|.+++.... .+++..+..++.|++.||+|||+
T Consensus 84 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH~ 121 (333)
T cd06650 84 HMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLRE 121 (333)
T ss_pred cCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999997654 46787888999999999999994
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-13 Score=149.26 Aligned_cols=115 Identities=17% Similarity=0.318 Sum_probs=100.7
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
++|+..+.||+|+||.||++.. .++..+|+|.+.... ....+++.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3688889999999999999984 468899999987542 23346789999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.++++... .+++..+..++.|+++||+|||+
T Consensus 81 ~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~ 117 (308)
T cd06615 81 MDGGSLDQVLKKAG---------RIPENILGKISIAVLRGLTYLRE 117 (308)
T ss_pred cCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999997653 56788888999999999999994
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.51 E-value=9.3e-14 Score=148.18 Aligned_cols=115 Identities=22% Similarity=0.264 Sum_probs=98.5
Q ss_pred CCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
|+..+.||+|+||.||++.. .+|+.||||.+.... ......+.+|++++.+++|++|+++.+++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66778999999999999984 579999999986542 22335688999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++...... .+++..+..++.|++.||+|||+
T Consensus 82 ~~~g~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~ 120 (285)
T cd05631 82 MNGGDLKFHIYNMGNP-------GFDEQRAIFYAAELCCGLEDLQR 120 (285)
T ss_pred cCCCcHHHHHHhhCCC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999888654321 57788889999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.51 E-value=9.9e-14 Score=150.85 Aligned_cols=109 Identities=19% Similarity=0.254 Sum_probs=95.4
Q ss_pred CeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCC
Q 003737 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~G 757 (799)
+.||+|+||.||++.. .+|+.||+|+++... ......+.+|++++.+++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999984 578999999997542 233457889999999999999999999999999999999999999
Q ss_pred cHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 758 CLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 758 sL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|.+++.... .+++..++.++.||+.||+|||+
T Consensus 81 ~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~ 113 (323)
T cd05595 81 ELFFHLSRER---------VFTEERARFYGAEIVSALEYLHS 113 (323)
T ss_pred cHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999987654 56788999999999999999995
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-13 Score=150.63 Aligned_cols=109 Identities=18% Similarity=0.245 Sum_probs=95.7
Q ss_pred CeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCC
Q 003737 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~G 757 (799)
+.||+|+||.||++.. .+|+.||+|+++... ......+.+|++++.+++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 578999999997542 233457889999999999999999999999999999999999999
Q ss_pred cHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 758 CLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 758 sL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|.+++.... .+++..++.++.||+.||+|||+
T Consensus 81 ~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH~ 113 (323)
T cd05571 81 ELFFHLSRER---------VFSEDRARFYGAEIVSALGYLHS 113 (323)
T ss_pred cHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999997654 57788999999999999999995
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=7.5e-14 Score=147.04 Aligned_cols=117 Identities=18% Similarity=0.302 Sum_probs=104.3
Q ss_pred cCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccChh-hHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
++|+..+.||.|..++||+|. .+.+..||||++..+... +.+...+|+..|+.++||||++.+..|..++..|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 457788999999999999998 678899999999776433 357899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|.+|++.+.++..-+. .+.|..+..+.+++++||+|||.
T Consensus 106 Ma~GS~ldIik~~~~~-------Gl~E~~Ia~iLre~LkaL~YLH~ 144 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPD-------GLEEASIATILREVLKALDYLHQ 144 (516)
T ss_pred hcCCcHHHHHHHHccc-------cccHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999865432 68899999999999999999993
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.4e-14 Score=152.97 Aligned_cols=116 Identities=22% Similarity=0.318 Sum_probs=103.0
Q ss_pred hcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccC---hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 749 (799)
..+|...++||+|+|++||+|. ..+++.+|||++.+.. +...+-..+|-++|.++ .||.||+|+..|.++...|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 3568888999999999999998 5689999999997652 22234567889999999 89999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+||++||+|.++|++.+ .++|...+.|+.||+.|++|||+
T Consensus 152 vLe~A~nGdll~~i~K~G---------sfde~caR~YAAeIldAleylH~ 192 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYG---------SFDETCARFYAAEILDALEYLHS 192 (604)
T ss_pred EEEecCCCcHHHHHHHhC---------cchHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999999876 78899999999999999999995
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.3e-13 Score=148.44 Aligned_cols=124 Identities=22% Similarity=0.393 Sum_probs=98.6
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-----------------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccce
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-----------------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKL 737 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-----------------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l 737 (799)
++|...+.||+|+||.||+|... ++..||+|.+.... .....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 45777889999999999999743 23479999997653 3345689999999999999999999
Q ss_pred eEEEEECCEEEEEEecCCCCcHHHHHhcCcccccc----------cccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHI----------SIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 738 ~g~~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~----------~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++++.+.+..++||||+++|+|.+++......... .....++...+..++.||+.||+|||+
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999654211100 011235566788889999999999995
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.6e-13 Score=144.71 Aligned_cols=116 Identities=20% Similarity=0.335 Sum_probs=101.9
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
.++|+..+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++.+++|+||+++++++...+..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 34688889999999999999994 57899999999765444456788999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.++++.+. .+++..+..++.|+++||+|||+
T Consensus 88 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~ 124 (267)
T cd06646 88 CGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLAYLHS 124 (267)
T ss_pred CCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999997553 46788899999999999999995
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=9.4e-14 Score=152.03 Aligned_cols=115 Identities=18% Similarity=0.289 Sum_probs=99.4
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-C-CcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-D-GTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
++|+..+.||+|+||.||+|... + +..||+|++.... ....+.+.+|++++..++|||||++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 45778899999999999999853 3 3689999986432 23346788999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.+++.... .+++..++.++.|++.||+|||+
T Consensus 110 ~Ey~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~aL~~LH~ 149 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK---------RFPNDVGCFYAAQIVLIFEYLQS 149 (340)
T ss_pred EeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999998654 57788889999999999999995
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.2e-13 Score=150.77 Aligned_cols=116 Identities=21% Similarity=0.260 Sum_probs=100.2
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||.||++.. .+++.||+|++... .....+.|.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 3678889999999999999995 46899999999643 2223456889999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++.+... .+++..++.++.||+.||+|||+
T Consensus 81 e~~~g~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~ 120 (331)
T cd05597 81 DYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVLAIDSVHQ 120 (331)
T ss_pred ecCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999975321 57788999999999999999995
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.50 E-value=1e-13 Score=146.98 Aligned_cols=109 Identities=19% Similarity=0.305 Sum_probs=92.0
Q ss_pred eecccCCeeEEEEEeCC-------------------------CcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccce
Q 003737 683 KVGEGGFGSVYKGILSD-------------------------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL 737 (799)
Q Consensus 683 ~lG~G~~g~Vy~~~~~~-------------------------g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l 737 (799)
.||+|+||.||+|.... ...||+|.+........++|..|++++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 13589999876544445689999999999999999999
Q ss_pred eEEEEECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 738 ~g~~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|.+....++||||+++|+|.+++..... .+++..+..++.||++||+|||+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~ 135 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--------RVPVAWKITVAQQLASALSYLED 135 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHc
Confidence 9999999999999999999999999875332 45677788889999999999995
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.1e-13 Score=147.61 Aligned_cols=116 Identities=22% Similarity=0.276 Sum_probs=98.8
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
+|+..+.||+|+||.||++.. .+++.||||++.... ......+.+|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 366778999999999999984 578999999996542 1223567899999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++|+|.+++...... .+++..+..++.|++.||+|||+
T Consensus 81 ~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~ 120 (285)
T cd05605 81 LMNGGDLKFHIYNMGNP-------GFDEERAVFYAAEITCGLEDLHR 120 (285)
T ss_pred ccCCCcHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999998754321 57788899999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.49 E-value=7.1e-14 Score=155.16 Aligned_cols=93 Identities=26% Similarity=0.418 Sum_probs=79.5
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECC
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN 745 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 745 (799)
..++|+..+.||+|+||.||+|.. .++..||||+++... ....+.+.+|++++..+ +|||||+++++|.+.+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345688889999999999999963 245689999997543 33456789999999999 8999999999999999
Q ss_pred EEEEEEecCCCCcHHHHHhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGK 766 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~ 766 (799)
..++||||+++|+|.++++..
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~ 133 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRK 133 (375)
T ss_pred cceeeehhccCCcHHHHHHhc
Confidence 999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.49 E-value=6.9e-14 Score=154.99 Aligned_cols=116 Identities=22% Similarity=0.265 Sum_probs=100.0
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
..++|+..+.||+|+||.||+++. .+++.||+|++... .....+.+.+|++++.+++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 345688889999999999999985 46889999999643 12234568899999999999999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+++|+|.++++.. .+++..+..++.||+.||+|||+
T Consensus 121 v~Ey~~gg~L~~~l~~~----------~l~~~~~~~~~~qi~~aL~~LH~ 160 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----------DIPEKWARFYTAEVVLALDAIHS 160 (370)
T ss_pred EEcCCCCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999998753 46677888899999999999995
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.1e-13 Score=154.47 Aligned_cols=93 Identities=22% Similarity=0.399 Sum_probs=79.3
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCC-CCcccceeEEEEECC
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGN 745 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~ 745 (799)
..++|...+.||+|+||.||+|+.. .+..||||+++... ....+.|.+|++++.++. |||||+++++|.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 4567888899999999999999842 23479999997543 334568999999999996 999999999999999
Q ss_pred EEEEEEecCCCCcHHHHHhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGK 766 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~ 766 (799)
..++|||||++|+|.++|+..
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~ 135 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKN 135 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHh
Confidence 999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.9e-13 Score=148.94 Aligned_cols=109 Identities=19% Similarity=0.271 Sum_probs=95.6
Q ss_pred CeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCC
Q 003737 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~G 757 (799)
+.||+|+||.||++.. .+|+.||+|++.... ......+.+|++++.+++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999984 578999999997542 234567889999999999999999999999999999999999999
Q ss_pred cHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 758 CLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 758 sL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|.+++.... .+++..+..++.||+.||+|||+
T Consensus 81 ~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~ 113 (328)
T cd05593 81 ELFFHLSRER---------VFSEDRTRFYGAEIVSALDYLHS 113 (328)
T ss_pred CHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999987654 56788899999999999999995
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.5e-13 Score=143.93 Aligned_cols=114 Identities=22% Similarity=0.466 Sum_probs=98.9
Q ss_pred CCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCC
Q 003737 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+|+..+.||+|+||.||++...++..+|+|.+.... ...++|.+|++++.+++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 466778899999999999998778889999986432 2356799999999999999999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.++++.... .++++.+..++.|++.||+|||+
T Consensus 84 ~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~ 118 (256)
T cd05114 84 GCLLNYLRQRQG--------KLSKDMLLSMCQDVCEGMEYLER 118 (256)
T ss_pred CcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999975431 35677888889999999999995
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.6e-13 Score=148.45 Aligned_cols=107 Identities=17% Similarity=0.217 Sum_probs=94.1
Q ss_pred ecccCCeeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCcH
Q 003737 684 VGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (799)
Q Consensus 684 lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL 759 (799)
||+|+||.||++.. .+++.||+|.++.. .......+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999995 46889999998653 233456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 760 SRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 760 ~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+++.... .+++..++.++.||+.||+|||+
T Consensus 81 ~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~ 111 (312)
T cd05585 81 FHHLQREG---------RFDLSRARFYTAELLCALENLHK 111 (312)
T ss_pred HHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99997654 56788899999999999999995
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.3e-13 Score=145.09 Aligned_cols=109 Identities=17% Similarity=0.265 Sum_probs=92.8
Q ss_pred CCeecccCCeeEEEEEeCCCcEEEEEEccccChhh---HHHHHHHHHHHHhCCCCcccceeEEEEE----CCEEEEEEec
Q 003737 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLLVYEY 753 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey 753 (799)
...||+|++|.||+|.. +|+.||||+++...... .+.|.+|++++.+++|||||+++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 46899999999999998 68899999997653322 4678899999999999999999999977 3468999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.++++.+. .+++.....++.|++.||+|||.
T Consensus 104 ~~~g~L~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~lH~ 140 (283)
T PHA02988 104 CTRGYLREVLDKEK---------DLSFKTKLDMAIDCCKGLYNLYK 140 (283)
T ss_pred CCCCcHHHHHhhCC---------CCChhHHHHHHHHHHHHHHHHHh
Confidence 99999999998654 34556677789999999999994
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.6e-13 Score=151.59 Aligned_cols=115 Identities=19% Similarity=0.303 Sum_probs=100.7
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||.||++.. .+++.||+|+++... ....+.+.+|++++.+++|++|+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3678889999999999999985 468999999996532 223457889999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++.... .+++..++.++.|++.||+|||+
T Consensus 81 E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~~L~~lH~ 119 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---------TLSEEATQFYIAETVLAIDAIHQ 119 (360)
T ss_pred eCCCCccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999997654 57788999999999999999995
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.48 E-value=8.4e-14 Score=152.39 Aligned_cols=126 Identities=21% Similarity=0.362 Sum_probs=99.0
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccceeEEEEEC-
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG- 744 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~- 744 (799)
+.++|+..+.||+|+||.||+|.. .++..||||+++... ....+.+.+|++++.++ +|||||+++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 456788889999999999999973 235689999997543 23346799999999999 899999999998764
Q ss_pred CEEEEEEecCCCCcHHHHHhcCccccc-----------------------------------------------------
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFH----------------------------------------------------- 771 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~----------------------------------------------------- 771 (799)
+..++||||+++|+|.++++.......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 468999999999999999975421100
Q ss_pred ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 772 ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 772 ~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..+...+.++.+..++.||++||+|||+
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~ 192 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS 192 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 0112346677888889999999999995
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.2e-13 Score=152.95 Aligned_cols=117 Identities=22% Similarity=0.298 Sum_probs=100.7
Q ss_pred HhhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEE
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 748 (799)
...++|+..+.||+|+||.||++.. .+++.||+|.+... .....+.+.+|++++..++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 3456788899999999999999995 46889999998643 2223456889999999999999999999999999999
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||+++|+|.+++... .+++..++.++.||+.||+|||+
T Consensus 120 lv~Ey~~gg~L~~~l~~~----------~~~~~~~~~~~~qil~aL~~LH~ 160 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY----------DVPEKWAKFYTAEVVLALDAIHS 160 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999998643 46788899999999999999995
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.48 E-value=8.3e-14 Score=146.19 Aligned_cols=119 Identities=20% Similarity=0.404 Sum_probs=104.7
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+..+|+..+.||+|+||.||+|...++..+|+|.+..........+.+|+.++.+++|+||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 44567888999999999999999877899999999876555567899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.++++..... .+++..+..++.|+++|++|||+
T Consensus 84 ~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~al~~lH~ 122 (261)
T cd05148 84 MEKGSLLAFLRSPEGQ-------VLPVASLIDMACQVAEGMAYLEE 122 (261)
T ss_pred cccCCHHHHHhcCCCC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999864322 46677888889999999999995
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.1e-14 Score=153.67 Aligned_cols=115 Identities=23% Similarity=0.465 Sum_probs=103.5
Q ss_pred hcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
...|.....||+|+.|.||.+. ..+++.||||++........+-..+|+.+|+..+|+|||+++..|...++.++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3456667889999999999998 668899999999887666677789999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|++|+|.|.+... .+.|.++..+++++++||+|||.
T Consensus 352 m~ggsLTDvVt~~----------~~~E~qIA~Icre~l~aL~fLH~ 387 (550)
T KOG0578|consen 352 MEGGSLTDVVTKT----------RMTEGQIAAICREILQGLKFLHA 387 (550)
T ss_pred cCCCchhhhhhcc----------cccHHHHHHHHHHHHHHHHHHHh
Confidence 9999999998754 58899999999999999999994
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.3e-13 Score=147.66 Aligned_cols=109 Identities=19% Similarity=0.336 Sum_probs=94.7
Q ss_pred CeecccCCeeEEEEEe----CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCC
Q 003737 682 NKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~----~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
+.||+|+||.||++.. .+|+.||+|+++... ......+.+|++++.+++||||+++++++.+.+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 368899999997542 2234567889999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.+++.+.. .++++.+..++.||++||+|||+
T Consensus 82 ~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~ 116 (318)
T cd05582 82 GGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLHS 116 (318)
T ss_pred CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999997643 57788999999999999999995
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=7.8e-14 Score=153.25 Aligned_cols=115 Identities=20% Similarity=0.345 Sum_probs=102.8
Q ss_pred cCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccCh---hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
+.|...+.||+|+.|.|-.|+ ..+|+.+|||++.+... .......+|+.+|+-+.||||++++.++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 346677899999999999999 57899999999976632 23457889999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||++|.|++++..++ .++|.++..|++||+.|++|+|.
T Consensus 92 Eyv~gGELFdylv~kG---------~l~e~eaa~ff~QIi~gv~yCH~ 130 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG---------PLPEREAAHFFRQILDGVSYCHA 130 (786)
T ss_pred EecCCchhHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHhh
Confidence 9999999999999887 67888999999999999999994
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.7e-13 Score=145.61 Aligned_cols=118 Identities=24% Similarity=0.445 Sum_probs=103.9
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
++++|+..+.||+|+||.||++.. .+++.||+|.+........+.|.+|++++++++|+||+++++++..++..++|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 345678888999999999999995 4689999999976655566789999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++|+|.+++..... .+++..+..++.|++.||+|||+
T Consensus 83 ~~~~~~L~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh~ 121 (280)
T cd06611 83 FCDGGALDSIMLELER--------GLTEPQIRYVCRQMLEALNFLHS 121 (280)
T ss_pred ccCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999875432 57788999999999999999995
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.47 E-value=3e-13 Score=147.15 Aligned_cols=109 Identities=19% Similarity=0.257 Sum_probs=95.2
Q ss_pred CeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCC
Q 003737 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~G 757 (799)
+.||+|+||.||++.. .+|+.||+|.+.... ......+.+|++++.+++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999984 578999999997542 233467889999999999999999999999999999999999999
Q ss_pred cHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 758 CLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 758 sL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|.+++.... .++++.+..++.||+.||+|||+
T Consensus 81 ~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~ 113 (325)
T cd05594 81 ELFFHLSRER---------VFSEDRARFYGAEIVSALDYLHS 113 (325)
T ss_pred cHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999987654 57788999999999999999994
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.4e-13 Score=151.29 Aligned_cols=115 Identities=26% Similarity=0.387 Sum_probs=101.2
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|...+.||+|+||.||+|.. .+|+.||||+++... ....+.+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 3577889999999999999995 478999999997542 234567899999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++.... .+++..++.++.||+.||+|||+
T Consensus 81 e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~ 119 (350)
T cd05573 81 EYMPGGDLMNLLIRKD---------VFPEETARFYIAELVLALDSVHK 119 (350)
T ss_pred cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998653 57788999999999999999995
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.6e-13 Score=148.14 Aligned_cols=116 Identities=19% Similarity=0.218 Sum_probs=99.5
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|...+.||+|+||.||+++. .+++.||+|.+.... ....+.+.+|+.++...+|++|+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4678889999999999999995 468899999986531 223456888999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.++++.... .+++..++.++.|++.||+|||+
T Consensus 81 Ey~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~~L~~lH~ 120 (331)
T cd05624 81 DYYVGGDLLTLLSKFED--------RLPEDMARFYIAEMVLAIHSIHQ 120 (331)
T ss_pred eCCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999976321 56788899999999999999995
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.3e-13 Score=147.15 Aligned_cols=109 Identities=17% Similarity=0.278 Sum_probs=94.7
Q ss_pred CeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEEecCCC
Q 003737 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
++||+|+||.||++.. .+++.||+|+++... ....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999985 478999999997542 22345688999999998 799999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++...+ .+++..+..++.|++.||+|||+
T Consensus 81 g~L~~~~~~~~---------~l~~~~~~~~~~qi~~~l~~lH~ 114 (329)
T cd05588 81 GDLMFHMQRQR---------KLPEEHARFYSAEISLALNFLHE 114 (329)
T ss_pred CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999987554 57888999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.7e-13 Score=147.88 Aligned_cols=116 Identities=22% Similarity=0.250 Sum_probs=100.7
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||.||++.. .+|+.||+|+++... ....+.+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3678889999999999999984 478999999997542 223467889999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++.+... .+++..++.++.||++||+|||+
T Consensus 81 e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~ 120 (330)
T cd05601 81 EYQPGGDLLSLLNRYED--------QFDEDMAQFYLAELVLAIHSVHQ 120 (330)
T ss_pred CCCCCCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999976521 57788899999999999999995
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.3e-13 Score=150.83 Aligned_cols=122 Identities=21% Similarity=0.310 Sum_probs=104.0
Q ss_pred HHHHHHhhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhCCCCcccceeEEEEE
Q 003737 668 LRQIKAATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743 (799)
Q Consensus 668 ~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 743 (799)
+.++....++|+..+.||+|+||.||++.. .+++.||+|.+... .....+.+.+|++++..++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 444555668899999999999999999995 46889999998642 22234568899999999999999999999999
Q ss_pred CCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 744 GNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 744 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++..++||||+++|+|.+++... .+++..++.++.||+.||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~----------~~~~~~~~~~~~qi~~aL~~LH~ 160 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY----------DVPEKWARFYTAEVVLALDAIHS 160 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999998653 46777888999999999999995
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.4e-13 Score=140.42 Aligned_cols=114 Identities=19% Similarity=0.450 Sum_probs=99.1
Q ss_pred CCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccC------hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS------RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
+|...+.||+|+||.||+|...+|+.+|||.++... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 366788999999999999998889999999986432 12235689999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.+++.+.. .++++.+..++.|++.||+|||+
T Consensus 81 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~ 120 (265)
T cd06631 81 MEFVPGGSISSILNRFG---------PLPEPVFCKYTKQILDGVAYLHN 120 (265)
T ss_pred EecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999997643 46788888899999999999995
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.8e-13 Score=148.54 Aligned_cols=117 Identities=18% Similarity=0.300 Sum_probs=103.0
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
-...|.....||+|.|++|..+.. .+|..||+|.+++.. ....+.+.+|+++|..++|||||+++.+.+.....|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 345678889999999999999994 478999999998753 23345699999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+.+|.+++++.+.+ ++.+...+.++.|+.+|++|||.
T Consensus 134 ~eya~~ge~~~yl~~~g---------r~~e~~ar~~F~q~vsaveYcH~ 173 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG---------RMKEKEARAKFRQIVSAVEYCHS 173 (596)
T ss_pred EEeccCchhHHHHHhcc---------cchhhhhhhhhHHHHHHHHHHhh
Confidence 99999999999999877 45567888899999999999995
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.7e-13 Score=142.50 Aligned_cols=116 Identities=25% Similarity=0.419 Sum_probs=98.5
Q ss_pred cCCCCCCeecccCCeeEEEEEe-----CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEE--CCEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLL 748 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 748 (799)
.+|+..+.||+|+||.||++.. .++..||+|++........+.|.+|++++.+++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4577788999999999999974 2578999999977666666789999999999999999999998754 34689
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+||+++|+|.+++.+... .+++..+..++.|++.||+|||+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~aL~~LH~ 126 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRE--------RLDHRKLLLYASQICKGMEYLGS 126 (284)
T ss_pred EEEEecCCCCHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999975431 45677888889999999999995
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.3e-13 Score=141.74 Aligned_cols=116 Identities=22% Similarity=0.362 Sum_probs=100.1
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCC
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
++|+..+.||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++.+++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 4577889999999999999998888899999986543 235789999999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.++++..... ..+...+..++.|+++||+|||+
T Consensus 85 ~~~L~~~l~~~~~~-------~~~~~~~~~~~~~l~~~l~~LH~ 121 (261)
T cd05072 85 KGSLLDFLKSDEGG-------KVLLPKLIDFSAQIAEGMAYIER 121 (261)
T ss_pred CCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999754321 45666788889999999999995
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.4e-13 Score=143.19 Aligned_cols=115 Identities=19% Similarity=0.354 Sum_probs=98.1
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
++|...+.||+|+||.||+|.. .+++.||+|+++... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 4578889999999999999985 478999999986543 22345788999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++ +|.+++..... .+++..+..++.||++||+|||+
T Consensus 85 ~~~-~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~ 121 (288)
T cd07871 85 LDS-DLKQYLDNCGN--------LMSMHNVKIFMFQLLRGLSYCHK 121 (288)
T ss_pred CCc-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 985 99999875432 46777889999999999999995
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.4e-13 Score=140.57 Aligned_cols=116 Identities=22% Similarity=0.445 Sum_probs=99.5
Q ss_pred cCCCCCCeecccCCeeEEEEEeC----CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
++|+..+.||+|+||.||+|... +...||||.++... .....+|.+|+.++.+++|+||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 46888899999999999999863 24589999987653 33456899999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.+++..... .+++..+..++.|++.|++|||+
T Consensus 84 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~Lh~ 124 (266)
T cd05033 84 TEYMENGSLDKFLRENDG--------KFTVGQLVGMLRGIASGMKYLSE 124 (266)
T ss_pred EEcCCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999976432 46677888889999999999995
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.3e-13 Score=141.47 Aligned_cols=114 Identities=24% Similarity=0.438 Sum_probs=98.5
Q ss_pred CCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCC
Q 003737 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+|...+.||+|+||.||+|...++..+|+|.+.... ...++|.+|++++.+++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 466678899999999999987777779999987543 3356799999999999999999999999998999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++..... .+++..+..++.||+.||+|||+
T Consensus 84 ~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~ 118 (256)
T cd05113 84 GCLLNYLREHGK--------RFQPSQLLEMCKDVCEGMAYLES 118 (256)
T ss_pred CcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999975432 46677888899999999999995
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.8e-13 Score=145.48 Aligned_cols=109 Identities=20% Similarity=0.349 Sum_probs=93.9
Q ss_pred CeecccCCeeEEEEEe----CCCcEEEEEEccccC----hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 682 NKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+.||+|+||.||+++. .+++.||||.++... ......+.+|++++.+++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999984 357899999986532 22335678999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++.... .++++.+..++.||+.||+|||+
T Consensus 82 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~ 118 (323)
T cd05584 82 LSGGELFMHLEREG---------IFMEDTACFYLSEISLALEHLHQ 118 (323)
T ss_pred CCCchHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999997654 45677888899999999999995
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.3e-13 Score=139.34 Aligned_cols=110 Identities=23% Similarity=0.443 Sum_probs=95.0
Q ss_pred CeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCcH
Q 003737 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL 759 (799)
+.||+|+||.||+|.. .+++.||+|...... ......|.+|++++++++|+||++++++|...+..++||||+++|+|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999985 578999999886543 33456799999999999999999999999999999999999999999
Q ss_pred HHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 760 SRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 760 ~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++++.... .+++..+..++.|+++||+|||+
T Consensus 81 ~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~ 112 (252)
T cd05084 81 LTFLRTEGP--------RLKVKELIQMVENAAAGMEYLES 112 (252)
T ss_pred HHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999975432 46677888889999999999995
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.4e-13 Score=143.78 Aligned_cols=115 Identities=23% Similarity=0.352 Sum_probs=97.3
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
++|+..+.||+|+||.||++... +++.||||++.... ....+.+.+|++++.+++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 35788899999999999999964 68899999986542 2334678899999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|++++.+..+..... .++++.++.++.|++.||+|||+
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~ 118 (287)
T cd07848 81 YVEKNMLELLEEMPN---------GVPPEKVRSYIYQLIKAIHWCHK 118 (287)
T ss_pred cCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999987765543322 57788899999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.44 E-value=5e-13 Score=140.80 Aligned_cols=114 Identities=20% Similarity=0.374 Sum_probs=99.1
Q ss_pred CCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccC------hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS------RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
+|+..+.||+|+||.||++. ..+++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47778899999999999998 4678999999986432 1124679999999999999999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+||+++|+|.+++.+.+ .+++..+..++.|++.||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~ql~~al~~LH~ 121 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---------AFKEAVIINYTEQLLRGLSYLHE 121 (268)
T ss_pred EEeccCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999997643 46777888889999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.44 E-value=5.8e-13 Score=143.36 Aligned_cols=116 Identities=20% Similarity=0.402 Sum_probs=98.3
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
.++|+..+.||+|+||.||+|... +++.||||+++.... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467888999999999999999954 789999999875432 223467899999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|++ |+|.+++..... .++++.++.++.||+.||+|||+
T Consensus 84 ~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~lH~ 121 (303)
T cd07869 84 YVH-TDLCQYMDKHPG--------GLHPENVKLFLFQLLRGLSYIHQ 121 (303)
T ss_pred CCC-cCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 996 688888765432 46777899999999999999995
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.44 E-value=5.3e-13 Score=141.31 Aligned_cols=124 Identities=22% Similarity=0.297 Sum_probs=102.2
Q ss_pred cCCCCCCeecccCCeeEEEEEeC------CCcEEEEEEccccChh-hHHHHHHHHHHHHhCCCCcccceeEEEEECCEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 748 (799)
++|+....||+|+||.||+|... +.+.||+|.+...... ..+.|.+|++++.+++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46788899999999999999853 2467999998765433 4578999999999999999999999999989999
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||+++|+|.++++.............+++..+..++.|++.||+|||+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~ 135 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN 135 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh
Confidence 999999999999999765422211122257788899999999999999995
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.44 E-value=6e-13 Score=144.93 Aligned_cols=112 Identities=15% Similarity=0.260 Sum_probs=95.0
Q ss_pred CCeeccc--CCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCC
Q 003737 681 ANKVGEG--GFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 681 ~~~lG~G--~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
.++||+| +|++||++.. .+|+.||+|+++... ....+.+.+|+++++.++|||||++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 5689999 6889999984 578999999997542 2234567789999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.+++...... .+++..+..++.|++.||+|||+
T Consensus 83 ~~~l~~~~~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~ 119 (327)
T cd08227 83 YGSAKDLICTHFMD-------GMSELAIAYILQGVLKALDYIHH 119 (327)
T ss_pred CCcHHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999653221 46778889999999999999995
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.9e-13 Score=150.19 Aligned_cols=93 Identities=27% Similarity=0.466 Sum_probs=78.8
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECC
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN 745 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 745 (799)
..++|+..+.||+|+||.||++.. .++..||||+++... ....+.+.+|+++++++ +|+|||+++++|...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 345688899999999999999873 134589999997643 23346789999999999 8999999999999999
Q ss_pred EEEEEEecCCCCcHHHHHhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGK 766 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~ 766 (799)
..++||||+++|+|.++++..
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~ 136 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKK 136 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhh
Confidence 999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.9e-13 Score=140.28 Aligned_cols=117 Identities=22% Similarity=0.397 Sum_probs=98.3
Q ss_pred CCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccCh--hhHHHHHHHHHHHHhCCCCc-ccceeEEEEECC------E
Q 003737 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPN-LVKLYGCCVEGN------Q 746 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~------~ 746 (799)
.|+..++||+|+||+||+|+ ..+|+.||+|+++.... +....-.+|+.++.+++|+| ||++++++.+.+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 35556789999999999999 56899999999976533 33456789999999999999 999999999877 7
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++|+||++. +|.+++....+.. ..++...++.+++||++||+|||+
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~-----~g~~~~~ik~~m~Qll~gl~~~H~ 138 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKP-----QGLPPRLIKSFMRQLLRGLAFLHS 138 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccc-----cCCCHHHHHHHHHHHHHHHHHHHh
Confidence 8999999987 9999998654211 245667899999999999999995
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.8e-13 Score=146.36 Aligned_cols=115 Identities=19% Similarity=0.373 Sum_probs=102.0
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccCh---hhHHHHHHHHHHHHhCC-CCcccceeEEEEECCEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 749 (799)
...|+..+.||+|.||.||+++.+ +|+.+|+|.+.+... .+.+.+.+|+++|.++. |||||.+.+++.+.+..++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 345777789999999999999954 599999999976533 24468999999999998 9999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||++.+|+|++.+... .++|.++..+++||+.|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~----------~~sE~da~~~~~~il~av~~lH~ 153 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----------HYSERDAAGIIRQILEAVKYLHS 153 (382)
T ss_pred EEEecCCchHHHHHHHc----------cCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999865 27789999999999999999995
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.3e-13 Score=141.33 Aligned_cols=115 Identities=18% Similarity=0.357 Sum_probs=100.9
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
++|...+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.++..++||||+++++++...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 3566678899999999999984 568999999987655445567889999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.++++..+ .+++..+..++.|++.|++|||+
T Consensus 89 ~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~ 124 (267)
T cd06645 89 GGGSLQDIYHVTG---------PLSESQIAYVSRETLQGLYYLHS 124 (267)
T ss_pred CCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999987654 56788999999999999999995
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.1e-13 Score=141.38 Aligned_cols=115 Identities=23% Similarity=0.304 Sum_probs=98.1
Q ss_pred CCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
|+..+.||+|+||.||++.. .+++.||||.+.... ....+.+.+|++++.+++|++++++++++.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 66678899999999999984 578999999986542 22235678899999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.++++..... .+++..+..++.|++.||+|||+
T Consensus 82 ~~g~~L~~~l~~~~~~-------~l~~~~~~~~~~qi~~~l~~lH~ 120 (285)
T cd05630 82 MNGGDLKFHIYHMGEA-------GFEEGRAVFYAAEICCGLEDLHQ 120 (285)
T ss_pred cCCCcHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999998654321 57788899999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.3e-13 Score=140.38 Aligned_cols=114 Identities=24% Similarity=0.286 Sum_probs=92.9
Q ss_pred CeecccCCeeEEEEEeC---CCcEEEEEEccccCh-hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCC
Q 003737 682 NKVGEGGFGSVYKGILS---DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~G 757 (799)
+.||+|+||.||+|... .+..+|+|.++.... .....|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 35899999999999854 345799999876532 33457999999999999999999999999999999999999999
Q ss_pred cHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 758 CLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 758 sL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|.++++...... ...+++..+..++.|++.|++|||+
T Consensus 81 ~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~ 118 (269)
T cd05087 81 DLKGYLRSCRKAE----LMTPDPTTLQRMACEIALGLLHLHK 118 (269)
T ss_pred cHHHHHHHhhhcc----cccccHHHHHHHHHHHHHHHHHHHH
Confidence 9999997543211 1145566777789999999999995
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.44 E-value=5.5e-13 Score=145.58 Aligned_cols=116 Identities=21% Similarity=0.246 Sum_probs=99.1
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|...+.||+|+||.||+++.. +++.+|+|.+.+.. ....+.|..|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36778899999999999999964 57889999986431 223346889999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++++... .++++.++.++.||+.||+|||+
T Consensus 81 ey~~~g~L~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~lH~ 120 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVIAIDSVHQ 120 (332)
T ss_pred eccCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999976321 56788899999999999999995
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.7e-13 Score=141.55 Aligned_cols=115 Identities=22% Similarity=0.278 Sum_probs=98.2
Q ss_pred CCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
|+..+.||+|+||+||++.. .+++.||+|.+.... ....+.+.+|++++.+++|++++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 55668899999999999985 578999999986542 22335678999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.++++..... .+++..+..++.|++.||+|||+
T Consensus 82 ~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~ 120 (285)
T cd05632 82 MNGGDLKFHIYNMGNP-------GFEEERALFYAAEILCGLEDLHR 120 (285)
T ss_pred ccCccHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999998754321 57888999999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.6e-13 Score=144.27 Aligned_cols=109 Identities=17% Similarity=0.286 Sum_probs=93.8
Q ss_pred CeecccCCeeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEEecCCC
Q 003737 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+.||+|+||.||++.. .+++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999995 46889999999754 223345678899888876 799999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++.... .+++..++.++.||+.||+|||+
T Consensus 81 ~~L~~~~~~~~---------~l~~~~~~~i~~qi~~~l~~lH~ 114 (329)
T cd05618 81 GDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLHE 114 (329)
T ss_pred CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999887554 57788999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.3e-13 Score=149.70 Aligned_cols=93 Identities=26% Similarity=0.483 Sum_probs=79.1
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeC------CCcEEEEEEccccCh-hhHHHHHHHHHHHHhCC-CCcccceeEEEEECC
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGN 745 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~ 745 (799)
..++|...+.||+|+||.||+|... .++.||+|+++.... ...+.+.+|++++.++. |||||+++++|...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 4456777899999999999999853 346899999976432 23457999999999997 999999999999999
Q ss_pred EEEEEEecCCCCcHHHHHhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGK 766 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~ 766 (799)
..++|+||+++|+|.+++++.
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~ 135 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRN 135 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhc
Confidence 999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2e-13 Score=147.43 Aligned_cols=117 Identities=24% Similarity=0.402 Sum_probs=101.8
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCE-EEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ-LLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 751 (799)
++|...+.+|+|+||.++.... .+++.+++|.+.... ...++...+|+.++++++|||||.+.+.+..++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 4577788999999999998874 467899999987653 3345578899999999999999999999988887 99999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||++||++.+.+...+. ..++|+++..|+.|++.|++|||+
T Consensus 84 ~Y~eGg~l~~~i~~~k~-------~~f~E~~i~~~~~Q~~~av~ylH~ 124 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKG-------VLFPEERILKWFVQILLAVNYLHE 124 (426)
T ss_pred eecCCCCHHHHHHHHhh-------ccccHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999987652 278999999999999999999995
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.7e-13 Score=139.98 Aligned_cols=118 Identities=23% Similarity=0.435 Sum_probs=102.1
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
..++|+..+.||+|+||.||+|...+++.||+|.++... ...++|.+|++++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 345688889999999999999998777889999987543 3456799999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++...... .+++..+..++.|++.|++|||+
T Consensus 83 ~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~ 121 (261)
T cd05068 83 MKYGSLLEYLQGGAGR-------ALKLPQLIDMAAQVASGMAYLEA 121 (261)
T ss_pred ccCCcHHHHHhccCCC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999754311 46677888899999999999995
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.7e-13 Score=143.38 Aligned_cols=109 Identities=22% Similarity=0.318 Sum_probs=92.6
Q ss_pred CeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEEecCCC
Q 003737 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+.||+|+||.||+|.. .+++.||||+++... ....+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999995 467899999997542 23345677888888764 899999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++.... .+++..+..++.|++.||+|||+
T Consensus 81 g~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~LH~ 114 (316)
T cd05619 81 GDLMFHIQSCH---------KFDLPRATFYAAEIICGLQFLHS 114 (316)
T ss_pred CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999997643 46677888899999999999995
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.43 E-value=6.2e-13 Score=144.37 Aligned_cols=109 Identities=24% Similarity=0.374 Sum_probs=93.9
Q ss_pred CeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEEecCCC
Q 003737 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+.||+|+||.||+++. .+++.||||+++... ....+.+.+|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 468899999987532 23346788899998876 699999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++.... .+++..+..++.|++.||+|||+
T Consensus 81 g~L~~~i~~~~---------~l~~~~~~~~~~ql~~~L~~lH~ 114 (320)
T cd05590 81 GDLMFHIQKSR---------RFDEARARFYAAEITSALMFLHD 114 (320)
T ss_pred chHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999987654 56788899999999999999995
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.2e-13 Score=143.63 Aligned_cols=109 Identities=20% Similarity=0.310 Sum_probs=92.0
Q ss_pred CeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEEecCCC
Q 003737 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+.||+|+||.||+|.. .+++.||+|+++... ....+.+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999995 468899999997542 22345567777777754 899999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++.... .+++..+..++.||+.||+|||+
T Consensus 81 g~L~~~~~~~~---------~~~~~~~~~~~~qi~~al~~LH~ 114 (316)
T cd05592 81 GDLMFHIQSSG---------RFDEARARFYAAEIICGLQFLHK 114 (316)
T ss_pred CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999987654 57788899999999999999995
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.5e-13 Score=144.06 Aligned_cols=109 Identities=23% Similarity=0.371 Sum_probs=92.1
Q ss_pred CeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHH-HHHhCCCCcccceeEEEEECCEEEEEEecCCC
Q 003737 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999984 578999999986542 223456667765 46779999999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++.... .+++..+..++.||++||+|||+
T Consensus 81 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~ 114 (325)
T cd05604 81 GELFFHLQRER---------SFPEPRARFYAAEIASALGYLHS 114 (325)
T ss_pred CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999987654 57788999999999999999995
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.1e-13 Score=141.00 Aligned_cols=111 Identities=21% Similarity=0.285 Sum_probs=93.0
Q ss_pred ecccCCeeEEEEEe-CCCcEEEEEEccccCh---hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCcH
Q 003737 684 VGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (799)
Q Consensus 684 lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL 759 (799)
||+|+||+||++.. .+|+.||+|++..... ...+.+..|++++.+++|+||+++.+++...+..++|||||++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999984 5789999999865422 2335678999999999999999999999999999999999999999
Q ss_pred HHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 760 SRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 760 ~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++++..... ...+++..+..++.||++||+|||+
T Consensus 81 ~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~ 115 (280)
T cd05608 81 RYHIYNVDEE-----NPGFPEPRACFYTAQIISGLEHLHQ 115 (280)
T ss_pred HHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 9888643211 1157888899999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.43 E-value=8.2e-13 Score=139.43 Aligned_cols=113 Identities=21% Similarity=0.331 Sum_probs=92.2
Q ss_pred eecccCCeeEEEEEeCC---CcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCc
Q 003737 683 KVGEGGFGSVYKGILSD---GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 758 (799)
Q Consensus 683 ~lG~G~~g~Vy~~~~~~---g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~Gs 758 (799)
.||+|+||.||+|...+ ...+|+|.+.... ......|.+|+++++.++|+||+++++++...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997533 3578899876543 3345678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 759 LSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 759 L~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|.+++......... ..++..+..++.||+.|++|||+
T Consensus 82 L~~~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~ 118 (269)
T cd05042 82 LKNYLRSNRGMVAQ----MAQKDVLQRMACEVASGLLWLHQ 118 (269)
T ss_pred HHHHHHhccccccc----cccHHHHHHHHHHHHHHHHHHHh
Confidence 99999765321111 34566778889999999999995
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.43 E-value=9.9e-14 Score=143.53 Aligned_cols=112 Identities=25% Similarity=0.404 Sum_probs=89.2
Q ss_pred CCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECC-----EEEEEE
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-----QLLLVY 751 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~ 751 (799)
|...+++|+|+||.||+|.+ .+++.||||+...+.. ---+|.++|++++|||||+|.-++.... ...+||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 55678999999999999995 4678999999865432 2347899999999999999998886432 235899
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||. +|.+.++.-.+. ...++.-.++.|+.||++||+|||+
T Consensus 102 eymP~-tL~~~~r~~~~~-----~~~mp~~~iKLYt~Qlfrgl~yLh~ 143 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRA-----NQRMPLLEIKLYTYQLFRGLAYLHS 143 (364)
T ss_pred HhchH-HHHHHHHHHhhc-----CCCCceeeeHHHHHHHHHHHHHHHh
Confidence 99998 999999842110 1157777899999999999999995
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.5e-13 Score=139.37 Aligned_cols=110 Identities=21% Similarity=0.314 Sum_probs=93.0
Q ss_pred CeecccCCeeEEEEEeCC-------------CcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEE
Q 003737 682 NKVGEGGFGSVYKGILSD-------------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~~~-------------g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 748 (799)
+.||+|+||.||+|...+ ...||+|.+..........|..|+.++..++||||+++++++.+....+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2358999987655555568899999999999999999999999999999
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||+++|+|..+++.+.. .+++..+..++.||++||+|||+
T Consensus 81 lv~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~ 123 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD--------VLTTPWKFKVAKQLASALSYLED 123 (262)
T ss_pred EEEecccCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHhhh
Confidence 99999999999999875432 46677788889999999999995
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.5e-13 Score=142.05 Aligned_cols=115 Identities=19% Similarity=0.372 Sum_probs=99.5
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
++|+..+.||+|+||+||++.. ++|+.||+|++.... ....+.+.+|++++.+++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 3466678999999999999994 578999999886543 33457899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++...+ .+++..+..++.|++.||+|||+
T Consensus 85 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~ 121 (284)
T cd06620 85 MDCGSLDRIYKKGG---------PIPVEILGKIAVAVVEGLTYLYN 121 (284)
T ss_pred CCCCCHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999987643 46777888999999999999994
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.8e-13 Score=143.66 Aligned_cols=109 Identities=24% Similarity=0.369 Sum_probs=91.6
Q ss_pred CeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHH-HHHhCCCCcccceeEEEEECCEEEEEEecCCC
Q 003737 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|.. ++..++|||||++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 468899999986532 223345666664 57889999999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++.... .+++..++.++.||++||+|||+
T Consensus 81 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH~ 114 (321)
T cd05603 81 GELFFHLQRER---------CFLEPRARFYAAEVASAIGYLHS 114 (321)
T ss_pred CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999887543 56788899999999999999995
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.1e-12 Score=137.22 Aligned_cols=113 Identities=27% Similarity=0.485 Sum_probs=98.1
Q ss_pred CCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC-----hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++|+||+++++++..++..++|+
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 667789999999999999965 78999999986532 223467999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++++|.+++.... .+++..+..++.|+++|++|||+
T Consensus 82 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~ 120 (258)
T cd06632 82 ELVPGGSLAKLLKKYG---------SFPEPVIRLYTRQILLGLEYLHD 120 (258)
T ss_pred EecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999997543 45677888889999999999995
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.43 E-value=6.6e-13 Score=143.89 Aligned_cols=115 Identities=22% Similarity=0.482 Sum_probs=95.8
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCc----EEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGT----VIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~----~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
.+|+..+.||+|+||.||+|+. .+|+ .||+|.++... ....++|.+|+++++.++|+||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 4588899999999999999985 3443 48999987543 33457899999999999999999999999764 5679
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+||+++|+|.++++.... .+++..+..++.||++||+|||+
T Consensus 86 v~e~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~ 127 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEE 127 (316)
T ss_pred eeecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999986532 45677788889999999999995
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.9e-13 Score=143.60 Aligned_cols=109 Identities=22% Similarity=0.317 Sum_probs=93.5
Q ss_pred CeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEEecCCC
Q 003737 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+.||+|+||.||+|+. .+++.||+|+++... ....+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999995 468899999987542 23345688899999876 799999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++.... .+++..+..++.||+.||+|||+
T Consensus 81 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~ 114 (321)
T cd05591 81 GDLMFQIQRSR---------KFDEPRSRFYAAEVTLALMFLHR 114 (321)
T ss_pred CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999987654 56778888999999999999995
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.43 E-value=8.3e-13 Score=139.27 Aligned_cols=116 Identities=22% Similarity=0.405 Sum_probs=97.9
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-C---CcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-D---GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~---g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
.+|+..+.||+|+||.||+|... + +..+|+|.++... ....+.|.+|++++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45777899999999999999852 2 3479999987543 33456899999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.+++..... .++...+..++.|++.|++|||+
T Consensus 84 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~ 124 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG--------QFTVIQLVGMLRGIASGMKYLSD 124 (267)
T ss_pred EEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999976432 35667788889999999999995
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.2e-12 Score=137.98 Aligned_cols=119 Identities=23% Similarity=0.382 Sum_probs=100.0
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||.||+|.. .+++.||||.+... .......|.+|++++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4688889999999999999994 57899999987542 2333467899999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++...... ...++++.+..++.|+++||+|||+
T Consensus 82 e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~ 124 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQ-----KRLIPERTVWKYFVQLCSAVEHMHS 124 (267)
T ss_pred EecCCCcHHHHHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 999999999988642211 1146788888999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.9e-13 Score=147.10 Aligned_cols=117 Identities=22% Similarity=0.455 Sum_probs=97.7
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeC---CC--cEEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILS---DG--TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~---~g--~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 747 (799)
.++.....++||+|.||.||+|++. .| ..||||.-+.. .....+.|.+|.-+|++++|||||+++|+|. +.+.
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccce
Confidence 3344556789999999999999953 23 36889998764 3445688999999999999999999999996 4688
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|||.++-|.|..+|..+.. .++-..+..|+.||+.||+|||+
T Consensus 466 WivmEL~~~GELr~yLq~nk~--------sL~l~tL~ly~~Qi~talaYLeS 509 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKD--------SLPLRTLTLYCYQICTALAYLES 509 (974)
T ss_pred eEEEecccchhHHHHHHhccc--------cchHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999999987653 56677788899999999999985
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.9e-13 Score=143.81 Aligned_cols=114 Identities=20% Similarity=0.250 Sum_probs=96.7
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhCCCC-cccceeEEEEECCEEEEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHP-NLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~ 751 (799)
+|+..+.||+|+||.||+|.. .+++.||||++... .....+.+..|++++..++|+ +|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 467788999999999999985 46789999999754 223456788999999999765 6888999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++.... .+++..+..++.||+.||+|||+
T Consensus 81 E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~qi~~al~~lH~ 119 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---------KFKEPHAVFYAAEIAIGLFFLHS 119 (324)
T ss_pred cCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999997654 46778889999999999999995
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.42 E-value=9.2e-13 Score=143.24 Aligned_cols=109 Identities=23% Similarity=0.402 Sum_probs=91.6
Q ss_pred CeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHH-HHHhCCCCcccceeEEEEECCEEEEEEecCCC
Q 003737 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+.||+|+||+||+|.. .+|+.||+|++.... ....+.+.+|.. ++..++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999995 478999999996532 223345666655 46779999999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++.... .+++..++.++.||++||+|||+
T Consensus 81 g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~ 114 (323)
T cd05575 81 GELFFHLQRER---------SFPEPRARFYAAEIASALGYLHS 114 (323)
T ss_pred CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999997654 57788899999999999999995
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.6e-14 Score=140.89 Aligned_cols=112 Identities=25% Similarity=0.482 Sum_probs=101.3
Q ss_pred CCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCC
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
|+...++|+|+||.|||+.. ..|+.+|+|+.... .+.++...|+.+|.+++.+.+|+++|.|......++|||||--
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 56678899999999999984 57999999998654 3567899999999999999999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+..|.++.+++ ++.|+++..+.+..++||+|||+
T Consensus 113 GSiSDI~R~R~K--------~L~E~EIs~iL~~TLKGL~YLH~ 147 (502)
T KOG0574|consen 113 GSISDIMRARRK--------PLSEQEISAVLRDTLKGLQYLHD 147 (502)
T ss_pred CcHHHHHHHhcC--------CccHHHHHHHHHHHHhHHHHHHH
Confidence 999999987654 78899999999999999999995
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.8e-13 Score=143.86 Aligned_cols=112 Identities=21% Similarity=0.380 Sum_probs=93.3
Q ss_pred CCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHH---HhCCCCcccceeEEEEECCEEEEE
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMI---SAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
|+..+.||+|+||.||++.. .+|+.||||+++... ....+.+.+|++++ ++++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 45578899999999999985 478999999997542 22335666776654 567899999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|..+++.. .+++..+..++.||+.||+|||+
T Consensus 81 ~E~~~~~~L~~~~~~~----------~l~~~~~~~~~~qi~~al~~lH~ 119 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----------VFSEPRAVFYAACVVLGLQYLHE 119 (324)
T ss_pred EcCCCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999888643 46788899999999999999995
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.42 E-value=9.1e-13 Score=138.28 Aligned_cols=118 Identities=23% Similarity=0.391 Sum_probs=102.4
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
..++|...+.||+|+||.||++...+++.||||.+.... ...+++.+|++++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 346788889999999999999998777889999987543 3456899999999999999999999999988999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.++++..... .++.+.+..++.|++.|++|||+
T Consensus 83 ~~~~~L~~~i~~~~~~-------~~~~~~~~~~~~~i~~al~~lh~ 121 (261)
T cd05034 83 MSKGSLLDFLKSGEGK-------KLRLPQLVDMAAQIAEGMAYLES 121 (261)
T ss_pred cCCCCHHHHHhccccC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999764321 46777888899999999999995
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.1e-12 Score=137.42 Aligned_cols=115 Identities=26% Similarity=0.464 Sum_probs=100.9
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCC
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
++|+..+.||+|+||.||+|... |+.||+|.+..... ..+++.+|++++.+++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46778899999999999999864 78899999976543 56789999999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.+++...... .+++..+..++.|++.|++|||+
T Consensus 84 ~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lh~ 120 (256)
T cd05039 84 KGSLVDYLRSRGRA-------VITLAQQLGFALDVCEGMEYLEE 120 (256)
T ss_pred CCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999765421 46778899999999999999995
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.6e-13 Score=150.34 Aligned_cols=115 Identities=23% Similarity=0.395 Sum_probs=98.7
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 749 (799)
.++|...++||+|.||+|+.++. .+++.+|||.+++.. ..+.+..+.|.+++.-. +||.++++++++.+.+..|.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 45788899999999999999995 468899999998863 34567788888888776 59999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+.||++..+.+.+ .++|.+++.||.+|+.||+|||+
T Consensus 447 vmey~~Ggdm~~~~~~~----------~F~e~rarfyaAev~l~L~fLH~ 486 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHTD----------VFSEPRARFYAAEVVLGLQFLHE 486 (694)
T ss_pred EEEecCCCcEEEEEecc----------cccHHHHHHHHHHHHHHHHHHHh
Confidence 99999999954433322 68999999999999999999996
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=5.2e-13 Score=147.11 Aligned_cols=109 Identities=21% Similarity=0.350 Sum_probs=92.4
Q ss_pred CCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCC
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
|+..+.||+|+||.||++.. .+|+.||||++.... ....+.+.+|++++++++|+||+++++++...+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 44567899999999999995 478999999986543 2335679999999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.+.. ...+..+..++.||+.||+|||+
T Consensus 156 ~~~L~~~~-------------~~~~~~~~~i~~qi~~aL~~LH~ 186 (353)
T PLN00034 156 GGSLEGTH-------------IADEQFLADVARQILSGIAYLHR 186 (353)
T ss_pred CCcccccc-------------cCCHHHHHHHHHHHHHHHHHHHH
Confidence 99986532 23466778889999999999995
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.1e-12 Score=142.42 Aligned_cols=109 Identities=22% Similarity=0.326 Sum_probs=94.1
Q ss_pred CeecccCCeeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEEecCCC
Q 003737 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+.||+|+||.||++... +++.||||+++... ......+.+|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999854 67899999997542 23345678899999887 799999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++.... .+++..+..++.|++.||+|||+
T Consensus 81 ~~L~~~~~~~~---------~l~~~~~~~~~~qi~~~l~~LH~ 114 (318)
T cd05570 81 GDLMFHIQRSG---------RFDEPRARFYAAEIVLGLQFLHE 114 (318)
T ss_pred CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999987654 57788899999999999999995
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.41 E-value=8.6e-13 Score=138.82 Aligned_cols=116 Identities=22% Similarity=0.408 Sum_probs=99.5
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
.+|+..+.||+|+||.||+|.. ..++.||+|.+... ....+++.+|++++.+++|+||+++++++..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 3467788999999999999995 46889999998754 334568999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.+++...... .+++..+..++.|+++||+|||+
T Consensus 85 ~~~~L~~~~~~~~~~-------~l~~~~~~~~~~ql~~~l~~lH~ 122 (263)
T cd05052 85 TYGNLLDYLRECNRQ-------EVNAVVLLYMATQISSAMEYLEK 122 (263)
T ss_pred CCCcHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999754321 46777888889999999999995
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.3e-12 Score=140.31 Aligned_cols=114 Identities=24% Similarity=0.483 Sum_probs=101.0
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
.+|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5688889999999999999994 578999999997655555677899999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.+++.+. .+++..+..++.|++.||+|||+
T Consensus 99 ~~~~L~~~~~~~----------~~~~~~~~~~~~~l~~~L~~LH~ 133 (297)
T cd06656 99 AGGSLTDVVTET----------CMDEGQIAAVCRECLQALDFLHS 133 (297)
T ss_pred CCCCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999998643 45677888889999999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.1e-12 Score=137.05 Aligned_cols=116 Identities=22% Similarity=0.413 Sum_probs=100.0
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+|+..+.||+|++|.||++.. .+++.||+|.+... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 466778999999999999995 47899999998643 334567899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++++|.++++..... .+++..+..++.|++.||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~~l~~al~~lH~ 119 (256)
T cd08529 81 AENGDLHKLLKMQRGR-------PLPEDQVWRFFIQILLGLAHLHS 119 (256)
T ss_pred CCCCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999864211 57777888889999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.1e-12 Score=140.35 Aligned_cols=115 Identities=24% Similarity=0.388 Sum_probs=100.3
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 3577789999999999999995 468999999986532 223467899999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++.... .+++..+..++.|+++||+|||+
T Consensus 81 e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~qil~~l~~lH~ 119 (290)
T cd05580 81 EYVPGGELFSHLRKSG---------RFPEPVARFYAAQVVLALEYLHS 119 (290)
T ss_pred ecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999997654 57788888999999999999995
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.41 E-value=1e-12 Score=138.91 Aligned_cols=113 Identities=18% Similarity=0.334 Sum_probs=96.6
Q ss_pred CCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh----------hhHHHHHHHHHHHHhCCCCcccceeEEEEECCE
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR----------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~----------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 746 (799)
|...+.||+|+||.||+|.. .+|+.||+|.++.... ...+.+.+|++++.+++|+|++++++++...+.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 55678999999999999984 4789999998854211 112468899999999999999999999999999
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++||||+++|+|.+++++.. .+++..++.++.||+.||+|||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~ 126 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTYG---------RFEEQLVRFFTEQVLEGLAYLHS 126 (272)
T ss_pred eEEEEecCCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHhh
Confidence 999999999999999997653 56777888899999999999995
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.41 E-value=9.5e-13 Score=143.12 Aligned_cols=114 Identities=20% Similarity=0.252 Sum_probs=96.5
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCC-CCcccceeEEEEECCEEEEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 751 (799)
+|+..+.||+|+||.||++.. .+|+.||+|++.... ....+.+..|.+++..+. |++|+++.+++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 366778999999999999984 578999999987542 223456888999998886 577888999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++.... .+++..+..++.||+.||+|||+
T Consensus 81 Ey~~~g~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH~ 119 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---------KFKEPQAVFYAAEISVGLFFLHR 119 (323)
T ss_pred cCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999987654 57788999999999999999995
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.2e-12 Score=142.98 Aligned_cols=114 Identities=18% Similarity=0.283 Sum_probs=97.8
Q ss_pred CCCCCCeecccCCeeEEEEEe----CCCcEEEEEEccccC----hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEE
Q 003737 677 NFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKS----RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL 747 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 747 (799)
+|+..+.||+|+||.||+++. .+++.||+|.+.... ....+.+.+|++++.++ +|++|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 467788999999999999874 367899999986532 22345688999999999 489999999999999999
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||+++|+|.+++..+. .++++.++.++.||+.||+|||+
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~ 123 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---------NFSEDEVRFYSGEIILALEHLHK 123 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999997654 57788999999999999999995
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.2e-12 Score=142.48 Aligned_cols=109 Identities=18% Similarity=0.285 Sum_probs=94.4
Q ss_pred CeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEEecCCC
Q 003737 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+.||+|+||.||++.. .+++.||+|+++... ....+.+.+|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999995 467899999997642 23345688999999888 699999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++...+ .+++..++.++.||+.||+|||+
T Consensus 81 ~~L~~~~~~~~---------~l~~~~~~~~~~qi~~al~~lH~ 114 (327)
T cd05617 81 GDLMFHMQRQR---------KLPEEHARFYAAEICIALNFLHE 114 (327)
T ss_pred CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999887544 57888999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.41 E-value=1e-12 Score=137.67 Aligned_cols=114 Identities=23% Similarity=0.441 Sum_probs=98.6
Q ss_pred CCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCC
Q 003737 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+|+..+.||+|+||.||++...++..+|+|.+.... .....|.+|++++.+++|+||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 466788999999999999997777789999986432 2345789999999999999999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.++++.+.. .++++.+..++.|+++|++|||+
T Consensus 84 ~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~ 118 (256)
T cd05059 84 GCLLNYLRERKG--------KLGTEWLLDMCSDVCEAMEYLES 118 (256)
T ss_pred CCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999975432 46777888889999999999995
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.6e-12 Score=135.99 Aligned_cols=116 Identities=22% Similarity=0.408 Sum_probs=100.2
Q ss_pred CCCCCCeecccCCeeEEEEE-eCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+|+..+.||+|+||.||.+. ..+++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47778999999999999988 457889999998654 234456899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++..... ..+++..+..++.|+++|++|||+
T Consensus 81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~ 119 (256)
T cd08221 81 ANGGTLYDKIVRQKG-------QLFEEEMVLWYLFQIVSAVSYIHK 119 (256)
T ss_pred cCCCcHHHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999976421 156788889999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.6e-12 Score=136.50 Aligned_cols=115 Identities=21% Similarity=0.387 Sum_probs=99.9
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-----hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
++|+..+.||+|++|.||++.. .+++.||+|.+.... ....+.+.+|++++.+++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5688899999999999999984 578999999986432 1224578999999999999999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+||+++|+|.+++.... .+++..+..++.|++.|++|||+
T Consensus 82 v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lH~ 122 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---------ALTETVTRKYTRQILEGVEYLHS 122 (263)
T ss_pred EEEECCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999987654 46677888899999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.5e-12 Score=139.66 Aligned_cols=114 Identities=21% Similarity=0.472 Sum_probs=100.2
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
.+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4677788999999999999984 578899999997655555678999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.++++.. .+++.++..++.|++.||+|||.
T Consensus 100 ~~~~L~~~~~~~----------~~~~~~~~~i~~ql~~aL~~LH~ 134 (296)
T cd06654 100 AGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLHS 134 (296)
T ss_pred CCCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999998643 35677888889999999999994
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.3e-12 Score=139.12 Aligned_cols=124 Identities=22% Similarity=0.418 Sum_probs=99.8
Q ss_pred cCCCCCCeecccCCeeEEEEEe-----CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
++|+..+.||+|+||.||+|.. .++..||+|.+.... ....+.|.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3466778999999999999983 246789999997543 3344689999999999999999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCccccc--------ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFH--------ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~--------~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+++|+|.+++..+..... ......+++..+..++.|++.||+|||+
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 142 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS 142 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999964432110 0112246777888889999999999995
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.41 E-value=9.9e-13 Score=138.94 Aligned_cols=119 Identities=24% Similarity=0.394 Sum_probs=99.4
Q ss_pred HhhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhC-CCCcccceeEEEEEC------
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG------ 744 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~------ 744 (799)
.+++.|+..+.||+|+||.||+|.. .+++.||+|++.... .....+.+|++++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 4667788889999999999999985 468899999986543 3446788999999998 799999999998753
Q ss_pred CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+..++||||+++|+|.+++...... .+++..+..++.|++.|++|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH~ 129 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGN-------TLKEEWIAYICREILRGLSHLHQ 129 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 4589999999999999999763321 56788888899999999999995
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=6.1e-13 Score=141.09 Aligned_cols=118 Identities=21% Similarity=0.362 Sum_probs=95.6
Q ss_pred HhhcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccCh--------------hhHHHHHHHHHHHHhCCCCcccce
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR--------------QGNREFVNEIGMISAQQHPNLVKL 737 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~--------------~~~~~f~~E~~~l~~l~H~niv~l 737 (799)
+..+.|...+.||+|.||.|-+|. ..+++.||||++.+... ...+...+||.+|++++|+|||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 345678889999999999999998 45799999999965311 112578999999999999999999
Q ss_pred eEEEEEC--CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 738 YGCCVEG--NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 738 ~g~~~~~--~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+.+..+. +.+|||+|||..|.+...=..+ ..+.+.+++.|+++++.||+|||.
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~---------~els~~~Ar~ylrDvv~GLEYLH~ 228 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDK---------PELSEQQARKYLRDVVLGLEYLHY 228 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCc---------ccccHHHHHHHHHHHHHHHHHHHh
Confidence 9998764 5799999999999875331111 127788999999999999999994
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.41 E-value=2e-12 Score=135.20 Aligned_cols=116 Identities=20% Similarity=0.278 Sum_probs=99.3
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
+|+..+.||+|+||.||++.. .+++.+|+|.++.. .....+.+.+|++++++++|+||+++++++.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 366778999999999999984 47889999998643 2334567889999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.+++...... .++++.+..++.|+++||+|||+
T Consensus 81 ~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~i~~al~~lH~ 118 (255)
T cd08219 81 DGGDLMQKIKLQRGK-------LFPEDTILQWFVQMCLGVQHIHE 118 (255)
T ss_pred CCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHhh
Confidence 999999998753321 46788888999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.3e-12 Score=142.11 Aligned_cols=114 Identities=20% Similarity=0.251 Sum_probs=96.5
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 751 (799)
+|+..+.||+|+||.||+|+. .+++.||+|.+.... ....+.+..|.+++... +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 467788999999999999985 467899999987542 22335677888888877 5899999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++.... .+++..+..++.||+.||+|||+
T Consensus 81 E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~qi~~aL~~LH~ 119 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---------RFKEPHAVFYAAEIAIGLFFLHS 119 (323)
T ss_pred cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999987654 56788899999999999999995
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.4e-12 Score=138.75 Aligned_cols=114 Identities=22% Similarity=0.464 Sum_probs=99.2
Q ss_pred CCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCC
Q 003737 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
|+..+.||+|+||.||+|... ++..+|+|.+........+.+.+|++++++++|+||+++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 345678999999999999954 5788999999766555667899999999999999999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++++... .+++..+..++.|+++||+|||+
T Consensus 87 ~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~~L~~LH~ 121 (282)
T cd06643 87 GAVDAVMLELER--------PLTEPQIRVVCKQTLEALNYLHE 121 (282)
T ss_pred CcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999998875332 46788889999999999999995
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.8e-12 Score=138.62 Aligned_cols=116 Identities=22% Similarity=0.433 Sum_probs=102.1
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
+.|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|++++++++|+||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 5577788999999999999995 468999999997766666778999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|..++.+... .+++..+..++.|++.|++|||+
T Consensus 92 ~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~ 128 (292)
T cd06644 92 PGGAVDAIMLELDR--------GLTEPQIQVICRQMLEALQYLHS 128 (292)
T ss_pred CCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHhc
Confidence 99999988865432 46778899999999999999995
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.2e-12 Score=137.48 Aligned_cols=116 Identities=25% Similarity=0.427 Sum_probs=98.7
Q ss_pred hcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
.++|+..+.||+|+||.||+|...+++.||+|.+.... ...+.|.+|++++++++|+||+++++++ ..+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 45677889999999999999998888999999987543 2356899999999999999999999886 456789999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.++++..... .+++..+..++.|++.||+|||+
T Consensus 83 ~~~~L~~~~~~~~~~-------~~~~~~~~~i~~~i~~al~~LH~ 120 (260)
T cd05067 83 ENGSLVDFLKTPEGI-------KLTINKLIDMAAQIAEGMAFIER 120 (260)
T ss_pred CCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHhc
Confidence 999999998754321 46677788889999999999995
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.40 E-value=2e-12 Score=134.74 Aligned_cols=110 Identities=25% Similarity=0.443 Sum_probs=95.3
Q ss_pred CeecccCCeeEEEEEeCCCcEEEEEEccccCh-hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCcHH
Q 003737 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS 760 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL~ 760 (799)
++||+|+||.||+|...+++.+|+|.+..... .....|.+|++++.+++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988889999999876533 33457999999999999999999999999999999999999999999
Q ss_pred HHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 761 RAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 761 ~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++..... .+.+..+..++.|++.||+|+|+
T Consensus 81 ~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~ 111 (250)
T cd05085 81 SFLRKKKD--------ELKTKQLVKFALDAAAGMAYLES 111 (250)
T ss_pred HHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99875432 35677788889999999999995
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.5e-12 Score=138.23 Aligned_cols=109 Identities=21% Similarity=0.269 Sum_probs=91.6
Q ss_pred ecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCcH
Q 003737 684 VGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (799)
Q Consensus 684 lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL 759 (799)
||+|+||.||++.. .+|+.||+|++.... ....+.+..|++++.+++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999985 568999999986432 12234567799999999999999999999999999999999999999
Q ss_pred HHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 760 SRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 760 ~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++++..... .+++..+..++.||+.||+|||+
T Consensus 81 ~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~lH~ 113 (277)
T cd05607 81 KYHIYNVGER-------GLEMERVIHYSAQITCGILHLHS 113 (277)
T ss_pred HHHHHhcccc-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9988754321 46677888889999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3e-13 Score=148.75 Aligned_cols=111 Identities=24% Similarity=0.401 Sum_probs=95.4
Q ss_pred CCCeecccCCeeEEEEEeC--CCc--EEEEEEccccChh-hHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 680 PANKVGEGGFGSVYKGILS--DGT--VIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 680 ~~~~lG~G~~g~Vy~~~~~--~g~--~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
..+.||+|.||.|++|.+. +|+ .||||+++..... ...+|.+|+.+|.+++|+|+++|||+..+ ...+||+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3578999999999999963 454 5899999877544 56899999999999999999999999987 7889999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhc
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFF 798 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH 798 (799)
+.|+|.+.|++..+ ..+.-..+..|+.|||.||+||-
T Consensus 193 plGSLldrLrka~~-------~~llv~~Lcdya~QiA~aM~YLe 229 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKK-------AILLVSRLCDYAMQIAKAMQYLE 229 (1039)
T ss_pred ccchHHHHHhhccc-------cceeHHHHHHHHHHHHHHHHHHh
Confidence 99999999997221 15667789999999999999983
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.3e-12 Score=140.71 Aligned_cols=117 Identities=23% Similarity=0.368 Sum_probs=99.2
Q ss_pred cCCCCCCeecccCCeeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL 747 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 747 (799)
++|...+.||+|+||.||++.. ..+..||||+++... ....+.+.+|+++++++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4688889999999999999973 135689999987653 33356799999999999 799999999999999999
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||+++|+|.++++..... .+++..+..++.|++.|++|||+
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~ 159 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRES-------FLTLEDLLSFSYQVAKGMAFLAS 159 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999754321 36788889999999999999995
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.2e-12 Score=138.10 Aligned_cols=115 Identities=23% Similarity=0.442 Sum_probs=97.9
Q ss_pred CCCCCCeecccCCeeEEEEEeC-CC---cEEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGILS-DG---TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~-~g---~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
+|+..+.||+|+||.||+|... ++ ..||||.+... .....++|.+|++++++++||||+++++++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4667889999999999999853 33 36999999764 3344578999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.++++.... .+++..+..++.|++.|++|||+
T Consensus 85 e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~~l~~al~~lH~ 124 (269)
T cd05065 85 EFMENGALDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLSE 124 (269)
T ss_pred ecCCCCcHHHHHhhCCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999976432 45677888889999999999995
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.1e-12 Score=139.03 Aligned_cols=126 Identities=21% Similarity=0.329 Sum_probs=100.9
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 746 (799)
.+++|+..+.||+|+||.||+|... .+..||||++.... .....+|.+|+.++.+++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567888999999999999998742 35679999986542 2345679999999999999999999999999999
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccc-cccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHI-SIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~-~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++||||+++|+|.++++........ .....++...+..++.|+++|++|||+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 137 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA 137 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999754321111 111245566778889999999999995
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.3e-13 Score=137.36 Aligned_cols=115 Identities=17% Similarity=0.332 Sum_probs=98.9
Q ss_pred hcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccc--cChhhHHHHHHHHHHHHhCCCCcccceeEEEEE-----CCE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE-----GNQ 746 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-----~~~ 746 (799)
...|...+.||+|+||.|+++. .++|+.||||++.. ......++-.||++++++++|+||+.++..+.. .+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 3445557889999999999998 56899999999963 345566788999999999999999999998865 357
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|+|+|+. ||+..++.+. .+.++.++.++.|+++||.|+|+
T Consensus 101 vYiV~elMet-DL~~iik~~~---------~L~d~H~q~f~YQiLrgLKyiHS 143 (359)
T KOG0660|consen 101 VYLVFELMET-DLHQIIKSQQ---------DLTDDHAQYFLYQILRGLKYIHS 143 (359)
T ss_pred eEEehhHHhh-HHHHHHHcCc---------cccHHHHHHHHHHHHHhcchhhc
Confidence 8999999965 9999998765 57888999999999999999996
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.5e-12 Score=139.05 Aligned_cols=124 Identities=28% Similarity=0.462 Sum_probs=102.1
Q ss_pred cCCCCCCeecccCCeeEEEEEe------CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
.+|...+.||+|+||.||++.. .++..+|+|.+........+.+.+|++++.+++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4577789999999999999974 2346789999976655566789999999999999999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCccccc----ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFH----ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~----~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+++|+|.++++....... ......+++..+..++.|++.||+|||+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~ 138 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS 138 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999975432100 0111247888899999999999999995
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.4e-12 Score=139.31 Aligned_cols=126 Identities=20% Similarity=0.276 Sum_probs=99.1
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 746 (799)
.+++|+..+.||+|+||.||+|... .+..||+|.+.... ......+.+|++++.+++|+||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567888999999999999999743 24589999986543 2234578899999999999999999999999999
Q ss_pred EEEEEecCCCCcHHHHHhcCccccc-ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFH-ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~-~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++||||+++|+|.++++....... ...........+..++.|++.||+|||+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 137 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA 137 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999999975432111 0011233455777889999999999995
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.3e-12 Score=138.57 Aligned_cols=124 Identities=20% Similarity=0.293 Sum_probs=102.6
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 746 (799)
.+++|+..+.||+|+||.||+|... .+..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3467888899999999999999864 35789999986543 3345679999999999999999999999999999
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++||||+++|+|.++++..+.... ....+++..+..++.||+.|++|||+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~ 134 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPE--RPSSLTMKDLLFCARDVAKGCKYLEE 134 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999976542211 12357777888889999999999995
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.8e-12 Score=139.66 Aligned_cols=115 Identities=14% Similarity=0.301 Sum_probs=99.7
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+++++.++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3678889999999999999995 467899999987543 223467889999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++...+ .+++..+..++.|+++||+|||+
T Consensus 81 e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~ 119 (305)
T cd05609 81 EYVEGGDCATLLKNIG---------ALPVDMARMYFAETVLALEYLHN 119 (305)
T ss_pred ecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999997654 46777888889999999999995
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.1e-12 Score=135.41 Aligned_cols=117 Identities=20% Similarity=0.398 Sum_probs=103.2
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
.++|+..+.+|+|+||.||++.. .+++.+|+|.+........+.+.+|++++++++||||+++++++...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 35688889999999999999985 46789999999766555667899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++++|.+++..... .++++.+..++.|++.||+|||+
T Consensus 82 ~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh~ 119 (262)
T cd06613 82 CGGGSLQDIYQVTRG--------PLSELQIAYVCRETLKGLAYLHE 119 (262)
T ss_pred CCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999876421 57788899999999999999995
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.4e-12 Score=149.46 Aligned_cols=117 Identities=18% Similarity=0.211 Sum_probs=98.9
Q ss_pred CCCCCeecccCCeeEEEEEe-CC-CcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCC
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
|...+.||+|+||.||++.. .+ +..||+|.+..........+.+|++++++++|||||++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 67788999999999999984 34 67889998765555555678899999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.++++..... ...+++..+..++.||+.||+|||+
T Consensus 149 gg~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~lH~ 187 (478)
T PTZ00267 149 GGDLNKQIKQRLKE-----HLPFQEYEVGLLFYQIVLALDEVHS 187 (478)
T ss_pred CCCHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999998743211 1257788898999999999999995
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.3e-12 Score=142.91 Aligned_cols=112 Identities=17% Similarity=0.371 Sum_probs=94.0
Q ss_pred CCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC-----CEEEE
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQLLL 749 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~l 749 (799)
|+..+.||+|+||.||+|.. .+|+.||||++... .......+.+|++++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 66778999999999999994 57899999998643 223345789999999999999999999988643 24799
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||||+ ++|.+++.... .++++.+..++.||++||+|||+
T Consensus 82 v~e~~~-~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~ 121 (338)
T cd07859 82 VFELME-SDLHQVIKAND---------DLTPEHHQFFLYQLLRALKYIHT 121 (338)
T ss_pred EEecCC-CCHHHHHHhcc---------cCCHHHHHHHHHHHHHHHHHHHH
Confidence 999996 68999987554 56788899999999999999995
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.6e-12 Score=137.04 Aligned_cols=117 Identities=21% Similarity=0.444 Sum_probs=99.1
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC-CC---cEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS-DG---TVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~-~g---~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
+++|+..+.||+|+||.||+|... ++ ..+|+|.++... ....+.+.+|++++.+++|+|++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 346778899999999999999864 33 379999987552 3345689999999999999999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+++|+|.++++.+.. .+++..+..++.|++.|++|||+
T Consensus 84 v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~al~~lH~ 125 (268)
T cd05063 84 ITEYMENGALDKYLRDHDG--------EFSSYQLVGMLRGIAAGMKYLSD 125 (268)
T ss_pred EEEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999975432 45667788889999999999995
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=5e-13 Score=142.19 Aligned_cols=116 Identities=20% Similarity=0.281 Sum_probs=101.9
Q ss_pred cCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccCh--hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
+=|+..+.||+|.|..|-.+. .-+|..||||++++..- -......+|++.|+-++|||||+||.+..+....|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 446777899999999998887 35899999999987643 334678899999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.-.+|+|+|||.++.. .+.|+..+.|+.||++|+.|+|.
T Consensus 98 LGD~GDl~DyImKHe~--------Gl~E~La~kYF~QI~~AI~YCHq 136 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--------GLNEDLAKKYFAQIVHAISYCHQ 136 (864)
T ss_pred ecCCchHHHHHHhhhc--------cccHHHHHHHHHHHHHHHHHHhh
Confidence 9999999999986653 57899999999999999999994
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.5e-13 Score=125.27 Aligned_cols=114 Identities=19% Similarity=0.356 Sum_probs=97.2
Q ss_pred CCCCCCeecccCCeeEEEEE-eCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+|+..++||+|.||+||||+ ..+++.||+|+.+.. +++-.....+|+.+++.++|+|||+++.+...++..-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 35556789999999999999 567899999998654 334456789999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|.. +|.++...-.. .+..+.++.++.|+++|+.|+|+
T Consensus 83 cdq-dlkkyfdslng--------~~d~~~~rsfmlqllrgl~fchs 119 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNG--------DLDPEIVRSFMLQLLRGLGFCHS 119 (292)
T ss_pred hhH-HHHHHHHhcCC--------cCCHHHHHHHHHHHHhhhhhhhh
Confidence 987 88888765443 45677899999999999999995
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.8e-12 Score=139.92 Aligned_cols=115 Identities=19% Similarity=0.358 Sum_probs=97.4
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
++|...+.||+|+||.||+|.. .+++.||+|+++... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 4577889999999999999985 467899999987543 22345688999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++ +|.+++..... .+++..++.++.|+++||+|||+
T Consensus 86 ~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~ 122 (309)
T cd07872 86 LDK-DLKQYMDDCGN--------IMSMHNVKIFLYQILRGLAYCHR 122 (309)
T ss_pred CCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 985 88888865432 46677889999999999999995
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.5e-12 Score=144.62 Aligned_cols=113 Identities=17% Similarity=0.362 Sum_probs=96.7
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECC-----EEE
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-----QLL 748 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 748 (799)
+|+..+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+++++.++|+||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999995 57899999998653 2234567899999999999999999999998776 789
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+||+. ++|.+++.... .+++..++.++.||+.||+|||+
T Consensus 81 lv~e~~~-~~l~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~ 121 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ---------PLSSDHVKVFLYQILRGLKYLHS 121 (372)
T ss_pred EEeeccc-cCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999997 58888886543 57788999999999999999995
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.39 E-value=2e-12 Score=137.55 Aligned_cols=115 Identities=25% Similarity=0.431 Sum_probs=98.7
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
++|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++.+++|+|++++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 35778889999999999999964 68999999986432 2234578899999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|++++.|..++.... .++++.+..++.|++.||+|||+
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~LH~ 118 (286)
T cd07847 81 YCDHTVLNELEKNPR---------GVPEHLIKKIIWQTLQAVNFCHK 118 (286)
T ss_pred ccCccHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999988876443 46788899999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.7e-12 Score=138.63 Aligned_cols=125 Identities=23% Similarity=0.382 Sum_probs=101.8
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 747 (799)
.++|+..+.||+|+||.||++... ++..||+|.+.... ....++|.+|++++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999853 46789999987543 33456799999999999999999999999999999
Q ss_pred EEEEecCCCCcHHHHHhcCcccccc-------------cccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHI-------------SIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~-------------~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||+++|+|.++++........ .....+++..+..++.|++.||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~ 148 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE 148 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999999754321110 011246777888899999999999995
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.4e-12 Score=138.36 Aligned_cols=124 Identities=25% Similarity=0.457 Sum_probs=101.8
Q ss_pred cCCCCCCeecccCCeeEEEEEeC------CCcEEEEEEccccChh-hHHHHHHHHHHHHhCCCCcccceeEEEEECCEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 748 (799)
++|...+.||+|+||.||+|... ++..||||.+...... ..+.|.+|++++.+++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45677889999999999999853 3478999999765443 4578999999999999999999999999999999
Q ss_pred EEEecCCCCcHHHHHhcCccccc-----ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFH-----ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~-----~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||+++|+|.++++..+.... ......+++..+..++.|++.|++|||+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~ 140 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS 140 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh
Confidence 99999999999999986532111 1112357788888999999999999995
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.8e-12 Score=140.55 Aligned_cols=109 Identities=22% Similarity=0.299 Sum_probs=92.7
Q ss_pred CeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEEecCCC
Q 003737 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+.||+|+||.||+|+. .+|+.||+|.++... ....+.+..|.+++... +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999995 468899999997542 22345677888888764 899999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++..+. .+++..+..++.|+++||+|||+
T Consensus 81 g~L~~~i~~~~---------~~~~~~~~~~~~qi~~~l~~lH~ 114 (316)
T cd05620 81 GDLMFHIQDKG---------RFDLYRATFYAAEIVCGLQFLHS 114 (316)
T ss_pred CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999987654 56777888999999999999995
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.1e-12 Score=135.74 Aligned_cols=112 Identities=22% Similarity=0.451 Sum_probs=97.5
Q ss_pred CCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCC
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
|+..+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|++++.+++|+||+++++++.+++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 66778999999999999985 478899999986442 3345679999999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.+++... .+++..+..++.|++.|++|||+
T Consensus 86 ~~~l~~~i~~~----------~~~~~~~~~~~~~l~~~l~~lh~ 119 (277)
T cd06641 86 GGSALDLLEPG----------PLDETQIATILREILKGLDYLHS 119 (277)
T ss_pred CCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHcc
Confidence 99999998643 45677888899999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.3e-13 Score=145.25 Aligned_cols=104 Identities=17% Similarity=0.354 Sum_probs=91.3
Q ss_pred CCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCc
Q 003737 679 DPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 758 (799)
Q Consensus 679 ~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~Gs 758 (799)
.+.+-+|+|+-|.||+|.++ ++.||||+++.-.+ .+|+-|++++|+||+.+.|+|.....+++|||||+.|-
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 34678999999999999986 67899999865433 46788999999999999999999999999999999999
Q ss_pred HHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 759 LSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 759 L~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|...|+.++ .+....+..+..+||.||.|||.
T Consensus 199 L~~VLka~~---------~itp~llv~Wsk~IA~GM~YLH~ 230 (904)
T KOG4721|consen 199 LYEVLKAGR---------PITPSLLVDWSKGIAGGMNYLHL 230 (904)
T ss_pred HHHHHhccC---------ccCHHHHHHHHHHhhhhhHHHHH
Confidence 999999876 45566888999999999999993
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.4e-12 Score=135.58 Aligned_cols=115 Identities=19% Similarity=0.327 Sum_probs=96.2
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-----hhhHHHHHHHHHHHHhCCCCcccceeEEEEEC--CEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQL 747 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 747 (799)
.+|+..+.||+|+||.||+|.. .+|..||+|.+.... ....+.+.+|++++.+++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4678889999999999999985 568999999885321 22346789999999999999999999988763 467
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH~ 124 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---------ALTENVTRKYTRQILEGVSYLHS 124 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 89999999999999987543 45667788889999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.9e-12 Score=135.87 Aligned_cols=115 Identities=23% Similarity=0.369 Sum_probs=97.7
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCC
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
++|+..+.||+|+||.||++...++..+|+|.+..... ..+.|.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 45777889999999999999987888899999875432 3467999999999999999999999875 456899999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.++++..... .+++..+..++.|++.||+|||+
T Consensus 84 ~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~al~~lH~ 120 (260)
T cd05070 84 KGSLLDFLKDGEGR-------ALKLPNLVDMAAQVAAGMAYIER 120 (260)
T ss_pred CCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999754321 46777888899999999999995
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.3e-12 Score=134.06 Aligned_cols=115 Identities=19% Similarity=0.390 Sum_probs=102.1
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
++|+..+.||+|++|.||++... +++.||||++..... ...+.+.+|++.+.+++|+|++++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 35778899999999999999965 589999999876543 3457899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++++|.+++.... .+++..+..++.|+++|++|||+
T Consensus 81 ~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lh~ 117 (264)
T cd06623 81 MDGGSLADLLKKVG---------KIPEPVLAYIARQILKGLDYLHT 117 (264)
T ss_pred cCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhc
Confidence 99999999997653 57788889999999999999995
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.39 E-value=3e-12 Score=136.06 Aligned_cols=110 Identities=16% Similarity=0.373 Sum_probs=95.0
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
+|+..+.||+|+||.||+|.. .+++.||+|.+... .....++|.+|++++.+++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 567788999999999999984 57899999998654 2334567999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|..+. .+++..+..++.|++.||+|||+
T Consensus 82 ~~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~ 113 (279)
T cd06619 82 DGGSLDVYR-------------KIPEHVLGRIAVAVVKGLTYLWS 113 (279)
T ss_pred CCCChHHhh-------------cCCHHHHHHHHHHHHHHHHHHHH
Confidence 999997542 34577888899999999999995
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=2e-12 Score=153.32 Aligned_cols=124 Identities=17% Similarity=0.350 Sum_probs=99.7
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||.||+|.. .+|+.||+|+++... ....+.|.+|++++++++|||||++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4688889999999999999985 468999999997542 223467999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCccc--ccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRI--FHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~--~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++...... .........+...+..++.||++||+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs 131 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS 131 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999743211 111111234455677789999999999995
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.9e-12 Score=138.63 Aligned_cols=114 Identities=24% Similarity=0.492 Sum_probs=99.7
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
++|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5677889999999999999984 578899999986554445578999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.+++.+. .+++..+..++.|++.|++|||+
T Consensus 99 ~~~~L~~~~~~~----------~l~~~~~~~i~~~l~~al~~LH~ 133 (293)
T cd06647 99 AGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLHS 133 (293)
T ss_pred CCCcHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999998753 34566788889999999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.9e-12 Score=134.76 Aligned_cols=119 Identities=27% Similarity=0.446 Sum_probs=101.2
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++.+++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999965 8899999988642 2233568999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++...... ...++++.+..++.|+++|++|||+
T Consensus 82 e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~ 124 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQ-----KRLIPERTIWKYFVQLCSALEHMHS 124 (267)
T ss_pred ecCCCCCHHHHHHHhccc-----CCCcCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999998642211 1146788899999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.5e-12 Score=134.48 Aligned_cols=116 Identities=22% Similarity=0.375 Sum_probs=99.4
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+|+..+.||+|+||.||++.. .+|+.||+|++... .....+++.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 367788999999999999984 57899999998643 233456899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++...... .+++..+..++.|++.|++|||+
T Consensus 81 ~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~ 119 (256)
T cd08218 81 CEGGDLYKKINAQRGV-------LFPEDQILDWFVQICLALKHVHD 119 (256)
T ss_pred CCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999998754321 46777888889999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.38 E-value=1e-12 Score=139.84 Aligned_cols=115 Identities=22% Similarity=0.372 Sum_probs=98.6
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++.+++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35777899999999999999964 68999999986532 2234678899999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++++|.++.+... .+++..+..++.||++||+|||+
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~ 118 (286)
T cd07846 81 FVDHTVLDDLEKYPN---------GLDESRVRKYLFQILRGIEFCHS 118 (286)
T ss_pred cCCccHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999998876543 46677889999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.7e-12 Score=134.77 Aligned_cols=114 Identities=24% Similarity=0.483 Sum_probs=99.4
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh--hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+|+..+.||+|+||.||+|.. .+++.||+|.++.... ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 366778999999999999985 4788999999876533 3567899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++++|.++++... ..+++.+..++.|+++||+|||+
T Consensus 81 ~~~~~L~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lh~ 117 (264)
T cd06626 81 CSGGTLEELLEHGR---------ILDEHVIRVYTLQLLEGLAYLHS 117 (264)
T ss_pred CCCCcHHHHHhhcC---------CCChHHHHHHHHHHHHHHHHHHH
Confidence 99999999997653 35667788889999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.38 E-value=1e-12 Score=137.68 Aligned_cols=114 Identities=19% Similarity=0.357 Sum_probs=100.2
Q ss_pred CCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
+|+..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4677889999999999999964 68999999996542 2345789999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++++|.+++.... .+++..+..++.|+++||+|||+
T Consensus 81 ~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lh~ 118 (258)
T cd05578 81 LLLGGDLRYHLSQKV---------KFSEEQVKFWICEIVLALEYLHS 118 (258)
T ss_pred CCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999997653 56788899999999999999995
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.38 E-value=2e-12 Score=135.43 Aligned_cols=108 Identities=26% Similarity=0.429 Sum_probs=90.6
Q ss_pred CeecccCCeeEEEEEeCC-C----------cEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 682 NKVGEGGFGSVYKGILSD-G----------TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~~~-g----------~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
+.||+|+||.||+|...+ + ..|++|.+...... ...|.+|++++++++|+||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999999643 3 25788887654332 6789999999999999999999999988 778999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.++++.... .+++..+..++.||+.||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~ 119 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--------NVSLHWKLDVAKQLASALHYLED 119 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhh
Confidence 999999999999986542 45677788889999999999995
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.9e-12 Score=133.94 Aligned_cols=116 Identities=20% Similarity=0.348 Sum_probs=100.0
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+|+..+.||+|+||.||++.. .+++.+|+|++... .....+.+.+|++++++++|+|++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 467788999999999999984 57889999998654 233456899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++...... .+++..+..++.|+++|++|||+
T Consensus 81 ~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lh~ 119 (256)
T cd08220 81 APGGTLAEYIQKRCNS-------LLDEDTILHFFVQILLALHHVHT 119 (256)
T ss_pred CCCCCHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999764321 46788888889999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.2e-12 Score=138.36 Aligned_cols=114 Identities=23% Similarity=0.454 Sum_probs=97.5
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChh-----hHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQ-----GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
+|+..+.||+|+||.||+|.. .+|+.||||+++..... ....+..|++++.+++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 366778999999999999995 46899999999754322 235678899999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+ +|+|.+++..... .++++.+..++.||++||+|||+
T Consensus 81 ~e~~-~~~L~~~i~~~~~--------~~~~~~~~~~~~qi~~al~~lH~ 120 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSI--------VLTPADIKSYMLMTLRGLEYLHS 120 (298)
T ss_pred Eccc-CCCHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999 8999999976431 46778888899999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.8e-12 Score=136.43 Aligned_cols=124 Identities=25% Similarity=0.474 Sum_probs=99.9
Q ss_pred cCCCCCCeecccCCeeEEEEEeCC------CcEEEEEEccccCh-hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~------g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 748 (799)
++|+..+.||+|+||.||+|.... ...||+|.++.... ...+.|.+|++++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357778899999999999998532 25799999975432 33467999999999999999999999999999999
Q ss_pred EEEecCCCCcHHHHHhcCcccccc-------cccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHI-------SIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~-------~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|||+++|+|.+++......... .....+++..+..++.|++.||+|||+
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~ 142 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS 142 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999999765322110 011256777888899999999999995
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.6e-12 Score=138.45 Aligned_cols=128 Identities=23% Similarity=0.410 Sum_probs=103.4
Q ss_pred ccHHHHHHhhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhC-CCCcccceeEEEE-
Q 003737 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCV- 742 (799)
Q Consensus 666 ~~~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~- 742 (799)
+.++.+..++++|+..+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 44556667888999999999999999999985 468899999986532 2345788999999999 6999999999884
Q ss_pred ----ECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 743 ----EGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 743 ----~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++..++||||+++|+|.++++..... ...+++..+..++.|+++||+|||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~ 142 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-----GERMEEPIIAYILHEALMGLQHLHV 142 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhcc-----CccccHHHHHHHHHHHHHHHHHHHh
Confidence 345689999999999999988642110 1156788899999999999999995
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.7e-12 Score=134.14 Aligned_cols=113 Identities=23% Similarity=0.421 Sum_probs=96.5
Q ss_pred CCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChh---------hHHHHHHHHHHHHhCCCCcccceeEEEEECCEE
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQ---------GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~---------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 747 (799)
|.....||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|++++.+++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 55678899999999999985 46889999988643211 125688999999999999999999999999999
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lH~ 124 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYG---------AFEETLVRNFVRQILKGLNYLHN 124 (267)
T ss_pred EEEEEecCCCCHHHHHHhcc---------CccHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999997643 46677888899999999999995
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.8e-12 Score=138.06 Aligned_cols=117 Identities=19% Similarity=0.427 Sum_probs=100.1
Q ss_pred CCCCCCeecccCCeeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
+|+..+.||+|+||.||++... +|+.||+|.+... .....+.+.+|++++.+++|+||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5677889999999999999964 7899999998654 2334568999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++++|.++++.... ...+++..+..++.|+++||+|||+
T Consensus 82 ~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~ 120 (286)
T cd06622 82 DAGSLDKLYAGGVA------TEGIPEDVLRRITYAVVKGLKFLKE 120 (286)
T ss_pred CCCCHHHHHHhccc------cCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999875321 1156788899999999999999994
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.2e-12 Score=135.69 Aligned_cols=116 Identities=22% Similarity=0.369 Sum_probs=96.7
Q ss_pred hcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
.++|...+.||+|+||.||+|...+...||+|+++.... ..+.|.+|++++.+++|+||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 345778899999999999999876667899999975332 3467999999999999999999999874 45689999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.++++..... .++++.+..++.|+++||+|||+
T Consensus 83 ~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~aL~~lH~ 120 (262)
T cd05071 83 SKGSLLDFLKGEMGK-------YLRLPQLVDMAAQIASGMAYVER 120 (262)
T ss_pred CCCcHHHHHhhcccc-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999753211 45677888889999999999995
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.38 E-value=8.6e-13 Score=138.46 Aligned_cols=110 Identities=25% Similarity=0.359 Sum_probs=92.8
Q ss_pred CeecccCCeeEEEEEeC-C-------CcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 682 NKVGEGGFGSVYKGILS-D-------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~~-~-------g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+.||+|+||.||+|... . ...||+|.+........+.|..|+.++..++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 36899999999999853 2 234888888665445567899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.++++.+.. .+++..+..++.||+.||+|||+
T Consensus 81 ~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~ 118 (258)
T cd05078 81 VKFGSLDTYLKKNKN--------LINISWKLEVAKQLAWALHFLED 118 (258)
T ss_pred CCCCcHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999986542 45677778889999999999995
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.37 E-value=3e-12 Score=139.36 Aligned_cols=109 Identities=20% Similarity=0.344 Sum_probs=90.4
Q ss_pred CeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHH-HHHhCCCCcccceeEEEEECCEEEEEEecCCC
Q 003737 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+.||+|+||.||+++. .+++.||+|++.... ......+.+|.. ++..++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999995 467899999986532 222345555554 56789999999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++.... .+++..++.++.||++||+|||+
T Consensus 81 ~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~ 114 (325)
T cd05602 81 GELFYHLQRER---------CFLEPRARFYAAEIASALGYLHS 114 (325)
T ss_pred CcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999997654 56777889899999999999995
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.8e-12 Score=133.40 Aligned_cols=115 Identities=20% Similarity=0.353 Sum_probs=96.7
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-----hhhHHHHHHHHHHHHhCCCCcccceeEEEEE--CCEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQL 747 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 747 (799)
.+|+..+.||+|+||.||++.. .++..||+|++.... ....+.+.+|++++++++|+||+++++++.+ .+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999985 468999999986432 1234578899999999999999999998875 3578
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++++||+++++|.+++.... .+++..+..++.|+++||+|||+
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~LH~ 124 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---------ALTESVTRKYTRQILEGMSYLHS 124 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 89999999999999997653 45677788889999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.7e-12 Score=135.56 Aligned_cols=112 Identities=23% Similarity=0.324 Sum_probs=91.0
Q ss_pred eecccCCeeEEEEEeCCC---cEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCc
Q 003737 683 KVGEGGFGSVYKGILSDG---TVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 758 (799)
Q Consensus 683 ~lG~G~~g~Vy~~~~~~g---~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~Gs 758 (799)
.||+|+||.||+|+..++ ..+++|.+.... ....+.|.+|+++++.++||||++++++|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999985333 356677765443 3345789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 759 LSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 759 L~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|.+++++.... ....++..+..++.||++||+|||+
T Consensus 82 L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~al~~lH~ 117 (268)
T cd05086 82 LKSYLSQEQWH-----RRNSQLLLLQRMACEIAAGVTHMHK 117 (268)
T ss_pred HHHHHHhhhcc-----cccccHHHHHHHHHHHHHHHHHHHH
Confidence 99999864321 1135566777889999999999995
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.7e-12 Score=138.26 Aligned_cols=124 Identities=25% Similarity=0.435 Sum_probs=99.7
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCc--EEEEEEcccc-ChhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGT--VIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~--~vAvK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 750 (799)
++|+..+.||+|+||.||+|... ++. .+|+|.++.. .....+.|.+|++++.++ +|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46778899999999999999853 454 4688887653 233456899999999999 899999999999999999999
Q ss_pred EecCCCCcHHHHHhcCccccc-------ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFH-------ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~-------~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||+++|+|.++++....... ......+++..+..++.|+++|++|||+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 142 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 142 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999986532110 0111257788899999999999999995
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.8e-12 Score=137.01 Aligned_cols=115 Identities=20% Similarity=0.388 Sum_probs=98.2
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
++|+..+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56788899999999999999954 789999999865432 2234678899999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++ +|.+++..... .+++..++.++.|+++||+|||+
T Consensus 85 ~~~-~L~~~~~~~~~--------~~~~~~~~~~~~ql~~al~~lH~ 121 (291)
T cd07844 85 LDT-DLKQYMDDCGG--------GLSMHNVRLFLFQLLRGLAYCHQ 121 (291)
T ss_pred CCC-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 985 99999875432 46778899999999999999995
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.3e-12 Score=137.36 Aligned_cols=115 Identities=19% Similarity=0.375 Sum_probs=97.9
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
++|...+.||+|+||.||+|.. .+++.||+|.++... ......+.+|++++.+++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 4577889999999999999985 468899999986543 22345688999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++ |+|.+++..... .+++..+..++.||++||+|||+
T Consensus 86 ~~-~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~ 122 (301)
T cd07873 86 LD-KDLKQYLDDCGN--------SINMHNVKLFLFQLLRGLNYCHR 122 (301)
T ss_pred cc-cCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 98 599998875432 46778899999999999999995
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=5e-13 Score=148.48 Aligned_cols=116 Identities=23% Similarity=0.434 Sum_probs=98.7
Q ss_pred CCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEEC------CEEEE
Q 003737 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------NQLLL 749 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 749 (799)
+...+.||+|+||.||+|. ..+|+.||||.++... ....+...+|+++|++++|+|||++++.-.+. +...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3446789999999999999 6789999999997753 34567899999999999999999999876553 35789
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||||++|||+..|.+.... ..++|..+..+..+++.||.|||+
T Consensus 95 vmEyC~gGsL~~~L~~PEN~------~GLpE~e~l~lL~d~~~al~~LrE 138 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENA------YGLPESEFLDLLSDLVSALRHLRE 138 (732)
T ss_pred EEeecCCCcHHHHhcCcccc------cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999864322 278999999999999999999996
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.9e-12 Score=134.98 Aligned_cols=113 Identities=23% Similarity=0.467 Sum_probs=98.2
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
.|+..+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 366678899999999999985 468899999987543 344578999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.+++... .+++..+..++.|++.|++|||+
T Consensus 85 ~~~~L~~~i~~~----------~l~~~~~~~~~~~l~~~l~~lh~ 119 (277)
T cd06640 85 GGGSALDLLRAG----------PFDEFQIATMLKEILKGLDYLHS 119 (277)
T ss_pred CCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999998643 45677888889999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.5e-12 Score=135.40 Aligned_cols=119 Identities=25% Similarity=0.446 Sum_probs=99.8
Q ss_pred cCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||.||++. ..+++.+|||.+.... ....++|.+|++++.+++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 357778899999999999999 4588999999886432 233468999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++...... ...+++..+..++.||+.||+|||+
T Consensus 82 e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~ 124 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQ-----KRLIPEKTVWKYFVQLCSALEHMHS 124 (267)
T ss_pred EecCCCCHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999998742210 1156788888889999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.6e-12 Score=135.31 Aligned_cols=115 Identities=23% Similarity=0.496 Sum_probs=97.1
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCc----EEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~----~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
.+|+..+.||+|+||.||+|... +|. .+|+|.+.... .....++.+|++++.+++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 35677889999999999999853 333 68999887653 3345689999999999999999999999987 78899
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+||+++|+|.++++.... .+++..+..++.||++|++|||+
T Consensus 86 v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~ 127 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD--------NIGSQYLLNWCVQIAKGMSYLEE 127 (279)
T ss_pred EEecCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999986432 46788899999999999999995
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.1e-12 Score=133.63 Aligned_cols=114 Identities=27% Similarity=0.514 Sum_probs=100.9
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
++|+..+.||+|+||.||+|... +++.+|+|.+..... .+++.+|++++++++|+||+++++++...+..++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 56888899999999999999965 478999999865432 678999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++++|.+++..... .+++..+..++.|+++|++|||+
T Consensus 81 ~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~~l~~lh~ 117 (256)
T cd06612 81 GAGSVSDIMKITNK--------TLTEEEIAAILYQTLKGLEYLHS 117 (256)
T ss_pred CCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999975432 57788899999999999999994
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=8.2e-13 Score=144.99 Aligned_cols=112 Identities=19% Similarity=0.317 Sum_probs=98.0
Q ss_pred CeecccCCeeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCcHH
Q 003737 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS 760 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL~ 760 (799)
-++|+|.||+||.|. ..+...+|||.+.....+..+....|+.+.++++|+|||+++|.|.+.+.+-+.||-+|||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 479999999999999 5566789999998877777788899999999999999999999999999999999999999999
Q ss_pred HHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 761 RAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 761 ~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+.+=.. +.=.|..+..|.+||++||.|||+
T Consensus 661 sLLrskWGP------lKDNEstm~fYtkQILeGLkYLHe 693 (1226)
T KOG4279|consen 661 SLLRSKWGP------LKDNESTMNFYTKQILEGLKYLHE 693 (1226)
T ss_pred HHHHhccCC------CccchhHHHHHHHHHHHHhhhhhh
Confidence 999864221 122577899999999999999996
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.37 E-value=3e-12 Score=137.42 Aligned_cols=114 Identities=21% Similarity=0.477 Sum_probs=100.4
Q ss_pred cCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
.+|+..+.||+|+||.||+|. ..+|+.||+|.+........+.+.+|++++++++|+|++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 457788899999999999998 4578999999997655445678899999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.+++... .+++.++..++.|++.|++|||+
T Consensus 99 ~~~~L~~~~~~~----------~l~~~~~~~i~~~l~~al~~LH~ 133 (296)
T cd06655 99 AGGSLTDVVTET----------CMDEAQIAAVCRECLQALEFLHA 133 (296)
T ss_pred CCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999988643 45677888889999999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.4e-12 Score=138.34 Aligned_cols=112 Identities=22% Similarity=0.474 Sum_probs=96.6
Q ss_pred CCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCC
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
|+..+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 44567799999999999985 467899999987543 3345689999999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.+++... .+++..+..++.|+++|++|||+
T Consensus 86 ~~~L~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lH~ 119 (277)
T cd06642 86 GGSALDLLKPG----------PLEETYIATILREILKGLDYLHS 119 (277)
T ss_pred CCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHhc
Confidence 99999998643 46677888889999999999995
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.9e-12 Score=134.61 Aligned_cols=116 Identities=21% Similarity=0.322 Sum_probs=98.2
Q ss_pred hcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
.++|+..+.||+|+||.||++...++..+|+|.+... ....+.|.+|++++++++|+||+++.+++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4567888999999999999999777788999998654 2345689999999999999999999999877 7789999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.+++...... ..+...+..++.|++.||+|||+
T Consensus 83 ~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~aL~~lH~ 120 (260)
T cd05073 83 AKGSLLDFLKSDEGS-------KQPLPKLIDFSAQIAEGMAFIEQ 120 (260)
T ss_pred CCCcHHHHHHhCCcc-------ccCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999764321 45566778889999999999995
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.2e-12 Score=134.44 Aligned_cols=113 Identities=21% Similarity=0.406 Sum_probs=99.2
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
+|+..+.||.|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++|+||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 567788999999999999995 468899999986543 334567899999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.++++.. .+++..+..++.|++.|++|||+
T Consensus 82 ~~~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lh~ 116 (274)
T cd06609 82 GGGSCLDLLKPG----------KLDETYIAFILREVLLGLEYLHE 116 (274)
T ss_pred CCCcHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999998754 46678899999999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.5e-12 Score=134.90 Aligned_cols=116 Identities=23% Similarity=0.403 Sum_probs=97.5
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+|+..+.||+|++|.||+|+. .+++.||+|.++... ....+.+.+|++++.+++|+||+++++++.+++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 366778999999999999995 478999999986542 22346788999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++ |+|.+++...... ..+++..+..++.|+++||+|||+
T Consensus 81 ~~-~~l~~~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~ 119 (285)
T cd07861 81 LS-MDLKKYLDSLPKG------QYMDAELVKSYLYQILQGILFCHS 119 (285)
T ss_pred CC-CCHHHHHhcCCCC------CcCCHHHHHHHHHHHHHHHHHHHh
Confidence 98 6899888653211 157788899999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.2e-12 Score=133.21 Aligned_cols=108 Identities=23% Similarity=0.430 Sum_probs=90.7
Q ss_pred eecccCCeeEEEEEeC---CCcEEEEEEccccCh-hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCc
Q 003737 683 KVGEGGFGSVYKGILS---DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 758 (799)
Q Consensus 683 ~lG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~Gs 758 (799)
.||+|+||.||+|... ++..||+|.+..... ...+.|.+|++++.+++|+||++++++|. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 456799999976533 33467999999999999999999999885 457899999999999
Q ss_pred HHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 759 LSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 759 L~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|.+++..+.. .+++..+..++.|++.||+|||+
T Consensus 81 L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~ 113 (257)
T cd05115 81 LNKFLSGKKD--------EITVSNVVELMHQVSMGMKYLEG 113 (257)
T ss_pred HHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999975432 56788899999999999999995
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.36 E-value=4e-12 Score=135.02 Aligned_cols=115 Identities=23% Similarity=0.410 Sum_probs=98.0
Q ss_pred CCCCCCeecccCCeeEEEEEeC-----CCcEEEEEEccccChh-hHHHHHHHHHHHHhCCCCcccceeEEEEE--CCEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGILS-----DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLL 748 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~-----~g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 748 (799)
.|+..+.||+|+||.||++... +++.||||.+...... ..+.|.+|++++++++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4666789999999999999853 3689999999765443 46789999999999999999999999887 55789
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||+++|+|.++++.... .+++..+..++.|++.||+|||+
T Consensus 85 lv~e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~l~~aL~~lH~ 127 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRD--------QINLKRLLLFSSQICKGMDYLGS 127 (284)
T ss_pred EEEecCCCCCHHHHHHhCcc--------ccCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999986532 46777888889999999999995
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.5e-12 Score=135.60 Aligned_cols=124 Identities=27% Similarity=0.471 Sum_probs=101.8
Q ss_pred cCCCCCCeecccCCeeEEEEEeC------CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
.+|+..+.||+|+||.||++... ++..+|+|.+........+.|.+|++++.+++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35667889999999999999632 456899999887666667789999999999999999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccc------cccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHI------SIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~------~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+||+++|+|.++++........ .....+++..+..++.|++.|++|||+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 140 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS 140 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999865321110 011246777888899999999999995
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.7e-12 Score=134.25 Aligned_cols=116 Identities=21% Similarity=0.401 Sum_probs=98.8
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+|+..+.||+|+||.||++.. .+|..+|+|.+.... ....+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 366778999999999999995 468899999986532 23446788999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++++|.+++...... .+++..+..++.|+++||+|||+
T Consensus 81 ~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~ 119 (257)
T cd08225 81 CDGGDLMKRINRQRGV-------LFSEDQILSWFVQISLGLKHIHD 119 (257)
T ss_pred CCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999754321 45777888889999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.1e-12 Score=132.92 Aligned_cols=114 Identities=25% Similarity=0.542 Sum_probs=98.6
Q ss_pred CCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCC
Q 003737 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+|+..+.||+|+||.||++...++..+|+|.+.... ....+|.+|++++++++|||++++++++......++||||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 566778999999999999987667899999986542 2346799999999999999999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.++++.... .++++.+..++.|++.|++|||+
T Consensus 84 ~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~ 118 (256)
T cd05112 84 GCLSDYLRAQRG--------KFSQETLLGMCLDVCEGMAYLES 118 (256)
T ss_pred CcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999975432 45677888889999999999995
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.36 E-value=3e-12 Score=137.18 Aligned_cols=124 Identities=23% Similarity=0.424 Sum_probs=98.1
Q ss_pred cCCCCCCeecccCCeeEEEEEeCC---------------CcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSD---------------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYG 739 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~---------------g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g 739 (799)
++|+..+.||+|+||.||++.... ...||+|.++... ....+.|.+|++++.+++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 467788999999999999987432 2358999997642 334567999999999999999999999
Q ss_pred EEEECCEEEEEEecCCCCcHHHHHhcCccccc---ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFH---ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 740 ~~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~---~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++...+..++||||+++|+|.+++........ ......+++..+..++.|+++||+|||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 147 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS 147 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999975421100 0111235667788889999999999995
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.1e-12 Score=137.54 Aligned_cols=116 Identities=20% Similarity=0.328 Sum_probs=100.3
Q ss_pred CCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccCh---hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
+|+..+.||+|+||.||++... +++.||+|.+..... ...+.+.+|++++.+++|+||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5778889999999999999954 589999999976432 244678999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++|+|.+++...... .+++..+..++.|+++||+|||+
T Consensus 82 ~~~~~~L~~~~~~~~~~-------~l~~~~~~~~~~qi~~~l~~lH~ 121 (316)
T cd05574 82 YCPGGELFRLLQRQPGK-------CLSEEVARFYAAEVLLALEYLHL 121 (316)
T ss_pred ecCCCCHHHHHHhCCCC-------ccCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999998754321 57788888899999999999995
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.3e-12 Score=151.75 Aligned_cols=115 Identities=21% Similarity=0.291 Sum_probs=100.2
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|...+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++..++|+||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56788899999999999999954 78999999996542 223467899999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.++++... .+++..++.++.||+.||+|||.
T Consensus 84 Ey~~g~~L~~li~~~~---------~l~~~~~~~i~~qil~aL~yLH~ 122 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---------YFDEEMAVKYISEVALALDYLHR 122 (669)
T ss_pred eCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999997543 45677889999999999999994
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.3e-12 Score=141.33 Aligned_cols=92 Identities=25% Similarity=0.453 Sum_probs=76.7
Q ss_pred hcCCCCCCeecccCCeeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccceeEEEEEC-C
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG-N 745 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-~ 745 (799)
.++|+..+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++.++ +|+||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45688899999999999999973 357899999997643 23346788999999999 689999999988654 5
Q ss_pred EEEEEEecCCCCcHHHHHhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGK 766 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~ 766 (799)
..++||||+++|+|.++++..
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~ 106 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSK 106 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhc
Confidence 689999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.36 E-value=4e-12 Score=135.27 Aligned_cols=114 Identities=25% Similarity=0.429 Sum_probs=99.1
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+|+..+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 366778999999999999995 478999999987543 33356899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+ +++|.++++.... .+++..+..++.||++||+|||+
T Consensus 81 ~-~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~ 117 (286)
T cd07832 81 M-PSDLSEVLRDEER--------PLPEAQVKSYMRMLLKGVAYMHA 117 (286)
T ss_pred c-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9 9999999875432 57788899999999999999995
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.3e-12 Score=134.89 Aligned_cols=123 Identities=24% Similarity=0.419 Sum_probs=98.4
Q ss_pred CCCCCCeecccCCeeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
+|+..+.||+|+||.||+|... ....+|+|.+.... ....+.+.+|++++.+++||||++++++|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3677889999999999999842 23578999886543 3345689999999999999999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccc---------------cccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIF---------------HISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~---------------~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+||+++|+|.+++....... .......+++..+..++.|++.|++|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 145 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE 145 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999987532110 00111246778888999999999999995
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.36 E-value=4e-12 Score=136.31 Aligned_cols=125 Identities=22% Similarity=0.383 Sum_probs=99.9
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC-----------------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccc
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS-----------------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVK 736 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~-----------------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~ 736 (799)
.++|+..+.||+|+||.||++... ++..||+|.+.... ....+.|.+|++++.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888899999999999998522 24578999997543 334568999999999999999999
Q ss_pred eeEEEEECCEEEEEEecCCCCcHHHHHhcCccccc--ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFH--ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 737 l~g~~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~--~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++++...+..++||||+++|+|.+++........ ......+++..+..++.|++.|++|||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~ 148 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS 148 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999976432111 0111245666788899999999999995
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.8e-12 Score=132.65 Aligned_cols=107 Identities=22% Similarity=0.405 Sum_probs=91.0
Q ss_pred eecccCCeeEEEEEe---CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCC
Q 003737 683 KVGEGGFGSVYKGIL---SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (799)
Q Consensus 683 ~lG~G~~g~Vy~~~~---~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~G 757 (799)
.||+|+||.||+|.. .++..+|+|+++... ....+++.+|++++.+++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 357899999986543 234578999999999999999999999885 45678999999999
Q ss_pred cHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 758 CLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 758 sL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|.+++.... .++++.+..++.|++.||+|||+
T Consensus 81 ~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~ 113 (257)
T cd05116 81 PLNKFLQKNK---------HVTEKNITELVHQVSMGMKYLEE 113 (257)
T ss_pred cHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999997543 46778888899999999999995
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.8e-12 Score=134.83 Aligned_cols=115 Identities=23% Similarity=0.344 Sum_probs=96.2
Q ss_pred CCCCCCeecccCCeeEEEEEe-----CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEEC--CEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLL 748 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 748 (799)
.|+..+.||+|+||.||++.. .++..||+|.++... ....+.+.+|++++++++|+|++++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 356788999999999999974 357889999997553 33346899999999999999999999998875 5689
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||+++|+|.+++.+... .+++..+..++.|++.||+|||+
T Consensus 85 lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~aL~~lH~ 127 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKN--------KINLKQQLKYAVQICKGMDYLGS 127 (284)
T ss_pred EEEEccCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999865421 35677788889999999999995
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.7e-12 Score=136.20 Aligned_cols=127 Identities=22% Similarity=0.373 Sum_probs=101.4
Q ss_pred HhhcCCCCCCeecccCCeeEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhC-CCCcccceeEEEEEC
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 744 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 744 (799)
...++|+..+.||+|+||.||++... ....+|+|.+... ......++.+|++++.++ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34556888899999999999999853 2368999998754 233446799999999999 899999999999999
Q ss_pred CEEEEEEecCCCCcHHHHHhcCcccccc-------cccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFHI-------SIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~-------~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+..++||||+++|+|.++++.+...... .....+++..+..++.|++.|++|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~ 150 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS 150 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999754311000 112256777888889999999999995
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.3e-12 Score=138.42 Aligned_cols=107 Identities=21% Similarity=0.307 Sum_probs=90.1
Q ss_pred ecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhC---CCCcccceeEEEEECCEEEEEEecCCC
Q 003737 684 VGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ---QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 684 lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
||+|+||+||+|+. .+++.||||++.... ......+..|..++.+. +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999985 468999999986432 12234566777777665 699999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++.... .+++..+..++.||++||+|||+
T Consensus 81 g~L~~~l~~~~---------~~~~~~~~~~~~qil~al~~LH~ 114 (330)
T cd05586 81 GELFWHLQKEG---------RFSEDRAKFYIAELVLALEHLHK 114 (330)
T ss_pred ChHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999987654 57788999999999999999995
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.35 E-value=5.9e-12 Score=132.90 Aligned_cols=119 Identities=25% Similarity=0.428 Sum_probs=95.8
Q ss_pred CCCCCeecccCCeeEEEEEeC-C---CcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCE-----
Q 003737 678 FDPANKVGEGGFGSVYKGILS-D---GTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ----- 746 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~-~---g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~----- 746 (799)
|+..+.||+|+||.||+|... + +..||+|+++... ......+.+|++.+++++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456788999999999999853 2 3689999987542 3345689999999999999999999999876554
Q ss_pred -EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 -LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 -~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++|+||+++|+|.+++...... .....+++..+..++.|++.||+|||+
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~---~~~~~~~~~~~~~~~~~i~~aL~~lH~ 131 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLG---GLPEKLPLQTLLKFMVDIALGMEYLSN 131 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhcc---CCcccCCHHHHHHHHHHHHHHHHHHHh
Confidence 79999999999999998654211 011257788889999999999999995
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.8e-12 Score=135.04 Aligned_cols=119 Identities=18% Similarity=0.310 Sum_probs=97.8
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh-hhHHHHHHHHHHHHhCCCCcccceeEEEEEC--CEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 751 (799)
++|+..+.||+|++|.||++.. .+++.+|+|.+..... .....+.+|++++++++|+||++++++|... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3577788999999999999996 4688999999875432 3456799999999999999999999998654 4689999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++...... ...+++..+..++.|+++||+|||+
T Consensus 81 e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~lH~ 123 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKR-----GGRIGEKVLGKIAESVLKGLSYLHS 123 (287)
T ss_pred EecCCCCHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999987642211 1256777888999999999999994
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.35 E-value=5.8e-12 Score=133.67 Aligned_cols=109 Identities=23% Similarity=0.339 Sum_probs=93.5
Q ss_pred ecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCcH
Q 003737 684 VGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (799)
Q Consensus 684 lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL 759 (799)
||+|+||+||++.. .+|+.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999984 578999999986532 22345678999999999999999999999999999999999999999
Q ss_pred HHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 760 SRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 760 ~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+++...... .+++..+..++.|++.|++|||+
T Consensus 81 ~~~l~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~ 113 (277)
T cd05577 81 KYHIYNVGEP-------GFPEARAIFYAAQIICGLEHLHQ 113 (277)
T ss_pred HHHHHHcCcC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999765421 57788899999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.6e-12 Score=134.56 Aligned_cols=124 Identities=18% Similarity=0.302 Sum_probs=100.8
Q ss_pred hcCCCCCCeecccCCeeEEEEEeCC-----CcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEE-CCEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILSD-----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQL 747 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~~-----g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 747 (799)
.++|...+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|++++.+++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4567788999999999999999654 6889999987543 3345679999999999999999999999876 4678
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++++||+++|+|.+++...... .......+++..+..++.|++.||+|||+
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~-~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 135 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLG-EANNPQALSTQQLVHMAIQIACGMSYLHK 135 (280)
T ss_pred EEEEEcCCCCcHHHHHHhcccc-ccccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999754321 11112357788888999999999999995
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.4e-12 Score=141.43 Aligned_cols=108 Identities=17% Similarity=0.170 Sum_probs=94.4
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
.+|+..+.||+|+||.||++.. .+++.||+|... .+.+.+|++++++++|||||++++++...+..++|+||+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 5688899999999999999984 578999999753 235789999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
. |+|.+++..+. .+++..+..++.||+.||+|||+
T Consensus 166 ~-~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~ylH~ 200 (391)
T PHA03212 166 K-TDLYCYLAAKR---------NIAICDILAIERSVLRAIQYLHE 200 (391)
T ss_pred C-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 6 68998887654 46777889999999999999995
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.35 E-value=8.2e-12 Score=131.29 Aligned_cols=118 Identities=20% Similarity=0.400 Sum_probs=101.3
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
++|+..+.||+|+||.||+|.. .++..+|+|++.... ....+.+.+|+++++.++|+|++++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 3678889999999999999994 468899999986543 23557899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++++|.++++..... ..+++..+..++.|++.||+|||+
T Consensus 81 ~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~ql~~al~~lh~ 120 (267)
T cd06610 81 LSGGSLLDIMKSSYPR------GGLDEAIIATVLKEVLKGLEYLHS 120 (267)
T ss_pred cCCCcHHHHHHHhccc------CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999764320 146788899999999999999995
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.8e-12 Score=137.33 Aligned_cols=111 Identities=23% Similarity=0.423 Sum_probs=96.5
Q ss_pred CCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCC
Q 003737 679 DPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (799)
Q Consensus 679 ~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~G 757 (799)
.....||+|+||.||++.. .++..||||.+........+.+.+|+.++.+++|+||+++++++...+..++||||++++
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 3346799999999999985 468899999987655555677999999999999999999999999999999999999999
Q ss_pred cHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 758 CLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 758 sL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|.+++... .++++.+..++.||+.||+|||+
T Consensus 105 ~L~~~~~~~----------~l~~~~~~~~~~qi~~~l~~LH~ 136 (292)
T cd06658 105 ALTDIVTHT----------RMNEEQIATVCLSVLRALSYLHN 136 (292)
T ss_pred cHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999988543 35677888999999999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.2e-12 Score=152.26 Aligned_cols=122 Identities=17% Similarity=0.328 Sum_probs=100.7
Q ss_pred HhhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEE--CCEE
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQL 747 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 747 (799)
...++|...+.||+|+||.||++.. .++..||+|.+... .......|.+|+.++.+++|||||++++++.. ....
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3456788899999999999999995 46788999998653 23345689999999999999999999998865 3568
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+||||+++|+|.++|...... ...+++..+..++.||+.||+|||+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~-----~g~L~E~~Il~Ia~QIL~ALaYLHs 136 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKM-----FGKIEEHAIVDITRQLLHALAYCHN 136 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999999753211 1157888999999999999999994
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.34 E-value=5e-12 Score=134.36 Aligned_cols=115 Identities=23% Similarity=0.372 Sum_probs=93.3
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCc----EEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGT----VIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~----~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
++|+..+.||+|+||.||+|.. .+++ .+|+|.+.... .....++..|+..+++++|+||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 3567788999999999999985 3454 47888875432 223467888999999999999999999885 455788
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||+++|+|.++++.... .+++..+..++.||+.||+|||+
T Consensus 86 i~e~~~~gsL~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~ 127 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD--------SLDPQRLLNWCVQIAKGMYYLEE 127 (279)
T ss_pred EEEeCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999976432 46777888889999999999995
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=7e-12 Score=131.02 Aligned_cols=114 Identities=30% Similarity=0.525 Sum_probs=98.7
Q ss_pred CCCCeecccCCeeEEEEEeCC-----CcEEEEEEccccChh-hHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 679 DPANKVGEGGFGSVYKGILSD-----GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 679 ~~~~~lG~G~~g~Vy~~~~~~-----g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
+..+.||+|+||.||++...+ +..||+|++...... ..+.+.+|++++.+++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456889999999999999643 388999999765433 56789999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++|+|.+++...... .+++..+..++.|++.|++|||+
T Consensus 82 ~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~ 121 (258)
T smart00219 82 YMEGGDLLDYLRKNRPK-------ELSLSDLLSFALQIARGMEYLES 121 (258)
T ss_pred ccCCCCHHHHHHhhhhc-------cCCHHHHHHHHHHHHHHHHHHhc
Confidence 99999999999865421 27888999999999999999995
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.8e-12 Score=132.35 Aligned_cols=107 Identities=19% Similarity=0.305 Sum_probs=94.0
Q ss_pred ecccCCeeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCcH
Q 003737 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (799)
Q Consensus 684 lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL 759 (799)
||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++|+||+++++++.+++..++|+||+++|+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999964 58999999986542 23346799999999999999999999999999999999999999999
Q ss_pred HHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 760 SRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 760 ~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+++.+.. .+++..+..++.|+++||+|||+
T Consensus 81 ~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lH~ 111 (262)
T cd05572 81 WTILRDRG---------LFDEYTARFYIACVVLAFEYLHN 111 (262)
T ss_pred HHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHhh
Confidence 99998654 46788888899999999999995
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.9e-12 Score=133.99 Aligned_cols=125 Identities=19% Similarity=0.306 Sum_probs=100.3
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 747 (799)
.++|...+.||+|+||.||+|... .+..||+|.+.... ......|.+|++++.+++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 346777899999999999999853 23689999986543 23456799999999999999999999999999999
Q ss_pred EEEEecCCCCcHHHHHhcCcccccc-cccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHI-SIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~-~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||+++|+|.+++......... .....+++..+..++.|++.|++|||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 137 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA 137 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999999754321110 111235667788889999999999995
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.8e-12 Score=133.67 Aligned_cols=115 Identities=21% Similarity=0.344 Sum_probs=95.5
Q ss_pred cCCCCCCeecccCCeeEEEEEeCC----CcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
++|...+.||+|+||.||+|...+ ...||||...... ....+.|.+|+.++++++|+||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 346778899999999999998532 2468999986554 4455789999999999999999999998865 567899
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.+++..... .+++..+..++.|++.|++|||+
T Consensus 85 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~ 125 (270)
T cd05056 85 MELAPLGELRSYLQVNKY--------SLDLASLILYSYQLSTALAYLES 125 (270)
T ss_pred EEcCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999976432 45677888889999999999995
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.3e-12 Score=132.71 Aligned_cols=115 Identities=17% Similarity=0.370 Sum_probs=100.4
Q ss_pred CCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
+|+..+.||+|+||.||++... +++.||+|++.... ....+++.+|++++++++|+||+++++++...+..++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677789999999999999964 68999999987653 344568999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++++|.+++..... .+++..+..++.|+++|++|||+
T Consensus 82 ~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~ 118 (265)
T cd06605 82 DGGSLDKILKEVQG--------RIPERILGKIAVAVLKGLTYLHE 118 (265)
T ss_pred CCCcHHHHHHHccC--------CCCHHHHHHHHHHHHHHHHHHcC
Confidence 99999999976421 56788888899999999999995
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.7e-12 Score=135.45 Aligned_cols=123 Identities=24% Similarity=0.424 Sum_probs=100.1
Q ss_pred CCCCCCeecccCCeeEEEEEe------CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
+|...+.||+|+||.||+++. .++..+|+|.+........+.+.+|++++.+++|+||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 466778999999999999973 23567899998766555567899999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCccccc-------ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFH-------ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~-------~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.+++........ ......+++..+..++.||+.|++|||+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 141 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS 141 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999975432100 0001136777888899999999999995
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.6e-12 Score=136.79 Aligned_cols=110 Identities=22% Similarity=0.366 Sum_probs=96.1
Q ss_pred CCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCc
Q 003737 680 PANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 758 (799)
Q Consensus 680 ~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~Gs 758 (799)
....||+|+||.||++.. .+++.||+|.+........+.+.+|+.++.+++||||+++++++..++..++|+||+++|+
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 345799999999999985 4789999999976544456778999999999999999999999999999999999999999
Q ss_pred HHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 759 LSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 759 L~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|.+++... .+++..+..++.|++.||+|||+
T Consensus 105 L~~~~~~~----------~~~~~~~~~~~~qi~~~L~~LH~ 135 (297)
T cd06659 105 LTDIVSQT----------RLNEEQIATVCESVLQALCYLHS 135 (297)
T ss_pred HHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99987542 46677889999999999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.1e-12 Score=135.21 Aligned_cols=113 Identities=24% Similarity=0.447 Sum_probs=96.4
Q ss_pred CCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChhhH--HHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~--~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
|+..+.||+|+||+||++... +++.||+|.+........ ....+|+.++.+++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 345678999999999999954 567899999977643332 34567999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.+++.... .+++..+..++.|+++||+|||+
T Consensus 81 ~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~Lh~ 116 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---------PLSEEEILKIAYQILEALAYLHS 116 (260)
T ss_dssp TTEBHHHHHHHHS---------SBBHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccc---------ccccccccccccccccccccccc
Confidence 9999999998333 56788899999999999999994
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.7e-12 Score=135.56 Aligned_cols=115 Identities=27% Similarity=0.447 Sum_probs=97.7
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+|+..+.||+|++|.||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 477889999999999999985 478999999986542 22335789999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++ ++|.+++...... .+++..+..++.|+++||+|||+
T Consensus 81 ~~-~~l~~~~~~~~~~-------~l~~~~~~~~~~~i~~~l~~lh~ 118 (284)
T cd07860 81 LH-QDLKKFMDASPLS-------GIPLPLIKSYLFQLLQGLAFCHS 118 (284)
T ss_pred cc-cCHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 96 6899988754321 56788899999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.34 E-value=8.7e-12 Score=131.26 Aligned_cols=115 Identities=20% Similarity=0.359 Sum_probs=97.0
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc-----ChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC--CEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK-----SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQL 747 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 747 (799)
.+|+..+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688889999999999999984 56899999987432 123346889999999999999999999998764 468
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+||+++++|.+++.... .+++..+..++.|+++||+|||+
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~al~~LH~ 124 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---------ALTENVTRRYTRQILQGVSYLHS 124 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 89999999999999987543 45677888899999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.2e-12 Score=136.22 Aligned_cols=124 Identities=19% Similarity=0.302 Sum_probs=99.2
Q ss_pred cCCCCCCeecccCCeeEEEEEeC--------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECC
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN 745 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 745 (799)
++|...+.||+|+||.||++... ++..+|+|.++... .....++.+|++++.++ +|+||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56788899999999999999742 23579999997642 33456788999999999 7999999999999999
Q ss_pred EEEEEEecCCCCcHHHHHhcCccccc-------ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFH-------ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~-------~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++||||+++|+|.+++..+..... ......++...+..++.|++.||+|||+
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~ 158 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS 158 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999986532110 0011246667788889999999999995
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.9e-12 Score=131.77 Aligned_cols=110 Identities=26% Similarity=0.416 Sum_probs=94.2
Q ss_pred CeecccCCeeEEEEEeC--CC--cEEEEEEccccCh-hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCC
Q 003737 682 NKVGEGGFGSVYKGILS--DG--TVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~~--~g--~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+.||+|++|.||+|... .+ ..||+|.+..... ...+.|.+|++++++++|+||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 46899999999999853 23 3699999987655 556789999999999999999999999988 889999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++..... ..+++..+..++.|++.||+|||+
T Consensus 80 ~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~ 115 (257)
T cd05040 80 GSLLDRLRKDAL-------GHFLISTLCDYAVQIANGMRYLES 115 (257)
T ss_pred CcHHHHHHhccc-------ccCcHHHHHHHHHHHHHHHHHHHh
Confidence 999999986532 146777888899999999999995
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.34 E-value=6e-12 Score=133.63 Aligned_cols=115 Identities=23% Similarity=0.466 Sum_probs=95.9
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCc----EEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGT----VIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~----~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
.+|+..+.||+|+||.||+|.. ++|+ .||+|.++... ....+++.+|+.++..++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 4577889999999999999984 4554 48999987543 3345689999999999999999999999975 45789
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||+++|+|.++++.... .+++..+..++.||++||+|||+
T Consensus 86 ~~~~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~ 127 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKD--------RIGSQDLLNWCVQIAKGMSYLEE 127 (279)
T ss_pred EEEcCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999976432 46777888899999999999995
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.8e-12 Score=134.02 Aligned_cols=114 Identities=20% Similarity=0.283 Sum_probs=97.5
Q ss_pred CCCCCCeecccCCeeEEEEEe----CCCcEEEEEEccccCh----hhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEE
Q 003737 677 NFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSR----QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL 747 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~----~~g~~vAvK~l~~~~~----~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 747 (799)
+|+..+.||+|+||.||++.. .+|..||+|++..... ...+.+.+|++++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 366778999999999999984 3689999999865322 2346788999999999 589999999999999999
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||+++|+|.+++.... .+++..+..++.|+++||+|||+
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~al~~lH~ 123 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---------RFKEQEVQIYSGEIVLALEHLHK 123 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999997654 46678899989999999999995
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.7e-12 Score=134.17 Aligned_cols=117 Identities=23% Similarity=0.405 Sum_probs=97.2
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh-hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++++|...+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|++++.+++|+||+++.+++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 456788899999999999999984 5788999999865432 23356789999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||++ +++.+++..... .+++..++.++.|+++||+|||.
T Consensus 83 e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~ 121 (291)
T cd07870 83 EYMH-TDLAQYMIQHPG--------GLHPYNVRLFMFQLLRGLAYIHG 121 (291)
T ss_pred eccc-CCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9996 677777654321 35566788889999999999995
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.8e-12 Score=133.43 Aligned_cols=116 Identities=25% Similarity=0.433 Sum_probs=98.3
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh-hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
+|+..+.||+|++|.||+|+. .+|+.||||+++.... ...+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 477789999999999999996 4689999999876532 23467789999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++ +|.+++...... ..++++.+..++.|+++||+|||+
T Consensus 81 ~~-~l~~~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~ 118 (284)
T cd07836 81 DK-DLKKYMDTHGVR------GALDPNTVKSFTYQLLKGIAFCHE 118 (284)
T ss_pred Cc-cHHHHHHhcCCC------CCcCHHHHHHHHHHHHHHHHHHHH
Confidence 85 899888654321 157788899999999999999995
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.3e-12 Score=131.98 Aligned_cols=115 Identities=20% Similarity=0.308 Sum_probs=95.7
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCC
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
++|.....||+|+||.||++...++..+|+|.+.... ...+.|.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4467778999999999999997776789999986543 23467899999999999999999998874 566899999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.++++..... .+++..+..++.|+++||+|||+
T Consensus 84 ~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~al~~lH~ 120 (260)
T cd05069 84 KGSLLDFLKEGDGK-------YLKLPQLVDMAAQIADGMAYIER 120 (260)
T ss_pred CCCHHHHHhhCCCC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999754321 35667788889999999999995
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.34 E-value=7.5e-12 Score=130.89 Aligned_cols=118 Identities=31% Similarity=0.542 Sum_probs=97.6
Q ss_pred CeecccCCeeEEEEEeC-C---CcEEEEEEccccChh-hHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCC
Q 003737 682 NKVGEGGFGSVYKGILS-D---GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~~-~---g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+.||+|+||.||+|... + +..||+|.+...... ..+.+.+|++.+.+++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46899999999999954 3 789999999765433 367899999999999999999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++..............+++..+..++.|+++||+|||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~ 123 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS 123 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc
Confidence 9999999865211000011267888999999999999999995
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.2e-12 Score=135.40 Aligned_cols=125 Identities=18% Similarity=0.322 Sum_probs=99.4
Q ss_pred hcCCCCCCeecccCCeeEEEEEe--------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccceeEEEEEC
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL--------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 744 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~--------~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 744 (799)
.++|...+.||+|+||.||++.. .++..||+|.+.... ....+++.+|++++..+ +|+||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 34577789999999999999973 134579999987542 33457899999999999 899999999999999
Q ss_pred CEEEEEEecCCCCcHHHHHhcCcccccc-------cccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFHI-------SIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~-------~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+..++||||+++|+|.+++..+...... .....++...+..++.||++||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~ 155 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS 155 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999865321100 011245666788889999999999995
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.34 E-value=8.8e-12 Score=132.67 Aligned_cols=112 Identities=24% Similarity=0.430 Sum_probs=94.4
Q ss_pred CCCCCeecccCCeeEEEEEe-----CCCcEEEEEEccccCh-hhHHHHHHHHHHHHhCCCCcccceeEEEEEC--CEEEE
Q 003737 678 FDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLL 749 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-----~~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 749 (799)
|+..+.||+|+||+||++.. .+++.||+|.++.... ...+.|.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 36778999999999987652 3678999999976432 3456889999999999999999999998764 46899
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+++|+|.+++... .+++..+..++.|+++|++|||+
T Consensus 86 v~e~~~~~~l~~~~~~~----------~l~~~~~~~i~~~l~~~l~~lH~ 125 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH----------KLNLAQLLLFAQQICEGMAYLHS 125 (283)
T ss_pred EecCCCCCCHHHHHHHc----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999753 46788899999999999999995
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.33 E-value=8.4e-12 Score=130.14 Aligned_cols=110 Identities=30% Similarity=0.527 Sum_probs=95.6
Q ss_pred CeecccCCeeEEEEEeCCCcEEEEEEccccChh-hHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCcHH
Q 003737 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS 760 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL~ 760 (799)
+.||+|+||.||++...+++.||+|.+...... ..+.|.+|++++++++|+||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999999766999999998765333 4568999999999999999999999999999999999999999999
Q ss_pred HHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 761 RAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 761 ~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++..... .+++..+..++.|++.|++|||+
T Consensus 81 ~~l~~~~~--------~~~~~~~~~~~~~~~~~l~~lH~ 111 (251)
T cd05041 81 TFLRKKKN--------RLTVKKLLQMSLDAAAGMEYLES 111 (251)
T ss_pred HHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99975432 35677788889999999999995
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.33 E-value=8.1e-12 Score=132.39 Aligned_cols=113 Identities=20% Similarity=0.470 Sum_probs=97.5
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc-ChhhHHHHHHHHHHHHhCC---CCcccceeEEEEECCEEEEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQ---HPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 751 (799)
.|+..+.||+|+||.||+|.. .+++.||+|.++.. .....+++.+|++++++++ |+|++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 366778999999999999995 57899999998654 2334567889999999987 999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++++|.+++... .+++..+..++.|+++||+|||+
T Consensus 82 e~~~~~~L~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~ 119 (277)
T cd06917 82 EYAEGGSVRTLMKAG----------PIAEKYISVIIREVLVALKYIHK 119 (277)
T ss_pred ecCCCCcHHHHHHcc----------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999998643 45677888899999999999995
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.33 E-value=8e-12 Score=133.79 Aligned_cols=125 Identities=21% Similarity=0.368 Sum_probs=101.0
Q ss_pred hcCCCCCCeecccCCeeEEEEEeCC-----------------CcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccc
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILSD-----------------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVK 736 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~~-----------------g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~ 736 (799)
..+|+..+.||+|+||.||++.... +..||+|.+.... ....++|.+|++++.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3568888999999999999987432 2468999987653 334678999999999999999999
Q ss_pred eeEEEEECCEEEEEEecCCCCcHHHHHhcCccccc--ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFH--ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 737 l~g~~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~--~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++++..++..++|+||+++|+|.+++........ ......+++..+..++.|++.||+|||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~ 148 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES 148 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999975431100 0111257788899999999999999995
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.33 E-value=6.5e-12 Score=133.49 Aligned_cols=118 Identities=18% Similarity=0.368 Sum_probs=95.4
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHH-HHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGM-ISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
++|+..+.||+|+||.||++.. .+|+.||+|+++... .....++..|++. ++..+|+||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 3678889999999999999995 479999999987642 2234566677765 556789999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+ |+|.+++...... ...+++..+..++.||+.||+|||+
T Consensus 81 ~~~-~~l~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~ 121 (283)
T cd06617 81 VMD-TSLDKFYKKVYDK-----GLTIPEDILGKIAVSIVKALEYLHS 121 (283)
T ss_pred hhc-ccHHHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 997 6898888643211 1267888999999999999999995
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.33 E-value=5.9e-12 Score=133.85 Aligned_cols=125 Identities=22% Similarity=0.387 Sum_probs=102.6
Q ss_pred cHHHHHHhhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhC-CCCcccceeEEEEE-
Q 003737 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE- 743 (799)
Q Consensus 667 ~~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~- 743 (799)
+..++..+.+.|+..+.+|+|+||.||+|.. .+++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4455556778889999999999999999995 568899999986542 3345788999999998 69999999999863
Q ss_pred -----CCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 744 -----GNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 744 -----~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+..++||||+++|+|.+++...... .++++.+..++.|+++||+|||+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH~ 139 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN-------ALKEDWIAYICREILRGLAHLHA 139 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 45789999999999999998754321 46777888889999999999995
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.33 E-value=6.1e-12 Score=134.45 Aligned_cols=129 Identities=26% Similarity=0.424 Sum_probs=104.7
Q ss_pred cccHHHHHHhhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhC-CCCcccceeEEEE
Q 003737 665 LYTLRQIKAATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCV 742 (799)
Q Consensus 665 ~~~~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~ 742 (799)
.++.+++..++++|+..+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 345566677889999999999999999999995 578899999986532 2245678899999998 8999999999987
Q ss_pred EC-----CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 743 EG-----NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 743 ~~-----~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.. +..++|+||+++|+|.++++..... ...+++..+..++.|++.||+|||+
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~ 146 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLIC-----GQRLDEAMISYILYGALLGLQHLHN 146 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 54 3589999999999999998642110 1156788888999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.33 E-value=1e-11 Score=132.45 Aligned_cols=118 Identities=24% Similarity=0.466 Sum_probs=103.0
Q ss_pred HhhcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
.+++.|+..+.+|+|+||.||++... +++.||+|++..... ..+.+.+|++++.+++|+|++++++++...+..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 35566888889999999999999965 688999999976544 5678899999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++++|.+++.... ..+++..+..++.|++.||+|||+
T Consensus 95 e~~~~~~L~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~lH~ 134 (286)
T cd06614 95 EYMDGGSLTDIITQNF--------VRMNEPQIAYVCREVLQGLEYLHS 134 (286)
T ss_pred eccCCCcHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999998653 146677788889999999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.8e-12 Score=134.18 Aligned_cols=114 Identities=21% Similarity=0.368 Sum_probs=97.5
Q ss_pred CCCCCCeecccCCeeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+|+..+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5778899999999999999954 6889999998653 223356899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++++.+..+..... .+++..+..++.||+.||+|||+
T Consensus 82 ~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~ 118 (288)
T cd07833 82 VERTLLELLEASPG---------GLPPDAVRSYIWQLLQAIAYCHS 118 (288)
T ss_pred CCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99988877665433 46778888999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.4e-13 Score=141.28 Aligned_cols=114 Identities=21% Similarity=0.437 Sum_probs=101.3
Q ss_pred CCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
.|...+.||+|+||.||||. ..+++.||+|+++... ..+.++..+|+.++.+++|+||.+.+|.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 46667899999999999999 4678999999998763 445688999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+|++.+.|.... .+.|..+..+++++..|+.|||.
T Consensus 94 ~gGsv~~lL~~~~---------~~~E~~i~~ilre~l~~l~ylH~ 129 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN---------ILDEFEIAVILREVLKGLDYLHS 129 (467)
T ss_pred cCcchhhhhccCC---------CCccceeeeehHHHHHHhhhhhh
Confidence 9999999998764 44677888889999999999995
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.32 E-value=8.1e-12 Score=131.86 Aligned_cols=121 Identities=22% Similarity=0.406 Sum_probs=100.6
Q ss_pred HhhcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhC-CCCcccceeEEEEECC-----
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN----- 745 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~----- 745 (799)
.++++|+..+.||+|+||.||+|... +++.+|+|.+..... ..+.|.+|++++.++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 46788999999999999999999964 678999999875433 346799999999999 6999999999997644
Q ss_pred -EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 -QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 -~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++||||+++++|.+++...... ...+++..+..++.|+++||+|||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~ql~~al~~lH~ 131 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKK-----GKRLKEEWIAYILRETLRGLAYLHE 131 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 489999999999999998753200 1157788899999999999999995
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.1e-11 Score=130.94 Aligned_cols=118 Identities=22% Similarity=0.409 Sum_probs=92.8
Q ss_pred CCCCeecccCCeeEEEEEeCC-Cc--EEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC------CEE
Q 003737 679 DPANKVGEGGFGSVYKGILSD-GT--VIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------NQL 747 (799)
Q Consensus 679 ~~~~~lG~G~~g~Vy~~~~~~-g~--~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 747 (799)
...+.||+|+||.||+|...+ +. .||+|.++.. .....+.|.+|++++.+++|+||++++++|... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999999643 33 6899998654 234457899999999999999999999988542 246
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|||++|+|.+++...... .....++++.+..++.|++.||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~ 130 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLG---DCPQYLPTQMLVKFMTDIASGMEYLSS 130 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhccc---CCcccCCHHHHHHHHHHHHHHHHHHHH
Confidence 8999999999999988533211 011247788899999999999999995
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=6.9e-13 Score=133.99 Aligned_cols=115 Identities=19% Similarity=0.274 Sum_probs=102.3
Q ss_pred cCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+++|+|.||+|..++ ..+|+.+|+|++++.. ..+...-..|-+++...+||.+..+...+...+..+.||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 567888999999999999998 5689999999998763 333456678999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+.+|.|+-+|.+.+ .++|++.+.|..+|+.||.|||+
T Consensus 248 eyanGGeLf~HLsrer---------~FsE~RtRFYGaEIvsAL~YLHs 286 (516)
T KOG0690|consen 248 EYANGGELFFHLSRER---------VFSEDRTRFYGAEIVSALGYLHS 286 (516)
T ss_pred EEccCceEeeehhhhh---------cccchhhhhhhHHHHHHhhhhhh
Confidence 9999999999887765 78999999999999999999995
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.32 E-value=9.8e-12 Score=133.42 Aligned_cols=124 Identities=22% Similarity=0.398 Sum_probs=99.0
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCc--EEEEEEcccc-ChhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGT--VIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~--~vAvK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 750 (799)
++|+..+.||+|+||.||+|... ++. .+|+|.++.. .....+.|.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46788899999999999999864 343 4788888743 333456799999999999 799999999999999999999
Q ss_pred EecCCCCcHHHHHhcCccccc-------ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFH-------ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~-------~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||+++|+|.++++....... ......+++..+..++.|++.|++|||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~ 137 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE 137 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999975431110 0111247778888899999999999995
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.32 E-value=9.8e-12 Score=133.08 Aligned_cols=116 Identities=22% Similarity=0.369 Sum_probs=97.1
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh--hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
++|+..+.||+|++|.||+|.. .+|+.||+|.+..... ...+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4678889999999999999995 4789999999865422 234678899999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|++ ++|.+++...... .+++..+..++.||+.||+|||+
T Consensus 82 ~~~-~~l~~~~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~ 120 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDF-------AKNPRLIKTYLYQILRGIAYCHS 120 (294)
T ss_pred ccc-ccHHHHHHhCCCC-------CcCHHHHHHHHHHHHHHHHHHHh
Confidence 996 5888887644321 45677888899999999999995
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.6e-11 Score=127.85 Aligned_cols=114 Identities=26% Similarity=0.537 Sum_probs=100.3
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh--hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+|+..+.||+|++|.||++.. .+++.||+|.+..... ...+.+.+|++++.+++|+|++++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 366788999999999999985 4678999999976543 4557899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++++|.+++.... .++++.+..++.|++.|++|||+
T Consensus 81 ~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~~l~~lH~ 117 (254)
T cd06627 81 AENGSLRQIIKKFG---------PFPESLVAVYVYQVLQGLAYLHE 117 (254)
T ss_pred CCCCcHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHhh
Confidence 99999999987653 57788888999999999999995
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=7.9e-14 Score=135.83 Aligned_cols=116 Identities=21% Similarity=0.353 Sum_probs=100.3
Q ss_pred hcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++.|+..+.||+|.|+.||++. .++|+.+|+|.+... +..+.++..+|+++-..++|||||++...+......|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 3456677889999999999998 568999999988543 2335678999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+|+|..-+-.+- .++|..+..+++||+++|.|+|.
T Consensus 90 e~m~G~dl~~eIV~R~---------~ySEa~aSH~~rQiLeal~yCH~ 128 (355)
T KOG0033|consen 90 DLVTGGELFEDIVARE---------FYSEADASHCIQQILEALAYCHS 128 (355)
T ss_pred ecccchHHHHHHHHHH---------HHHHHHHHHHHHHHHHHHHHHHh
Confidence 9999999987766542 67899999999999999999994
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.3e-12 Score=144.96 Aligned_cols=122 Identities=19% Similarity=0.237 Sum_probs=100.2
Q ss_pred HhhcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECC----
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN---- 745 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~---- 745 (799)
...++|...+.||+|+||.||++. ..+|+.||||++... .......+.+|+.++..++|+|++++...+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 345688899999999999999998 457999999998654 2344567899999999999999999988765432
Q ss_pred ----EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 ----QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ----~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++||||+++|+|.++++.+... ...+++..+..++.|++.||+|||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-----~~~l~e~~~~~i~~qll~aL~~lH~ 161 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKT-----NRTFREHEAGLLFIQVLLAVHHVHS 161 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 368999999999999999754321 1257888999999999999999995
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.32 E-value=6.7e-14 Score=151.16 Aligned_cols=170 Identities=29% Similarity=0.471 Sum_probs=92.3
Q ss_pred eEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCC
Q 003737 142 VELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221 (799)
Q Consensus 142 ~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 221 (799)
...||+.|++. .+|..+..+..|+.|.|++|.+. .+|..++++..|.+|||+.|+++ .+|..++.|+ |+.|-+++|
T Consensus 78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNN 153 (722)
T KOG0532|consen 78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNN 153 (722)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecC
Confidence 34455555555 55555555555666666666654 55666666666666666666665 4555555554 566666666
Q ss_pred cCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCcc
Q 003737 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDY 301 (799)
Q Consensus 222 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~ 301 (799)
+++ .+|+.++.+..|..||.+.|.+. .+|..+..+.+|+.|.+..| ++. .+|..
T Consensus 154 kl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn-----------------------~l~-~lp~E 207 (722)
T KOG0532|consen 154 KLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRN-----------------------HLE-DLPEE 207 (722)
T ss_pred ccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhh-----------------------hhh-hCCHH
Confidence 665 55566665566666666666655 34555555555555444432 222 23333
Q ss_pred ccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCC
Q 003737 302 IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343 (799)
Q Consensus 302 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 343 (799)
+..| .|..||+|+|+++ .+|..|.+|..|++|-|.+|.|+
T Consensus 208 l~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 208 LCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred HhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 3322 2444555555554 45555555555555555555554
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.2e-11 Score=129.58 Aligned_cols=114 Identities=24% Similarity=0.415 Sum_probs=95.7
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEE-ECCEEEEEEecC
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV-EGNQLLLVYEYM 754 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~Ey~ 754 (799)
.+|+..+.||+|+||.||++... |..||+|.++... ..+.|.+|+.++++++|+|++++++++. .++..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 35777899999999999999864 7889999986432 3467999999999999999999999765 456789999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.++++..... .++++.+..++.|++.||+|||+
T Consensus 83 ~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~ 120 (256)
T cd05082 83 AKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEA 120 (256)
T ss_pred CCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999765421 46677888889999999999995
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=7e-12 Score=131.46 Aligned_cols=107 Identities=21% Similarity=0.348 Sum_probs=93.9
Q ss_pred ecccCCeeEEEEEeC-CCcEEEEEEccccCh---hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCcH
Q 003737 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (799)
Q Consensus 684 lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL 759 (799)
||+|+||.||+++.. +|+.+|+|.+..... ...+.+.+|++++.+++|+||+++++.+..++..++||||+++|+|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999965 589999999865432 3456789999999999999999999999999999999999999999
Q ss_pred HHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 760 SRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 760 ~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+++++.. .+++..+..++.||++||+|||+
T Consensus 81 ~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~lH~ 111 (265)
T cd05579 81 ASLLENVG---------SLDEDVARIYIAEIVLALEYLHS 111 (265)
T ss_pred HHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99997643 56777888899999999999995
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=6e-12 Score=134.45 Aligned_cols=111 Identities=21% Similarity=0.400 Sum_probs=94.2
Q ss_pred CCeecccCCeeEEEEE-eCCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCC
Q 003737 681 ANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~G 757 (799)
.+++|+|.||+||-|+ .++|+.||||.+++.. .....+..+|+.+|.+++||.||.+...|++.+..++|||-+.+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 5899999999999999 4689999999997653 23346889999999999999999999999999999999999965
Q ss_pred cHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 758 CLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 758 sL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|.-+.|-..... +++|...+++..||+.||.|||+
T Consensus 648 DMLEMILSsEkg-------RL~er~TkFlvtQIL~ALr~LH~ 682 (888)
T KOG4236|consen 648 DMLEMILSSEKG-------RLPERITKFLVTQILVALRYLHF 682 (888)
T ss_pred hHHHHHHHhhcc-------cchHHHHHHHHHHHHHHHHHhhh
Confidence 555555433222 78898899999999999999996
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=1e-11 Score=133.91 Aligned_cols=116 Identities=21% Similarity=0.396 Sum_probs=96.8
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
...|+..+.||+|+||.||+|.. .+|+.||+|++.... ....+++.+|++++++++||||+++.++|.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 34577889999999999999985 468999999986432 23346789999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||++ |++.+++..... .+++..+..++.|++.||+|||+
T Consensus 94 ~e~~~-g~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~L~~LH~ 133 (307)
T cd06607 94 MEYCL-GSASDILEVHKK--------PLQEVEIAAICHGALQGLAYLHS 133 (307)
T ss_pred HHhhC-CCHHHHHHHccc--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99997 577777754321 46777888899999999999995
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.2e-12 Score=145.20 Aligned_cols=115 Identities=18% Similarity=0.329 Sum_probs=97.5
Q ss_pred CCCCCeecccCCeeEEEEEeCCC-cEEEEEEccccChhhHHHHHHHHHHHHhCC-CCcccceeE-EEEE------CCEEE
Q 003737 678 FDPANKVGEGGFGSVYKGILSDG-TVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYG-CCVE------GNQLL 748 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~~g-~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g-~~~~------~~~~~ 748 (799)
....+.|.+|||+.||.+....+ ..||+|++-..++...+...+||++|++++ |+|||.+++ .... .-+++
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 34568899999999999996554 999999997767777889999999999997 999999999 3322 23689
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|.||||++|.|-|++..+... .+.|.++..|+.|+|+|+++||-
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq~-------~lte~eVLkIf~dv~~AVa~mH~ 162 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQT-------RLTEDEVLKIFYDVCEAVAAMHY 162 (738)
T ss_pred eehhhccCCcHHHHHHHHHhc-------cCChHHHHHHHHHHHHHHHHHhc
Confidence 999999999999999865422 58899999999999999999993
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.31 E-value=1e-11 Score=132.96 Aligned_cols=109 Identities=23% Similarity=0.439 Sum_probs=95.6
Q ss_pred CCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCcH
Q 003737 681 ANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL 759 (799)
...||+|+||.||++.. .+|+.||||++..........+.+|+.++++++|+|++++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35799999999999985 57899999998655555567899999999999999999999999999999999999999999
Q ss_pred HHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 760 SRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 760 ~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+++... .++++.+..++.|++.||+|||+
T Consensus 105 ~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lH~ 134 (292)
T cd06657 105 TDIVTHT----------RMNEEQIAAVCLAVLKALSVLHA 134 (292)
T ss_pred HHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9987543 35677888899999999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.5e-11 Score=131.34 Aligned_cols=115 Identities=22% Similarity=0.446 Sum_probs=91.3
Q ss_pred CCCCCCeecccCCeeEEEEEe-C-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhC---CCCcccceeEEEEE-----C
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-S-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQ---QHPNLVKLYGCCVE-----G 744 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~-----~ 744 (799)
+|+..+.||+|+||.||+|+. . +|+.||+|+++... ......+.+|++++.++ +||||++++++|.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 577889999999999999985 3 46889999986542 22335677788777765 69999999999863 3
Q ss_pred CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
...++||||++ |+|.+++...... .+++..+..++.||+.||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~ 128 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLHS 128 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 46899999997 6999998754321 46788899999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.8e-11 Score=127.67 Aligned_cols=114 Identities=25% Similarity=0.431 Sum_probs=99.6
Q ss_pred CCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHhCCCCcccceeEEEEEC--CEEEEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLVY 751 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 751 (799)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++++... +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999965 789999999866532 4467899999999999999999999999988 8999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++++|.+++.... .+++..+..++.|+++|++|||+
T Consensus 81 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh~ 119 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---------KLPEPVIRKYTRQILEGLAYLHS 119 (260)
T ss_pred EecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999997654 46677888889999999999995
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.4e-12 Score=127.78 Aligned_cols=119 Identities=20% Similarity=0.255 Sum_probs=104.1
Q ss_pred cCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC-----CEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~l 749 (799)
++|...+.+|+|+|..||.++ ..++..+|+|++.....++.+...+|++.-++++||||+++++++..+ .+.|+
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 457778899999999999999 788999999999887777788999999999999999999999887543 35899
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++.|...|+|.+.+...... ...++|.++..++.+|++||+|||+
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~k-----g~~~sE~~iL~if~gic~gL~~lH~ 145 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIK-----GNFVSEAQILWIFLGICRGLEALHE 145 (302)
T ss_pred EeehhccccHHHHHHHHhhc-----CCccCHHHHHHHHHHHHHHHHHHhc
Confidence 99999999999999755422 2268899999999999999999996
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.31 E-value=8.6e-12 Score=135.01 Aligned_cols=125 Identities=17% Similarity=0.295 Sum_probs=98.8
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC--------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccceeEEEEEC
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 744 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 744 (799)
.++|...+.||+|+||.||++... ....+|+|.++... .....++.+|++++.++ +||||++++++|...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356778899999999999999731 24579999987542 33456789999999999 699999999999999
Q ss_pred CEEEEEEecCCCCcHHHHHhcCccccc-------ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFH-------ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~-------~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+..++||||+++|+|.+++........ ......++...+..++.|++.||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~ 152 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES 152 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999976432100 0011246777788889999999999995
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.6e-11 Score=130.86 Aligned_cols=112 Identities=25% Similarity=0.465 Sum_probs=98.0
Q ss_pred CCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCC
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
|...+.||+|++|.||++.. .+++.+|+|+++.......+.+.+|+.++++++|+||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 45567999999999999984 57889999998765545566789999999999999999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|.+++... .++++.+..++.|++.||+|||+
T Consensus 101 ~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lH~ 133 (285)
T cd06648 101 GALTDIVTHT----------RMNEEQIATVCLAVLKALSFLHA 133 (285)
T ss_pred CCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999998762 45677888889999999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.7e-11 Score=128.48 Aligned_cols=108 Identities=29% Similarity=0.510 Sum_probs=91.3
Q ss_pred CeecccCCeeEEEEEeC--C--CcEEEEEEccccCh-hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCC
Q 003737 682 NKVGEGGFGSVYKGILS--D--GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~~--~--g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+.||+|+||.||+|+.. + +..+|+|.+..... ...+++.+|+++++++.|+|||++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999842 2 26899999976543 34568999999999999999999999876 4568999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++.... .+++..+..++.|++.|++|||+
T Consensus 80 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lh~ 113 (257)
T cd05060 80 GPLLKYLKKRR---------EIPVSDLKELAHQVAMGMAYLES 113 (257)
T ss_pred CcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHhh
Confidence 99999998654 46677888899999999999995
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.3e-11 Score=134.51 Aligned_cols=111 Identities=16% Similarity=0.304 Sum_probs=94.1
Q ss_pred Ceeccc--CCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCC
Q 003737 682 NKVGEG--GFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 682 ~~lG~G--~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
..||+| +||+||++.. .+|+.||+|++.... ....+.+.+|+.++..++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999985 579999999986542 23346789999999999999999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++...... .+++..+..++.|++.||+|||+
T Consensus 84 ~~l~~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~lH~ 119 (328)
T cd08226 84 GSANSLLKTYFPE-------GMSEALIGNILFGALRGLNYLHQ 119 (328)
T ss_pred CCHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999998764321 57788888999999999999995
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.3e-11 Score=132.94 Aligned_cols=115 Identities=26% Similarity=0.507 Sum_probs=94.5
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCc----EEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGT----VIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~----~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
++|+..+.||+|+||.||+|.. .+|. .||+|.+.... .....++.+|+.++++++|+||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 4577788999999999999984 4454 57899886543 23345789999999999999999999998754 4679
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||+++|+|.+++..+.. .+++..+..++.|++.||+|||+
T Consensus 86 v~e~~~~g~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~ 127 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKD--------NIGSQLLLNWCVQIAKGMMYLEE 127 (303)
T ss_pred eehhcCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHhh
Confidence 9999999999999876432 46777888889999999999995
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.6e-11 Score=129.69 Aligned_cols=118 Identities=25% Similarity=0.444 Sum_probs=94.0
Q ss_pred CeecccCCeeEEEEEeC-CCc--EEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEEecCCC
Q 003737 682 NKVGEGGFGSVYKGILS-DGT--VIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~~-~g~--~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+.||+|+||.||+|... ++. .+|+|.+.... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46899999999999964 443 56888887532 33456899999999999 799999999999999999999999999
Q ss_pred CcHHHHHhcCccccc-------ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFH-------ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~-------~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.++++....... ......++++.+..++.|++.|++|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~ 130 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 130 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999976431100 0111246777888899999999999995
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.4e-11 Score=131.96 Aligned_cols=119 Identities=20% Similarity=0.317 Sum_probs=96.5
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh--hhHHHHHHHHHHHHhCC-CCcccceeEEEEECCE-----
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQ----- 746 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~----- 746 (799)
++|+..+.||+|+||.||+|.. .+|+.||+|.++.... .....+.+|++++.+++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3578889999999999999995 4789999999865422 23467889999999995 6999999999987665
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.|+||||+++ +|.+++........ ..+++..+..++.||++||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~ 128 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPG----RPLPAKTIKSFMYQLLKGVAHCHK 128 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCC----CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 8999999985 89998875432111 156788999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.7e-11 Score=128.68 Aligned_cols=110 Identities=25% Similarity=0.404 Sum_probs=89.2
Q ss_pred CeecccCCeeEEEEEeC----CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEEEE-CCEEEEEEecCC
Q 003737 682 NKVGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLLVYEYMK 755 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~~----~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~~ 755 (799)
+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++.. ++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999843 2457999998643 33445789999999999999999999998764 556899999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.+++++... ...+..+..++.|+++|++|||+
T Consensus 81 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~ 116 (262)
T cd05058 81 HGDLRNFIRSETH--------NPTVKDLIGFGLQVAKGMEYLAS 116 (262)
T ss_pred CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999975432 23455677779999999999995
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.2e-11 Score=132.33 Aligned_cols=115 Identities=22% Similarity=0.422 Sum_probs=97.0
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChh--hHHHHHHHHHHHHhCCCCcccceeEEEEEC--CEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 750 (799)
++|+..+.||+|+||.||+|... +++.+|+|.++..... ....+.+|++++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 45778899999999999999964 6889999999654322 234678899999999999999999999887 889999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||++ ++|.+++..... .++++.+..++.||++||+|||+
T Consensus 85 ~e~~~-~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~ 124 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ--------PFLQSEVKCLMLQLLSGVAHLHD 124 (293)
T ss_pred ehhcC-cCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99998 499998875432 46788899999999999999995
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.29 E-value=7.1e-12 Score=132.74 Aligned_cols=115 Identities=19% Similarity=0.283 Sum_probs=100.1
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhCC-CCcccceeEEEEECCEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 750 (799)
++|...+.||+|+||.||++.. .+|+.||+|.+... .....+.+.+|++++.+++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 3577888999999999999995 47899999998653 2233467889999999998 99999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+
T Consensus 81 ~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~ql~~~l~~Lh~ 120 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---------SLDEKCTRFYAAEILLALEYLHS 120 (280)
T ss_pred EcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999997654 57788899999999999999995
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.1e-11 Score=129.52 Aligned_cols=113 Identities=23% Similarity=0.405 Sum_probs=94.8
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCC
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
++|...+.||+|+||.||++.. +++.||+|.++... ..+.+.+|++++.+++|+|++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3467789999999999999975 67889999986532 346799999999999999999999998654 5799999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.+++...... .+++..+..++.|++.|++|||+
T Consensus 82 ~~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~al~~lH~ 118 (254)
T cd05083 82 KGNLVNFLRTRGRA-------LVSVIQLLQFSLDVAEGMEYLES 118 (254)
T ss_pred CCCHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999765321 46677788889999999999995
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.7e-12 Score=130.79 Aligned_cols=119 Identities=17% Similarity=0.356 Sum_probs=97.9
Q ss_pred cCCCCCCeecccCCeeEEEEEeCC-----CcEEEEEEccccCh--hhHHHHHHHHHHHHhCCCCcccceeEEEEE-CCEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSD-----GTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQL 747 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~-----g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 747 (799)
..|+....||+|.||.|||++..+ .+.+|+|+++..+. +-.....+|+.+++.++|||||.|..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 457778899999999999997432 23789999976533 234678899999999999999999998887 7889
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|++||.+. ||...|+..+..... .+|...++.+..||+.|+.|||+
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~----~lp~~mvKsilwQil~Gv~YLH~ 150 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAK----QLPRSMVKSILWQILDGVHYLHS 150 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhc----cCCHHHHHHHHHHHHhhhHHHhh
Confidence 999999998 999999855432222 67888999999999999999996
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.7e-11 Score=132.53 Aligned_cols=117 Identities=21% Similarity=0.380 Sum_probs=95.8
Q ss_pred CCCCCeecccCCeeEEEEEeC---CCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEEC--CEEEE
Q 003737 678 FDPANKVGEGGFGSVYKGILS---DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLL 749 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 749 (799)
|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++.+++||||+++++++.+. +..++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 667788999999999999953 57899999997632 33346788999999999999999999999988 78999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+++ ++.+++........ ..+++..+..++.||+.||+|||+
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~ 126 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKR----VSIPPSMVKSLLWQILNGVHYLHS 126 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCC----cCcCHHHHHHHHHHHHHHHHHHHh
Confidence 9999985 67777653322111 267888999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.4e-11 Score=132.31 Aligned_cols=118 Identities=23% Similarity=0.409 Sum_probs=97.4
Q ss_pred HhhcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECC----
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN---- 745 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~---- 745 (799)
...++|+..+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35567888999999999999999964 68999999996542 223457889999999999999999999987655
Q ss_pred ------EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 ------QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ------~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++|+||+++ ++.+.+..... .++++.+..++.||+.||+|||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~ 134 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLV--------HFSEDHIKSFMKQLLEGLNYCHK 134 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 78999999986 77777764321 56788899999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.29 E-value=2e-11 Score=132.24 Aligned_cols=116 Identities=22% Similarity=0.356 Sum_probs=91.2
Q ss_pred CCeecccCCeeEEEEEeC---CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEE--CCEEEEEEecCC
Q 003737 681 ANKVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLVYEYMK 755 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~ 755 (799)
.+.||+|+||.||+|... +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999853 46789999986532 23467899999999999999999998864 456899999997
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+ +|.+++..............+++..++.++.||+.||+|||+
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~ 126 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh
Confidence 5 888887643221111222358888999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.5e-11 Score=124.86 Aligned_cols=115 Identities=26% Similarity=0.531 Sum_probs=101.7
Q ss_pred CCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCC
Q 003737 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++.+++++|++++++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3667789999999999999964 789999999977655566789999999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|.+++..... .+++..+..++.|+++|++|||+
T Consensus 81 ~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lh~ 116 (253)
T cd05122 81 GGSLKDLLKSTNQ--------TLTESQIAYVCKELLKGLEYLHS 116 (253)
T ss_pred CCcHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHhhc
Confidence 9999999876531 56788889999999999999995
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.29 E-value=8.4e-12 Score=131.60 Aligned_cols=116 Identities=26% Similarity=0.383 Sum_probs=93.8
Q ss_pred CeecccCCeeEEEEEeCC-------CcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 682 NKVGEGGFGSVYKGILSD-------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~~~-------g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+.||+|+||.||+|...+ ++.+|+|.+.... ......|.+|++++++++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998532 2579999986543 23456899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.++++....... ....+++..+..++.|+++|++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~ 124 (269)
T cd05044 81 MEGGDLLSYLRDARVERF--GPPLLTLKELLDICLDVAKGCVYLEQ 124 (269)
T ss_pred cCCCcHHHHHHHhhhccc--CCccccHHHHHHHHHHHHHHHHHHHh
Confidence 999999999975431100 11246677788889999999999995
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.5e-12 Score=140.79 Aligned_cols=113 Identities=22% Similarity=0.444 Sum_probs=95.3
Q ss_pred CCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccChh---hHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQ---GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
|...+.||.|+||.||-+. ..+.+.||||++.-..++ .++++..||+.|.+++|||+|.+.|||..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 5556779999999999998 567889999999654433 467899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|-| +-.|++.=..+ .+.|..|..++.+.++||+|||+
T Consensus 108 ClG-SAsDlleVhkK--------plqEvEIAAi~~gaL~gLaYLHS 144 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHS 144 (948)
T ss_pred Hhc-cHHHHHHHHhc--------cchHHHHHHHHHHHHHHHHHHHH
Confidence 964 77787753222 56677888889999999999996
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.29 E-value=7.2e-12 Score=133.31 Aligned_cols=114 Identities=20% Similarity=0.374 Sum_probs=96.0
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+|+..+.||+|+||.||+|.. .+|+.||+|+++... ......+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 366778899999999999995 478999999986532 22235688899999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++ |+|.++++.... .++++.+..++.||++||+|||+
T Consensus 81 ~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~LH~ 117 (284)
T cd07839 81 CD-QDLKKYFDSCNG--------DIDPEIVKSFMFQLLKGLAFCHS 117 (284)
T ss_pred CC-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 97 588888765321 57788899999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.8e-11 Score=130.23 Aligned_cols=114 Identities=23% Similarity=0.407 Sum_probs=96.9
Q ss_pred CCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
|+..+.||+|++|.||+|.. .+|+.||+|++.... ....+.+.+|++++++++|+|++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 45678899999999999985 579999999986543 223467889999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+ ++|.+++..... ..+++..+..++.|+++||+|||+
T Consensus 81 ~-~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~~L~~lH~ 117 (283)
T cd07835 81 D-LDLKKYMDSSPL-------TGLDPPLIKSYLYQLLQGIAYCHS 117 (283)
T ss_pred C-cCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 5 699999875432 156788889999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.2e-11 Score=135.54 Aligned_cols=115 Identities=21% Similarity=0.319 Sum_probs=95.4
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEEC------
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------ 744 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 744 (799)
..++|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 456788899999999999999984 578899999986542 22345688999999999999999999987543
Q ss_pred CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
...++++|++ +++|.+++... .+++..++.++.||++||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH~ 136 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ----------KLSDEHVQFLIYQLLRGLKYIHS 136 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 3578999998 77998887643 47788999999999999999995
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.3e-11 Score=127.30 Aligned_cols=116 Identities=18% Similarity=0.296 Sum_probs=96.5
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEE-CCEEEEEEe
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLLVYE 752 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 752 (799)
+|+..+.||+|++|.||++.. .+++.||+|++.... ....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 367788999999999999984 467899999986532 2345678999999999999999999988764 446799999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++|+|.++++..... .+++.++..++.|++.|++|||+
T Consensus 81 ~~~~~~l~~~l~~~~~~-------~l~~~~~~~~~~~l~~~l~~lH~ 120 (257)
T cd08223 81 FCEGGDLYHKLKEQKGK-------LLPENQVVEWFVQIAMALQYLHE 120 (257)
T ss_pred ccCCCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999753221 46788899999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.7e-11 Score=127.73 Aligned_cols=118 Identities=19% Similarity=0.401 Sum_probs=95.8
Q ss_pred CCCCCCeecccCCeeEEEEEeCC--CcEEEEEEcccc----------ChhhHHHHHHHHHHHHh-CCCCcccceeEEEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGILSD--GTVIAVKQLSSK----------SRQGNREFVNEIGMISA-QQHPNLVKLYGCCVE 743 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~~--g~~vAvK~l~~~----------~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~ 743 (799)
+|+..+.||+|+||.||+|.... ++.+|+|.+... ......++.+|++++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46778899999999999999654 688999988532 12233568889988875 799999999999999
Q ss_pred CCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 744 GNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 744 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++..++||||+++++|.+++..... ....+++..+..++.|++.||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lh~ 131 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKE-----KKQRFTEERIWNIFVQMVLALRYLHK 131 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHhcc
Confidence 9999999999999999998853211 01257888889999999999999994
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.8e-11 Score=126.89 Aligned_cols=117 Identities=21% Similarity=0.374 Sum_probs=96.1
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEE--CCEEEEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLVY 751 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 751 (799)
+|+..+.+|+|+||.||++.. .+|+.||+|.+... .....+.+.+|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 366778999999999999984 57889999998643 23345678999999999999999999998764 45679999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhc
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFF 798 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH 798 (799)
||+++|+|.+++...... ...++++.+..++.|++.|++|||
T Consensus 81 e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH 122 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKE-----RKYIEEEFIWRILTQLLLALYECH 122 (265)
T ss_pred hhccCCCHHHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHh
Confidence 999999999999753211 115677788889999999999999
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.7e-11 Score=133.94 Aligned_cols=124 Identities=19% Similarity=0.296 Sum_probs=97.1
Q ss_pred cCCCCCCeecccCCeeEEEEEeC--------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECC
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN 745 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 745 (799)
.+|...+.||+|+||.||++... .+..||+|.++... ....+++.+|++++.++ +|+||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 35777899999999999999731 12378999887542 33457899999999999 8999999999999999
Q ss_pred EEEEEEecCCCCcHHHHHhcCccccc-------ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFH-------ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~-------~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++||||+++|+|.+++..+..... ......++...+..++.|+++||+|||+
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 152 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS 152 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999976432100 0011235556777789999999999995
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.27 E-value=3e-11 Score=125.96 Aligned_cols=118 Identities=23% Similarity=0.435 Sum_probs=100.7
Q ss_pred CCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+|+..+.||+|+||.||++... +++.||+|++..... ...+.+.+|++++++++|+|++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677789999999999999954 688999999976432 4567899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++++|.+++...... ...+++..+..++.|++.||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~ 121 (258)
T cd08215 81 ADGGDLSQKIKKQKKE-----GKPFPEEQILDWFVQLCLALKYLHS 121 (258)
T ss_pred cCCCcHHHHHHHhhcc-----CCCcCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999864210 0157788899999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.2e-11 Score=135.18 Aligned_cols=125 Identities=21% Similarity=0.356 Sum_probs=97.2
Q ss_pred hcCCCCCCeecccCCeeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccceeEEEEEC-C
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG-N 745 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-~ 745 (799)
.++|+..+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|++++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 34688889999999999999963 235789999997543 23346788999999999 899999999988654 5
Q ss_pred EEEEEEecCCCCcHHHHHhcCccccc----------------------------------------------------cc
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFH----------------------------------------------------IS 773 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~----------------------------------------------------~~ 773 (799)
..++++||+++|+|.++++....... ..
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 68899999999999999975321100 00
Q ss_pred ccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 774 IYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 774 ~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
....++++.+..++.||++||+|||+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~ 191 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLAS 191 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHh
Confidence 01256777888999999999999995
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.8e-11 Score=131.18 Aligned_cols=113 Identities=21% Similarity=0.409 Sum_probs=95.0
Q ss_pred CCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
|+..+.||+|+||.||++.. .++..||+|.+.... ....+.+.+|++++++++|+|++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 66678899999999999995 478899999986432 22345789999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++ |+|.+.+..... .+++..+..++.|++.||+|||+
T Consensus 107 ~~-g~l~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~ 143 (317)
T cd06635 107 CL-GSASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHS 143 (317)
T ss_pred CC-CCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 97 588887764321 46777888889999999999995
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.7e-11 Score=130.32 Aligned_cols=122 Identities=25% Similarity=0.387 Sum_probs=97.3
Q ss_pred CCCCCeecccCCeeEEEEEeC------CCcEEEEEEccccChh-hHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 678 FDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
|+..+.||+|+||.||+|... +++.||+|+++..... ..+.|.+|++++.+++||||+++++++.+.+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 455678999999999999852 2578999999754332 346789999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCccccc-------ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFH-------ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~-------~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||+++++|.+++..+..... ......+++..+..++.|++.||+|||+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~ 142 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS 142 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999964321110 0112246777788889999999999995
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.27 E-value=3e-11 Score=126.75 Aligned_cols=109 Identities=22% Similarity=0.285 Sum_probs=89.5
Q ss_pred CeecccCCeeEEEEEe-CCCcEEEEEEccccCh---hhHHHHHHHHHHHH-hCCCCcccceeEEEEECCEEEEEEecCCC
Q 003737 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR---QGNREFVNEIGMIS-AQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+.||+|+||.||+|.. .+|+.||+|.+..... .....+..|..++. ..+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999985 4689999999865422 22234556655544 45899999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++.... .+++..+..++.|+++||+|||+
T Consensus 82 ~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~ 115 (260)
T cd05611 82 GDCASLIKTLG---------GLPEDWAKQYIAEVVLGVEDLHQ 115 (260)
T ss_pred CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999997654 56788899999999999999995
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.8e-13 Score=147.92 Aligned_cols=189 Identities=22% Similarity=0.405 Sum_probs=154.6
Q ss_pred CCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCE
Q 003737 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK 239 (799)
Q Consensus 160 ~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 239 (799)
..++.-...||+.|++. .+|..+..+..|+.+.|..|.+. .+|..++++..|++|||+.|+++ ..|..+..++ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 44666678899999998 89999999999999999999998 89999999999999999999998 6788777764 899
Q ss_pred EEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCC
Q 003737 240 LHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319 (799)
Q Consensus 240 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 319 (799)
|-+++|+++ .+|+.++.+..|. .||.+.|.+. .+|..++.+.+|+.|.+..|++.
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~-----------------------~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~ 202 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLA-----------------------HLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE 202 (722)
T ss_pred EEEecCccc-cCCcccccchhHH-----------------------Hhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh
Confidence 999999987 5666666555444 4555556665 67888999999999999999999
Q ss_pred CCCchhhhccCCCCEEeccCCcCCCcCChhhh--cCCCEEEeecCcCcccCCCCCcCCCCCccce
Q 003737 320 GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESSDPIECPRGSVNLV 382 (799)
Q Consensus 320 ~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~l~~l~ls~N~~~g~~p~~~~~~~~~~~~~ 382 (799)
.+|..+..|+ |..||++.|+++ .||..+- ..+++|.|.+|.++. .|..+ |..+.+-.+
T Consensus 203 -~lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS-PPAqI-C~kGkVHIF 262 (722)
T KOG0532|consen 203 -DLPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS-PPAQI-CEKGKVHIF 262 (722)
T ss_pred -hCCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC-ChHHH-Hhccceeee
Confidence 6788888664 899999999999 7898774 468999999999974 34444 777654433
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.2e-11 Score=128.27 Aligned_cols=108 Identities=22% Similarity=0.306 Sum_probs=87.2
Q ss_pred eecccCCeeEEEEEe-CCCcEEEEEEccccCh---hhHHHHHHHHHHH---HhCCCCcccceeEEEEECCEEEEEEecCC
Q 003737 683 KVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR---QGNREFVNEIGMI---SAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 683 ~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~f~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
.||+|+||.||++.. .+++.+|+|.+..... .....+.+|..++ ...+|++|+++.+++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 5689999999865421 1223344554433 34479999999999999999999999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.+++.... .+++..+..++.|++.||+|||+
T Consensus 81 ~~~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH~ 115 (279)
T cd05633 81 GGDLHYHLSQHG---------VFSEKEMRFYATEIILGLEHMHN 115 (279)
T ss_pred CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999987654 57788899999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.8e-11 Score=133.41 Aligned_cols=118 Identities=18% Similarity=0.285 Sum_probs=97.9
Q ss_pred HHHhhcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEE-CCE
Q 003737 671 IKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQ 746 (799)
Q Consensus 671 ~~~~t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~ 746 (799)
+...+++|+..+.||+|+||.||++. ..+++.||+|++.... ....+.+.+|++++.+++||||+++.+++.. .+.
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 34567889999999999999999998 4578999999986432 2234678899999999999999999998865 567
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++|+||+ +++|.++++.. .+++..+..++.|+++||+|||+
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~----------~~~~~~~~~~~~ql~~aL~~LH~ 126 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR----------PLEKQFIQYFLYQILRGLKYVHS 126 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 89999998 56899888643 45676788889999999999995
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.4e-11 Score=133.30 Aligned_cols=116 Identities=17% Similarity=0.356 Sum_probs=96.6
Q ss_pred HhhcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECC----
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN---- 745 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~---- 745 (799)
...++|+..+.||+|+||.||++. ..+|..||||++.... ....+.+.+|++++.+++|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 355778889999999999999998 4578999999986432 223457889999999999999999999987643
Q ss_pred --EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 --QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 --~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++||||+ +++|.+++... .++++.++.++.||++||+|||+
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~----------~l~~~~~~~i~~qi~~al~~LH~ 136 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE----------KLSEDRIQFLVYQMLKGLKYIHA 136 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 458999999 67999887643 46788999999999999999995
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.8e-11 Score=130.60 Aligned_cols=113 Identities=19% Similarity=0.334 Sum_probs=96.1
Q ss_pred CCCCCeecccCCeeEEEEEe----CCCcEEEEEEccccC----hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEE
Q 003737 678 FDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKS----RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLL 748 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 748 (799)
|+..+.||+|+||.||++.. .+++.||||+++... ....+.+.+|++++.++ +|+||+++++++..++..+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 56678999999999999874 357889999986532 22345788999999999 5999999999999999999
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||+++|+|.+++..+. .+++..++.++.|+++||+|||+
T Consensus 82 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~lH~ 123 (288)
T cd05583 82 LILDYVNGGELFTHLYQRE---------HFTESEVRVYIAEIVLALDHLHQ 123 (288)
T ss_pred EEEecCCCCcHHHHHhhcC---------CcCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999987543 46777888899999999999994
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.6e-11 Score=129.22 Aligned_cols=115 Identities=23% Similarity=0.445 Sum_probs=91.0
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh--hhHHHHHHHHHHHHhC---CCCcccceeEEEEE-----CC
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQ---QHPNLVKLYGCCVE-----GN 745 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~-----~~ 745 (799)
+|+..+.||+|+||.||+|.. .+|+.||+|.++.... .....+.+|++++.++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 367788999999999999985 4789999999865422 2234566777777655 79999999998864 24
Q ss_pred EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++||||+++ +|.+++...... .++++.++.++.|++.||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~lH~ 126 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPP-------GLPAETIKDLMRQFLRGLDFLHA 126 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 57999999984 899988754321 47888999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.4e-11 Score=132.81 Aligned_cols=109 Identities=20% Similarity=0.392 Sum_probs=92.6
Q ss_pred CCeecccCCeeEEEEEe-CCCcEEEEEEccccChhh--------------HHHHHHHHHHHHhCCCCcccceeEEEEECC
Q 003737 681 ANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQG--------------NREFVNEIGMISAQQHPNLVKLYGCCVEGN 745 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~--------------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 745 (799)
.+.||+|+||.||+|.. .+++.||||.+....... ...+.+|++++.+++|+||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 46799999999999994 478999999986432111 125789999999999999999999999999
Q ss_pred EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++||||++ |+|.+++..+. .++++.+..++.|+++||+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~ 137 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKI---------RLTESQVKCILLQILNGLNVLHK 137 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999997 69999987543 57788899999999999999995
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.5e-11 Score=133.97 Aligned_cols=114 Identities=19% Similarity=0.299 Sum_probs=93.7
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECC-----
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----- 745 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----- 745 (799)
..++|+..+.||+|+||.||++.. .+|+.||||++... .......+.+|+.++..++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 346788899999999999999984 56899999998653 2234567889999999999999999999986543
Q ss_pred -EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 -QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 -~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++||||+++ +|.+.++. .++++.+..++.||++||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~~~~qi~~~L~~LH~ 141 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----------ELDHERMSYLLYQMLCGIKHLHS 141 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----------cCCHHHHHHHHHHHHHHHHHHHh
Confidence 47999999976 56666642 35677888899999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.8e-11 Score=138.63 Aligned_cols=116 Identities=16% Similarity=0.270 Sum_probs=91.1
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC--------
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-------- 744 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-------- 744 (799)
...+|...+.||+|+||.||+|.. .+++.||||++.... ....+|+.++++++|+|||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 345788899999999999999995 578899999885432 2345799999999999999999887532
Q ss_pred CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
...++||||+++ +|.+++...... ...+++..++.++.||+.||+|||+
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~gL~yLH~ 188 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARN-----NHALPLFLVKLYSYQLCRALAYIHS 188 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 246799999985 777777532110 1157788899999999999999995
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.8e-11 Score=128.69 Aligned_cols=113 Identities=21% Similarity=0.437 Sum_probs=96.3
Q ss_pred CCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEEC--CEEEEEEe
Q 003737 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLVYE 752 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 752 (799)
|+..+.||+|+||.||+|... +|+.+|+|++.... ....+.+.+|++++.+++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456678999999999999954 68899999997653 33456789999999999999999999999888 88999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++ +|.+++..... .+++..+..++.||++||+|||+
T Consensus 81 ~~~~-~l~~~~~~~~~--------~~~~~~~~~i~~~i~~al~~LH~ 118 (287)
T cd07840 81 YMDH-DLTGLLDSPEV--------KFTESQIKCYMKQLLEGLQYLHS 118 (287)
T ss_pred cccc-cHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9985 89998875421 57788888999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.2e-11 Score=127.13 Aligned_cols=118 Identities=29% Similarity=0.459 Sum_probs=99.1
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+|+..+.||+|+||.||+++. .+++.+|+|.+... ......++.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 367788999999999999984 47889999998654 233456788999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++++|.+++.+.... ...++++.+..++.|+++||+|||+
T Consensus 81 ~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lh~ 121 (256)
T cd08530 81 APFGDLSKAISKRKKK-----RKLIPEQEIWRIFIQLLRGLQALHE 121 (256)
T ss_pred cCCCCHHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 9999999998763211 1156777888889999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=5e-11 Score=125.87 Aligned_cols=114 Identities=17% Similarity=0.198 Sum_probs=89.4
Q ss_pred HHhhcCCCCCCee--cccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEE
Q 003737 672 KAATNNFDPANKV--GEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL 747 (799)
Q Consensus 672 ~~~t~~f~~~~~l--G~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 747 (799)
....++|+..+.+ |+|+||.||++.. .++..+|+|.+........ |+.....+ +|+||+++++++...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3344566666665 9999999999984 5788999999865322111 22222212 799999999999999999
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||+++|+|.+++.... .++++.+..++.||++|++|||+
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~ 127 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG---------KLSEAEVKKIIRQLVEALNDLHK 127 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999997654 56788999999999999999995
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.25 E-value=4e-11 Score=126.67 Aligned_cols=119 Identities=24% Similarity=0.373 Sum_probs=93.7
Q ss_pred CCCCCeecccCCeeEEEEEeC----CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECC------
Q 003737 678 FDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------ 745 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~----~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 745 (799)
|...+.||+|+||.||+|... +++.||||++... .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 455678999999999999853 3688999998654 2334567999999999999999999999886542
Q ss_pred EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++++||+++|+|.+++...... .....++...+..++.||+.|++|||+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lH~ 131 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIG---EEPFTLPLQTLVRFMIDIASGMEYLSS 131 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhccc---CCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 347899999999999988643211 011246777888899999999999995
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.25 E-value=9.4e-12 Score=139.24 Aligned_cols=198 Identities=31% Similarity=0.515 Sum_probs=104.5
Q ss_pred EEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCC-CCCEEEcccCcCCccCChhccCCCCCCEEEccCC
Q 003737 143 ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLI-NLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221 (799)
Q Consensus 143 ~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 221 (799)
.++++.|.+.. ....+..++.++.|++.+|.++ .+|.....+. +|+.|++++|.+. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 34444444421 1222333455566666666655 4444455553 5666666666655 44445556666666666666
Q ss_pred cCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCc
Q 003737 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPD 300 (799)
Q Consensus 222 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~ 300 (799)
++. .+|...+..++|+.|++++|+++ .+|........|++|.++.|..... +..+.. .++..+.+.+|++. .++.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~-~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIEL-LSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcceec-chhhhhcccccccccCCceee-eccc
Confidence 665 34444445556666666666665 3444433344455555554321111 111111 34444445555554 2255
Q ss_pred cccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChh
Q 003737 301 YIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY 349 (799)
Q Consensus 301 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 349 (799)
.++.+++++.|++++|+++. ++. ++.+.+++.|++++|.++...|..
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred hhccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchhh
Confidence 66666677777777777763 333 666777777777777776555543
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.8e-11 Score=133.57 Aligned_cols=111 Identities=14% Similarity=0.198 Sum_probs=93.9
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
...+|...+.||+|+||.||+|... ++..||+|..... ....|+.++.+++|+|||++++++...+..++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457889999999999999999954 5788999985432 23568999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+. |+|.+++..... .+++..+..++.||+.||+|||+
T Consensus 138 ~~~-~~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~ 175 (357)
T PHA03209 138 HYS-SDLYTYLTKRSR--------PLPIDQALIIEKQILEGLRYLHA 175 (357)
T ss_pred ccC-CcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 995 689998875432 56778889999999999999995
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=3e-11 Score=136.84 Aligned_cols=110 Identities=18% Similarity=0.190 Sum_probs=94.0
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
..+|...+.||+|+||.||++... .++.||||.... ..+.+|++++++++|+|||++++++...+..++||||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 456888899999999999999954 578999996432 3467899999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+. |+|.+++..... .+++..+..++.||++||+|||+
T Consensus 242 ~~-~~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~ 278 (461)
T PHA03211 242 YR-SDLYTYLGARLR--------PLGLAQVTAVARQLLSAIDYIHG 278 (461)
T ss_pred cC-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 95 799998865432 46778889999999999999995
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.6e-11 Score=129.30 Aligned_cols=116 Identities=22% Similarity=0.336 Sum_probs=90.4
Q ss_pred CCeecccCCeeEEEEEeC---CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEE--CCEEEEEEecCC
Q 003737 681 ANKVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLVYEYMK 755 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~ 755 (799)
...||+|+||.||+|... ++..||+|.+.... ....+.+|++++.+++||||+++++++.. +...++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999864 45789999986532 23468899999999999999999998854 457899999987
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+ +|.+++..............+++..+..++.||+.||+|||+
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~ 126 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh
Confidence 5 788887533211111122357888899999999999999995
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.6e-11 Score=127.60 Aligned_cols=113 Identities=24% Similarity=0.393 Sum_probs=92.7
Q ss_pred CCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCC-CCcccceeEEEEEC--CEEEEEEe
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEG--NQLLLVYE 752 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 752 (799)
|+..+.||+|+||.||+|.. .+++.||+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 44567899999999999994 578999999986542 222334568999999985 99999999999987 88999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|++ |+|.+++..+.. .+++..+..++.|++.||+|||+
T Consensus 81 ~~~-~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~ 118 (282)
T cd07831 81 LMD-MNLYELIKGRKR--------PLPEKRVKSYMYQLLKSLDHMHR 118 (282)
T ss_pred cCC-ccHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 997 588888875431 56788899999999999999994
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.6e-11 Score=129.56 Aligned_cols=115 Identities=21% Similarity=0.374 Sum_probs=94.3
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECC-------
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------- 745 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------- 745 (799)
++|+..+.||+|+||.||+|.. .+++.||||.+.... ......+.+|++++++++||||++++++|...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 4688889999999999999995 478999999986432 222345678999999999999999999987654
Q ss_pred -EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 -QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 -~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++||||+++ +|.+++..... .+++..+..++.||++||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~ 137 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKNV--------KFTLSEIKKVMKMLLNGLYYIHR 137 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 35999999975 88888765431 46788899999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.5e-11 Score=137.48 Aligned_cols=126 Identities=16% Similarity=0.239 Sum_probs=91.1
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-----------------CCCcEEEEEEccccChhhHH--------------HHHHH
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-----------------SDGTVIAVKQLSSKSRQGNR--------------EFVNE 722 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-----------------~~g~~vAvK~l~~~~~~~~~--------------~f~~E 722 (799)
.+++|+..++||+|+||.||+|.. ..++.||||++........+ .+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 23568999998654332223 34457
Q ss_pred HHHHHhCCCCcc-----cceeEEEEE--------CCEEEEEEecCCCCcHHHHHhcCccccc---------------ccc
Q 003737 723 IGMISAQQHPNL-----VKLYGCCVE--------GNQLLLVYEYMKNNCLSRAIFGKLRIFH---------------ISI 774 (799)
Q Consensus 723 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~Ey~~~GsL~~~L~~~~~~~~---------------~~~ 774 (799)
+.++.+++|.++ +++++||.. .+..+||||||++|+|.++++....... ...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888877655 678888753 3568999999999999999985421110 000
Q ss_pred cCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 775 YATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 775 ~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
....+...++.++.|+++||+|||+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~ 327 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR 327 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH
Confidence 1123456788889999999999995
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.23 E-value=5.4e-11 Score=126.35 Aligned_cols=108 Identities=21% Similarity=0.305 Sum_probs=87.2
Q ss_pred eecccCCeeEEEEEe-CCCcEEEEEEccccCh---hhHHHHHHHHH---HHHhCCCCcccceeEEEEECCEEEEEEecCC
Q 003737 683 KVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR---QGNREFVNEIG---MISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 683 ~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~f~~E~~---~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
.||+|+||.||++.. .+++.||+|.+..... .....+..|.. .+....|++|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999984 5689999999865421 12223444443 4445679999999999999999999999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.+++.... .+++..++.++.|+++||+|||+
T Consensus 81 g~~L~~~l~~~~---------~l~~~~~~~~~~ql~~~l~~lH~ 115 (278)
T cd05606 81 GGDLHYHLSQHG---------VFSEAEMRFYAAEIILGLEHMHN 115 (278)
T ss_pred CCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999987543 57788999999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=8.3e-12 Score=137.30 Aligned_cols=111 Identities=17% Similarity=0.316 Sum_probs=92.3
Q ss_pred CCCeecccCCeeEEEEEe-CCCcEEEEEEcccc----ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCE--EEEEEe
Q 003737 680 PANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK----SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ--LLLVYE 752 (799)
Q Consensus 680 ~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lV~E 752 (799)
...+||+|+|-+||||.. .+|..||--.++.. .....+.|..|+++|+.++|+|||+++.++.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 356899999999999994 46778875433221 33445789999999999999999999999987654 788999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.|..|+|+.|+++.+ .+..+.++.|++||++||.|||+
T Consensus 124 L~TSGtLr~Y~kk~~---------~vn~kaik~W~RQILkGL~yLHs 161 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR---------RVNIKAIKSWCRQILKGLVYLHS 161 (632)
T ss_pred cccCCcHHHHHHHhc---------cCCHHHHHHHHHHHHHHhhhhhc
Confidence 999999999998766 45667899999999999999995
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.23 E-value=4.3e-11 Score=131.43 Aligned_cols=121 Identities=21% Similarity=0.337 Sum_probs=99.1
Q ss_pred HHHHHHhhcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEEC
Q 003737 668 LRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG 744 (799)
Q Consensus 668 ~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 744 (799)
..++...+++|+..+.||+|+||.||++. ..+|+.||+|++.... ....+.+.+|++++.+++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 34566678899999999999999999998 4578999999997532 22346788999999999999999999988643
Q ss_pred ------CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 ------NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ------~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
...++++|++ +++|.+++..+ .+++..+..++.|+++||+|||+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH~ 138 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIHS 138 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 3467888876 78998887643 46677888899999999999995
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.7e-11 Score=132.80 Aligned_cols=113 Identities=19% Similarity=0.335 Sum_probs=95.8
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC----------
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG---------- 744 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~---------- 744 (799)
.+|...+.||+|+||.||+|.. .+|+.||+|++........+.+.+|++++++++|+||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5688889999999999999984 57899999998766555567899999999999999999999776543
Q ss_pred ----CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 ----NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ----~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
...++|+||++ ++|.+++... .+++..++.++.||++||+|||+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH~ 132 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG----------PLSEEHARLFMYQLLRGLKYIHS 132 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 35789999997 5998887542 46788999999999999999995
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.23 E-value=5.1e-11 Score=128.58 Aligned_cols=116 Identities=22% Similarity=0.450 Sum_probs=95.8
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh--hhHHHHHHHHHHHHhCCCCcccceeEEEEEC--CEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLL 749 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 749 (799)
.++|+..+.||+|+||.||+|.. .+|+.||+|.++.... .....+.+|++++.+++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 45788899999999999999995 4689999999865422 2234567899999999999999999998764 56899
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+++ +|.+++..... .+++..+..++.||++||+|||+
T Consensus 86 v~e~~~~-~l~~~l~~~~~--------~l~~~~~~~~~~qi~~~l~~lH~ 126 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPT--------PFSESQVKCLMLQLLRGLQYLHE 126 (309)
T ss_pred EEecCCC-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999975 89888875321 56788889999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.3e-11 Score=130.36 Aligned_cols=109 Identities=17% Similarity=0.205 Sum_probs=89.5
Q ss_pred eecccCCeeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCcHH
Q 003737 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS 760 (799)
Q Consensus 683 ~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL~ 760 (799)
.+|.|+++.||++.. +++.||||++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 344455555555544 7899999998654 2334578999999999999999999999999999999999999999999
Q ss_pred HHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 761 RAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 761 ~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++++..... .+++..+..++.|+++||+|||+
T Consensus 88 ~~l~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~ 119 (314)
T cd08216 88 DLLKTHFPE-------GLPELAIAFILKDVLNALDYIHS 119 (314)
T ss_pred HHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999864321 57788899999999999999995
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=2e-12 Score=140.44 Aligned_cols=114 Identities=21% Similarity=0.433 Sum_probs=99.4
Q ss_pred CCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCC
Q 003737 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+.++-.||.|+||+|||++-+ ++-..|.|.+........++|.-||++|..+.||+||+|++.|..++..+++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 334556899999999999954 4556678998777777788999999999999999999999999999999999999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|-.+..+-.-++ .+.+++++.+++|++.||.|||+
T Consensus 114 GAVDaimlEL~r--------~LtE~QIqvvc~q~ldALn~LHs 148 (1187)
T KOG0579|consen 114 GAVDAIMLELGR--------VLTEDQIQVVCYQVLDALNWLHS 148 (1187)
T ss_pred chHhHHHHHhcc--------ccchHHHHHHHHHHHHHHHHHhh
Confidence 999988876543 68899999999999999999996
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.6e-11 Score=131.54 Aligned_cols=115 Identities=18% Similarity=0.365 Sum_probs=96.1
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC-----CE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQ 746 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 746 (799)
.++|...+.||+|+||.||++.. .+++.||||.+... .......+.+|++++.+++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35688889999999999999984 57899999998653 223345778899999999999999999988654 34
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++||||+. ++|.+++.... .++++.+..++.|+++||+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~ 126 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---------TLSDDHCQYFLYQLLRGLKYIHS 126 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 799999996 68999887544 57788999999999999999995
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.22 E-value=9.9e-11 Score=126.68 Aligned_cols=113 Identities=22% Similarity=0.416 Sum_probs=94.0
Q ss_pred CCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
|...+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+.+|++++.+++|+|++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 44567799999999999985 468899999986432 22346788999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++ |++.+++..... .+++..+..++.||+.|++|||+
T Consensus 103 ~~-~~l~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~LH~ 139 (313)
T cd06633 103 CL-GSASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHS 139 (313)
T ss_pred CC-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 96 588888765432 46677888889999999999995
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.1e-11 Score=131.84 Aligned_cols=115 Identities=15% Similarity=0.333 Sum_probs=96.3
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEE----CCEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQL 747 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 747 (799)
.++|+..+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|++++.+++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36788889999999999999984 578999999986542 2335678899999999999999999988763 3468
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||+. |+|.+++.... .+++..+..++.||++||+|||+
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~ 125 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---------PLTEEHIRYFLYQLLRGLKYIHS 125 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999996 69999987554 46788899999999999999995
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.8e-11 Score=130.51 Aligned_cols=114 Identities=18% Similarity=0.329 Sum_probs=95.5
Q ss_pred hcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEEC-----CEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQL 747 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 747 (799)
+++|+..+.||+|+||.||+|. ..+|+.||+|++.... ......+.+|++++.+++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 4678889999999999999998 4578999999986432 23346788999999999999999999987654 357
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+||+++ +|.+++..+ .+++..+..++.|+++||+|||+
T Consensus 84 ~lv~e~~~~-~l~~~~~~~----------~l~~~~~~~i~~ql~~aL~~LH~ 124 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ----------HLSNDHIQYFLYQILRGLKYIHS 124 (336)
T ss_pred EEEehhccc-CHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999975 888887643 57788899999999999999995
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.7e-11 Score=124.26 Aligned_cols=107 Identities=22% Similarity=0.301 Sum_probs=93.8
Q ss_pred ecccCCeeEEEEEeC-CCcEEEEEEccccCh---hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCcH
Q 003737 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (799)
Q Consensus 684 lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL 759 (799)
||+|+||.||++... +++.+|+|.+..... ...+.+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999954 589999999876432 2356889999999999999999999999999999999999999999
Q ss_pred HHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 760 SRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 760 ~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+++.... .+++..+..++.|+++|++|||+
T Consensus 81 ~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lh~ 111 (250)
T cd05123 81 FSHLSKEG---------RFSEERARFYAAEIVLALEYLHS 111 (250)
T ss_pred HHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99997654 56778889999999999999995
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.6e-11 Score=127.78 Aligned_cols=114 Identities=25% Similarity=0.419 Sum_probs=95.3
Q ss_pred CCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHHhCC-CCcccceeEEEEECCEEEEEEecC
Q 003737 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
|+..+.||+|++|.||+|... +++.||+|++..... .......+|++.+.+++ |+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456788999999999999964 578999999865422 22345667999999999 999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.+++..... ..+++..+..++.|+++||+|||+
T Consensus 81 -~~~l~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~Lh~ 117 (283)
T cd07830 81 -EGNLYQLMKDRKG-------KPFSESVIRSIIYQILQGLAHIHK 117 (283)
T ss_pred -CCCHHHHHHhccc-------ccCCHHHHHHHHHHHHHHHHHHHH
Confidence 8899999876531 156788889999999999999995
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.7e-11 Score=127.66 Aligned_cols=114 Identities=22% Similarity=0.413 Sum_probs=95.0
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
.|+..+.||+|+||.||+|.. .+++.+|+|.+... .....+++.+|++++++++|+|++++.+++...+..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 366678899999999999995 46889999998643 22334678899999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+. |++.+++..... .+++..+..++.|++.||+|||+
T Consensus 96 ~~~-~~l~~~~~~~~~--------~l~~~~~~~~~~~l~~~l~~LH~ 133 (308)
T cd06634 96 YCL-GSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHS 133 (308)
T ss_pred ccC-CCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 997 688887764332 46777888889999999999995
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=6e-11 Score=132.60 Aligned_cols=110 Identities=12% Similarity=0.119 Sum_probs=93.6
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC---CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
...|...+.||+|+||.||++... .+..||||.+... +.+.+|++++++++|||||++++++...+..++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 346888899999999999999743 4578999998643 23568999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+. ++|.+++.... .+++..+..++.||+.||+|||+
T Consensus 166 e~~~-~~l~~~l~~~~---------~l~~~~~~~i~~ql~~aL~~LH~ 203 (392)
T PHA03207 166 PKYK-CDLFTYVDRSG---------PLPLEQAITIQRRLLEALAYLHG 203 (392)
T ss_pred hhcC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9996 68999885433 57788899999999999999995
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.5e-11 Score=130.49 Aligned_cols=114 Identities=18% Similarity=0.265 Sum_probs=93.5
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC------
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------ 744 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 744 (799)
..++|+..+.||+|+||.||++.. ..++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 456788899999999999999984 46889999999754 223346788999999999999999999988643
Q ss_pred CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
...++||||+++ ++.+.+.. .+++..+..++.|+++||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----------~l~~~~~~~~~~qi~~aL~~LH~ 137 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHS 137 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----------cCCHHHHHHHHHHHHHHHHHHHh
Confidence 357999999975 67666643 35677888899999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.5e-11 Score=126.19 Aligned_cols=117 Identities=17% Similarity=0.237 Sum_probs=92.8
Q ss_pred CCCCCeecccCCeeEEEEEeC-CCcEEEEEEcccc-----ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-----SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
|...+.||+|+||.||++... .+..+++|.++.. ......++.+|+.++.+++||||+++++++.+.+..++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 667789999999999999853 3444555555432 1223346778999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++++|.+++...... ...+++..+..++.|+++|++|||+
T Consensus 82 e~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~ 124 (260)
T cd08222 82 EYCEGRDLDCKLEELKHT-----GKTLSENQVCEWFIQLLLGVHYMHQ 124 (260)
T ss_pred EeCCCCCHHHHHHHHhhc-----ccccCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999998742211 1157788899999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.19 E-value=8.6e-11 Score=130.01 Aligned_cols=114 Identities=17% Similarity=0.253 Sum_probs=93.4
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC------
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------ 744 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 744 (799)
..++|+..+.||+|+||.||++.. ..++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 346788899999999999999984 46889999999653 233456788999999999999999999987643
Q ss_pred CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
...|+||||+++ +|.+.+.. .+++..+..++.|+++||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~ 144 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHS 144 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----------cCCHHHHHHHHHHHHHHHHHHhh
Confidence 357999999975 67777642 35567888899999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.6e-11 Score=138.66 Aligned_cols=129 Identities=22% Similarity=0.400 Sum_probs=103.5
Q ss_pred HHHhhcCCCCCCeecccCCeeEEEEEeC----C----CcEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccceeEE
Q 003737 671 IKAATNNFDPANKVGEGGFGSVYKGILS----D----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGC 740 (799)
Q Consensus 671 ~~~~t~~f~~~~~lG~G~~g~Vy~~~~~----~----g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~ 740 (799)
++...+++...+.+|+|.||.|++|... . ...||||.++... ..+.+.+..|+++|+.+ +|+|||.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 4445555566679999999999999842 1 3579999997653 34567899999999998 69999999999
Q ss_pred EEECCEEEEEEecCCCCcHHHHHhcCccccccccc-------CCCChHHHHHHHHHHHHHHhhhcC
Q 003737 741 CVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIY-------ATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 741 ~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~-------~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|...++.++|+||+++|+|.++|+.++........ ..++..++..++.|||.||+||++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~ 436 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS 436 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh
Confidence 99999999999999999999999977611111111 247888999999999999999974
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.2e-11 Score=130.64 Aligned_cols=117 Identities=23% Similarity=0.332 Sum_probs=102.8
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
+.|..-++||+|+||.||-+.. .+|+-+|.|++.+. ..+....-.+|-.++.+++.+.||.+-..|.+.+..++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 4577889999999999999984 58999999999654 2234456788999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..|.||||.-+|.+.+.. .++|++++.|+.||+.||+|||.
T Consensus 265 tlMNGGDLkfHiyn~g~~-------gF~e~ra~FYAAEi~cGLehlH~ 305 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNP-------GFDEQRARFYAAEIICGLEHLHR 305 (591)
T ss_pred EeecCCceeEEeeccCCC-------CCchHHHHHHHHHHHhhHHHHHh
Confidence 999999999999877643 78999999999999999999994
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.18 E-value=7.5e-11 Score=129.02 Aligned_cols=115 Identities=22% Similarity=0.404 Sum_probs=93.9
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhC-CCCcccceeEEEEEC--CEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG--NQL 747 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~--~~~ 747 (799)
..++|+..+.||+|+||.||+|... +|+.+|+|++... .......+.+|++++.++ +|+||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3456788899999999999999954 6889999998543 223345688899999999 999999999998654 368
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||++ ++|.+++... .+++.....++.||+.||+|||+
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~i~~qi~~~L~~LH~ 125 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----------ILEDVHKRYIMYQLLKALKYIHS 125 (337)
T ss_pred EEEecccc-cCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999998 5999988653 34566777789999999999995
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.6e-11 Score=140.20 Aligned_cols=110 Identities=34% Similarity=0.570 Sum_probs=99.7
Q ss_pred CCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEcc
Q 003737 164 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQ 243 (799)
Q Consensus 164 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 243 (799)
.++.|+|++|.++|.+|..++.+++|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|+.++++++|++|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhhcC-CCCCeEEcCCCCCCC
Q 003737 244 GSSLEGPIPASISAL-TSLTDLRISDLKGSE 273 (799)
Q Consensus 244 ~N~l~~~~p~~~~~l-~~L~~L~L~~n~~~~ 273 (799)
+|+++|.+|..+..+ .++..+++.+|...-
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc 529 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLC 529 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCcccc
Confidence 999999999988764 467788888865443
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=9.4e-11 Score=133.15 Aligned_cols=125 Identities=22% Similarity=0.430 Sum_probs=105.0
Q ss_pred cHHHHHHhhcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhC-CCCcccceeEEEEE-
Q 003737 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE- 743 (799)
Q Consensus 667 ~~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~- 743 (799)
.++.+...++-|...++||+|.+|.||+++ .++++.+|||++..... ..++...|.++++.. .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 344455677888899999999999999999 67899999999976533 346777888888876 69999999999874
Q ss_pred ----CCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 744 ----GNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 744 ----~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++.++||||||.+|+..|++++-.. ..+.|+.+..+.+.++.|++|||.
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g-------~rl~E~~IaYI~re~lrgl~HLH~ 141 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKG-------NRLKEEWIAYILREILRGLAHLHN 141 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcc-------cchhhHHHHHHHHHHHHHHHHHhh
Confidence 5789999999999999999986542 267888999999999999999993
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3e-11 Score=135.23 Aligned_cols=200 Identities=31% Similarity=0.448 Sum_probs=158.8
Q ss_pred EEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCC-CCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCc
Q 003737 120 QLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNIT-TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS 198 (799)
Q Consensus 120 ~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 198 (799)
.|+++.|.+...+......-.++.|++.+|.++ .+|.....++ +|+.|++++|.+. .+|..++.+++|+.|++++|+
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeeccccccccCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence 688888887544433333324999999999998 6777777775 9999999999997 677788999999999999999
Q ss_pred CCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCc
Q 003737 199 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPK 278 (799)
Q Consensus 199 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~ 278 (799)
++ .+|...+.+++|+.|++++|++. .+|........|++|++++|.+. ..+..+.++.++..|.+.+|..... ...
T Consensus 175 l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~-~~~ 250 (394)
T COG4886 175 LS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL-PES 250 (394)
T ss_pred hh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeec-cch
Confidence 98 67776668899999999999998 67777777778999999999643 4677788889999888777544331 122
Q ss_pred cCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhh
Q 003737 279 LDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327 (799)
Q Consensus 279 l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 327 (799)
+.. .++++|++++|.++...+ ++.+.+|+.|++++|.+...+|....
T Consensus 251 ~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 251 IGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred hccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhc
Confidence 333 569999999999984443 88999999999999999977776543
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.17 E-value=7e-11 Score=128.75 Aligned_cols=113 Identities=18% Similarity=0.354 Sum_probs=96.7
Q ss_pred CCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECC-----EEE
Q 003737 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-----QLL 748 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 748 (799)
+|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++|+||+++.+++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 3677889999999999999954 58999999987643 334568999999999999999999999988775 789
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||++ ++|.++++... .+++..+..++.|+++||+|||+
T Consensus 81 lv~e~~~-~~l~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH~ 121 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---------PLTDDHIQYFLYQILRGLKYLHS 121 (330)
T ss_pred EEecchh-hhHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999998 48999987654 56778888899999999999995
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.17 E-value=9.3e-11 Score=125.07 Aligned_cols=115 Identities=19% Similarity=0.449 Sum_probs=92.3
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCC-CCcccceeEEEEECCEEEEEEec
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+|...+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 345567899999999999984 468999999987543 234567899999999996 99999999999999999999999
Q ss_pred CCCCcHHHHH---hcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAI---FGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L---~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++. ++.++. ..... ..+++..+..++.|++.||+|||+
T Consensus 85 ~~~-~l~~l~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~ 125 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLK-------SVIPEEILGKIAVATVKALNYLKE 125 (288)
T ss_pred ccC-CHHHHHHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhh
Confidence 874 554433 22211 157888899999999999999984
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1e-11 Score=144.11 Aligned_cols=123 Identities=20% Similarity=0.231 Sum_probs=107.2
Q ss_pred HHHHHHhhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhCCCCcccceeEEEEE
Q 003737 668 LRQIKAATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743 (799)
Q Consensus 668 ~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 743 (799)
..+++.-.++|...++||+|+||.|...++ .++++||+|++.+. ...+..-|..|-++|..-+.+-||++...|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 445555678899999999999999999985 57899999999774 23345678888999999999999999999999
Q ss_pred CCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 744 GNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 744 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++.|+|||||+||||-.+|-+-. .+||+.+++|+..|+-|++-||+
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---------~~pE~~ArFY~aEiVlAldslH~ 193 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---------RLPEDWARFYTAEIVLALDSLHS 193 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---------CChHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999999999997654 58999999999999999999984
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.17 E-value=6.4e-11 Score=125.62 Aligned_cols=113 Identities=23% Similarity=0.414 Sum_probs=96.8
Q ss_pred CCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 445678999999999999954 68999999997653 233467889999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+ ++|.+++..... .+++..+..++.|+++||+|||+
T Consensus 81 ~-~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~ 116 (282)
T cd07829 81 D-MDLKKYLDKRPG--------PLSPNLIKSIMYQLLRGLAYCHS 116 (282)
T ss_pred C-cCHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 8 599999986531 57788888999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.17 E-value=9.3e-11 Score=134.21 Aligned_cols=118 Identities=21% Similarity=0.315 Sum_probs=93.2
Q ss_pred HHHhhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCC------cccceeEEEEE
Q 003737 671 IKAATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHP------NLVKLYGCCVE 743 (799)
Q Consensus 671 ~~~~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~------niv~l~g~~~~ 743 (799)
+...+++|+..+.||+|+||+||+|.. .+++.||||+++... ...+++..|++++.+++|. +++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 344567899999999999999999985 468899999996432 2234566777777776654 58888888876
Q ss_pred C-CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 744 G-NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 744 ~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
. ...++|||++ +++|.+++.+.+ .+++..+..++.||+.||+|||+
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~---------~l~~~~~~~i~~qi~~aL~yLH~ 249 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHG---------PFSHRHLAQIIFQTGVALDYFHT 249 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 4 5688999988 678999887654 57788899999999999999994
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.1e-11 Score=120.82 Aligned_cols=115 Identities=17% Similarity=0.306 Sum_probs=99.8
Q ss_pred cCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccCh-----h---hHHHHHHHHHHHHhC-CCCcccceeEEEEECC
Q 003737 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR-----Q---GNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN 745 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~-----~---~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 745 (799)
+.|.+.+++|+|..++|-++. .++|+.+|+|++..... . -.+.-.+|+++++++ -||+|+++.++|..+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 457888999999999999988 45788999999864321 1 124567899999998 5999999999999999
Q ss_pred EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++|+|.|+.|.|+|+|.... +++|++.+.+|+|+.+|++|||.
T Consensus 97 F~FlVFdl~prGELFDyLts~V---------tlSEK~tR~iMrqlfegVeylHa 141 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKV---------TLSEKETRRIMRQLFEGVEYLHA 141 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhe---------eecHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999998765 88999999999999999999993
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.7e-10 Score=116.07 Aligned_cols=114 Identities=28% Similarity=0.500 Sum_probs=98.9
Q ss_pred CCCCCeecccCCeeEEEEEeCC-CcEEEEEEccccChh-hHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCC
Q 003737 678 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
|+..+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556789999999999999754 889999999766444 56789999999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|.+++..... .+++..+..++.|++.+++|||+
T Consensus 81 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lh~ 116 (225)
T smart00221 81 GGDLFDYLRKKGG--------KLSEEEARFYLRQILEALEYLHS 116 (225)
T ss_pred CCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999986531 15677888889999999999995
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.9e-10 Score=122.41 Aligned_cols=114 Identities=25% Similarity=0.426 Sum_probs=92.0
Q ss_pred CCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHhC---CCCcccceeEEEEECCE-----
Q 003737 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQ---QHPNLVKLYGCCVEGNQ----- 746 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 746 (799)
|+..+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|++++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456788999999999999965 589999999975322 2234677888777665 59999999999988776
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+++|||+++ +|.+++...... .+++..+..++.|+++||+|||+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~-------~l~~~~~~~~~~~i~~al~~LH~ 125 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKP-------GLPPETIKDLMRQLLRGVDFLHS 125 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999974 899988754321 46788899999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.4e-10 Score=126.03 Aligned_cols=110 Identities=19% Similarity=0.141 Sum_probs=83.5
Q ss_pred HHHhhcCCCCCCeecccCCeeEEEEEeC--CCcEEEEEEcccc-----ChhhHHHHHHHHHHHHhCCCCcccceeEEEEE
Q 003737 671 IKAATNNFDPANKVGEGGFGSVYKGILS--DGTVIAVKQLSSK-----SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743 (799)
Q Consensus 671 ~~~~t~~f~~~~~lG~G~~g~Vy~~~~~--~g~~vAvK~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 743 (799)
+....++|+..+.||+|+||+||+|... +++.||||++... .....+.|.+|++++.+++|+|+++.+..
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 3445577999999999999999999853 5788899987533 12235679999999999999999863322
Q ss_pred CCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 744 GNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 744 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+..++||||+++++|... ... .. ..++.|+++||+|||+
T Consensus 90 ~~~~~LVmE~~~G~~L~~~-~~~--------------~~-~~~~~~i~~aL~~lH~ 129 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHLA-RPH--------------GD-PAWFRSAHRALRDLHR 129 (365)
T ss_pred cCCcEEEEEccCCCCHHHh-Ccc--------------ch-HHHHHHHHHHHHHHHH
Confidence 2467999999999999632 110 01 3468899999999995
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.6e-10 Score=126.80 Aligned_cols=113 Identities=21% Similarity=0.380 Sum_probs=92.3
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEEC------C
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------N 745 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~ 745 (799)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+|++++.+++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36788889999999999999994 578999999986532 22345688999999999999999999998754 3
Q ss_pred EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++|+||+.. +|.++... .++++.+..++.|++.||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~ 135 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMGH-----------PLSEDKVQYLVYQMLCGLKYIHS 135 (342)
T ss_pred eEEEEeccccc-CHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 46999999975 77766421 46677888899999999999995
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.5e-10 Score=122.96 Aligned_cols=113 Identities=26% Similarity=0.470 Sum_probs=96.0
Q ss_pred CCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh--hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
|+..+.||+|++|.||++.. .+++.+|+|++..... .....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 45567899999999999995 4789999999865432 24567889999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++ ++.+++..+.. .+++..+..++.|+++||+|||+
T Consensus 81 ~~-~l~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~ 116 (283)
T cd05118 81 DT-DLYKLIKDRQR--------GLPESLIKSYLYQLLQGLAFCHS 116 (283)
T ss_pred CC-CHHHHHHhhcc--------cCCHHHHHHHHHHHHHHHHHHHH
Confidence 85 88888876431 56777888899999999999995
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.3e-10 Score=122.66 Aligned_cols=115 Identities=21% Similarity=0.473 Sum_probs=93.8
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCC-CCcccceeEEEEECCEEEEEEe
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 752 (799)
++|+..+.||+|+||.||+|... +++.||||.++... .....++.+|++++.+.. |+||++++++|.++...++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 55777899999999999999975 48999999997543 233456778888777775 9999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++ ++.+++..... .+++..+..++.||++||+|||+
T Consensus 95 ~~~~-~l~~l~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~ 132 (296)
T cd06618 95 LMST-CLDKLLKRIQG--------PIPEDILGKMTVAIVKALHYLKE 132 (296)
T ss_pred ccCc-CHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9864 77777654321 56777788889999999999994
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.3e-10 Score=126.12 Aligned_cols=114 Identities=18% Similarity=0.278 Sum_probs=94.0
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC------
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------ 744 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 744 (799)
..++|+..+.||+|+||.||++.. .+|+.||+|++... .....+.+.+|++++.+++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 346788899999999999999984 57899999998643 233446788999999999999999999988643
Q ss_pred CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
...++||||++ |+|.+.+.. .+++..+..++.|++.||+|||.
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----------~l~~~~~~~~~~ql~~aL~~LH~ 136 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----------DLDHERMSYLLYQMLCGIKHLHS 136 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----------cCCHHHHHHHHHHHHHHHHHHHh
Confidence 35799999996 488888753 25677888899999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.8e-10 Score=124.05 Aligned_cols=116 Identities=25% Similarity=0.415 Sum_probs=94.4
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh--hhHHHHHHHHHHHHhCCCCcccceeEEEEECC------
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------ 745 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 745 (799)
.++|+..+.||+|+||.||+|+. .+++.+|+|++..... .....+.+|++++.+++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46788899999999999999995 4688999999865422 22356789999999999999999999875433
Q ss_pred --EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 --QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 --~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++|+||++. ++.+.+..... .+++..+..++.|+++||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~--------~~~~~~~~~i~~~l~~al~~lH~ 133 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSV--------KLTESQIKCYMLQLLEGINYLHE 133 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 46999999975 67777765321 57888999999999999999995
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.7e-10 Score=126.65 Aligned_cols=115 Identities=19% Similarity=0.357 Sum_probs=96.1
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCE----
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ---- 746 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~---- 746 (799)
..++|+....||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 356788889999999999999995 46889999998653 22234668889999999999999999998876654
Q ss_pred --EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 --LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 --~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++|+||+ +++|.+++... .+++..+..++.|+++||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~----------~l~~~~~~~~~~ql~~aL~~LH~ 136 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ----------KLSDDHIQFLVYQILRGLKYIHS 136 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 89999999 56999988752 56788899999999999999995
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.1e-11 Score=136.51 Aligned_cols=118 Identities=21% Similarity=0.407 Sum_probs=105.8
Q ss_pred HhhcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
.+.++|+....+|+|.||.|||++ ...++..|||.++.....+.+...+|+-+++..+|+|||.++|-|...+..++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 355678888999999999999999 5679999999998876666677889999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+.+|+|.+.-|..+ .+.|.++..++++.++|++|||+
T Consensus 92 EycgggslQdiy~~Tg---------plselqiayvcRetl~gl~ylhs 130 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLKYLHS 130 (829)
T ss_pred EecCCCcccceeeecc---------cchhHHHHHHHhhhhccchhhhc
Confidence 9999999999877655 67888999999999999999995
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.08 E-value=6e-10 Score=121.62 Aligned_cols=113 Identities=18% Similarity=0.291 Sum_probs=91.4
Q ss_pred CCCCCCeecccCCeeEEEEEeC-C--CcEEEEEEccccC--hhhHHHHHHHHHHHHhC-CCCcccceeEEEEEC----CE
Q 003737 677 NFDPANKVGEGGFGSVYKGILS-D--GTVIAVKQLSSKS--RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG----NQ 746 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~-~--g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 746 (799)
+|+..+.||+|+||.||++... + ++.||+|++.... ....+.+.+|++++.++ .|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3666788999999999999953 4 7899999986532 22346788999999999 599999999876533 45
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++++||+. ++|.+++.... .+++..++.++.||+.||+|||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~ 123 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---------PLTDAHFQSFIYQILCGLKYIHS 123 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 788999986 69999987543 57788899999999999999995
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.8e-11 Score=142.26 Aligned_cols=118 Identities=21% Similarity=0.401 Sum_probs=101.6
Q ss_pred HhhcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
..+-+++....||.|.||.||.|. ..+|...|||.++-.. .........|..++..++|||+|+.+|+-..++..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 345567778999999999999999 7789999999986442 2234568899999999999999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.||||++|+|.+.+...+ ..+|-..+.|..|++.|++|||+
T Consensus 1312 FMEyC~~GsLa~ll~~gr---------i~dE~vt~vyt~qll~gla~LH~ 1352 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR---------IEDEMVTRVYTKQLLEGLAYLHE 1352 (1509)
T ss_pred HHHHhccCcHHHHHHhcc---------hhhhhHHHHHHHHHHHHHHHHHh
Confidence 999999999999997654 35577888999999999999996
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.8e-10 Score=126.47 Aligned_cols=114 Identities=20% Similarity=0.293 Sum_probs=98.4
Q ss_pred CCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhCC-C-----CcccceeEEEEECCEEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-H-----PNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 749 (799)
.|...++||+|+||.|.||. ..+++.||||+++.... -..+-..|+.+|.+++ | -|+|++++|+.-.+..||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 57889999999999999999 56799999999976432 3345667899999987 4 389999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+.. +|.++|+..... .++-..++.|+.||++||.+||+
T Consensus 266 VfELL~~-NLYellK~n~f~-------Glsl~~ir~~~~Qil~~L~~L~~ 307 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFR-------GLSLPLVRKFAQQILTALLFLHE 307 (586)
T ss_pred eehhhhh-hHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999977 999999977643 67788999999999999999995
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.5e-10 Score=112.63 Aligned_cols=108 Identities=10% Similarity=0.108 Sum_probs=79.3
Q ss_pred CCeecccCCeeEEEEEeCCCcEEEEEEccccChh--h-------HHH-----------------HHHHHHHHHhCCCCcc
Q 003737 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ--G-------NRE-----------------FVNEIGMISAQQHPNL 734 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~--~-------~~~-----------------f~~E~~~l~~l~H~ni 734 (799)
...||+|+||.||+|..++|+.||||+++..... . ... ..+|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999778999999999654211 1 112 2359999999988887
Q ss_pred cceeEEEEECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhh-cC
Q 003737 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFF-FF 799 (799)
Q Consensus 735 v~l~g~~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yL-H~ 799 (799)
.....+.. ...++||||++++++........ .++++.+..++.|++.+|+|+ |+
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~---------~~~~~~~~~i~~qi~~~L~~l~H~ 136 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDA---------PLSESKARELYLQVIQIMRILYQD 136 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcC---------CCCHHHHHHHHHHHHHHHHHHHHh
Confidence 55443322 23389999999987765533222 466778899999999999999 53
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.9e-10 Score=124.79 Aligned_cols=115 Identities=17% Similarity=0.214 Sum_probs=96.3
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChh--------hHHHHHHHHHHHHhCC---CCcccceeEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--------GNREFVNEIGMISAQQ---HPNLVKLYGCCVE 743 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~--------~~~~f~~E~~~l~~l~---H~niv~l~g~~~~ 743 (799)
.+|...+.+|+|+||.|+.|..+ +...|+||.+.+.+.- .....-.|+.+|..++ |+||++++.++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45788899999999999999964 5678999998664211 1123568999999997 9999999999999
Q ss_pred CCEEEEEEecC-CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 744 GNQLLLVYEYM-KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 744 ~~~~~lV~Ey~-~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++.||++|-- ++-+|+++|..+. .+.|...+.+++||+.|++|||+
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp---------~m~E~eAk~IFkQV~agi~hlh~ 688 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP---------RMDEPEAKLIFKQVVAGIKHLHD 688 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC---------ccchHHHHHHHHHHHhccccccc
Confidence 99999999964 4559999998765 67888999999999999999996
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.06 E-value=5.5e-10 Score=115.61 Aligned_cols=99 Identities=20% Similarity=0.176 Sum_probs=83.9
Q ss_pred cCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHhc
Q 003737 687 GGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG 765 (799)
Q Consensus 687 G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL~~~L~~ 765 (799)
|.||.||++.. .+++.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 78999999994 578999999997543 234555556666799999999999999999999999999999999875
Q ss_pred CcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 766 KLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 766 ~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.. .+++..+..++.|+++||+|||+
T Consensus 79 ~~---------~l~~~~~~~~~~ql~~~l~~lH~ 103 (237)
T cd05576 79 FL---------NIPEECVKRWAAEMVVALDALHR 103 (237)
T ss_pred hc---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 43 46788899999999999999995
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=9.6e-11 Score=122.97 Aligned_cols=115 Identities=22% Similarity=0.361 Sum_probs=95.5
Q ss_pred cCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccCh--h-----hHHHHHHHHHHHHhCCCCcccceeEEEE-ECCE
Q 003737 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR--Q-----GNREFVNEIGMISAQQHPNLVKLYGCCV-EGNQ 746 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~--~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~-~~~~ 746 (799)
++|-....||+|+|+.|||++ +...+.||||+-..... . -.+...+|-++.+.+.||.||+++.|+. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 344456889999999999999 55678899998643211 1 1245689999999999999999999986 5678
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++-|+|||++.+|+-+|+..+ .++|++++.++-||+.||.||.+
T Consensus 543 FCTVLEYceGNDLDFYLKQhk---------lmSEKEARSIiMQiVnAL~YLNE 586 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK---------LMSEKEARSIIMQIVNALKYLNE 586 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh---------hhhHHHHHHHHHHHHHHHHHHhc
Confidence 999999999999999998765 67899999999999999999964
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=5.8e-10 Score=128.48 Aligned_cols=121 Identities=11% Similarity=0.147 Sum_probs=87.9
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeC--CCcEEEEEEc--------------cc---cChhhHHHHHHHHHHHHhCCCCcc
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILS--DGTVIAVKQL--------------SS---KSRQGNREFVNEIGMISAQQHPNL 734 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~--~g~~vAvK~l--------------~~---~~~~~~~~f~~E~~~l~~l~H~ni 734 (799)
..++|+..+.||+|+||+||+|..+ ++..+++|.+ .+ ........+.+|++++.+++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3467999999999999999998743 2222222211 00 111234568899999999999999
Q ss_pred cceeEEEEECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 735 v~l~g~~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|++++++...+..|+|+|++. ++|.+++........ .......++.++.||+.||+|||+
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~----~~~~~~~~~~i~~ql~~aL~yLH~ 285 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWK----DRPLLKQTRAIMKQLLCAVEYIHD 285 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhcccccc----ccccHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999999999985 578888765431111 122344677889999999999995
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.6e-09 Score=109.05 Aligned_cols=108 Identities=10% Similarity=0.221 Sum_probs=82.6
Q ss_pred CCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhC-----CCCcccceeEEEEECC---EE-E
Q 003737 678 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-----QHPNLVKLYGCCVEGN---QL-L 748 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-----~H~niv~l~g~~~~~~---~~-~ 748 (799)
+...+.||+|+||.||. ...++.. +||++........+.+.+|++++.++ .||||++++|++.++. .. .
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34568899999999996 3234444 79988765444567899999999999 5799999999998863 43 4
Q ss_pred EEEec--CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHH-hhhcC
Q 003737 749 LVYEY--MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNI-DFFFF 799 (799)
Q Consensus 749 lV~Ey--~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL-~yLH~ 799 (799)
+|+|| +++|+|.+++.+. .+++. . .++.|++.++ +|||+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~----------~~~e~-~-~~~~~~L~~l~~yLh~ 123 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC----------RYEED-V-AQLRQLLKKLKRYLLD 123 (210)
T ss_pred EEecCCCCcchhHHHHHHcc----------cccHh-H-HHHHHHHHHHHHHHHH
Confidence 78999 6689999999653 23443 3 4478888888 99995
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.7e-09 Score=106.80 Aligned_cols=108 Identities=28% Similarity=0.527 Sum_probs=93.7
Q ss_pred ecccCCeeEEEEEeC-CCcEEEEEEccccChh-hHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCcHHH
Q 003737 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSR 761 (799)
Q Consensus 684 lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL~~ 761 (799)
||+|.+|.||++... +++.+++|++...... ..+.+.+|++.+.+++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999965 4899999999765432 35689999999999999999999999999999999999999999999
Q ss_pred HHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 762 AIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 762 ~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++.... ..++.+.+..++.|++++++|||+
T Consensus 81 ~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~ 110 (215)
T cd00180 81 LLKENE--------GKLSEDEILRILLQILEGLEYLHS 110 (215)
T ss_pred HHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 987652 145677888889999999999995
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.3e-10 Score=116.85 Aligned_cols=114 Identities=18% Similarity=0.233 Sum_probs=94.9
Q ss_pred hhcCCCCC-CeecccCCeeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhC-CCCcccceeEEEEE----CCE
Q 003737 674 ATNNFDPA-NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE----GNQ 746 (799)
Q Consensus 674 ~t~~f~~~-~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~----~~~ 746 (799)
.|++|+.. ++||-|-.|+|-.++ .++|+.+|+|.+... ....+|+++.... .|||||+++++|.. .+.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 44555543 589999999999998 457899999998643 3456889887766 59999999998864 457
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++|||+|+||+|+..+..++.. .+.|.++..+++||+.|++|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~-------afTErea~eI~~qI~~Av~~lH~ 179 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQ-------AFTEREASEIMKQIGLAVRYLHS 179 (400)
T ss_pred eEeeeecccchHHHHHHHHcccc-------cchHHHHHHHHHHHHHHHHHHHh
Confidence 88999999999999999987754 68899999999999999999995
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.1e-10 Score=122.38 Aligned_cols=115 Identities=17% Similarity=0.237 Sum_probs=101.8
Q ss_pred cCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccCh---hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
.-|..++.||-|+||.|..+. .++...+|.|.+++.+. .......+|-++|.....+-||+|+..|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 447788999999999999987 55677899999987642 33456788999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||++|||+-.+|.+.+ .|+|+.+++|+.++..|+++.|.
T Consensus 709 dYIPGGDmMSLLIrmg---------IFeE~LARFYIAEltcAiesVHk 747 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG---------IFEEDLARFYIAELTCAIESVHK 747 (1034)
T ss_pred eccCCccHHHHHHHhc---------cCHHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999998876 68899999999999999999984
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.3e-09 Score=113.25 Aligned_cols=130 Identities=17% Similarity=0.223 Sum_probs=102.2
Q ss_pred HHHHHhhcCCCCCCeecccCCeeEEEEEeCC------CcEEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEE
Q 003737 669 RQIKAATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCC 741 (799)
Q Consensus 669 ~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~~~------g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~ 741 (799)
+++....++++....+-+|.||+||+|.+.+ .+.|-||.++.. +......|..|.-.+..+.|||+.++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3444556678888899999999999997643 345667777654 333456799999999999999999999999
Q ss_pred EEC-CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 742 VEG-NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 742 ~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++ +..+++|.|+.-|+|..+|...+ ..+.....+....++..++.|++.||+|||.
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr-~~~~~~aqtvtt~qlV~masQla~am~hlh~ 414 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICR-GDDPSYAQTVTTIQLVLMASQLAMAMEHLHN 414 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhc-cCCCccccchhHHHHHHHHHHHHHHHHHHHh
Confidence 864 56789999999999999998443 2233344567788888999999999999994
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.5e-09 Score=108.91 Aligned_cols=103 Identities=20% Similarity=0.405 Sum_probs=90.4
Q ss_pred CCeeEEEEEeC-CCcEEEEEEccccChhh-HHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHhc
Q 003737 688 GFGSVYKGILS-DGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG 765 (799)
Q Consensus 688 ~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL~~~L~~ 765 (799)
+||.||+|+.. +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999965 58999999997654444 67899999999999999999999999999999999999999999999876
Q ss_pred CcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 766 KLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 766 ~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.. .+++..+..++.|+++|++|||+
T Consensus 81 ~~---------~~~~~~~~~~~~~l~~~l~~lh~ 105 (244)
T smart00220 81 RG---------RLSEDEARFYARQILSALEYLHS 105 (244)
T ss_pred cc---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 43 25677888889999999999995
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.1e-10 Score=117.11 Aligned_cols=223 Identities=23% Similarity=0.250 Sum_probs=133.6
Q ss_pred ccEEEEEeCCCC--------CcccCCccccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCC
Q 003737 92 CHVVTIALKAQN--------LTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNIT 163 (799)
Q Consensus 92 ~~v~~L~L~~~~--------l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~ 163 (799)
++++.|..++.. +...+|-.+.-+++|+.+.+|++.-..+..-.....+|+++.+.+..++. .|. +--.+
T Consensus 182 ~~l~~l~vs~~~~p~~~sni~~~~l~f~l~~f~~l~~~~~s~~~~~~i~~~~~~kptl~t~~v~~s~~~~-~~~-l~pe~ 259 (490)
T KOG1259|consen 182 TQLVALVVTPVKDPIDRSNIIPNRLSFNLNAFRNLKTLKFSALSTENIVDIELLKPTLQTICVHNTTIQD-VPS-LLPET 259 (490)
T ss_pred hheeEEEecCCCCCCccccccccccccchHHhhhhheeeeeccchhheeceeecCchhheeeeecccccc-ccc-ccchh
Confidence 456666665421 22334555667788888888887654332223333347777776655442 111 11111
Q ss_pred CCCEEEeeC-CcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEc
Q 003737 164 TLKNLSIEG-NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHI 242 (799)
Q Consensus 164 ~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 242 (799)
.+..+.-+. .-.+|..-..+...+.|++||||+|.++ .+.++..-+|.++.|++|+|.+.. + +.+..+++|+.|||
T Consensus 260 ~~~D~~~~E~~t~~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDL 336 (490)
T KOG1259|consen 260 ILADPSGSEPSTSNGSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDL 336 (490)
T ss_pred hhcCccCCCCCccCCceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeec
Confidence 221111111 1122333334444567888888888887 667777777888888888888762 2 23677777888888
Q ss_pred cCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCC
Q 003737 243 QGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 322 (799)
Q Consensus 243 ~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 322 (799)
++|.++. +..+-.++. +++.|.|+.|.+... +.++.+-+|..||+++|+|....
T Consensus 337 S~N~Ls~-~~Gwh~KLG-----------------------NIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ld 390 (490)
T KOG1259|consen 337 SGNLLAE-CVGWHLKLG-----------------------NIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELD 390 (490)
T ss_pred ccchhHh-hhhhHhhhc-----------------------CEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHH
Confidence 8777652 111211222 466667777766522 35667788889999999887432
Q ss_pred c-hhhhccCCCCEEeccCCcCCCc
Q 003737 323 P-TTFEKLAKTNFMYLTGNKLTGP 345 (799)
Q Consensus 323 p-~~~~~l~~L~~L~L~~N~l~g~ 345 (799)
. ..++++|-|+.+.|.+|.+.+.
T Consensus 391 eV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 391 EVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred HhcccccccHHHHHhhcCCCcccc
Confidence 2 3578889999999999998853
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.5e-10 Score=110.59 Aligned_cols=110 Identities=21% Similarity=0.435 Sum_probs=92.8
Q ss_pred hcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhCC-CCcccceeEEEEECC--EEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGN--QLLLV 750 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~lV 750 (799)
.++|+..+.+|+|.|+.|+.|. ..+.+.++||.+++- ..+...+|+.++..++ ||||++++....++. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 3567778899999999999998 567788999999764 3467899999999998 999999999988754 46899
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||+.+-+...+-. +++..+++.|+.|+++||+|+|+
T Consensus 114 FE~v~n~Dfk~ly~------------tl~d~dIryY~~elLkALdyCHS 150 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP------------TLTDYDIRYYIYELLKALDYCHS 150 (338)
T ss_pred hhhhccccHHHHhh------------hhchhhHHHHHHHHHHHHhHHHh
Confidence 99999977665432 56677999999999999999996
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=98.94 E-value=4.1e-09 Score=105.21 Aligned_cols=108 Identities=12% Similarity=0.124 Sum_probs=79.8
Q ss_pred CCeecccCCeeEEEEEeCCCcEEEEEEccccChh---------------------h-----HHHHHHHHHHHHhCCCCcc
Q 003737 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ---------------------G-----NREFVNEIGMISAQQHPNL 734 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~---------------------~-----~~~f~~E~~~l~~l~H~ni 734 (799)
...||+|+||.||+|...+|+.||||+++..... . ...+.+|.+.+.+++|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4579999999999999778999999998754210 0 1224688999999999998
Q ss_pred cceeEEEEECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 735 v~l~g~~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.....+.... .++||||++++++........ .++++....++.|++.++.|+|+
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~---------~~~~~~~~~i~~~l~~~l~~lH~ 135 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDV---------PLEEEEAEELYEQVVEQMRRLYQ 135 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhhc---------cCCHHHHHHHHHHHHHHHHHHHH
Confidence 6555544332 489999999886544322222 34566788889999999999994
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.94 E-value=6.8e-10 Score=107.60 Aligned_cols=123 Identities=28% Similarity=0.359 Sum_probs=44.8
Q ss_pred eeEEEccCCcCcCcCCcccC-CCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhc-cCCCCCCEEEc
Q 003737 141 LVELSVMGNRLSGPFPKVLT-NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAEL-TKLTNLNDLRI 218 (799)
Q Consensus 141 L~~L~Ls~N~l~~~~p~~~~-~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L 218 (799)
+++|+|.+|.|+. + +.++ .+.+|+.|+|++|.++. ++ .+..++.|++|++++|+++. +++.+ ..+++|++|++
T Consensus 21 ~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L 95 (175)
T PF14580_consen 21 LRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYL 95 (175)
T ss_dssp -----------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE-
T ss_pred ccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEEC
Confidence 5666666666653 2 2344 46677777777777763 32 46667777777777777773 44334 35677777777
Q ss_pred cCCcCCCcC-CccccCCCCCCEEEccCCCCCCCC---chhhhcCCCCCeEEcCC
Q 003737 219 SDNNFSGKI-PEFIGKWKKIQKLHIQGSSLEGPI---PASISALTSLTDLRISD 268 (799)
Q Consensus 219 s~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~---p~~~~~l~~L~~L~L~~ 268 (799)
++|+|...- -..+..+++|+.|+|.+|.+.... ...+..+++|+.||-..
T Consensus 96 ~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~~ 149 (175)
T PF14580_consen 96 SNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQD 149 (175)
T ss_dssp TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTEE
T ss_pred cCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCCEE
Confidence 777775321 234566778888888888776432 23466788888887653
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.1e-10 Score=120.27 Aligned_cols=232 Identities=16% Similarity=0.235 Sum_probs=135.6
Q ss_pred ccEEEEEeCCCCCcc----cCCccccCCCCCCEEEccCC---cCCCcCcccc-------ccc-ceeEEEccCCcCcCcCC
Q 003737 92 CHVVTIALKAQNLTG----TLPTELSKLRYLKQLDLSRN---CLTGSFSPQW-------ASL-QLVELSVMGNRLSGPFP 156 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g----~~p~~~~~l~~L~~L~Ls~N---~l~~~~p~~~-------~~l-~L~~L~Ls~N~l~~~~p 156 (799)
..+++|+|++|.+.. .+.+.+.+.++|+..++|+- ++...+|..+ ... +|++||||+|-|.-..+
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~ 109 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI 109 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence 568999999998853 24556778889999998863 2233344433 223 48888888888865444
Q ss_pred cc----cCCCCCCCEEEeeCCcCCCCC-------------CccccCCCCCCEEEcccCcCCcc----CChhccCCCCCCE
Q 003737 157 KV----LTNITTLKNLSIEGNLFTGSI-------------PPDIRKLINLQKLILSSNSFTGE----LPAELTKLTNLND 215 (799)
Q Consensus 157 ~~----~~~L~~L~~L~Ls~N~l~~~~-------------p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~ 215 (799)
.. +..+..|+.|+|.+|.+.-.- -.-...-++|+++..+.|++... +...|...+.|+.
T Consensus 110 ~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~lee 189 (382)
T KOG1909|consen 110 RGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEE 189 (382)
T ss_pred HHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccce
Confidence 33 455778888888888764110 11223446777777777777631 2334566677777
Q ss_pred EEccCCcCCCc----CCccccCCCCCCEEEccCCCCCCC----CchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEE
Q 003737 216 LRISDNNFSGK----IPEFIGKWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTL 287 (799)
Q Consensus 216 L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L 287 (799)
+.++.|.|... +-..|..+++|+.|||..|-++-. +...+..+++|+.|++++|+......-.+
T Consensus 190 vr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~-------- 261 (382)
T KOG1909|consen 190 VRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAF-------- 261 (382)
T ss_pred EEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHH--------
Confidence 77777776421 123455667777777777766532 22334445555555555544432211110
Q ss_pred EccCCcCcccCCccc-cCCCCCCeeccccccCCC----CCchhhhccCCCCEEeccCCcC
Q 003737 288 ILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTG----GIPTTFEKLAKTNFMYLTGNKL 342 (799)
Q Consensus 288 ~L~~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l 342 (799)
-+.+ ...++|+.|.|.+|.++. .+-..+...+.|..|+|++|.+
T Consensus 262 -----------~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 262 -----------VDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred -----------HHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 0011 124566666666666653 2223344566677777777777
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=6.8e-10 Score=112.83 Aligned_cols=116 Identities=18% Similarity=0.283 Sum_probs=98.1
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 749 (799)
..+|+...+||+|+|.+|..+++ ++.+.+|+|++++.- ..+..-...|-.+..+. +||.+|.+..++.++...+.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46788899999999999999984 577899999997652 22334455666666665 79999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|.||+++|+|--++.+++ .+||+.++.|..+|+-||.|||+
T Consensus 329 vieyv~ggdlmfhmqrqr---------klpeeharfys~ei~lal~flh~ 369 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEICLALNFLHE 369 (593)
T ss_pred EEEEecCcceeeehhhhh---------cCcHHHhhhhhHHHHHHHHHHhh
Confidence 999999999988777665 68999999999999999999996
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.8e-10 Score=120.18 Aligned_cols=203 Identities=21% Similarity=0.222 Sum_probs=130.8
Q ss_pred eeEEEccCCcCcCcCC--cccCCCCCCCEEEeeCCcCCCCC--CccccCCCCCCEEEcccCcCCccCChh-ccCCCCCCE
Q 003737 141 LVELSVMGNRLSGPFP--KVLTNITTLKNLSIEGNLFTGSI--PPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLND 215 (799)
Q Consensus 141 L~~L~Ls~N~l~~~~p--~~~~~L~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~ 215 (799)
|+...|.+.... ..+ .....+++++.||||+|-++.-. -.....|++|+.|+|+.|++.....+. -..++.|+.
T Consensus 123 L~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~ 201 (505)
T KOG3207|consen 123 LREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQ 201 (505)
T ss_pred hhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhhe
Confidence 666666666554 222 34556778888888888765321 223456788888888888776333222 124567888
Q ss_pred EEccCCcCCCc-CCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCC-CCccCC-CCccEEEccCC
Q 003737 216 LRISDNNFSGK-IPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA-FPKLDK-MNLKTLILTKC 292 (799)
Q Consensus 216 L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~-~~~l~~-~~L~~L~L~~N 292 (799)
|.|+.|.++-. +...+..+++|+.|+|..|..-+........+..|+.|||++|+..... ++.... +.|+.|+++.+
T Consensus 202 L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~t 281 (505)
T KOG3207|consen 202 LVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSST 281 (505)
T ss_pred EEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhcccc
Confidence 88888877621 2233455778888888888533333344455677888888886665432 344444 67888888888
Q ss_pred cCccc-CCcc-----ccCCCCCCeeccccccCCC-CCchhhhccCCCCEEeccCCcCCC
Q 003737 293 LIHGE-IPDY-----IGDMTKLKNIDLSFNNLTG-GIPTTFEKLAKTNFMYLTGNKLTG 344 (799)
Q Consensus 293 ~l~~~-~p~~-----l~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~g 344 (799)
.+... +|+. ...+++|++|+++.|++.. ..-..+..+++|+.|.+..|.|+-
T Consensus 282 gi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 282 GIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred CcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 87643 3333 3567899999999999962 112245667888888888888874
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.6e-10 Score=120.38 Aligned_cols=205 Identities=19% Similarity=0.201 Sum_probs=138.3
Q ss_pred CCCCCCCEEEeeCCcCCCCCC--ccccCCCCCCEEEcccCcCCccCC--hhccCCCCCCEEEccCCcCCCcCCccc-cCC
Q 003737 160 TNITTLKNLSIEGNLFTGSIP--PDIRKLINLQKLILSSNSFTGELP--AELTKLTNLNDLRISDNNFSGKIPEFI-GKW 234 (799)
Q Consensus 160 ~~L~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l 234 (799)
.++++|+...|.+.... ..+ .....+++++.||||.|-|....| .-...+++|+.|+|+.|++.-...... ..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 56788999999888765 233 246678999999999998874332 335678999999999998863322211 246
Q ss_pred CCCCEEEccCCCCCCC-CchhhhcCCCCCeEEcCCCCC-CCCCCCccCCCCccEEEccCCcCcccC-CccccCCCCCCee
Q 003737 235 KKIQKLHIQGSSLEGP-IPASISALTSLTDLRISDLKG-SESAFPKLDKMNLKTLILTKCLIHGEI-PDYIGDMTKLKNI 311 (799)
Q Consensus 235 ~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~n~~-~~~~~~~l~~~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L 311 (799)
+.|+.|.|+.|.++.. +-.....+++|+.|+|..|+. .....+.--...|+.|||++|++-... -...+.++.|+.|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 7889999999988742 233445678999999998742 222222111157899999999876322 1346788999999
Q ss_pred ccccccCCCC-Cchh-----hhccCCCCEEeccCCcCCCcCCh----hhhcCCCEEEeecCcCcc
Q 003737 312 DLSFNNLTGG-IPTT-----FEKLAKTNFMYLTGNKLTGPVPK----YIFNSNKNVDISLNNFTW 366 (799)
Q Consensus 312 ~Ls~N~l~~~-~p~~-----~~~l~~L~~L~L~~N~l~g~~p~----~~~~~l~~l~ls~N~~~g 366 (799)
+++.+.+... .|+. ...+++|++|++..|++. ..+. ....+++.+.+..|.|+-
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR-DWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccc-cccccchhhccchhhhhhcccccccc
Confidence 9999988742 3333 356789999999999986 2332 123355666666666653
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=3e-10 Score=112.50 Aligned_cols=112 Identities=19% Similarity=0.393 Sum_probs=92.4
Q ss_pred CCCCCeecccCCeeEEEEE-eCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC-----CEEEE
Q 003737 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQLLL 749 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~l 749 (799)
.+..+.||-|+||.||... -++|+.||.|++..- .-...+.+.+|+++++.++|.|+...++..... .+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 4567899999999999888 458999999998532 223457899999999999999999988876654 35789
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|.|.. +|++.+-... .++.+.++.|..||++||+|||+
T Consensus 135 ~TELmQS-DLHKIIVSPQ---------~Ls~DHvKVFlYQILRGLKYLHs 174 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQ---------ALTPDHVKVFVYQILRGLKYLHT 174 (449)
T ss_pred HHHHHHh-hhhheeccCC---------CCCcchhhhhHHHHHhhhHHHhh
Confidence 9999975 8888876554 67778999999999999999995
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.5e-10 Score=113.60 Aligned_cols=114 Identities=20% Similarity=0.388 Sum_probs=92.2
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEE--------CC
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--------GN 745 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--------~~ 745 (799)
.|.....||+|.||.||+++. .+|+.||+|+.-.+ ..+-...-.+|++++..++|+|++.++..|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 345567899999999999984 46788998876432 33334567899999999999999999998864 23
Q ss_pred EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+|+|+++++. +|..+|..... .+....++.++.++..||.|+|.
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~v--------r~sls~Ikk~Mk~Lm~GL~~iHr 142 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRKV--------RFSLSEIKKVMKGLMNGLYYIHR 142 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCccc--------cccHHHHHHHHHHHHHHHHHHHH
Confidence 58999999998 99999876532 56677899999999999999994
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.8e-09 Score=104.69 Aligned_cols=124 Identities=25% Similarity=0.289 Sum_probs=39.6
Q ss_pred CCCCCCEEEccCCcCCCcCccccc-ccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccc-cCCCCCC
Q 003737 114 KLRYLKQLDLSRNCLTGSFSPQWA-SLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQ 190 (799)
Q Consensus 114 ~l~~L~~L~Ls~N~l~~~~p~~~~-~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~ 190 (799)
+...+++|+|++|.|+.+. .++ .+. |+.|+|++|.|+.. +.+..+++|++|++++|+++. +.+.+ ..+++|+
T Consensus 17 n~~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--
T ss_pred ccccccccccccccccccc--chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCC
Confidence 3345566666666665432 222 233 66666666666633 236667777777777777763 43333 3577777
Q ss_pred EEEcccCcCCccC-ChhccCCCCCCEEEccCCcCCCcC---CccccCCCCCCEEEc
Q 003737 191 KLILSSNSFTGEL-PAELTKLTNLNDLRISDNNFSGKI---PEFIGKWKKIQKLHI 242 (799)
Q Consensus 191 ~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L~L 242 (799)
+|+|++|++...- -..+..+++|++|+|.+|.++... ...+..+++|+.||-
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 7777777776321 134566777777777777776321 113456777777764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.9e-09 Score=125.08 Aligned_cols=67 Identities=31% Similarity=0.553 Sum_probs=56.1
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGC 740 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~ 740 (799)
...+|++.+.||+||||.|||++- -||+.||||++.... ........+|+.++++++|||||+++..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysA 545 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSA 545 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehh
Confidence 446788889999999999999993 489999999997653 3334678899999999999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.8e-08 Score=102.28 Aligned_cols=104 Identities=14% Similarity=0.108 Sum_probs=84.6
Q ss_pred CeecccCCeeEEEEEeCCCcEEEEEEccccCh--------hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+.||+|++|.||+|.. +|..|++|....... .....+.+|++++.+++|++++....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 677899998654321 1124688999999999999998888888888889999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++++|.+++.... . ....++.+++.+|+++|.
T Consensus 81 ~~G~~L~~~~~~~~------------~-~~~~i~~~i~~~l~~lH~ 113 (211)
T PRK14879 81 IEGEPLKDLINSNG------------M-EELELSREIGRLVGKLHS 113 (211)
T ss_pred eCCcCHHHHHHhcc------------H-HHHHHHHHHHHHHHHHHh
Confidence 99999999986432 1 455669999999999994
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.1e-09 Score=114.21 Aligned_cols=115 Identities=21% Similarity=0.248 Sum_probs=96.9
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 750 (799)
.+|....+||+|+||+|..++.+ +.+.+|||++++.. ..+.+--+.|-++|.-- +-|.+|++..++.+.+..|.|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46888999999999999999854 45789999998762 22334456677777766 678999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+.+|+|--++.+-+ .+.|..+..||.+||-||=|||+
T Consensus 429 MEyvnGGDLMyhiQQ~G---------kFKEp~AvFYAaEiaigLFFLh~ 468 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG---------KFKEPVAVFYAAEIAIGLFFLHS 468 (683)
T ss_pred EEEecCchhhhHHHHhc---------ccCCchhhhhhHHHHHHhhhhhc
Confidence 99999999998887665 57788999999999999999996
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.4e-08 Score=108.88 Aligned_cols=115 Identities=17% Similarity=0.284 Sum_probs=94.0
Q ss_pred cCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhCC-----C---CcccceeEEEEE---
Q 003737 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-----H---PNLVKLYGCCVE--- 743 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-----H---~niv~l~g~~~~--- 743 (799)
.+|...++||=|.|++||.+. ..+.+.||+|+.+.. ..-.+.-+.||++|.+++ | ..||+|+.+|.-
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 567788999999999999999 567789999998653 222356788999999884 3 368999999864
Q ss_pred -CCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 744 -GNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 744 -~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+..++||+||. |-+|-.+|.....+ .+|-..++.+++||+.||+|||.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Yr-------Glpl~~VK~I~~qvL~GLdYLH~ 205 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYR-------GLPLSCVKEICRQVLTGLDYLHR 205 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCC-------CCcHHHHHHHHHHHHHHHHHHHH
Confidence 45799999998 55899999865533 67888999999999999999995
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.9e-08 Score=114.24 Aligned_cols=107 Identities=15% Similarity=0.170 Sum_probs=82.7
Q ss_pred hcCCCCCCeecccCCeeEEEEEeCCCcEEEEEE-cccc-C------hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQ-LSSK-S------RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~-l~~~-~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 746 (799)
...|...+.||+|+||.||+|...+.. +++|+ .... . ....+.+.+|++++.+++|++++....++.+.+.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344567889999999999999875443 33333 2211 1 1123568999999999999999998888888888
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++||||+++++|.+++.. ...++.|++++|+|||+
T Consensus 411 ~~lv~E~~~g~~L~~~l~~-----------------~~~~~~~i~~~L~~lH~ 446 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLEG-----------------NPELVRKVGEIVAKLHK 446 (535)
T ss_pred CEEEEEecCCCcHHHHHHH-----------------HHHHHHHHHHHHHHHHh
Confidence 8999999999999998751 23468999999999995
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.2e-08 Score=110.72 Aligned_cols=114 Identities=21% Similarity=0.300 Sum_probs=96.6
Q ss_pred CCCCCCeecccCCeeEEEEEeCCCcEEEEEEccc--cChhhHHHHHHHHHHHHhCC-CCcccceeEEEEECCEEEEEEec
Q 003737 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~--~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
.|+..+.||+||.++||++...+.+.+|+|++.. .+.+....|.+|++.|.+++ |.+||+|+.|-..++..||||||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~ 441 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC 441 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence 3667889999999999999988888899888743 35556789999999999995 89999999999999999999998
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
-+. ||..+|..+... .+.--++.|-.|++.++.++|.
T Consensus 442 Gd~-DL~kiL~k~~~~--------~~~~~lk~ywkqML~aV~~IH~ 478 (677)
T KOG0596|consen 442 GDI-DLNKILKKKKSI--------DPDWFLKFYWKQMLLAVKTIHQ 478 (677)
T ss_pred ccc-cHHHHHHhccCC--------CchHHHHHHHHHHHHHHHHHHH
Confidence 765 999999877642 2212688899999999999994
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.75 E-value=8.6e-10 Score=110.85 Aligned_cols=124 Identities=23% Similarity=0.298 Sum_probs=76.1
Q ss_pred eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccC
Q 003737 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220 (799)
Q Consensus 141 L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 220 (799)
|++||||+|.|+ .+.++..-+++++.|++|+|.+.. + +.+..|++|+.||||+|.++ .+-.+-.++-+.+.|.|+.
T Consensus 286 LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~ 361 (490)
T KOG1259|consen 286 LTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQ 361 (490)
T ss_pred hhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhh
Confidence 666777777666 556666666777777777777652 2 33666677777777777666 3344444556667777777
Q ss_pred CcCCCcCCccccCCCCCCEEEccCCCCCCCC-chhhhcCCCCCeEEcCCCC
Q 003737 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI-PASISALTSLTDLRISDLK 270 (799)
Q Consensus 221 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~n~ 270 (799)
|.+.. -..++.+-+|..||+++|++.... -..+++++.|+.|.|.+|.
T Consensus 362 N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NP 410 (490)
T KOG1259|consen 362 NKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNP 410 (490)
T ss_pred hhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCC
Confidence 76642 234555666677777777665321 2345666666666666643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.74 E-value=3.1e-08 Score=99.52 Aligned_cols=100 Identities=17% Similarity=0.157 Sum_probs=79.4
Q ss_pred eecccCCeeEEEEEeCCCcEEEEEEccccCh--------hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 683 ~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
.||+|+||.||+|.. +|..|++|....... ...+.+.+|++++.+++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 577899998643211 12356889999999999988777666777777889999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++++|.+++.... . .++.|++++|+++|.
T Consensus 80 ~g~~l~~~~~~~~--------------~--~~~~~i~~~l~~lH~ 108 (199)
T TIGR03724 80 EGKPLKDVIEEGN--------------D--ELLREIGRLVGKLHK 108 (199)
T ss_pred CCccHHHHHhhcH--------------H--HHHHHHHHHHHHHHH
Confidence 9999999875431 1 458999999999994
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.1e-09 Score=122.90 Aligned_cols=175 Identities=26% Similarity=0.283 Sum_probs=80.4
Q ss_pred cCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCC
Q 003737 159 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQ 238 (799)
Q Consensus 159 ~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 238 (799)
+..+++|+.|++.+|+|.. +...+..+++|++|++++|.|+... .+..++.|+.|++++|.++. ...+..+..|+
T Consensus 91 l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~--~~~~~~l~~L~ 165 (414)
T KOG0531|consen 91 LSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISD--ISGLESLKSLK 165 (414)
T ss_pred cccccceeeeeccccchhh-cccchhhhhcchheecccccccccc--chhhccchhhheeccCcchh--ccCCccchhhh
Confidence 4444455555555555442 2222444555555555555554222 13344445555555555542 12233345555
Q ss_pred EEEccCCCCCCCCc-hhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCC--CCCeeccc
Q 003737 239 KLHIQGSSLEGPIP-ASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMT--KLKNIDLS 314 (799)
Q Consensus 239 ~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~--~L~~L~Ls 314 (799)
.+++++|.+...-+ . ...+.+++.+++.+|.+.... .+.. ..+..+++..|.++..-+ +..+. +|+.++++
T Consensus 166 ~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~--~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~ 240 (414)
T KOG0531|consen 166 LLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIE--GLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLS 240 (414)
T ss_pred cccCCcchhhhhhhhh-hhhccchHHHhccCCchhccc--chHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcc
Confidence 55555555543222 1 244444444444443221111 0111 123333555555542221 11222 36777777
Q ss_pred cccCCCCCchhhhccCCCCEEeccCCcCCC
Q 003737 315 FNNLTGGIPTTFEKLAKTNFMYLTGNKLTG 344 (799)
Q Consensus 315 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g 344 (799)
+|.+. .++..+..+..+..|++.+|++..
T Consensus 241 ~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~ 269 (414)
T KOG0531|consen 241 GNRIS-RSPEGLENLKNLPVLDLSSNRISN 269 (414)
T ss_pred cCccc-cccccccccccccccchhhccccc
Confidence 77776 333555666777777777777664
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=98.72 E-value=4e-08 Score=101.36 Aligned_cols=109 Identities=13% Similarity=0.079 Sum_probs=79.3
Q ss_pred CCCCCeecccCCeeEEEEE--eCCCcEEEEEEccccChh------------------------hHHHHHHHHHHHHhCCC
Q 003737 678 FDPANKVGEGGFGSVYKGI--LSDGTVIAVKQLSSKSRQ------------------------GNREFVNEIGMISAQQH 731 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~--~~~g~~vAvK~l~~~~~~------------------------~~~~f~~E~~~l~~l~H 731 (799)
|+..+.||+|+||.||+|. ..+|+.||+|+++..... ....+.+|++.+.++.|
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 5667899999999999998 568999999998643210 01236789999999976
Q ss_pred Cc--ccceeEEEEECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 732 PN--LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 732 ~n--iv~l~g~~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.. +.+++++ ...++||||+++++|........ .+.+..+..++.||+.+++|||.
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~ 166 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---------EPEEEEEFELYDDILEEMRKLYK 166 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccC---------CcchHHHHHHHHHHHHHHHHHHh
Confidence 43 3344432 23489999999988876543222 23344667789999999999994
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.8e-09 Score=111.39 Aligned_cols=244 Identities=20% Similarity=0.251 Sum_probs=136.2
Q ss_pred ccccCCCCCCEEEccCCcCCCc----Ccccccccc-eeEEEccCCcCcC----cCCcc-------cCCCCCCCEEEeeCC
Q 003737 110 TELSKLRYLKQLDLSRNCLTGS----FSPQWASLQ-LVELSVMGNRLSG----PFPKV-------LTNITTLKNLSIEGN 173 (799)
Q Consensus 110 ~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~-L~~L~Ls~N~l~~----~~p~~-------~~~L~~L~~L~Ls~N 173 (799)
+.+..+..++.++||+|.|... +...+...+ |+..++|+- ++| .+|+. +-..++|++||||.|
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDN 102 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDN 102 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeecccc
Confidence 4466677888888988888643 333344444 777777653 222 23332 334557777777777
Q ss_pred cCCCCCCcc----ccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCC
Q 003737 174 LFTGSIPPD----IRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (799)
Q Consensus 174 ~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 249 (799)
-+.-.-++. +..++.|++|.|.+|.+.-.--..++. .|..|. .| .-.+.-++|+++...+|++..
T Consensus 103 A~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~-------kk~~~~~~Lrv~i~~rNrlen 171 (382)
T KOG1909|consen 103 AFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VN-------KKAASKPKLRVFICGRNRLEN 171 (382)
T ss_pred ccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HH-------hccCCCcceEEEEeecccccc
Confidence 765333332 344566777777777665110000000 010000 00 011222345555555555432
Q ss_pred C----CchhhhcCCCCCeEEcCCCCCCCCCCC----ccCC-CCccEEEccCCcCccc----CCccccCCCCCCeeccccc
Q 003737 250 P----IPASISALTSLTDLRISDLKGSESAFP----KLDK-MNLKTLILTKCLIHGE----IPDYIGDMTKLKNIDLSFN 316 (799)
Q Consensus 250 ~----~p~~~~~l~~L~~L~L~~n~~~~~~~~----~l~~-~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N 316 (799)
. +...|...+.|+.+.+..|.+...... .+.. ++|+.|||..|.|+.. +...+..+++|+.|++++|
T Consensus 172 ~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dc 251 (382)
T KOG1909|consen 172 GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDC 251 (382)
T ss_pred ccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccc
Confidence 2 122334445555555555444332221 1223 5677777777777632 3345677899999999999
Q ss_pred cCCCCCchhh-----hccCCCCEEeccCCcCCCcCChhh------hcCCCEEEeecCcCc
Q 003737 317 NLTGGIPTTF-----EKLAKTNFMYLTGNKLTGPVPKYI------FNSNKNVDISLNNFT 365 (799)
Q Consensus 317 ~l~~~~p~~~-----~~l~~L~~L~L~~N~l~g~~p~~~------~~~l~~l~ls~N~~~ 365 (799)
.+...-...| ...|+|++|.|.+|.++..--..+ .+.+..|+|+.|.+.
T Consensus 252 ll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 252 LLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 9986444443 247899999999999984221111 245679999999984
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=1e-07 Score=102.21 Aligned_cols=114 Identities=14% Similarity=0.186 Sum_probs=79.3
Q ss_pred cCCCCCCeecccCCeeEEEEEeCC----CcEEEEEEccccChhh-----------HHHHHHHHHHHHhCCCCcccceeEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQG-----------NREFVNEIGMISAQQHPNLVKLYGC 740 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~----g~~vAvK~l~~~~~~~-----------~~~f~~E~~~l~~l~H~niv~l~g~ 740 (799)
+.|...+.||+|+||.||+|...+ +..+|+|......... ......+...+..+.|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 568888999999999999999643 4566777643222111 0122334445667799999999998
Q ss_pred EEECC----EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 741 CVEGN----QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 741 ~~~~~----~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+.... ..++++|++.. ++.+.+.... ..++..+..++.|+++||+|||+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~ 144 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---------CKNKKLIKNIMKDMLTTLEYIHE 144 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhc---------cCCHHHHHHHHHHHHHHHHHHHh
Confidence 76543 45778887754 6666655332 34566788899999999999995
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=3.4e-09 Score=105.18 Aligned_cols=111 Identities=19% Similarity=0.378 Sum_probs=91.5
Q ss_pred CCeecccCCeeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCc
Q 003737 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 758 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~Gs 758 (799)
..+|.+...|..|+|+++. ..+++|++... .....++|..|.-.++-+.||||..++|.|..+....++..|||.|+
T Consensus 195 ~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 4457778889999999864 45566776443 23334689999988999999999999999999999999999999999
Q ss_pred HHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 759 LSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 759 L~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+..||+...- ..+..+...|+.+||+||+|||+
T Consensus 274 lynvlhe~t~v-------vvd~sqav~faldiargmaflhs 307 (448)
T KOG0195|consen 274 LYNVLHEQTSV-------VVDHSQAVRFALDIARGMAFLHS 307 (448)
T ss_pred HHHHHhcCccE-------EEecchHHHHHHHHHhhHHHHhh
Confidence 99999987632 45566888889999999999995
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.5e-09 Score=122.04 Aligned_cols=220 Identities=25% Similarity=0.332 Sum_probs=156.6
Q ss_pred cCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCE
Q 003737 113 SKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191 (799)
Q Consensus 113 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 191 (799)
..+..++.+++..|.+.. +-..+..+. |++|++.+|+|..+ ...+..+++|++|+|++|.|+... .+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhh
Confidence 456777888888888875 223345555 99999999999844 333778999999999999998543 4677888999
Q ss_pred EEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCC-ccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCC
Q 003737 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIP-EFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK 270 (799)
Q Consensus 192 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~ 270 (799)
|++++|.++. + ..+..+++|+.+++++|++...-+ . ...+.+++.+++.+|.+... ..+..+..+..+++.+|.
T Consensus 145 L~l~~N~i~~-~-~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 145 LNLSGNLISD-I-SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred heeccCcchh-c-cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhccccc
Confidence 9999999983 2 346668999999999999985544 2 57788999999999998732 333344445555666544
Q ss_pred CCCCC-CCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCC
Q 003737 271 GSESA-FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG 344 (799)
Q Consensus 271 ~~~~~-~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g 344 (799)
+.... ++......|+.+++++|.+. ..+..+..+..+..|++.+|++...- .+...+.+..+.+..|.+..
T Consensus 220 i~~~~~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~~ 291 (414)
T KOG0531|consen 220 ISKLEGLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLAL 291 (414)
T ss_pred ceeccCcccchhHHHHHHhcccCccc-cccccccccccccccchhhccccccc--cccccchHHHhccCcchhcc
Confidence 32211 11111113889999999987 33366778899999999999998532 24455667777777777763
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.4e-09 Score=105.21 Aligned_cols=115 Identities=20% Similarity=0.414 Sum_probs=90.2
Q ss_pred CCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEEecCC
Q 003737 679 DPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 679 ~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
+....||.|+||+|+|... +.|+..|||+++... ..+.+++..|.++..+- +.||||+++|.+..++..++-||.|.
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 3456799999999999984 689999999998764 35677899999866554 78999999999999999999999997
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhc
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFF 798 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH 798 (799)
- +++.+-+ .. +.-....++|..+-.++...+.||+||-
T Consensus 147 ~-SlDklYk-~v---y~vq~~~ipE~Ilg~ItvatV~AL~yLK 184 (361)
T KOG1006|consen 147 I-SLDKLYK-RV---YSVQKSRIPENILGHITVATVDALDYLK 184 (361)
T ss_pred h-hHHHHHH-HH---HHHHhccCcHhhhhheeeeehhHHHHHH
Confidence 5 6654332 11 1112237889888888889999999983
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.1e-08 Score=96.18 Aligned_cols=120 Identities=19% Similarity=0.389 Sum_probs=95.6
Q ss_pred hhcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEcccc-ChhhHHHHHHHHHHHHh-CCCCcccceeEEEEECCEEEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK-SRQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV 750 (799)
+.++......||+|+||.|-+.. ..+|+..|||+++.. ..+..++..+|+.+..+ ...|.+|+++|.+.+....++.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 33445556789999999998888 468999999999765 44566788899987665 5789999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||.|.- +|+.+-++- ......+||..+-.+|..|.+||.|||+
T Consensus 124 ME~M~t-Sldkfy~~v-----~~~g~~ipE~vlGkIa~Svv~al~~L~~ 166 (282)
T KOG0984|consen 124 MELMDT-SLDKFYRKV-----LKKGGTIPEDVLGKIAVSVVHALEFLHS 166 (282)
T ss_pred HHHhhh-hHHHHHHHH-----HhcCCcCchHHhhHhHHHHHHHHHHHHH
Confidence 999976 776654321 1112278999999999999999999996
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=4.6e-08 Score=113.77 Aligned_cols=122 Identities=18% Similarity=0.213 Sum_probs=78.5
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeC-C----CcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEE------EE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILS-D----GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC------CV 742 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~-~----g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~------~~ 742 (799)
..++|+..+.||+|+||.||+|... + +..||||++..... .+.+..| .+.+..+.+++.+... +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999964 5 78999999864322 1122222 1222222233222211 24
Q ss_pred ECCEEEEEEecCCCCcHHHHHhcCcccccc-----------cccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 743 EGNQLLLVYEYMKNNCLSRAIFGKLRIFHI-----------SIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 743 ~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~-----------~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+++.++||||+++|+|.++++.+...... .......+..+..++.||++||+|||+
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~ 273 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS 273 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH
Confidence 567899999999999999999754311000 000112234567789999999999995
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.1e-08 Score=104.65 Aligned_cols=118 Identities=18% Similarity=0.245 Sum_probs=96.6
Q ss_pred HhhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCC--C----cccceeEEEEECC
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH--P----NLVKLYGCCVEGN 745 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H--~----niv~l~g~~~~~~ 745 (799)
..++.|.....+|+|.||.|-++.. ..+..||||+++.-. .-.+.-.-|++++.++.+ | -+|++.+|+.-.+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 3477899999999999999999984 457899999996532 223456779999999943 2 3578888898899
Q ss_pred EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++|+|.| +-|+.++|...... .+|-+.++.++.|++++|+|||+
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~-------~fpi~~ir~m~~QL~~sv~fLh~ 210 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYI-------PFPIDHIRHMGYQLLESVAFLHD 210 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCcc-------ccchHHHHHHHHHHHHHHHHHHh
Confidence 999999988 44999999876543 78899999999999999999996
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.8e-08 Score=80.23 Aligned_cols=57 Identities=35% Similarity=0.484 Sum_probs=22.2
Q ss_pred CCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCC
Q 003737 165 LKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221 (799)
Q Consensus 165 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 221 (799)
|++|++++|+++...+..|.++++|++|++++|.++...|..|.++++|++|++++|
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 59 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN 59 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence 334444444443222233334444444444444443333333344444444444433
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=4.3e-08 Score=117.83 Aligned_cols=268 Identities=18% Similarity=0.212 Sum_probs=143.1
Q ss_pred cEEEEEeCCCCCcccCCccccCCCCCCEEEccCCc--CCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEE
Q 003737 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNC--LTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (799)
Q Consensus 93 ~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~--l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 169 (799)
.++.+.+-++.+. .++.... .+.|++|-+..|. +.......|..++ |++|||++|.=-+.+|..+++|-+|++|+
T Consensus 524 ~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~ 601 (889)
T KOG4658|consen 524 SVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD 601 (889)
T ss_pred heeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence 4556666666554 2332222 2357777777775 4444455566666 77777777766667777777777777777
Q ss_pred eeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCc--CCCcCCccccCCCCCCEEEccCCCC
Q 003737 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN--FSGKIPEFIGKWKKIQKLHIQGSSL 247 (799)
Q Consensus 170 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~--l~~~~p~~~~~l~~L~~L~L~~N~l 247 (799)
|++..++ .+|..+.+|.+|.+|++..+.-...+|.....|++|++|.+..-. .+...-..+.++.+|+.+.......
T Consensus 602 L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~ 680 (889)
T KOG4658|consen 602 LSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV 680 (889)
T ss_pred ccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh
Confidence 7777776 677777777777777777776555556666667777777775543 1222223344445555544433222
Q ss_pred CCCCchhhhcCCCCC----eEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccC------CCCCCeeccccc
Q 003737 248 EGPIPASISALTSLT----DLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGD------MTKLKNIDLSFN 316 (799)
Q Consensus 248 ~~~~p~~~~~l~~L~----~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~------l~~L~~L~Ls~N 316 (799)
.+-..+..++.|. .+.+.. ......+..+.. .+|+.|.+.++.+.......... ++++..+...++
T Consensus 681 --~~~e~l~~~~~L~~~~~~l~~~~-~~~~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~ 757 (889)
T KOG4658|consen 681 --LLLEDLLGMTRLRSLLQSLSIEG-CSKRTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNC 757 (889)
T ss_pred --HhHhhhhhhHHHHHHhHhhhhcc-cccceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhcc
Confidence 1111122222222 111111 111111222233 57888888888776333222222 122222222222
Q ss_pred cCCCCCchhhhccCCCCEEeccCCcCCCcCChhh--hcCCCEEEeecCcCccc
Q 003737 317 NLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWE 367 (799)
Q Consensus 317 ~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~--~~~l~~l~ls~N~~~g~ 367 (799)
..- ..+...-..++|+.|++..+.....+.+.. ...++.+-+..+.+.+.
T Consensus 758 ~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l 809 (889)
T KOG4658|consen 758 HML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGL 809 (889)
T ss_pred ccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccc
Confidence 211 122223455788999998877765444332 22334455666666544
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=4.8e-09 Score=112.44 Aligned_cols=115 Identities=15% Similarity=0.249 Sum_probs=99.0
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCC-cEEEEEEcccc---ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDG-TVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g-~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
.++.....||-|+||.|-....... ..+|+|++++. .....+....|-.+|...+.+.||+++-.|.+.++.|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 4566678899999999998886433 34899998765 2334567889999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|-|-+|.|+..|++++ .+.+...++|+..+++|++|||.
T Consensus 500 EaClGGElWTiLrdRg---------~Fdd~tarF~~acv~EAfeYLH~ 538 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG---------SFDDYTARFYVACVLEAFEYLHR 538 (732)
T ss_pred HhhcCchhhhhhhhcC---------CcccchhhhhHHHHHHHHHHHHh
Confidence 9999999999999887 67888999999999999999994
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.4e-08 Score=79.47 Aligned_cols=61 Identities=33% Similarity=0.484 Sum_probs=56.0
Q ss_pred CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcC
Q 003737 282 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 342 (799)
Q Consensus 282 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 342 (799)
++|+.|++++|+++...+..|..+++|++|++++|+++...|..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3688999999999977778999999999999999999988888999999999999999986
|
... |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.6e-07 Score=95.17 Aligned_cols=108 Identities=12% Similarity=0.086 Sum_probs=84.1
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhH---HH------HHHHHHHHHhCCCCcccceeEEEEEC
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN---RE------FVNEIGMISAQQHPNLVKLYGCCVEG 744 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~---~~------f~~E~~~l~~l~H~niv~l~g~~~~~ 744 (799)
..++|...+++|+|+||.||.... ++..+|+|.+++...... +. |.+|++.+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467899999999999999999765 567899999976532222 22 68999999999999999998886643
Q ss_pred --------CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 --------NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 --------~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
...++||||++|.+|.++. .++++ ...|++.+++.+|.
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-------------~~~~~----~~~~i~~~l~~lH~ 153 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP-------------EISED----VKAKIKASIESLHQ 153 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh-------------hccHH----HHHHHHHHHHHHHH
Confidence 3578999999999998873 12232 25588999999984
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=4e-08 Score=118.14 Aligned_cols=248 Identities=24% Similarity=0.256 Sum_probs=165.8
Q ss_pred cEEEEEeCCCC--CcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEE
Q 003737 93 HVVTIALKAQN--LTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (799)
Q Consensus 93 ~v~~L~L~~~~--l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 169 (799)
.+++|-+..+. +.-..+..|..++.|++|||++|.=-+.+|..++.+- |++|+|++..++ .+|..+++|++|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 58888888886 4433334588899999999999888788999999886 999999999998 8999999999999999
Q ss_pred eeCCcCCCCCCccccCCCCCCEEEcccCcC--CccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCC----EEEcc
Q 003737 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSF--TGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQ----KLHIQ 243 (799)
Q Consensus 170 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l--~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~L~ 243 (799)
+..+.-...+|.....|++|++|.+..-.. +...-..+.++.+|+.+....... .+-..+..+..|. .+.+.
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~ 702 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIE 702 (889)
T ss_pred cccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhc
Confidence 999887666777788899999999976542 222333455666666666543332 1111222233322 33333
Q ss_pred CCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-------CCccEEEccCCcCcccCCccccCCCCCCeeccccc
Q 003737 244 GSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-------MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN 316 (799)
Q Consensus 244 ~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-------~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 316 (799)
++... ..+..+..+.+|+.|.+.++...+........ +++..+...++..- ..+.+....++|+.|.+..+
T Consensus 703 ~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~ 780 (889)
T KOG4658|consen 703 GCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSC 780 (889)
T ss_pred ccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEecc
Confidence 33322 34566778888888888886665433321111 01222222222111 22334445689999999988
Q ss_pred cCCCCCchhhhccCCCCEEeccCCcCCCc
Q 003737 317 NLTGGIPTTFEKLAKTNFMYLTGNKLTGP 345 (799)
Q Consensus 317 ~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ 345 (799)
.....+.+....+..++.+-+..+.+.+.
T Consensus 781 ~~~e~~i~~~k~~~~l~~~i~~f~~~~~l 809 (889)
T KOG4658|consen 781 RLLEDIIPKLKALLELKELILPFNKLEGL 809 (889)
T ss_pred cccccCCCHHHHhhhcccEEecccccccc
Confidence 88877777777887787777777777653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=9.9e-08 Score=95.22 Aligned_cols=113 Identities=17% Similarity=0.291 Sum_probs=91.2
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhC-CCCcccceeE-EEEECCEEEEEEe
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYG-CCVEGNQLLLVYE 752 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g-~~~~~~~~~lV~E 752 (799)
+.|...+.+|+|.||.+-.++.+ +.+.+++|-+.... ...++|.+|..---.+ .|.||+.-++ .+.+.+....++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 45778899999999999999954 56788999886542 2457899998655555 5899998765 4667788889999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.|+|.+-+... .+-|...+.++.|+++|++|+|+
T Consensus 103 ~aP~gdL~snv~~~----------GigE~~~K~v~~ql~SAi~fMHs 139 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA----------GIGEANTKKVFAQLLSAIEFMHS 139 (378)
T ss_pred cCccchhhhhcCcc----------cccHHHHHHHHHHHHHHHHHhhc
Confidence 99999999887654 35577889999999999999996
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.5e-07 Score=107.15 Aligned_cols=112 Identities=21% Similarity=0.294 Sum_probs=85.8
Q ss_pred CCCCCeecccCCe-eEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEEecCC
Q 003737 678 FDPANKVGEGGFG-SVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 678 f~~~~~lG~G~~g-~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
|...+++|.|+-| .||+|.. +|+.||||++-.+. ..-..+||..+..- .|||||++++.-.++...|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 5566889998877 5799998 47899999985432 23456899999887 69999999988888999999999997
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
. +|.+++........ ....-.......|+++||+|||+
T Consensus 587 ~-sL~dlie~~~~d~~-----~~~~i~~~~~l~q~~~GlaHLHs 624 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVE-----MQSDIDPISVLSQIASGLAHLHS 624 (903)
T ss_pred h-hHHHHHhccccchh-----hcccccHHHHHHHHHHHHHHHHh
Confidence 6 99999987421111 11102445568999999999995
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.3e-07 Score=98.30 Aligned_cols=113 Identities=23% Similarity=0.396 Sum_probs=96.1
Q ss_pred HhhcCCCCCCeecccCCeeEEEEEeC----CCcEEEEEEccccChhhHHHHHHHHHHHHhCC-CCcccceeEEEEECCEE
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQL 747 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 747 (799)
...+.|...++||+|.|++||+++.. ....||+|.+.... ......+|+++|..+. |.||+++.+++...+..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 34466888999999999999999842 46789999997653 3456889999999985 89999999999999999
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+|+||++.-+-.++... ++-..++.|++.+..||+|+|.
T Consensus 111 ~ivlp~~~H~~f~~l~~~------------l~~~~i~~Yl~~ll~Al~~~h~ 150 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS------------LSLAEIRWYLRNLLKALAHLHK 150 (418)
T ss_pred EEEecccCccCHHHHHhc------------CCHHHHHHHHHHHHHHhhhhhc
Confidence 999999999988888763 3456799999999999999994
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.44 E-value=7.8e-07 Score=89.37 Aligned_cols=103 Identities=18% Similarity=0.135 Sum_probs=76.2
Q ss_pred CCCCCeecccCCeeEEEEEeCCCcEEEEEEccccCh----------------------hhHHHHHHHHHHHHhCCCCc--
Q 003737 678 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR----------------------QGNREFVNEIGMISAQQHPN-- 733 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~----------------------~~~~~f~~E~~~l~~l~H~n-- 733 (799)
|...+.||+|+||.||++..++|+.||||+++.... .....+.+|..++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 666789999999999999988899999998754320 01123678899999998874
Q ss_pred ccceeEEEEECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 734 iv~l~g~~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++.++ ....++||||+++++|.+.... .....++.|+++++.++|.
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------------~~~~~~~~~i~~~l~~lh~ 143 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL---------------EDPEEVLDEILEEIVKAYK 143 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc---------------ccHHHHHHHHHHHHHHHHH
Confidence 444443 2456899999999998765321 1344568899999999984
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=2e-07 Score=103.62 Aligned_cols=111 Identities=24% Similarity=0.334 Sum_probs=89.8
Q ss_pred hcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEEe
Q 003737 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 752 (799)
++.|.....+|.|+|+.|-++. .++++..|||++.+.. .+-.+|+.++... .|+||+++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 4456666779999999999998 5678899999997652 2345677666665 69999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++.+|-+.+.+..... +. ..+..|+.||+.|++|||+
T Consensus 397 ~l~g~ell~ri~~~~~---------~~-~e~~~w~~~lv~Av~~LH~ 433 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE---------FC-SEASQWAAELVSAVDYLHE 433 (612)
T ss_pred hccccHHHHHHHhcch---------hH-HHHHHHHHHHHHHHHHHHh
Confidence 9999999888876542 22 3566689999999999995
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.1e-07 Score=92.98 Aligned_cols=110 Identities=18% Similarity=0.422 Sum_probs=90.4
Q ss_pred CCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCC-CCcccceeEEEEECCEEEEEEecCCC
Q 003737 680 PANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 680 ~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
....+|.|..|.|+++.. .+|..+|||++.+.. ..+.+.....++++.+.+ .|.||+.+|||..+...++.||.|..
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 356799999999999995 578999999997764 445577888888888775 89999999999999999999999965
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhc
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFF 798 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH 798 (799)
.+++++++-.. .+||..+-.+...+++||.||-
T Consensus 176 -C~ekLlkrik~--------piPE~ilGk~tva~v~AL~YLK 208 (391)
T KOG0983|consen 176 -CAEKLLKRIKG--------PIPERILGKMTVAIVKALYYLK 208 (391)
T ss_pred -HHHHHHHHhcC--------CchHHhhhhhHHHHHHHHHHHH
Confidence 56666654322 6889888888899999999994
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.5e-06 Score=82.21 Aligned_cols=100 Identities=12% Similarity=0.091 Sum_probs=80.9
Q ss_pred CCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCC--CcccceeEEEEECCEEEEEEecCCCCc
Q 003737 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH--PNLVKLYGCCVEGNQLLLVYEYMKNNC 758 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~Gs 758 (799)
.+.+|+|.++.||++...+ ..+++|....... ...+.+|++++.+++| ..+++++++....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999999754 7899999865433 5679999999999977 588999988888888999999999887
Q ss_pred HHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 759 LSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 759 L~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+..+ +......++.+++++++++|.
T Consensus 80 ~~~~----------------~~~~~~~~~~~~~~~l~~lh~ 104 (155)
T cd05120 80 LDEV----------------SEEEKEDIAEQLAELLAKLHQ 104 (155)
T ss_pred cccC----------------CHHHHHHHHHHHHHHHHHHhC
Confidence 7644 122444568899999999984
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=98.26 E-value=8.2e-06 Score=87.30 Aligned_cols=114 Identities=25% Similarity=0.460 Sum_probs=94.9
Q ss_pred CCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChh---hHHHHHHHHHHHHhCCCC-cccceeEEEEECCEEEEEEec
Q 003737 678 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ---GNREFVNEIGMISAQQHP-NLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~---~~~~f~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~Ey 753 (799)
|.....+|.|+||.||++... ..+|+|.+...... ....|.+|+.++.++.|+ +++++..++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 455678999999999999976 78899999765332 367899999999999988 799999999777778999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+.++++.+++...... ..+++.....++.|++.+++|+|+
T Consensus 80 ~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~H~ 119 (384)
T COG0515 80 VDGGSLEDLLKKIGRK------GPLSESEALFILAQILSALEYLHS 119 (384)
T ss_pred CCCCcHHHHHHhcccc------cCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999777654311 256777899999999999999995
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.6e-06 Score=83.93 Aligned_cols=114 Identities=21% Similarity=0.349 Sum_probs=92.0
Q ss_pred hcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCC-CcccceeEEEEECCEEEEEEe
Q 003737 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 752 (799)
.+.|...+.||+|+||.+|.|. ..+|..||+|.=..... .-+...|.++...++| ..|..+.-|..+.+.-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4568889999999999999999 67899999998543221 2356778888888876 577777778888888999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.. +.+|+++..-..+ .++...+...|-|++.-++|+|.
T Consensus 92 LL-GPsLEdLfnfC~R--------~ftmkTvLMLaDQml~RiEyvH~ 129 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR--------RFTMKTVLMLADQMLSRIEYVHL 129 (341)
T ss_pred cc-CccHHHHHHHHhh--------hhhHHhHHHHHHHHHHHHHHHHh
Confidence 87 6699998875543 46667888899999999999993
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.16 E-value=6.7e-06 Score=89.30 Aligned_cols=115 Identities=17% Similarity=0.191 Sum_probs=88.5
Q ss_pred CCCCCCeecccCCeeEEEEEeCCC--cEEEEEEccccChhhHHHHHHHHHHHHhCCC----CcccceeEEE-EECCEEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGILSDG--TVIAVKQLSSKSRQGNREFVNEIGMISAQQH----PNLVKLYGCC-VEGNQLLL 749 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~~g--~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 749 (799)
.|.....||+|+||.||.+..... ..+|+|.-..........+..|+.++..+.+ +++.+++... ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 688899999999999999995432 4788888755433322378888888888863 5888888887 47778999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+.. +-+|.++....... .++...+..++.|++.+|+|+|+
T Consensus 99 VM~l~-G~sL~dl~~~~~~~-------~fs~~T~l~ia~q~l~~l~~lH~ 140 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPG-------RFSRKTVLRIAIQNLNALEDLHS 140 (322)
T ss_pred EEecc-CccHHHHHHhCCCC-------CcCHhHHHHHHHHHHHHHHHHHh
Confidence 99976 66999977544311 56677788889999999999995
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.15 E-value=9.6e-08 Score=106.70 Aligned_cols=177 Identities=21% Similarity=0.293 Sum_probs=117.9
Q ss_pred CcccCCCCCCCEEEeeCCcCCCCCCccccCC-CCCCEEEcccCcCC----------ccCChhccCCCCCCEEEccCCcCC
Q 003737 156 PKVLTNITTLKNLSIEGNLFTGSIPPDIRKL-INLQKLILSSNSFT----------GELPAELTKLTNLNDLRISDNNFS 224 (799)
Q Consensus 156 p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~----------~~~p~~~~~l~~L~~L~Ls~N~l~ 224 (799)
|-.+..+.+|+.|.|.++.+.. . ..+..+ ..|++|.-+ |.+. |.+..++. -..|.+.+.+.|.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~-~-~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~-Wn~L~~a~fsyN~L~ 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST-A-KGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPV-WNKLATASFSYNRLV 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh-h-hhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchh-hhhHhhhhcchhhHH
Confidence 5556677888888888887752 1 111111 234444322 2221 11111111 124677788888887
Q ss_pred CcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCC--CCccEEEccCCcCcccCCccc
Q 003737 225 GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK--MNLKTLILTKCLIHGEIPDYI 302 (799)
Q Consensus 225 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~--~~L~~L~L~~N~l~~~~p~~l 302 (799)
.+..++.-++.|+.|+|++|+++.. +.+..++.|+.|||+.|.... +|.+.. ..|..|.|++|.++.. ..+
T Consensus 178 -~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~--vp~l~~~gc~L~~L~lrnN~l~tL--~gi 250 (1096)
T KOG1859|consen 178 -LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRH--VPQLSMVGCKLQLLNLRNNALTTL--RGI 250 (1096)
T ss_pred -hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhcc--ccccchhhhhheeeeecccHHHhh--hhH
Confidence 5666777788888888888888743 367778888888888765433 344333 5699999999998743 246
Q ss_pred cCCCCCCeeccccccCCCCCc-hhhhccCCCCEEeccCCcCC
Q 003737 303 GDMTKLKNIDLSFNNLTGGIP-TTFEKLAKTNFMYLTGNKLT 343 (799)
Q Consensus 303 ~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 343 (799)
.++.+|+.||+++|-|.+.-. .-+..|..|+.|+|.+|.+.
T Consensus 251 e~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 251 ENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred HhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 789999999999999886322 22467788999999999986
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.2e-05 Score=80.01 Aligned_cols=101 Identities=11% Similarity=0.017 Sum_probs=74.7
Q ss_pred CCCCCeecccCCeeEEEEEeCCCcEEEEEEccccCh----hhHHHHHHHHHHHHhCC-CCcccceeEEEEECCEEEEEEe
Q 003737 678 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR----QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~----~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 752 (799)
+.....+++|+||+||.+.. ++..++.+.+..... .....|.+|+++|.++. |+++++++++ +..+++||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34567899999999996665 567777777754322 12235889999999995 4889999886 44699999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++.+|.+.+.. .. ..++.|++++++|+|.
T Consensus 79 yI~G~~L~~~~~~---------------~~-~~~~~qi~~~L~~lH~ 109 (218)
T PRK12274 79 YLAGAAMYQRPPR---------------GD-LAYFRAARRLLQQLHR 109 (218)
T ss_pred eecCccHHhhhhh---------------hh-HHHHHHHHHHHHHHHH
Confidence 9999998654311 11 2357899999999994
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.12 E-value=9.2e-08 Score=106.83 Aligned_cols=102 Identities=25% Similarity=0.320 Sum_probs=48.4
Q ss_pred eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCCh-hccCCCCCCEEEcc
Q 003737 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPA-ELTKLTNLNDLRIS 219 (799)
Q Consensus 141 L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls 219 (799)
|.+.+.++|.+. .+..++.-++.|+.|||++|+++.. +.+..++.|++|||++|++. .+|. ....++ |..|.++
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeeec
Confidence 344444555544 3344444455555555555555421 24455555555555555555 2332 111222 5555555
Q ss_pred CCcCCCcCCccccCCCCCCEEEccCCCCCC
Q 003737 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (799)
Q Consensus 220 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 249 (799)
+|.++.. ..+.++.+|+.|||+.|-+.+
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~ 268 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSE 268 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhc
Confidence 5555421 234455555555555555443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.12 E-value=6.3e-06 Score=81.79 Aligned_cols=104 Identities=15% Similarity=0.193 Sum_probs=68.5
Q ss_pred CCeecccCCeeEEEEEeCCCcEEEEEEccccChh--hHHH----------------------HHHHHHHHHhCCCCc--c
Q 003737 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ--GNRE----------------------FVNEIGMISAQQHPN--L 734 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~--~~~~----------------------f~~E~~~l~~l~H~n--i 734 (799)
.+.||+|+||.||+|...+|+.||||+++..... .... ...|.+.+.++++.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999778999999998653211 1111 135666666665443 4
Q ss_pred cceeEEEEECCEEEEEEecCCCCcHHHH-HhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRA-IFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 735 v~l~g~~~~~~~~~lV~Ey~~~GsL~~~-L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+.+++ ...++||||+++|.+... +... ... ++++.++.|++.+++++|.
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----------~~~-~~~~~~~~~~~~~l~~lh~ 132 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----------RLL-EDPEELYDQILELMRKLYR 132 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----------hhc-ccHHHHHHHHHHHHHHHhh
Confidence 444443 245899999999654321 1111 011 3567779999999999994
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.10 E-value=8.2e-08 Score=96.98 Aligned_cols=132 Identities=24% Similarity=0.275 Sum_probs=68.5
Q ss_pred eeEEEccCCcCcC-cCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCc-CCcc-CChhccCCCCCCEEE
Q 003737 141 LVELSVMGNRLSG-PFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS-FTGE-LPAELTKLTNLNDLR 217 (799)
Q Consensus 141 L~~L~Ls~N~l~~-~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~-~p~~~~~l~~L~~L~ 217 (799)
|++||||+..|+. .+-..+..+.+|+.|.|.++++...+...+.+-.+|+.|+|+.+. ++.. ..--+.+++.|..|+
T Consensus 187 lq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~LN 266 (419)
T KOG2120|consen 187 LQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDELN 266 (419)
T ss_pred hHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhcC
Confidence 6666766666542 222334556667777777777666665666666667777776543 3211 111245666666666
Q ss_pred ccCCcCCCcCC-ccccC-CCCCCEEEccCCC---CCCCCchhhhcCCCCCeEEcCCCCCC
Q 003737 218 ISDNNFSGKIP-EFIGK-WKKIQKLHIQGSS---LEGPIPASISALTSLTDLRISDLKGS 272 (799)
Q Consensus 218 Ls~N~l~~~~p-~~~~~-l~~L~~L~L~~N~---l~~~~p~~~~~l~~L~~L~L~~n~~~ 272 (799)
++.+.+....- ..+.+ -.+|..|+|++.. ....+......+++|.+|||+++...
T Consensus 267 lsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l 326 (419)
T KOG2120|consen 267 LSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVML 326 (419)
T ss_pred chHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeecccccccc
Confidence 66665542211 11111 1355566665542 11122223344566666666665443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.09 E-value=7.8e-06 Score=84.21 Aligned_cols=112 Identities=20% Similarity=0.296 Sum_probs=87.9
Q ss_pred CCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhCC-CCcccceeEEEEECCEEEEEEecC
Q 003737 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
+|...++||+|.||..+.|+ +-+++.||||.=...+ +.-+...|-+..+.+. .+.|...+-+-..+..-.||+|..
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 57788999999999999999 6689999999753322 2234556666666664 588888887777777888999987
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+-+|+|+..-.++ .|+.+.+.++|.|++.-++|+|+
T Consensus 107 -GPSLEDLFD~CgR--------~FSvKTV~miA~Qmi~rie~vH~ 142 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGR--------RFSVKTVAMIAKQMITRIEYVHE 142 (449)
T ss_pred -CcCHHHHHHHhcC--------cccHHhHHHHHHHHHHHHHHHHh
Confidence 5689888875554 56677899999999999999996
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.6e-07 Score=84.57 Aligned_cols=108 Identities=23% Similarity=0.254 Sum_probs=65.8
Q ss_pred EEEEeCCCCCcccCCcc---ccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 95 VTIALKAQNLTGTLPTE---LSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 95 ~~L~L~~~~l~g~~p~~---~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
-.++|+++.+. .+++. +....+|+..+|++|.|...++..-...+ ++.|+|++|.|+ .+|..+..++.|+.|++
T Consensus 30 h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl 107 (177)
T KOG4579|consen 30 HFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNL 107 (177)
T ss_pred hhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhccc
Confidence 34556666554 34433 44445666667777777754443333343 667777777776 56666777777777777
Q ss_pred eCCcCCCCCCccccCCCCCCEEEcccCcCCccCChh
Q 003737 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE 206 (799)
Q Consensus 171 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 206 (799)
+.|.+. ..|..+..|.+|..|+..+|.+. ++|..
T Consensus 108 ~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~d 141 (177)
T KOG4579|consen 108 RFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVD 141 (177)
T ss_pred ccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHH
Confidence 777766 45566666667777776666665 44444
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.5e-05 Score=81.14 Aligned_cols=108 Identities=11% Similarity=0.172 Sum_probs=82.9
Q ss_pred CeecccCCeeEEEEEeCCCcEEEEEEccccCh-hhHHHHHHHHHHHHhCCCC--cccceeEEEEECC---EEEEEEecCC
Q 003737 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHP--NLVKLYGCCVEGN---QLLLVYEYMK 755 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~--niv~l~g~~~~~~---~~~lV~Ey~~ 755 (799)
+.++.|..+.||+++..+|+.+++|....... .....+.+|++++..+++. .+.+++.+....+ ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778899999865422 2345789999999999764 4567777766532 5689999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++++.+.+.. . .+++++...++.+++++|++||+
T Consensus 84 G~~l~~~~~~-~---------~~~~~~~~~i~~~i~~~l~~lH~ 117 (223)
T cd05154 84 GRVLRDRLLR-P---------ELSPEERRALARALADTLAALHS 117 (223)
T ss_pred CEecCCCCCC-C---------CCCHHHHHHHHHHHHHHHHHHhC
Confidence 9888765532 1 34566777779999999999995
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.92 E-value=4.2e-07 Score=81.91 Aligned_cols=104 Identities=25% Similarity=0.339 Sum_probs=68.1
Q ss_pred CCCEEEccCCcCCCcCcccc----cccceeEEEccCCcCcCcCCcccCC-CCCCCEEEeeCCcCCCCCCccccCCCCCCE
Q 003737 117 YLKQLDLSRNCLTGSFSPQW----ASLQLVELSVMGNRLSGPFPKVLTN-ITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191 (799)
Q Consensus 117 ~L~~L~Ls~N~l~~~~p~~~----~~l~L~~L~Ls~N~l~~~~p~~~~~-L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 191 (799)
.+..+||+.+++-- ++... ....|+..+|++|.+. .+|+.|.. .+.++.|+|++|.++ .+|..+..++.|+.
T Consensus 28 E~h~ldLssc~lm~-i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLMY-IADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred HhhhcccccchhhH-HHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 45667777776642 22222 2223777777777776 45555543 446777777777776 56777777777777
Q ss_pred EEcccCcCCccCChhccCCCCCCEEEccCCcCC
Q 003737 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFS 224 (799)
Q Consensus 192 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 224 (799)
|+++.|.+. ..|..+..|.+|.+|+..+|.+.
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 777777776 55666666777777777777665
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.91 E-value=9e-06 Score=97.03 Aligned_cols=114 Identities=19% Similarity=0.274 Sum_probs=86.6
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCC---CCcccceeEEEEECCEEEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ---HPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 750 (799)
--+.|.+...+|+|+||+||+|...+|+.||+|.-++....+ |.-=.+++.+++ -+.|.++..++...+.-+||
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 345677788999999999999998789999999987654321 211123344444 23455555556667888999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||.+.|+|-+++...+ .+++..+..+..|++.-+++||.
T Consensus 773 ~ey~~~Gtlld~~N~~~---------~m~e~lv~~~~~qml~ive~lH~ 812 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTNK---------VMDEYLVMFFSCQMLRIVEHLHA 812 (974)
T ss_pred eeccccccHHHhhccCC---------CCCchhhhHHHHHHHHHHHHHHh
Confidence 99999999999998443 67888888999999999999994
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.91 E-value=6.3e-05 Score=77.80 Aligned_cols=104 Identities=13% Similarity=0.090 Sum_probs=76.0
Q ss_pred CCeec-ccCCeeEEEEEeCCCcEEEEEEccccC-------------hhhHHHHHHHHHHHHhCCCCcc--cceeEEEEEC
Q 003737 681 ANKVG-EGGFGSVYKGILSDGTVIAVKQLSSKS-------------RQGNREFVNEIGMISAQQHPNL--VKLYGCCVEG 744 (799)
Q Consensus 681 ~~~lG-~G~~g~Vy~~~~~~g~~vAvK~l~~~~-------------~~~~~~f~~E~~~l~~l~H~ni--v~l~g~~~~~ 744 (799)
..++| .|+.|+||+.... +..++||++.... ......+.+|++++.+++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 8999999999875 6778999885421 1123568899999999999885 6777775443
Q ss_pred -CE---EEEEEecCCC-CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 -NQ---LLLVYEYMKN-NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 -~~---~~lV~Ey~~~-GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.. .++|+||+++ .+|.+++... .++++ .+.||++++++||+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----------~l~~~----~~~~i~~~l~~lH~ 160 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----------PLSEE----QWQAIGQLIARFHD 160 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----------CCCHH----HHHHHHHHHHHHHH
Confidence 22 3599999997 6999988642 23342 25789999999995
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.82 E-value=1e-05 Score=83.04 Aligned_cols=110 Identities=18% Similarity=0.300 Sum_probs=84.8
Q ss_pred CCCCCCeecccCCeeEEEEE-eCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC------CEE
Q 003737 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------NQL 747 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 747 (799)
+|.....+|.|+= .|..+. .-.++.||+|++... .....+.-.+|..++..+.|+|+++++.++... .+.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 3445566777766 454444 235789999988543 334567888999999999999999999998754 357
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|||||.. +|...++. .++.+.+..+..|++.|++|||+
T Consensus 97 y~v~e~m~~-nl~~vi~~-----------elDH~tis~i~yq~~~~ik~lhs 136 (369)
T KOG0665|consen 97 YLVMELMDA-NLCQVILM-----------ELDHETISYILYQMLCGIKHLHS 136 (369)
T ss_pred HHHHHhhhh-HHHHHHHH-----------hcchHHHHHHHHHHHHHHHHHHh
Confidence 999999975 99988873 34466899999999999999995
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.81 E-value=4.9e-06 Score=84.40 Aligned_cols=115 Identities=24% Similarity=0.331 Sum_probs=66.5
Q ss_pred CccccCCCCCCEEEccCCcCCCc-Cccccccc-c-eeEEEccCCcCcC--cCCcccCCCCCCCEEEeeCCcCCCCCCccc
Q 003737 109 PTELSKLRYLKQLDLSRNCLTGS-FSPQWASL-Q-LVELSVMGNRLSG--PFPKVLTNITTLKNLSIEGNLFTGSIPPDI 183 (799)
Q Consensus 109 p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l-~-L~~L~Ls~N~l~~--~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~ 183 (799)
+-.+..+..++.|.+.++.+... ....|+.. + +++|||.+|.|+. .+-..+.+|+.|++|+|+.|.+...|-..-
T Consensus 38 ~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp 117 (418)
T KOG2982|consen 38 YLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLP 117 (418)
T ss_pred eeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCc
Confidence 33344444555666666555422 11223322 3 7778888887763 233445677888888888887764432221
Q ss_pred cCCCCCCEEEcccCcCCc-cCChhccCCCCCCEEEccCCcC
Q 003737 184 RKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNF 223 (799)
Q Consensus 184 ~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l 223 (799)
..+.+|++|-|.+..+.- .....+..+|.++.|++|.|.+
T Consensus 118 ~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~ 158 (418)
T KOG2982|consen 118 LPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSL 158 (418)
T ss_pred ccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchh
Confidence 355677777777766652 2233455667777777777743
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.76 E-value=7.2e-06 Score=82.17 Aligned_cols=175 Identities=19% Similarity=0.259 Sum_probs=99.7
Q ss_pred ccEEEEEeCCCCCccc----CCccccCCCCCCEEEccCCcCC---CcCccc-------ccccc-eeEEEccCCcCcCcCC
Q 003737 92 CHVVTIALKAQNLTGT----LPTELSKLRYLKQLDLSRNCLT---GSFSPQ-------WASLQ-LVELSVMGNRLSGPFP 156 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~----~p~~~~~l~~L~~L~Ls~N~l~---~~~p~~-------~~~l~-L~~L~Ls~N~l~~~~p 156 (799)
..++.++|++|-+... +...+.+-++|+..+++.-... ..++.. +..++ |+..+||+|.|....|
T Consensus 30 d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~~~~ 109 (388)
T COG5238 30 DELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSEFP 109 (388)
T ss_pred cceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCcccc
Confidence 4578888888887543 3345666678888887764221 222222 22233 7777888887776666
Q ss_pred ccc----CCCCCCCEEEeeCCcCCCCCCc-cc-------------cCCCCCCEEEcccCcCCccCCh-----hccCCCCC
Q 003737 157 KVL----TNITTLKNLSIEGNLFTGSIPP-DI-------------RKLINLQKLILSSNSFTGELPA-----ELTKLTNL 213 (799)
Q Consensus 157 ~~~----~~L~~L~~L~Ls~N~l~~~~p~-~~-------------~~l~~L~~L~Ls~N~l~~~~p~-----~~~~l~~L 213 (799)
+.+ +.-+.|++|.|++|.+- .+.. -+ ..-+.|++.....|++.. .|. .+..-.+|
T Consensus 110 e~L~d~is~~t~l~HL~l~NnGlG-p~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlen-gs~~~~a~~l~sh~~l 187 (388)
T COG5238 110 EELGDLISSSTDLVHLKLNNNGLG-PIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLEN-GSKELSAALLESHENL 187 (388)
T ss_pred hHHHHHHhcCCCceeEEeecCCCC-ccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhcc-CcHHHHHHHHHhhcCc
Confidence 543 45567778888777653 2221 11 234667777777777662 221 12222467
Q ss_pred CEEEccCCcCCCcCCc--------cccCCCCCCEEEccCCCCCCCC----chhhhcCCCCCeEEcCCCCC
Q 003737 214 NDLRISDNNFSGKIPE--------FIGKWKKIQKLHIQGSSLEGPI----PASISALTSLTDLRISDLKG 271 (799)
Q Consensus 214 ~~L~Ls~N~l~~~~p~--------~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~n~~ 271 (799)
+.+.+..|.|. |. .+..+.+|+.|||..|-++-.- ...+..++.|++|.+.+|-.
T Consensus 188 k~vki~qNgIr---pegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDCll 254 (388)
T COG5238 188 KEVKIQQNGIR---PEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLL 254 (388)
T ss_pred eeEEeeecCcC---cchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchhh
Confidence 77777777664 33 2234567777777777665321 22333445566666655433
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=97.75 E-value=9.2e-05 Score=80.69 Aligned_cols=31 Identities=35% Similarity=0.519 Sum_probs=14.0
Q ss_pred CccEEEccCCcCcccCCccccCCCCCCeeccccc
Q 003737 283 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN 316 (799)
Q Consensus 283 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 316 (799)
+|++|++++|... .+|..+. .+|+.|+++.|
T Consensus 157 SLk~L~Is~c~~i-~LP~~LP--~SLk~L~ls~n 187 (426)
T PRK15386 157 SLKTLSLTGCSNI-ILPEKLP--ESLQSITLHIE 187 (426)
T ss_pred cccEEEecCCCcc-cCccccc--ccCcEEEeccc
Confidence 4555555555433 2222222 34555555544
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.69 E-value=9.5e-06 Score=81.32 Aligned_cols=85 Identities=16% Similarity=-0.001 Sum_probs=45.6
Q ss_pred CCccEEEccCCcCccc-----CCccccCCCCCCeeccccccCCCC----CchhhhccCCCCEEeccCCcCCCcCChhh--
Q 003737 282 MNLKTLILTKCLIHGE-----IPDYIGDMTKLKNIDLSFNNLTGG----IPTTFEKLAKTNFMYLTGNKLTGPVPKYI-- 350 (799)
Q Consensus 282 ~~L~~L~L~~N~l~~~-----~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~~p~~~-- 350 (799)
.+|+.+.+.+|.|.-. +-..+..+.+|+.|||..|-|+-. +...+...+.|+.|.+..|-++..-.+.+
T Consensus 185 ~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDClls~~G~~~v~~ 264 (388)
T COG5238 185 ENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLR 264 (388)
T ss_pred cCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchhhccccHHHHHH
Confidence 3566666766665411 001123456777777777777632 22334455667777777777764333222
Q ss_pred ------hcCCCEEEeecCcCcc
Q 003737 351 ------FNSNKNVDISLNNFTW 366 (799)
Q Consensus 351 ------~~~l~~l~ls~N~~~g 366 (799)
++.+..|-..+|...+
T Consensus 265 ~f~e~~~p~l~~L~~~Yne~~~ 286 (388)
T COG5238 265 RFNEKFVPNLMPLPGDYNERRG 286 (388)
T ss_pred HhhhhcCCCccccccchhhhcC
Confidence 2344555555554443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=97.65 E-value=8.9e-05 Score=83.61 Aligned_cols=88 Identities=18% Similarity=0.168 Sum_probs=59.9
Q ss_pred CCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhh----------------------------------------H
Q 003737 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG----------------------------------------N 716 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~----------------------------------------~ 716 (799)
.|+ .+.||+|++|.||+|++.+|+.||||+.++..... .
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 36899999999999999999999999987642110 0
Q ss_pred HHHHHHHHHHHhCC----CCcccceeEEEE-ECCEEEEEEecCCCCcHHHHHhc
Q 003737 717 REFVNEIGMISAQQ----HPNLVKLYGCCV-EGNQLLLVYEYMKNNCLSRAIFG 765 (799)
Q Consensus 717 ~~f~~E~~~l~~l~----H~niv~l~g~~~-~~~~~~lV~Ey~~~GsL~~~L~~ 765 (799)
-+|.+|++.+.+++ |.+-|.+-.+|. .....+|||||+++++|.++...
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~ 251 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAAL 251 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHH
Confidence 13566776666653 332233222332 24457999999999999887653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.61 E-value=4.8e-05 Score=55.75 Aligned_cols=36 Identities=28% Similarity=0.539 Sum_probs=22.0
Q ss_pred CCCeeccccccCCCCCchhhhccCCCCEEeccCCcCC
Q 003737 307 KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343 (799)
Q Consensus 307 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 343 (799)
+|++|++++|+|+ .+|..+.++++|+.|++++|+++
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 5666666666666 45555666666666666666666
|
... |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=97.60 E-value=5.9e-05 Score=86.25 Aligned_cols=111 Identities=14% Similarity=0.167 Sum_probs=71.9
Q ss_pred cCCCCCCeecccCCeeEEEEEeCC-CcEEEEEEccccChhh----------------------------------H----
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQG----------------------------------N---- 716 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~~~~----------------------------------~---- 716 (799)
..|+. +.+|+|++|.||+|++++ |+.||||++++..... .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45766 789999999999999877 9999999997542100 0
Q ss_pred --HHHHHHHHHHHhCC----CCcccceeEEEEE-CCEEEEEEecCCCCcHHHH--HhcCcccccccccCCCChHHHHHHH
Q 003737 717 --REFVNEIGMISAQQ----HPNLVKLYGCCVE-GNQLLLVYEYMKNNCLSRA--IFGKLRIFHISIYATFPQGNIQILI 787 (799)
Q Consensus 717 --~~f~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~Ey~~~GsL~~~--L~~~~~~~~~~~~~~~~~~~i~~~~ 787 (799)
-+|.+|++.+.+++ +...+.+-.++.+ ....+|||||++|+.+.+. +...+.. ...+.+..+..|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d-----~~~la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTD-----MKLLAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCC-----HHHHHHHHHHHHH
Confidence 13556665555543 4444443344433 4567899999999999874 3322210 0124466677888
Q ss_pred HHHHH
Q 003737 788 ISAAN 792 (799)
Q Consensus 788 ~qi~~ 792 (799)
.|+.+
T Consensus 274 ~Qif~ 278 (537)
T PRK04750 274 TQVFR 278 (537)
T ss_pred HHHHh
Confidence 88875
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.59 E-value=1.9e-06 Score=87.28 Aligned_cols=154 Identities=21% Similarity=0.255 Sum_probs=107.2
Q ss_pred CCCCEEEccCCcCCCc-Ccccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCc-CCCC-CCccccCCCCCCE
Q 003737 116 RYLKQLDLSRNCLTGS-FSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL-FTGS-IPPDIRKLINLQK 191 (799)
Q Consensus 116 ~~L~~L~Ls~N~l~~~-~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~-l~~~-~p~~~~~l~~L~~ 191 (799)
+.|++||||...++.. .-..+..++ |+.|.|.++++...+-..++.-..|+.|+|+.+. ++.. ..--+..++.|..
T Consensus 185 sRlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~ 264 (419)
T KOG2120|consen 185 SRLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDE 264 (419)
T ss_pred hhhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhh
Confidence 3599999999888743 222334455 9999999999999888899999999999999864 3311 1123678999999
Q ss_pred EEcccCcCCccCCh-hccCC-CCCCEEEccCCcCC---CcCCccccCCCCCCEEEccCCC-CCCCCchhhhcCCCCCeEE
Q 003737 192 LILSSNSFTGELPA-ELTKL-TNLNDLRISDNNFS---GKIPEFIGKWKKIQKLHIQGSS-LEGPIPASISALTSLTDLR 265 (799)
Q Consensus 192 L~Ls~N~l~~~~p~-~~~~l-~~L~~L~Ls~N~l~---~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~ 265 (799)
|+|+.|.++...-. .+... ++|+.|++++..-. ..+..-...+++|.+|||++|. ++...-..|.+++.|++|.
T Consensus 265 LNlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lS 344 (419)
T KOG2120|consen 265 LNLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLS 344 (419)
T ss_pred cCchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheeee
Confidence 99999988744321 12222 47888999876421 1222234578999999999875 5544455666777777777
Q ss_pred cCCC
Q 003737 266 ISDL 269 (799)
Q Consensus 266 L~~n 269 (799)
++.+
T Consensus 345 lsRC 348 (419)
T KOG2120|consen 345 LSRC 348 (419)
T ss_pred hhhh
Confidence 6653
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.58 E-value=6.6e-05 Score=55.04 Aligned_cols=34 Identities=38% Similarity=0.675 Sum_probs=12.2
Q ss_pred CCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcC
Q 003737 165 LKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSF 199 (799)
Q Consensus 165 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 199 (799)
|++|++++|+|+ .+|+.+.+|++|++|++++|++
T Consensus 3 L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i 36 (44)
T PF12799_consen 3 LEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPI 36 (44)
T ss_dssp -SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCC
T ss_pred ceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCC
Confidence 334444444433 2333333333333333333333
|
... |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.55 E-value=8.5e-05 Score=80.82 Aligned_cols=126 Identities=15% Similarity=0.224 Sum_probs=96.7
Q ss_pred ccccHHHHHHhhcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCC------Ccccc
Q 003737 664 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH------PNLVK 736 (799)
Q Consensus 664 ~~~~~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H------~niv~ 736 (799)
+.|.+.-.+..-..|......|+|-|++|.+|. ...|+.||||+++... ...+.=.+|+++|.++.. -+.++
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 445554445555678888889999999999998 4468899999997542 223445689999999852 37889
Q ss_pred eeEEEEECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhh
Q 003737 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFF 797 (799)
Q Consensus 737 l~g~~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yL 797 (799)
++-.|...+.+|||+|-..- +|.+.|+.-+... .+.-..++.|+.|+.-||.+|
T Consensus 499 l~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nv------GL~ikaVRsYaqQLflALklL 552 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNV------GLHIKAVRSYAQQLFLALKLL 552 (752)
T ss_pred HHHHhhhcceeEEEehhhhc-hHHHHHHHhCccc------ceeehHHHHHHHHHHHHHHHH
Confidence 99888889999999998765 8999998655332 334457899999999999876
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00033 Score=76.85 Aligned_cols=110 Identities=18% Similarity=0.178 Sum_probs=83.0
Q ss_pred eeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEE----CCEEEEEEecCCC-CcHHHHH
Q 003737 690 GSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLLVYEYMKN-NCLSRAI 763 (799)
Q Consensus 690 g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey~~~-GsL~~~L 763 (799)
.+.||+. -.||..|+.|+++....+.......-++.++++.|.|+|++..++.. +....+||+|.|+ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 4678998 45899999999955444444445566889999999999999998873 4568999999985 5787765
Q ss_pred hcCcccc------cccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 764 FGKLRIF------HISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 764 ~~~~~~~------~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
....... ........+|..+..|+.|+..||.++|+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs 411 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS 411 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh
Confidence 5333222 12223467888999999999999999995
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00035 Score=76.22 Aligned_cols=135 Identities=16% Similarity=0.261 Sum_probs=64.5
Q ss_pred ccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCC-cCCCCCCccccCCCCCC
Q 003737 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN-LFTGSIPPDIRKLINLQ 190 (799)
Q Consensus 112 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~ 190 (799)
+..+.++++|++++|.++.. |. + ...|++|+++++.--..+|+.+. ++|++|++++| .+. .+|. +|+
T Consensus 48 ~~~~~~l~~L~Is~c~L~sL-P~-L-P~sLtsL~Lsnc~nLtsLP~~LP--~nLe~L~Ls~Cs~L~-sLP~------sLe 115 (426)
T PRK15386 48 IEEARASGRLYIKDCDIESL-PV-L-PNELTEITIENCNNLTTLPGSIP--EGLEKLTVCHCPEIS-GLPE------SVR 115 (426)
T ss_pred HHHhcCCCEEEeCCCCCccc-CC-C-CCCCcEEEccCCCCcccCCchhh--hhhhheEccCccccc-cccc------ccc
Confidence 33445666666666655543 21 1 01266666665332234554442 46677777766 333 3443 355
Q ss_pred EEEcccCcCC--ccCChhccCCCCCCEEEccCCcCC--CcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEc
Q 003737 191 KLILSSNSFT--GELPAELTKLTNLNDLRISDNNFS--GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRI 266 (799)
Q Consensus 191 ~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 266 (799)
.|+++.|... +.+|. +|+.|.+.+++.. ..+|..+ -++|++|++++|... ..|..+. .+|+.|++
T Consensus 116 ~L~L~~n~~~~L~~LPs------sLk~L~I~~~n~~~~~~lp~~L--PsSLk~L~Is~c~~i-~LP~~LP--~SLk~L~l 184 (426)
T PRK15386 116 SLEIKGSATDSIKNVPN------GLTSLSINSYNPENQARIDNLI--SPSLKTLSLTGCSNI-ILPEKLP--ESLQSITL 184 (426)
T ss_pred eEEeCCCCCcccccCcc------hHhheecccccccccccccccc--CCcccEEEecCCCcc-cCccccc--ccCcEEEe
Confidence 6666555432 12332 3555555432211 0111110 146777777776644 2333222 46777777
Q ss_pred CCC
Q 003737 267 SDL 269 (799)
Q Consensus 267 ~~n 269 (799)
+.+
T Consensus 185 s~n 187 (426)
T PRK15386 185 HIE 187 (426)
T ss_pred ccc
Confidence 653
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00023 Score=51.93 Aligned_cols=34 Identities=41% Similarity=0.915 Sum_probs=25.7
Q ss_pred HHHHHHHHHHHHhcCC------CCCCCC--CCCCCCCCCCcccCCCCCCCCCCeEec
Q 003737 38 AEEVKALKQIGRKLGK------KDWNFG--VDPCSQKGNWELSSDDKKGFESNVTCD 86 (799)
Q Consensus 38 ~~~~~aL~~~~~~~~~------~~W~~~--~d~C~~~~~W~~~~~~~~~~~~gv~c~ 86 (799)
++|++||++||+++.. .+|+.+ .+|| +| .||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C----~W-----------~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC----SW-----------SGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC----CS-----------TTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCe----ee-----------ccEEeC
Confidence 5799999999999963 689876 7999 79 799995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.00039 Score=67.33 Aligned_cols=81 Identities=25% Similarity=0.224 Sum_probs=37.6
Q ss_pred eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccC-ChhccCCCCCCEEEcc
Q 003737 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGEL-PAELTKLTNLNDLRIS 219 (799)
Q Consensus 141 L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls 219 (799)
...+||++|.+... ..|..++.|.+|.|++|+|+..-|.--..+++|+.|.|.+|++...- -.-+..++.|++|.+-
T Consensus 44 ~d~iDLtdNdl~~l--~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl~pLa~~p~L~~Ltll 121 (233)
T KOG1644|consen 44 FDAIDLTDNDLRKL--DNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDLDPLASCPKLEYLTLL 121 (233)
T ss_pred cceecccccchhhc--ccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhcchhccCCccceeeec
Confidence 34455555554311 23445556666666666665433333333455666666665554110 0113344444555444
Q ss_pred CCcC
Q 003737 220 DNNF 223 (799)
Q Consensus 220 ~N~l 223 (799)
+|..
T Consensus 122 ~Npv 125 (233)
T KOG1644|consen 122 GNPV 125 (233)
T ss_pred CCch
Confidence 4443
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.33 E-value=3.5e-05 Score=78.35 Aligned_cols=181 Identities=21% Similarity=0.250 Sum_probs=88.8
Q ss_pred CCCCCEEEeeCCcCCC--CCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCC-cCCccccCCCCCC
Q 003737 162 ITTLKNLSIEGNLFTG--SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG-KIPEFIGKWKKIQ 238 (799)
Q Consensus 162 L~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~ 238 (799)
.+.++.|||.+|.|+. .+-..+.+|+.|++|+|+.|.+...|-..-..+.+|++|-|.+..+.- .....+..++.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 4567777777777652 222234567777777777777664332211344566677666665532 1223345566666
Q ss_pred EEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCc---cCC-CCccEEEccCCcCcccCCccccCCCCCCeeccc
Q 003737 239 KLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPK---LDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLS 314 (799)
Q Consensus 239 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~---l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 314 (799)
+|+++.|++.. +++.++.... .-+. +.. ..+..++++-|++...+ +++..+-+.
T Consensus 150 elHmS~N~~rq--------------~n~Dd~c~e~-~s~~v~tlh~~~c~~~~w~~~~~l~r~F-------pnv~sv~v~ 207 (418)
T KOG2982|consen 150 ELHMSDNSLRQ--------------LNLDDNCIED-WSTEVLTLHQLPCLEQLWLNKNKLSRIF-------PNVNSVFVC 207 (418)
T ss_pred hhhhccchhhh--------------hccccccccc-cchhhhhhhcCCcHHHHHHHHHhHHhhc-------ccchheeee
Confidence 66666664331 1111111100 0000 000 22333334444444332 455566666
Q ss_pred cccCCCC-CchhhhccCCCCEEeccCCcCCCcCC--hh--hhcCCCEEEeecCcCc
Q 003737 315 FNNLTGG-IPTTFEKLAKTNFMYLTGNKLTGPVP--KY--IFNSNKNVDISLNNFT 365 (799)
Q Consensus 315 ~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~g~~p--~~--~~~~l~~l~ls~N~~~ 365 (799)
.|.+... -...+..++.+..|+|+.|++-. .. +. -++.+..|.+++|.+.
T Consensus 208 e~PlK~~s~ek~se~~p~~~~LnL~~~~ids-wasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 208 EGPLKTESSEKGSEPFPSLSCLNLGANNIDS-WASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred cCcccchhhcccCCCCCcchhhhhccccccc-HHHHHHHcCCchhheeeccCCccc
Confidence 6655432 12234556666677777777652 11 11 1345566667776654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.00072 Score=65.65 Aligned_cols=98 Identities=12% Similarity=0.010 Sum_probs=68.5
Q ss_pred CCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCccc-ceeEEEEECCEEEEEEecCCCCcH
Q 003737 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV-KLYGCCVEGNQLLLVYEYMKNNCL 759 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~GsL 759 (799)
.+.++.|.++.||++... +..|++|....... ....+.+|++++..+.+.+++ +++++ .....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcc
Confidence 356889999999999865 77899999865422 223567899999988766554 44443 33345899999999887
Q ss_pred HHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 760 SRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 760 ~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+. . .. ....+.+++++++.||.
T Consensus 79 ~~~----~---------~~----~~~~~~~l~~~l~~LH~ 101 (170)
T cd05151 79 LTE----D---------FS----DPENLEKIAKLLKKLHS 101 (170)
T ss_pred ccc----c---------cc----CHHHHHHHHHHHHHHhC
Confidence 543 0 01 11236789999999984
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.00081 Score=65.18 Aligned_cols=85 Identities=21% Similarity=0.310 Sum_probs=56.0
Q ss_pred CCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcC-CccccCCCCCCEE
Q 003737 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKI-PEFIGKWKKIQKL 240 (799)
Q Consensus 162 L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L 240 (799)
+.+...+||++|.+.. + +.|..++.|.+|.|++|+|+..-|.--.-+++|+.|.|.+|.|...- -+-+..+++|++|
T Consensus 41 ~d~~d~iDLtdNdl~~-l-~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl~pLa~~p~L~~L 118 (233)
T KOG1644|consen 41 LDQFDAIDLTDNDLRK-L-DNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDLDPLASCPKLEYL 118 (233)
T ss_pred ccccceecccccchhh-c-ccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhcchhccCCcccee
Confidence 4466778888887752 2 34667778888888888888555544445567888888888775211 1224556677777
Q ss_pred EccCCCCC
Q 003737 241 HIQGSSLE 248 (799)
Q Consensus 241 ~L~~N~l~ 248 (799)
.+-+|..+
T Consensus 119 tll~Npv~ 126 (233)
T KOG1644|consen 119 TLLGNPVE 126 (233)
T ss_pred eecCCchh
Confidence 77777665
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.00022 Score=83.22 Aligned_cols=111 Identities=19% Similarity=0.264 Sum_probs=79.8
Q ss_pred CCCCeecccCCeeEEEEEe-CCCcEEEEEEcc----cc-Chhh-HHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 679 DPANKVGEGGFGSVYKGIL-SDGTVIAVKQLS----SK-SRQG-NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 679 ~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~----~~-~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
....++|.|++|.|+.... ...+..+.|..+ .. .... ...+..|..+-..++|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3467899999998877763 333444444332 11 1111 123667777888899999988877776666666669
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++ ||+.++.... .+...++..++.|++.|++|+|+
T Consensus 401 E~~~~-Dlf~~~~~~~---------~~~~~e~~c~fKqL~~Gv~y~h~ 438 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG---------KLTPLEADCFFKQLLRGVKYLHS 438 (601)
T ss_pred hcccH-HHHHHHhccc---------ccchhhhhHHHHHHHHHHHHHHh
Confidence 99999 9999998763 34556888899999999999995
|
|
| >KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0002 Score=84.47 Aligned_cols=81 Identities=27% Similarity=0.353 Sum_probs=34.3
Q ss_pred CCCCCEEEcccCcCCc-cCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCC-CCchhhhcCCCCCe
Q 003737 186 LINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTD 263 (799)
Q Consensus 186 l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~ 263 (799)
||+|+.|.+++=.+.. .+-.-..++++|..||+|+.+++.. ..++++++|+.|.+.+=.+.. ..-..+.+|++|+.
T Consensus 147 LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq~L~mrnLe~e~~~~l~~LF~L~~L~v 224 (699)
T KOG3665|consen 147 LPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQVLSMRNLEFESYQDLIDLFNLKKLRV 224 (699)
T ss_pred CcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc--HHHhccccHHHHhccCCCCCchhhHHHHhcccCCCe
Confidence 4555555554433321 1112223445555555555554422 334444555554444433321 11223344455555
Q ss_pred EEcCC
Q 003737 264 LRISD 268 (799)
Q Consensus 264 L~L~~ 268 (799)
||+|.
T Consensus 225 LDIS~ 229 (699)
T KOG3665|consen 225 LDISR 229 (699)
T ss_pred eeccc
Confidence 55443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.00036 Score=78.31 Aligned_cols=108 Identities=19% Similarity=0.294 Sum_probs=88.4
Q ss_pred eecccCCeeEEEEE----eCCCcEEEEEEccccCh--hhHHHHHHHHHHHHhCC-CCcccceeEEEEECCEEEEEEecCC
Q 003737 683 KVGEGGFGSVYKGI----LSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 683 ~lG~G~~g~Vy~~~----~~~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
++|+|+||.|+.+. ...|..+|.|.+++... ........|..++..++ ||.+|++...+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 36899999998654 23577889998866432 12225667778888887 9999999999999999999999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|...+.... .+.+.+.+.|...++-|++++|+
T Consensus 81 gg~lft~l~~~~---------~f~~~~~~~~~aelaLald~lh~ 115 (612)
T KOG0603|consen 81 GGDLFTRLSKEV---------MFDELDVAFYLAELALALDHLHK 115 (612)
T ss_pred cchhhhccccCC---------chHHHHHHHHHHHHHHHHhhcch
Confidence 999999888765 67788999999999999999995
|
|
| >KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0004 Score=82.00 Aligned_cols=126 Identities=22% Similarity=0.284 Sum_probs=68.4
Q ss_pred eeEEEccCCcCc-CcCCcccCC-CCCCCEEEeeCCcCCC-CCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEE
Q 003737 141 LVELSVMGNRLS-GPFPKVLTN-ITTLKNLSIEGNLFTG-SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217 (799)
Q Consensus 141 L~~L~Ls~N~l~-~~~p~~~~~-L~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 217 (799)
|++||+++...- ...|..++. ||.|+.|.+++=.+.. ..-....++++|..||+|+.+++.. ..+++|++|+.|.
T Consensus 124 L~~LdI~G~~~~s~~W~~kig~~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq~L~ 201 (699)
T KOG3665|consen 124 LQHLDISGSELFSNGWPKKIGTMLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQVLS 201 (699)
T ss_pred hhhcCccccchhhccHHHHHhhhCcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc--HHHhccccHHHHh
Confidence 777777665432 222333333 6677777776644431 1112234567777777777776632 4566777777776
Q ss_pred ccCCcCCC-cCCccccCCCCCCEEEccCCCCCCCC--c----hhhhcCCCCCeEEcCC
Q 003737 218 ISDNNFSG-KIPEFIGKWKKIQKLHIQGSSLEGPI--P----ASISALTSLTDLRISD 268 (799)
Q Consensus 218 Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~--p----~~~~~l~~L~~L~L~~ 268 (799)
+.+=.+.. ..-..+.+|++|+.||+|........ . +.-..+++|+.||.+.
T Consensus 202 mrnLe~e~~~~l~~LF~L~~L~vLDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcSg 259 (699)
T KOG3665|consen 202 MRNLEFESYQDLIDLFNLKKLRVLDISRDKNNDDTKIIEQYLECGMVLPELRFLDCSG 259 (699)
T ss_pred ccCCCCCchhhHHHHhcccCCCeeeccccccccchHHHHHHHHhcccCccccEEecCC
Confidence 66555442 11224556777777777765543221 1 1112366777777765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.0035 Score=71.23 Aligned_cols=89 Identities=15% Similarity=0.169 Sum_probs=71.4
Q ss_pred eCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHhcCcccccccccC
Q 003737 697 LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYA 776 (799)
Q Consensus 697 ~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~ 776 (799)
..++.+|.|...+.......+...+.++.|+.+|||||++++.....++..|+|+|-+. -|..++.+.+
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~--------- 102 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG--------- 102 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---------
Confidence 45788899988876554333456677889999999999999999999999999999886 5777877654
Q ss_pred CCChHHHHHHHHHHHHHHhhhcC
Q 003737 777 TFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 777 ~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+..+..-+.||+.||.|||+
T Consensus 103 ---~~~v~~Gl~qIl~AL~FL~~ 122 (690)
T KOG1243|consen 103 ---KEEVCLGLFQILAALSFLND 122 (690)
T ss_pred ---HHHHHHHHHHHHHHHHHHhc
Confidence 33566668999999999983
|
|
| >KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0011 Score=66.91 Aligned_cols=105 Identities=26% Similarity=0.252 Sum_probs=57.0
Q ss_pred CCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccC--cCCccCChhccCCCCCCEEEccCCcCCCcCCccc---cCC
Q 003737 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN--SFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI---GKW 234 (799)
Q Consensus 160 ~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l 234 (799)
..+..|+.|++.+..++.. ..|-.|++|++|.+|.| ++.+.++.....+++|++|+++.|++.- +..+ ..+
T Consensus 40 d~~~~le~ls~~n~gltt~--~~~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~~--lstl~pl~~l 115 (260)
T KOG2739|consen 40 DEFVELELLSVINVGLTTL--TNFPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIKD--LSTLRPLKEL 115 (260)
T ss_pred ccccchhhhhhhccceeec--ccCCCcchhhhhcccCCcccccccceehhhhCCceeEEeecCCcccc--ccccchhhhh
Confidence 3344555555555554421 23445667777777777 5555555545556777777777777652 3332 344
Q ss_pred CCCCEEEccCCCCCCCC---chhhhcCCCCCeEEcCC
Q 003737 235 KKIQKLHIQGSSLEGPI---PASISALTSLTDLRISD 268 (799)
Q Consensus 235 ~~L~~L~L~~N~l~~~~---p~~~~~l~~L~~L~L~~ 268 (799)
.+|..|++.+|.-+..- -..|.-+++|++||-.+
T Consensus 116 ~nL~~Ldl~n~~~~~l~dyre~vf~ll~~L~~LD~~d 152 (260)
T KOG2739|consen 116 ENLKSLDLFNCSVTNLDDYREKVFLLLPSLKYLDGCD 152 (260)
T ss_pred cchhhhhcccCCccccccHHHHHHHHhhhhccccccc
Confidence 55666666666554311 12344456666665443
|
|
| >PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.0067 Score=55.86 Aligned_cols=83 Identities=16% Similarity=0.264 Sum_probs=28.5
Q ss_pred cccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCC
Q 003737 157 KVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 236 (799)
Q Consensus 157 ~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 236 (799)
..|.++++|+.+.+..+ +...-...|.++++|+.+.+.+ .+...-...|..+++|+.+++..+ +.......|.+. +
T Consensus 29 ~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~~~~l~~i~~~~~-~~~i~~~~f~~~-~ 104 (129)
T PF13306_consen 29 NAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSNCTNLKNIDIPSN-ITEIGSSSFSNC-N 104 (129)
T ss_dssp TTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT-TTECEEEETTT--BEEHTTTTTT--T
T ss_pred hhccccccccccccccc-ccccceeeeecccccccccccc-cccccccccccccccccccccCcc-ccEEchhhhcCC-C
Confidence 34444444444444443 3322223344444455555433 222122233444455555555433 322223334443 4
Q ss_pred CCEEEcc
Q 003737 237 IQKLHIQ 243 (799)
Q Consensus 237 L~~L~L~ 243 (799)
|+.+.+.
T Consensus 105 l~~i~~~ 111 (129)
T PF13306_consen 105 LKEINIP 111 (129)
T ss_dssp --EEE-T
T ss_pred ceEEEEC
Confidence 5554444
|
|
| >PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.0067 Score=55.87 Aligned_cols=121 Identities=13% Similarity=0.180 Sum_probs=49.5
Q ss_pred cccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCC
Q 003737 111 ELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINL 189 (799)
Q Consensus 111 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L 189 (799)
.|.+.++|+.+.+.. .+..+....|.... |+.+.+..+ +...-...|.++++|+.+.+.+ .+.......|..+++|
T Consensus 7 ~F~~~~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~~~~l 83 (129)
T PF13306_consen 7 AFYNCSNLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSNCTNL 83 (129)
T ss_dssp TTTT-TT--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT-TTE
T ss_pred HHhCCCCCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeecccccccccccc-cccccccccccccccc
Confidence 345555555555553 34444445555553 666665553 4444445566666677777654 3332233455666777
Q ss_pred CEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCC
Q 003737 190 QKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237 (799)
Q Consensus 190 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 237 (799)
+.+++..+ +...-...|.+. +|+.+.+.. .+.......|.++++|
T Consensus 84 ~~i~~~~~-~~~i~~~~f~~~-~l~~i~~~~-~~~~i~~~~F~~~~~l 128 (129)
T PF13306_consen 84 KNIDIPSN-ITEIGSSSFSNC-NLKEINIPS-NITKIEENAFKNCTKL 128 (129)
T ss_dssp CEEEETTT--BEEHTTTTTT--T--EEE-TT-B-SS----GGG-----
T ss_pred cccccCcc-ccEEchhhhcCC-CceEEEECC-CccEECCccccccccC
Confidence 77777554 443334455565 677776654 3333344455555444
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.0048 Score=69.22 Aligned_cols=66 Identities=18% Similarity=0.324 Sum_probs=54.3
Q ss_pred HHhCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 726 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 726 l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.|.+..... .++.-=...+.++|+.||+|+|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~--------~~d~~F~~s~~rdi~~Gl~ylh~ 66 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI--------KLDYFFILSFIRDISKGLAYLHN 66 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc--------CccHHHHHHHHHHHHHHHHHHhc
Confidence 3568899999999999999999999999999999999987432 23333334458899999999995
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.0007 Score=80.25 Aligned_cols=112 Identities=14% Similarity=0.157 Sum_probs=86.8
Q ss_pred CCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccC-hhhHHHHHHHHHH--HHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS-RQGNREFVNEIGM--ISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~f~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
++...+.+|++.|=+|.||+.+.|. |+||++-+.. .-..+.|.++++- ....+|||.+++.-+-..++..|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4666788999999999999988887 8899985543 3344555555443 4456899999988777777888999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+.+ +|+|.|--+. .+..-+-+.+|.|++.|+.-+|+
T Consensus 103 vkh-nLyDRlSTRP---------FL~~iEKkWiaFQLL~al~qcH~ 138 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP---------FLVLIEKKWIAFQLLKALSQCHK 138 (1431)
T ss_pred Hhh-hhhhhhccch---------HHHHHHHHHHHHHHHHHHHHHHH
Confidence 987 9999987654 34444677889999999999984
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.0027 Score=65.98 Aligned_cols=70 Identities=14% Similarity=0.204 Sum_probs=56.4
Q ss_pred HHHhCCCCcccceeEEEEECC-----EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 725 MISAQQHPNLVKLYGCCVEGN-----QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 725 ~l~~l~H~niv~l~g~~~~~~-----~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
-+-.+-|.|||++..|+.+.. +..++.|||..|++..+|++..+. .. .+.+...+.|+.||..||.|||+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~-~~----a~~~~~wkkw~tqIlsal~yLhs 194 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN-QK----ALFQKAWKKWCTQILSALSYLHS 194 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh-hh----hhhHHHHHHHHHHHHhhhhhhhc
Confidence 344567999999999987543 468899999999999999865432 22 56777899999999999999995
|
|
| >KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.0035 Score=63.43 Aligned_cols=68 Identities=22% Similarity=0.364 Sum_probs=49.8
Q ss_pred CCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCC--cCCCcCCccccCCCCCCEEEccCCCCC
Q 003737 179 IPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN--NFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (799)
Q Consensus 179 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~~l~~L~~L~L~~N~l~ 248 (799)
+..-.-.+..|+.|.+.+..++. -..|-.|++|+.|.+|.| ++++.++.....+++|++|+|++|++.
T Consensus 35 ~~gl~d~~~~le~ls~~n~gltt--~~~~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~ 104 (260)
T KOG2739|consen 35 LGGLTDEFVELELLSVINVGLTT--LTNFPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIK 104 (260)
T ss_pred cccccccccchhhhhhhccceee--cccCCCcchhhhhcccCCcccccccceehhhhCCceeEEeecCCccc
Confidence 44445556778888888877762 134667889999999999 566666655666788999999999886
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.043 Score=54.59 Aligned_cols=103 Identities=9% Similarity=0.064 Sum_probs=68.0
Q ss_pred CeecccCCeeEEEEEeCC-------CcEEEEEEccccC------------h---------hh-HHHH----HHHHHHHHh
Q 003737 682 NKVGEGGFGSVYKGILSD-------GTVIAVKQLSSKS------------R---------QG-NREF----VNEIGMISA 728 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~~~-------g~~vAvK~l~~~~------------~---------~~-~~~f----~~E~~~l~~ 728 (799)
..||.|.-+.||.|.-.+ +..+|||..+... . .. .+.+ .+|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 4789999874320 0 01 1223 389999999
Q ss_pred CCC--CcccceeEEEEECCEEEEEEecCCCCcHHH-HHhcCcccccccccCCCChHHHHHHHHHHHHHHhhh-c
Q 003737 729 QQH--PNLVKLYGCCVEGNQLLLVYEYMKNNCLSR-AIFGKLRIFHISIYATFPQGNIQILIISAANNIDFF-F 798 (799)
Q Consensus 729 l~H--~niv~l~g~~~~~~~~~lV~Ey~~~GsL~~-~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yL-H 798 (799)
++. -++.+++++ ..-++||||+.++.+.. .++.. .++++++..+..|++.+|.++ |
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----------~~~~~~~~~i~~~i~~~l~~l~H 142 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----------KLNDEEMKNAYYQVLSMMKQLYK 142 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----------ccCHHHHHHHHHHHHHHHHHHHH
Confidence 864 455666654 56689999998754422 22211 344446666688999999888 6
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.011 Score=57.70 Aligned_cols=107 Identities=43% Similarity=0.711 Sum_probs=66.2
Q ss_pred HHHHhhhccCCcceeeeeeeecCCceEEEeccccceecCCCccccCCceEEEEEeCCeeeecccccchhcCCCCccEEee
Q 003737 485 LELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKN 564 (799)
Q Consensus 485 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~ 564 (799)
..+++..+..+.++.+...|..+|.|.++|+|.|..+.........+.|+||+.+++..++.+||+-...|+...+....
T Consensus 56 ~~Lyqt~R~g~~~f~Y~ip~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~ 135 (174)
T PF11721_consen 56 DPLYQTERYGPSSFSYDIPVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRR 135 (174)
T ss_dssp HHTTT-----SSSEEEEEE--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEE
T ss_pred hhhhHhhcCCCCceEEEEecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEE
Confidence 45666667766678776667899999999999998776544444568899999999999999999999998766444443
Q ss_pred e-eeeecCcccEEEEeecCCCccccCCC
Q 003737 565 F-PAEVTSHTLKIHLYWAGRGTTGIPLR 591 (799)
Q Consensus 565 ~-~~~~s~n~l~~~~~~~~~~~~~~p~~ 591 (799)
+ .+.+....|.+...+.+.+.+.+|..
T Consensus 136 ~~~v~v~dg~L~i~f~~~~~~~~~i~~~ 163 (174)
T PF11721_consen 136 FFNVTVTDGTLNIQFVWAGKGTLCIPFI 163 (174)
T ss_dssp EEEEEEETTEEETTEEEE--SEEEEEEE
T ss_pred EEEEEEeCCcEEEEEEecCCCcEEeecc
Confidence 3 67777777877667777777776643
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 799 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-21 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-21 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-18 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-17 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-17 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-13 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-05 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-05 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-05 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-05 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-05 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-05 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-05 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-05 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-05 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-05 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-05 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-05 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-05 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-05 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-05 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-05 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-05 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-05 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-05 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-04 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-04 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-04 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-04 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-04 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-04 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-04 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-04 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-04 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-04 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-04 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-04 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-04 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-04 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-04 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-04 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-04 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-04 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-04 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 9e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 4e-59
Identities = 76/321 (23%), Positives = 121/321 (37%), Gaps = 47/321 (14%)
Query: 37 HAEEVKALKQIGRKLGK----KDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATC 92
+ ++ +AL QI + LG W D C+ W V CD + T
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN--RTW-----------LGVLCDTDTQTY 50
Query: 93 HVVTIALKAQNLTGT--LPTELSKLRYLKQLDLS-RNCLTGSFSPQWASLQ-LVELSVMG 148
V + L NL +P+ L+ L YL L + N L G P A L L L +
Sbjct: 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110
Query: 149 NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELT 208
+SG P L+ I TL L N +G++PP I L NL + N +G +P
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170
Query: 209 KLTNL-NDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRIS 267
+ L + IS N +GKIP + + + + LEG + +
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQ----- 224
Query: 268 DLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327
+ L K + ++ +G L +DL N + G +P
Sbjct: 225 ------------------KIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLT 265
Query: 328 KLAKTNFMYLTGNKLTGPVPK 348
+L + + ++ N L G +P+
Sbjct: 266 QLKFLHSLNVSFNNLCGEIPQ 286
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 5e-52
Identities = 65/270 (24%), Positives = 106/270 (39%), Gaps = 32/270 (11%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
G L ++ + LDLS L P P L N+
Sbjct: 37 TWLGVLCDTDTQTYRVNNLDLSGLNLPKP---------------------YPIPSSLANL 75
Query: 163 TTLKNLSIEG-NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
L L I G N G IPP I KL L L ++ + +G +P L+++ L L S N
Sbjct: 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSL-TDLRISD--LKGSESAFPK 278
SG +P I + + G+ + G IP S + + L T + IS L G P
Sbjct: 136 ALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK---IPP 192
Query: 279 -LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL 337
+NL + L++ ++ G+ G + I L+ N+L + N + L
Sbjct: 193 TFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDL 251
Query: 338 TGNKLTGPVPKYIFNSN--KNVDISLNNFT 365
N++ G +P+ + ++++S NN
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 28/223 (12%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTN 161
N++G +P LS+++ L LD S N L+G+ P +SL LV ++ GNR+SG P +
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 162 ITTL-KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220
+ L +++I N TG IPP L NL + LS N G+ N + ++
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLD 280
N+ + + + +G K + L ++ + + G +P ++ L L L +S
Sbjct: 231 NSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF------------ 277
Query: 281 KMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323
N + GEIP G++ + + N G P
Sbjct: 278 --NN---------LCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 9e-59
Identities = 46/117 (39%), Positives = 71/117 (60%), Gaps = 2/117 (1%)
Query: 652 ADKELRGLDL-QTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS 710
+E + L Q ++LR+++ A++NF N +G GGFG VYKG L+DGT++AVK+L
Sbjct: 5 PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKE 64
Query: 711 KSRQGN-REFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK 766
+ QG +F E+ MIS H NL++L G C+ + LLVY YM N ++ + +
Sbjct: 65 ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 121
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-55
Identities = 74/276 (26%), Positives = 122/276 (44%), Gaps = 19/276 (6%)
Query: 103 NLTGTLPTEL---SKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVL 159
+++G LK L +S N ++G + L L V N S P L
Sbjct: 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDV-DVSRCVNLEFLDVSSNNFSTGIP-FL 219
Query: 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219
+ + L++L I GN +G I L+ L +SSN F G +P L +L L ++
Sbjct: 220 GDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLA 277
Query: 220 DNNFSGKIPEFI-GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGS--ES 274
+N F+G+IP+F+ G + L + G+ G +P + + L L +S G
Sbjct: 278 ENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMD 337
Query: 275 AFPKLDKMNLKTLILTKCLIHGEIPDYIGDMT-KLKNIDLSFNNLTGGIPTTFEKLAKTN 333
K+ LK L L+ GE+P+ + +++ L +DLS NN +G I + K
Sbjct: 338 TLLKMR--GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395
Query: 334 --FMYLTGNKLTGPVPKYIFN-SN-KNVDISLNNFT 365
+YL N TG +P + N S ++ +S N +
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLS 431
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 3e-54
Identities = 79/279 (28%), Positives = 125/279 (44%), Gaps = 24/279 (8%)
Query: 103 NLTGTLPTE-LSKLRYLKQLDLSRNCLTGSFSPQWASL----QLVELSVMGNRLSGPFPK 157
L KL L+ LDLS N ++G+ W +L L++ GN++SG
Sbjct: 137 TLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD- 195
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
++ L+ L + N F+ IP + LQ L +S N +G+ ++ T L L
Sbjct: 196 -VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLN 253
Query: 218 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISA-LTSLTDLRISD--LKGSES 274
IS N F G IP K +Q L + + G IP +S +LT L +S G+
Sbjct: 254 ISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA-- 309
Query: 275 AFPK-LDKM-NLKTLILTKCLIHGEIP-DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331
P L++L L+ GE+P D + M LK +DLSFN +G +P + L+
Sbjct: 310 -VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSA 368
Query: 332 T-NFMYLTGNKLTGPVPKYIFNSNKN----VDISLNNFT 365
+ + L+ N +GP+ + + KN + + N FT
Sbjct: 369 SLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFT 407
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 3e-53
Identities = 73/272 (26%), Positives = 125/272 (45%), Gaps = 14/272 (5%)
Query: 103 NLTGTLPTELSK--LRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVL 159
N +G + L + L++L L N TG P ++ +LV L + N LSG P L
Sbjct: 379 NFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 438
Query: 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219
+++ L++L + N+ G IP ++ + L+ LIL N TGE+P+ L+ TNLN + +S
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLS 498
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFP 277
+N +G+IP++IG+ + + L + +S G IPA + SL L ++ G+ P
Sbjct: 499 NNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGT---IP 555
Query: 278 KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN--NLTGGIPTTFEKLAKTNFM 335
M ++ + I G+ YI + K + N G +L+ N
Sbjct: 556 A--AMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPC 613
Query: 336 YLTGNKLTGPVPKYIFNSNK--NVDISLNNFT 365
+T G N+ +D+S N +
Sbjct: 614 NITSRVYGGHTSPTFDNNGSMMFLDMSYNMLS 645
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 4e-52
Identities = 73/270 (27%), Positives = 127/270 (47%), Gaps = 12/270 (4%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 161
L G +P EL ++ L+ L L N LTG ++ L +S+ NRL+G PK +
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
+ L L + N F+G+IP ++ +L L L++N F G +PA + K + I+ N
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAAN 568
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGS--SLEGPIPASISALTSLTDLRISD--LKGSESAFP 277
+GK +I ++ H G+ +G ++ L++ I+ G S
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628
Query: 278 KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL 337
+ ++ L ++ ++ G IP IG M L ++L N+++G IP L N + L
Sbjct: 629 DNNG-SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDL 687
Query: 338 TGNKLTGPVPKYI--FNSNKNVDISLNNFT 365
+ NKL G +P+ + +D+S NN +
Sbjct: 688 SSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 3e-51
Identities = 78/323 (24%), Positives = 127/323 (39%), Gaps = 59/323 (18%)
Query: 55 DWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLT---GTLPTE 111
DW+ +PC+ ++ G VTC V +I L ++ L + +
Sbjct: 32 DWSSNKNPCT----FD-------G----VTCR----DDKVTSIDLSSKPLNVGFSAVSSS 72
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV--LTNITTLKNLS 169
L L L+ L LS + + GS S S L L + N LSGP + L + + LK L+
Sbjct: 73 LLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLN 132
Query: 170 IEGNLFTGSIP-PDIRKLINLQKLILSSNSFTGELPAELT---KLTNLNDLRISDNNFSG 225
+ N KL +L+ L LS+NS +G L L IS N SG
Sbjct: 133 VSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISG 192
Query: 226 KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLK 285
+ + + ++ L + ++ IP + ++L L IS
Sbjct: 193 DVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISG----------------- 232
Query: 286 TLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP 345
+ G+ I T+LK +++S N G IP L ++ L NK TG
Sbjct: 233 ------NKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGE 284
Query: 346 VPKYIFNSNKN---VDISLNNFT 365
+P ++ + +D+S N+F
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFY 307
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-44
Identities = 60/248 (24%), Positives = 93/248 (37%), Gaps = 30/248 (12%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 161
LTG +P + +L L L LS N +G+ + L+ L + N +G P +
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN--SFTGELPAELTKLTNLNDLRIS 219
+ I N G I+ ++ + N F G +L +L+ N I+
Sbjct: 561 QSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNIT 616
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL 279
+ G + L + + L G IP I ++ L L +
Sbjct: 617 SRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLG------------ 664
Query: 280 DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG 339
N I G IPD +GD+ L +DLS N L G IP L + L+
Sbjct: 665 --HND---------ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 713
Query: 340 NKLTGPVP 347
N L+GP+P
Sbjct: 714 NNLSGPIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-41
Identities = 57/225 (25%), Positives = 85/225 (37%), Gaps = 28/225 (12%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
+ +G +P EL R L LDL+ N G+ + N ++G + N
Sbjct: 525 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG---KIAANFIAGKRYVYIKND 581
Query: 163 TTLKNLSIEGNL--FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220
K GNL F G + +L ++S + G ++ L +S
Sbjct: 582 GMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSY 641
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLD 280
N SG IP+ IG + L++ + + G IP + L L L +S
Sbjct: 642 NMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSS------------ 689
Query: 281 KMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTT 325
N L G IP + +T L IDLS NNL+G IP
Sbjct: 690 --NK----LD-----GRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 9e-55
Identities = 45/101 (44%), Positives = 65/101 (64%)
Query: 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGM 725
L ++ ATNNFD +G G FG VYKG+L DG +A+K+ + +S QG EF EI
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 726 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK 766
+S +HP+LV L G C E N+++L+Y+YM+N L R ++G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-52
Identities = 45/124 (36%), Positives = 69/124 (55%), Gaps = 11/124 (8%)
Query: 653 DKELRGLDLQTGLYTLRQIKAATNNFDP------ANKVGEGGFGSVYKGILSDGTVIAVK 706
+K L D + ++ ++K TNNFD NK+GEGGFG VYKG + + T +AVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 707 QLSS----KSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRA 762
+L++ + + ++F EI +++ QH NLV+L G +G+ L LVY YM N L
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 763 IFGK 766
+
Sbjct: 121 LSCL 124
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 8e-45
Identities = 51/323 (15%), Positives = 109/323 (33%), Gaps = 27/323 (8%)
Query: 43 ALKQIGRKLGKKDWNFGVDPCSQKGNWELSSD-DKKGFESNVTCDCSSATCHVVTIALKA 101
ALK+I L K+W+ NW + + D G + V+ + + V ++L+
Sbjct: 34 ALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNG---RVTGLSLEG 90
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWAS-----LQLVELSVMGNRLSGPFP 156
+G +P + +L L+ L L + + + + M F
Sbjct: 91 FGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFV 150
Query: 157 KVLT--NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLN 214
+ + L I + SI R + ++ SN+ T + + +LT L
Sbjct: 151 DYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLR 209
Query: 215 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSES 274
+ ++ F + + + + L LTD+ + +
Sbjct: 210 QFYMGNSPFVAENICEAWENENSEYA-----QQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264
Query: 275 AFPKLDKM-NLKTLILTKCLIHG--------EIPDYIGDMTKLKNIDLSFNNLTGG-IPT 324
L + ++ + + + K++ I + +NNL + T
Sbjct: 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVET 324
Query: 325 TFEKLAKTNFMYLTGNKLTGPVP 347
+ +K+ K + N+L G +P
Sbjct: 325 SLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-38
Identities = 40/285 (14%), Positives = 83/285 (29%), Gaps = 31/285 (10%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL--QLVELSVMGNRLSG-PFPKVL 159
L G LP L L+L+ N +T + Q+ LS N+L P
Sbjct: 341 QLEGKLP-AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNIFDA 398
Query: 160 TNITTLKNLSIEGNLFTG-------SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 212
+++ + + N + P K IN+ + LS+N + + +
Sbjct: 399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458
Query: 213 LNDLRISDNNFSG-------KIPEFIGKWKKIQKLHIQGSSLEGPIPASISA--LTSLTD 263
L+ + + N + E + + ++ + L + A L L
Sbjct: 459 LSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVG 517
Query: 264 LRISD--LKG-SESAF--PKLDKMNLKT-LILTKCLIHGEIPDYIGDMTKLKNIDLSFNN 317
+ +S L ++ E P+ I L + + N+
Sbjct: 518 IDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577
Query: 318 LTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLN 362
+ + + + + N Y+ + L
Sbjct: 578 IRKVNEKITPNI---SVLDIKDNPNISIDLSYVCPYIEAGMYMLF 619
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-34
Identities = 42/290 (14%), Positives = 95/290 (32%), Gaps = 32/290 (11%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPK 157
+ + ++ Q+ N +T S L L + + +
Sbjct: 166 INSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENIC 224
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
+ + L +L + + + +LP L L + +
Sbjct: 225 EAWENENSEYAQ-----QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLIN 279
Query: 218 ISDNNF--------SGKIPEFIGKWKKIQKLHIQGSSL-EGPIPASISALTSLTDLRISD 268
++ N + +KIQ ++I ++L P+ S+ + L L
Sbjct: 280 VACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLY 339
Query: 269 --LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTF 326
L+G AF + L +L L I ++ G +++N+ + N L IP F
Sbjct: 340 NQLEGKLPAFGSE--IKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIF 396
Query: 327 E--KLAKTNFMYLTGNKLTG-------PVPKYIFNSNK--NVDISLNNFT 365
+ ++ + + + N++ P+ F ++++S N +
Sbjct: 397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS 446
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-25
Identities = 27/217 (12%), Positives = 66/217 (30%), Gaps = 17/217 (7%)
Query: 159 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTG----ELPAELTKLTNLN 214
L + + LS+EG +G +P I +L L+ L L S+ P ++ +
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 215 DLRISDNNFSGKIPEFIGKWK--KIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LK 270
+ ++ ++ + + K I + I S T + +
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196
Query: 271 GSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLA 330
A +L L+ + E +N + + ++ L
Sbjct: 197 FVSKAVMRL--TKLRQFYMGNSPFVAENI-----CEAWENENSEYAQQYKTEDLKWDNLK 249
Query: 331 KTNFMYLTGNKLTGPVPKYIFN-SN-KNVDISLNNFT 365
+ + +P ++ + ++++ N
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGI 286
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-20
Identities = 31/210 (14%), Positives = 57/210 (27%), Gaps = 32/210 (15%)
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK 226
N + E +++ + + L L +G +P + +LT L L + +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 227 IPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSES---AFPKLDKMN 283
F P ISA S + + ++ P+ D +
Sbjct: 121 ERLF--------------------GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSD 160
Query: 284 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
L + I K I NN+T + +L K Y+ +
Sbjct: 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFV 219
Query: 344 GPVPK--------YIFNSNKNVDISLNNFT 365
K D+ +N
Sbjct: 220 AENICEAWENENSEYAQQYKTEDLKWDNLK 249
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 8e-39
Identities = 53/270 (19%), Positives = 96/270 (35%), Gaps = 9/270 (3%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 161
L ++ L LD+ N ++ L L L++ N LS K
Sbjct: 36 QLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
T L L + N K NL L LS N + +L NL +L +S+N
Sbjct: 96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155
Query: 222 NFSGKIPEFIG--KWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA---- 275
E + ++KL + + ++ P A+ L L +++++ S
Sbjct: 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGDM--TKLKNIDLSFNNLTGGIPTTFEKLAKTN 333
+L +++ L L+ + + T L +DLS+NNL +F L +
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLE 275
Query: 334 FMYLTGNKLTGPVPKYIFNSNKNVDISLNN 363
+ +L N + + ++L
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-37
Identities = 53/293 (18%), Positives = 90/293 (30%), Gaps = 25/293 (8%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGS----FSPQWASLQLVELSVMGNRLSGPFPKV 158
+ P + L L L+ L S + A+ + LS+ ++LS
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 159 LTN--ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDL 216
T L L + N L L+ L N+ L L N+ L
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301
Query: 217 R---------ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL--- 264
IS + K ++ L+++ + + G + L +L L
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361
Query: 265 --RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 322
S + F L L L LTK I D + L+ +DL N + +
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL 421
Query: 323 P-TTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFTWESSDP 371
+ L +YL+ NK + + F + + + S P
Sbjct: 422 TGQEWRGLENIFEIYLSYNKYLQ-LTRNSFALVPSLQRLMLRRVALKNVDSSP 473
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 6e-36
Identities = 50/283 (17%), Positives = 94/283 (33%), Gaps = 20/283 (7%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSP-----QWASLQLVELSVMGNRLSGPFPK 157
++ G + L LK L LS + + A L L++ N++S
Sbjct: 340 DIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD 399
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPD-IRKLINLQKLILSSNSFTGELPAELTKLTNLNDL 216
+ + L+ L + N + R L N+ ++ LS N + + +L L
Sbjct: 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRL 459
Query: 217 RISDNNFSG--KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDL 269
+ P + + L + +++ + L L L ++ L
Sbjct: 460 MLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARL 519
Query: 270 KGSESAFPKLDKM----NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTT 325
+ + + +L L L + D+ +LK IDL NNL +
Sbjct: 520 WKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579
Query: 326 FEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 365
F + L N +T K + +N +D+ N F
Sbjct: 580 FNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFD 622
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-33
Identities = 55/289 (19%), Positives = 108/289 (37%), Gaps = 25/289 (8%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPK 157
+ +L L+ L+ L++ N + G S + L L LS+ + S
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371
Query: 158 VLT----NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPA-ELTKLTN 212
T + L L++ N + L +L+ L L N EL E L N
Sbjct: 372 NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG--PIPASISALTSLTDLRISD-- 268
+ ++ +S N + +Q+L ++ +L+ P+ L +LT L +S+
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN 491
Query: 269 LKG-SESAFPKLDKMNLKTLILTKCLIH--------GEIPDYIGDMTKLKNIDLSFNNLT 319
+ ++ L+ L+ L L + G ++ ++ L ++L N
Sbjct: 492 IANINDDMLEGLE--KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD 549
Query: 320 GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 365
F+ L + + L N L +P +FN+ + +++ N T
Sbjct: 550 EIPVEVFKDLFELKIIDLGLNNLNT-LPASVFNNQVSLKSLNLQKNLIT 597
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-32
Identities = 50/262 (19%), Positives = 85/262 (32%), Gaps = 18/262 (6%)
Query: 117 YLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFT 176
+ D S LT P + L++ N+L T + L +L + N +
Sbjct: 5 SHEVADCSHLKLTQV--PDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 177 GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 236
P +KL L+ L L N + TNL +L + N+ K K
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122
Query: 237 IQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTK 291
+ L + + L + L +L +L +I L +LK L L+
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL--KSEELDIFANSSLKKLELSS 180
Query: 292 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTF---EKLAKTNFMYLTGNKLTGPVPK 348
I P + +L + L+ L + + L+ ++L+
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST-TSN 239
Query: 349 YIFNSNKNV-----DISLNNFT 365
F K D+S NN
Sbjct: 240 TTFLGLKWTNLTMLDLSYNNLN 261
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-16
Identities = 30/158 (18%), Positives = 58/158 (36%), Gaps = 10/158 (6%)
Query: 106 GTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLS--------GPFP 156
+ P+ LR L LDLS N + L +L L + N L+ G
Sbjct: 470 DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPI 529
Query: 157 KVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDL 216
L ++ L L++E N F + L L+ + L N+ + +L L
Sbjct: 530 YFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSL 589
Query: 217 RISDNNFSGKIPE-FIGKWKKIQKLHIQGSSLEGPIPA 253
+ N + + F ++ + +L ++ + + +
Sbjct: 590 NLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-39
Identities = 36/207 (17%), Positives = 63/207 (30%), Gaps = 40/207 (19%)
Query: 409 ADQYHYTLHINCGGAKIN-TGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLD 467
AD+ + +N GG Y D + G+ + + + +
Sbjct: 3 ADKVIW--AVNAGGESHVDVHGIHYRKD------PLEGRVGRASDYGMKLPILRSNPE-- 52
Query: 468 NYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTF 527
D LY+T R + S Y G Y + L FAE F
Sbjct: 53 ----------------DQVLYQTERYNEDSFGYDIPIKEEGEYVLVLKFAE------VYF 90
Query: 528 NSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHL---YWAGRG 584
+++FD+ + V KD +I D G + P + L + + G+
Sbjct: 91 AQSQQKVFDVRVNGHTVVKDLDIFDRVGH-STAHDEIIPISIKKGKLSVQGEVSTFTGKL 149
Query: 585 TTGIPLRGTYGPLISAISVKSNFKPPV 611
+ P + A+ + K
Sbjct: 150 SVEFVKGYYDNPKVCALFI---MKGTA 173
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-36
Identities = 47/265 (17%), Positives = 95/265 (35%), Gaps = 15/265 (5%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV-LTNITTLKNL 168
+ S + L+L P L L+ N+ F +V L ++ L +L
Sbjct: 298 KDFSYNFGWQHLELVNCKFGQF--PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFL-DL 354
Query: 169 SIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIP 228
S G F G +L+ L LS N + + L L L +N
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSE 413
Query: 229 -EFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGS--ESAFPKLDKMN 283
+ + L I + + L+SL L+++ + + F +L N
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR--N 471
Query: 284 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
L L L++C + P ++ L+ +++S NN ++ L + + N +
Sbjct: 472 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 531
Query: 344 GPVPKYIFNSNKN---VDISLNNFT 365
+ + + + ++++ N+F
Sbjct: 532 TSKKQELQHFPSSLAFLNLTQNDFA 556
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-30
Identities = 46/270 (17%), Positives = 95/270 (35%), Gaps = 15/270 (5%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLT--GSFSPQWASL-QLVELSVMGNRLSGPFPKVL 159
+ G L L+ LDLSRN L+ G S L L + N +
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNF 392
Query: 160 TNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 218
+ L++L + + + L NL L +S L++L L++
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 219 SDNNFSGKI-PEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKG-SES 274
+ N+F P+ + + + L + LE P + ++L+SL L +S
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 512
Query: 275 AFPKLDKMNLKTLILTKCLIHGEIPDYIGDM-TKLKNIDLSFNNLTGGIPTT--FEKLAK 331
+ L+ +L+ L + I + + L ++L+ N+ + +
Sbjct: 513 PYKCLN--SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKD 570
Query: 332 TNFMYLTGNKLTGPVPKYIFNSN-KNVDIS 360
+ + ++ P +++I+
Sbjct: 571 QRQLLVEVERMECATPSDKQGMPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-29
Identities = 52/308 (16%), Positives = 89/308 (28%), Gaps = 43/308 (13%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQW----ASLQLVELSVMGNRLSGPFPKV 158
+ P ++R L +L L N + + A L++ L + R G K
Sbjct: 188 PMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 159 -LTNITTLKNLSIEGN------LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLT 211
+ + L NL+IE + I L N+ L S + +
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNF 304
Query: 212 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGS---------------------SLEGP 250
L + + F + K++ +G S +G
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGC 364
Query: 251 IPASISALTSLTDLRISD--LKGSESAFPKLDKMNLKTLILTKCLIHGEIP-DYIGDMTK 307
S TSL L +S + S F L L+ L + +
Sbjct: 365 CSQSDFGTTSLKYLDLSFNGVITMSSNFLGL--EQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 308 LKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV---DISLNNF 364
L +D+S + F L+ + + GN IF +N+ D+S
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 365 TWESSDPI 372
S
Sbjct: 483 EQLSPTAF 490
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 40/214 (18%), Positives = 73/214 (34%), Gaps = 14/214 (6%)
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
+ KNL + N LQ L LS L++L+ L ++ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSE--SAFPK 278
+QKL ++L I L +L +L ++ ++ + F
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 279 LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKN----IDLSFNNLTGGIPTTFEKLAKTNF 334
L NL+ L L+ I + + ++ +DLS N + P F+++ + +
Sbjct: 148 LT--NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHK 204
Query: 335 MYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 365
+ L N + V K + L F
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-28
Identities = 52/296 (17%), Positives = 91/296 (30%), Gaps = 51/296 (17%)
Query: 82 NVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQL 141
N+T C N +P L K LDLS
Sbjct: 9 NITYQCME------------LNFY-KIPDNLP--FSTKNLDLS----------------- 36
Query: 142 VELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTG 201
N L + L+ L + + L +L LIL+ N
Sbjct: 37 ------FNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 90
Query: 202 ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTS 260
+ L++L L + N + IG K +++L++ + ++ +P S LT+
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150
Query: 261 LTDLRISD--LKG-SESAFPKLDKMNLK--TLILTKCLIHGEIPDYIGDMTKLKNIDLSF 315
L L +S ++ + L +M L +L L+ ++ I +L + L
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRN 209
Query: 316 NNLTGGIP-TTFEKLAKTNFMYLTGNKLTG-----PVPKYIFNSNKNVDISLNNFT 365
N + + T + LA L + K N+ I
Sbjct: 210 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-32
Identities = 52/352 (14%), Positives = 104/352 (29%), Gaps = 57/352 (16%)
Query: 29 IAATANKLHAEEVKALKQIGRKLGKKDWNF---GVDPCSQKGNWELSSD-DKKGFESNVT 84
I + ++ KALK I L K+W + ++ NW + + D G + V
Sbjct: 259 IQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVD 318
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTG--------SFSPQW 136
D + V ++L G +P + +L LK L + T +P
Sbjct: 319 LDNNG---RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDM 375
Query: 137 ASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG------------------- 177
+ + + + ++ + + L L++
Sbjct: 376 SEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTN 435
Query: 178 ---SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKW 234
I I++L LQ + +++ FT + A + N
Sbjct: 436 RITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANS-----DYAKQYENEELSWSNL 490
Query: 235 KKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLI 294
K + + + +P + L L L I+ N
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIAC--------------NRGISAAQLKAD 536
Query: 295 HGEIPDYIGDMTKLKNIDLSFNNLTG-GIPTTFEKLAKTNFMYLTGNKLTGP 345
+ D K++ + +NNL + +K+ K + NK+
Sbjct: 537 WTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHL 588
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-29
Identities = 55/304 (18%), Positives = 97/304 (31%), Gaps = 47/304 (15%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
+ L+ L+ + SL+ ++ + NR++ K + +
Sbjct: 389 KMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRL 447
Query: 163 TTLKNLSIEGNLFTG-------------------SIPPDIRKLINLQKLILSSNSFTGEL 203
T L+ + + FT + L +L + L + +L
Sbjct: 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507
Query: 204 PAELTKLTNLNDLRISDNNFSG---------KIPEFIGKWKKIQKLHIQGSSLEG-PIPA 253
P L L L L I+ N ++ + KIQ ++ ++LE P A
Sbjct: 508 PDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASA 567
Query: 254 SISALTSLTDLRISDLKGSE-SAFPKLDKMNLKTLILTKCLIHGEIPDYIG-DMTKLKNI 311
S+ + L L K AF L L L I EIP+ +++ +
Sbjct: 568 SLQKMVKLGLLDCVHNKVRHLEAFGTNV--KLTDLKLDYNQIE-EIPEDFCAFTDQVEGL 624
Query: 312 DLSFNNLTGGIPTTFE--KLAKTNFMYLTGNKLTGPVPKYIFNSNKN--------VDISL 361
S N L IP F + + + NK+ + I S + V +S
Sbjct: 625 GFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSY 682
Query: 362 NNFT 365
N
Sbjct: 683 NEIQ 686
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-29
Identities = 37/293 (12%), Positives = 78/293 (26%), Gaps = 38/293 (12%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL--QLVELSVMGNRLSG-PFPKVLTNIT 163
L L L N + + + Q+ L N+L P ++
Sbjct: 586 RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVY 644
Query: 164 TLKNLSIEGNLFTG-----SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 218
+ ++ N S D K IN + LS N + ++ + +
Sbjct: 645 VMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIIL 704
Query: 219 SDNNFS-------GKIPEFIGKWKKIQKLHIQGSSLEGPIPASI--SALTSLTDL----- 264
S+N + + + ++ + L + + L L+++
Sbjct: 705 SNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYN 763
Query: 265 RISDLKGSESAFPKLDKMNL-KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323
S +L + I + P I L + + N++
Sbjct: 764 CFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDE 823
Query: 324 TTFEKLAKTNFMYLTGNKLT-GPVP---------KYIFNSNKNVDISLNNFTW 366
+L + + N V Y+ +K DI +
Sbjct: 824 KLTPQL---YILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALG 873
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 7e-21
Identities = 43/267 (16%), Positives = 85/267 (31%), Gaps = 45/267 (16%)
Query: 140 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPD----------------- 182
++ LS+ G G P + +T LK LS + T S
Sbjct: 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383
Query: 183 --------IRKLINLQKLILSSNSFTGEL---PAELTKLTNLNDLRISD-NNFSGKIPEF 230
+ L L ++ P + +L D +I + N I +
Sbjct: 384 RMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKA 443
Query: 231 IGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILT 290
I + K+Q ++ S A + + + E ++ L +L + L
Sbjct: 444 IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQ--YENEELSWSNLK--DLTDVELY 499
Query: 291 KCLIHGEIPDYIGDMTKLKNIDLSFNNLTG---------GIPTTFEKLAKTNFMYLTGNK 341
C ++PD++ D+ +L++++++ N + + K Y+ N
Sbjct: 500 NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNN 559
Query: 342 LTG-PVPKYIFNSNK--NVDISLNNFT 365
L P + K +D N
Sbjct: 560 LEEFPASASLQKMVKLGLLDCVHNKVR 586
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 5e-17
Identities = 35/145 (24%), Positives = 49/145 (33%), Gaps = 15/145 (10%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVM---GNRLSGPFPKV 158
+N L +DL N LT S S + + L LS M N S FP
Sbjct: 714 ENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQ 771
Query: 159 LTNITTLKNLSIEGNL------FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 212
N + LK I P I +L +L + SN ++ +L
Sbjct: 772 PLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQ 828
Query: 213 LNDLRISDN-NFSGKIPEFIGKWKK 236
L L I+DN N S + +
Sbjct: 829 LYILDIADNPNISIDVTSVCPYIEA 853
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-16
Identities = 29/227 (12%), Positives = 69/227 (30%), Gaps = 29/227 (12%)
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK 226
N + E +++ D+ + L L+ G +P + +LT L L ++ +
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362
Query: 227 IPEFIGKWKKIQKLHIQGSSLEGPI-PASISALTSLTDLRISDLKGSE----SAFPKLDK 281
F + + + + L + + K +
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422
Query: 282 MNLKTLILTKC--LIHGEIPDYIGDMTKLKNIDLSFNNLTG------------------- 320
++LK + I I I +TKL+ I + + T
Sbjct: 423 ISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481
Query: 321 GIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK--NVDISLNNFT 365
++ L + L +P ++++ + +++I+ N
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGI 528
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-31
Identities = 46/272 (16%), Positives = 96/272 (35%), Gaps = 12/272 (4%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTN 161
+ L L L+ N L + + L L + +S L N
Sbjct: 68 QIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHN 127
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS-D 220
TL++L + N + P L+ L +N+ +++ L +L ++ +
Sbjct: 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLN 187
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASIS--ALTSLTDLRISDLKG---SESA 275
N I Q L+ G+ I + + SL D+ S +
Sbjct: 188 GNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335
F L +M+++++ L K + + L+ +DL+ +L+ +P+ L+ +
Sbjct: 248 FEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKL 306
Query: 336 YLTGNKLTGPVPKYIFNSNKNV---DISLNNF 364
L+ NK + + ++ ++ I N
Sbjct: 307 VLSANKFEN-LCQISASNFPSLTHLSIKGNTK 337
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-30
Identities = 54/272 (19%), Positives = 96/272 (35%), Gaps = 16/272 (5%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGP-FPKVLTNITT 164
LP+ L L LK+L LS N ++ L LS+ GN L N+
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351
Query: 165 LKNLSIEGNLFTGS--IPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
L+ L + + S +R L +LQ L LS N + L L ++
Sbjct: 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411
Query: 223 FSGKIPE-FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD------LKGSESA 275
K + ++ L++ S L+ L +L L + ++
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335
L L+ L+L+ C + + + ++DLS N LT L ++
Sbjct: 472 LQTLG--RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YL 528
Query: 336 YLTGNKLTGPVPK--YIFNSNKNVDISLNNFT 365
L N ++ +P I + + +++ N
Sbjct: 529 NLASNHISIILPSLLPILSQQRTINLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-28
Identities = 40/279 (14%), Positives = 93/279 (33%), Gaps = 15/279 (5%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 158
G + + L D+ ++ + + + +++ +
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273
Query: 159 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 218
+ L+ L + + +P + L L+KL+LS+N F + +L L I
Sbjct: 274 FHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSI 332
Query: 219 SDNNFSGKI-PEFIGKWKKIQKLHIQGSSLE--GPIPASISALTSLTDLRISD--LKGSE 273
N ++ + + +++L + +E + L+ L L +S +
Sbjct: 333 KGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLK 392
Query: 274 S-AFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331
+ AF + L+ L L + + ++ LK ++LS + L F+ L
Sbjct: 393 TEAFKECP--QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPA 450
Query: 332 TNFMYLTGNKLTG--PVPKYIFNSNKNV---DISLNNFT 365
+ L GN + + +S + +
Sbjct: 451 LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-24
Identities = 43/229 (18%), Positives = 77/229 (33%), Gaps = 14/229 (6%)
Query: 103 NLTGTLPTE-LSKLRYLKQLDLSRNCLTGS--FSPQWASL-QLVELSVMGNRLSGPFPKV 158
L T L L L++LDLS + + S + Q +L L L++ N +
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395
Query: 159 LTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
L+ L + + L L+ L LS + L L L
Sbjct: 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN 455
Query: 218 ISDNNFSGKI---PEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKG- 271
+ N+F + +++ L + L + ++L + + +S L
Sbjct: 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSS 515
Query: 272 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG 320
S A L L L I +P + +++ + I+L N L
Sbjct: 516 SIEALSHL---KGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 35/258 (13%), Positives = 72/258 (27%), Gaps = 16/258 (6%)
Query: 119 KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGS 178
K + L P L N L + + L L +
Sbjct: 15 KTYNCENLGLN-EI-PGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 179 IPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQ 238
+ L L+L++N L+ L L S + K ++
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 239 KLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKCL 293
L++ + + L L I L S+ L + +L L
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL--SKEDMSSLQQATNLSLNLNGND 190
Query: 294 IHGEIPDYIGDMTKLKNIDLSFNNLTGGIP-----TTFEKLAKTNFMYLTGNKLTGPVPK 348
I I D ++++ I +T + L F + ++ V +
Sbjct: 191 I-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE 249
Query: 349 YIFNSN-KNVDISLNNFT 365
+ + +++++ + F
Sbjct: 250 GLCEMSVESINLQKHYFF 267
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 21/122 (17%), Positives = 45/122 (36%), Gaps = 4/122 (3%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
+L+ + L+ + +DLS N LT S + L+ + L++ N +S P +L +
Sbjct: 487 DLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPIL 546
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
+ + +++ N + + + L +R+SD
Sbjct: 547 SQQRTINLRQNPLDCT--CSNIYFLEW--YKENMQKLEDTEDTLCENPPLLRGVRLSDVT 602
Query: 223 FS 224
S
Sbjct: 603 LS 604
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 47/234 (20%), Positives = 85/234 (36%), Gaps = 20/234 (8%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPK 157
L++ L P + +L +L+ + + L L L++ N L P
Sbjct: 88 LRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPA 144
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDI---------RKLINLQKLILSSNSFTGELPAELT 208
+ ++ L+ LSI +P + + L+NLQ L L LPA +
Sbjct: 145 SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIA 203
Query: 209 KLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
L NL L+I ++ S + I K+++L ++G + P L L + D
Sbjct: 204 NLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKD 262
Query: 269 LKGSES---AFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319
+ +L L+ L L C+ +P I + I + +
Sbjct: 263 CSNLLTLPLDIHRLT--QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 52/251 (20%), Positives = 89/251 (35%), Gaps = 20/251 (7%)
Query: 107 TLPTELSKLRY--LKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNIT 163
L L+L L F Q L L +++ L P +
Sbjct: 70 ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFA 127
Query: 164 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAEL---------TKLTNLN 214
L+ L++ N ++P I L L++L + + ELP L L NL
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ 186
Query: 215 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSES 274
LR+ +P I + ++ L I+ S L + +I L L +L + +
Sbjct: 187 SLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRN 244
Query: 275 AFPK-LDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT 332
+P LK LIL C +P I +T+L+ +DL +P+ +L
Sbjct: 245 -YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303
Query: 333 NFMYLTGNKLT 343
+ + +
Sbjct: 304 CIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 42/244 (17%), Positives = 81/244 (33%), Gaps = 38/244 (15%)
Query: 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG-------------------SIPP 181
L G+ P+ VL+ N +
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATAD 73
Query: 182 DIRKL--INLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK 239
+ L L S + P + +L++L + I ++P+ + ++ ++
Sbjct: 74 LLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLET 131
Query: 240 LHIQGSSLEGPIPASISALTSLTDLRISDLK---------GSESAFPKLDKM-NLKTLIL 289
L + + L +PASI++L L +L I S A + + NL++L L
Sbjct: 132 LTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRL 190
Query: 290 TKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG-NKLTGPVPK 348
I +P I ++ LK++ + + L+ + L K + L G L P
Sbjct: 191 EWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRN-YPP 247
Query: 349 YIFN 352
Sbjct: 248 IFGG 251
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 32/156 (20%), Positives = 55/156 (35%), Gaps = 3/156 (1%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTL 165
E L L+ L L + S A+LQ L L + + LS + ++ L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKL 231
Query: 166 KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG 225
+ L + G + PP L++LIL S LP ++ +LT L L +
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291
Query: 226 KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSL 261
++P I + + + A +
Sbjct: 292 RLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 19/167 (11%), Positives = 44/167 (26%), Gaps = 28/167 (16%)
Query: 177 GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 236
GS + L ++ L++ + + + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN------- 54
Query: 237 IQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHG 296
S + LK + + L L +
Sbjct: 55 -------------------SNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP- 94
Query: 297 EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
+ PD ++ L+++ + L +P T ++ A + L N L
Sbjct: 95 QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR 140
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-29
Identities = 59/280 (21%), Positives = 97/280 (34%), Gaps = 39/280 (13%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 166
+LP L L L S L +L + GN+L+ P + L+
Sbjct: 95 SLPVLPPGLLELSIFSNPLTHLPALPS------GLCKLWIFGNQLTS-LPVLPPG---LQ 144
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK 226
LS+ N S+P L KL +N T LP + L L+ +SDN +
Sbjct: 145 ELSVSDNQLA-SLPALPS---ELCKLWAYNNQLT-SLPMLPSGLQELS---VSDNQLA-S 195
Query: 227 IPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT--DLRISDLKGSESAFPKLDKMNL 284
+P + K+ + + +SL PA S L L R++ L S L
Sbjct: 196 LPTLPSELYKLWAYNNRLTSL----PALPSGLKELIVSGNRLTSLPVLPS--------EL 243
Query: 285 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG 344
K L+++ + +P L ++ + N LT +P + L+ + L GN L+
Sbjct: 244 KELMVSGNRL-TSLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS- 297
Query: 345 PVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVES 384
+ PR + L +
Sbjct: 298 ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLA 337
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 4e-16
Identities = 34/181 (18%), Positives = 67/181 (37%), Gaps = 26/181 (14%)
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
L++ + T ++P + ++ L++ N+ T LPA +L L +S N
Sbjct: 40 NGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTLE---VSGNQ 92
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM 282
+ +P ++ + L PA S L L + + L P
Sbjct: 93 LT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCKL-WIFGNQLTSLPVLPP----- 141
Query: 283 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 342
L+ L ++ + +P ++ KL N LT +P L + + ++ N+L
Sbjct: 142 GLQELSVSDNQL-ASLPALPSELCKL---WAYNNQLT-SLPMLPSGLQE---LSVSDNQL 193
Query: 343 T 343
Sbjct: 194 A 194
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 47/265 (17%), Positives = 97/265 (36%), Gaps = 18/265 (6%)
Query: 111 ELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170
++ K + L + R L + L+ + L+ N+ S F + +L L +
Sbjct: 302 DVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLT--MNKGSISFK--KVALPSLSYLDL 357
Query: 171 EGNLFT--GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIP 228
N + G +L+ L LS N + A L L L +
Sbjct: 358 SRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTE 416
Query: 229 -EFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGS--ESAFPKLDKMN 283
+K+ L I ++ + LTSL L+++ K + + F N
Sbjct: 417 FSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTT--N 474
Query: 284 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
L L L+KC + + +L+ +++S NNL + + +L + + + N++
Sbjct: 475 LTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE 534
Query: 344 GPVPKYIFNSNKN---VDISLNNFT 365
+ + K+ +++ N+
Sbjct: 535 T-SKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-26
Identities = 48/303 (15%), Positives = 91/303 (30%), Gaps = 39/303 (12%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVE 143
C +T Q L+ +P ++ K +DLS N L S +++ +L
Sbjct: 7 CIEV---VPNITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQW 60
Query: 144 LSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGEL 203
L + + K + L NL + GN P L +L+ L+
Sbjct: 61 LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLE 120
Query: 204 PAELTKLTNLNDLRISDNNFSG-KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT 262
+ +L L L ++ N K+P + + + + + ++ + L
Sbjct: 121 SFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENP 180
Query: 263 DLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 322
+ +L ++ I I D KL + L N + I
Sbjct: 181 QV-------------------NLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNI 220
Query: 323 P-TTFEKLAKTNFMYLTGNKLTGPVPKYIFN----------SNKNVDISLNNFTWESSDP 371
T + LA + L + IF + ++ N +
Sbjct: 221 MKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK 280
Query: 372 IEC 374
C
Sbjct: 281 FHC 283
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-26
Identities = 53/279 (18%), Positives = 90/279 (32%), Gaps = 17/279 (6%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTN 161
L S L+ LDLSR + W L L L + GN + P +
Sbjct: 43 PLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG 102
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISD 220
+T+L+NL I +LI L+KL ++ N +LPA + LTNL + +S
Sbjct: 103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162
Query: 221 NNFSGKIPEFIGKWKK----IQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAF 276
N + ++ L + + ++ I L +L + S +
Sbjct: 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIM 221
Query: 277 PKLDKM--NLKTLILTKCLIHGEI------PDYIGDMTKL--KNIDLSFNNLTGGIPTTF 326
+ L L E P + + + L++ N F
Sbjct: 222 KTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKF 281
Query: 327 EKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
LA + M L G + +++ I
Sbjct: 282 HCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLK 320
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-24
Identities = 32/169 (18%), Positives = 54/169 (31%), Gaps = 3/169 (1%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQ-WASLQ-LVELSVMGNRLSGPFPKVLT 160
N + L L+ LD + L + SL+ L+ L + F +
Sbjct: 386 NGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL 445
Query: 161 NITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219
+T+L L + GN F + ++ NL L LS L L L +S
Sbjct: 446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMS 505
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
NN + + L + +E SL +++
Sbjct: 506 HNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 46/286 (16%), Positives = 83/286 (29%), Gaps = 26/286 (9%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQ---------WASLQLVELSVMGNRLS 152
N + + T L L L L + + + + E +
Sbjct: 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDF 274
Query: 153 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 212
+ + +S+ G D+ K Q L + + P L
Sbjct: 275 SDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-QFPTL--DLPF 329
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE--GPIPASISALTSLTDLRISD-- 268
L L ++ N S + + + L + ++L G S SL L +S
Sbjct: 330 LKSLTLTMNKGSI-SFKKVA-LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNG 387
Query: 269 LKGSESAFPKLDKMNLKTLILTKCLIHGEIP-DYIGDMTKLKNIDLSFNNLTGGIPTTFE 327
+ F L+ L+ L + + KL +D+S+ N F
Sbjct: 388 AIIMSANFMGLE--ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL 445
Query: 328 KLAKTNFMYLTGNKLTGPVPKYIFNSNKNV---DISLNNFTWESSD 370
L N + + GN +F + N+ D+S S
Sbjct: 446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-21
Identities = 45/257 (17%), Positives = 86/257 (33%), Gaps = 32/257 (12%)
Query: 130 GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI-TTLKNLSIEGNLFTGSIPPDIRKLIN 188
GS +P + + M +LS KV +I ++ KN+ + N
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLS----KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 189 LQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248
LQ L LS L +L++L ++ N P ++ L + L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKL 308
I L +L L ++ N + ++P Y ++T L
Sbjct: 118 SLESFPIGQLITLKKLNVAH--------------NF--------IHSCKLPAYFSNLTNL 155
Query: 309 KNIDLSFNNLTGGIPTTFEKLAKTNFM----YLTGNKLTGPVPKYIFNSNKNVDISLNNF 364
++DLS+N + + L + + ++ N + + F K +++L
Sbjct: 156 VHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGN 214
Query: 365 TWESSDPIECPRGSVNL 381
S+ C + L
Sbjct: 215 FNSSNIMKTCLQNLAGL 231
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-21
Identities = 38/214 (17%), Positives = 62/214 (28%), Gaps = 27/214 (12%)
Query: 109 PTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSG-PFPKVLTNITTLK 166
L+ LDLS N S + L +L L + L ++ L
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLL 427
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSG 225
L I L +L L ++ NSF + TNL L +S
Sbjct: 428 YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ 487
Query: 226 KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLK 285
++Q L++ ++L + + L SL+ L S N
Sbjct: 488 ISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSF--------------N-- 531
Query: 286 TLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319
I L +L+ N++
Sbjct: 532 -------RIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 8e-16
Identities = 25/170 (14%), Positives = 53/170 (31%), Gaps = 5/170 (2%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL--QLVELSVMGNRLSGPFPKVLT 160
N L L L ++ N + + L L + +L V
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494
Query: 161 NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220
+ L+ L++ N +L +L L S N +L +++
Sbjct: 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL--TSLTDLRISD 268
N+ + I E + +++ ++E A+ + + + D S
Sbjct: 555 NSVA-CICEHQKFLQWVKEQKQFLVNVEQMTCATPVEMNTSLVLDFNNST 603
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 44/279 (15%), Positives = 96/279 (34%), Gaps = 26/279 (9%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 161
+L L + +K+LDLS N L+ + A +L L++ N L L +
Sbjct: 21 SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LES 78
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
++TL+ L + N ++ +++ L ++N+ + + ++ +++N
Sbjct: 79 LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANN 130
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTDL-----RISDLKGSESA 275
+ G ++Q L ++ + ++ ++ +L L I D+
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV--KGQV 188
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335
LKTL L+ + + + I L N L I
Sbjct: 189 VFA----KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242
Query: 336 YLTGNKLT-GPVPKYIFNSNKNVDISLNNFTWESSDPIE 373
L GN G + + + + ++ + E
Sbjct: 243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 54/289 (18%), Positives = 108/289 (37%), Gaps = 22/289 (7%)
Query: 108 LPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLK 166
+ K ++ + L + + S + EL + GN LS L T L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK 226
L++ N+ D+ L L+ L L++N EL ++ L ++NN S +
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 227 IPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM--NL 284
+ + + + +++ + + + + L + + F +L L
Sbjct: 114 VSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 285 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG 344
+ L L I+ ++ + KLK +DLS N L + F+ A ++ L NKL
Sbjct: 172 EHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL 228
Query: 345 PVPKYIFNSN--KNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNK 391
+ K + S ++ D+ N F + V++ + K
Sbjct: 229 -IEKALRFSQNLEHFDLRGNGF---HCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 53/243 (21%), Positives = 98/243 (40%), Gaps = 23/243 (9%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 166
T + L L L++L L+ + ++ SP ++ L++ N L+N+T L
Sbjct: 101 TDISALQNLTNLRELYLNEDNIS-DISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLN 158
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK 226
L++ + P I L +L L L+ N P L LT+L+ N +
Sbjct: 159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI 214
Query: 227 IPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDK 281
P + ++ L I + + P ++ L+ LT L +ISD+ +A L
Sbjct: 215 TP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI----NAVKDLT- 265
Query: 282 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 341
LK L + I + ++++L ++ L+ N L L ++L+ N
Sbjct: 266 -KLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
Query: 342 LTG 344
+T
Sbjct: 323 ITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-26
Identities = 56/238 (23%), Positives = 92/238 (38%), Gaps = 23/238 (9%)
Query: 111 ELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170
L+ L + L+L N SP L L+V +++ P + N+T L +LS+
Sbjct: 127 PLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSL 184
Query: 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEF 230
N P + L +L N T P + +T LN L+I +N + P
Sbjct: 185 NYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-- 238
Query: 231 IGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDKMNLK 285
+ ++ L I + + + LT L L +ISD+ S L L
Sbjct: 239 LANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISDI----SVLNNLS--QLN 290
Query: 286 TLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
+L L + E + IG +T L + LS N++T P L+K + +
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-24
Identities = 52/281 (18%), Positives = 110/281 (39%), Gaps = 33/281 (11%)
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 152
+ L+ ++T + +L + +L ++ + S L L++ GN+++
Sbjct: 23 EGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQGIEYLTNLEYLNLNGNQIT 79
Query: 153 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 212
P L+N+ L NL I N T ++ L NL++L L+ ++ + + L LT
Sbjct: 80 DISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--ISPLANLTK 133
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RIS 267
+ L + N+ + + L + S ++ P I+ LT L L +I
Sbjct: 134 MYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIE 190
Query: 268 DLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327
D+ S L +L I P + +MT+L ++ + N +T P
Sbjct: 191 DI----SPLASLT--SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LA 240
Query: 328 KLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 365
L++ ++ + N+++ +++ N +
Sbjct: 241 NLSQLTWLEIGTNQISDINA---VKDLTKLKMLNVGSNQIS 278
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 49/236 (20%), Positives = 99/236 (41%), Gaps = 17/236 (7%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
+ L + L + +T + + + +L V G +++ + + +T L+ L+
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVTQEELE-SITKLVVAGEKVAS--IQGIEYLTNLEYLN 72
Query: 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 229
+ GN T P + L+ L L + +N T + L LTNL +L ++++N S P
Sbjct: 73 LNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDISP- 127
Query: 230 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKMNLKTLI 288
+ K+ L++ + + +S +T L L +++ K + + L +L +L
Sbjct: 128 -LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTPIANLT--DLYSLS 183
Query: 289 LTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG 344
L I P + +T L N +T P + + N + + NK+T
Sbjct: 184 LNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD 235
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 9e-21
Identities = 44/250 (17%), Positives = 88/250 (35%), Gaps = 19/250 (7%)
Query: 118 LKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG 177
L + P + + + ++ + ++ L + G
Sbjct: 2 AATLATLPAPIN-QIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA- 57
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
SI I L NL+ L L+ N T P L+ L L +L I N + + +
Sbjct: 58 SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNL 112
Query: 238 QKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDKMNLKTLILTKCLIH 295
++L++ ++ P ++ LT + L + S + L L +T+ +
Sbjct: 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMT--GLNYLTVTESKVK 168
Query: 296 GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK 355
P I ++T L ++ L++N + P L ++ N++T P
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVANMTRLN 224
Query: 356 NVDISLNNFT 365
++ I N T
Sbjct: 225 SLKIGNNKIT 234
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-19
Identities = 34/159 (21%), Positives = 68/159 (42%), Gaps = 9/159 (5%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
+ L+ L L N +T +P +L L + N+++ P L N++ L L
Sbjct: 193 SPLASLTSLHYFTAYVNQIT-DITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLE 249
Query: 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 229
I N + I ++ L L+ L + SN + + L L+ LN L +++N + E
Sbjct: 250 IGTNQIS-DINA-VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDME 305
Query: 230 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
IG + L + + + P +++L+ + ++
Sbjct: 306 VIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFAN 342
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 7e-26
Identities = 46/279 (16%), Positives = 97/279 (34%), Gaps = 26/279 (9%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 161
+L L + +K+LDLS N L+ + A +L L++ N L L +
Sbjct: 21 SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LES 78
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
++TL+ L + N ++ +++ L ++N+ + + ++ +++N
Sbjct: 79 LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANN 130
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTDL-----RISDLKGSESA 275
+ G ++Q L ++ + ++ ++ +L L I D+
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV--KGQV 188
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335
LKTL L+ + + + I L N L I
Sbjct: 189 VFA----KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242
Query: 336 YLTGNKLTGPVPKYIFNSNKNV-DISLNNFTWESSDPIE 373
L GN + F+ N+ V ++ + E
Sbjct: 243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-25
Identities = 52/259 (20%), Positives = 102/259 (39%), Gaps = 19/259 (7%)
Query: 115 LRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN 173
K ++ + L + + S + EL + GN LS L T L+ L++ N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 174 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGK 233
+ D+ L L+ L L++N EL ++ L ++NN S ++ +
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSC--SR 118
Query: 234 WKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM--NLKTLILTK 291
+ + +++ + + + + L + + F +L L+ L L
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 292 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351
I+ ++ + KLK +DLS N L + F+ A ++ L NKL + K +
Sbjct: 179 NFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALR 234
Query: 352 NSN--KNVDISLNNFTWES 368
S ++ D+ N F +
Sbjct: 235 FSQNLEHFDLRGNGFHCGT 253
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 35/270 (12%), Positives = 76/270 (28%), Gaps = 17/270 (6%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKV 158
+T + ++ LDL N + + +L+ L++ N +
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE--HLNLQYNFIYD-VKG- 186
Query: 159 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 218
LK L + N + P+ + + + L +N + L NL +
Sbjct: 187 QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDL 244
Query: 219 SDNNFS-GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 277
N F G + +F K +++Q + Q + +L + + F
Sbjct: 245 RGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFA 304
Query: 278 ----KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN 333
L + L + + + + ID I +
Sbjct: 305 DRLIALKRKEHALLSGQGSET-ERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKI 363
Query: 334 FMYLTGNKLTGPVPKYIFNSNKNVDISLNN 363
+ L ++ +D +L
Sbjct: 364 TLEQKKKALD-EQVSNGRRAHAELDGTLQQ 392
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 35/216 (16%), Positives = 71/216 (32%), Gaps = 22/216 (10%)
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
+ N K + + ++ + N+++L LS N + A+L T L L
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 218 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGS 272
+S N + ++ L + + ++ + S+ L IS + S
Sbjct: 65 LSSNVLYE-TLDL-ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV--S 115
Query: 273 ESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG-GIPTTFEKLAK 331
S K + L I G ++++ +DL N +
Sbjct: 116 CSRGQ-----GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 332 TNFMYLTGNKLTGPVPKYIFNSN-KNVDISLNNFTW 366
+ L N + V + + K +D+S N +
Sbjct: 171 LEHLNLQYNFIYD-VKGQVVFAKLKTLDLSSNKLAF 205
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 27/218 (12%), Positives = 59/218 (27%), Gaps = 5/218 (2%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 166
+ L + L+ DL N + S +V + + T
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILS----SNSFTGELPAELTKLTNLNDLRISDNN 222
P +LI L++ + S T L E ++
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM 282
+ I + + + L + +L+ + A L + E ++
Sbjct: 348 YRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQS 407
Query: 283 NLKTLI-LTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319
L+ L + K + +++ D+ + T
Sbjct: 408 PLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-25
Identities = 57/262 (21%), Positives = 103/262 (39%), Gaps = 20/262 (7%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 166
+ + L+KL L+ L + N ++ +P L ELS+ GN+L L ++T L
Sbjct: 190 SDISVLAKLTNLESLIATNNQIS-DITPLGILTNLDELSLNGNQLKDI--GTLASLTNLT 246
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK 226
+L + N + P + L L +L L +N + P L LT L +L +++N
Sbjct: 247 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI 302
Query: 227 IPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDKM-N 283
P I K + L + +++ P +S+LT L L + + L + N
Sbjct: 303 SP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD----VSSLANLTN 354
Query: 284 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
+ L I P + ++T++ + L+ T ++ N + L
Sbjct: 355 INWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI 412
Query: 344 GPVPKYIFNSNKNVDISLNNFT 365
P S DI+ N +
Sbjct: 413 APATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 42/254 (16%), Positives = 93/254 (36%), Gaps = 17/254 (6%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171
+ L + L + +T + Q Q+ L + + + L ++
Sbjct: 20 DTALAEKMKTVLGKTNVTDT-VSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFS 76
Query: 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI 231
N T P ++ L L +++++N L LTNL L + +N + P +
Sbjct: 77 NNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP--L 130
Query: 232 GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTK 291
+ +L + +++ +S LTSL L + L L+ L ++
Sbjct: 131 KNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQVTDLKPLANLT--TLERLDISS 186
Query: 292 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351
+ + +T L+++ + N ++ P L + + L GN+L
Sbjct: 187 NKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLASL 242
Query: 352 NSNKNVDISLNNFT 365
+ ++D++ N +
Sbjct: 243 TNLTDLDLANNQIS 256
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 69/274 (25%), Positives = 110/274 (40%), Gaps = 21/274 (7%)
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 152
+ L N+T T+ + L + L R + S L +++ N+L+
Sbjct: 25 EKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQLT 81
Query: 153 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 212
P L N+T L ++ + N P + L NL L L +N T P L LTN
Sbjct: 82 DITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTN 135
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 272
LN L +S N S + +Q+L G+ + P ++ LT+L L IS K S
Sbjct: 136 LNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVS 190
Query: 273 ESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331
+ L K+ NL++LI T I P +G +T L + L+ N L T L
Sbjct: 191 D--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTN 244
Query: 332 TNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
+ L N+++ P + + N +
Sbjct: 245 LTDLDLANNQISNLAPLSGLTKLTELKLGANQIS 278
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 34/186 (18%), Positives = 67/186 (36%), Gaps = 17/186 (9%)
Query: 164 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 223
L + +I + I D L K +L + T + T L + L+
Sbjct: 2 PLGSATITQDTPINQIFTDT-ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58
Query: 224 SGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDK 281
+ + + +++ + L P + LT L D+ +++ + + L
Sbjct: 59 K--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-TPLANLT- 112
Query: 282 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 341
NL L L I P + ++T L ++LS N ++ + L + GN+
Sbjct: 113 -NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQ 166
Query: 342 LTGPVP 347
+T P
Sbjct: 167 VTDLKP 172
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 27/141 (19%), Positives = 51/141 (36%), Gaps = 7/141 (4%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
+ +S L+ L L L N ++ SP + +L L N++S L N+T + LS
Sbjct: 303 SPISNLKNLTYLTLYFNNIS-DISPVSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLS 359
Query: 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 229
N + P + L + +L L+ ++T ++ N ++ P
Sbjct: 360 AGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APA 415
Query: 230 FIGKWKKIQKLHIQGSSLEGP 250
I + I +
Sbjct: 416 TISDGGSYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-09
Identities = 25/154 (16%), Positives = 56/154 (36%), Gaps = 10/154 (6%)
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 272
L I+ + +I + K + +++ + + L +T L+ L
Sbjct: 3 LGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK 59
Query: 273 E-SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331
L+ NL + + + P + ++TKL +I ++ N + P L
Sbjct: 60 SIDGVEYLN--NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTN 113
Query: 332 TNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
+ L N++T P + +++S N +
Sbjct: 114 LTGLTLFNNQITDIDPLKNLTNLNRLELSSNTIS 147
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-08
Identities = 24/142 (16%), Positives = 51/142 (35%), Gaps = 28/142 (19%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
+ +S L L++L N ++ S + LS N++S P L N+T + L
Sbjct: 325 SPVSSLTKLQRLFFYNNKVS-DVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLG 381
Query: 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN-------- 221
+ +T + P + + +++ + + PA ++ + + I+ N
Sbjct: 382 LNDQAWT-NAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPSYTNEV 439
Query: 222 ---------------NFSGKIP 228
FSG +
Sbjct: 440 SYTFSQPVTIGKGTTTFSGTVT 461
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 63/312 (20%), Positives = 120/312 (38%), Gaps = 40/312 (12%)
Query: 85 CDCSSATCHV------------------VTIALKAQNLTGTLPTELSKLRYLKQLDLSRN 126
C+CS+ V + L + E + +L++L+L+ N
Sbjct: 7 CECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN 66
Query: 127 CLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPD 182
++ G+F+ +L+ + L NRL V T ++ L L I N +
Sbjct: 67 IVSAVEPGAFNNL-FNLRTLGLR--SNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDY 122
Query: 183 I-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKIPE--FIGKWKKIQ 238
+ + L NL+ L + N + + L +L L + N + IP +
Sbjct: 123 MFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSH-LHGLI 179
Query: 239 KLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPK-LDKMNLKTLILTKCLIHGE 297
L ++ ++ S L L L IS ++ P L +NL +L +T C +
Sbjct: 180 VLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-A 238
Query: 298 IPDY-IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN 356
+P + + L+ ++LS+N ++ + +L + + L G +L V Y F
Sbjct: 239 VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAV-VEPYAFRGLNY 297
Query: 357 V---DISLNNFT 365
+ ++S N T
Sbjct: 298 LRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-21
Identities = 51/248 (20%), Positives = 86/248 (34%), Gaps = 21/248 (8%)
Query: 107 TLPTE-LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
+P + L L +LD+S N + F L L V N L + +
Sbjct: 94 LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDL---YNLKSLEVGDNDLVYISHRAFSG 150
Query: 162 ITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220
+ +L+ L++E T SIP + L L L L + +L L L IS
Sbjct: 151 LNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESA 275
+ + + L I +L ++ L L L IS + S
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTI--EGSM 267
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNF 334
+L L+ + L + + Y + L+ +++S N LT + F +
Sbjct: 268 LHELL--RLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLET 324
Query: 335 MYLTGNKL 342
+ L N L
Sbjct: 325 LILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 26/135 (19%), Positives = 47/135 (34%), Gaps = 11/135 (8%)
Query: 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRL 151
+ + T+ L L ++ LT + L+ + LS N +
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHL-VYLRFLNLS--YNPI 260
Query: 152 SGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TK 209
S +L + L+ + + G + P R L L+ L +S N T L +
Sbjct: 261 STIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHS 318
Query: 210 LTNLNDLRISDNNFS 224
+ NL L + N +
Sbjct: 319 VGNLETLILDSNPLA 333
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-22
Identities = 55/299 (18%), Positives = 99/299 (33%), Gaps = 34/299 (11%)
Query: 99 LKAQNLTGTLPTE-LSKLRYLKQLDLSRNCLTGSFSPQW-ASLQ-LVELSVMGNRLSGPF 155
L +Q T+ E L L+ LDL + + P L L EL + LS
Sbjct: 55 LGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAV 113
Query: 156 --PKVLTNITTLKNLSIEGNLFTG-SIPPDIRKLINLQKLILSSNSFTGELPAELTKLT- 211
N+ L L + N + P KL +L+ + SSN EL L
Sbjct: 114 LKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173
Query: 212 -NLNDLRISDNNFSGKIPEFIGKWKK------IQKLHIQGSSLEGPIPA---------SI 255
L+ ++ N+ ++ GK ++ L + G+ I
Sbjct: 174 KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQA 233
Query: 256 SALTSLTDLRISDLKG------SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLK 309
+L + + ++ F L + +++ L L+ + + LK
Sbjct: 234 FSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLK 293
Query: 310 NIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV---DISLNNFT 365
++L++N + F L + L+ N L + F V D+ N+
Sbjct: 294 VLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE-LYSSNFYGLPKVAYIDLQKNHIA 351
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-21
Identities = 46/274 (16%), Positives = 95/274 (34%), Gaps = 22/274 (8%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTN 161
+ L+ LK L+L+ N + + L L L++ N L +
Sbjct: 277 FVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYG 336
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
+ + + ++ N + L LQ L L N+ T + + ++ D+ +S N
Sbjct: 337 LPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGN 391
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTDLRISDLK----GSESAF 276
+H+ + LE I + + L L ++ + +
Sbjct: 392 KLV----TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTP 447
Query: 277 PKLDKMNLKTLILTKCLIHGEIPDYI-----GDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331
+ +L+ L L + ++ + ++ L+ + L+ N L P F L
Sbjct: 448 SENP--SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTA 505
Query: 332 TNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
+ L N+LT + + + +DIS N
Sbjct: 506 LRGLSLNSNRLTVLSHNDLPANLEILDISRNQLL 539
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 8e-20
Identities = 41/276 (14%), Positives = 89/276 (32%), Gaps = 20/276 (7%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQW-ASL-QLVELSVMGNRLSGPFPKVLT 160
+ + L L+ L+L + + +L L L + +++ P
Sbjct: 35 YIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ 94
Query: 161 NITTLKNLSIEGNLFTGSIPPD--IRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLR 217
+ L L + + ++ D R L L +L LS N L KL +L +
Sbjct: 95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSID 154
Query: 218 ISDNNFSGKIPE-FIG-KWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISDLKGSES 274
S N + K + + +SL + + ++ + L S +
Sbjct: 155 FSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN 214
Query: 275 AFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN- 333
+ N I + + F+N+ TF LA+++
Sbjct: 215 GWTVDITGNFSN------AISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSV 268
Query: 334 -FMYLTGNKLTGPVPKYIFNSNKNV---DISLNNFT 365
+ L+ + + +F + K++ +++ N
Sbjct: 269 RHLDLSHGFVFS-LNSRVFETLKDLKVLNLAYNKIN 303
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 3e-17
Identities = 45/271 (16%), Positives = 91/271 (33%), Gaps = 43/271 (15%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 161
+ L L+ L+LS N L +S + L ++ + + N ++ +
Sbjct: 301 KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTG-------------------- 201
+ L+ L + N T I + ++ + LS N
Sbjct: 361 LEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLEN 415
Query: 202 -ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKW-KKIQKLHIQGSSLEGPIPASI--SA 257
++ L ++ +L L ++ N FS + +++L + + L+ +
Sbjct: 416 LDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDV 475
Query: 258 LTSLTDLRISDLKG------SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNI 311
L+ L++ L F L L+ L L + + L+ +
Sbjct: 476 FEGLSHLQVLYLNHNYLNSLPPGVFSHLT--ALRGLSLNSNRLT-VLSHND-LPANLEIL 531
Query: 312 DLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 342
D+S N L P F L + + +T NK
Sbjct: 532 DISRNQLLAPNPDVFVSL---SVLDITHNKF 559
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 8e-16
Identities = 51/297 (17%), Positives = 89/297 (29%), Gaps = 51/297 (17%)
Query: 84 TCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVE 143
+C + NLT +P L+ L LS N +
Sbjct: 1 SCSFDGRIAF-----YRFCNLT-QVPQVLNTTERL---LLSFN-------------YIRT 38
Query: 144 LSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGE 202
++ + L+ L + +I + R L NL+ L L S+
Sbjct: 39 VT----------ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-F 87
Query: 203 LPAE-LTKLTNLNDLRISDNNFSGKI--PEFIGKWKKIQKLHIQGSSLEG-PIPASISAL 258
L + L +L +LR+ S + + K + +L + + + + S L
Sbjct: 88 LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKL 147
Query: 259 TSLTDLRISDLK---GSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTK------LK 309
SL + S + E L L L ++ + G L+
Sbjct: 148 NSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLE 207
Query: 310 NIDLSFNNLTGGIPTTFEK-LAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
+D+S N T I F ++K+ L F + D N F
Sbjct: 208 ILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGA---GFGFHNIKDPDQNTFA 261
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 3e-15
Identities = 43/210 (20%), Positives = 68/210 (32%), Gaps = 22/210 (10%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKI-PEFIGKWKK 236
+P + ++L+LS N + L L L + I E
Sbjct: 18 QVPQVLN---TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74
Query: 237 IQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTK 291
++ L + S + P + L L +L +SD + F L L L L+K
Sbjct: 75 LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK--ALTRLDLSK 132
Query: 292 CLIHG-EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN--FMYLTGNKLTGPVPK 348
I + G + LK+ID S N + E L F L N L V
Sbjct: 133 NQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSV 192
Query: 349 YIFNSNKN--------VDISLNNFTWESSD 370
+D+S N +T + +
Sbjct: 193 DWGKCMNPFRNMVLEILDVSGNGWTVDITG 222
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-14
Identities = 43/298 (14%), Positives = 98/298 (32%), Gaps = 44/298 (14%)
Query: 111 ELSKLRYLKQLDLSRNCLT----GSFSPQWASLQ---------LVELSVMGNRLSGPFPK 157
+ L+ LD+S N T G+FS + Q ++ + + P
Sbjct: 199 NPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN 258
Query: 158 VLTNI--TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLN 214
+ +++++L + S+ + L +L+ L L+ N L NL
Sbjct: 259 TFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQ 317
Query: 215 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDL 269
L +S N K+ + +Q + + + L L L ++ +
Sbjct: 318 VLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI 377
Query: 270 KGSES------------AFPKLDKMNLKTLILTKCLIHG-EIPDYIGDMTKLKNIDLSFN 316
S PK++ + + L++ + +I ++ + L+ + L+ N
Sbjct: 378 HFIPSIPDIFLSGNKLVTLPKIN-LTANLIHLSENRLENLDILYFLLRVPHLQILILNQN 436
Query: 317 NLTGGIPT-TFEKLAKTNFMYLTGNKLTGP----VPKYIFNSNKNV---DISLNNFTW 366
+ T + ++L N L + +F ++ ++ N
Sbjct: 437 RFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNS 494
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 40/197 (20%), Positives = 73/197 (37%), Gaps = 17/197 (8%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSG-PFPK 157
L+ +L T + + + + LS N L + + L+ LS NRL
Sbjct: 364 LQTLDLRDNALTTIHFIPSIPDIFLSGNKLV-TLPKINLTANLIHLS--ENRLENLDILY 420
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPD--IRKLINLQKLILSSNSFTGELPAELTK-----L 210
L + L+ L + N F+ S D + +L++L L N EL L
Sbjct: 421 FLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGL 479
Query: 211 TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD-- 268
++L L ++ N + P ++ L + + L + + +L L IS
Sbjct: 480 SHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV-LSHN-DLPANLEILDISRNQ 537
Query: 269 -LKGSESAFPKLDKMNL 284
L + F L +++
Sbjct: 538 LLAPNPDVFVSLSVLDI 554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 29/125 (23%), Positives = 48/125 (38%), Gaps = 7/125 (5%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPK 157
L+ T L +L+ L L+ N L ++ L L LS+ NRL+
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHN 522
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELP-AELTKLTNLNDL 216
L L+ L I N + PD+ ++L L ++ N F E + N ++
Sbjct: 523 DLP--ANLEILDISRNQLL-APNPDV--FVSLSVLDITHNKFICECELSTFINWLNHTNV 577
Query: 217 RISDN 221
I+
Sbjct: 578 TIAGP 582
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 45/240 (18%), Positives = 81/240 (33%), Gaps = 39/240 (16%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTL 165
LP L ++ N L P+ +L L + N L P + + L
Sbjct: 167 KLPDLPPSLEFI---AAGNNQLE--ELPELQNLPFLTAIYADNNSLKK-LPDLPLS---L 217
Query: 166 KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG 225
+++ N+ P+++ L L + +N LP L LN + DN +
Sbjct: 218 ESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALN---VRDNYLT- 270
Query: 226 KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT--DLRISDLKGSESAFPKLDKMN 283
+PE + S L L L I L +
Sbjct: 271 DLPELPQSLTFLDVSENIFSGL----SELPPNLYYLNASSNEIRSLCDLPP--------S 318
Query: 284 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
L+ L ++ + E+P +L+ + SFN+L +P + L + +++ N L
Sbjct: 319 LEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQNLKQ---LHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-21
Identities = 50/251 (19%), Positives = 95/251 (37%), Gaps = 39/251 (15%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 166
EL L +L + N L + SL+ L+V N L+ P++ ++T L
Sbjct: 228 EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLE--ALNVRDNYLTD-LPELPQSLTFLD 283
Query: 167 NLSIEGNLFTGSIPPDIRKLI--------------NLQKLILSSNSFTGELPAELTKLTN 212
+ + +PP++ L +L++L +S+N ELPA +L
Sbjct: 284 VSENIFSGLS-ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER 341
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 272
L S N+ + ++PE +++LH++ + L P S+ DLR++
Sbjct: 342 LI---ASFNHLA-EVPELPQN---LKQLHVEYNPLRE-FPDIPE---SVEDLRMNSHLAE 390
Query: 273 ESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT 332
P+ NLK L + + E PD ++++ ++ + E K
Sbjct: 391 VPELPQ----NLKQLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKL 442
Query: 333 NFMYLTGNKLT 343
+
Sbjct: 443 EDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-20
Identities = 46/258 (17%), Positives = 93/258 (36%), Gaps = 46/258 (17%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL--------------QLVELSVMG 148
NLT +P E ++ + + + + P Q EL +
Sbjct: 22 NLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNN 80
Query: 149 NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELT 208
LS P++ + L++L N T +P + L +L + + + +LP L
Sbjct: 81 LGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS-DLPPLLE 134
Query: 209 KLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT--DLRI 266
L +S+N K+PE + ++ + + +SL+ +P +L + + ++
Sbjct: 135 Y------LGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAAGNNQL 185
Query: 267 SDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTT 325
+L P+L + L + + ++PD L++I N L
Sbjct: 186 EEL-------PELQNLPFLTAIYADNNSLK-KLPDLPL---SLESIVAGNNILE--ELPE 232
Query: 326 FEKLAKTNFMYLTGNKLT 343
+ L +Y N L
Sbjct: 233 LQNLPFLTTIYADNNLLK 250
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 7e-15
Identities = 32/196 (16%), Positives = 71/196 (36%), Gaps = 35/196 (17%)
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKL------------ 210
T L+ + T +P + + + + + + + P +
Sbjct: 11 TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL 69
Query: 211 -TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT--DLRIS 267
++L +++ S +PE ++ L +SL +P +L SL + +
Sbjct: 70 DRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLK 124
Query: 268 DLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327
L S P L+ L ++ + ++P+ + + + LK ID+ N+L +P
Sbjct: 125 AL----SDLPP----LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPP 173
Query: 328 KLAKTNFMYLTGNKLT 343
L + N+L
Sbjct: 174 SLEF---IAAGNNQLE 186
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 55/298 (18%), Positives = 102/298 (34%), Gaps = 51/298 (17%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQ 140
C CS+ V+ +NL +P +S + L+L N + SF
Sbjct: 39 CSCSNQFSKVI---CVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLR---H 89
Query: 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSF 199
L L + N + + L L + N T +IP L L++L L +N
Sbjct: 90 LEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI 148
Query: 200 TGELPAEL-TKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 258
+P+ ++ +L L + + ++ +I + EG L
Sbjct: 149 E-SIPSYAFNRIPSLRRLDLGELK-------------RLS--YISEGAFEG--------L 184
Query: 259 TSLTDLRISDLKGSE-SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNN 317
++L L ++ E L L L L+ + P + L+ + + +
Sbjct: 185 SNLRYLNLAMCNLREIPNLTPLI--KLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ 242
Query: 318 LTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN-VDISLNNFTWESSDPIEC 374
+ F+ L + L N LT +P +F + I L++ +P C
Sbjct: 243 IQVIERNAFDNLQSLVEINLAHNNLTL-LPHDLFTPLHHLERIHLHH------NPWNC 293
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 6e-22
Identities = 53/295 (17%), Positives = 106/295 (35%), Gaps = 45/295 (15%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVE 143
C CS+ VV + L+ +P + + L+L N + + + L L
Sbjct: 50 CSCSNQFSKVV---CTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEV 103
Query: 144 LSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGE 202
L + N + + +L L + N T IP L L++L L +N
Sbjct: 104 LQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-S 161
Query: 203 LPAE-LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSL 261
+P+ ++ +L L + + K++ +I + EG L +L
Sbjct: 162 IPSYAFNRVPSLMRLDLGELK-------------KLE--YISEGAFEG--------LFNL 198
Query: 262 TDLRISDLKGSE-SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG 320
L + + L L+ L ++ P ++ LK + + + ++
Sbjct: 199 KYLNLGMCNIKDMPNLTPLV--GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL 256
Query: 321 GIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN-VDISLNNFTWESSDPIEC 374
F+ LA + L N L+ +P +F + V++ L++ +P C
Sbjct: 257 IERNAFDGLASLVELNLAHNNLSS-LPHDLFTPLRYLVELHLHH------NPWNC 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 19/99 (19%), Positives = 35/99 (35%), Gaps = 6/99 (6%)
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMI 726
+ + G FG V+K L +AVK + +Q + E+ +
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYSL 72
Query: 727 SAQQHPNLVKLYGCCVEGN----QLLLVYEYMKNNCLSR 761
+H N+++ G G L L+ + + LS
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD 111
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 96.6 bits (240), Expect = 6e-21
Identities = 52/271 (19%), Positives = 91/271 (33%), Gaps = 43/271 (15%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
NL+ +LP L + L++++N L S ASL+ L NRLS P++ +
Sbjct: 70 NLS-SLPDNLPPQ--ITVLEITQNALI-SLPELPASLE--YLDACDNRLST-LPELPAS- 121
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
LK+L ++ N T +P L+ + +N T LP T L L+ + +N
Sbjct: 122 --LKHLDVDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELPTSLEVLS---VRNNQ 171
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM 282
+ +PE ++ L + + LE +PA + I
Sbjct: 172 LT-FLPELPES---LEALDVSTNLLES-LPAVPVRNHHSEETEIF--------------- 211
Query: 283 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 342
+ I IP+ I + I L N L+ I + + +
Sbjct: 212 ----FRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266
Query: 343 TGPVPKYIFNSNKNVDISLNNFTWESSDPIE 373
+ + D F +
Sbjct: 267 SMSDGQQNTLHRPLADAVTAWFPENKQSDVS 297
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 1e-14
Identities = 43/278 (15%), Positives = 87/278 (31%), Gaps = 43/278 (15%)
Query: 149 NRLSGPFPKVLTNITTLKNLSIEGNLFTG--SIPPDIRKLINLQKLILSSNSFTGELPAE 206
N +SG + + + ++ G S+ + + +L L+ + + LP
Sbjct: 20 NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC-LINQFSELQLNRLNLS-SLPDN 77
Query: 207 LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSL----- 261
L + L I+ N +PE ++ L + L +P ++L L
Sbjct: 78 L--PPQITVLEITQNALI-SLPELPA---SLEYLDACDNRLST-LPELPASLKHLDVDNN 130
Query: 262 ---------TDLRISDLKGSE-SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNI 311
L + ++ + P+L +L+ L + + +P+ + L
Sbjct: 131 QLTMLPELPALLEYINADNNQLTMLPELPT-SLEVLSVRNNQL-TFLPELPESLEAL--- 185
Query: 312 DLSFNNLTGGIPTTFEKLAK----TNFMYLTGNKLTGPVPKYIFN--SNKNVDISLNNFT 365
D+S N L +P + F N++T +P+ I + + + N
Sbjct: 186 DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPL- 242
Query: 366 WESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNF 403
S I Y PR
Sbjct: 243 ---SSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLH 277
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 36/246 (14%), Positives = 69/246 (28%), Gaps = 18/246 (7%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
N LP + L L + N LT SL+ L V N L P V
Sbjct: 149 NNQLTMLPELPTSLEVL---SVRNNQLT-FLPELPESLE--ALDVSTNLLES-LPAVPVR 201
Query: 162 ITTLKN----LSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
+ N T IP +I L +IL N + + L++ T D
Sbjct: 202 NHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYH 260
Query: 218 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 277
FS + + + + + +S + + + +
Sbjct: 261 GPRIYFSMSDGQQNTLHRPLA--DAVTAWFPENKQSDVSQIWH----AFEHEEHANTFSA 314
Query: 278 KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL 337
LD+++ ++ ++ ++ + + + E + L
Sbjct: 315 FLDRLSDTVSARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNL 374
Query: 338 TGNKLT 343
L
Sbjct: 375 RKTLLV 380
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 53/268 (19%), Positives = 85/268 (31%), Gaps = 50/268 (18%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQ 140
C C + + Q L +P + +++ L N ++ SF
Sbjct: 6 CVCYNEPKVTTS--CPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRAC---RN 57
Query: 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSF 199
L L + N L+ T + L+ L + N S+ P L L L L
Sbjct: 58 LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
Query: 200 TGELPAE-LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 258
EL L L L + DN + + L
Sbjct: 118 Q-ELGPGLFRGLAALQYLYLQDNALQ----------------ALPDDTFRD--------L 152
Query: 259 TSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNID 312
+LT L RIS + E AF L +L L+L + + + + D+ +L +
Sbjct: 153 GNLTHLFLHGNRISSV--PERAFRGLH--SLDRLLLHQNRVA-HVHPHAFRDLGRLMTLY 207
Query: 313 LSFNNLTGGIPTTFEKLAKTNFMYLTGN 340
L NNL+ L ++ L N
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 50/219 (22%), Positives = 81/219 (36%), Gaps = 21/219 (9%)
Query: 159 LTNI-----TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTN 212
L + + + + GN + +P R NL L L SN A T L
Sbjct: 23 LQAVPVGIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 213 LNDLRISDNNFSGKIPE--FIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISD- 268
L L +SDN + F G ++ LH+ L+ + + L +L L + D
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHG-LGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDN 139
Query: 269 -LKG-SESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTT 325
L+ + F L NL L L I +P+ + L + L N + P
Sbjct: 140 ALQALPDDTFRDL--GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
Query: 326 FEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV-DISLNN 363
F L + +YL N L+ +P + + + LN+
Sbjct: 197 FRDLGRLMTLYLFANNLSA-LPTEALAPLRALQYLRLND 234
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 34/119 (28%), Positives = 49/119 (41%), Gaps = 13/119 (10%)
Query: 112 LSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLK 166
L L+ L L N L +F L L L + GNR+S + + +L
Sbjct: 125 FRGLAALQYLYLQDNALQALPDDTFR----DLGNLTHLFLHGNRISSVPERAFRGLHSLD 180
Query: 167 NLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNF 223
L + N + P R L L L L +N+ + LP E L L L LR++DN +
Sbjct: 181 RLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 1e-20
Identities = 29/100 (29%), Positives = 43/100 (43%), Gaps = 11/100 (11%)
Query: 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNE--IGMISAQQH 731
+N +G G +G+VYKG L D +AVK S +RQ F+NE I + +H
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEH 66
Query: 732 PNLVKLYGCCVEGN-----QLLLVYEYMKNNCLSRAIFGK 766
N+ + + LLV EY N L + +
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH 106
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 45/244 (18%), Positives = 98/244 (40%), Gaps = 24/244 (9%)
Query: 107 TLPTE-LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
LP L R ++ L+L+ + +F+ ++Q + + N + P V N
Sbjct: 59 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYA-HTIQKLYMG--FNAIRYLPPHVFQN 115
Query: 162 ITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRIS 219
+ L L +E N + S+P I L L +S+N+ + + T+L +L++S
Sbjct: 116 VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLS 173
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL 279
N + + + + ++ + L +++ ++ +L S +
Sbjct: 174 SNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV--VRGP 223
Query: 280 DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG 339
+ L L L + + + + L +DLS+N L + F K+ + +Y++
Sbjct: 224 VNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 281
Query: 340 NKLT 343
N+L
Sbjct: 282 NRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-18
Identities = 48/275 (17%), Positives = 92/275 (33%), Gaps = 38/275 (13%)
Query: 112 LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKN 167
+ L L L RN L+ G F +L LS+ N L T+L+N
Sbjct: 113 FQNVPLLTVLVLERNDLSSLPRGIFHNT---PKLTTLSMSNNNLERIEDDTFQATTSLQN 169
Query: 168 LSIEGNLFTGSIPPD-----------------IRKLINLQKLILSSNSFTGELPAELTKL 210
L + N T + + I +++L S NS + +
Sbjct: 170 LQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--N 225
Query: 211 TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD-- 268
L L++ NN + + + + ++ + + LE + + L L IS+
Sbjct: 226 VELTILKLQHNNLT-DTAWLLN-YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283
Query: 269 LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328
L + LK L L+ + + +L+N+ L N++ +T
Sbjct: 284 LVALNLYGQPIP--TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHT 340
Query: 329 LAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNN 363
L + L+ N + +F + + +
Sbjct: 341 LKN---LTLSHNDWDCNSLRALFRNVARPAVDDAD 372
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 9e-18
Identities = 49/284 (17%), Positives = 101/284 (35%), Gaps = 31/284 (10%)
Query: 80 ESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQ 135
+SN+ DC + V I ++ Q++ E L K + + +
Sbjct: 14 DSNLQYDC---VFYDVHIDMQTQDVYFGF--EDITLNNQKIVTFKNSTMRKLPAALLDSF 68
Query: 136 WASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLIL 194
++L+ L+ ++ T++ L + N +PP + + + L L+L
Sbjct: 69 -RQVELLNLN--DLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVL 124
Query: 195 SSNSFTGELPAEL-TKLTNLNDLRISDNNFSGKIPEFIGKW-KKIQKLHIQGSSLEGPIP 252
N + LP + L L +S+NN +I + + +Q L + + L +
Sbjct: 125 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VD 181
Query: 253 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNID 312
+S + SL +S S + ++ L + I+ + +L +
Sbjct: 182 --LSLIPSLFHANVSYNLLST--LAIP--IAVEELDASHNSIN-VVRG--PVNVELTILK 232
Query: 313 LSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN 356
L NNLT + L+ N+L + + F +
Sbjct: 233 LQHNNLTD--TAWLLNYPGLVEVDLSYNELEK-IMYHPFVKMQR 273
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 33/171 (19%), Positives = 71/171 (41%), Gaps = 11/171 (6%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 158
L N++ L + L+ +++LD S N + +++L L + N L+
Sbjct: 188 LFHANVSYNLLSTLAIPIAVEELDASHNSIN--VVRGPVNVELTILKLQHNNLTD--TAW 243
Query: 159 LTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
L N L + + N I K+ L++L +S+N L + L L
Sbjct: 244 LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLD 301
Query: 218 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
+S N+ + ++ +++ L++ +S+ + +S +L +L +S
Sbjct: 302 LSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSH 348
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 41/236 (17%), Positives = 78/236 (33%), Gaps = 36/236 (15%)
Query: 156 PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLN 214
L ++ I+ + L N + + +++ +LPA L +
Sbjct: 14 DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVE 72
Query: 215 DLRISDNNFSGKIPEFI-GKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDL-----RIS 267
L ++D +I + IQKL++ +++ +P + + LT L +S
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS 130
Query: 268 DLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIP--- 323
L F L TL ++ + I D T L+N+ LS N LT +
Sbjct: 131 SL--PRGIFHNTP--KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSL 184
Query: 324 --------------TTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
+T + + N + V + + + NN T
Sbjct: 185 IPSLFHANVSYNLLSTLAIPIAVEELDASHNSINV-VRGPVNVELTILKLQHNNLT 239
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 5e-20
Identities = 50/269 (18%), Positives = 107/269 (39%), Gaps = 27/269 (10%)
Query: 107 TLPTE-LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
LP L R ++ L+L+ + +F+ ++Q + + N + P V N
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYA-HTIQKLYMG--FNAIRYLPPHVFQN 121
Query: 162 ITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRIS 219
+ L L +E N + S+P I L L +S+N+ + + T+L +L++S
Sbjct: 122 VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLS 179
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL 279
N + + + + ++ + L +++ ++ +L S +
Sbjct: 180 SNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNS--INVVRGP 229
Query: 280 DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG 339
+ L L L + + + + L +DLS+N L + F K+ + +Y++
Sbjct: 230 VNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 287
Query: 340 NKLTGPVPKYIFNSN--KNVDISLNNFTW 366
N+L + Y K +D+S N+
Sbjct: 288 NRLVA-LNLYGQPIPTLKVLDLSHNHLLH 315
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 5e-18
Identities = 51/307 (16%), Positives = 101/307 (32%), Gaps = 44/307 (14%)
Query: 112 LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKN 167
+ L L L RN L+ G F +L LS+ N L T+L+N
Sbjct: 119 FQNVPLLTVLVLERNDLSSLPRGIFHNTP---KLTTLSMSNNNLERIEDDTFQATTSLQN 175
Query: 168 LSIEGNLFTGSIPPD-----------------IRKLINLQKLILSSNSFTGELPAELTKL 210
L + N T + + I +++L S NS + +
Sbjct: 176 LQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--N 231
Query: 211 TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD-- 268
L L++ NN + + + + ++ + + LE + + L L IS+
Sbjct: 232 VELTILKLQHNNLT-DTAWLLN-YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 289
Query: 269 LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328
L + LK L L+ + + +L+N+ L N++ +T
Sbjct: 290 LVALNLYGQPIP--TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHT 346
Query: 329 LAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSP 388
L + L+ N + +F + + + + + + S
Sbjct: 347 LKN---LTLSHNDWDCNSLRALFRNVARPAVDDADQH------CKIDYQLEHGLCCKESD 397
Query: 389 RNKLDKV 395
+ LD++
Sbjct: 398 KPYLDRL 404
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 9e-18
Identities = 49/284 (17%), Positives = 101/284 (35%), Gaps = 31/284 (10%)
Query: 80 ESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQ 135
+SN+ DC + V I ++ Q++ E L K + + +
Sbjct: 20 DSNLQYDC---VFYDVHIDMQTQDVYFGF--EDITLNNQKIVTFKNSTMRKLPAALLDSF 74
Query: 136 WASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLIL 194
++L+ L+ ++ T++ L + N +PP + + + L L+L
Sbjct: 75 -RQVELLNLN--DLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVL 130
Query: 195 SSNSFTGELPAEL-TKLTNLNDLRISDNNFSGKIPEFIGKW-KKIQKLHIQGSSLEGPIP 252
N + LP + L L +S+NN +I + + +Q L + + L +
Sbjct: 131 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VD 187
Query: 253 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNID 312
+S + SL +S S + ++ L + I+ + +L +
Sbjct: 188 --LSLIPSLFHANVSYNLLST--LAIP--IAVEELDASHNSIN-VVRG--PVNVELTILK 238
Query: 313 LSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN 356
L NNLT + L+ N+L + + F +
Sbjct: 239 LQHNNLTD--TAWLLNYPGLVEVDLSYNELEK-IMYHPFVKMQR 279
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 72.3 bits (177), Expect = 3e-13
Identities = 36/217 (16%), Positives = 74/217 (34%), Gaps = 38/217 (17%)
Query: 156 PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLN 214
L ++ I+ + L N + + +++ +LPA L +
Sbjct: 20 DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVE 78
Query: 215 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDL 269
L ++D +I+++ + + ++ L I L
Sbjct: 79 LLNLNDL--------------QIEEID----------TYAFAYAHTIQKLYMGFNAIRYL 114
Query: 270 KGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEK 328
F + L L+L + + +P I + KL + +S NNL TF+
Sbjct: 115 --PPHVFQNVP--LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA 169
Query: 329 LAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
+ L+ N+LT V + S + ++S N +
Sbjct: 170 TTSLQNLQLSSNRLTH-VDLSLIPSLFHANVSYNLLS 205
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 7e-20
Identities = 54/271 (19%), Positives = 93/271 (34%), Gaps = 28/271 (10%)
Query: 108 LPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNIT 163
+ + L + L + S++ W L+LV + K L +T
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF--GQFPTLKLKSLKRLT 331
Query: 164 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFT--GELPAELTKLTNLNDLRISDN 221
N L +L+ L LS N + G T+L L +S N
Sbjct: 332 FTSNKGGNAFSEVD--------LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISDLKGS---ESAFP 277
+ ++++ L Q S+L+ S+ +L +L L IS F
Sbjct: 384 GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442
Query: 278 KLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 336
L +L+ L + I ++ L +DLS L PT F L+ +
Sbjct: 443 GL--SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500
Query: 337 LTGNKLTGPVPKYIFNSNKN---VDISLNNF 364
+ N+L VP IF+ + + + N +
Sbjct: 501 MASNQLKS-VPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-19
Identities = 61/352 (17%), Positives = 108/352 (30%), Gaps = 68/352 (19%)
Query: 61 DPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQ 120
+PC + N+T C N +P L K
Sbjct: 1 EPCVEVVP-------------NITYQCME------------LNFY-KIPDNLP--FSTKN 32
Query: 121 LDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIP 180
LDLS N L L + L+ L + +I
Sbjct: 33 LDLSFN-------------PLRHLG----------SYSFFSFPELQVLDLSRCEIQ-TIE 68
Query: 181 PD-IRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK 239
+ L +L LIL+ N + L++L L + N + IG K +++
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128
Query: 240 LHIQGSSL-EGPIPASISALTSLTDLRISD--LKG-SESAFPKLDKMNLK--TLILTKCL 293
L++ + + +P S LT+L L +S ++ + L +M L +L L+
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 294 IHGEIPDYIGDMTKLKNIDLSFNNLTGGIP-TTFEKLAKTNFMYLTGNKLTG-----PVP 347
++ I +L + L N + + T + LA L +
Sbjct: 189 MN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247
Query: 348 KYIFNSNKNVDISLNNFTWESSDPIECPRGSVNL--VESYSSPRNKLDKVHP 397
K N+ I + + L V S+S +++V
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-15
Identities = 46/283 (16%), Positives = 85/283 (30%), Gaps = 29/283 (10%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNC---------LTGSFSPQWASLQLVELSVMGNRLS 152
+ + T + L L+ L S +L + E +
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270
Query: 153 G-PFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLT 211
+ +T + + S+ D Q L L + F + P KL
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFG-QFPTL--KLK 325
Query: 212 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE--GPIPASISALTSLTDLRISD- 268
+L L + N + ++ L + + L G S TSL L +S
Sbjct: 326 SLKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 269 -LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI--GDMTKLKNIDLSFNNLTGGIPTT 325
+ S F L L+ L + ++ ++ + L +D+S +
Sbjct: 384 GVITMSSNFLGL--EQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 326 FEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV---DISLNNFT 365
F L+ + + GN IF +N+ D+S
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-11
Identities = 33/140 (23%), Positives = 55/140 (39%), Gaps = 8/140 (5%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPK-VLTNITTLKNLS 169
LR L LD+S +F+ + L L L + GN F + T + L L
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476
Query: 170 IEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKI 227
+ + P L +LQ L ++SN +P +LT+L + + N +
Sbjct: 477 LSQCQLE-QLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 534
Query: 228 P--EFIGKWKKIQKLHIQGS 245
P +++ +W QGS
Sbjct: 535 PRIDYLSRWLNKNSQKEQGS 554
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 21/88 (23%), Positives = 37/88 (42%), Gaps = 3/88 (3%)
Query: 103 NLTGTLPTE-LSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLT 160
+ + ++LR L LDLS+ L + SL L L++ N+L +
Sbjct: 456 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFD 515
Query: 161 NITTLKNLSIEGNLFTGSIPPDIRKLIN 188
+T+L+ + + N + S P I L
Sbjct: 516 RLTSLQKIWLHTNPWDCS-CPRIDYLSR 542
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 51/291 (17%), Positives = 101/291 (34%), Gaps = 36/291 (12%)
Query: 81 SNVTCDCSSA---------TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT-- 129
N C SS T V ++ L +T ++L + L+ L L+ N +
Sbjct: 32 RNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTI 91
Query: 130 --GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI--RK 185
SFS L L + N LS +++L L++ GN + ++
Sbjct: 92 EEDSFSSLG---SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSH 147
Query: 186 LINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKIPE--FIGKWKKIQKLHI 242
L LQ L + + ++ + LT L +L I ++ + L +
Sbjct: 148 LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQ-NVSHLIL 205
Query: 243 QGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL---------DKMNLKTLILTKCL 293
+ + +S+ L + D F +L K + + +T
Sbjct: 206 HMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDES 265
Query: 294 IHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT-TFEKLAKTNFMYLTGNKLT 343
+ ++ + ++ L ++ S N L +P F++L ++L N
Sbjct: 266 LF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 39/211 (18%), Positives = 77/211 (36%), Gaps = 41/211 (19%)
Query: 159 LTNI-----TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLT 211
L +I +K+L + N T I ++ +NLQ L+L+SN + + + L
Sbjct: 43 LNSIPSGLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLG 100
Query: 212 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--L 269
+L L +S N + L + L+SLT L +
Sbjct: 101 SLEHLDLSYN--------------YLSNLS----------SSWFKPLSSLTFLNLLGNPY 136
Query: 270 K--GSESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTF 326
K G S F L L+ L + +I +T L+ +++ ++L P +
Sbjct: 137 KTLGETSLFSHL--TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSL 194
Query: 327 EKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV 357
+ + + + L + + + + +V
Sbjct: 195 KSIQNVSHLILHMKQHIL-LLEIFVDVTSSV 224
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 54/276 (19%), Positives = 100/276 (36%), Gaps = 36/276 (13%)
Query: 109 PTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITT 164
+ L++L L L N ++ +FSP +L +L + N L P + ++
Sbjct: 71 KDDFKGLQHLYALVLVNNKISKIHEKAFSPL---RKLQKLYISKNHLVEIPPNLPSS--- 124
Query: 165 LKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFT-GELPAELTKLTNLNDLRISDNN 222
L L I N +P + L N+ + + N LN LRIS+
Sbjct: 125 LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA-SISALTSLTDL-----RISDLKGSESAF 276
+ IP+ + + +LH+ + ++ I + + L L +I + +
Sbjct: 184 LT-GIPK--DLPETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIRMI--ENGSL 237
Query: 277 PKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT---- 332
L L+ L L + +P + D+ L+ + L NN+T F +
Sbjct: 238 SFLP--TLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRA 294
Query: 333 --NFMYLTGNKLT-GPVPKYIFNSNKN-VDISLNNF 364
N + L N + V F + + I N+
Sbjct: 295 YYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 58/273 (21%), Positives = 96/273 (35%), Gaps = 32/273 (11%)
Query: 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELS 145
CH+ + L +P E+S LDL N ++ F L L L
Sbjct: 32 HCHLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFK----GLQHLYALV 84
Query: 146 VMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPA 205
++ N++S K + + L+ L I N IPP++ +L +L + N
Sbjct: 85 LVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKG 141
Query: 206 ELTKLTNLNDLRISDNNF-SGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL 264
+ L N+N + + N + K+ L I + L G IP +L +L
Sbjct: 142 VFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPK--DLPETLNEL 198
Query: 265 -----RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNL 318
+I + + L L L I I + + L+ + L N L
Sbjct: 199 HLDHNKIQAI--ELEDLLRYS--KLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKL 253
Query: 319 TGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351
+ +P L +YL N +T V F
Sbjct: 254 S-RVPAGLPDLKLLQVVYLHTNNITK-VGVNDF 284
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 44/187 (23%), Positives = 73/187 (39%), Gaps = 23/187 (12%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE--FIGKWK 235
++P +I + L L +N + + L +L L + +N S KI E F +
Sbjct: 47 AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSP-LR 102
Query: 236 KIQKLHIQGSSLEGPIPASISALTSLTDLR-----ISDLKGSESAFPKLDKMNLKTLILT 290
K+QKL+I + L IP + +SL +LR I + + F L N+ + +
Sbjct: 103 KLQKLYISKNHLVE-IPP--NLPSSLVELRIHDNRIRKV--PKGVFSGLR--NMNCIEMG 155
Query: 291 K-CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY 349
L + D KL + +S LTG E L N ++L NK+ +
Sbjct: 156 GNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETL---NELHLDHNKIQA-IELE 211
Query: 350 IFNSNKN 356
Sbjct: 212 DLLRYSK 218
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 56/281 (19%), Positives = 99/281 (35%), Gaps = 56/281 (19%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL- 139
C CS ++ LT ++PT + +L+L N L G F L
Sbjct: 5 CSCSGTEIR-----CNSKGLT-SVPTGIPS--SATRLELESNKLQSLPHGVFD----KLT 52
Query: 140 QLVELSVMGNRLS--GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN 197
QL +LS+ N LS G + T+LK L + N ++ + L L+ L +
Sbjct: 53 QLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS 111
Query: 198 SFTGELPAE--LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI 255
+ ++ L NL L IS + G
Sbjct: 112 NLK-QMSEFSVFLSLRNLIYLDISHTHTR----------------VAFNGIFNG------ 148
Query: 256 SALTSLTDLRISDLKGSES----AFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKN 310
L+SL L+++ E+ F +L NL L L++C + ++ ++ L+
Sbjct: 149 --LSSLEVLKMAGNSFQENFLPDIFTELR--NLTFLDLSQCQLE-QLSPTAFNSLSSLQV 203
Query: 311 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351
+++S NN ++ L + + N + K
Sbjct: 204 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-SKKQEL 243
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 38/168 (22%), Positives = 62/168 (36%), Gaps = 8/168 (4%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQW-ASL-QLVELSVMGNRLSGPFPKVLTNITT 164
T+ + L L+ LD + L SL L+ L + F + +++
Sbjct: 92 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 151
Query: 165 LKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNN 222
L+ L + GN F + PDI +L NL L LS +L L++L L +S NN
Sbjct: 152 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNN 210
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI--SALTSLTDLRISD 268
F +Q L + + +SL L ++
Sbjct: 211 FFSLDTFPYKCLNSLQVLDYSLNHIMT-SKKQELQHFPSSLAFLNLTQ 257
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 49/249 (19%), Positives = 80/249 (32%), Gaps = 41/249 (16%)
Query: 111 ELSKLRYLKQLDLSRNCLTGSFSPQWASL---QLVELSVMGNRLSGPFPKVLTNI----- 162
+ + L++L L +TG+ P L L++ + L +
Sbjct: 90 RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLK 148
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELT----KLTNLNDLRI 218
LK LSI +R L L LS N GE K L L +
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208
Query: 219 SDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRIS--DLKGSESAF 276
+ + G A +A L L +S L+ + A
Sbjct: 209 RNAGM---------------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAP 247
Query: 277 PKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 336
L +L L+ + ++P + KL +DLS+N L P + ++L + +
Sbjct: 248 SCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD-RNP-SPDELPQVGNLS 302
Query: 337 LTGNKLTGP 345
L GN
Sbjct: 303 LKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 9e-12
Identities = 49/296 (16%), Positives = 84/296 (28%), Gaps = 57/296 (19%)
Query: 86 DCSSATCHVVTIALKAQNLTGTLPTELSK-LRYLKQLDLSRNCLTGSFSPQWA--SLQLV 142
CS A N G EL R L+ L + SL L
Sbjct: 12 SCSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLK 71
Query: 143 ELSVMGNRLSGPFPK---VLTNITTLKNLSIEGNLFTGSIPPDIRKLI--NLQKLILSSN 197
L+V R+ + I+ L+ L++E TG+ PP + + +L L L +
Sbjct: 72 RLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV 131
Query: 198 SFTGELPAELTKL-----TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252
S+ A L +L L L I+ + E + + + L + + G
Sbjct: 132 SWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 253 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNID 312
+ FP L + L+ + G +L+ +D
Sbjct: 191 LISALC--------------PLKFPTLQVLALRNAGMET--PSGVCSALAAARVQLQGLD 234
Query: 313 LSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV---DISLNNFT 365
LS N+L + + ++S
Sbjct: 235 LSHNSL------------------------RDAAGAPSCDWPSQLNSLNLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 27/246 (10%), Positives = 63/246 (25%), Gaps = 51/246 (20%)
Query: 168 LSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKL---TNLNDLRISDNNFS 224
L DI K ++L++L + + + ++ + L +L + + +
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 225 GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNL 284
G P + + L L + ++
Sbjct: 109 GTAPPPLLEAT----------------------GPDLNILNLRNVS-------------- 132
Query: 285 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG 344
T+ E+ ++ LK + ++ + + + L+ N G
Sbjct: 133 ---WATRDAWLAELQQWL--KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187
Query: 345 PVP------KYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPC 398
F + + + + S V L S N L
Sbjct: 188 ERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLS-HNSLRDAAGA 246
Query: 399 LRQNFP 404
++P
Sbjct: 247 PSCDWP 252
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-18
Identities = 41/261 (15%), Positives = 91/261 (34%), Gaps = 25/261 (9%)
Query: 107 TLPTE-LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
+L + L LK L+L N S P +LQ + + + S
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNV-ETFSEIRRIDFAG 146
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
+T+L L I+ ++ + ++ L L + L L+++ L + D
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 222 N---FSGKIPEFIGKWKKIQKLHIQGSSLE----GPIPASISALTSLTDLRISDLKGSE- 273
N F ++KL +GS L + + + L+++ D +
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGL 266
Query: 274 -----------SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 322
S K++ + ++ L + + + ++ + K+K I + + +
Sbjct: 267 GDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVP 326
Query: 323 PTTFEKLAKTNFMYLTGNKLT 343
+ + L F+ L+ N +
Sbjct: 327 CSFSQHLKSLEFLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-18
Identities = 47/276 (17%), Positives = 95/276 (34%), Gaps = 29/276 (10%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWAS---------LQLVELSVMGNRLSGPFPK 157
L + +L ++ D + N L + + + L + L
Sbjct: 245 KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST 304
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGEL---PAELTKLTNL 213
V + + +K +++E + +P + L +L+ L LS N E A +L
Sbjct: 305 VYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363
Query: 214 NDLRISDNNFS--GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG 271
L +S N+ K E + K + L I ++ P+P S + L +S
Sbjct: 364 QTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI 422
Query: 272 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331
L+ L ++ + + +L+ + +S N L +
Sbjct: 423 RV--VKTCIPQTLEVLDVSNNNL-DSFSL---FLPRLQELYISRNKLKTLPDASL--FPV 474
Query: 332 TNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNF 364
M ++ N+L VP IF+ + + + N +
Sbjct: 475 LLVMKISRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-17
Identities = 50/299 (16%), Positives = 112/299 (37%), Gaps = 29/299 (9%)
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRL 151
+ + +KA +L L +R + L L + L + L + L
Sbjct: 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208
Query: 152 SGPFP---KVLTNITTLKNLSIEGNLFT----GSIPPDIRKLINLQKLILSSNSFTG--- 201
+ V + +K L+ G++ T + +R ++ L ++ + G
Sbjct: 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGD 268
Query: 202 ------ELPAELTKL--TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA 253
++ +EL K+ + L I + +K++++ ++ S + +
Sbjct: 269 FNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCS 328
Query: 254 SISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIH--GEIPDYIGDMT 306
L SL L + + SA K +L+TL+L++ + + + + +
Sbjct: 329 FSQHLKSLEFLDLSENLMVEEYLKNSAC-KGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387
Query: 307 KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
L ++D+S N +P + + K F+ L+ + V I + + +D+S NN
Sbjct: 388 NLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIRV-VKTCIPQTLEVLDVSNNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-16
Identities = 51/341 (14%), Positives = 105/341 (30%), Gaps = 77/341 (22%)
Query: 80 ESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL 139
+++ CD S ++ T ++P+ L+ +K LDLS N +T +
Sbjct: 5 DASGVCDGRS------------RSFT-SIPSGLT--AAMKSLDLSFNKIT--------YI 41
Query: 140 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNS 198
L L+ L ++ + +I D L +L+ L LS N
Sbjct: 42 G---------------HGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNH 85
Query: 199 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 258
+ + L++L L + N + + + L
Sbjct: 86 LSSLSSSWFGPLSSLKYLNLMGNPYQ-----------------------TLGVTSLFPNL 122
Query: 259 TSLTDLRISDLKG----SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLS 314
T+L LRI +++ F L +L L + + + + + ++ L
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLT--SLNELEIKALSLRNYQSQSLKSIRDIHHLTLH 180
Query: 315 FNNLTGGIPTTFEKLAKTNFMYLTGNKLTG-----PVPKYIFNSNKNVDISLNNFTWESS 369
+ + + L+ ++ L L + + K + + T ES
Sbjct: 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240
Query: 370 DPI---ECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSA 407
+ + ++ VE N L +P
Sbjct: 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG 281
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 5e-13
Identities = 30/173 (17%), Positives = 55/173 (31%), Gaps = 19/173 (10%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLT------GSFSPQWASLQLVELSVMGNRLSGPF 155
L+ L LS+N L +L +++S N P
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILL-TLKNLTSLDIS--RNTFH-PM 402
Query: 156 PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLND 215
P ++ L++ + I L+ L +S+N+ L +L L
Sbjct: 403 PDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQELY- 457
Query: 216 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
IS N +P+ + + + I + L+ LTSL + +
Sbjct: 458 --ISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 27/146 (18%), Positives = 54/146 (36%), Gaps = 10/146 (6%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
+N +P ++ L+LS + + +L+++++S N L F L
Sbjct: 396 RNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVS--NNNLDS-FSLFLPR 452
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
L+ L I N ++P L + +S N +LT+L + + N
Sbjct: 453 ---LQELYISRNKLK-TLPDAS-LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
Query: 222 NFSG--KIPEFIGKWKKIQKLHIQGS 245
+ +++ +W QGS
Sbjct: 508 PWDCSCPRIDYLSRWLNKNSQKEQGS 533
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 28/84 (33%), Positives = 47/84 (55%), Gaps = 6/84 (7%)
Query: 682 NKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
++GEG FG V+ D ++AVK L + ++F E +++ QH ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCL 759
K YG C +G+ L++V+EYMK+ L
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDL 104
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 27/84 (32%), Positives = 46/84 (54%), Gaps = 6/84 (7%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
++GEG FG V+ + ++AVK L S ++F E +++ QH ++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCL 759
+ +G C EG LL+V+EYM++ L
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDL 130
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 46/266 (17%), Positives = 86/266 (32%), Gaps = 23/266 (8%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 158
L +++ L LD S N +T Q L L+ N ++
Sbjct: 153 LDCHLNKKITKLDVTPQTQLTTLDCSFNKITELDVSQNKLLN--RLNCDTNNITKL---D 207
Query: 159 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 218
L L L N T I D+ L L S N T EL ++ L+ L L
Sbjct: 208 LNQNIQLTFLDCSSNKLT-EI--DVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHC 261
Query: 219 SDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPK 278
+ +I + ++ +G + ++ T L L +E +
Sbjct: 262 IQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITELDLSQ 316
Query: 279 LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLT 338
L L L + E+ + TKLK++ ++ + K+ N +
Sbjct: 317 N--PKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEA 369
Query: 339 GNKLTGPVPKYIFNSNKNVDISLNNF 364
+ + + N++ + +S +
Sbjct: 370 EGQTITMPKETLTNNSLTIAVSPDLL 395
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 8e-17
Identities = 47/263 (17%), Positives = 91/263 (34%), Gaps = 24/263 (9%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
+ T +L L LD + +T + L +L N ++ L+
Sbjct: 29 EMQATDTISEEQLATLTSLDCHNSSIT-DMTGIEKLTGLTKLICTSNNITT-LD--LSQN 84
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
T L L+ + N T ++ + L L L +N T +L +++ L L + N
Sbjct: 85 TNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNT 138
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM 282
+ +I + ++ +L + + ++ T LT L S K +E +
Sbjct: 139 LT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITELDVSQNK-- 191
Query: 283 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 342
L L I ++ + +L +D S N LT I L + + + N L
Sbjct: 192 LLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPL 245
Query: 343 TGPVPKYIFNSNKNVDISLNNFT 365
T + + + +
Sbjct: 246 T-ELDVSTLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 44/261 (16%), Positives = 81/261 (31%), Gaps = 26/261 (9%)
Query: 111 ELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
++S+ + L +L+ N +T QL L N+L+ +T +T L
Sbjct: 186 DVSQNKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFD 239
Query: 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 229
N T + + L L L E+ LT T L + ++
Sbjct: 240 CSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD- 292
Query: 230 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDKMNLKTL 287
+ ++ L Q + + + +S L L +++ L + LK+L
Sbjct: 293 -VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL----TELDVSHNTKLKSL 344
Query: 288 ILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 347
I + +G + L N + T + T + G
Sbjct: 345 SCVNAHI-QDFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPM 402
Query: 348 KYIFNSNKNVDISLNNFTWES 368
D + N TWE+
Sbjct: 403 NIEPGDGGVYDQATNTITWEN 423
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 31/179 (17%), Positives = 62/179 (34%), Gaps = 15/179 (8%)
Query: 165 LKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS 224
+ + +L L L ++S T ++ + KLT L L + NN +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77
Query: 225 GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNL 284
+ + + + L + L + ++ LT LT L K ++ + L
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTKLDVSQNP--LL 129
Query: 285 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
L + + EI + T+L +D N + + + + NK+T
Sbjct: 130 TYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 27/178 (15%), Positives = 55/178 (30%), Gaps = 13/178 (7%)
Query: 188 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL 247
N + ++ +L L L +++ + + I K + KL +++
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNI 76
Query: 248 EGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTK 307
+ +S T+LT L K + L L L + ++ +
Sbjct: 77 TT-LD--LSQNTNLTYLACDSNKLTNLDVTPLT--KLTYLNCDTNKLT-KLD--VSQNPL 128
Query: 308 LKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
L ++ + N LT + + NK + +D S N T
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT 183
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 56/280 (20%), Positives = 103/280 (36%), Gaps = 25/280 (8%)
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 152
+ + IA N+T T+ + L + L +T + L+ L + N+++
Sbjct: 20 NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQIT 76
Query: 153 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 212
P L N+T + L + GN ++ I L +++ L L+S T P L L+N
Sbjct: 77 DLAP--LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLSN 130
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 272
L L + N + I + +Q L I + + ++ L +L+ L +
Sbjct: 131 LQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS-----DLTPLANLSKLTTLKADDN 183
Query: 273 E-SAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLA 330
+ S L + NL + L I P + + + L + L+ +T L
Sbjct: 184 KISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLV 241
Query: 331 KTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSD 370
N + P I + N + N TW +
Sbjct: 242 VPNVVKGPSGAPI--APATISD---NGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 30/167 (17%), Positives = 64/167 (38%), Gaps = 16/167 (9%)
Query: 179 IPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQ 238
I PD L N K+ ++ T + L + L + I E + +
Sbjct: 12 IFPD-PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLI 66
Query: 239 KLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKM-NLKTLILTKCLIHG 296
L ++ + + ++ L +LT + +L G+ + + ++KTL LT I
Sbjct: 67 GLELKDNQIT-----DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITD 121
Query: 297 EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
P + ++ L+ + L N +T P L ++ + +++
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS 164
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-17
Identities = 42/261 (16%), Positives = 91/261 (34%), Gaps = 19/261 (7%)
Query: 117 YLKQLDLSRNCLTGSFSPQWAS----LQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172
L ++ + N W + + + + G F T++ L +
Sbjct: 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285
Query: 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIG 232
++F N+ + + +K++ L S+N + + E G
Sbjct: 286 DVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCG 345
Query: 233 KWKKIQKLHIQGSSLE--GPIPASISALTSLTDLRISD----LKGSESAFPKLDKMNLKT 286
+++ L +Q + L+ I + + SL L IS + +L +
Sbjct: 346 HLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK--SLLS 403
Query: 287 LILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPV 346
L ++ ++ I + ++K +DL N + IP KL + + N+L V
Sbjct: 404 LNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-V 459
Query: 347 PKYIFNSNKN---VDISLNNF 364
P IF+ + + + N +
Sbjct: 460 PDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 5e-12
Identities = 37/170 (21%), Positives = 64/170 (37%), Gaps = 7/170 (4%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLS--GPFPKVL 159
SK+ LD S N LT + L +L L + N+L ++
Sbjct: 311 GTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMT 370
Query: 160 TNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 218
T + +L+ L I N + +L L +SSN T + L + L +
Sbjct: 371 TQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDL 428
Query: 219 SDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
N IP+ + K + +Q+L++ + L+ LTSL + +
Sbjct: 429 HSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHT 477
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 9e-11
Identities = 44/303 (14%), Positives = 90/303 (29%), Gaps = 32/303 (10%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKV 158
++ +++ L L+ L +S N + F +L L + N+L
Sbjct: 32 YISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQ---ELEYLDLSHNKLVKISCHP 88
Query: 159 LTNITTLKNLSIEGNLFTGSIPPD--IRKLINLQKLILSSNSFTGELPAELTKLTNLNDL 216
N LK+L + N F ++P + L+ L LS+ + L L
Sbjct: 89 TVN---LKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVL 144
Query: 217 RISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA- 275
+ + K + + LHI + + ++ ++ +L +S++K
Sbjct: 145 LVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDN 204
Query: 276 ---------FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNI-DLSFNNLT------ 319
L L L I + + S +N+
Sbjct: 205 KCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLD 264
Query: 320 -GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGS 378
+ L + + + P YI+ N++I + + CP
Sbjct: 265 FRDFDYSGTSLKALSIHQVVSDVFGFP-QSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKI 323
Query: 379 VNL 381
Sbjct: 324 SPF 326
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 35/209 (16%), Positives = 67/209 (32%), Gaps = 7/209 (3%)
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDN 221
L+I N + DI L L+ LI+S N L L L +S N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHN 79
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTDLRISDLKGSESAFPKLD 280
KI ++ L + ++ + PI ++ L L +S +S+ +
Sbjct: 80 KLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 281 KMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 340
+N+ ++L +GE D + L T ++ L +
Sbjct: 137 HLNISKVLLVLGETYGEKED-PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS 195
Query: 341 KLTGPVPKYIFNSNKNVDISLNNFTWESS 369
+ + + ++ L S+
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSN 224
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 34/243 (13%), Positives = 68/243 (27%), Gaps = 27/243 (11%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
+P D+ L +S N + +++ L+ L L IS N +++
Sbjct: 14 HVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGE 297
+ L + + L S +L L +S L + K
Sbjct: 72 EYLDLSHNKLVK---ISCHPTVNLKHLDLSFNA-------------FDALPICK------ 109
Query: 298 IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV 357
G+M++LK + LS +L L + + + G
Sbjct: 110 ---EFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTE 166
Query: 358 DISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLH 417
+ + T + I S+ + L+ + + L
Sbjct: 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLT 226
Query: 418 INC 420
+N
Sbjct: 227 LNN 229
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 54/286 (18%), Positives = 102/286 (35%), Gaps = 50/286 (17%)
Query: 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELS 145
CH+ + L +P +L LDL N +T G F +L L L
Sbjct: 30 QCHLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFK----NLKNLHTLI 82
Query: 146 VMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPA 205
++ N++S P + L+ L + N +P + LQ+L + N T +
Sbjct: 83 LINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKS 139
Query: 206 ELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLR 265
L + + + N ++ I+ + +G + L+ +R
Sbjct: 140 VFNGLNQMIVVELGTN--------------PLKSSGIENGAFQG--------MKKLSYIR 177
Query: 266 ISD--LKG-SESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGG 321
I+D + + P +L L L I ++ + L + LSFN+++
Sbjct: 178 IADTNITTIPQGLPP-----SLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAV 231
Query: 322 IPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSN--KNVDISLNNFT 365
+ ++L NKL VP + + + V + NN +
Sbjct: 232 DNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 43/249 (17%), Positives = 84/249 (33%), Gaps = 33/249 (13%)
Query: 112 LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKN 167
+ L L++L LS+N L L EL V N ++ V + +
Sbjct: 96 FAPLVKLERLYLSKNQLKELPEKMPK------TLQELRVHENEITKVRKSVFNGLNQMIV 149
Query: 168 LSIEGN-LFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG 225
+ + N L + I + + L + ++ + T +P L +L +L + N +
Sbjct: 150 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT- 205
Query: 226 KIPE--FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDK 281
K+ G + KL + +S+ S++ L +L +++ L
Sbjct: 206 KVDAASLKGL-NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADH-- 262
Query: 282 MNLKTLILTKCLIHGEIPD-------YIGDMTKLKNIDLSFNNLTGGI--PTTFEKLAKT 332
++ + L I I Y + L N + P+TF +
Sbjct: 263 KYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR 321
Query: 333 NFMYLTGNK 341
+ L K
Sbjct: 322 AAVQLGNYK 330
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 55/274 (20%), Positives = 84/274 (30%), Gaps = 60/274 (21%)
Query: 84 TCDCSSAT--CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWA 137
+ T C N +P L K LDLS N L SF
Sbjct: 4 VEVVPNITYQCM-------ELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFF---- 49
Query: 138 SL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILS 195
S +L L + + +++ L L + GN S+ L +LQKL+
Sbjct: 50 SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAV 108
Query: 196 SNSFTGELPAEL-TKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPAS 254
+ L L L +L ++ N IQ +P
Sbjct: 109 ETNLA-SLENFPIGHLKTLKELNVAHN--------------LIQSF---------KLPEY 144
Query: 255 ISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIH---GEIPDYIGDMT 306
S LT+L L +I + + L + L L+ L I
Sbjct: 145 FSNLTNLEHLDLSSNKIQSI--YCTDLRVLH--QMPLLNLSLDLSLNPMNFIQPGAFKEI 200
Query: 307 KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 340
+LK + L N L F++L ++L N
Sbjct: 201 RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 36/218 (16%), Positives = 70/218 (32%), Gaps = 63/218 (28%)
Query: 160 TNI-TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLNDL 216
N+ + KNL + N + LQ L LS + L++L+ L
Sbjct: 24 DNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTL 81
Query: 217 RISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAF 276
++ N + SL + AF
Sbjct: 82 ILTGNP-----------------------------------IQSL----------ALGAF 96
Query: 277 PKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTG-GIPTTFEKLAKTNF 334
L +L+ L+ + + + ++ G + LK ++++ N + +P F L
Sbjct: 97 SGL--SSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEH 153
Query: 335 MYLTGNKLTGPVPKYIFNS-------NKNVDISLNNFT 365
+ L+ NK+ + N ++D+SLN
Sbjct: 154 LDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMN 190
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 28/85 (32%), Positives = 44/85 (51%), Gaps = 7/85 (8%)
Query: 682 NKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
++G+G FGSV + G V+AVK+L + + R+F EI ++ + QH N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 737 LYGCCVEGNQ--LLLVYEYMKNNCL 759
G C + L L+ EY+ L
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSL 131
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 28/85 (32%), Positives = 44/85 (51%), Gaps = 7/85 (8%)
Query: 682 NKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
++G+G FGSV + G V+AVK+L + + R+F EI ++ + QH N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 737 LYGCCVEGNQ--LLLVYEYMKNNCL 759
G C + L L+ EY+ L
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSL 100
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 27/89 (30%), Positives = 41/89 (46%), Gaps = 5/89 (5%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQL----SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+G GGFG VY+ G +AVK Q E + + +HPN++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGK 766
G C++ L LV E+ + L+R + GK
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGK 100
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 82.8 bits (204), Expect = 2e-16
Identities = 44/257 (17%), Positives = 87/257 (33%), Gaps = 18/257 (7%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171
+ +L + +T Q + ++ + + + + + L +
Sbjct: 17 DDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 73
Query: 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI 231
GN T I P + L NL L L N +L + L L L L + N S I +
Sbjct: 74 GNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DI-NGL 127
Query: 232 GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKM-NLKTLIL 289
+++ L++ + + I+ L+ LT L L+ ++ S L + L+ L L
Sbjct: 128 VHLPQLESLYLGNNKIT-----DITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYL 182
Query: 290 TKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY 349
+K I + + L ++L L N + T L P
Sbjct: 183 SKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240
Query: 350 IFNSNKNVDISLNNFTW 366
+ ++ + +
Sbjct: 241 DDGDYEKPNVKWHLPEF 257
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 79.0 bits (194), Expect = 2e-15
Identities = 47/300 (15%), Positives = 103/300 (34%), Gaps = 19/300 (6%)
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 152
+ LK +++T + ++L + Q+ + + + S + +L + GN+L+
Sbjct: 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGNKLT 78
Query: 153 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 212
P LTN+ L L ++ N + ++ L L+ L L N + ++ L L
Sbjct: 79 DIKP--LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQ 132
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 272
L L + +N + + + K+ L ++ + + I L LT L+ L +
Sbjct: 133 LESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-----DIVPLAGLTKLQNLYLSKN 185
Query: 273 E-SAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLA 330
S L + NL L L + ++ ++ + + +L +
Sbjct: 186 HISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV-TPEIISDDGD 244
Query: 331 KTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRN 390
+IF + + F + P++ V+
Sbjct: 245 YEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTK 304
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 44/275 (16%), Positives = 83/275 (30%), Gaps = 17/275 (6%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171
L L L+ L L N +T + +L LS+ N++S P L +T L+NL +
Sbjct: 127 LVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLS 183
Query: 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI 231
N + + + L NL L L S + + L N ++ +D + PE I
Sbjct: 184 KNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEII 239
Query: 232 GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTK 291
+K +++ E S + I K + T+
Sbjct: 240 SDDGDYEKPNVKWHLPEFTNEVS---FIFYQPVTIGKAKARFHGRVTQPLKEVYTVS--- 293
Query: 292 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351
++ + ++ F+ N T + F
Sbjct: 294 ----YDVDGTVIKTKVEAGTRITAPKPPTKQGYVFKGWYTEKNGGHEWNFNTDYMSGNDF 349
Query: 352 NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYS 386
T + ++ RG+ + +
Sbjct: 350 TLYAVFKAETTEKTVNLTRYVKYIRGNAGIYKLPR 384
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 7/85 (8%)
Query: 682 NKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
+++G+G FGSV + G ++AVKQL R+F EI ++ A +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 737 LYGCCVEGNQ--LLLVYEYMKNNCL 759
G + L LV EY+ + CL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCL 113
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 26/85 (30%), Positives = 39/85 (45%), Gaps = 7/85 (8%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNL 734
++GE FG VYKG L +A+K L K EF +E + + QHPN+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCL 759
V L G + L +++ Y + L
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDL 99
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 25/85 (29%), Positives = 40/85 (47%), Gaps = 8/85 (9%)
Query: 683 KVGEGGFGSVYKGIL--------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
+G+G F ++KG+ T + +K L R + F M+S H +L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCL 759
V YG CV G++ +LV E++K L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSL 99
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 29/96 (30%), Positives = 44/96 (45%), Gaps = 15/96 (15%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNL 734
+GEG FG V++ T++AVK L + S +F E +++ +PN+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIF 770
VKL G C G + L++EYM G L F
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAY--------GDLNEF 140
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 24/83 (28%), Positives = 38/83 (45%), Gaps = 5/83 (6%)
Query: 682 NKVGEGGFGSVYKGILSDG---TVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPNLVK 736
+ +GEG FG V K + A+K++ S+ +R+F E+ + HPN++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 737 LYGCCVEGNQLLLVYEYMKNNCL 759
L G C L L EY + L
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNL 113
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 3/94 (3%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 739
K+G G FG+V++ G+ +AVK L + EF+ E+ ++ +HPN+V G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHIS 773
+ L +V EY+ L R + +
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLD 135
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 27/166 (16%), Positives = 64/166 (38%), Gaps = 6/166 (3%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
+ T +++ L + L+ +T + + + +L++ + P ++ +
Sbjct: 31 GQSSTANITEAQMNSLTYITLANINVT-DLTGIEYAHNIKDLTINNIHATNYNP--ISGL 87
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
+ L+ L I G T P++ L +L L +S ++ + ++ L +N + +S N
Sbjct: 88 SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
I + +++ L+IQ + I L L
Sbjct: 148 AITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 31/168 (18%), Positives = 62/168 (36%), Gaps = 20/168 (11%)
Query: 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219
+ +L +++ T + I N++ L +++ T P ++ L+NL LRI
Sbjct: 41 AQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIM 96
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL------RISDLKGSE 273
+ + + + L I S+ + I I+ L + + I+D+
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-- 154
Query: 274 SAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG 320
L + LK+L + +H I D KL + + G
Sbjct: 155 -----LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 5e-10
Identities = 29/163 (17%), Positives = 56/163 (34%), Gaps = 33/163 (20%)
Query: 181 PDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKL 240
PD +L +S A++ LT + +++ N +
Sbjct: 18 PD-STFKAYLNGLLGQSSTANITEAQMNSLTYIT---LANINVT---------------- 57
Query: 241 HIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKMNLKTLILTKCLIHGEIP 299
L G I ++ DL I+++ + + L NL+ L + + +
Sbjct: 58 -----DLTG-----IEYAHNIKDLTINNIHATNYNPISGLS--NLERLRIMGKDVTSDKI 105
Query: 300 DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 342
+ +T L +D+S + I T L K N + L+ N
Sbjct: 106 PNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 23/85 (27%), Positives = 42/85 (49%), Gaps = 7/85 (8%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNL 734
++G+G FG VY+G+ T +A+K ++ + R EF+NE ++ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCL 759
V+L G +G L++ E M L
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDL 115
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 25/86 (29%), Positives = 37/86 (43%), Gaps = 8/86 (9%)
Query: 682 NKVGEGGFGSVYKGIL-----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 735
+GEG FG V G ++AVK L + Q + EI ++ H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 736 KLYGCCVE--GNQLLLVYEYMKNNCL 759
K GCC + L LV EY+ L
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSL 122
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
VG G FG V K +A+KQ+ S+S + + F+ E+ +S HPN+VKLYG C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKLRIFHIS 773
+ N + LV EY + L + G + + +
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHGAEPLPYYT 100
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 29/85 (34%), Positives = 42/85 (49%), Gaps = 7/85 (8%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNL 734
+GEG FG V K T +AVK L + S R+ ++E ++ HP++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCL 759
+KLYG C + LLL+ EY K L
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSL 113
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 25/85 (29%), Positives = 38/85 (44%), Gaps = 7/85 (8%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNL 734
+G G FG VY+G +S +AVK L S Q +F+ E +IS H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCL 759
V+ G ++ ++ E M L
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDL 120
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 22/79 (27%), Positives = 39/79 (49%), Gaps = 1/79 (1%)
Query: 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
+G+G FG K G V+ +K+L + R F+ E+ ++ +HPN++K G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 741 CVEGNQLLLVYEYMKNNCL 759
+ +L + EY+K L
Sbjct: 76 LYKDKRLNFITEYIKGGTL 94
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 25/86 (29%), Positives = 37/86 (43%), Gaps = 8/86 (9%)
Query: 682 NKVGEGGFGSVYKGIL-----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 735
+GEG FG V + G +AVK L + EI ++ H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 736 KLYGCCVE--GNQLLLVYEYMKNNCL 759
K G C E GN + L+ E++ + L
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSL 112
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 25/85 (29%), Positives = 38/85 (44%), Gaps = 7/85 (8%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNL 734
+G G FG VY+G +S +AVK L S Q +F+ E +IS H N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCL 759
V+ G ++ ++ E M L
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDL 161
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 10/90 (11%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-------REFVNEIGMISAQQHPN 733
++G+GGFG V+KG + D +V+A+K L +G +EF E+ ++S HPN
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI 763
+VKLYG N +V E++ L +
Sbjct: 85 IVKLYGLMH--NPPRMVMEFVPCGDLYHRL 112
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 28/79 (35%), Positives = 37/79 (46%), Gaps = 5/79 (6%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
++G G FG V G +AVK + S S EF E + HP LVK YG
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGV 71
Query: 741 CVEGNQLLLVYEYMKNNCL 759
C + + +V EY+ N CL
Sbjct: 72 CSKEYPIYIVTEYISNGCL 90
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 26/80 (32%), Positives = 39/80 (48%), Gaps = 5/80 (6%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
++G G FG V G +A+K + S S EF+ E ++ H LV+LYG
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYG 86
Query: 740 CCVEGNQLLLVYEYMKNNCL 759
C + + ++ EYM N CL
Sbjct: 87 VCTKQRPIFIITEYMANGCL 106
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 21/79 (26%), Positives = 37/79 (46%), Gaps = 2/79 (2%)
Query: 683 KVGEGGFGSVYKGILSDGTV-IAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
++G G FG V+ G L +AVK + +F+ E ++ HPN+V+L G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 741 CVEGNQLLLVYEYMKNNCL 759
C + + +V E ++
Sbjct: 181 CTQKQPIYIVMELVQGGDF 199
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 25/94 (26%), Positives = 46/94 (48%), Gaps = 7/94 (7%)
Query: 668 LRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV 720
R+ + + DP ++G+G FG VYK G + A K + +KS + +++
Sbjct: 5 SREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI 64
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754
EI +++ HP +VKL G +L ++ E+
Sbjct: 65 VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 21/86 (24%), Positives = 30/86 (34%), Gaps = 8/86 (9%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPN 733
+G G FG V +AVK L ++E+ M H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCL 759
+V L G C + L++EY L
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDL 136
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 26/80 (32%), Positives = 45/80 (56%), Gaps = 5/80 (6%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
++G G FG V+ G + +A+K + + S + +F+ E ++ HP LV+LYG
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYG 70
Query: 740 CCVEGNQLLLVYEYMKNNCL 759
C+E + LV E+M++ CL
Sbjct: 71 VCLEQAPICLVTEFMEHGCL 90
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 20/79 (25%), Positives = 31/79 (39%), Gaps = 5/79 (6%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 739
K+ E G ++KG G I VK L + R+F E + HPN++ + G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 740 CCVE--GNQLLLVYEYMKN 756
C L+ +M
Sbjct: 75 ACQSPPAPHPTLITHWMPY 93
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 29/109 (26%), Positives = 50/109 (45%), Gaps = 12/109 (11%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
+G+G +G VY G LS+ IA+K++ + + ++ EI + +H N+V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 743 EGNQLLLVYEYMKNNCLS---RAIFGKLRIF--HISIYATFPQGNIQIL 786
E + + E + LS R+ +G L+ I Y QIL
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK------QIL 132
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 25/81 (30%), Positives = 43/81 (53%), Gaps = 6/81 (7%)
Query: 682 NKVGEGGFGSVYKGILSDGTV-IAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
+K+G G +G VY+G+ ++ +AVK L + + EF+ E ++ +HPNLV+L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 75
Query: 739 GCCVEGNQLLLVYEYMKNNCL 759
G C ++ E+M L
Sbjct: 76 GVCTREPPFYIITEFMTYGNL 96
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 22/88 (25%), Positives = 35/88 (39%), Gaps = 10/88 (11%)
Query: 682 NKVGEGGFGSVYKGILSD--------GTVIAVKQLSSK-SRQGNREFVNEIG-MISAQQH 731
+GEG FG V +AVK L + + + V+E+ M +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCL 759
N++ L G C + L ++ EY L
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNL 128
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 24/100 (24%), Positives = 54/100 (54%), Gaps = 7/100 (7%)
Query: 668 LRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV 720
L ++++ + DP K+G+G G+VY + ++ G +A++Q++ + + +
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS 760
NEI ++ ++PN+V + G++L +V EY+ L+
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 7e-15
Identities = 23/84 (27%), Positives = 47/84 (55%), Gaps = 7/84 (8%)
Query: 682 NKVGEGGFGSVYKGILSDG-----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 735
+G G FG+VYKG+ +A+K+L + S + N+E ++E ++++ +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCL 759
+L G C+ + + L+ + M CL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCL 103
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 22/86 (25%), Positives = 33/86 (38%), Gaps = 8/86 (9%)
Query: 682 NKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNR-EFVNEIG-MISAQQHPN 733
+G G FG V + +AVK L + R ++E+ + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCL 759
+V L G C G L++ EY L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDL 114
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 27/79 (34%), Positives = 39/79 (49%), Gaps = 4/79 (5%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
+G+G FG V G V AVK + K+ + F+ E +++ +H NLV+L G
Sbjct: 27 QTIGKGEFGDVMLGDYRGNKV-AVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 742 VEGN-QLLLVYEYMKNNCL 759
VE L +V EYM L
Sbjct: 84 VEEKGGLYIVTEYMAKGSL 102
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 24/86 (27%), Positives = 35/86 (40%), Gaps = 8/86 (9%)
Query: 682 NKVGEGGFGSVYKGILSD------GTVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPN 733
+G G FG V + +AVK L S+ ++E+ M QH N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCL 759
+V L G C G +L++ EY L
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDL 137
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 9e-15
Identities = 23/88 (26%), Positives = 38/88 (43%), Gaps = 10/88 (11%)
Query: 682 NKVGEGGFGSVYKGIL--------SDGTVIAVKQL-SSKSRQGNREFVNEIG-MISAQQH 731
+GEG FG V + T +AVK L S + + + ++E+ M +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCL 759
N++ L G C + L ++ EY L
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNL 162
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 23/94 (24%), Positives = 43/94 (45%), Gaps = 7/94 (7%)
Query: 668 LRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV 720
++ + DP K+GEG G V G +AVK + + +Q
Sbjct: 31 KAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF 90
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754
NE+ ++ QH N+V++Y + G +L ++ E++
Sbjct: 91 NEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 27/84 (32%), Positives = 37/84 (44%), Gaps = 6/84 (7%)
Query: 682 NKVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
+G G FG VY G L D AVK L +F+ E ++ HPN++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 737 LYGCCVEG-NQLLLVYEYMKNNCL 759
L G C+ L+V YMK+ L
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDL 114
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 23/87 (26%), Positives = 38/87 (43%), Gaps = 9/87 (10%)
Query: 682 NKVGEGGFGSVYKGIL------SDGTVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPN 733
+G G FG V + + +AVK L + +R ++E+ +I H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 734 LVKLYGCC-VEGNQLLLVYEYMKNNCL 759
+V L G C G L+++ E+ K L
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNL 119
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 22/88 (25%), Positives = 35/88 (39%), Gaps = 10/88 (11%)
Query: 682 NKVGEGGFGSVYKGILSD--------GTVIAVKQLSSK-SRQGNREFVNEIG-MISAQQH 731
+GEG FG V +AVK L + + + V+E+ M +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCL 759
N++ L G C + L ++ EY L
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNL 174
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 44/254 (17%), Positives = 88/254 (34%), Gaps = 18/254 (7%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171
+ +L + +T Q + ++ + + + + + L +
Sbjct: 20 DDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76
Query: 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI 231
GN T I P + L NL L L N +L + L L L L + N S I +
Sbjct: 77 GNKLT-DIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DI-NGL 130
Query: 232 GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKM-NLKTLIL 289
+++ L++ + + I+ L+ LT L L+ ++ S L + L+ L L
Sbjct: 131 VHLPQLESLYLGNNKIT-----DITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYL 185
Query: 290 TKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY 349
+K I ++ + + L ++L L N + T L P
Sbjct: 186 SKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 243
Query: 350 IFNSNKNVDISLNN 363
+ ++ +
Sbjct: 244 DDGDYEKPNVKWHL 257
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 26/80 (32%), Positives = 40/80 (50%), Gaps = 6/80 (7%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
++G G FG V+ G + T +AVK L S S F+ E ++ QH LV+LY
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLYA 75
Query: 740 CCVEGNQLLLVYEYMKNNCL 759
+ + ++ EYM+N L
Sbjct: 76 VVTQ-EPIYIITEYMENGSL 94
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 44/173 (25%), Positives = 64/173 (36%), Gaps = 9/173 (5%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 158
L L L L QL+L R LT L L + N+L P +
Sbjct: 38 LSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLGTLDLSHNQLQS-LPLL 95
Query: 159 LTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLNDL 216
+ L L + N T S+P R L LQ+L L N LP L T L L
Sbjct: 96 GQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKL 153
Query: 217 RISDNNFSGKIPEFI-GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
+++NN + ++P + + + L +Q +SL IP L +
Sbjct: 154 SLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHG 204
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 46/195 (23%), Positives = 73/195 (37%), Gaps = 17/195 (8%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
++PPD+ + L LS N A L T L L + + K+ G +
Sbjct: 24 ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVL 79
Query: 238 QKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKC 292
L + + L+ +P L +LT L R++ L A L L+ L L
Sbjct: 80 GTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSL--PLGALRGLG--ELQELYLKGN 134
Query: 293 LIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351
+ +P + KL+ + L+ NNLT L + + L N L +PK F
Sbjct: 135 ELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFF 192
Query: 352 NSNKNVDISLNNFTW 366
S+ L+ W
Sbjct: 193 GSHLLPFAFLHGNPW 207
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 24/83 (28%), Positives = 41/83 (49%), Gaps = 5/83 (6%)
Query: 682 NKVGEGGFGSVYKGIL----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
+G G G V G L +A+K L + + + R+F++E ++ HPN+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 737 LYGCCVEGNQLLLVYEYMKNNCL 759
L G G ++V EYM+N L
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSL 137
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 20/84 (23%), Positives = 35/84 (41%), Gaps = 4/84 (4%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 739
+G+G FG VY G G V A++ + + + + F E+ +H N+V G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAI 763
C+ L ++ K L +
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVV 120
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 27/84 (32%), Positives = 37/84 (44%), Gaps = 6/84 (7%)
Query: 682 NKVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
+G G FG VY G L D AVK L +F+ E ++ HPN++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 737 LYGCCVEG-NQLLLVYEYMKNNCL 759
L G C+ L+V YMK+ L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDL 178
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 24/83 (28%), Positives = 45/83 (54%), Gaps = 6/83 (7%)
Query: 683 KVGEGGFGSVYKGILSDGTV-----IAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
+G G FG VYKG+L + +A+K L + + + +F+ E G++ H N+++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 737 LYGCCVEGNQLLLVYEYMKNNCL 759
L G + ++++ EYM+N L
Sbjct: 111 LEGVISKYKPMMIITEYMENGAL 133
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 22/84 (26%), Positives = 34/84 (40%), Gaps = 6/84 (7%)
Query: 682 NKVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
+G+G FG VY G D A+K L Q F+ E ++ HPN++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 737 LYGCCVEGN-QLLLVYEYMKNNCL 759
L G + ++ YM + L
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDL 110
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 35/249 (14%), Positives = 75/249 (30%), Gaps = 29/249 (11%)
Query: 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSF 199
+ + + N ++ + + L+ L +E I + R L +L L L N F
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 200 TGELPAE-LTKLTNLNDLRISDNNF-SGKIPEFI-GKWKKIQKLHIQGSSLEGPIPASI- 255
+L L NL L ++ N + ++ L ++ ++++ PAS
Sbjct: 92 L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 256 SALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKN 310
+ L ++ + E + L L + +
Sbjct: 151 LNMRRFHVLDLTFNKVKSIC--EEDLLNFQGKHFTLLRL----------------SSITL 192
Query: 311 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSD 370
D++ L K + L+GN + K F++ I + +
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM 252
Query: 371 PIECPRGSV 379
+
Sbjct: 253 GSSFGHTNF 261
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 51/293 (17%), Positives = 99/293 (33%), Gaps = 54/293 (18%)
Query: 114 KLRYLKQLDLSRNCLT-----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTL--- 165
L L+ L L N + F +++L+ N++ + L N
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLN-MRRFHVLDLT--FNKVKSICEEDLLNFQGKHFT 183
Query: 166 -------KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR- 217
+ + K ++ L LS N F + ++
Sbjct: 184 LLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQS 243
Query: 218 ------------ISDNNFSGKIPE--FIG-KWKKIQKLHIQGSSLEGPIPASI-SALTSL 261
NF F G + ++ + S + + S+ S T L
Sbjct: 244 LILSNSYNMGSSFGHTNFK-DPDNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDL 301
Query: 262 TDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSF 315
L I+ + ++AF L +L L L++ + G I + + + KL+ +DLS+
Sbjct: 302 EQLTLAQNEINKI--DDNAFWGLT--HLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSY 356
Query: 316 NNLTGGIPT-TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNF 364
N++ + +F L + L N+L VP IF+ + + + N +
Sbjct: 357 NHIRA-LGDQSFLGLPNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 54/280 (19%), Positives = 93/280 (33%), Gaps = 40/280 (14%)
Query: 107 TLPTE-LSKLRYLKQLDLSRNCLTGSFSPQ--WASL-QLVELSVMGNRLSGPFPK-VLTN 161
L T + L L+ L L++ L G+ + L L L + N + P N
Sbjct: 93 QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLN 152
Query: 162 ITTLKNLSIEGNLFTGSIPPDI-----------RKLINLQKLILSSNSFTGELPAELTKL 210
+ L + N SI + +L ++ ++ E K
Sbjct: 153 MRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211
Query: 211 TNLNDLRISDNNFSGKIPEFIGKWKKIQKL--------HIQGSSLEGPIPASISALT--- 259
T++ L +S N F + + K+ + GSS T
Sbjct: 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271
Query: 260 -SLTDLRISDLKG------SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNI 311
+ ++ DL +S F +L+ L L + I+ +I D +T L +
Sbjct: 272 LEASGVKTCDLSKSKIFALLKSVFSHFT--DLEQLTLAQNEIN-KIDDNAFWGLTHLLKL 328
Query: 312 DLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351
+LS N L FE L K + L+ N + + F
Sbjct: 329 NLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSF 367
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 35/258 (13%), Positives = 78/258 (30%), Gaps = 46/258 (17%)
Query: 163 TTLKNLSIEGNLFTGSIPP-DIRKLINLQKLILSSNSFTGELPAEL-TKLTNLNDLRISD 220
+ + + N + +L +LQ L + + + L++L L++
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGS---ESA 275
N + +L + + L +L L ++ L G+ +
Sbjct: 89 N--------------QFLQLE----------TGAFNGLANLEVLTLTQCNLDGAVLSGNF 124
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAKTNF 334
F L +L+ L+L I P M + +DL+FN + +F
Sbjct: 125 FKPLT--SLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHF 182
Query: 335 --MYLTGNKLT-------GPVPKYIFNSNKNVDI-SLNNFTWESSDPIECPRGSVNLVES 384
+ L+ L G N ++ L+ ++ S + ++ +
Sbjct: 183 TLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKES-MAKRFFDAIAGTKI 241
Query: 385 YSSPRNKLDKVHPCLRQN 402
S + +
Sbjct: 242 QSLILSNSYNMGSSFGHT 259
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 43/260 (16%), Positives = 80/260 (30%), Gaps = 37/260 (14%)
Query: 113 SKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMG-----------NRLSGPFPKVLTN 161
+R LDL+ N + + Q +++ L
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLI-------------LSSNSFTGELPAELT 208
T++ L + GN F S+ I K+ +F
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270
Query: 209 KL--TNLNDLRISDNNFSGKIPEFIGKW-KKIQKLHIQGSSLEGPIPASI-SALTSLTDL 264
L + + +S + + + + +++L + + + I + LT L L
Sbjct: 271 GLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKL 328
Query: 265 RISD--LKG-SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTG 320
+S L F LD L+ L L+ I + D + LK + L N L
Sbjct: 329 NLSQNFLGSIDSRMFENLD--KLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKS 385
Query: 321 GIPTTFEKLAKTNFMYLTGN 340
F++L ++L N
Sbjct: 386 VPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 26/129 (20%), Positives = 54/129 (41%), Gaps = 16/129 (12%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFP 156
L ++ + + L L L++N + +F L L++L++ N L
Sbjct: 288 FALLKSVFSHFTDLEQL---TLAQNEINKIDDNAF----WGLTHLLKLNLSQNFLGSIDS 340
Query: 157 KVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLN 214
++ N+ L+ L + N ++ L NL++L L +N +P +LT+L
Sbjct: 341 RMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQ 398
Query: 215 DLRISDNNF 223
+ + N +
Sbjct: 399 KIWLHTNPW 407
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 22/90 (24%), Positives = 37/90 (41%), Gaps = 12/90 (13%)
Query: 682 NKVGEGGFGSVYKGILSDG----TVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLV 735
+G+G FGSV + L +AVK L + EF+ E + HP++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 736 KLYGCCVEG------NQLLLVYEYMKNNCL 759
KL G + +++ +MK+ L
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDL 118
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 26/89 (29%), Positives = 46/89 (51%), Gaps = 11/89 (12%)
Query: 682 NKVGEGGFGSVYKGILSDG----TVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLV 735
+GEG FGSV +G L +AVK + + S++ EF++E + HPN++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 736 KLYGCCVEGN-----QLLLVYEYMKNNCL 759
+L G C+E + + +++ +MK L
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDL 128
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 22/84 (26%), Positives = 39/84 (46%), Gaps = 7/84 (8%)
Query: 682 NKVGEGGFGSVYKGILSDG-----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 735
+G G FG+V+KG+ + +K + RQ + + + I + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCL 759
+L G C G+ L LV +Y+ L
Sbjct: 79 RLLGLC-PGSSLQLVTQYLPLGSL 101
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 24/80 (30%), Positives = 41/80 (51%), Gaps = 5/80 (6%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 739
++G G FG+VYKG G V AVK L+ + + F NE+G++ +H N++ G
Sbjct: 30 QRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 740 CCVEGNQLLLVYEYMKNNCL 759
L +V ++ + + L
Sbjct: 88 YSTAPQ-LAIVTQWCEGSSL 106
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 25/83 (30%), Positives = 41/83 (49%), Gaps = 5/83 (6%)
Query: 682 NKVGEGGFGSVYKGIL----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
VG G FG V G L +A+K L + + R+F+ E ++ HPN+++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 737 LYGCCVEGNQLLLVYEYMKNNCL 759
L G + +++V EYM+N L
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSL 133
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 64/272 (23%), Positives = 99/272 (36%), Gaps = 38/272 (13%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL- 139
C CS+ + +T +P++L R +L L G+FS
Sbjct: 7 CHCSNRVFL-----CQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFS----GFG 54
Query: 140 QLVELSVMGNR-LSGPFPKVLTNITTLKNLSIE-GNLFTGSIPPDI-RKLINLQKLILSS 196
L ++ + N L V +N+ L + IE N I P+ + L NLQ L++S+
Sbjct: 55 DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISN 113
Query: 197 NSFTGELPAEL-TKLTNLNDLRISDNNFSGKIPE--FIGKWKKIQKLHIQGSSLEGPIPA 253
LP L I DN I F+G + L + + ++ I
Sbjct: 114 TGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHN 171
Query: 254 SISALTSLTDLRISDLKG----SESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKL 308
S T L +L +SD F L +++ IH +P Y ++ KL
Sbjct: 172 SAFNGTQLDELNLSDNNNLEELPNDVFHGAS--GPVILDISRTRIH-SLPSYGLENLKKL 228
Query: 309 KNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 340
+ S NL +P T EKL LT
Sbjct: 229 RA--RSTYNLK-KLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 32/213 (15%), Positives = 62/213 (29%), Gaps = 37/213 (17%)
Query: 163 TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISD 220
L I +L+K+ +S N + A+ + L L+++RI
Sbjct: 30 RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKG-SESAFP 277
N + ++ P + L +L L IS+ +K +
Sbjct: 89 AN-------------NLLYIN----------PEAFQNLPNLQYLLISNTGIKHLPDVHKI 125
Query: 278 KLDKMNLKTLILTKCLIHGEIPDYI--GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335
+ L + + I G + + L+ N + + F
Sbjct: 126 HS--LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELN 183
Query: 336 YLTGNKLTGPVPKYIF---NSNKNVDISLNNFT 365
N L +P +F + +DIS
Sbjct: 184 LSDNNNLEE-LPNDVFHGASGPVILDISRTRIH 215
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 23/84 (27%), Positives = 47/84 (55%), Gaps = 7/84 (8%)
Query: 682 NKVGEGGFGSVYKGILSDG-----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 735
+G G FG+VYKG+ +A+K+L + S + N+E ++E ++++ +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCL 759
+L G C+ + + L+ + M CL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCL 103
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 27/79 (34%), Positives = 39/79 (49%), Gaps = 4/79 (5%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
+G+G FG V G V AVK + K+ + F+ E +++ +H NLV+L G
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKV-AVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 742 VEGN-QLLLVYEYMKNNCL 759
VE L +V EYM L
Sbjct: 256 VEEKGGLYIVTEYMAKGSL 274
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 25/103 (24%), Positives = 47/103 (45%), Gaps = 10/103 (9%)
Query: 662 QTGLYTLRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQ 714
+ G + DP ++G G FG+VY + + V+A+K++S +Q
Sbjct: 34 RAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ 93
Query: 715 GNREF---VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754
N ++ + E+ + +HPN ++ GC + + LV EY
Sbjct: 94 SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 136
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 25/81 (30%), Positives = 41/81 (50%), Gaps = 6/81 (7%)
Query: 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
+K+G G +G VY+G+ +AVK L + + EF+ E ++ +HPNLV+L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 282
Query: 739 GCCVEGNQLLLVYEYMKNNCL 759
G C ++ E+M L
Sbjct: 283 GVCTREPPFYIITEFMTYGNL 303
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 29/94 (30%), Positives = 48/94 (51%), Gaps = 9/94 (9%)
Query: 668 LRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV 720
L+++ + P K+GEG +GSVYK I G ++A+KQ+ +S +E +
Sbjct: 15 LKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEII 72
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754
EI ++ P++VK YG + L +V EY
Sbjct: 73 KEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 22/81 (27%), Positives = 37/81 (45%), Gaps = 5/81 (6%)
Query: 683 KVGEGGFGSVYKGILSDG---TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
++G G FGSV +G+ +A+K L + E + E ++ +P +V+L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 739 GCCVEGNQLLLVYEYMKNNCL 759
G C + L+LV E L
Sbjct: 77 GVC-QAEALMLVMEMAGGGPL 96
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 23/82 (28%), Positives = 37/82 (45%), Gaps = 6/82 (7%)
Query: 683 KVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+GEG FG V++GI +A+K + S +F+ E + HP++VKL
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 738 YGCCVEGNQLLLVYEYMKNNCL 759
G E N + ++ E L
Sbjct: 82 IGVITE-NPVWIIMELCTLGEL 102
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 22/84 (26%), Positives = 37/84 (44%), Gaps = 8/84 (9%)
Query: 683 KVGEGGFGSVYKGIL----SDGTVIAVKQL---SSKSRQGNREFVNEIGMISAQQHPNLV 735
K+G+G FG V +G +AVK L + +F+ E+ + + H NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCL 759
+LYG + + +V E L
Sbjct: 85 RLYGVVLT-PPMKMVTELAPLGSL 107
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 25/80 (31%), Positives = 40/80 (50%), Gaps = 6/80 (7%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
K+G+G FG V+ G + T +A+K L + S + F+ E ++ +H LV+LY
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYA 246
Query: 740 CCVEGNQLLLVYEYMKNNCL 759
E + +V EYM L
Sbjct: 247 VVSE-EPIYIVTEYMSKGSL 265
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 24/79 (30%), Positives = 41/79 (51%), Gaps = 2/79 (2%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLV 735
F K+G+G FG V+KGI V+A+K + + + E EI ++S P +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 736 KLYGCCVEGNQLLLVYEYM 754
K YG ++ +L ++ EY+
Sbjct: 84 KYYGSYLKDTKLWIIMEYL 102
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 6e-13
Identities = 22/82 (26%), Positives = 37/82 (45%), Gaps = 6/82 (7%)
Query: 683 KVGEGGFGSVYKGIL----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+GEG FG VY+G+ + +AVK + +F++E ++ HP++VKL
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 738 YGCCVEGNQLLLVYEYMKNNCL 759
G E ++ E L
Sbjct: 79 IGII-EEEPTWIIMELYPYGEL 99
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 20/86 (23%), Positives = 36/86 (41%), Gaps = 10/86 (11%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNE--IGMISAQQHPNLVKLYG 739
++G+G +G V+ G G +AVK + + E I +H N++
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 740 CCVEGN----QLLLVYEYMKNNCLSR 761
++G QL L+ +Y +N L
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYD 124
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 7e-13
Identities = 25/80 (31%), Positives = 40/80 (50%), Gaps = 6/80 (7%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
K+G+G FG V+ G + T +A+K L + S + F+ E ++ +H LV+LY
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYA 329
Query: 740 CCVEGNQLLLVYEYMKNNCL 759
E + +V EYM L
Sbjct: 330 VVSE-EPIYIVTEYMSKGSL 348
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 9e-13
Identities = 22/82 (26%), Positives = 36/82 (43%), Gaps = 6/82 (7%)
Query: 683 KVGEGGFGSVYKGIL---SDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
++G G FG+V KG +AVK L + E + E ++ +P +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 738 YGCCVEGNQLLLVYEYMKNNCL 759
G C E +LV E + L
Sbjct: 84 IGIC-EAESWMLVMEMAELGPL 104
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 25/110 (22%), Positives = 41/110 (37%), Gaps = 18/110 (16%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
+VG G FG V++ G AVK++ + + V E+ + P +V LYG
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 741 CVEGNQLLLVYEYMKN----NCLSRAIFGKLRIFHISIYATFPQGNIQIL 786
EG + + E ++ + + G L Y Q L
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLG------QAL 160
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 1e-12
Identities = 47/302 (15%), Positives = 96/302 (31%), Gaps = 22/302 (7%)
Query: 55 DWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSK 114
N V+ + +D+ + ++ + L+ T +L +
Sbjct: 212 QVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQ 271
Query: 115 L---RYLKQLDLSRNCLTGSFSPQWASLQLVELSVMG------NRLSGPFPKVLTNITTL 165
R ++ L++ +T + + L + + + +
Sbjct: 272 FFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEM 331
Query: 166 K--NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 223
LSI F + P + L + N FT + + L L L + N
Sbjct: 332 NIKMLSISDTPFIHMVCPPS--PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389
Query: 224 SGKIPEFIGKWKKIQKLHIQGSSL----EGPIPASISALTSLTDLRISDLKGSESAFPKL 279
+ K + L SL + + S+ L +S + S F L
Sbjct: 390 K-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448
Query: 280 DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT-TFEKLAKTNFMYLT 338
+K L L I IP + + L+ ++++ N L +P F++L +++L
Sbjct: 449 -PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLH 505
Query: 339 GN 340
N
Sbjct: 506 DN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 40/245 (16%), Positives = 88/245 (35%), Gaps = 14/245 (5%)
Query: 118 LKQLDLSRNCLTGSFSPQWAS----LQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN 173
L+ ++ + C F W L + L++ F T + +L ++
Sbjct: 256 LQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQ 315
Query: 174 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGK 233
+F S + +LS + ++ L + N F+ + +
Sbjct: 316 VFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCST 375
Query: 234 WKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG---SESAFPKL--DKMNLKTLI 288
K++Q L +Q + L+ +++ L D+ + A+ + ++ L
Sbjct: 376 LKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLN 434
Query: 289 LTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK 348
L+ ++ G + + K+K +DL N + IP L + + N+L VP
Sbjct: 435 LSSNMLTGSVFRCLP--PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKS-VPD 490
Query: 349 YIFNS 353
+F+
Sbjct: 491 GVFDR 495
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 35/191 (18%), Positives = 64/191 (33%), Gaps = 10/191 (5%)
Query: 158 VLTNI-TTLKNLSIEGNLFTGSIPP-DIRKLINLQKLILSSNSFTGELPAEL-TKLTNLN 214
V ++ K LS+ N + + DI L L+ L LS N L + +L
Sbjct: 46 VPKDLPPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLE 103
Query: 215 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTDLRISDLKGSE 273
L +S N I ++ L + + + P+ LT LT L +S K +
Sbjct: 104 YLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ 160
Query: 274 SAFPKLDKMNLKTLIL-TKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT 332
+ ++L ++L + + L F+ + +
Sbjct: 161 LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNAL 220
Query: 333 NFMYLTGNKLT 343
+ L+ KL
Sbjct: 221 GHLQLSNIKLN 231
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 52/333 (15%), Positives = 107/333 (32%), Gaps = 39/333 (11%)
Query: 80 ESNVTCDCSSATCHVV--TIALKAQNL-------TGTLPTELSKLRYLKQLDLSRNCLT- 129
E D S+ V + + + L + ++S L L+ L LS N +
Sbjct: 31 ELESMVDYSNRNLTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS 90
Query: 130 ---GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPP--DIR 184
F L L V NRL + + L++L + N F +P +
Sbjct: 91 LDFHVFLFNQ---DLEYLDVSHNRLQNISCCPMAS---LRHLDLSFNDFD-VLPVCKEFG 143
Query: 185 KLINLQKLILSSNSFTGELPAELTKL-TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQ 243
L L L LS+ F + L + L + + G E + LH+
Sbjct: 144 NLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQI-PNTTVLHLV 202
Query: 244 GSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM------NLKTLILTKCLIHGE 297
++ +L L++S++K ++ +L L +T I
Sbjct: 203 FHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT 262
Query: 298 IPDYIGDM-----TKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPV----PK 348
+ ++ +++ +T I ++T L + V +
Sbjct: 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322
Query: 349 YIFNSNKNVDISLNNFTWESSDPIECPRGSVNL 381
+++ ++I + + + + CP +
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSF 355
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 32/116 (27%), Positives = 55/116 (47%), Gaps = 9/116 (7%)
Query: 112 LSKLRYLKQLDLSRNCLT-GSFSP--QWASLQLVELSVMGNRLSGPFPKVLTNITTLKNL 168
+ L+ LD+S N L ++ WA ++ L++ N L+G + L +K L
Sbjct: 399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAE-SILVLNLSSNMLTGSVFRCLP--PKVKVL 455
Query: 169 SIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNF 223
+ N SIP D+ L LQ+L ++SN +P +LT+L + + DN +
Sbjct: 456 DLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 1e-12
Identities = 23/82 (28%), Positives = 37/82 (45%), Gaps = 6/82 (7%)
Query: 683 KVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+GEG FG V++GI +A+K + S +F+ E + HP++VKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 738 YGCCVEGNQLLLVYEYMKNNCL 759
G E N + ++ E L
Sbjct: 457 IGVITE-NPVWIIMELCTLGEL 477
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 27/113 (23%), Positives = 47/113 (41%), Gaps = 15/113 (13%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
++G G F +VYKG+ +A + ++ + F E M+ QHPN+V+ Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 740 CCV----EGNQLLLVYEYMKNNCLSRAI--FGKLRIFHISIYATFPQGNIQIL 786
++LV E M + L + F ++I + + QIL
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR------QIL 139
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 22/78 (28%), Positives = 36/78 (46%), Gaps = 2/78 (2%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+G G FG V+ + T +AVK + S F+ E ++ QH LVKL+
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 742 VEGNQLLLVYEYMKNNCL 759
+ + ++ E+M L
Sbjct: 253 TK-EPIYIITEFMAKGSL 269
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 20/86 (23%), Positives = 35/86 (40%), Gaps = 10/86 (11%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNE--IGMISAQQHPNLVKLYG 739
VG+G +G V++G G +AVK SS + + + E + +H N++
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 740 CCVEGN----QLLLVYEYMKNNCLSR 761
+ QL L+ Y + L
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYD 95
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 22/81 (27%), Positives = 38/81 (46%), Gaps = 5/81 (6%)
Query: 683 KVGEGGFGSVYKGIL--SDGTV-IAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
++G G FGSV +G+ + +A+K L + E + E ++ +P +V+L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 739 GCCVEGNQLLLVYEYMKNNCL 759
G C + L+LV E L
Sbjct: 403 GVC-QAEALMLVMEMAGGGPL 422
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 33/233 (14%), Positives = 71/233 (30%), Gaps = 35/233 (15%)
Query: 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSF 199
L ++ L +N+ + + + ++ + L + + + +
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 200 TGELPAE-LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 258
+ + L +L L L I + ++ P + +
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNT--------------GLKMF---------PDLTKVYST 129
Query: 259 TSLTDLRISDLKG----SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLS 314
L I+D +AF L TL L + Y + TKL + L+
Sbjct: 130 DIFFILEITDNPYMTSIPVNAFQGLCNE-TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLN 187
Query: 315 FNNLTGGIPT-TFEKLAKT-NFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
N I F + + + ++ +T +P K + I+ N +T
Sbjct: 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSKGLEHLKEL-IARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 39/195 (20%), Positives = 67/195 (34%), Gaps = 43/195 (22%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKIPEFIGKWKK 236
S+PP + Q L L +P+ + L N++ + +S +
Sbjct: 28 SLPP------STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDV-------------T 67
Query: 237 IQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG----SESAFPKLDKMNLKTLILTKC 292
+Q+L S L+ +T + I + + A +L LK L +
Sbjct: 68 LQQLE----------SHSFYNLSKVTHIEIRNTRNLTYIDPDALKELP--LLKFLGIFNT 115
Query: 293 LIHGEIPDY--IGDMTKLKNIDLSFNNLTGGIPT-TFEKLAK-TNFMYLTGNKLTGPVPK 348
+ PD + ++++ N IP F+ L T + L N T V
Sbjct: 116 GLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQG 173
Query: 349 YIFNSNKNVDISLNN 363
Y FN K + LN
Sbjct: 174 YAFNGTKLDAVYLNK 188
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 24/86 (27%), Positives = 38/86 (44%), Gaps = 10/86 (11%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNE--IGMISAQQHPNLVKLYG 739
+G+G FG V++G G +AVK SS + R + E I +H N++
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 740 CCVEGN----QLLLVYEYMKNNCLSR 761
+ N QL LV +Y ++ L
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFD 129
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 22/83 (26%), Positives = 39/83 (46%), Gaps = 4/83 (4%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQ-Q 730
T F K+G G FGSV+K + DG + A+K+ + + E+ + Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 731 HPNLVKLYGCCVEGNQLLLVYEY 753
H ++V+ + E + +L+ EY
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEY 92
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 18/81 (22%), Positives = 38/81 (46%), Gaps = 2/81 (2%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPN 733
++++ +G G V +A+K+++ + Q + + + EI +S HPN
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 734 LVKLYGCCVEGNQLLLVYEYM 754
+V Y V ++L LV + +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLL 95
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 56/216 (25%), Positives = 87/216 (40%), Gaps = 40/216 (18%)
Query: 160 TNI-TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLNDL 216
+NI K L ++ N + S+P +L L+ L L+ N LPA + +L NL L
Sbjct: 33 SNIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETL 90
Query: 217 RISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISD--LKG-S 272
++DN K+Q L P + L +L +LR+ LK
Sbjct: 91 WVTDN--------------KLQAL-----------PIGVFDQLVNLAELRLDRNQLKSLP 125
Query: 273 ESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAK 331
F L L L L + +P + D +T LK + L N L F+KL +
Sbjct: 126 PRVFDSL--TKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTE 182
Query: 332 TNFMYLTGNKLTGPVPKYIFNSNKNV-DISLNNFTW 366
+ L N+L VP+ F+S + + + L W
Sbjct: 183 LKTLKLDNNQLKR-VPEGAFDSLEKLKMLQLQENPW 217
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 44/174 (25%), Positives = 72/174 (41%), Gaps = 15/174 (8%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPK 157
L+ +L L+ L L+ N L G F L L L V N+L
Sbjct: 48 KLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFK----ELKNLETLWVTDNKLQALPIG 103
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLND 215
V + L L ++ N S+PP + L L L L N LP + KLT+L +
Sbjct: 104 VFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKE 161
Query: 216 LRISDNNFSGKIPEFI-GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
LR+ +N ++PE K +++ L + + L+ + +L L L++ +
Sbjct: 162 LRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQE 214
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL------SSKSRQGNREFVNEIGMISA 728
NF K+G G F VY+ L DG +A+K++ +K+R + + EI ++
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQ 88
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI 763
HPN++K Y +E N+L +V E LSR I
Sbjct: 89 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMI 123
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 23/91 (25%), Positives = 40/91 (43%), Gaps = 3/91 (3%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHP 732
+ K+GEG FG DG +K+ +S S + E E+ +++ +HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI 763
N+V+ E L +V +Y + L + I
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI 114
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 16/85 (18%), Positives = 33/85 (38%), Gaps = 5/85 (5%)
Query: 675 TNNFDPANKVGEG--GFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQ 729
++ +G+G +V G + V++ L + S + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYM 754
HPN+V + N+L +V +M
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFM 108
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 25/82 (30%), Positives = 39/82 (47%), Gaps = 6/82 (7%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQ-QH 731
+F +++G G +G V+K DG + AVK+ S +G ++ + E+G QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 732 PNLVKLYGCCVEGNQLLLVYEY 753
P V+L EG L L E
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL 138
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 25/100 (25%), Positives = 41/100 (41%), Gaps = 5/100 (5%)
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMIS 727
+ ++ K+GEGGF V L DG A+K++ +Q E E M
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 728 AQQHPNLVKLYGCCVE----GNQLLLVYEYMKNNCLSRAI 763
HPN+++L C+ ++ L+ + K L I
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI 121
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 23/87 (26%), Positives = 38/87 (43%), Gaps = 9/87 (10%)
Query: 682 NKVGEGGFGSVYKGIL------SDGTVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPN 733
+G G FG V + + +AVK L + +R ++E+ +I H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 734 LVKLYGCC-VEGNQLLLVYEYMKNNCL 759
+V L G C G L+++ E+ K L
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNL 114
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.6 bits (151), Expect = 4e-10
Identities = 87/572 (15%), Positives = 169/572 (29%), Gaps = 184/572 (32%)
Query: 35 KLH---AEEVKALKQIGRKLGKKDWNF--GVDPCSQKGNWELSSD---DKK---GFESNV 83
K + + L+Q +L GV G ++ D K + +
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS---GKTWVALDVCLSYKVQCKMDFKI 184
Query: 84 ------TCDCSSAT-------CHVVTIALKAQ-NLTGTLPTEL----SKLRYLKQLDLSR 125
C+ + + ++ + + + + ++LR L +
Sbjct: 185 FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE 244
Query: 126 NCLTGSFSPQWASLQLVELSVMGNRLSGPFP---KVLTNITTLKNLSIEGNLFTGSIPPD 182
NCL LV L+V + F K+L +TT + + T +
Sbjct: 245 NCL------------LVLLNVQNAKAWNAFNLSCKIL--LTT-RFKQV-----TDFLSAA 284
Query: 183 IRKLINLQKLILSSNSFT----------------GELPAELTKLTNLNDLRISDNNFSGK 226
I+L S + T +LP E+ N R+S +
Sbjct: 285 TTTHISLDHH---SMTLTPDEVKSLLLKYLDCRPQDLPREVLTT---NPRRLS--IIAES 336
Query: 227 IPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLR--ISDLKGSESAFPKLDKMNL 284
I + + W + H+ L I +S++ L + R L S FP +
Sbjct: 337 IRDGLATWDNWK--HVNCDKLTTIIESSLNVLEP-AEYRKMFDRL----SVFPPSAHIPT 389
Query: 285 KTLILTKCLIHGEIPDYIGD--MTKLKN---IDLSFNNLTGGIPTTFEKLAKTNFMYLTG 339
L LI ++ + KL ++ T IP+ +YL
Sbjct: 390 ILL----SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS----------IYL-- 433
Query: 340 NKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCL 399
+L + + +L+ ++V+ Y+ P+
Sbjct: 434 -ELKVKLEN---------EYALHR----------------SIVDHYNIPK--------TF 459
Query: 400 RQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMF---Y----------- 445
+ DQY Y+ HI GH + R ++F +
Sbjct: 460 DSDDLIPPYLDQYFYS-HI---------GHHLKNIEHPER-MTLFRMVFLDFRFLEQKIR 508
Query: 446 SSGQYWAFSSTGKFMDDDTDLDNY---IRTNTSTLSKVSAVDLELYRTARVSPLSLTYYG 502
W +++G ++ L Y I N ++ + + L
Sbjct: 509 HDSTAW--NASGSILNTLQQLKFYKPYICDNDPKYERLVN-AILDF---------LPKIE 556
Query: 503 LCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRI 534
L YT L A ++ ++++ F K++
Sbjct: 557 ENLICSKYTDLLRIA-LMAEDEAIFEEAHKQV 587
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 41/259 (15%), Positives = 83/259 (32%), Gaps = 20/259 (7%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
L + +L + +T Q + + + + + T LK L
Sbjct: 13 FPDPGLANAVKQNLGKQSVT-DLVSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELH 69
Query: 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 229
+ N + + P ++ L L++L ++ N L+ L + +N +
Sbjct: 70 LSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---LDNNELRD--TD 122
Query: 230 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKM-NLKTL 287
+ K ++ L I+ + L+ SI L L+ L + DL G+E + L ++ + +
Sbjct: 123 SLIHLKNLEILSIRNNKLK-----SIVMLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWI 177
Query: 288 ILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG-PV 346
LT E Y ++ + P +
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPVYTDE 235
Query: 347 PKYIFNSNKNVDISLNNFT 365
Y F+ NV + F
Sbjct: 236 VSYKFSEYINVGETEAIFD 254
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 25/85 (29%), Positives = 35/85 (41%), Gaps = 9/85 (10%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLV 735
F+ VG G +G VYKG + G + A+K + E EI M+ H N+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84
Query: 736 KLYGC------CVEGNQLLLVYEYM 754
YG +QL LV E+
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFC 109
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 21/90 (23%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 671 IKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIG 724
+K+ ++ + +GEG F +VYK + ++A+K++ R ++ +N EI
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 725 MISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754
++ HPN++ L + + LV+++M
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFM 94
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 32/142 (22%), Positives = 50/142 (35%), Gaps = 16/142 (11%)
Query: 112 LSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLK 166
++L L L LS N L +F + L L + N L + +++ L+
Sbjct: 60 PTRLTNLHSLLLSHNHLNFISSEAFV----PVPNLRYLDLSSNHLHTLDEFLFSDLQALE 115
Query: 167 NLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE----LTKLTNLNDLRISDN 221
L + N + + + LQKL LS N + P E KL L L +S N
Sbjct: 116 VLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSN 173
Query: 222 NFSGKIPEFIGKWKKIQKLHIQ 243
+ K K +
Sbjct: 174 KLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 43/198 (21%), Positives = 71/198 (35%), Gaps = 43/198 (21%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAE--LTKLTNLNDLRISDNNFSGKIPEFIGKWK 235
++P + L LS N+ + L AE T+LTNL+ L +S N
Sbjct: 32 NVPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHN-------------- 74
Query: 236 KIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKG-SESAFPKLDKMNLKTLILTKC 292
+ + + + +L L +S L E F L L+ L+L
Sbjct: 75 HLNFIS----------SEAFVPVPNLRYLDLSSNHLHTLDEFLFSDL--QALEVLLLYNN 122
Query: 293 LIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTF---EKLAKTNFMYLTGNKLTGPVPK 348
I + DM +L+ + LS N ++ KL K + L+ NKL +P
Sbjct: 123 HIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK-LPL 180
Query: 349 YIFN---SNKNVDISLNN 363
+ + L+N
Sbjct: 181 TDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 31/123 (25%), Positives = 45/123 (36%), Gaps = 16/123 (13%)
Query: 112 LSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLK 166
+ L+ LDLS N L FS L L L + N + ++ L+
Sbjct: 84 FVPVPNLRYLDLSSNHLHTLDEFLFS----DLQALEVLLLYNNHIVVVDRNAFEDMAQLQ 139
Query: 167 NLSIEGNLFTGSIPPDI----RKLINLQKLILSSNSFTGELPAELTKLTNL--NDLRISD 220
L + N + P ++ KL L L LSSN +L KL N L + +
Sbjct: 140 KLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
Query: 221 NNF 223
N
Sbjct: 199 NPL 201
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 2e-09
Identities = 27/89 (30%), Positives = 40/89 (44%), Gaps = 10/89 (11%)
Query: 672 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN-REFVN-----EIGM 725
+ + KVGEG +G VYK S G ++A+K + R E + EI +
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALK----RIRLDAEDEGIPSTAIREISL 72
Query: 726 ISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754
+ HPN+V L L LV+E+M
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFM 101
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 31/160 (19%), Positives = 58/160 (36%), Gaps = 25/160 (15%)
Query: 85 CDCSSAT--CH--------------VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCL 128
C CS+ C + I L+ + P S + L+++DLS N +
Sbjct: 9 CTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI 68
Query: 129 T----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI- 183
+ +F L L + GN+++ + + +L+ L + N + D
Sbjct: 69 SELAPDAFQGL---RSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAF 124
Query: 184 RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 223
+ L NL L L N + L + + ++ N F
Sbjct: 125 QDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 41/247 (16%), Positives = 82/247 (33%), Gaps = 62/247 (25%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
IP ++ + ++ L N+ P + L + +S+N +I
Sbjct: 25 EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNN--------------QI 68
Query: 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGE 297
+L + AF L +L +L+L I E
Sbjct: 69 SEL-------------------------------APDAFQGL--RSLNSLVLYGNKIT-E 94
Query: 298 IPDYIGD-MTKLKNIDLSFNNLTGGIPT-TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK 355
+P + + + L+ + L+ N + + F+ L N + L NKL + K F+ +
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQT-IAKGTFSPLR 152
Query: 356 NV-DISLNNFTWES-------SDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSA 407
+ + L + +D + + S R ++ + F CSA
Sbjct: 153 AIQTMHLAQNPFICDCHLKWLADYLHTNPIETSGARCTSPRRLANKRIGQIKSKKFRCSA 212
Query: 408 PADQYHY 414
A +H+
Sbjct: 213 AAHHHHH 219
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 41/193 (21%), Positives = 60/193 (31%), Gaps = 60/193 (31%)
Query: 157 KVLTNI-----TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TK 209
K LT I T+ + +E N IPP L+++ LS+N + EL +
Sbjct: 21 KGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQG 78
Query: 210 LTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISD 268
L +LN L + N KI +L P S+ L SL L
Sbjct: 79 LRSLNSLVLYGN--------------KITEL-----------PKSLFEGLFSLQLL---- 109
Query: 269 LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFE 327
L+ + + + L + L N L TF
Sbjct: 110 ---------LLNANKINC-----------LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 328 KLAKTNFMYLTGN 340
L M+L N
Sbjct: 150 PLRAIQTMHLAQN 162
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 3e-09
Identities = 27/159 (16%), Positives = 57/159 (35%), Gaps = 9/159 (5%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
+ +R DL L + + + L + L+ L + + +L
Sbjct: 412 KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLD 469
Query: 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG-KIP 228
+ N ++PP + L L+ L S N+ + + L L +L + +N
Sbjct: 470 LSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAI 526
Query: 229 EFIGKWKKIQKLHIQG---SSLEGPIPASISALTSLTDL 264
+ + ++ L++QG EG L S++ +
Sbjct: 527 QPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 50/310 (16%), Positives = 95/310 (30%), Gaps = 31/310 (10%)
Query: 55 DWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSK 114
++ + S+ G L D+ T D + HV L A +L LP +
Sbjct: 260 CFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFR 319
Query: 115 LRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGP----FPKVLTNITTLKNLSI 170
+ + L W + + LS L + L+ L
Sbjct: 320 VIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEP 379
Query: 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD-----NNFSG 225
E +I +R L L E + L ++ +R + + F
Sbjct: 380 ENKWCLLTIILLMRALDPLLYEK--------ETLQYFSTLKAVDPMRAAYLDDLRSKFLL 431
Query: 226 KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDKMN 283
+ ++ ++ LH+ L + + L +T L +S L+ A L
Sbjct: 432 ENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALR--C 487
Query: 284 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN---FMYLTGN 340
L+ L + + + + ++ +L+ + L N L + L + L GN
Sbjct: 488 LEVLQASDNAL-ENVDG-VANLPRLQELLLCNNRLQQ--SAAIQPLVSCPRLVLLNLQGN 543
Query: 341 KLTGPVPKYI 350
L
Sbjct: 544 SLCQE-EGIQ 552
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 22/84 (26%), Positives = 34/84 (40%), Gaps = 3/84 (3%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSG-PFPKVLTNITTL 165
LP L+ LR L+ L S N L + +L EL + NRL + L + L
Sbjct: 477 ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 535
Query: 166 KNLSIEGNLFTGSIPPDIRKLINL 189
L+++GN +L +
Sbjct: 536 VLLNLQGNSLC-QEEGIQERLAEM 558
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 4e-09
Identities = 25/88 (28%), Positives = 47/88 (53%), Gaps = 10/88 (11%)
Query: 673 AATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIGMI 726
++++ F K+G G + +VYKG+ + G +A+K + + + E EI ++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK----EVKLDSEEGTPSTAIREISLM 57
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYM 754
+H N+V+LY N+L LV+E+M
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFM 85
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 16/85 (18%), Positives = 38/85 (44%), Gaps = 2/85 (2%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
++F+ +G+G FG V K D A+K++ + + ++E+ ++++ H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNC 758
+V+ Y +E + +K
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKS 88
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 5e-09
Identities = 25/89 (28%), Positives = 40/89 (44%), Gaps = 11/89 (12%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 728
++ K+GEG +G V+K G ++A+K K + + EI M+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK----KFLESEDDPVIKKIALREIRMLKQ 58
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757
+HPNLV L +L LV+EY +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDHT 87
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 5e-09
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 11/89 (12%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 728
++ VGEG +G V K G ++A+K K + + + V EI ++
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK----KFLESDDDKMVKKIAMREIKLLKQ 80
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757
+H NLV L C + + LV+E++ +
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHT 109
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 37/161 (22%), Positives = 58/161 (36%), Gaps = 26/161 (16%)
Query: 85 CDCSSAT--CH--------------VVTIALKAQNLTGTLPT-ELSKLRYLKQLDLSRNC 127
C C T C + L T T KL L++++ S N
Sbjct: 9 CRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNK 68
Query: 128 LT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI 183
+T G+F + E+ + NRL K+ + +LK L + N T + D
Sbjct: 69 ITDIEEGAFEGA---SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDS 124
Query: 184 -RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 223
L +++ L L N T P L +L+ L + N F
Sbjct: 125 FIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 33/168 (19%), Positives = 61/168 (36%), Gaps = 34/168 (20%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 236
IP I +L L++N FT E KL L + S+N K
Sbjct: 25 KIPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNN--------------K 68
Query: 237 IQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKG-SESAFPKLDKMNLKTLILTKCL 293
I + + + + ++ ++ L+ F L+ +LKTL+L
Sbjct: 69 ITDIE----------EGAFEGASGVNEILLTSNRLENVQHKMFKGLE--SLKTLMLRSNR 116
Query: 294 IHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 340
I + + ++ ++ + L N +T P F+ L + + L N
Sbjct: 117 IT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 16/76 (21%), Positives = 32/76 (42%), Gaps = 4/76 (5%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNL--VKL 737
++G GG V++ + + A+K L Q + NEI ++ Q + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 738 YGCCVEGNQLLLVYEY 753
Y + + +V E
Sbjct: 122 YDYEITDQYIYMVMEC 137
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 20/100 (20%), Positives = 40/100 (40%), Gaps = 4/100 (4%)
Query: 658 GLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQ--LSSKSRQG 715
G+DL T + + + ++G GG V++ + + A+K L Q
Sbjct: 10 GVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT 69
Query: 716 NREFVNEIGMISAQQHPNL--VKLYGCCVEGNQLLLVYEY 753
+ NEI ++ Q + ++LY + + +V E
Sbjct: 70 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 109
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 57.1 bits (139), Expect = 6e-09
Identities = 26/85 (30%), Positives = 41/85 (48%), Gaps = 10/85 (11%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISAQ 729
+ K+GEG +G VYK + G A+K K R E + EI ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALK----KIRLEKEDEGIPSTTIREISILKEL 57
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYM 754
+H N+VKLY +L+LV+E++
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHL 82
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 16/76 (21%), Positives = 32/76 (42%), Gaps = 4/76 (5%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNL--VKL 737
++G GG V++ + + A+K L Q + NEI ++ Q + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 738 YGCCVEGNQLLLVYEY 753
Y + + +V E
Sbjct: 75 YDYEITDQYIYMVMEC 90
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 7e-09
Identities = 18/102 (17%), Positives = 41/102 (40%), Gaps = 9/102 (8%)
Query: 654 KELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR 713
E D +T + + +I F P + +G G G++ + D +AVK++ +
Sbjct: 7 LEQDDGDEETSVVIVGKIS-----FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF 61
Query: 714 QGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754
E+ + + +HPN+++ + + + E
Sbjct: 62 SFAD---REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 17/82 (20%), Positives = 39/82 (47%), Gaps = 3/82 (3%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL-SSKSRQGNREFVNEIGMI-SAQQHP 732
+ ++G G +GSV K + G ++AVK++ S+ + ++ + ++ ++ + P
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 733 NLVKLYGCCVEGNQLLLVYEYM 754
+V+ YG + E M
Sbjct: 82 YIVQFYGALFREGDCWICMELM 103
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 19/90 (21%), Positives = 36/90 (40%), Gaps = 5/90 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
+F +G GGFG V+K DG +K++ + N + E+ ++ H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIF 764
V GC + + ++ +F
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLF 96
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 15/97 (15%), Positives = 28/97 (28%), Gaps = 6/97 (6%)
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNREFVNE 722
+ + + + +GEG F VY+ D +K +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 723 IGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759
+ + +K Y + N +LV E L
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL 154
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 17/82 (20%), Positives = 38/82 (46%), Gaps = 3/82 (3%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQ-QHP 732
++ +P ++G G +G V K + G ++AVK++ ++ + Q + + ++ + P
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 733 NLVKLYGCCVEGNQLLLVYEYM 754
V YG + + E M
Sbjct: 67 FTVTFYGALFREGDVWICMELM 88
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 23/79 (29%), Positives = 39/79 (49%), Gaps = 1/79 (1%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
+G G FG V+K + G +A K + ++ + E NEI +++ H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 736 KLYGCCVEGNQLLLVYEYM 754
+LY N ++LV EY+
Sbjct: 150 QLYDAFESKNDIVLVMEYV 168
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 2e-08
Identities = 22/86 (25%), Positives = 42/86 (48%), Gaps = 11/86 (12%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 728
++ K+GEG +G+V+K ++A+K + R + E V EI ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALK----RVRLDDDDEGVPSSALREICLLKE 57
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYM 754
+H N+V+L+ +L LV+E+
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFC 83
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 2e-08
Identities = 31/86 (36%), Positives = 42/86 (48%), Gaps = 11/86 (12%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 728
NF K+GEG +G VYK G V+A+K K R E V EI ++
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALK----KIRLDTETEGVPSTAIREISLLKE 58
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYM 754
HPN+VKL N+L LV+E++
Sbjct: 59 LNHPNIVKLLDVIHTENKLYLVFEFL 84
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 22/93 (23%), Positives = 44/93 (47%), Gaps = 5/93 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHP 732
+++ +G G +G K SDG ++ K+ S + + V+E+ ++ +HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 733 NLVKLYGCCVE--GNQLLLVYEYMKNNCLSRAI 763
N+V+ Y ++ L +V EY + L+ I
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI 98
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 22/85 (25%), Positives = 40/85 (47%), Gaps = 10/85 (11%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIGMISAQ 729
+ +K+GEG + +VYKG ++A+K + R + E E+ ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALK----EIRLEHEEGAPCTAIREVSLLKDL 57
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYM 754
+H N+V L+ L LV+EY+
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL 82
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 23/86 (26%), Positives = 41/86 (47%), Gaps = 11/86 (12%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 728
+ + K+GEG +G VYK I +A+K + R + E V E+ ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIK----RIRLEHEEEGVPGTAIREVSLLKE 89
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYM 754
QH N+++L ++L L++EY
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYA 115
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 17/81 (20%), Positives = 38/81 (46%), Gaps = 2/81 (2%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPN 733
++F+ +++G G G V+K G V+A K + + + + + E+ ++ P
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 734 LVKLYGCCVEGNQLLLVYEYM 754
+V YG ++ + E+M
Sbjct: 93 IVGFYGAFYSDGEISICMEHM 113
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 23/82 (28%), Positives = 45/82 (54%), Gaps = 3/82 (3%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHP 732
+++D ++G G FG V++ + G A K + + ++E V EI +S +HP
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM-TPHESDKETVRKEIQTMSVLRHP 214
Query: 733 NLVKLYGCCVEGNQLLLVYEYM 754
LV L+ + N+++++YE+M
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFM 236
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 24/110 (21%), Positives = 50/110 (45%), Gaps = 7/110 (6%)
Query: 648 GKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK 706
G + + G G ++ +A N+ + ++G G G V+K G VIAVK
Sbjct: 1 GSSGSSGKQTGYLTIGG----QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVK 56
Query: 707 QL-SSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYM 754
Q+ S +++ N+ + ++ ++ P +V+ +G + + + E M
Sbjct: 57 QMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM 106
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 18/81 (22%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
+ +D ++G G FG V++ + + G V K +++ NEI +++ HP
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 734 LVKLYGCCVEGNQLLLVYEYM 754
L+ L+ + +++L+ E++
Sbjct: 110 LINLHDAFEDKYEMVLILEFL 130
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 3e-08
Identities = 56/306 (18%), Positives = 106/306 (34%), Gaps = 53/306 (17%)
Query: 88 SSATCHVVTIALKAQNLTGT----LPTELSKLRYLKQLDLSRNCLTGSFSPQWASL---- 139
+ +C + ++L+ LTG L + L L L++L LS N L +
Sbjct: 81 QTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDP 140
Query: 140 --QLVELSVMGNRLS----GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKL------- 186
+L +L + LS P VL K L++ N + +R L
Sbjct: 141 QCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEA---GVRVLCQGLKDS 197
Query: 187 -INLQKLILSSNSFTGE----LPAELTKLTNLNDLRISDNNFSGKIPEFIGKW-----KK 236
L+ L L S T + L + +L +L + N + +
Sbjct: 198 PCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSR 257
Query: 237 IQKLHIQGSSL--EG--PIPASISALTSLTDLRISDLK-GSESA---FPKLDKMN--LKT 286
++ L I + +G + + A SL +L ++ + G E A L + L++
Sbjct: 258 LRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLES 317
Query: 287 LILTKCLIHGEIPDYIGDM----TKLKNIDLSFNNLT-GGIPTTFEKLAKTN----FMYL 337
L + C + + L + +S N L G+ + L + ++L
Sbjct: 318 LWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWL 377
Query: 338 TGNKLT 343
++
Sbjct: 378 ADCDVS 383
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 50/281 (17%), Positives = 95/281 (33%), Gaps = 55/281 (19%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWA------SLQLVELSVMGNRLS----GPFPKVLTN 161
L L +L+L N L S ++ +LS+ L+ G L
Sbjct: 52 LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT 111
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLI--------NLQKLILSSNSFTGE----LPAELTK 209
+ TL+ L + NL + ++ L L+KL L S + L + L
Sbjct: 112 LPTLQELHLSDNLLGDA---GLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRA 168
Query: 210 LTNLNDLRISDNNFSGKIPEFIGK-----WKKIQKLHIQGSSLEGPIPASISAL------ 258
+ +L +S+N+ + + + +++ L ++ + + L
Sbjct: 169 KPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT---SDNCRDLCGIVAS 225
Query: 259 -TSLTDLRISD----LKGSESAFPKLDKMN--LKTLILTKCLIHGEIPDYIGDM----TK 307
SL +L + G P L + L+TL + +C I + + +
Sbjct: 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKES 285
Query: 308 LKNIDLSFNNLTG-GIPTTFEKLAKTNFM----YLTGNKLT 343
LK + L+ N L G E L + ++ T
Sbjct: 286 LKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT 326
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 44/242 (18%), Positives = 85/242 (35%), Gaps = 46/242 (19%)
Query: 118 LKQLDLSRNCLTGSFSPQWASL-----QLVELSVMGNRLS----GPFPKVLTNITTLKNL 168
++ LD+ L+ +WA L Q + + L+ L L L
Sbjct: 5 IQSLDIQCEELS---DARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 169 SIEGNLFTGSIPPDIRKL--------INLQKLILSSNSFTGE----LPAELTKLTNLNDL 216
++ N + + +QKL L + TG L + L L L +L
Sbjct: 62 NLRSNELGDV---GVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 118
Query: 217 RISDNNFSGKIPEFIGK-----WKKIQKLHIQGSSL--EG--PIPASISALTSLTDLRIS 267
+SDN + + + +++KL ++ SL P+ + + A +L +S
Sbjct: 119 HLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVS 178
Query: 268 DLKGSESAFPKLDKM------NLKTLILTKCLIHGEIPDYIGDM----TKLKNIDLSFNN 317
+ +E+ L + L+ L L C + + + + L+ + L N
Sbjct: 179 NNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 238
Query: 318 LT 319
L
Sbjct: 239 LG 240
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 33/125 (26%), Positives = 50/125 (40%), Gaps = 21/125 (16%)
Query: 640 MRWKGCLGGKVSADK-ELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-L 697
M G LGG D+ + G ++ G LR + + EGGF VY+ +
Sbjct: 1 MAGPGSLGGASGRDQSDFVGQTVELGELRLRVRR----------VLAEGGFAFVYEAQDV 50
Query: 698 SDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQ--------LL 748
G A+K+L S + NR + E+ M HPN+V+ G + L
Sbjct: 51 GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFL 110
Query: 749 LVYEY 753
L+ E
Sbjct: 111 LLTEL 115
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 21/86 (24%), Positives = 41/86 (47%), Gaps = 2/86 (2%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPN 733
+F+P +G GGFG V++ D A+K++ +R+ RE + E+ ++ +HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCL 759
+V+ + +E N + L
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYL 90
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 22/120 (18%), Positives = 39/120 (32%), Gaps = 5/120 (4%)
Query: 640 MRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LS 698
M L G++ + + + K+G G +G V
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 699 DGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755
A+K + K+ + E+ ++ HPN++KLY + LV E K
Sbjct: 61 THVERAIKIIR-KTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 16/78 (20%), Positives = 34/78 (43%), Gaps = 4/78 (5%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLYGC 740
+G+G +V++G G + A+K ++ S + + E ++ H N+VKL+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 741 --CVEGNQLLLVYEYMKN 756
+L+ E+
Sbjct: 76 EEETTTRHKVLIMEFCPC 93
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 24/95 (25%), Positives = 46/95 (48%), Gaps = 14/95 (14%)
Query: 674 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIG--- 724
AT+ ++P ++G G +G+VYK G +A+K + + G + E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 725 MISAQQHPNLVKLYGCCV-----EGNQLLLVYEYM 754
+ A +HPN+V+L C ++ LV+E++
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV 101
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 24/95 (25%), Positives = 40/95 (42%), Gaps = 11/95 (11%)
Query: 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
+ +G G FG V++ L + +A+K++ R NR E+ ++ +HPN+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNV 94
Query: 735 VKLYGCCVEGNQ------LLLVYEYMKNNCLSRAI 763
V L L LV EY+ + RA
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRAS 128
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 19/75 (25%), Positives = 37/75 (49%), Gaps = 2/75 (2%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLVKLYGC 740
K+G G FG V+ S G +K ++ Q E + EI ++ + HPN++K++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 741 CVEGNQLLLVYEYMK 755
+ + + +V E +
Sbjct: 89 FEDYHNMYIVMETCE 103
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 23/102 (22%), Positives = 39/102 (38%), Gaps = 6/102 (5%)
Query: 659 LDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNR 717
L G++ ++ + +G+G FG V G AVK +S K + +
Sbjct: 9 LHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS-KRQVKQK 67
Query: 718 EFV----NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755
E+ ++ HPN++KLY + LV E
Sbjct: 68 TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 109
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 21/82 (25%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
T+ ++ +G G + + I + AVK + R E EI ++ QHPN
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEI-LLRYGQHPN 77
Query: 734 LVKLYGCCVEGNQLLLVYEYMK 755
++ L +G + +V E MK
Sbjct: 78 IITLKDVYDDGKYVYVVTELMK 99
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 19/73 (26%), Positives = 30/73 (41%), Gaps = 2/73 (2%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPNLVKLYGCCV 742
GEG V I L AVK + + E+ + Q H N+++L
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81
Query: 743 EGNQLLLVYEYMK 755
E ++ LV+E M+
Sbjct: 82 EEDRFYLVFEKMR 94
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 24/98 (24%), Positives = 43/98 (43%), Gaps = 8/98 (8%)
Query: 664 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNR 717
G+ T +Q + + +D ++G G F V K S G A K Q + R R
Sbjct: 1 GMETFKQ-QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCR 59
Query: 718 EFV-NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754
E + E+ ++ HPN++ L+ ++L+ E +
Sbjct: 60 EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELV 97
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 17/82 (20%), Positives = 39/82 (47%), Gaps = 4/82 (4%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHP 732
+ A +G G FG V++ + S K + K ++ V EI +++ +H
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHR 61
Query: 733 NLVKLYGCCVEGNQLLLVYEYM 754
N++ L+ +L++++E++
Sbjct: 62 NILHLHESFESMEELVMIFEFI 83
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 52.6 bits (125), Expect = 2e-07
Identities = 25/120 (20%), Positives = 44/120 (36%), Gaps = 23/120 (19%)
Query: 662 QTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQL--------SSKSR 713
Q G T K+GEG FG V++ I D T +A+K + + +
Sbjct: 7 QKGPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQ 64
Query: 714 QGNREFVNEIGM---------ISAQQHPNLVKLYGC-CVEGN---QLLLVYEYMKNNCLS 760
+ E + EI + + + L CV+G+ LL +++ + S
Sbjct: 65 KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 23/88 (26%), Positives = 39/88 (44%), Gaps = 9/88 (10%)
Query: 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
+ F G+G FG+V G G +A+K++ R NRE + + ++ HPN
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 734 LVKLYGCCVEGNQ-------LLLVYEYM 754
+V+L + L +V EY+
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYV 108
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 20/117 (17%), Positives = 45/117 (38%), Gaps = 10/117 (8%)
Query: 649 KVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ 707
K + + + + + L K +DP + +G G V + + + G AVK
Sbjct: 67 KGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126
Query: 708 LSSKSRQGNREFV--------NEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755
+ + + + E + E + HP+++ L + + LV++ M+
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMR 183
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 39/152 (25%), Positives = 63/152 (41%), Gaps = 9/152 (5%)
Query: 119 KQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG 177
++LDL L + L +L L++ N+L V ++T L L + N
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 178 SIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLNDLRISDNNFSGKIPE--FIGK 233
S+P + L L KL L N LP+ + +LT L +LR++ N IP F K
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF-DK 153
Query: 234 WKKIQKLHIQGSSLEGPIPASISALTSLTDLR 265
+Q L + + L+ + L L +
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTIT 185
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 45/190 (23%), Positives = 65/190 (34%), Gaps = 36/190 (18%)
Query: 158 VLTNI-TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAEL-TKLTNLND 215
V + I + L ++ R L L L L N L A + LT L
Sbjct: 29 VPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGT 87
Query: 216 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISD--LKG- 271
L +++N ++ L P + LT L L + LK
Sbjct: 88 LGLANN--------------QLASL-----------PLGVFDHLTQLDKLYLGGNQLKSL 122
Query: 272 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLA 330
F +L LK L L + IP D +T L+ + LS N L F++L
Sbjct: 123 PSGVFDRL--TKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLG 179
Query: 331 KTNFMYLTGN 340
K + L GN
Sbjct: 180 KLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 37/116 (31%), Positives = 47/116 (40%), Gaps = 11/116 (9%)
Query: 114 KLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNL 168
L L L L+ N L G F L QL +L + GN+L V +T LK L
Sbjct: 81 DLTELGTLGLANNQLASLPLGVFD----HLTQLDKLYLGGNQLKSLPSGVFDRLTKLKEL 136
Query: 169 SIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 223
+ N SIP KL NLQ L LS+N +L L + + N F
Sbjct: 137 RLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 3e-07
Identities = 19/85 (22%), Positives = 38/85 (44%), Gaps = 5/85 (5%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQ 730
++ +G+G FG V K AVK ++ K+ N++ + E+ ++
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLD 79
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMK 755
HPN++KL+ + + +V E
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYT 104
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 3e-07
Identities = 21/87 (24%), Positives = 41/87 (47%), Gaps = 7/87 (8%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFV-NEIGMIS 727
++++ ++G G F V K G A K +LSS R +RE + E+ ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYM 754
+HPN++ L+ ++L+ E +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELV 90
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 16/78 (20%), Positives = 34/78 (43%), Gaps = 4/78 (5%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLYGC 740
+G+G +V++G G + A+K ++ S + + E ++ H N+VKL+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 741 --CVEGNQLLLVYEYMKN 756
+L+ E+
Sbjct: 76 EEETTTRHKVLIMEFCPC 93
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 24/96 (25%), Positives = 42/96 (43%), Gaps = 12/96 (12%)
Query: 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
++ +G G FG VY+ L D G ++A+K++ R NR E+ ++ H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 108
Query: 734 LVKLYGCCVEGNQ------LLLVYEYMKNNCLSRAI 763
+V+L + L LV +Y+ + R
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVA 143
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 24/80 (30%), Positives = 33/80 (41%), Gaps = 8/80 (10%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLVKLY---- 738
G GGFG V + I G +A+KQ + NRE EI ++ HPN+V
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82
Query: 739 --GCCVEGNQLLLVYEYMKN 756
+ LL EY +
Sbjct: 83 GLQKLAPNDLPLLAMEYCEG 102
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 19/78 (24%), Positives = 36/78 (46%), Gaps = 5/78 (6%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKL 737
+G+G FG V K AVK ++ K+ N++ + E+ ++ HPN++KL
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 738 YGCCVEGNQLLLVYEYMK 755
+ + + +V E
Sbjct: 87 FEILEDSSSFYIVGELYT 104
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 7e-07
Identities = 20/87 (22%), Positives = 37/87 (42%), Gaps = 7/87 (8%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFV-NEIGMIS 727
+ +D ++G G F V K S G A K Q + R +RE + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYM 754
H N++ L+ ++L+ E +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELV 97
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 7e-07
Identities = 17/74 (22%), Positives = 31/74 (41%), Gaps = 1/74 (1%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
+G G +G V + A K++ + F EI ++ + HPN+++LY
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 742 VEGNQLLLVYEYMK 755
+ + LV E
Sbjct: 76 EDNTDIYLVMELCT 89
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 16/86 (18%), Positives = 33/86 (38%), Gaps = 6/86 (6%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFVNEIGMISA 728
+ +G+G +G V I + A+K ++ + + E+ ++
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYM 754
HPN+ +LY + + LV E
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELC 110
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 23/95 (24%), Positives = 43/95 (45%), Gaps = 7/95 (7%)
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFV 720
T+ + + + +D ++G G F V K S G A K + S R +RE +
Sbjct: 2 TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 721 -NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754
E+ ++ QHPN++ L+ ++L+ E +
Sbjct: 62 EREVSILKEIQHPNVITLHEVYENKTDVILILELV 96
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 23/96 (23%), Positives = 44/96 (45%), Gaps = 22/96 (22%)
Query: 676 NNFDPANKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGN----------REFVNEI 723
++ ++GEG +G V+K + + G +A+K + R RE V +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALK----RVRVQTGEEGMPLSTIRE-VAVL 65
Query: 724 GMISAQQHPNLVKLYGCCV-----EGNQLLLVYEYM 754
+ +HPN+V+L+ C +L LV+E++
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV 101
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 26/102 (25%), Positives = 46/102 (45%), Gaps = 5/102 (4%)
Query: 658 GLDLQTGLYTLRQIKAATNNFDPANKV-GEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQ 714
G+DL T + ++ N + +K G G F V + I S G A K L + Q
Sbjct: 10 GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ 69
Query: 715 GNREFV-NEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754
R + +EI + A+ P ++ L+ ++++L+ EY
Sbjct: 70 DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYA 111
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 23/119 (19%), Positives = 50/119 (42%), Gaps = 14/119 (11%)
Query: 649 KVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ 707
+ +G+ + G+Y ++ ++ K+G G +G V + + A+K
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68
Query: 708 LS------------SKSRQGNREFV-NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753
+ +K+ + E + NEI ++ + HPN++KL+ + LV E+
Sbjct: 69 IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEF 127
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 17/80 (21%), Positives = 29/80 (36%), Gaps = 4/80 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPNL 734
N +G G G+V G +AVK++ + EI + + HPN+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNV 71
Query: 735 VKLYGCCVEGNQLLLVYEYM 754
++ Y L + E
Sbjct: 72 IRYYCSETTDRFLYIALELC 91
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 21/85 (24%), Positives = 40/85 (47%), Gaps = 2/85 (2%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPN 733
+F+P +G GGFG V++ D A+K++ +R+ RE V E+ ++ +HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNC 758
+V+ + +E E +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWL 90
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 19/84 (22%), Positives = 35/84 (41%), Gaps = 6/84 (7%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFVNEIGMISAQQH 731
++ +G+G F V + I G AVK + +S + E + +H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMK 755
P++V+L L +V+E+M
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMD 109
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 22/94 (23%), Positives = 39/94 (41%), Gaps = 19/94 (20%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 728
+ ++ K+G+G FG V+K G +A+K K N +E EI ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQL 72
Query: 729 QQHPNLVKLYGCCVE--------GNQLLLVYEYM 754
+H N+V L C + LV+++
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC 106
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 20/84 (23%), Positives = 42/84 (50%), Gaps = 3/84 (3%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREFV-NEIGMISAQQH 731
++N+D ++G+G F V + + + G A K ++ K + + + E + QH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMK 755
PN+V+L+ E + LV++ +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVT 88
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 18/75 (24%), Positives = 30/75 (40%), Gaps = 3/75 (4%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLVKLYGC 740
+G G F V+ G + A+K + KS + NEI ++ +H N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 741 CVEGNQLLLVYEYMK 755
LV + +
Sbjct: 75 YESTTHYYLVMQLVS 89
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 19/114 (16%), Positives = 38/114 (33%), Gaps = 7/114 (6%)
Query: 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL----QLVELSV 146
H + ++ L L +L + + L +L L++
Sbjct: 6 CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHL--ELRDLRGLGELRNLTI 63
Query: 147 MGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFT 200
+ + L P L L++ N S+ + ++LQ+L+LS N
Sbjct: 64 VKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 20/98 (20%), Positives = 37/98 (37%), Gaps = 9/98 (9%)
Query: 251 IPASISALTSLTDLRISDLKGSES----AFPKLDKMNLKTLILTKCLIHGEIPDYI-GDM 305
+ +LT+L I + + + L L+ L + K + +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLG--ELRNLTIVKSGLR-FVAPDAFHFT 79
Query: 306 TKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
+L ++LSFN L T + L+ + L+GN L
Sbjct: 80 PRLSRLNLSFNALESLSWKTVQGLSLQE-LVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 3e-04
Identities = 17/94 (18%), Positives = 34/94 (36%), Gaps = 6/94 (6%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKIPE--FIGKW 234
+ NL +L + + L L L L +L I + + F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFT- 79
Query: 235 KKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
++ +L++ ++LE + SL +L +S
Sbjct: 80 PRLSRLNLSFNALES-LSWKTVQGLSLQELVLSG 112
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 4/105 (3%)
Query: 119 KQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG 177
+ L L N +T + SL L EL + N+L V ++T L L + N T
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 178 SIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
+P + +L++L++L + N T ELP + +LT+L L + N
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 20/77 (25%), Positives = 35/77 (45%), Gaps = 7/77 (9%)
Query: 683 KVGEGGFGSVYKGI---LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
KVG G +G VYK D A+KQ+ + EI ++ +HPN++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 85
Query: 740 CCVE--GNQLLLVYEYM 754
+ ++ L+++Y
Sbjct: 86 VFLSHADRKVWLLFDYA 102
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 39/282 (13%), Positives = 85/282 (30%), Gaps = 71/282 (25%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQ-----------LVELSVMGNRLSG----PFP 156
++ + L+ + S +L+ L + + N P
Sbjct: 56 IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI 115
Query: 157 KVLTNITTLKNLSIEGN-------------LFTGSIPPDIRKLINLQKLILSSNSFTGE- 202
L+ T L++L + N L ++ + L+ +I N
Sbjct: 116 DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGS 175
Query: 203 ---LPAELTKLTNLNDLRISDNNFSGK-----IPEFIGKWKKIQKLHIQGSSLEGPIPAS 254
L+ +++ N + + E + ++++ L +Q ++ + +S
Sbjct: 176 MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF-THLGSS 234
Query: 255 I--SALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDM------T 306
AL S NL+ L L CL+ + D
Sbjct: 235 ALAIALKSWP--------------------NLRELGLNDCLLSARGAAAVVDAFSKLENI 274
Query: 307 KLKNIDLSFNNLTGGIPTTFEKLAKTN-----FMYLTGNKLT 343
L+ + L +N + T + + F+ L GN+ +
Sbjct: 275 GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 36/235 (15%), Positives = 76/235 (32%), Gaps = 43/235 (18%)
Query: 141 LVELSVMGNRLSG----PFPKVLTNITTLKNLSIEGNLFTG----SIPPDIRKLINLQKL 192
+ S+ + ++ VL ++K + + GN + +I +L+
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 193 ILSSNSFTGELPAE-----------LTKLTNLNDLRISDNNFSGK----IPEFIGKWKKI 237
S FTG + E L K L+ +R+SDN F + +F+ K +
Sbjct: 66 EFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGE 297
+ L++ + L P + + + L+ + L+++I + +
Sbjct: 125 EHLYLHNNGLG---PQAGAKIARA-------LQELAVNKKAKNAPPLRSIICGRNRLENG 174
Query: 298 IPDYIGDM----TKLKNIDLSFNNLTG-GIPTTFEKLAKTN----FMYLTGNKLT 343
L + + N + GI + + L N T
Sbjct: 175 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 16/84 (19%), Positives = 37/84 (44%), Gaps = 3/84 (3%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREFV-NEIGMISAQQH 731
T + ++G+G F V + + + G A ++ K + + + E + +H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMK 755
PN+V+L+ E L+++ +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVT 93
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 20/75 (26%), Positives = 31/75 (41%), Gaps = 5/75 (6%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPNLVKLYGC 740
+GEG F K + AVK +S + + EI + + HPN+VKL+
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHPNIVKLHEV 74
Query: 741 CVEGNQLLLVYEYMK 755
+ LV E +
Sbjct: 75 FHDQLHTFLVMELLN 89
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 5e-06
Identities = 23/98 (23%), Positives = 48/98 (48%), Gaps = 10/98 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQ 730
+F+ +G+G FG+VY ++A+K L K+ ++ E+ + S +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLR 67
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLR 768
HPN+++LYG + ++ L+ EY + + +L+
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQ 101
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 39/115 (33%), Positives = 52/115 (45%), Gaps = 13/115 (11%)
Query: 114 KLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNL 168
+L L L L+ N L G F L L EL ++ N+L V +T L L
Sbjct: 83 ELTNLTYLILTGNQLQSLPNGVF----DKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL 138
Query: 169 SIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLNDLRISDN 221
++ N S+P + KL NL +L LS N LP + KLT L DLR+ N
Sbjct: 139 NLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQN 191
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 35/192 (18%), Positives = 75/192 (39%), Gaps = 34/192 (17%)
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
+++ T +L ++ ++I +++ + + L N+ L + N
Sbjct: 19 AETIKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNK 74
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISDLKGSESAFPKLDK 281
I + + L + G+ L+ +P + LT+L +L L +
Sbjct: 75 LH-DISAL-KELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELV-------------LVE 118
Query: 282 MNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 340
L++L PD + D +T L ++L+ N L F+KL + L+ N
Sbjct: 119 NQLQSL-----------PDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYN 167
Query: 341 KLTGPVPKYIFN 352
+L +P+ +F+
Sbjct: 168 QLQS-LPEGVFD 178
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 20/85 (23%), Positives = 41/85 (48%), Gaps = 5/85 (5%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQ 730
++N+D ++G+G F V + + + G A K ++ + R+ E + Q
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQ 86
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMK 755
HPN+V+L+ E + LV++ +
Sbjct: 87 HPNIVRLHDSIQEESFHYLVFDLVT 111
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 22/98 (22%), Positives = 35/98 (35%), Gaps = 11/98 (11%)
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK--------QLSSKSRQGNREF 719
N++P +G G V + I AVK S++ Q RE
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 720 V-NEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755
E+ + HPN+++L LV++ MK
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMK 107
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 39/140 (27%), Positives = 61/140 (43%), Gaps = 13/140 (9%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVE 143
C CS T + + + +P + LDL N L + + L L +
Sbjct: 5 CSCSGTTVECYSQGRTS--VPTGIPAQT------TYLDLETNSLKSLPNGVFDELTSLTQ 56
Query: 144 LSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGE 202
L + GN+L V +T+L L++ N S+P + KL L++L L++N
Sbjct: 57 LYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-S 114
Query: 203 LPAEL-TKLTNLNDLRISDN 221
LP + KLT L DLR+ N
Sbjct: 115 LPDGVFDKLTQLKDLRLYQN 134
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 14/82 (17%), Positives = 29/82 (35%), Gaps = 10/82 (12%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLS--------SKSRQGNREFVNEIGMISAQQHPN 733
+G G G V +A++ +S ++ EI ++ HP
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 734 LVKLYGCCVEGNQLLLVYEYMK 755
++K+ + +V E M+
Sbjct: 202 IIKIKN-FFDAEDYYIVLELME 222
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 17/76 (22%), Positives = 28/76 (36%), Gaps = 9/76 (11%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC-- 741
G G G V + G A+K L S + +E + A P++V +
Sbjct: 38 GLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQEV--DH-HWQASGGPHIVCILDVYEN 93
Query: 742 --VEGNQLLLVYEYMK 755
LL++ E M+
Sbjct: 94 MHHGKRCLLIIMECME 109
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 18/84 (21%), Positives = 35/84 (41%), Gaps = 13/84 (15%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMI-----------SAQQHP 732
G+GGFG+V+ G L+D +A+K + ++R +++ + HP
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVI-PRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKN 756
+++L +LV E
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLP 122
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 24/89 (26%), Positives = 39/89 (43%), Gaps = 6/89 (6%)
Query: 143 ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTG 201
EL + GN+ + PK L+N L + + N + ++ + L LILS N
Sbjct: 35 ELYLDGNQFTLV-PKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR- 91
Query: 202 ELPAELT-KLTNLNDLRISDNNFSGKIPE 229
+P L +L L + N+ S +PE
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVPE 119
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 36/116 (31%), Positives = 52/116 (44%), Gaps = 7/116 (6%)
Query: 108 LPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKN 167
+ LS L+ K L LS N + S L LS+ N + + TL+
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLIKK-IENLDAVADTLEE 97
Query: 168 LSIEGNLFTGSIPPDIRKLINLQKLILSSNSFT--GELPAELTKLTNLNDLRISDN 221
L I N S+ I KL+NL+ L +S+N T GE+ +L L L DL ++ N
Sbjct: 98 LWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN 150
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 7e-05
Identities = 16/77 (20%), Positives = 31/77 (40%), Gaps = 6/77 (7%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
G+GGF ++ V A K + K Q + EI + + H ++V +G
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHG 82
Query: 740 CCVEGNQLLLVYEYMKN 756
+ + + +V E +
Sbjct: 83 FFEDNDFVFVVLELCRR 99
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 15/90 (16%), Positives = 32/90 (35%), Gaps = 10/90 (11%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--------SKSRQGNREFVNEIGM 725
+ + + +G G G V +A+K +S ++ EI +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 726 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755
+ HP ++K+ + +V E M+
Sbjct: 69 LKKLNHPCIIKIKN-FFDAEDYYIVLELME 97
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 16/77 (20%), Positives = 31/77 (40%), Gaps = 6/77 (7%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
G+GGF ++ V A K + K Q + EI + + H ++V +G
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHG 108
Query: 740 CCVEGNQLLLVYEYMKN 756
+ + + +V E +
Sbjct: 109 FFEDNDFVFVVLELCRR 125
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 18/76 (23%), Positives = 28/76 (36%), Gaps = 9/76 (11%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG---- 739
G G G V + A+K L + RE E+ A Q P++V++
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYEN 126
Query: 740 CCVEGNQLLLVYEYMK 755
LL+V E +
Sbjct: 127 LYAGRKCLLIVMECLD 142
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 23/91 (25%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
G+G F VY+ + G +A+K + K+ R NE+ + +HP++++LY
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELYN 78
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKLRIF 770
+ N + LV E N ++R + +++ F
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPF 109
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 30/129 (23%), Positives = 54/129 (41%), Gaps = 12/129 (9%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTG-SFSPQWASLQLVELSVMGNRLSGPFPKVLT 160
++ G + ++ L+ L L L S P+ L+ +ELS NR+ G +
Sbjct: 35 KSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLKKLELS--ENRIFGGLDMLAE 92
Query: 161 NITTLKNLSIEGNLFT--GSIPPDIRKLINLQKLILSSNSFTGE------LPAELTKLTN 212
+ L +L++ GN ++ P ++KL L+ L L + T + L +LT
Sbjct: 93 KLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTY 151
Query: 213 LNDLRISDN 221
L+ D
Sbjct: 152 LDGYDREDQ 160
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 18/76 (23%), Positives = 28/76 (36%), Gaps = 9/76 (11%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC-- 741
G G G V + A+K L + RE E+ A Q P++V++
Sbjct: 27 GLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYEN 82
Query: 742 --VEGNQLLLVYEYMK 755
LL+V E +
Sbjct: 83 LYAGRKCLLIVMECLD 98
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 22/85 (25%), Positives = 44/85 (51%), Gaps = 4/85 (4%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNRE--FVNEIGMISAQQH 731
++FD +G+G FG+VY + ++A+K L S+ + E EI + S +H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKN 756
PN++++Y + ++ L+ E+
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPR 98
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 31/235 (13%), Positives = 76/235 (32%), Gaps = 30/235 (12%)
Query: 112 LSKLRYLKQLDLSRNCLT-------GSFSPQWASLQLVELSVMGNRLSGP--FPKVLTNI 162
++ R +K L + + + + SL+++ + P + N
Sbjct: 160 VTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC 219
Query: 163 TTLKNLSIEG--NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220
+L ++ + L L L+ + E L L L +S
Sbjct: 220 RSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSY 279
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG--SESAFPK 278
+ +P +I+KL + + LE + + +L + + + +
Sbjct: 280 MGPNE-MPILFPFAAQIRKLDLLYALLETE--DHCTLIQKCPNLEVLETRNVIGDRGLEV 336
Query: 279 LDKM--NLKTLILTKCLIHGEIPDYIGDMT------------KLKNIDLSFNNLT 319
L + LK L + + + D G ++ +L+ + + +++T
Sbjct: 337 LAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDIT 391
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 32/213 (15%), Positives = 81/213 (38%), Gaps = 13/213 (6%)
Query: 119 KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG-NLFTG 177
+ LDL+ L + + S ++ + + P + + ++++ + +
Sbjct: 50 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEVS 108
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD-NNFSGKIPEFIGK-WK 235
++ + + LQ L L + + L K +NL L +S + FS + +
Sbjct: 109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 168
Query: 236 KIQKLHIQGSSL---EGPIPASISALTSLTDLRISDLKG--SESAFPKLDKM--NLKTLI 288
++ +L++ + A ++T L +S + +S L + NL L
Sbjct: 169 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228
Query: 289 LTKC-LIHGEIPDYIGDMTKLKNIDLSF-NNLT 319
L+ ++ + + L+++ LS ++
Sbjct: 229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDII 261
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 24/117 (20%), Positives = 42/117 (35%), Gaps = 11/117 (9%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
+ + ++LDL + + Q + N + + L L+ L
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEI-----RKLDGFPLLRRLK 67
Query: 170 ---IEGNLFTGSIPPDIRKLINLQKLILSSNSFT--GELPAELTKLTNLNDLRISDN 221
+ N + L +L +LIL++NS G+L L L +L L I N
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 30/166 (18%), Positives = 53/166 (31%), Gaps = 13/166 (7%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMG------NRLSGPFPKVLTNITT 164
+++ LK L L+R + QL EL G + L+
Sbjct: 207 VTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKE 266
Query: 165 LKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGE-LPAELTKLTNLNDLRISDNNF 223
L+ LS + +P L L LS + L L + L L + D
Sbjct: 267 LRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIE 326
Query: 224 SGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDL 269
+ K +++L + S P + +LT+ + +
Sbjct: 327 DAGLEVLASTCKDLRELRVFPSE-----PFVMEPNVALTEQGLVSV 367
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 26/86 (30%), Positives = 37/86 (43%), Gaps = 3/86 (3%)
Query: 140 QLVELSVMGNRLS-GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS 198
+ EL + +R + G + L+ LS T SI ++ KL L+KL LS N
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNR 75
Query: 199 FTGELPAELTKLTNLNDLRISDNNFS 224
+G L K NL L +S N
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 4e-04
Identities = 26/112 (23%), Positives = 48/112 (42%), Gaps = 5/112 (4%)
Query: 161 NITTLKNLSIEGNLFT-GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219
+ +K L ++ + G + + L+ L + T + A L KL L L +S
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG 271
DN SG + K + L++ G+ ++ ++I L L +L+ DL
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFN 122
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 25/122 (20%), Positives = 38/122 (31%), Gaps = 28/122 (22%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
++ G L + L+ L LT ++ L
Sbjct: 28 RSNEGKLEGLTDEFEELEFLSTINVGLT--------------------SIAN-----LPK 62
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFT--GELPAELTKLTNLNDLRIS 219
+ LK L + N +G + K NL L LS N + L KL NL L +
Sbjct: 63 LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI-EPLKKLENLKSLDLF 121
Query: 220 DN 221
+
Sbjct: 122 NC 123
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 18/74 (24%), Positives = 30/74 (40%), Gaps = 3/74 (4%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
++G G VY+ A+K L + EIG++ HPN++KL
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHPNIIKLKEIF 117
Query: 742 VEGNQLLLVYEYMK 755
++ LV E +
Sbjct: 118 ETPTEISLVLELVT 131
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 20/82 (24%), Positives = 33/82 (40%), Gaps = 5/82 (6%)
Query: 143 ELSVMGNRLSG-PFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFT 200
EL + N L + + L L ++ N T I P+ ++Q+L L N
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91
Query: 201 GELPAEL-TKLTNLNDLRISDN 221
E+ ++ L L L + DN
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDN 112
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 5e-04
Identities = 24/74 (32%), Positives = 31/74 (41%), Gaps = 2/74 (2%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLVKLYGCCV 742
GEG +G V + +AVK + K E + EI + H N+VK YG
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 743 EGNQLLLVYEYMKN 756
EGN L EY
Sbjct: 76 EGNIQYLFLEYCSG 89
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 16/67 (23%), Positives = 29/67 (43%), Gaps = 5/67 (7%)
Query: 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
+ + +G G FG V + + G A+K++ R NR E+ ++ H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61
Query: 734 LVKLYGC 740
++KL
Sbjct: 62 IIKLVDY 68
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 24/74 (32%), Positives = 31/74 (41%), Gaps = 2/74 (2%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLVKLYGCCV 742
GEG +G V + +AVK + K E + EI + H N+VK YG
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 743 EGNQLLLVYEYMKN 756
EGN L EY
Sbjct: 76 EGNIQYLFLEYCSG 89
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 20/82 (24%), Positives = 36/82 (43%), Gaps = 11/82 (13%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-------EIGMISAQQH--PNL 734
G GGFGSVY GI +SD +A+K + K R + + E+ ++ +
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHV-EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 735 VKLYGCCVEGNQLLLVYEYMKN 756
++L + +L+ E +
Sbjct: 111 IRLLDWFERPDSFVLILERPEP 132
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 799 | |||
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.98 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.97 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.97 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.97 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.97 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.97 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.97 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.97 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.97 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.97 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.96 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.96 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.96 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.96 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.96 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.96 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.96 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.96 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.96 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.96 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.95 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.95 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.95 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.94 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.94 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.94 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.94 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.94 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.93 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.92 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.92 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.91 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.91 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.89 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.87 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.87 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.86 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.84 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.83 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.83 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.82 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.81 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.81 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.81 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.81 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.8 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.8 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.79 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.78 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.78 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.77 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.76 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.75 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.75 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.75 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.75 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.75 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.75 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.75 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.74 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.74 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.74 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.73 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.73 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.72 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.7 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.7 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.7 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.69 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.67 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.67 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.67 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.66 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.65 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.65 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.65 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.63 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.62 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.62 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.62 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.61 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.61 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.59 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.59 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.59 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.59 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.59 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.59 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.59 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.58 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.58 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.58 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.58 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.58 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.58 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.58 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.57 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.57 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.57 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.57 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.57 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.57 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.57 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.57 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.57 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.57 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.57 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.56 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.56 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.56 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.56 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.56 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.56 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.56 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.55 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.55 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.55 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.55 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.55 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.55 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.55 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.55 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.55 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.55 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.55 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.55 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.55 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.54 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.54 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.54 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.54 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.54 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.54 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.54 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.54 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.54 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.54 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.54 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.54 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.53 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.53 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.53 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.53 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.53 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.53 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.53 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.53 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.52 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.52 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.52 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.52 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.52 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.52 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.52 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.52 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.52 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.52 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.52 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.52 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.52 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.52 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.51 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.51 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.51 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.51 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.51 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.51 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.51 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.51 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.51 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.51 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.51 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.51 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.51 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.51 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.51 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.51 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.51 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.5 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.5 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.5 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.5 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.5 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.5 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.5 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.5 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.5 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.5 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.5 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.5 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.5 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.5 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.49 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.49 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.49 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.49 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.49 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.49 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.49 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.49 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.49 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.49 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.49 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.49 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.49 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.48 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.48 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.48 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.48 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.48 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.48 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.48 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.48 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.48 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.48 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.48 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.48 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.48 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.48 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.48 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.47 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.47 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.47 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.47 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.47 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.47 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.47 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.47 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.47 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.46 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.46 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.46 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.46 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.46 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.46 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.46 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.46 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.46 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.46 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.46 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.46 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.45 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.45 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.45 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.45 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.45 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.45 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.44 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.44 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.44 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.44 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.44 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.44 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.44 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.44 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.43 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.43 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.43 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.43 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.43 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.43 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.42 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.42 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.42 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.42 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.42 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.42 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.42 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.42 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.41 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.41 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.41 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.41 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.41 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.41 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.41 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.41 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.41 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.4 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.4 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.4 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.4 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.4 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.39 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.39 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.39 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.39 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.38 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.38 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.38 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.38 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.38 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.38 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.38 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.37 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.37 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.37 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.37 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.37 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.36 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.36 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.35 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.35 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.35 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.35 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.34 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.34 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.34 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.33 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.32 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.31 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.31 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.31 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.3 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.3 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.28 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.28 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.28 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.28 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.27 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.27 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.26 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.24 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.2 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.18 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.15 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.12 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.11 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.1 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.09 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.86 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 98.77 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 98.72 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.69 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.55 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.46 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.44 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.37 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.31 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.28 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.19 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.18 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.16 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.96 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.84 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.46 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.45 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.43 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.32 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 96.81 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.37 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.19 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.19 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 95.97 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 95.85 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 95.53 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 95.51 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 95.05 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 94.47 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 94.28 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 94.26 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 93.69 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 93.41 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 92.4 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.05 |
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=362.00 Aligned_cols=294 Identities=25% Similarity=0.431 Sum_probs=238.9
Q ss_pred CCCHHHHHHHHHHHHhcCC----CCCCCCCCCCCCCCCCcccCCCCCCCCCCeEecCCCCcccEEEEEeCCCCCcc--cC
Q 003737 35 KLHAEEVKALKQIGRKLGK----KDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTG--TL 108 (799)
Q Consensus 35 ~~~~~~~~aL~~~~~~~~~----~~W~~~~d~C~~~~~W~~~~~~~~~~~~gv~c~~~~~~~~v~~L~L~~~~l~g--~~ 108 (799)
.|.++|++||++||+++.+ ++|..+.|||. +.| .||+|+.....++|+.|+|++++++| .+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~--~~w-----------~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~ 68 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN--RTW-----------LGVLCDTDTQTYRVNNLDLSGLNLPKPYPI 68 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTT--TCS-----------TTEEECCSSSCCCEEEEEEECCCCSSCEEC
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCCc--CCC-----------cceEeCCCCCCceEEEEECCCCCccCCccc
Confidence 5899999999999999965 58988889993 138 79999864334799999999999999 99
Q ss_pred CccccCCCCCCEEEccC-CcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCC
Q 003737 109 PTELSKLRYLKQLDLSR-NCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKL 186 (799)
Q Consensus 109 p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l 186 (799)
|..|.++++|++|+|++ |.+.+.+|..+..++ |++|+|++|++++.+|..|.++++|++|+|++|.+++.+|..|..+
T Consensus 69 ~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 148 (313)
T 1ogq_A 69 PSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148 (313)
T ss_dssp CGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGC
T ss_pred ChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcC
Confidence 99999999999999995 999999999999988 9999999999999999999999999999999999999999999999
Q ss_pred CCCCEEEcccCcCCccCChhccCCC-CCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEE
Q 003737 187 INLQKLILSSNSFTGELPAELTKLT-NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLR 265 (799)
Q Consensus 187 ~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 265 (799)
++|++|++++|++++.+|..+..++ +|++|++++|++++.+|..+..++ |++|+|++|.+++.+|..+..+++|+.|+
T Consensus 149 ~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 227 (313)
T 1ogq_A 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIH 227 (313)
T ss_dssp TTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEE
T ss_pred CCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEE
Confidence 9999999999999999999999998 999999999999999999999987 99999999999988888888888777776
Q ss_pred cCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCc
Q 003737 266 ISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP 345 (799)
Q Consensus 266 L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ 345 (799)
+++ |.+++.+|. +..+++|++|+|++|++++.+|..|..+++|+.|+|++|+++|.
T Consensus 228 L~~-----------------------N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 283 (313)
T 1ogq_A 228 LAK-----------------------NSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283 (313)
T ss_dssp CCS-----------------------SEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEE
T ss_pred CCC-----------------------CceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCccccc
Confidence 665 333333333 44455555555555555555555555555555555555555555
Q ss_pred CChhh-hcCCCEEEeecCc-Ccc
Q 003737 346 VPKYI-FNSNKNVDISLNN-FTW 366 (799)
Q Consensus 346 ~p~~~-~~~l~~l~ls~N~-~~g 366 (799)
+|..- ...++.+++++|. ++|
T Consensus 284 ip~~~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 284 IPQGGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp CCCSTTGGGSCGGGTCSSSEEES
T ss_pred CCCCccccccChHHhcCCCCccC
Confidence 55431 2344555555555 444
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=379.69 Aligned_cols=326 Identities=20% Similarity=0.299 Sum_probs=275.0
Q ss_pred CCHHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCCcccCC-CCCCCCCCeEecCCCCcccEEEEEeCCCCCcccCCccccC
Q 003737 36 LHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSD-DKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSK 114 (799)
Q Consensus 36 ~~~~~~~aL~~~~~~~~~~~W~~~~d~C~~~~~W~~~~~-~~~~~~~gv~c~~~~~~~~v~~L~L~~~~l~g~~p~~~~~ 114 (799)
....|++||.++|+++++.+|....++|....+|..... |.++...||+|+.. ++|+.|+|++++++|.+|++|++
T Consensus 27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~---~~V~~L~L~~~~l~g~lp~~l~~ 103 (636)
T 4eco_A 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN---GRVTGLSLEGFGASGRVPDAIGQ 103 (636)
T ss_dssp HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT---CCEEEEECTTSCCEEEECGGGGG
T ss_pred hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC---CCEEEEEecCcccCCcCChHHhc
Confidence 345799999999999988888766555544456865433 22333489999853 79999999999999999999999
Q ss_pred CCCCCEEEccCCcC------------------------------------------------------------------
Q 003737 115 LRYLKQLDLSRNCL------------------------------------------------------------------ 128 (799)
Q Consensus 115 l~~L~~L~Ls~N~l------------------------------------------------------------------ 128 (799)
|++|++|+|++|.+
T Consensus 104 L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l 183 (636)
T 4eco_A 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL 183 (636)
T ss_dssp CTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCC
T ss_pred CccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccch
Confidence 99999999999843
Q ss_pred ------------CCcCcccccccc-eeEEEccCCcCcCc-----------------CCcccC--CCCCCCEEEeeCCcCC
Q 003737 129 ------------TGSFSPQWASLQ-LVELSVMGNRLSGP-----------------FPKVLT--NITTLKNLSIEGNLFT 176 (799)
Q Consensus 129 ------------~~~~p~~~~~l~-L~~L~Ls~N~l~~~-----------------~p~~~~--~L~~L~~L~Ls~N~l~ 176 (799)
++ +|..++.++ |++|+|++|.+++. +|..++ ++++|++|+|++|.+.
T Consensus 184 ~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~ 262 (636)
T 4eco_A 184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNL 262 (636)
T ss_dssp CTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTC
T ss_pred hhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCC
Confidence 34 677888887 99999999999986 999999 9999999999999999
Q ss_pred CCCCccccCCCCCCEEEcccCc-CCc-cCChhccCC------CCCCEEEccCCcCCCcCCc--cccCCCCCCEEEccCCC
Q 003737 177 GSIPPDIRKLINLQKLILSSNS-FTG-ELPAELTKL------TNLNDLRISDNNFSGKIPE--FIGKWKKIQKLHIQGSS 246 (799)
Q Consensus 177 ~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l------~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~ 246 (799)
+.+|..|+++++|++|++++|+ +++ .+|..++++ ++|++|++++|+++ .+|. .++++++|++|++++|+
T Consensus 263 ~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~ 341 (636)
T 4eco_A 263 TKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQ 341 (636)
T ss_dssp SSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCC
T ss_pred ccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCc
Confidence 9999999999999999999998 998 899988876 89999999999999 7888 89999999999999999
Q ss_pred CCCCCchhhhcCCCCCeEEcCCCCCCCCCCCc-cCC-CC-ccEEEccCCcCcccCCccccCCC--CCCeeccccccCCCC
Q 003737 247 LEGPIPASISALTSLTDLRISDLKGSESAFPK-LDK-MN-LKTLILTKCLIHGEIPDYIGDMT--KLKNIDLSFNNLTGG 321 (799)
Q Consensus 247 l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~-l~~-~~-L~~L~L~~N~l~~~~p~~l~~l~--~L~~L~Ls~N~l~~~ 321 (799)
++|.+| .+..+++|+.|++++|... .+|. +.. .+ |+.|++++|.++ .+|..+..++ +|+.|++++|++++.
T Consensus 342 l~g~ip-~~~~l~~L~~L~L~~N~l~--~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~ 417 (636)
T 4eco_A 342 LEGKLP-AFGSEIKLASLNLAYNQIT--EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSV 417 (636)
T ss_dssp CEEECC-CCEEEEEESEEECCSSEEE--ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTT
T ss_pred Cccchh-hhCCCCCCCEEECCCCccc--cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCc
Confidence 998899 8999999999999986655 4444 444 67 999999999999 7888877655 899999999999999
Q ss_pred Cchhhh-------ccCCCCEEeccCCcCCCcCChhhh---cCCCEEEeecCcCcccCCCCC
Q 003737 322 IPTTFE-------KLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLNNFTWESSDPI 372 (799)
Q Consensus 322 ~p~~~~-------~l~~L~~L~L~~N~l~g~~p~~~~---~~l~~l~ls~N~~~g~~p~~~ 372 (799)
+|..|. .+++|+.|+|++|+++ .+|..++ ..++.|+|++|.++ .+|...
T Consensus 418 ~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~ 476 (636)
T 4eco_A 418 DGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLT-EIPKNS 476 (636)
T ss_dssp TTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCS-BCCSSS
T ss_pred chhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCC-CcCHHH
Confidence 998888 7889999999999999 6776654 46889999999998 666543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=376.36 Aligned_cols=325 Identities=19% Similarity=0.280 Sum_probs=260.3
Q ss_pred cCCCCHHHHHHHHHHHHhcCCCCCCCCC-----CC--CCCCCCCcccCC-CCCCCCCCeEecCCCCcccEEEEEeCCCCC
Q 003737 33 ANKLHAEEVKALKQIGRKLGKKDWNFGV-----DP--CSQKGNWELSSD-DKKGFESNVTCDCSSATCHVVTIALKAQNL 104 (799)
Q Consensus 33 ~~~~~~~~~~aL~~~~~~~~~~~W~~~~-----d~--C~~~~~W~~~~~-~~~~~~~gv~c~~~~~~~~v~~L~L~~~~l 104 (799)
++.+..+|++||++||+++++++|+.+. +| | .|..... +..+...||+|++ .++|+.|+|+++++
T Consensus 263 ~~~~~~~d~~ALl~~k~~l~~~~W~~~~~~~~~~~~~C----~W~~~~~~~~w~~~~GV~C~~---~~~V~~L~Ls~~~L 335 (876)
T 4ecn_A 263 ETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSL----NWNFNKELDMWGDQPGVDLDN---NGRVTGLSLAGFGA 335 (876)
T ss_dssp CCCHHHHHHHHHHHHHHHTTGGGCCCCCSSCSSCCCCC----SCCCSSCGGGTTCCTTEEECT---TSCEEEEECTTTCC
T ss_pred ccccchHHHHHHHHHHHHcCCCCCCcCCCcccccCCcc----ccccccccccccCcCceEecC---CCCEEEEECccCCC
Confidence 3345578999999999999888997654 66 7 6744322 3334458999986 47999999999999
Q ss_pred cccCCccccCCCCCCEEEc-cCCcCCCc----------------------------------------------------
Q 003737 105 TGTLPTELSKLRYLKQLDL-SRNCLTGS---------------------------------------------------- 131 (799)
Q Consensus 105 ~g~~p~~~~~l~~L~~L~L-s~N~l~~~---------------------------------------------------- 131 (799)
.|.+|++|++|++|++||| ++|.+.|.
T Consensus 336 ~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~ 415 (876)
T 4ecn_A 336 KGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMK 415 (876)
T ss_dssp EEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSC
T ss_pred CCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccc
Confidence 9999999999999999999 77765444
Q ss_pred ------------------------Ccccccccc-eeEEEccCCcCcC-----------------cCCcccC--CCCCCCE
Q 003737 132 ------------------------FSPQWASLQ-LVELSVMGNRLSG-----------------PFPKVLT--NITTLKN 167 (799)
Q Consensus 132 ------------------------~p~~~~~l~-L~~L~Ls~N~l~~-----------------~~p~~~~--~L~~L~~ 167 (799)
+|..++.++ |++|+|++|+|++ .+|..++ ++++|++
T Consensus 416 ~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~ 495 (876)
T 4ecn_A 416 PIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTD 495 (876)
T ss_dssp CCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCE
T ss_pred ccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCE
Confidence 667777777 8999999999888 3888877 8899999
Q ss_pred EEeeCCcCCCCCCccccCCCCCCEEEcccCc-CCc-cCChhccCCC-------CCCEEEccCCcCCCcCCc--cccCCCC
Q 003737 168 LSIEGNLFTGSIPPDIRKLINLQKLILSSNS-FTG-ELPAELTKLT-------NLNDLRISDNNFSGKIPE--FIGKWKK 236 (799)
Q Consensus 168 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l~-------~L~~L~Ls~N~l~~~~p~--~~~~l~~ 236 (799)
|+|++|.+.+.+|..|+++++|++|+|++|+ +++ .+|..+++++ +|++|+|++|+++ .+|. .|+++++
T Consensus 496 L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~ 574 (876)
T 4ecn_A 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVK 574 (876)
T ss_dssp EEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTT
T ss_pred EECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCC
Confidence 9999998888888888889999999999987 887 7887666554 8999999999888 7787 8888889
Q ss_pred CCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCc-cCC-CC-ccEEEccCCcCcccCCccccCCCC--CCee
Q 003737 237 IQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPK-LDK-MN-LKTLILTKCLIHGEIPDYIGDMTK--LKNI 311 (799)
Q Consensus 237 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~-l~~-~~-L~~L~L~~N~l~~~~p~~l~~l~~--L~~L 311 (799)
|++|+|++|+++ .+| .+..+++|+.|++++|.+. .+|. +.. .+ |+.|+|++|.++ .+|..+..++. |+.|
T Consensus 575 L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~--~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L 649 (876)
T 4ecn_A 575 LGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE--EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSV 649 (876)
T ss_dssp CCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS--CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEE
T ss_pred CCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc--cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEE
Confidence 999999999888 777 7888888899999886655 4553 554 66 889999999888 77877776654 8889
Q ss_pred ccccccCCCCCchh---hh--ccCCCCEEeccCCcCCCcCChhhh---cCCCEEEeecCcCcccCCCCC
Q 003737 312 DLSFNNLTGGIPTT---FE--KLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLNNFTWESSDPI 372 (799)
Q Consensus 312 ~Ls~N~l~~~~p~~---~~--~l~~L~~L~L~~N~l~g~~p~~~~---~~l~~l~ls~N~~~g~~p~~~ 372 (799)
+|++|++++.+|.. +. .+++|+.|+|++|+++ .+|..++ ..++.|+|++|.++ .+|..+
T Consensus 650 ~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~ 716 (876)
T 4ecn_A 650 DFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENS 716 (876)
T ss_dssp ECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTS
T ss_pred ECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHH
Confidence 99999888866632 22 3457888999999888 6777665 46788999999888 666543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=380.21 Aligned_cols=317 Identities=29% Similarity=0.426 Sum_probs=253.2
Q ss_pred cCCCCHHHHHHHHHHHHhcCC----CCCCCCCCCCCCCCCCcccCCCCCCCCCCeEecCCCCcccEEEEEeCCCCCccc-
Q 003737 33 ANKLHAEEVKALKQIGRKLGK----KDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGT- 107 (799)
Q Consensus 33 ~~~~~~~~~~aL~~~~~~~~~----~~W~~~~d~C~~~~~W~~~~~~~~~~~~gv~c~~~~~~~~v~~L~L~~~~l~g~- 107 (799)
++...++|++||++||+++.+ ++|+.+.||| .| .||+|+ .++|+.|+|+++.+.|.
T Consensus 6 ~~~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C----~w-----------~gv~C~----~~~v~~L~L~~~~l~g~~ 66 (768)
T 3rgz_A 6 PSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPC----TF-----------DGVTCR----DDKVTSIDLSSKPLNVGF 66 (768)
T ss_dssp --CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGG----GS-----------TTEEEE----TTEEEEEECTTSCCCEEH
T ss_pred cccCCHHHHHHHHHHHhhCCCcccccCCCCCCCCc----CC-----------cceEEC----CCcEEEEECCCCCcCCcc
Confidence 334468899999999999864 6898788999 79 799998 37999999999999987
Q ss_pred --CC-----------------------ccccCCCCCCEEEccCCcCCCcCcc--cccccc-eeEEEccCCcCcCcCCccc
Q 003737 108 --LP-----------------------TELSKLRYLKQLDLSRNCLTGSFSP--QWASLQ-LVELSVMGNRLSGPFPKVL 159 (799)
Q Consensus 108 --~p-----------------------~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~-L~~L~Ls~N~l~~~~p~~~ 159 (799)
+| ..|..+++|++|||++|.+++.+|. .++.++ |++|+|++|.+++.+|..+
T Consensus 67 ~~l~~~l~~L~~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~ 146 (768)
T 3rgz_A 67 SAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSG 146 (768)
T ss_dssp HHHHHHTTTCTTCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCS
T ss_pred CccChhHhccCcccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHH
Confidence 54 4667777888888888888777776 777776 8888888888877777665
Q ss_pred -CCCCCCCEEEeeCCcCCCCCCcc---ccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCC
Q 003737 160 -TNITTLKNLSIEGNLFTGSIPPD---IRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWK 235 (799)
Q Consensus 160 -~~L~~L~~L~Ls~N~l~~~~p~~---~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 235 (799)
.++++|++|+|++|.+++..|.. +.++++|++|++++|.+++..|. ..+++|++|++++|++++.+|. +++++
T Consensus 147 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~ 223 (768)
T 3rgz_A 147 GLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCS 223 (768)
T ss_dssp CCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCC
T ss_pred hccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCC
Confidence 67788888888888887766665 67778888888888887766553 7888999999999999887777 89999
Q ss_pred CCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCC-CCCCeeccc
Q 003737 236 KIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDM-TKLKNIDLS 314 (799)
Q Consensus 236 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~Ls 314 (799)
+|++|+|++|.+++.+|..+.++++|++|++++|.. .+.+|.....+|++|+|++|.+++.+|..+..+ ++|++|+|+
T Consensus 224 ~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l-~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls 302 (768)
T 3rgz_A 224 ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF-VGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLS 302 (768)
T ss_dssp SCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCC-EESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECC
T ss_pred CCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcc-cCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECc
Confidence 999999999999999999999999999999998544 444555544778888888888888888877665 888888888
Q ss_pred cccCCCCCchhhhccCCCCEEeccCCcCCCcCChh-hh--cCCCEEEeecCcCcccCCCCC
Q 003737 315 FNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY-IF--NSNKNVDISLNNFTWESSDPI 372 (799)
Q Consensus 315 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-~~--~~l~~l~ls~N~~~g~~p~~~ 372 (799)
+|++++.+|..|..+++|+.|++++|+++|.+|.. +. ..++.|++++|.++|.+|..+
T Consensus 303 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l 363 (768)
T 3rgz_A 303 GNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL 363 (768)
T ss_dssp SSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTH
T ss_pred CCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHH
Confidence 88888888888888888888888888888777765 32 356788888888887777665
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=357.58 Aligned_cols=277 Identities=30% Similarity=0.507 Sum_probs=179.4
Q ss_pred EEEEEeCCCCCcccCCccccC--CCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 94 VVTIALKAQNLTGTLPTELSK--LRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 94 v~~L~L~~~~l~g~~p~~~~~--l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
++.|++++|.++|.+|+.+.. +++|++|++++|.+++.+|..+..++ |++|++++|++++.+|..++++++|++|+|
T Consensus 370 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 449 (768)
T 3rgz_A 370 LLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL 449 (768)
T ss_dssp CSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEEC
T ss_pred CcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEEC
Confidence 444444444444444444443 45555666666666556666666655 666666666666666666666666666666
Q ss_pred eCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCC
Q 003737 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP 250 (799)
Q Consensus 171 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 250 (799)
++|.+++.+|..+..+++|++|++++|++++.+|..+.++++|++|++++|++++.+|.+++.+++|++|+|++|++++.
T Consensus 450 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 529 (768)
T 3rgz_A 450 WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGN 529 (768)
T ss_dssp CSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEE
T ss_pred CCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCc
Confidence 66666666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred CchhhhcCCCCCeEEcCCCCCCCCCCCc----------------------------------------------------
Q 003737 251 IPASISALTSLTDLRISDLKGSESAFPK---------------------------------------------------- 278 (799)
Q Consensus 251 ~p~~~~~l~~L~~L~L~~n~~~~~~~~~---------------------------------------------------- 278 (799)
+|..+.++++|+.|++++|... +.+|.
T Consensus 530 ~p~~l~~l~~L~~L~Ls~N~l~-g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (768)
T 3rgz_A 530 IPAELGDCRSLIWLDLNTNLFN-GTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS 608 (768)
T ss_dssp CCGGGGGCTTCCEEECCSSEEE-SBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGG
T ss_pred CCHHHcCCCCCCEEECCCCccC-CcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccc
Confidence 6666666666666666664321 11110
Q ss_pred -------------------cCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEecc
Q 003737 279 -------------------LDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLT 338 (799)
Q Consensus 279 -------------------l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 338 (799)
+.. .+|+.|+|++|+++|.+|..++++++|+.|+|++|+++|.+|..|+++++|+.|+|+
T Consensus 609 ~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs 688 (768)
T 3rgz_A 609 TRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLS 688 (768)
T ss_dssp GTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECC
T ss_pred cccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECC
Confidence 111 356677777777777777777777777777777777777777777777777777777
Q ss_pred CCcCCCcCChhhh--cCCCEEEeecCcCcccCCCC
Q 003737 339 GNKLTGPVPKYIF--NSNKNVDISLNNFTWESSDP 371 (799)
Q Consensus 339 ~N~l~g~~p~~~~--~~l~~l~ls~N~~~g~~p~~ 371 (799)
+|+++|.+|..+. ..++.||+++|+++|.||..
T Consensus 689 ~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~ 723 (768)
T 3rgz_A 689 SNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723 (768)
T ss_dssp SSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS
T ss_pred CCcccCcCChHHhCCCCCCEEECcCCcccccCCCc
Confidence 7777777776654 35677777777777777653
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=315.51 Aligned_cols=281 Identities=17% Similarity=0.200 Sum_probs=231.4
Q ss_pred cccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcC-cccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEE
Q 003737 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSF-SPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNL 168 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L 168 (799)
+.++++|+|++|.+++..|..|.++++|++|+|++|.+.+.+ +..|..++ |++|+|++|++++..|..|+++++|++|
T Consensus 29 ~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 108 (455)
T 3v47_A 29 PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVL 108 (455)
T ss_dssp CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEE
T ss_pred CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEE
Confidence 357999999999999998999999999999999999998655 56788887 9999999999999999999999999999
Q ss_pred EeeCCcCCCCCCcc--ccCCCCCCEEEcccCcCCccCChh-ccCCCCCCEEEccCCcCCCcCCccccCC-----------
Q 003737 169 SIEGNLFTGSIPPD--IRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKIPEFIGKW----------- 234 (799)
Q Consensus 169 ~Ls~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l----------- 234 (799)
+|++|.+++.+|.. |..+++|++|+|++|++++..|.. +.++++|++|++++|++++..|..+..+
T Consensus 109 ~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~ 188 (455)
T 3v47_A 109 TLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLS 188 (455)
T ss_dssp ECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECT
T ss_pred eCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccc
Confidence 99999998766555 999999999999999999887876 8899999999999999998888766544
Q ss_pred -----------------------CCCCEEEccCCCCCCCCchhhhcC---------------------------------
Q 003737 235 -----------------------KKIQKLHIQGSSLEGPIPASISAL--------------------------------- 258 (799)
Q Consensus 235 -----------------------~~L~~L~L~~N~l~~~~p~~~~~l--------------------------------- 258 (799)
++|++|++++|.+++..|..+...
T Consensus 189 ~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~ 268 (455)
T 3v47_A 189 SITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268 (455)
T ss_dssp TCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTT
T ss_pred cCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccc
Confidence 578888888888876666554332
Q ss_pred ------CCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCC
Q 003737 259 ------TSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331 (799)
Q Consensus 259 ------~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 331 (799)
++|+.|++++|.........+.. ++|+.|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++
T Consensus 269 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 348 (455)
T 3v47_A 269 FKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDK 348 (455)
T ss_dssp TGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTT
T ss_pred cccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCccc
Confidence 46777777775544332223555 78888888888888888888888888888888888888777888888888
Q ss_pred CCEEeccCCcCCCcCChhhh--cCCCEEEeecCcCcccCCCC
Q 003737 332 TNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESSDP 371 (799)
Q Consensus 332 L~~L~L~~N~l~g~~p~~~~--~~l~~l~ls~N~~~g~~p~~ 371 (799)
|+.|+|++|++++..|..+. ..++.|++++|++++..+..
T Consensus 349 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 390 (455)
T 3v47_A 349 LEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGI 390 (455)
T ss_dssp CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred CCEEECCCCcccccChhhccccccccEEECCCCccccCCHhH
Confidence 88888888888877776654 46788888888888655443
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=328.20 Aligned_cols=262 Identities=21% Similarity=0.308 Sum_probs=236.6
Q ss_pred CCcccCCccccCCCCCCEEEccCCcCCCc-----------------Cccccc--ccc-eeEEEccCCcCcCcCCcccCCC
Q 003737 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGS-----------------FSPQWA--SLQ-LVELSVMGNRLSGPFPKVLTNI 162 (799)
Q Consensus 103 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~-----------------~p~~~~--~l~-L~~L~Ls~N~l~~~~p~~~~~L 162 (799)
+++| +|..|+++++|++|+|++|.+++. +|..++ .++ |++|+|++|++.+.+|..|+++
T Consensus 194 ~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 272 (636)
T 4eco_A 194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL 272 (636)
T ss_dssp EEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTC
T ss_pred CCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcC
Confidence 4446 899999999999999999999996 888888 887 9999999999999999999999
Q ss_pred CCCCEEEeeCCc-CCC-CCCccccCC------CCCCEEEcccCcCCccCCh--hccCCCCCCEEEccCCcCCCcCCcccc
Q 003737 163 TTLKNLSIEGNL-FTG-SIPPDIRKL------INLQKLILSSNSFTGELPA--ELTKLTNLNDLRISDNNFSGKIPEFIG 232 (799)
Q Consensus 163 ~~L~~L~Ls~N~-l~~-~~p~~~~~l------~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 232 (799)
++|++|+|++|+ +++ .+|..++.+ ++|++|++++|+++ .+|. .+.++++|++|++++|+++|.+| .|+
T Consensus 273 ~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~ 350 (636)
T 4eco_A 273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFG 350 (636)
T ss_dssp SSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCE
T ss_pred CCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhC
Confidence 999999999998 998 899988887 99999999999999 8998 99999999999999999999999 999
Q ss_pred CCCCCCEEEccCCCCCCCCchhhhcCCC-CCeEEcCCCCCCCCCCCc-cCC---CCccEEEccCCcCcccCCcccc----
Q 003737 233 KWKKIQKLHIQGSSLEGPIPASISALTS-LTDLRISDLKGSESAFPK-LDK---MNLKTLILTKCLIHGEIPDYIG---- 303 (799)
Q Consensus 233 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~n~~~~~~~~~-l~~---~~L~~L~L~~N~l~~~~p~~l~---- 303 (799)
.+++|++|+|++|+++ .+|..+..+++ |++|++++|... .+|. +.. .+|+.|++++|.+++.+|..+.
T Consensus 351 ~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~--~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~ 427 (636)
T 4eco_A 351 SEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK--YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427 (636)
T ss_dssp EEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS--SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCS
T ss_pred CCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc--ccchhhhhcccCccCEEECcCCcCCCcchhhhccccc
Confidence 9999999999999999 78999999999 999999997755 4554 333 3799999999999999999988
Q ss_pred ---CCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhhc----------CCCEEEeecCcCcccCCC
Q 003737 304 ---DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN----------SNKNVDISLNNFTWESSD 370 (799)
Q Consensus 304 ---~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~----------~l~~l~ls~N~~~g~~p~ 370 (799)
.+++|++|+|++|+++...+..+..+++|+.|+|++|+++ .+|...+. .++.|+|++|+++ .+|.
T Consensus 428 ~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~ 505 (636)
T 4eco_A 428 TPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSD 505 (636)
T ss_dssp SCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCG
T ss_pred ccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccCh
Confidence 8889999999999999555555677999999999999999 78877654 7899999999999 6775
Q ss_pred CC
Q 003737 371 PI 372 (799)
Q Consensus 371 ~~ 372 (799)
.+
T Consensus 506 ~~ 507 (636)
T 4eco_A 506 DF 507 (636)
T ss_dssp GG
T ss_pred hh
Confidence 54
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-31 Score=306.59 Aligned_cols=280 Identities=20% Similarity=0.216 Sum_probs=250.3
Q ss_pred cccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEE
Q 003737 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 169 (799)
..+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|..++ |++|+|++|++++..+..|.++++|++|+
T Consensus 31 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 110 (477)
T 2id5_A 31 PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLD 110 (477)
T ss_dssp CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEE
T ss_pred CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEE
Confidence 35789999999999998899999999999999999999999999999987 99999999999987778899999999999
Q ss_pred eeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCC
Q 003737 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (799)
Q Consensus 170 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 249 (799)
|++|.+++..|..|.++++|++|++++|.+++..|..|.++++|++|++++|++++..+..|..+++|+.|+|++|.+.+
T Consensus 111 Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~ 190 (477)
T 2id5_A 111 ISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINA 190 (477)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCE
T ss_pred CCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcE
Confidence 99999998888999999999999999999998889999999999999999999998777889999999999999999999
Q ss_pred CCchhhhcCCCCCeEEcCCCCCCCCCCCc-cCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhc
Q 003737 250 PIPASISALTSLTDLRISDLKGSESAFPK-LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328 (799)
Q Consensus 250 ~~p~~~~~l~~L~~L~L~~n~~~~~~~~~-l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 328 (799)
..+..|..+++|+.|++++|+......+. +...+|+.|+|++|+++...+..+..+++|+.|+|++|++++..+..|..
T Consensus 191 ~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 270 (477)
T 2id5_A 191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHE 270 (477)
T ss_dssp ECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTT
T ss_pred eChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccc
Confidence 88889999999999999986655443333 33368999999999999655567889999999999999999888888999
Q ss_pred cCCCCEEeccCCcCCCcCChhhh--cCCCEEEeecCcCcccCCC
Q 003737 329 LAKTNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESSD 370 (799)
Q Consensus 329 l~~L~~L~L~~N~l~g~~p~~~~--~~l~~l~ls~N~~~g~~p~ 370 (799)
+++|+.|+|++|++++..|..+. ..++.|||++|.+++..+.
T Consensus 271 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 314 (477)
T 2id5_A 271 LLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEES 314 (477)
T ss_dssp CTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGG
T ss_pred cccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHh
Confidence 99999999999999987777664 5788999999999875543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=295.04 Aligned_cols=231 Identities=26% Similarity=0.408 Sum_probs=185.1
Q ss_pred CCCCEEEccCCcCCC--cCcccccccc-eeEEEccC-CcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCE
Q 003737 116 RYLKQLDLSRNCLTG--SFSPQWASLQ-LVELSVMG-NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191 (799)
Q Consensus 116 ~~L~~L~Ls~N~l~~--~~p~~~~~l~-L~~L~Ls~-N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 191 (799)
.++++|+|++|.+++ .+|..+..++ |++|++++ |.+.+.+|..|+++++|++|+|++|.+++.+|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 467778888888877 6777777776 77777773 7777777777777777777777777777777777777777777
Q ss_pred EEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCC-CCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCC
Q 003737 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWK-KIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK 270 (799)
Q Consensus 192 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~ 270 (799)
|+|++|.+++.+|..+..+++|++|++++|++++.+|..++.++ +|++|+|++|++++.+|..+..++
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~----------- 198 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN----------- 198 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-----------
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-----------
Confidence 77777777777777777777777777777777777777777776 777777777777766666665443
Q ss_pred CCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhh
Q 003737 271 GSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI 350 (799)
Q Consensus 271 ~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~ 350 (799)
|+.|++++|.+++.+|..+..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+
T Consensus 199 -------------L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l 264 (313)
T 1ogq_A 199 -------------LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp -------------CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGG
T ss_pred -------------ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHH
Confidence 56677778888888999999999999999999999987776 8899999999999999999999887
Q ss_pred h--cCCCEEEeecCcCcccCCCC
Q 003737 351 F--NSNKNVDISLNNFTWESSDP 371 (799)
Q Consensus 351 ~--~~l~~l~ls~N~~~g~~p~~ 371 (799)
. ..++.|+|++|+++|.+|..
T Consensus 265 ~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 265 TQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCCS
T ss_pred hcCcCCCEEECcCCcccccCCCC
Confidence 5 47899999999999999875
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=294.62 Aligned_cols=267 Identities=21% Similarity=0.312 Sum_probs=193.4
Q ss_pred CCCCHHHHHHHHHHHHhcC-C-----CCC----CCCCCCCCCCCCCcccCCCCCCCCCCeEecCC------CCcccEEEE
Q 003737 34 NKLHAEEVKALKQIGRKLG-K-----KDW----NFGVDPCSQKGNWELSSDDKKGFESNVTCDCS------SATCHVVTI 97 (799)
Q Consensus 34 ~~~~~~~~~aL~~~~~~~~-~-----~~W----~~~~d~C~~~~~W~~~~~~~~~~~~gv~c~~~------~~~~~v~~L 97 (799)
.....+|++||++||+.+. + .+| ....++| .| .|+.|... ....+|+.|
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~----~~-----------~g~~~~~~~~~l~~~~~~~l~~L 86 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE----TR-----------TGRALKATADLLEDATQPGRVAL 86 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSC----CS-----------HHHHHHHHHHHHHHHTSTTCCEE
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhccccccccccc----cc-----------CCcchhhhHHHHhcccccceeEE
Confidence 3455789999999999872 2 346 3345666 57 67777421 023578889
Q ss_pred EeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCC
Q 003737 98 ALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFT 176 (799)
Q Consensus 98 ~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~ 176 (799)
+|++++++ .+|+.+.++++|++|+|++|.++ .+|..++.++ |++|+|++|.++ .+|..++++++|++|+|++|++.
T Consensus 87 ~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~ 163 (328)
T 4fcg_A 87 ELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPEL 163 (328)
T ss_dssp EEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTC
T ss_pred EccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCc
Confidence 99998888 78888888888999988888888 6677777776 888888888887 67778888888888888887777
Q ss_pred CCCCccccC---------CCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCC
Q 003737 177 GSIPPDIRK---------LINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL 247 (799)
Q Consensus 177 ~~~p~~~~~---------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 247 (799)
+.+|..+.. +++|++|+|++|+++ .+|..+.++++|++|++++|++++ +|..++.+++|++|+|++|++
T Consensus 164 ~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~ 241 (328)
T 4fcg_A 164 TELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTA 241 (328)
T ss_dssp CCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTT
T ss_pred cccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcc
Confidence 777776654 677777777777776 666667777777777777777763 455566667777777777666
Q ss_pred CCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhh
Q 003737 248 EGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327 (799)
Q Consensus 248 ~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 327 (799)
.+.+|..+..+++| +.|+|++|.+.+.+|..+..+++|+.|+|++|++.+.+|..+.
T Consensus 242 ~~~~p~~~~~l~~L-----------------------~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~ 298 (328)
T 4fcg_A 242 LRNYPPIFGGRAPL-----------------------KRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIA 298 (328)
T ss_dssp CCBCCCCTTCCCCC-----------------------CEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGG
T ss_pred hhhhHHHhcCCCCC-----------------------CEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHh
Confidence 66666655555444 4444555566667777777888888888888888888888888
Q ss_pred ccCCCCEEeccCCcCC
Q 003737 328 KLAKTNFMYLTGNKLT 343 (799)
Q Consensus 328 ~l~~L~~L~L~~N~l~ 343 (799)
++++|+.+++..|.+.
T Consensus 299 ~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 299 QLPANCIILVPPHLQA 314 (328)
T ss_dssp GSCTTCEEECCGGGSC
T ss_pred hccCceEEeCCHHHHH
Confidence 8888888877776655
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-30 Score=314.81 Aligned_cols=282 Identities=16% Similarity=0.168 Sum_probs=234.4
Q ss_pred cccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcC-cccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEE
Q 003737 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSF-SPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNL 168 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L 168 (799)
+.+++.|+|++|.+++..|..|.++++|++|||++|.+.+.+ |..|..++ |++|+|++|.+++..|..|+++++|++|
T Consensus 23 p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 102 (844)
T 3j0a_A 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFEL 102 (844)
T ss_dssp CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCE
T ss_pred CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEe
Confidence 468999999999999999999999999999999999766555 78899998 9999999999999999999999999999
Q ss_pred EeeCCcCCCCCCcc--ccCCCCCCEEEcccCcCCccCC-hhccCCCCCCEEEccCCcCCCcCCccccCC--CCCCEEEcc
Q 003737 169 SIEGNLFTGSIPPD--IRKLINLQKLILSSNSFTGELP-AELTKLTNLNDLRISDNNFSGKIPEFIGKW--KKIQKLHIQ 243 (799)
Q Consensus 169 ~Ls~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~L~ 243 (799)
+|++|.+++.+|.. |.++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..|..+..+ ++|+.|+|+
T Consensus 103 ~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~ 182 (844)
T 3j0a_A 103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182 (844)
T ss_dssp ECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEEC
T ss_pred eCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECC
Confidence 99999999877765 9999999999999999997655 679999999999999999999889888877 789999999
Q ss_pred CCCCCCCCchhhhcCCC------CCeEEcCCCCCCCCCCC---------------------------------------c
Q 003737 244 GSSLEGPIPASISALTS------LTDLRISDLKGSESAFP---------------------------------------K 278 (799)
Q Consensus 244 ~N~l~~~~p~~~~~l~~------L~~L~L~~n~~~~~~~~---------------------------------------~ 278 (799)
.|.+.+..|..+..+.+ |+.|++++|........ .
T Consensus 183 ~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~ 262 (844)
T 3j0a_A 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAG 262 (844)
T ss_dssp CSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTT
T ss_pred CCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhc
Confidence 99888887777666555 88888887633211100 0
Q ss_pred cCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhh--cCCCE
Q 003737 279 LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF--NSNKN 356 (799)
Q Consensus 279 l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~l~~ 356 (799)
+...+|+.|+|++|.+++..|..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..+. ..++.
T Consensus 263 l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 342 (844)
T 3j0a_A 263 LARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY 342 (844)
T ss_dssp TTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCE
T ss_pred cccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCE
Confidence 1114688888888888888888888888888888888888888888888888888888888888876666553 36788
Q ss_pred EEeecCcCcccCCCCC
Q 003737 357 VDISLNNFTWESSDPI 372 (799)
Q Consensus 357 l~ls~N~~~g~~p~~~ 372 (799)
|++++|.+++..+..+
T Consensus 343 L~L~~N~i~~~~~~~~ 358 (844)
T 3j0a_A 343 IDLQKNHIAIIQDQTF 358 (844)
T ss_dssp EECCSCCCCCCCSSCS
T ss_pred EECCCCCCCccChhhh
Confidence 8888888876655544
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=295.28 Aligned_cols=275 Identities=18% Similarity=0.186 Sum_probs=250.2
Q ss_pred cccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEE
Q 003737 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 169 (799)
..++++|+|++|.+++..|..|.++++|++|+|++|++++.++..|..++ |++|+|++|++++..|..|.++++|++|+
T Consensus 55 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 134 (477)
T 2id5_A 55 FPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134 (477)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE
Confidence 35799999999999999999999999999999999999988888888887 99999999999999999999999999999
Q ss_pred eeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCC
Q 003737 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (799)
Q Consensus 170 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 249 (799)
|++|.+++..|..|.++++|++|+|++|++++..+..+.++++|+.|++++|.+.+..+..|..+++|++|++++|.+.+
T Consensus 135 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~ 214 (477)
T 2id5_A 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLD 214 (477)
T ss_dssp ECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCC
T ss_pred CCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCcccc
Confidence 99999998888899999999999999999997777789999999999999999999888899999999999999999988
Q ss_pred CCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhc
Q 003737 250 PIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328 (799)
Q Consensus 250 ~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 328 (799)
.+|.......+|+.|++++|++.......+.. .+|+.|+|++|.+++..+..|..+++|+.|+|++|++++..|..|..
T Consensus 215 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 294 (477)
T 2id5_A 215 TMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRG 294 (477)
T ss_dssp EECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTT
T ss_pred ccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcC
Confidence 88888777889999999997665432223555 89999999999999988889999999999999999999999999999
Q ss_pred cCCCCEEeccCCcCCCcCChhh--hcCCCEEEeecCcCc
Q 003737 329 LAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFT 365 (799)
Q Consensus 329 l~~L~~L~L~~N~l~g~~p~~~--~~~l~~l~ls~N~~~ 365 (799)
+++|+.|+|++|++++..+..+ ...++.|+|++|.+.
T Consensus 295 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 295 LNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333 (477)
T ss_dssp CTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred cccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCcc
Confidence 9999999999999996444433 247899999999886
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-30 Score=282.70 Aligned_cols=266 Identities=17% Similarity=0.140 Sum_probs=213.7
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.+++.|+++++.++...+..|..+++|++|+|++|.+++..+..|..++ |++|+|++|.+++..|..|+++++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 5688899999998865555678999999999999999988888898887 999999999999988899999999999999
Q ss_pred eCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCC-------------
Q 003737 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI------------- 237 (799)
Q Consensus 171 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L------------- 237 (799)
++|.++...+..|.++++|++|++++|.+++..|..+..+++|++|++++|++++.. +..+++|
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~~~ 201 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTL 201 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCCSEE
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeeccccccccc
Confidence 999998544455789999999999999999888888999999999999999998653 3334444
Q ss_pred ------CEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCe
Q 003737 238 ------QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKN 310 (799)
Q Consensus 238 ------~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 310 (799)
++|++++|.++.. |. ...++|+.|++++|.... .+.+.. ++|+.|+|++|.+++..|..+..+++|++
T Consensus 202 ~~~~~L~~L~l~~n~l~~~-~~--~~~~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 276 (390)
T 3o6n_A 202 AIPIAVEELDASHNSINVV-RG--PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLER 276 (390)
T ss_dssp ECCSSCSEEECCSSCCCEE-EC--CCCSSCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCE
T ss_pred CCCCcceEEECCCCeeeec-cc--cccccccEEECCCCCCcc--cHHHcCCCCccEEECCCCcCCCcChhHccccccCCE
Confidence 4444555544432 22 123578888888765543 244555 78999999999998888888999999999
Q ss_pred eccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhh--hcCCCEEEeecCcCccc
Q 003737 311 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWE 367 (799)
Q Consensus 311 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~--~~~l~~l~ls~N~~~g~ 367 (799)
|+|++|++++ +|..+..+++|+.|++++|+++ .+|..+ +..++.|++++|.++..
T Consensus 277 L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~ 333 (390)
T 3o6n_A 277 LYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL 333 (390)
T ss_dssp EECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC
T ss_pred EECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee
Confidence 9999999985 5666778889999999999988 456554 36788999999988755
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-30 Score=298.37 Aligned_cols=268 Identities=16% Similarity=0.134 Sum_probs=215.1
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.+++.++++++.+....+..|..+++|++|+|++|.+++.+|..|..++ |++|+|++|.+++..|..|+++++|++|+|
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 4578899999998876666788899999999999999998888999887 999999999999988889999999999999
Q ss_pred eCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCC
Q 003737 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP 250 (799)
Q Consensus 171 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 250 (799)
++|.+++..+..|+++++|++|+|++|.+++..|..|..+++|++|++++|.+++.. ++.+++|+.|++++|.+++.
T Consensus 131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l 207 (597)
T 3oja_B 131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTL 207 (597)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEE
T ss_pred eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccc
Confidence 999999665566799999999999999999888888999999999999999998653 33344555555554444321
Q ss_pred ------------------CchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCee
Q 003737 251 ------------------IPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNI 311 (799)
Q Consensus 251 ------------------~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 311 (799)
++..+ .++|+.|++++|.... .+.+.. ++|+.|+|++|.+++.+|..|..+++|+.|
T Consensus 208 ~~~~~L~~L~ls~n~l~~~~~~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 283 (597)
T 3oja_B 208 AIPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERL 283 (597)
T ss_dssp ECCTTCSEEECCSSCCCEEECSC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEE
T ss_pred cCCchhheeeccCCccccccccc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEE
Confidence 11111 2467777777755443 244555 789999999999998888889999999999
Q ss_pred ccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhh--hcCCCEEEeecCcCcccC
Q 003737 312 DLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWES 368 (799)
Q Consensus 312 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~--~~~l~~l~ls~N~~~g~~ 368 (799)
+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+ +..++.|+|++|.+++..
T Consensus 284 ~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~ 340 (597)
T 3oja_B 284 YISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK 340 (597)
T ss_dssp ECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC
T ss_pred ECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC
Confidence 999999986 5777778899999999999998 566655 457889999999987653
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-29 Score=288.14 Aligned_cols=272 Identities=21% Similarity=0.217 Sum_probs=234.2
Q ss_pred EEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcC-CcccCCCCCCCEEEeeCCc
Q 003737 97 IALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPF-PKVLTNITTLKNLSIEGNL 174 (799)
Q Consensus 97 L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~-p~~~~~L~~L~~L~Ls~N~ 174 (799)
+++++++++ .+|. + .++|++|+|++|.+++..|..|..++ |++|+|++|.+.+.+ |..|.++++|++|+|++|.
T Consensus 15 ~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~ 90 (455)
T 3v47_A 15 AICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90 (455)
T ss_dssp EECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCT
T ss_pred cCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCc
Confidence 455566666 5665 3 27899999999999999999999998 999999999998655 6789999999999999999
Q ss_pred CCCCCCccccCCCCCCEEEcccCcCCccCChh--ccCCCCCCEEEccCCcCCCcCCcc-ccCCCCCCEEEccCCCCCCCC
Q 003737 175 FTGSIPPDIRKLINLQKLILSSNSFTGELPAE--LTKLTNLNDLRISDNNFSGKIPEF-IGKWKKIQKLHIQGSSLEGPI 251 (799)
Q Consensus 175 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~ 251 (799)
+++..|..|+++++|++|+|++|++++.+|.. |.++++|++|++++|++++..|.. +.++++|++|++++|.+++..
T Consensus 91 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 170 (455)
T 3v47_A 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSIC 170 (455)
T ss_dssp TCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCC
T ss_pred cCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccC
Confidence 99888999999999999999999999866655 999999999999999999887876 899999999999999999888
Q ss_pred chhhhcC----------------------------------CCCCeEEcCCCCCCCCC----------------------
Q 003737 252 PASISAL----------------------------------TSLTDLRISDLKGSESA---------------------- 275 (799)
Q Consensus 252 p~~~~~l----------------------------------~~L~~L~L~~n~~~~~~---------------------- 275 (799)
|..+..+ ++|++|++++|......
T Consensus 171 ~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~ 250 (455)
T 3v47_A 171 EEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250 (455)
T ss_dssp TTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCT
T ss_pred hhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccc
Confidence 8776654 57888888876442100
Q ss_pred ------------------CCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEec
Q 003737 276 ------------------FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL 337 (799)
Q Consensus 276 ------------------~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 337 (799)
+..+...+|+.|++++|.+++.+|..+..+++|++|+|++|++++..|..|..+++|+.|+|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 330 (455)
T 3v47_A 251 NMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNL 330 (455)
T ss_dssp TTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEEC
Confidence 00111247999999999999999999999999999999999999999999999999999999
Q ss_pred cCCcCCCcCChhhh--cCCCEEEeecCcCcccCCCCC
Q 003737 338 TGNKLTGPVPKYIF--NSNKNVDISLNNFTWESSDPI 372 (799)
Q Consensus 338 ~~N~l~g~~p~~~~--~~l~~l~ls~N~~~g~~p~~~ 372 (799)
++|++++..|..+. ..++.|||++|.+++..|..+
T Consensus 331 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 367 (455)
T 3v47_A 331 SQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSF 367 (455)
T ss_dssp CSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTT
T ss_pred CCCccCCcChhHhcCcccCCEEECCCCcccccChhhc
Confidence 99999977776653 578999999999999888766
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-29 Score=298.26 Aligned_cols=136 Identities=22% Similarity=0.244 Sum_probs=125.1
Q ss_pred cccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEE
Q 003737 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 169 (799)
+..+++|||++|+|++..+.+|.++++|++|||++|+|+++.+..|..++ |++|+|++|+|++..+..|.++++|++|+
T Consensus 51 p~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~ 130 (635)
T 4g8a_A 51 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 130 (635)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred CcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence 45799999999999988888999999999999999999999999999997 99999999999988888999999999999
Q ss_pred eeCCcCCCCCCccccCCCCCCEEEcccCcCCc-cCChhccCCCCCCEEEccCCcCCCc
Q 003737 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSGK 226 (799)
Q Consensus 170 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~ 226 (799)
|++|++++..+..|+++++|++|+|++|.+++ .+|..+..+++|++|++++|++++.
T Consensus 131 Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 188 (635)
T 4g8a_A 131 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 188 (635)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEE
T ss_pred CCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccc
Confidence 99999998777789999999999999999975 4688899999999999999987653
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-29 Score=298.06 Aligned_cols=139 Identities=27% Similarity=0.303 Sum_probs=125.7
Q ss_pred cccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEE
Q 003737 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 169 (799)
+.++++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|..++ |++|+|++|.+++..|..|+++++|++|+
T Consensus 31 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 46799999999999988888999999999999999999998899998887 99999999999988899999999999999
Q ss_pred eeCCcCCCCCCccccCCCCCCEEEcccCcCCc-cCChhccCCCCCCEEEccCCcCCCcCCc
Q 003737 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSGKIPE 229 (799)
Q Consensus 170 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 229 (799)
|++|.+++..|..|+++++|++|++++|.+++ .+|..|.++++|++|++++|++++..|.
T Consensus 111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~ 171 (606)
T 3vq2_A 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171 (606)
T ss_dssp CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence 99999987777889999999999999999986 6799999999999999999988765554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-29 Score=298.03 Aligned_cols=276 Identities=20% Similarity=0.209 Sum_probs=175.3
Q ss_pred cEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEee
Q 003737 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (799)
Q Consensus 93 ~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls 171 (799)
+++.|+++++.+++..+..|..+++|++|++++|+++ .+|..+..++ |++|++++|.+++..|..+.++++|++|+++
T Consensus 255 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 333 (606)
T 3t6q_A 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIK 333 (606)
T ss_dssp EEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECC
T ss_pred ceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECC
Confidence 5777777777777666666777777777777777776 4455566655 7777777777776666667777777777777
Q ss_pred CCcCCCCCCcc-ccCCCCCCEEEcccCcCCccC--ChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCC
Q 003737 172 GNLFTGSIPPD-IRKLINLQKLILSSNSFTGEL--PAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (799)
Q Consensus 172 ~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 248 (799)
+|.+.+.+|.. +..+++|++|++++|.+++.. |..+..+++|++|++++|++.+..|..|..+++|++|++++|.++
T Consensus 334 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 413 (606)
T 3t6q_A 334 GNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK 413 (606)
T ss_dssp SCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEE
T ss_pred CCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCC
Confidence 77766555543 666777777777777666544 556666667777777777666666666666666666666666666
Q ss_pred CCCch-hhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCccc---CCccccCCCCCCeeccccccCCCCCc
Q 003737 249 GPIPA-SISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGE---IPDYIGDMTKLKNIDLSFNNLTGGIP 323 (799)
Q Consensus 249 ~~~p~-~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~---~p~~l~~l~~L~~L~Ls~N~l~~~~p 323 (799)
+..|. .+..+++|+.|++++|.........+.. ++|++|++++|.+++. .+..+..+++|++|++++|++++..|
T Consensus 414 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 493 (606)
T 3t6q_A 414 VKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQ 493 (606)
T ss_dssp CCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECT
T ss_pred CcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccCh
Confidence 55443 3666666666666664433222222443 5666666666666542 22445666666666666666666666
Q ss_pred hhhhccCCCCEEeccCCcCCCcCChhhh--cCCCEEEeecCcCcccCCC
Q 003737 324 TTFEKLAKTNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESSD 370 (799)
Q Consensus 324 ~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~l~~l~ls~N~~~g~~p~ 370 (799)
..|..+++|+.|+|++|++++..|..+. ..+ .|++++|++++.+|.
T Consensus 494 ~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~ 541 (606)
T 3t6q_A 494 HAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPS 541 (606)
T ss_dssp TTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGG
T ss_pred hhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHh
Confidence 6666666666666666666665555443 234 666666666655443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-30 Score=293.50 Aligned_cols=273 Identities=16% Similarity=0.172 Sum_probs=201.5
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.+++.|+|++|.+++..|..|..+++|++|+|++|++++..|..|..++ |++|+|++|+++ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 5788899999998877778888899999999999998888888888887 999999999888 45555 7888889999
Q ss_pred eCCcCCC-CCCccccCCCCCCEEEcccCcCCccCChhccCCCCC--CEEEccCCcC--CCcCCccccCCC----------
Q 003737 171 EGNLFTG-SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNL--NDLRISDNNF--SGKIPEFIGKWK---------- 235 (799)
Q Consensus 171 s~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~~l~---------- 235 (799)
++|.+++ .+|..|+++++|++|++++|.+++ ..+..+++| ++|++++|.+ .+..|..+..+.
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~ 174 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCS
T ss_pred cCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEecc
Confidence 9888886 467888888888888888888875 345555555 7777777666 555555544422
Q ss_pred -------------------------------------------------------------------------CCCEEEc
Q 003737 236 -------------------------------------------------------------------------KIQKLHI 242 (799)
Q Consensus 236 -------------------------------------------------------------------------~L~~L~L 242 (799)
+|++|++
T Consensus 175 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l 254 (520)
T 2z7x_B 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI 254 (520)
T ss_dssp SSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEE
T ss_pred CcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEe
Confidence 5566666
Q ss_pred cCCCCCCCCchhh-----hcCCCCCeEEcC--------------------------CCCCCCCCCCccCC-CCccEEEcc
Q 003737 243 QGSSLEGPIPASI-----SALTSLTDLRIS--------------------------DLKGSESAFPKLDK-MNLKTLILT 290 (799)
Q Consensus 243 ~~N~l~~~~p~~~-----~~l~~L~~L~L~--------------------------~n~~~~~~~~~l~~-~~L~~L~L~ 290 (799)
++|+++|.+|..+ .++++|+.++++ +|......++ .. .+|++|+++
T Consensus 255 ~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~--~~l~~L~~L~Ls 332 (520)
T 2z7x_B 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP--SKISPFLHLDFS 332 (520)
T ss_dssp EEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCC--SSCCCCCEEECC
T ss_pred ecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccch--hhCCcccEEEeE
Confidence 6666666666555 444444444444 3332221111 23 678888888
Q ss_pred CCcCcccCCccccCCCCCCeeccccccCCC--CCchhhhccCCCCEEeccCCcCCCcCChhhh---cCCCEEEeecCcCc
Q 003737 291 KCLIHGEIPDYIGDMTKLKNIDLSFNNLTG--GIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLNNFT 365 (799)
Q Consensus 291 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~---~~l~~l~ls~N~~~ 365 (799)
+|++++.+|..+..+++|++|++++|++++ .+|..+..+++|+.|++++|++++.+|...+ ..++.|++++|.++
T Consensus 333 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~ 412 (520)
T 2z7x_B 333 NNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412 (520)
T ss_dssp SSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCC
T ss_pred CCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCC
Confidence 888888888888888888888888888886 5667788888888888888888876776533 46788888888888
Q ss_pred ccCCCCC
Q 003737 366 WESSDPI 372 (799)
Q Consensus 366 g~~p~~~ 372 (799)
+.+|..+
T Consensus 413 ~~~~~~l 419 (520)
T 2z7x_B 413 DTIFRCL 419 (520)
T ss_dssp GGGGGSC
T ss_pred cchhhhh
Confidence 7776544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=294.27 Aligned_cols=272 Identities=21% Similarity=0.267 Sum_probs=231.0
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCc-ccCCCCCCCEEE
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPK-VLTNITTLKNLS 169 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~-~~~~L~~L~~L~ 169 (799)
.+++.|++++|.++ .+|..+..+++|++|++++|.+++..|..+..++ |++|++++|.+.+.+|. .+..+++|++|+
T Consensus 278 ~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~ 356 (606)
T 3t6q_A 278 SGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELD 356 (606)
T ss_dssp TTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEE
T ss_pred cCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEE
Confidence 57889999999988 7888889999999999999999988888888887 99999999988876665 488899999999
Q ss_pred eeCCcCCCCC--CccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCcc-ccCCCCCCEEEccCCC
Q 003737 170 IEGNLFTGSI--PPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEF-IGKWKKIQKLHIQGSS 246 (799)
Q Consensus 170 Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~ 246 (799)
+++|.+++.. |..+..+++|++|++++|++++..|..|..+++|++|++++|++++..|.. +..+++|++|++++|.
T Consensus 357 l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~ 436 (606)
T 3t6q_A 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSL 436 (606)
T ss_dssp CCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCC
T ss_pred CCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCc
Confidence 9999988655 677888999999999999998888888899999999999999988776554 8889999999999999
Q ss_pred CCCCCchhhhcCCCCCeEEcCCCCCCCCCCC---ccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCC
Q 003737 247 LEGPIPASISALTSLTDLRISDLKGSESAFP---KLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 322 (799)
Q Consensus 247 l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~---~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 322 (799)
+++..|..+..+++|++|++++|......++ .+.. .+|+.|++++|++++..|..+..+++|+.|+|++|++++..
T Consensus 437 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 516 (606)
T 3t6q_A 437 LDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSS 516 (606)
T ss_dssp CBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGG
T ss_pred cCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCC
Confidence 9888888888999999999998766553332 2444 78999999999999888888999999999999999999888
Q ss_pred chhhhccCCCCEEeccCCcCCCcCChhh--hcCCCEEEeecCcCc
Q 003737 323 PTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFT 365 (799)
Q Consensus 323 p~~~~~l~~L~~L~L~~N~l~g~~p~~~--~~~l~~l~ls~N~~~ 365 (799)
|..|..++.| .|++++|++++..|..+ ...++.+++++|.++
T Consensus 517 ~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 560 (606)
T 3t6q_A 517 IEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLD 560 (606)
T ss_dssp GGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEE
T ss_pred hhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcc
Confidence 8899999999 99999999997777654 357889999999876
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=295.28 Aligned_cols=274 Identities=20% Similarity=0.212 Sum_probs=217.3
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.++++|+|++|++++..|..|.++++|++|+|++|++++.+|..|..++ |++|+|++|++++..|..|+++++|++|+|
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 105 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence 5799999999999999899999999999999999999999999999987 999999999999888888999999999999
Q ss_pred eCCcCCC-CCCccccCCCCCCEEEcccCcCCccCC-hhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCC
Q 003737 171 EGNLFTG-SIPPDIRKLINLQKLILSSNSFTGELP-AELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (799)
Q Consensus 171 s~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 248 (799)
++|.+++ ..|..++++++|++|++++|.+.+.+| ..|.++++|++|++++|++++..|..++.+++|++|+++.|.+.
T Consensus 106 s~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~ 185 (549)
T 2z81_A 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185 (549)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST
T ss_pred CCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCccc
Confidence 9999986 457789999999999999999555565 68999999999999999999888888776555555544444433
Q ss_pred CCCchhhhcCCCCCeEEcCCCCCCC-------------------------------------------------------
Q 003737 249 GPIPASISALTSLTDLRISDLKGSE------------------------------------------------------- 273 (799)
Q Consensus 249 ~~~p~~~~~l~~L~~L~L~~n~~~~------------------------------------------------------- 273 (799)
......+..+++|++|++++|+...
T Consensus 186 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~ 265 (549)
T 2z81_A 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265 (549)
T ss_dssp THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEEC
T ss_pred ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccc
Confidence 2111112233333333333322211
Q ss_pred ---------------------------------------------------------CCCCc-c-CC-CCccEEEccCCc
Q 003737 274 ---------------------------------------------------------SAFPK-L-DK-MNLKTLILTKCL 293 (799)
Q Consensus 274 ---------------------------------------------------------~~~~~-l-~~-~~L~~L~L~~N~ 293 (799)
..+|. + .. .+|+.|++++|+
T Consensus 266 ~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~ 345 (549)
T 2z81_A 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENL 345 (549)
T ss_dssp CSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSC
T ss_pred cccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCCc
Confidence 01222 1 22 689999999999
Q ss_pred CcccCCc---cccCCCCCCeeccccccCCCCCc--hhhhccCCCCEEeccCCcCCCcCChhhh--cCCCEEEeecCcCcc
Q 003737 294 IHGEIPD---YIGDMTKLKNIDLSFNNLTGGIP--TTFEKLAKTNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTW 366 (799)
Q Consensus 294 l~~~~p~---~l~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~l~~l~ls~N~~~g 366 (799)
+++.+|. .++.+++|+.|+|++|++++..+ ..+..+++|++|++++|+++ .+|..+. ..++.|++++|.++.
T Consensus 346 l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~ 424 (549)
T 2z81_A 346 MVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV 424 (549)
T ss_dssp CCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC
T ss_pred cccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc
Confidence 9987743 47889999999999999996543 56899999999999999999 6777653 478999999999874
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=291.01 Aligned_cols=273 Identities=19% Similarity=0.168 Sum_probs=199.4
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.+++.|+|++|.+++..|..|..+++|++|+|++|++++..|..|..++ |++|+|++|+++ .+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 5789999999999988888999999999999999999998899999887 999999999998 56665 7999999999
Q ss_pred eCCcCCC-CCCccccCCCCCCEEEcccCcCCccCChhccCCCCC--CEEEccCCcC--CCcCCccccCCC----------
Q 003737 171 EGNLFTG-SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNL--NDLRISDNNF--SGKIPEFIGKWK---------- 235 (799)
Q Consensus 171 s~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~~l~---------- 235 (799)
++|++++ .+|..|+++++|++|++++|++++. .+..+++| ++|++++|.+ ++..|..+..+.
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~ 205 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHP 205 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECS
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecC
Confidence 9999986 4568899999999999999998853 34555555 9999999988 777676665543
Q ss_pred -----------------------------------------------------------------------CCCEEEccC
Q 003737 236 -----------------------------------------------------------------------KIQKLHIQG 244 (799)
Q Consensus 236 -----------------------------------------------------------------------~L~~L~L~~ 244 (799)
+|++|++++
T Consensus 206 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~ 285 (562)
T 3a79_B 206 NSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYN 285 (562)
T ss_dssp SSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEE
T ss_pred ccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEec
Confidence 667777777
Q ss_pred CCCCCCCchhh-----hcC--------------------------CCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCC
Q 003737 245 SSLEGPIPASI-----SAL--------------------------TSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKC 292 (799)
Q Consensus 245 N~l~~~~p~~~-----~~l--------------------------~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N 292 (799)
|.++|.+|..+ .++ .+|+.|++++|......++ .. .+|++|++++|
T Consensus 286 n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~--~~l~~L~~L~l~~n 363 (562)
T 3a79_B 286 LTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP--PSPSSFTFLNFTQN 363 (562)
T ss_dssp EEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCC--SSCCCCCEEECCSS
T ss_pred cEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCc--cCCCCceEEECCCC
Confidence 77777777655 222 2244444444332221111 22 56777777777
Q ss_pred cCcccCCccccCCCCCCeeccccccCCC--CCchhhhccCCCCEEeccCCcCCCcCChhhh---cCCCEEEeecCcCccc
Q 003737 293 LIHGEIPDYIGDMTKLKNIDLSFNNLTG--GIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLNNFTWE 367 (799)
Q Consensus 293 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~---~~l~~l~ls~N~~~g~ 367 (799)
.+++.+|..+..+++|+.|+|++|++++ .+|..|..+++|+.|++++|++++.+|...+ ..++.|++++|.+++.
T Consensus 364 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 443 (562)
T 3a79_B 364 VFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS 443 (562)
T ss_dssp CCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGG
T ss_pred ccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcc
Confidence 7777777777777777777777777775 2345567777777777777777765665433 3566777777777766
Q ss_pred CCCCC
Q 003737 368 SSDPI 372 (799)
Q Consensus 368 ~p~~~ 372 (799)
+|..+
T Consensus 444 ~~~~l 448 (562)
T 3a79_B 444 VFRCL 448 (562)
T ss_dssp GGSSC
T ss_pred hhhhh
Confidence 65543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-29 Score=301.08 Aligned_cols=271 Identities=21% Similarity=0.283 Sum_probs=202.0
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCc-CCC-cCccccccc--------ceeEEEccCCcCcCcCCc--cc
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNC-LTG-SFSPQWASL--------QLVELSVMGNRLSGPFPK--VL 159 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l--------~L~~L~Ls~N~l~~~~p~--~~ 159 (799)
.+++.|+|++|++.|.+|..|.++++|++|+|++|+ +++ .+|..++.+ +|++|+|++|+++ .+|. .|
T Consensus 491 ~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l 569 (876)
T 4ecn_A 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASL 569 (876)
T ss_dssp TTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHH
T ss_pred CCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhh
Confidence 579999999999999999999999999999999998 998 788776654 4999999999999 8888 99
Q ss_pred CCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCC-CCEEEccCCcCCCcCCccccCCCC--
Q 003737 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN-LNDLRISDNNFSGKIPEFIGKWKK-- 236 (799)
Q Consensus 160 ~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~-- 236 (799)
+++++|++|+|++|.++ .+| .|+.+++|++|+|++|+++ .+|..+.++++ |++|+|++|.++ .+|..+..++.
T Consensus 570 ~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~ 645 (876)
T 4ecn_A 570 QKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYV 645 (876)
T ss_dssp TTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSC
T ss_pred hcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCC
Confidence 99999999999999998 888 8999999999999999999 89999999998 999999999998 77888777654
Q ss_pred CCEEEccCCCCCCCCchhh---h--cCCCCCeEEcCCCCCCCCCCCc--cCC-CCccEEEccCCcCcccCCccccC----
Q 003737 237 IQKLHIQGSSLEGPIPASI---S--ALTSLTDLRISDLKGSESAFPK--LDK-MNLKTLILTKCLIHGEIPDYIGD---- 304 (799)
Q Consensus 237 L~~L~L~~N~l~~~~p~~~---~--~l~~L~~L~L~~n~~~~~~~~~--l~~-~~L~~L~L~~N~l~~~~p~~l~~---- 304 (799)
|+.|+|++|++++.+|... . .+++|+.|++++|.+. .+|. +.. ++|+.|+|++|+++ .+|..+..
T Consensus 646 L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~--~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~ 722 (876)
T 4ecn_A 646 MGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ--KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDG 722 (876)
T ss_dssp EEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC--SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTS
T ss_pred CCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC--ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccc
Confidence 8888888888877554322 2 2336666666665444 2332 222 55666666666666 44443322
Q ss_pred ----CCCCCeeccccccCCCCCchhhh--ccCCCCEEeccCCcCCCcCChhhh--cCCCEEEeec------CcCcccCCC
Q 003737 305 ----MTKLKNIDLSFNNLTGGIPTTFE--KLAKTNFMYLTGNKLTGPVPKYIF--NSNKNVDISL------NNFTWESSD 370 (799)
Q Consensus 305 ----l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~g~~p~~~~--~~l~~l~ls~------N~~~g~~p~ 370 (799)
+++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+. ..++.|+|++ |++.+.+|.
T Consensus 723 ~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~ 800 (876)
T 4ecn_A 723 NYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPT 800 (876)
T ss_dssp CCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCT
T ss_pred cccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChH
Confidence 226666666666666 5555554 66666666666666665 555443 2456666654 555666665
Q ss_pred CC
Q 003737 371 PI 372 (799)
Q Consensus 371 ~~ 372 (799)
.+
T Consensus 801 ~l 802 (876)
T 4ecn_A 801 GI 802 (876)
T ss_dssp TG
T ss_pred HH
Confidence 54
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-29 Score=291.47 Aligned_cols=279 Identities=18% Similarity=0.153 Sum_probs=203.6
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.++++|+|++|.+++..|..|.++++|++|+|++|.+++..|..|+.++ |++|+|++|.+++..|..++++++|++|+|
T Consensus 56 ~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 135 (606)
T 3vq2_A 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135 (606)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEEC
T ss_pred ccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeC
Confidence 5788999999999988888899999999999999999988888888887 999999999998877788999999999999
Q ss_pred eCCcCCC-CCCccccCCCCCCEEEcccCcCCccCChhccCC---------------------------------------
Q 003737 171 EGNLFTG-SIPPDIRKLINLQKLILSSNSFTGELPAELTKL--------------------------------------- 210 (799)
Q Consensus 171 s~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--------------------------------------- 210 (799)
++|.+++ .+|..|+++++|++|++++|++++..|..+..+
T Consensus 136 ~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~ 215 (606)
T 3vq2_A 136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNF 215 (606)
T ss_dssp CSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCC
T ss_pred CCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCc
Confidence 9999875 568889999999999999888876554433221
Q ss_pred --------------------------------------------------------------------------------
Q 003737 211 -------------------------------------------------------------------------------- 210 (799)
Q Consensus 211 -------------------------------------------------------------------------------- 210 (799)
T Consensus 216 ~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~ 295 (606)
T 3vq2_A 216 NSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295 (606)
T ss_dssp SCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESC
T ss_pred cchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCc
Confidence
Q ss_pred -----------CCCCEEEccCCcCCCcCCc--------------------cccCCCCCCEEEccCCCCCCC--Cchhhhc
Q 003737 211 -----------TNLNDLRISDNNFSGKIPE--------------------FIGKWKKIQKLHIQGSSLEGP--IPASISA 257 (799)
Q Consensus 211 -----------~~L~~L~Ls~N~l~~~~p~--------------------~~~~l~~L~~L~L~~N~l~~~--~p~~~~~ 257 (799)
++|++|++++|.+ +.+|. .+..+++|++|++++|.+++. +|..+..
T Consensus 296 ~~~~l~~l~~~~~L~~L~l~~n~l-~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~ 374 (606)
T 3vq2_A 296 SIKYLEDVPKHFKWQSLSIIRCQL-KQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374 (606)
T ss_dssp CCCCCCCCCTTCCCSEEEEESCCC-SSCCCCCCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHC
T ss_pred cchhhhhccccccCCEEEcccccC-cccccCCCCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhcc
Confidence 2333333333333 22221 234566777888888888765 3788888
Q ss_pred CCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCC-ccccCCCCCCeeccccccCCCCCchhhhccCCCCEE
Q 003737 258 LTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIP-DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335 (799)
Q Consensus 258 l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 335 (799)
+++|++|++++|...... ..+.. .+|+.|++++|.+++..| ..+..+++|++|++++|++++..|..+..+++|+.|
T Consensus 375 ~~~L~~L~L~~n~l~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 453 (606)
T 3vq2_A 375 TNSLRHLDLSFNGAIIMS-ANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTL 453 (606)
T ss_dssp CSCCCEEECCSCSEEEEC-CCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred CCcccEeECCCCccccch-hhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEE
Confidence 888888888886543322 33444 677777777777776666 566777777777777777777777777777777777
Q ss_pred eccCCcCCCc-CChhhh--cCCCEEEeecCcCcccCCCCC
Q 003737 336 YLTGNKLTGP-VPKYIF--NSNKNVDISLNNFTWESSDPI 372 (799)
Q Consensus 336 ~L~~N~l~g~-~p~~~~--~~l~~l~ls~N~~~g~~p~~~ 372 (799)
++++|++++. +|..+. ..++.|++++|.+++.+|..+
T Consensus 454 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 493 (606)
T 3vq2_A 454 KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVF 493 (606)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred ECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhh
Confidence 7777777763 454442 456777777777776666554
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-28 Score=264.49 Aligned_cols=264 Identities=20% Similarity=0.284 Sum_probs=213.9
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
++++.++++++.++ .+|..+. +.|++|+|++|++++..+..|..++ |++|+|++|++++..|..|.++++|++|+|
T Consensus 31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 45677888888887 5676554 6899999999999988888888887 999999999999888999999999999999
Q ss_pred eCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCC--cCCccccCCCCCCEEEccCCCCC
Q 003737 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG--KIPEFIGKWKKIQKLHIQGSSLE 248 (799)
Q Consensus 171 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~ 248 (799)
++|.++ .+|..+. ++|++|++++|.+++..+..|.++++|++|++++|.+.. ..+..+..+++|++|++++|.++
T Consensus 108 s~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 108 SKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184 (330)
T ss_dssp CSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence 999988 5676654 789999999999997777789999999999999999863 67788899999999999999988
Q ss_pred CCCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhh
Q 003737 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327 (799)
Q Consensus 249 ~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 327 (799)
. +|..+. ++|++|++++|.........+.. .+|+.|+|++|.+++..+..+..+++|++|+|++|+++ .+|..+.
T Consensus 185 ~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~ 260 (330)
T 1xku_A 185 T-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260 (330)
T ss_dssp S-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTT
T ss_pred c-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhc
Confidence 5 454443 78888888886654433334555 78888888888888877778888888888888888888 7788888
Q ss_pred ccCCCCEEeccCCcCCCcCChhhh--------cCCCEEEeecCcCc
Q 003737 328 KLAKTNFMYLTGNKLTGPVPKYIF--------NSNKNVDISLNNFT 365 (799)
Q Consensus 328 ~l~~L~~L~L~~N~l~g~~p~~~~--------~~l~~l~ls~N~~~ 365 (799)
.+++|++|++++|++++..+..+. ..++.+++++|.+.
T Consensus 261 ~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~ 306 (330)
T 1xku_A 261 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306 (330)
T ss_dssp TCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred cCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCccc
Confidence 888888888888888854443331 34567888888775
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=275.46 Aligned_cols=261 Identities=18% Similarity=0.220 Sum_probs=149.5
Q ss_pred CCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCC
Q 003737 101 AQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSI 179 (799)
Q Consensus 101 ~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~ 179 (799)
+++++ .+|..+. ++|++|+|++|++++..+..+..++ |++|++++|++++..|..|.++++|++|+|++|++++..
T Consensus 40 ~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 116 (353)
T 2z80_A 40 SGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLS 116 (353)
T ss_dssp STTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCC
T ss_pred CCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCC
Confidence 34444 3444333 3566666666666655555555555 666666666666555556666666666666666665433
Q ss_pred CccccCCCCCCEEEcccCcCCccCC-hhccCCCCCCEEEccCC-cCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhc
Q 003737 180 PPDIRKLINLQKLILSSNSFTGELP-AELTKLTNLNDLRISDN-NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISA 257 (799)
Q Consensus 180 p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 257 (799)
+..|.++++|++|++++|++++..+ ..+.++++|++|++++| .+....+..|..+++|++|++++|.+++..|..+..
T Consensus 117 ~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~ 196 (353)
T 2z80_A 117 SSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKS 196 (353)
T ss_dssp HHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTT
T ss_pred HhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhc
Confidence 3335666666666666666653222 24556666666666666 344444555666666666666666666655666666
Q ss_pred CCCCCeEEcCCCCCCCCCCCc--cCC-CCccEEEccCCcCcccCCcccc---CCCCCCeeccccccCCC----CCchhhh
Q 003737 258 LTSLTDLRISDLKGSESAFPK--LDK-MNLKTLILTKCLIHGEIPDYIG---DMTKLKNIDLSFNNLTG----GIPTTFE 327 (799)
Q Consensus 258 l~~L~~L~L~~n~~~~~~~~~--l~~-~~L~~L~L~~N~l~~~~p~~l~---~l~~L~~L~Ls~N~l~~----~~p~~~~ 327 (799)
+++|++|++++|... .+|. +.. .+|+.|++++|.+++..+..+. ..+.++.++|++|.+++ .+|..+.
T Consensus 197 l~~L~~L~l~~n~l~--~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~ 274 (353)
T 2z80_A 197 IQNVSHLILHMKQHI--LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLN 274 (353)
T ss_dssp CSEEEEEEEECSCST--THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHH
T ss_pred cccCCeecCCCCccc--cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHh
Confidence 666666666654432 1221 221 4566666666666654443322 34556666666666664 3566667
Q ss_pred ccCCCCEEeccCCcCCCcCChhhh---cCCCEEEeecCcCccc
Q 003737 328 KLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLNNFTWE 367 (799)
Q Consensus 328 ~l~~L~~L~L~~N~l~g~~p~~~~---~~l~~l~ls~N~~~g~ 367 (799)
.+++|+.|++++|+++ .+|..++ ..++.|++++|.+++.
T Consensus 275 ~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~ 316 (353)
T 2z80_A 275 QISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 316 (353)
T ss_dssp TCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred cccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCc
Confidence 7777777777777777 5555542 3456777777766543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-28 Score=280.65 Aligned_cols=270 Identities=18% Similarity=0.202 Sum_probs=187.5
Q ss_pred cccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcC-cCCcccCCCCCCCEE
Q 003737 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSG-PFPKVLTNITTLKNL 168 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~-~~p~~~~~L~~L~~L 168 (799)
..++++|+|++|.+++..|..|..+++|++|||++|+++. +|.. .++ |++|+|++|++++ .+|..|+++++|++|
T Consensus 44 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L 120 (520)
T 2z7x_B 44 LSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFL 120 (520)
T ss_dssp CTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEE
T ss_pred cccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc--ccCCccEEeccCCccccccchhhhccCCcceEE
Confidence 3579999999999999889999999999999999999995 4544 555 9999999999997 578999999999999
Q ss_pred EeeCCcCCCCCCccccCCCCC--CEEEcccCcC--CccCChhccCCC---------------------------------
Q 003737 169 SIEGNLFTGSIPPDIRKLINL--QKLILSSNSF--TGELPAELTKLT--------------------------------- 211 (799)
Q Consensus 169 ~Ls~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~~l~--------------------------------- 211 (799)
++++|.+++ ..+..+++| ++|++++|.+ .+..|..+..++
T Consensus 121 ~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l 197 (520)
T 2z7x_B 121 GLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197 (520)
T ss_dssp EEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCE
T ss_pred EecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccc
Confidence 999998864 234444444 5555555555 334444333322
Q ss_pred --------------------------------------------------CCCEEEccCCcCCCcCCccc----------
Q 003737 212 --------------------------------------------------NLNDLRISDNNFSGKIPEFI---------- 231 (799)
Q Consensus 212 --------------------------------------------------~L~~L~Ls~N~l~~~~p~~~---------- 231 (799)
+|++|++++|+++|.+|..+
T Consensus 198 ~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~ 277 (520)
T 2z7x_B 198 KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKA 277 (520)
T ss_dssp EECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCE
T ss_pred cccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCce
Confidence 44445555555444444333
Q ss_pred -------------------------------------------cCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCC
Q 003737 232 -------------------------------------------GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268 (799)
Q Consensus 232 -------------------------------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 268 (799)
..+++|++|++++|++++.+|..+..+++|++|++++
T Consensus 278 L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 357 (520)
T 2z7x_B 278 LSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357 (520)
T ss_dssp EEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCS
T ss_pred eEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccC
Confidence 4566777777777777777777777777777777777
Q ss_pred CCCCCC-CCCc-cCC-CCccEEEccCCcCcccCCcc-ccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCC
Q 003737 269 LKGSES-AFPK-LDK-MNLKTLILTKCLIHGEIPDY-IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG 344 (799)
Q Consensus 269 n~~~~~-~~~~-l~~-~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g 344 (799)
|.+... .+|. +.. ++|++|++++|.+++.+|.. +..+++|+.|++++|++++.+|..+. ++|+.|++++|+++
T Consensus 358 N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~- 434 (520)
T 2z7x_B 358 NQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK- 434 (520)
T ss_dssp SCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-
T ss_pred CccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-
Confidence 555431 2222 444 67777777777777645543 66677777777777777766665543 57777777777777
Q ss_pred cCChhhh--cCCCEEEeecCcCcccCCC
Q 003737 345 PVPKYIF--NSNKNVDISLNNFTWESSD 370 (799)
Q Consensus 345 ~~p~~~~--~~l~~l~ls~N~~~g~~p~ 370 (799)
.+|..++ ..++.|++++|+++ .+|.
T Consensus 435 ~ip~~~~~l~~L~~L~L~~N~l~-~l~~ 461 (520)
T 2z7x_B 435 SIPKQVVKLEALQELNVASNQLK-SVPD 461 (520)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCC-CCCT
T ss_pred ccchhhhcCCCCCEEECCCCcCC-ccCH
Confidence 6666554 35677777777777 3444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-28 Score=289.27 Aligned_cols=282 Identities=19% Similarity=0.207 Sum_probs=233.3
Q ss_pred cccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEE
Q 003737 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 169 (799)
+.+++.|+|++|.+++..+..|.++++|++|+|++|.+++..|..|..++ |++|+|++|++++..+..|+++++|++|+
T Consensus 24 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103 (680)
T ss_dssp CTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence 35899999999999988888899999999999999999999999999988 99999999999977777899999999999
Q ss_pred eeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCcccc--CCCCCCEEEccCCCC
Q 003737 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIG--KWKKIQKLHIQGSSL 247 (799)
Q Consensus 170 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l 247 (799)
|++|.+++..|..|+++++|++|++++|.+++..|..+.++++|++|++++|.+++..+..+. .+++|++|++++|.+
T Consensus 104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l 183 (680)
T 1ziw_A 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183 (680)
T ss_dssp CCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred CCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcc
Confidence 999999987778999999999999999999998899999999999999999999988777665 568999999999999
Q ss_pred CCCCchhhhcCCC---------------------------CCeEEcCCCCCCCCCCCccCC---CCccEEEccCCcCccc
Q 003737 248 EGPIPASISALTS---------------------------LTDLRISDLKGSESAFPKLDK---MNLKTLILTKCLIHGE 297 (799)
Q Consensus 248 ~~~~p~~~~~l~~---------------------------L~~L~L~~n~~~~~~~~~l~~---~~L~~L~L~~N~l~~~ 297 (799)
++..|..+..+.+ |+.|++++|.........+.. .+|+.|+|++|.+++.
T Consensus 184 ~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~ 263 (680)
T 1ziw_A 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263 (680)
T ss_dssp CCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEE
T ss_pred cccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCcc
Confidence 9988888876654 455555554332222122322 4588888888888888
Q ss_pred CCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCc-----CCh----hh--hcCCCEEEeecCcCcc
Q 003737 298 IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP-----VPK----YI--FNSNKNVDISLNNFTW 366 (799)
Q Consensus 298 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~-----~p~----~~--~~~l~~l~ls~N~~~g 366 (799)
.|..+..+++|++|++++|++++..|..|..+++|+.|++++|...+. +|. .+ ...++.|++++|.+++
T Consensus 264 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~ 343 (680)
T 1ziw_A 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343 (680)
T ss_dssp CTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCC
T ss_pred CcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCC
Confidence 888888888888888888888888888888888888888887766542 232 12 2467888888888888
Q ss_pred cCCCCC
Q 003737 367 ESSDPI 372 (799)
Q Consensus 367 ~~p~~~ 372 (799)
..|..+
T Consensus 344 ~~~~~~ 349 (680)
T 1ziw_A 344 IKSNMF 349 (680)
T ss_dssp CCTTTT
T ss_pred CChhHh
Confidence 766554
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-28 Score=264.60 Aligned_cols=263 Identities=22% Similarity=0.321 Sum_probs=217.0
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
++++.+++++++++ .+|..+. ++|++|+|++|.+++..|..|..++ |++|++++|++++..|..|+++++|++|+|
T Consensus 33 c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 33 CHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp EETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred ccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 45678899999988 6777664 7899999999999988888898887 999999999999888999999999999999
Q ss_pred eCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCC--CcCCccccCCCCCCEEEccCCCCC
Q 003737 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS--GKIPEFIGKWKKIQKLHIQGSSLE 248 (799)
Q Consensus 171 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~ 248 (799)
++|.++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|.++ +..|..+..+ +|++|++++|+++
T Consensus 110 ~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 110 SKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT 185 (332)
T ss_dssp CSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS
T ss_pred CCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC
Confidence 999998 6676655 79999999999999776777999999999999999996 4678888888 9999999999998
Q ss_pred CCCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhh
Q 003737 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327 (799)
Q Consensus 249 ~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 327 (799)
+ +|..+. ++|++|++++|.........+.. .+|+.|+|++|.+++..+..+..+++|++|+|++|+++ .+|..+.
T Consensus 186 ~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~ 261 (332)
T 2ft3_A 186 G-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLP 261 (332)
T ss_dssp S-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGG
T ss_pred c-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhh
Confidence 6 555443 68888899886665544344555 78888999999988877778888889999999999888 7788888
Q ss_pred ccCCCCEEeccCCcCCCcCChhhh--------cCCCEEEeecCcCc
Q 003737 328 KLAKTNFMYLTGNKLTGPVPKYIF--------NSNKNVDISLNNFT 365 (799)
Q Consensus 328 ~l~~L~~L~L~~N~l~g~~p~~~~--------~~l~~l~ls~N~~~ 365 (799)
.+++|+.|++++|++++..+..+. ..++.+++++|.+.
T Consensus 262 ~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~ 307 (332)
T 2ft3_A 262 DLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307 (332)
T ss_dssp GCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSC
T ss_pred cCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccc
Confidence 889999999999988854444332 23568888888876
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-28 Score=281.76 Aligned_cols=138 Identities=22% Similarity=0.231 Sum_probs=104.8
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.+++.|+|++|++++..+..|.++++|++|+|++|++++..+..|..++ |++|+|++|++++..|..|+++++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 4677888888888877777788888888888888888877777777776 888888888887777777888888888888
Q ss_pred eCCcCCCCCCccccCCCCCCEEEcccCcCCc-cCChhccCCCCCCEEEccCCcCCCcCCc
Q 003737 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSGKIPE 229 (799)
Q Consensus 171 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 229 (799)
++|.+++..+..|+++++|++|++++|.+++ .+|..|.++++|++|++++|++++..|.
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~ 167 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGG
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHH
Confidence 8887775555467777788888888777775 4677777777777777777766544333
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-28 Score=261.73 Aligned_cols=266 Identities=20% Similarity=0.237 Sum_probs=227.1
Q ss_pred cccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEE
Q 003737 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 169 (799)
..+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|..++ |++|++++|+++ .+|..+. ++|++|+
T Consensus 51 ~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~ 127 (330)
T 1xku_A 51 PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELR 127 (330)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEE
T ss_pred CCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEE
Confidence 35789999999999988888999999999999999999999999999987 999999999998 5666554 7999999
Q ss_pred eeCCcCCCCCCccccCCCCCCEEEcccCcCCc--cCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCC
Q 003737 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTG--ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL 247 (799)
Q Consensus 170 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 247 (799)
+++|.+++..+..|.++++|++|++++|.++. ..+..+.++++|++|++++|+++. +|..+. ++|++|++++|.+
T Consensus 128 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l 204 (330)
T 1xku_A 128 VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKI 204 (330)
T ss_dssp CCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCC
T ss_pred CCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcC
Confidence 99999997777789999999999999999963 678889999999999999999984 566554 8999999999999
Q ss_pred CCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhh
Q 003737 248 EGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTF 326 (799)
Q Consensus 248 ~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 326 (799)
++..|..+..+++|+.|++++|.........+.. ++|+.|+|++|.++ .+|..+..+++|++|++++|++++..+..|
T Consensus 205 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f 283 (330)
T 1xku_A 205 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 283 (330)
T ss_dssp CEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSS
T ss_pred CccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhc
Confidence 9988999999999999999997665433334555 79999999999999 788899999999999999999998777777
Q ss_pred hc------cCCCCEEeccCCcCCC-cCChhhh---cCCCEEEeecCc
Q 003737 327 EK------LAKTNFMYLTGNKLTG-PVPKYIF---NSNKNVDISLNN 363 (799)
Q Consensus 327 ~~------l~~L~~L~L~~N~l~g-~~p~~~~---~~l~~l~ls~N~ 363 (799)
.. .+.|+.|++++|.+.. .+++..+ ..++.++|++|+
T Consensus 284 ~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 284 CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp SCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 54 3789999999999973 3443333 346789999885
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-28 Score=281.53 Aligned_cols=269 Identities=21% Similarity=0.175 Sum_probs=216.1
Q ss_pred EEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeC
Q 003737 94 VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (799)
Q Consensus 94 v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~ 172 (799)
.+.++++++++++ +|..+. ++|++|+|++|.+++..|..|..++ |++|+|++|++++..|+.|.++++|++|+|++
T Consensus 33 ~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 33 ESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 3789999999995 787665 8999999999999999999999998 99999999999999999999999999999999
Q ss_pred CcCCCCCCccccCCCCCCEEEcccCcCCc-cCChhccCCCCCCEEEccCCcCCCcCCccccCCCCC--CEEEccCCCC--
Q 003737 173 NLFTGSIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI--QKLHIQGSSL-- 247 (799)
Q Consensus 173 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~L~~N~l-- 247 (799)
|+++ .+|.. .+++|++|+|++|++++ .+|..|.++++|++|++++|++++. .+..+++| ++|++++|.+
T Consensus 110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~ 183 (562)
T 3a79_B 110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI 183 (562)
T ss_dssp SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence 9998 67766 89999999999999997 4578999999999999999999863 45555556 9999999999
Q ss_pred CCCCchhhhcCC--------------------------CCCeEEcCCCCCC----------------------------C
Q 003737 248 EGPIPASISALT--------------------------SLTDLRISDLKGS----------------------------E 273 (799)
Q Consensus 248 ~~~~p~~~~~l~--------------------------~L~~L~L~~n~~~----------------------------~ 273 (799)
++..|..+..+. +|+.|++++|... .
T Consensus 184 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~ 263 (562)
T 3a79_B 184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263 (562)
T ss_dssp CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECH
T ss_pred cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcH
Confidence 777777766543 4444444443100 0
Q ss_pred C----CCCccCCCCccEEEccCCcCcccCCccc-----------------------------------------------
Q 003737 274 S----AFPKLDKMNLKTLILTKCLIHGEIPDYI----------------------------------------------- 302 (799)
Q Consensus 274 ~----~~~~l~~~~L~~L~L~~N~l~~~~p~~l----------------------------------------------- 302 (799)
. ..+.+...+|++|++++|.++|.+|..+
T Consensus 264 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~ 343 (562)
T 3a79_B 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF 343 (562)
T ss_dssp HHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCC
T ss_pred HHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCc
Confidence 0 0000011256666666666665555543
Q ss_pred ------cCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCc--CChhh--hcCCCEEEeecCcCcccCCCC
Q 003737 303 ------GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP--VPKYI--FNSNKNVDISLNNFTWESSDP 371 (799)
Q Consensus 303 ------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~--~p~~~--~~~l~~l~ls~N~~~g~~p~~ 371 (799)
..+++|++|++++|++++.+|..+..+++|+.|++++|++++. +|..+ ...++.|++++|.+++.+|..
T Consensus 344 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 422 (562)
T 3a79_B 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDR 422 (562)
T ss_dssp CCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSC
T ss_pred ccccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChh
Confidence 6789999999999999999999999999999999999999962 23333 357899999999999977765
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-28 Score=261.31 Aligned_cols=264 Identities=20% Similarity=0.235 Sum_probs=226.4
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.+++.|++++|.+++..|..|.++++|++|+|++|.+++..|..|..++ |++|++++|+++ .+|..+. ++|++|++
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l 130 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRI 130 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEEC
Confidence 5799999999999988888999999999999999999999999999987 999999999998 5666555 89999999
Q ss_pred eCCcCCCCCCccccCCCCCCEEEcccCcCC--ccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCC
Q 003737 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFT--GELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (799)
Q Consensus 171 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 248 (799)
++|.+++..+..|.++++|++|++++|.++ +..|..+..+ +|++|++++|++++ +|..+. ++|++|++++|.++
T Consensus 131 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~ 206 (332)
T 2ft3_A 131 HDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQ 206 (332)
T ss_dssp CSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCC
T ss_pred CCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCC
Confidence 999999776677999999999999999996 4678888888 99999999999985 666554 79999999999999
Q ss_pred CCCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhh
Q 003737 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327 (799)
Q Consensus 249 ~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 327 (799)
+..+..+..+++|+.|++++|.........+.. ++|+.|+|++|+++ .+|..+..+++|+.|++++|++++..+..|.
T Consensus 207 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 285 (332)
T 2ft3_A 207 AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFC 285 (332)
T ss_dssp CCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSS
T ss_pred ccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcc
Confidence 988899999999999999997665543334655 89999999999999 7888899999999999999999988777776
Q ss_pred c------cCCCCEEeccCCcCC--CcCChhhh--cCCCEEEeecCc
Q 003737 328 K------LAKTNFMYLTGNKLT--GPVPKYIF--NSNKNVDISLNN 363 (799)
Q Consensus 328 ~------l~~L~~L~L~~N~l~--g~~p~~~~--~~l~~l~ls~N~ 363 (799)
. .+.|+.|++++|++. +..|..+. ..++.+++++|+
T Consensus 286 ~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 286 PVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 5 367999999999997 44444442 467889998884
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-27 Score=284.92 Aligned_cols=274 Identities=19% Similarity=0.218 Sum_probs=229.8
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCc--Cccccccc---ceeEEEccCCcCcCcCCcccCCCCCCC
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGS--FSPQWASL---QLVELSVMGNRLSGPFPKVLTNITTLK 166 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l---~L~~L~Ls~N~l~~~~p~~~~~L~~L~ 166 (799)
.+++.|++++|.+++..+..|..+++|++|++++|.+... ....|..+ +|++|++++|++++..|..|..+++|+
T Consensus 329 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 408 (680)
T 1ziw_A 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLE 408 (680)
T ss_dssp TTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred CCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCC
Confidence 4677888888888887777888888888888888875432 22333332 488999999999988899999999999
Q ss_pred EEEeeCCcCCCCCC-ccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCC--CcCCccccCCCCCCEEEcc
Q 003737 167 NLSIEGNLFTGSIP-PDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS--GKIPEFIGKWKKIQKLHIQ 243 (799)
Q Consensus 167 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~ 243 (799)
+|+|++|.+++.+| ..|..+++|++|++++|++++..+..|..+++|+.|++++|.+. +.+|..|..+++|++|+|+
T Consensus 409 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls 488 (680)
T 1ziw_A 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLS 488 (680)
T ss_dssp EEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECC
T ss_pred EEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECC
Confidence 99999999987666 67899999999999999999888889999999999999999986 5788999999999999999
Q ss_pred CCCCCCCCchhhhcCCCCCeEEcCCCCCCCC---CCC-----ccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccc
Q 003737 244 GSSLEGPIPASISALTSLTDLRISDLKGSES---AFP-----KLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLS 314 (799)
Q Consensus 244 ~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~---~~~-----~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 314 (799)
+|++++..+..|..+++|++|++++|..... .+| .+.. .+|+.|+|++|+++...+..|..+++|+.|+|+
T Consensus 489 ~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 568 (680)
T 1ziw_A 489 NNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLG 568 (680)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECC
Confidence 9999988888899999999999999765432 111 2445 789999999999995555678999999999999
Q ss_pred cccCCCCCchhhhccCCCCEEeccCCcCCCcCChhh---hcCCCEEEeecCcCc
Q 003737 315 FNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDISLNNFT 365 (799)
Q Consensus 315 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~---~~~l~~l~ls~N~~~ 365 (799)
+|++++..+..|..+++|+.|+|++|++++..|..+ +..++.+++++|.+.
T Consensus 569 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~ 622 (680)
T 1ziw_A 569 LNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFD 622 (680)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCC
T ss_pred CCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcc
Confidence 999998777788999999999999999997666544 468899999999775
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.7e-28 Score=293.39 Aligned_cols=277 Identities=21% Similarity=0.205 Sum_probs=239.8
Q ss_pred cccEEEEEeCCCCCcccC-CccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcc--cCCCCCCC
Q 003737 91 TCHVVTIALKAQNLTGTL-PTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKV--LTNITTLK 166 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~--~~~L~~L~ 166 (799)
..+++.|+|++|...+.+ |..|.++++|++|+|++|.+++..|..|..++ |++|+|++|.+++.+|.. |.++++|+
T Consensus 47 l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~ 126 (844)
T 3j0a_A 47 LEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT 126 (844)
T ss_dssp CCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCC
T ss_pred cccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCC
Confidence 357899999999877777 67899999999999999999999999999998 999999999999877665 99999999
Q ss_pred EEEeeCCcCCCCCC-ccccCCCCCCEEEcccCcCCccCChhccCC--CCCCEEEccCCcCCCcCCccccCCCC------C
Q 003737 167 NLSIEGNLFTGSIP-PDIRKLINLQKLILSSNSFTGELPAELTKL--TNLNDLRISDNNFSGKIPEFIGKWKK------I 237 (799)
Q Consensus 167 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~------L 237 (799)
+|+|++|.+++..+ ..|+++++|++|+|++|.+++..|..+..+ ++|+.|+++.|.+.+..|..++.+.+ |
T Consensus 127 ~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L 206 (844)
T 3j0a_A 127 RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVL 206 (844)
T ss_dssp EEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCB
T ss_pred EEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCce
Confidence 99999999987665 579999999999999999999999999887 89999999999999988888777665 9
Q ss_pred CEEEccCCCCCCCCchhhhc--------------------------------------CCCCCeEEcCCCCCCCCCCCcc
Q 003737 238 QKLHIQGSSLEGPIPASISA--------------------------------------LTSLTDLRISDLKGSESAFPKL 279 (799)
Q Consensus 238 ~~L~L~~N~l~~~~p~~~~~--------------------------------------l~~L~~L~L~~n~~~~~~~~~l 279 (799)
++|++++|.+++..+..+.. .++|+.|++++|.........+
T Consensus 207 ~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~ 286 (844)
T 3j0a_A 207 EILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVF 286 (844)
T ss_dssp SEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCS
T ss_pred eEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhh
Confidence 99999999888766655443 2578999999866554333335
Q ss_pred CC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhh--hcCCCE
Q 003737 280 DK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKN 356 (799)
Q Consensus 280 ~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~--~~~l~~ 356 (799)
.. .+|+.|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|+.|++++|++++..+..+ ...++.
T Consensus 287 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 366 (844)
T 3j0a_A 287 ETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQT 366 (844)
T ss_dssp SSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCE
T ss_pred hcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCE
Confidence 55 789999999999999989999999999999999999998889999999999999999999986655544 357889
Q ss_pred EEeecCcCccc
Q 003737 357 VDISLNNFTWE 367 (799)
Q Consensus 357 l~ls~N~~~g~ 367 (799)
|+|++|.+++.
T Consensus 367 L~Ls~N~l~~i 377 (844)
T 3j0a_A 367 LDLRDNALTTI 377 (844)
T ss_dssp EEEETCCSCCC
T ss_pred EECCCCCCCcc
Confidence 99999998853
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=279.38 Aligned_cols=280 Identities=18% Similarity=0.174 Sum_probs=199.5
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.+++.|+|++|.+++..|..|.++++|++|+|++|.+++..|..|..++ |++|++++|++++..+..++++++|++|++
T Consensus 52 ~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 131 (570)
T 2z63_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (570)
T ss_dssp SSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEEC
T ss_pred CCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEec
Confidence 3567777777777766666677777777777777777766666666665 777777777666555545666666666666
Q ss_pred eCCcCCC-CCCccccCCCCCCEEEcccCcCCccCChhc------------------------------------------
Q 003737 171 EGNLFTG-SIPPDIRKLINLQKLILSSNSFTGELPAEL------------------------------------------ 207 (799)
Q Consensus 171 s~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~------------------------------------------ 207 (799)
++|.+++ .+|..|+++++|++|++++|++++..|..+
T Consensus 132 ~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~ 211 (570)
T 2z63_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNF 211 (570)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCC
T ss_pred CCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEeccccc
Confidence 6666664 356666666666666666665543221111
Q ss_pred --------------------------------------------------------------------------------
Q 003737 208 -------------------------------------------------------------------------------- 207 (799)
Q Consensus 208 -------------------------------------------------------------------------------- 207 (799)
T Consensus 212 ~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~ 291 (570)
T 2z63_A 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291 (570)
T ss_dssp SCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEES
T ss_pred ccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecC
Confidence
Q ss_pred ----------------------------------------------------cCCCCCCEEEccCCcCCCcC--CccccC
Q 003737 208 ----------------------------------------------------TKLTNLNDLRISDNNFSGKI--PEFIGK 233 (799)
Q Consensus 208 ----------------------------------------------------~~l~~L~~L~Ls~N~l~~~~--p~~~~~ 233 (799)
..+++|++|++++|++++.. |..+..
T Consensus 292 ~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~ 371 (570)
T 2z63_A 292 VTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371 (570)
T ss_dssp CEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHHHHT
T ss_pred ccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCccccccccccc
Confidence 12334455555555554332 556677
Q ss_pred CCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCC-CccCC-CCccEEEccCCcCcccCCccccCCCCCCee
Q 003737 234 WKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAF-PKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNI 311 (799)
Q Consensus 234 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~-~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 311 (799)
+++|++|++++|.+++..+. +..+++|+.|++++|....... ..+.. ++|++|++++|.+++..|..+..+++|++|
T Consensus 372 ~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 450 (570)
T 2z63_A 372 TTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450 (570)
T ss_dssp CSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred cCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEE
Confidence 88999999999998865544 8899999999999865543322 23444 789999999999998888889999999999
Q ss_pred ccccccCC-CCCchhhhccCCCCEEeccCCcCCCcCChhhh--cCCCEEEeecCcCcccCCCCC
Q 003737 312 DLSFNNLT-GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESSDPI 372 (799)
Q Consensus 312 ~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~l~~l~ls~N~~~g~~p~~~ 372 (799)
++++|+++ +.+|..+..+++|+.|++++|++++..|..+. ..++.|++++|++++.+|..+
T Consensus 451 ~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 514 (570)
T 2z63_A 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIF 514 (570)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTT
T ss_pred ECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHh
Confidence 99999987 57888889999999999999999987777664 468899999999988776554
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.8e-28 Score=279.33 Aligned_cols=120 Identities=24% Similarity=0.292 Sum_probs=106.0
Q ss_pred cccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcC-cCCcccCCCCCCCEE
Q 003737 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSG-PFPKVLTNITTLKNL 168 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~-~~p~~~~~L~~L~~L 168 (799)
..++++|+|++|.+++..|..|..+++|++|+|++|.+++.+|..|+.++ |++|++++|.+++ ..|..++++++|++|
T Consensus 49 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 128 (549)
T 2z81_A 49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128 (549)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence 35799999999999998889999999999999999999999888899887 9999999999987 467889999999999
Q ss_pred EeeCCcCCCCCC-ccccCCCCCCEEEcccCcCCccCChhccCC
Q 003737 169 SIEGNLFTGSIP-PDIRKLINLQKLILSSNSFTGELPAELTKL 210 (799)
Q Consensus 169 ~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 210 (799)
++++|.+.+.+| ..|.++++|++|++++|.+++..|..+.++
T Consensus 129 ~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l 171 (549)
T 2z81_A 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSI 171 (549)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTC
T ss_pred ECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhcc
Confidence 999998555555 579999999999999999998888776554
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=261.92 Aligned_cols=245 Identities=20% Similarity=0.220 Sum_probs=148.8
Q ss_pred EEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcC--cCCcccCCCCCCCEEEeeC
Q 003737 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSG--PFPKVLTNITTLKNLSIEG 172 (799)
Q Consensus 96 ~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~--~~p~~~~~L~~L~~L~Ls~ 172 (799)
.+++++++++ .+|..+. ++|++|+|++|+++...+..|..++ |++|+|++|.++. ..|..+..+++|++|+|++
T Consensus 11 ~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~ 87 (306)
T 2z66_A 11 EIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87 (306)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred EEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence 4555556665 4555443 5788888888888766655666665 7777777777763 2355666677777777777
Q ss_pred CcCCCCCCccccCCCCCCEEEcccCcCCccCC-hhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCC-C
Q 003737 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELP-AELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG-P 250 (799)
Q Consensus 173 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~ 250 (799)
|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+.+..|..+..+++|++|++++|.+++ .
T Consensus 88 n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 166 (306)
T 2z66_A 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 166 (306)
T ss_dssp CSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGE
T ss_pred Cccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccccc
Confidence 7776 466667777777777777777775443 467777777777777777777777777777777777777777765 4
Q ss_pred CchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhcc
Q 003737 251 IPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL 329 (799)
Q Consensus 251 ~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 329 (799)
+|..+..+++|++|++++|.........+.. ++|+.|+|++|.+++..+..+..+++|+.|+|++|++++..|..+..+
T Consensus 167 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 246 (306)
T 2z66_A 167 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 246 (306)
T ss_dssp ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCC
T ss_pred chhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhh
Confidence 5556666655555555543322211111222 344444444444444444444444555555555555554444444444
Q ss_pred C-CCCEEeccCCcCCC
Q 003737 330 A-KTNFMYLTGNKLTG 344 (799)
Q Consensus 330 ~-~L~~L~L~~N~l~g 344 (799)
+ +|+.|+|++|++++
T Consensus 247 ~~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 247 PSSLAFLNLTQNDFAC 262 (306)
T ss_dssp CTTCCEEECTTCCEEC
T ss_pred hccCCEEEccCCCeec
Confidence 2 45555555555543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.4e-27 Score=260.30 Aligned_cols=249 Identities=18% Similarity=0.194 Sum_probs=212.4
Q ss_pred cCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCE
Q 003737 113 SKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191 (799)
Q Consensus 113 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 191 (799)
..++++++|++++|.++..++..+..++ |++|++++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|++
T Consensus 42 ~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 121 (390)
T 3o6n_A 42 ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 121 (390)
T ss_dssp GGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence 4568999999999999988777788887 999999999999888889999999999999999999888888999999999
Q ss_pred EEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCC
Q 003737 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG 271 (799)
Q Consensus 192 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~ 271 (799)
|++++|.++...+..|.++++|++|++++|.+++..|..|..+++|++|++++|.+++.. +..+++|+.|++++|..
T Consensus 122 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l 198 (390)
T 3o6n_A 122 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLL 198 (390)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCC
T ss_pred EECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeecccccc
Confidence 999999999544455799999999999999999888889999999999999999998753 45566777777666443
Q ss_pred CCCCCC-----------------ccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCE
Q 003737 272 SESAFP-----------------KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNF 334 (799)
Q Consensus 272 ~~~~~~-----------------~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 334 (799)
.....+ .....+|+.|++++|.+++. ..+..+++|++|+|++|++++..|..|..+++|+.
T Consensus 199 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 276 (390)
T 3o6n_A 199 STLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLER 276 (390)
T ss_dssp SEEECCSSCSEEECCSSCCCEEECCCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCE
T ss_pred cccCCCCcceEEECCCCeeeeccccccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCE
Confidence 321111 11114799999999999864 57899999999999999999999999999999999
Q ss_pred EeccCCcCCCcCChhh--hcCCCEEEeecCcCccc
Q 003737 335 MYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWE 367 (799)
Q Consensus 335 L~L~~N~l~g~~p~~~--~~~l~~l~ls~N~~~g~ 367 (799)
|+|++|++++ +|... .+.++.|++++|+++..
T Consensus 277 L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~~ 310 (390)
T 3o6n_A 277 LYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHV 310 (390)
T ss_dssp EECCSSCCCE-EECSSSCCTTCCEEECCSSCCCCC
T ss_pred EECCCCcCcc-cCcccCCCCCCCEEECCCCcceec
Confidence 9999999996 45443 45789999999999843
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-27 Score=267.23 Aligned_cols=242 Identities=14% Similarity=0.171 Sum_probs=180.9
Q ss_pred EEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCc
Q 003737 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL 174 (799)
Q Consensus 96 ~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~ 174 (799)
.+++++.+++ .+|..+. ++|++|+|++|++++..+..|..++ |++|+|++|++++..|..|.++++|++|+|++|+
T Consensus 58 ~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 58 KVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 4566666776 5666554 6888888888888887777777776 8888888888887777788888888888888888
Q ss_pred CCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCC-cCCCcCCccccCCCCCCEEEccCCCCCCCCch
Q 003737 175 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN-NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA 253 (799)
Q Consensus 175 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 253 (799)
+++..+..|..+++|++|+|++|+++...+..|.++++|++|++++| .+....+..|..+++|++|+|++|++++. |
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~- 212 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P- 212 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-
T ss_pred CCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-
Confidence 87665566777888888888888887666667777888888888774 34433344577777777777777776632 2
Q ss_pred hhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCC
Q 003737 254 SISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN 333 (799)
Q Consensus 254 ~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 333 (799)
.+..+ .+|+.|+|++|.+++..|..|..+++|+.|+|++|++++..|..|..+++|+
T Consensus 213 ~~~~l-----------------------~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 269 (452)
T 3zyi_A 213 NLTPL-----------------------VGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLV 269 (452)
T ss_dssp CCTTC-----------------------TTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred ccccc-----------------------ccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCC
Confidence 12222 4677777888888888888888899999999999999888888888899999
Q ss_pred EEeccCCcCCCcCChhh--hcCCCEEEeecCcCc
Q 003737 334 FMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFT 365 (799)
Q Consensus 334 ~L~L~~N~l~g~~p~~~--~~~l~~l~ls~N~~~ 365 (799)
.|+|++|++++..+..+ ...++.|+|++|.+.
T Consensus 270 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 270 ELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp EEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred EEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 99999999885444433 246788999998664
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-27 Score=275.34 Aligned_cols=252 Identities=18% Similarity=0.192 Sum_probs=216.5
Q ss_pred CCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEE
Q 003737 114 KLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKL 192 (799)
Q Consensus 114 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 192 (799)
.+.+++.|++++|.+...++..+..++ |++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 468999999999999988888888887 9999999999999999999999999999999999999888889999999999
Q ss_pred EcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCC
Q 003737 193 ILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 272 (799)
Q Consensus 193 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~ 272 (799)
+|++|.+++..+..|.++++|++|+|++|.+++..|..|+.+++|++|+|++|.+++.. +..+++|+.|++++|...
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~ 205 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLS 205 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCS
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccc
Confidence 99999999666666799999999999999999999999999999999999999999753 455667777777665433
Q ss_pred CCCCC-----------------ccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEE
Q 003737 273 ESAFP-----------------KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335 (799)
Q Consensus 273 ~~~~~-----------------~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 335 (799)
....| .....+|+.|+|++|.+++ +..+..+++|+.|+|++|.+++.+|..|..+++|+.|
T Consensus 206 ~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 283 (597)
T 3oja_B 206 TLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERL 283 (597)
T ss_dssp EEECCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEE
T ss_pred cccCCchhheeeccCCcccccccccCCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEE
Confidence 21111 1111479999999999986 4678999999999999999999999999999999999
Q ss_pred eccCCcCCCcCChhh--hcCCCEEEeecCcCcccCCCCC
Q 003737 336 YLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPI 372 (799)
Q Consensus 336 ~L~~N~l~g~~p~~~--~~~l~~l~ls~N~~~g~~p~~~ 372 (799)
+|++|++++ +|..+ .+.++.|+|++|.++. +|..+
T Consensus 284 ~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~-i~~~~ 320 (597)
T 3oja_B 284 YISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQ 320 (597)
T ss_dssp ECTTSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGH
T ss_pred ECCCCCCCC-CCcccccCCCCcEEECCCCCCCc-cCccc
Confidence 999999996 45544 4578999999999984 55443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-28 Score=263.86 Aligned_cols=255 Identities=19% Similarity=0.251 Sum_probs=222.1
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.++++|++++|++++..+..|.++++|++|+|++|++++..|..|..++ |++|++++|++++..+..|.++++|++|+|
T Consensus 52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 131 (353)
T 2z80_A 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL 131 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence 4799999999999987777999999999999999999999899999987 999999999999766666999999999999
Q ss_pred eCCcCCCCCC-ccccCCCCCCEEEcccC-cCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCC
Q 003737 171 EGNLFTGSIP-PDIRKLINLQKLILSSN-SFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (799)
Q Consensus 171 s~N~l~~~~p-~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 248 (799)
++|++++..+ ..|.++++|++|++++| .+++..+..|.++++|++|++++|++++..|..+..+++|++|++++|.++
T Consensus 132 ~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~ 211 (353)
T 2z80_A 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211 (353)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST
T ss_pred CCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc
Confidence 9999985433 37899999999999999 477666788999999999999999999999999999999999999999997
Q ss_pred CCCchhhhcCCCCCeEEcCCCCCCCCCCCccC---C-CCccEEEccCCcCcc----cCCccccCCCCCCeeccccccCCC
Q 003737 249 GPIPASISALTSLTDLRISDLKGSESAFPKLD---K-MNLKTLILTKCLIHG----EIPDYIGDMTKLKNIDLSFNNLTG 320 (799)
Q Consensus 249 ~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~---~-~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~ 320 (799)
...+..+..+++|+.|++++|......+..+. . ..++.++|+++.+++ .+|..+..+++|+.|+|++|+++.
T Consensus 212 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~ 291 (353)
T 2z80_A 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS 291 (353)
T ss_dssp THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCC
T ss_pred cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCc
Confidence 55445566799999999999776654433322 2 578899999999886 467889999999999999999995
Q ss_pred CCchh-hhccCCCCEEeccCCcCCCcCC
Q 003737 321 GIPTT-FEKLAKTNFMYLTGNKLTGPVP 347 (799)
Q Consensus 321 ~~p~~-~~~l~~L~~L~L~~N~l~g~~p 347 (799)
+|.. |..+++|+.|++++|++++..|
T Consensus 292 -i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 292 -VPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp -CCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred -cCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 5554 6999999999999999998776
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=252.02 Aligned_cols=251 Identities=18% Similarity=0.198 Sum_probs=200.4
Q ss_pred EEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCC
Q 003737 95 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN 173 (799)
Q Consensus 95 ~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N 173 (799)
+.+++++++++ .+|..+ .++|++|+|++|.+++..+..|..++ |++|++++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 67788888887 566544 47899999999999988877888876 889999988888888888888888999999888
Q ss_pred c-CCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCc
Q 003737 174 L-FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252 (799)
Q Consensus 174 ~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 252 (799)
. ++...|..|..+++|++|++++|.+++..|..+.++++|++|++++|++++..+..|+.+++|++|+|++|++++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 7 766667788888888888888888887778888888888888888888887767778888888888888888876555
Q ss_pred hhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCC
Q 003737 253 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT 332 (799)
Q Consensus 253 ~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 332 (799)
..+..+++ |+.|++++|.+++..|..+..+++|+.|++++|++++..+..+..+++|
T Consensus 171 ~~~~~l~~-----------------------L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 227 (285)
T 1ozn_A 171 RAFRGLHS-----------------------LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRAL 227 (285)
T ss_dssp TTTTTCTT-----------------------CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTC
T ss_pred HHhcCccc-----------------------cCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCccc
Confidence 55555544 5556666777777888899999999999999999998777889999999
Q ss_pred CEEeccCCcCCCcCCh-hhhcCCCEEEeecCcCcccCCCC
Q 003737 333 NFMYLTGNKLTGPVPK-YIFNSNKNVDISLNNFTWESSDP 371 (799)
Q Consensus 333 ~~L~L~~N~l~g~~p~-~~~~~l~~l~ls~N~~~g~~p~~ 371 (799)
+.|++++|+++...+. .+...++.++.+.|.+....|..
T Consensus 228 ~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p~~ 267 (285)
T 1ozn_A 228 QYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQR 267 (285)
T ss_dssp CEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGG
T ss_pred CEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCchH
Confidence 9999999999875553 23344455556677776666654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.8e-27 Score=274.73 Aligned_cols=155 Identities=21% Similarity=0.252 Sum_probs=137.8
Q ss_pred EEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCc
Q 003737 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL 174 (799)
Q Consensus 96 ~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~ 174 (799)
+.+.++.+++ .+|..+. +++++|||++|+|++..+..|..++ |++|+|++|+|++..|.+|.+|++|++|+|++|+
T Consensus 35 ~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~ 111 (635)
T 4g8a_A 35 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 111 (635)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCc
Confidence 3466777787 6776653 5899999999999999999999998 9999999999999889999999999999999999
Q ss_pred CCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCC-cCCccccCCCCCCEEEccCCCCCCCCch
Q 003737 175 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG-KIPEFIGKWKKIQKLHIQGSSLEGPIPA 253 (799)
Q Consensus 175 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 253 (799)
+++..+..|.++++|++|+|++|++++..+..|+++++|++|++++|.+++ .+|..++.+++|++|+|++|++++..+.
T Consensus 112 l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 191 (635)
T 4g8a_A 112 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 191 (635)
T ss_dssp CCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred CCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccc
Confidence 997777789999999999999999998777789999999999999999976 4688899999999999999988764443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.8e-27 Score=263.37 Aligned_cols=253 Identities=17% Similarity=0.186 Sum_probs=193.5
Q ss_pred EEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCC
Q 003737 95 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN 173 (799)
Q Consensus 95 ~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N 173 (799)
..+++.+.+++ .+|..+. ++++.|+|++|++++..+..|..++ |++|+|++|.+++..+..|.++++|++|+|++|
T Consensus 46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 45677777777 6776665 6889999999999888888888887 888888888888777788888888888888888
Q ss_pred cCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCc-CCCcCCccccCCCCCCEEEccCCCCCCCCc
Q 003737 174 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN-FSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252 (799)
Q Consensus 174 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 252 (799)
+++...+..|..+++|++|+|++|.++...+..|.++++|++|++++|+ +....+..|.++++|++|+|++|+++. +|
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~ 201 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP 201 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc
Confidence 8886666678888888888888888886666678888888888888844 443344467778888888888887763 22
Q ss_pred hhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCC
Q 003737 253 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT 332 (799)
Q Consensus 253 ~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 332 (799)
. +..+ .+|+.|+|++|.+++..|..|..+++|+.|+|++|++++..+..|..+++|
T Consensus 202 ~-~~~l-----------------------~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 257 (440)
T 3zyj_A 202 N-LTPL-----------------------IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSL 257 (440)
T ss_dssp C-CTTC-----------------------SSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTC
T ss_pred c-cCCC-----------------------cccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCC
Confidence 1 2222 457777788888888888888888899999999999888888888888899
Q ss_pred CEEeccCCcCCCcCChhh--hcCCCEEEeecCcCcccCCCCCcCCCCCcccee
Q 003737 333 NFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRGSVNLVE 383 (799)
Q Consensus 333 ~~L~L~~N~l~g~~p~~~--~~~l~~l~ls~N~~~g~~p~~~~~~~~~~~~~~ 383 (799)
+.|+|++|++++..+..+ ...++.|+|++|.+. |++....+..
T Consensus 258 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~--------CdC~l~~l~~ 302 (440)
T 3zyj_A 258 VEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN--------CNCDILWLSW 302 (440)
T ss_dssp CEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE--------CSSTTHHHHH
T ss_pred CEEECCCCCCCccChhHhccccCCCEEEcCCCCcc--------CCCCchHHHH
Confidence 999999998885444433 246788899988764 7765444333
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.4e-27 Score=252.02 Aligned_cols=224 Identities=22% Similarity=0.303 Sum_probs=184.7
Q ss_pred CCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEE
Q 003737 114 KLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKL 192 (799)
Q Consensus 114 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 192 (799)
..++++.|+|++|.++ .+|..+..++ |++|+|++|.++ .+|..++++++|++|+|++|.++ .+|..++++++|++|
T Consensus 79 ~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L 155 (328)
T 4fcg_A 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155 (328)
T ss_dssp TSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEE
T ss_pred cccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEE
Confidence 3578899999999998 5566666676 888888888888 78888888888888888888888 778888888888888
Q ss_pred EcccCcCCccCChhccC---------CCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCe
Q 003737 193 ILSSNSFTGELPAELTK---------LTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTD 263 (799)
Q Consensus 193 ~Ls~N~l~~~~p~~~~~---------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 263 (799)
++++|++.+.+|..+.. +++|++|++++|+++ .+|..++.+++|++|+|++|.+++ +|..+..+++
T Consensus 156 ~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~--- 230 (328)
T 4fcg_A 156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPK--- 230 (328)
T ss_dssp EEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTT---
T ss_pred ECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCC---
Confidence 88888888888877654 778888888888777 677777778888888888887774 4445665555
Q ss_pred EEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCC
Q 003737 264 LRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343 (799)
Q Consensus 264 L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 343 (799)
|+.|+|++|.+.+.+|..+..+++|++|+|++|++.+.+|..+..+++|+.|+|++|++.
T Consensus 231 --------------------L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~ 290 (328)
T 4fcg_A 231 --------------------LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290 (328)
T ss_dssp --------------------CCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTC
T ss_pred --------------------CCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCch
Confidence 455566667777888999999999999999999999999999999999999999999999
Q ss_pred CcCChhhhc--CCCEEEeecCcCc
Q 003737 344 GPVPKYIFN--SNKNVDISLNNFT 365 (799)
Q Consensus 344 g~~p~~~~~--~l~~l~ls~N~~~ 365 (799)
+.+|..+.. .++.+++..|.+.
T Consensus 291 ~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 291 SRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCCCGGGGGSCTTCEEECCGGGSC
T ss_pred hhccHHHhhccCceEEeCCHHHHH
Confidence 999998864 6788888877654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=265.39 Aligned_cols=241 Identities=20% Similarity=0.267 Sum_probs=119.7
Q ss_pred cEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCC-CcCccccc-------ccc-eeEEEccCCcCcCcCCccc--CC
Q 003737 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT-GSFSPQWA-------SLQ-LVELSVMGNRLSGPFPKVL--TN 161 (799)
Q Consensus 93 ~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~-------~l~-L~~L~Ls~N~l~~~~p~~~--~~ 161 (799)
+++.+++++|.+ .+|..+... |++|+|++|.++ ..+|..+. .++ |++|+|++|++++.+|..+ ..
T Consensus 44 ~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~ 119 (312)
T 1wwl_A 44 SLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEAT 119 (312)
T ss_dssp ECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCC
T ss_pred CceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhc
Confidence 344455555555 445444433 555555555552 23333332 233 5555555555555555544 55
Q ss_pred CCCCCEEEeeCCcCCCCCCccccCC-----CCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCc--CCccc--c
Q 003737 162 ITTLKNLSIEGNLFTGSIPPDIRKL-----INLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK--IPEFI--G 232 (799)
Q Consensus 162 L~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~--~ 232 (799)
+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..|.++++|++|++++|++.+. .|..+ +
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 55555555555555544 4444444 5555555555555555555555555555555555555443 22222 4
Q ss_pred CCCCCCEEEccCCCCCC--CCc-hhhhcCCCCCeEEcCCCCCCCCC-CCccCC-CCccEEEccCCcCcccCCccccCCCC
Q 003737 233 KWKKIQKLHIQGSSLEG--PIP-ASISALTSLTDLRISDLKGSESA-FPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTK 307 (799)
Q Consensus 233 ~l~~L~~L~L~~N~l~~--~~p-~~~~~l~~L~~L~L~~n~~~~~~-~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~ 307 (799)
.+++|++|+|++|++++ .++ ..+.++++|++|++++|...... .+.+.. .+|+.|+|++|+++ .+|..+. ++
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~ 275 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AK 275 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SE
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CC
Confidence 55555555555555552 111 22334455555555554333222 122222 45555555555555 4444443 45
Q ss_pred CCeeccccccCCCCCchhhhccCCCCEEeccCCcCC
Q 003737 308 LKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343 (799)
Q Consensus 308 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 343 (799)
|++|||++|+|++. |. +..+++|++|++++|+++
T Consensus 276 L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 276 LSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp EEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred ceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 55555555555543 33 455555555555555554
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-26 Score=250.05 Aligned_cols=259 Identities=21% Similarity=0.292 Sum_probs=216.1
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.++++|++++|.+++. +. +..+++|++|++++|.++.. + .+..++ |++|++++|.+++..+ +..+++|++|++
T Consensus 66 ~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~~-~-~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l 139 (347)
T 4fmz_A 66 TNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITDI-S-ALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNL 139 (347)
T ss_dssp TTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEEC
T ss_pred CCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccCc-h-HHcCCCcCCEEECcCCcccCchh--hccCCceeEEEC
Confidence 5799999999999854 44 99999999999999999874 3 577776 9999999999986543 889999999999
Q ss_pred eCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCC
Q 003737 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP 250 (799)
Q Consensus 171 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 250 (799)
++|.....+ ..+..+++|++|++++|.+.+..+ +..+++|++|++++|.+.+..+ +..+++|+.|++++|.+++.
T Consensus 140 ~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 214 (347)
T 4fmz_A 140 GANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI 214 (347)
T ss_dssp TTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred CCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCC
Confidence 999766444 448999999999999999985443 8899999999999999985433 88899999999999999865
Q ss_pred CchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhcc
Q 003737 251 IPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL 329 (799)
Q Consensus 251 ~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 329 (799)
.+ +..+++|+.|++++|..... +.+.. ++|+.|++++|.+++. ..+..+++|++|++++|++++. ..+..+
T Consensus 215 ~~--~~~~~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l 286 (347)
T 4fmz_A 215 TP--VANMTRLNSLKIGNNKITDL--SPLANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNL 286 (347)
T ss_dssp GG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGC
T ss_pred ch--hhcCCcCCEEEccCCccCCC--cchhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCC
Confidence 54 88899999999998665432 22555 7899999999999864 4688899999999999999864 458899
Q ss_pred CCCCEEeccCCcCCCcCChhhh--cCCCEEEeecCcCcccCC
Q 003737 330 AKTNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESS 369 (799)
Q Consensus 330 ~~L~~L~L~~N~l~g~~p~~~~--~~l~~l~ls~N~~~g~~p 369 (799)
++|+.|++++|++++..|..+. ..++.|++++|.+++..|
T Consensus 287 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp TTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred CCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence 9999999999999987777664 478899999999988766
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=254.64 Aligned_cols=258 Identities=17% Similarity=0.166 Sum_probs=215.3
Q ss_pred cccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCc--Ccccccccc-eeEEEccCCcCcCcCCcccCCCCCCCE
Q 003737 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGS--FSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKN 167 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~ 167 (799)
..+++.|+|++++++...+..|.++++|++|+|++|.++.. .+..+..+. |++|++++|.++ .+|..+..+++|++
T Consensus 27 ~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~ 105 (306)
T 2z66_A 27 PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEH 105 (306)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCE
T ss_pred CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCE
Confidence 35799999999999954445689999999999999999844 355555565 999999999998 57778999999999
Q ss_pred EEeeCCcCCCCCC-ccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCC-cCCccccCCCCCCEEEccCC
Q 003737 168 LSIEGNLFTGSIP-PDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG-KIPEFIGKWKKIQKLHIQGS 245 (799)
Q Consensus 168 L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N 245 (799)
|++++|.+++..+ ..+..+++|++|++++|.+++..|..+..+++|++|++++|.+++ .+|..+..+++|++|+|++|
T Consensus 106 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n 185 (306)
T 2z66_A 106 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185 (306)
T ss_dssp EECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred EECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCC
Confidence 9999999986655 579999999999999999999899999999999999999999987 68999999999999999999
Q ss_pred CCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCC-CCCeeccccccCCCCCc
Q 003737 246 SLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMT-KLKNIDLSFNNLTGGIP 323 (799)
Q Consensus 246 ~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p 323 (799)
.+++..|..+..+++|+.|++++|.........+.. .+|+.|+|++|.+++..|..+..++ +|++|+|++|.+++.-+
T Consensus 186 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 186 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred CcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 999988999999999999999997765543334555 8999999999999999999999985 99999999999987533
Q ss_pred h--hhhccCCCCEEeccCCcCCCcCChh
Q 003737 324 T--TFEKLAKTNFMYLTGNKLTGPVPKY 349 (799)
Q Consensus 324 ~--~~~~l~~L~~L~L~~N~l~g~~p~~ 349 (799)
. -...+...+.+.+..+.+....|..
T Consensus 266 ~~~~~~~l~~~~~~~~~~~~~~C~~p~~ 293 (306)
T 2z66_A 266 HQSFLQWIKDQRQLLVEVERMECATPSD 293 (306)
T ss_dssp GHHHHHHHHHTGGGBSCGGGCBEEESGG
T ss_pred hHHHHHHHHhhhhhhccccccccCCchh
Confidence 1 1222333444445555555555544
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-26 Score=259.59 Aligned_cols=254 Identities=20% Similarity=0.162 Sum_probs=212.1
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.+++.|+++++.+++. | .+..+++|++|+|++|++++. | ++.++ |++|++++|++++. | ++++++|++|++
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNC 113 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEEC
Confidence 5799999999999974 5 799999999999999999986 3 77776 99999999999975 4 899999999999
Q ss_pred eCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCC
Q 003737 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP 250 (799)
Q Consensus 171 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 250 (799)
++|++++ +| ++.+++|++|++++|++++ ++ +..+++|++|++++|+..+.+ .++.+++|++|++++|++++
T Consensus 114 ~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~- 184 (457)
T 3bz5_A 114 DTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE- 184 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-
T ss_pred CCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-
Confidence 9999986 44 8999999999999999997 43 889999999999999766666 48899999999999999997
Q ss_pred CchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhcc
Q 003737 251 IPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL 329 (799)
Q Consensus 251 ~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 329 (799)
+| +..+++|+.|++++|+..... +.. ++|+.|++++|++++ +| +..+++|+.|++++|++++..+..+.++
T Consensus 185 l~--l~~l~~L~~L~l~~N~l~~~~---l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L 256 (457)
T 3bz5_A 185 LD--VSQNKLLNRLNCDTNNITKLD---LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKL 256 (457)
T ss_dssp CC--CTTCTTCCEEECCSSCCSCCC---CTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTC
T ss_pred ec--cccCCCCCEEECcCCcCCeec---cccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCC
Confidence 44 888999999999997665542 444 789999999999997 56 8899999999999999998765555544
Q ss_pred C-------CCCEEeccCCcCCCcCChhhhcCCCEEEeecCcCcccCCC
Q 003737 330 A-------KTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSD 370 (799)
Q Consensus 330 ~-------~L~~L~L~~N~l~g~~p~~~~~~l~~l~ls~N~~~g~~p~ 370 (799)
. +|+.|++++|++.|.+|..-...++.||+++|.+.+.+|.
T Consensus 257 ~~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~n~~l~~l~~ 304 (457)
T 3bz5_A 257 TTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDC 304 (457)
T ss_dssp CEEECTTCCCSCCCCTTCTTCCEEECTTCTTCCCCCCTTCTTCCEEEC
T ss_pred CEEeccCCCCCEEECCCCccCCcccccccccCCEEECCCCcccceecc
Confidence 4 4566666667766767655556778888888887777663
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.94 E-value=5.3e-26 Score=257.49 Aligned_cols=227 Identities=17% Similarity=0.177 Sum_probs=172.3
Q ss_pred CEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCc
Q 003737 119 KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS 198 (799)
Q Consensus 119 ~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 198 (799)
..++.+++.++.. |..+. ..+++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus 57 ~~v~c~~~~l~~i-P~~~~-~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 57 SKVVCTRRGLSEV-PQGIP-SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp CEEECCSSCCSSC-CSCCC-TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred cEEEECCCCcCcc-CCCCC-CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 4577777777754 33222 237888888888888778888888888888888888887777778888888888888888
Q ss_pred CCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCC-CCCCCchhhhcCCCCCeEEcCCCCCCCCCCC
Q 003737 199 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSS-LEGPIPASISALTSLTDLRISDLKGSESAFP 277 (799)
Q Consensus 199 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~ 277 (799)
+++..+..|..+++|++|+|++|+++...+..|.++++|++|+|++|+ +....+..|.++++
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~----------------- 197 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFN----------------- 197 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTT-----------------
T ss_pred CCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCC-----------------
Confidence 886666667778888888888888876666677777788888877743 33222233444444
Q ss_pred ccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhh--cCCC
Q 003737 278 KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF--NSNK 355 (799)
Q Consensus 278 ~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~l~ 355 (799)
|+.|+|++|++++. | .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..+. ..++
T Consensus 198 ------L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 269 (452)
T 3zyi_A 198 ------LKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLV 269 (452)
T ss_dssp ------CCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred ------CCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCC
Confidence 55556666666643 3 478899999999999999999999999999999999999999987777664 5789
Q ss_pred EEEeecCcCcccCCCCC
Q 003737 356 NVDISLNNFTWESSDPI 372 (799)
Q Consensus 356 ~l~ls~N~~~g~~p~~~ 372 (799)
.|||++|++++..+..+
T Consensus 270 ~L~L~~N~l~~~~~~~~ 286 (452)
T 3zyi_A 270 ELNLAHNNLSSLPHDLF 286 (452)
T ss_dssp EEECCSSCCSCCCTTSS
T ss_pred EEECCCCcCCccChHHh
Confidence 99999999997665443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-25 Score=244.53 Aligned_cols=261 Identities=18% Similarity=0.297 Sum_probs=219.9
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.+++.|+++++.++. ++ .+..+++|++|++++|.+++..+ +..++ |++|++++|.++.. +.+.++++|++|++
T Consensus 44 ~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~l 117 (347)
T 4fmz_A 44 ESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYL 117 (347)
T ss_dssp TTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEEC
T ss_pred ccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEEC
Confidence 578999999999984 44 48999999999999999997655 77777 99999999999863 46999999999999
Q ss_pred eCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCC
Q 003737 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP 250 (799)
Q Consensus 171 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 250 (799)
++|.+++. +. +..+++|++|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|++|++++|.+++.
T Consensus 118 ~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~ 192 (347)
T 4fmz_A 118 NEDNISDI-SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI 192 (347)
T ss_dssp TTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCC
T ss_pred cCCcccCc-hh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccc
Confidence 99999854 44 8999999999999997665554 49999999999999999986544 88999999999999999865
Q ss_pred CchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhcc
Q 003737 251 IPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL 329 (799)
Q Consensus 251 ~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 329 (799)
.+ +..+++|+.|++++|...... .+.. .+|+.|++++|.+++..+ +..+++|++|++++|++++. ..+..+
T Consensus 193 ~~--~~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l 264 (347)
T 4fmz_A 193 SP--LASLTSLHYFTAYVNQITDIT--PVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDL 264 (347)
T ss_dssp GG--GGGCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTC
T ss_pred cc--ccCCCccceeecccCCCCCCc--hhhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcC
Confidence 44 889999999999996554322 2444 789999999999986544 88999999999999999964 468999
Q ss_pred CCCCEEeccCCcCCCcCCh-hhhcCCCEEEeecCcCcccCCCCC
Q 003737 330 AKTNFMYLTGNKLTGPVPK-YIFNSNKNVDISLNNFTWESSDPI 372 (799)
Q Consensus 330 ~~L~~L~L~~N~l~g~~p~-~~~~~l~~l~ls~N~~~g~~p~~~ 372 (799)
++|+.|++++|++++. |. .-...++.|++++|.+++..|..+
T Consensus 265 ~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l 307 (347)
T 4fmz_A 265 TKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVI 307 (347)
T ss_dssp TTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHH
T ss_pred CCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHh
Confidence 9999999999999964 43 224678999999999998776554
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-26 Score=256.34 Aligned_cols=227 Identities=19% Similarity=0.209 Sum_probs=170.0
Q ss_pred CEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCc
Q 003737 119 KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS 198 (799)
Q Consensus 119 ~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 198 (799)
+.++.+++.++..+ ..+. -.+++|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|+
T Consensus 46 ~~v~c~~~~l~~iP-~~~~-~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 46 SKVICVRKNLREVP-DGIS-TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp CEEECCSCCCSSCC-SCCC-TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred CEEEeCCCCcCcCC-CCCC-CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 46788888877543 3222 237778888888887777778888888888888888876666777788888888888888
Q ss_pred CCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCC-chhhhcCCCCCeEEcCCCCCCCCCCC
Q 003737 199 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI-PASISALTSLTDLRISDLKGSESAFP 277 (799)
Q Consensus 199 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~n~~~~~~~~ 277 (799)
++...+..|..+++|++|+|++|+++...+..|..+++|++|+|++|+..+.+ +..|.++++
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~----------------- 186 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSN----------------- 186 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSS-----------------
T ss_pred CCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccc-----------------
Confidence 77655566777788888888888777666667777777777777774433222 334444444
Q ss_pred ccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhh--cCCC
Q 003737 278 KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF--NSNK 355 (799)
Q Consensus 278 ~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~l~ 355 (799)
|+.|+|++|+++ .+| .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..+. ..++
T Consensus 187 ------L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 258 (440)
T 3zyj_A 187 ------LRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLV 258 (440)
T ss_dssp ------CCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCC
T ss_pred ------cCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCC
Confidence 555555566665 344 478899999999999999999999999999999999999999987776654 5789
Q ss_pred EEEeecCcCcccCCCCC
Q 003737 356 NVDISLNNFTWESSDPI 372 (799)
Q Consensus 356 ~l~ls~N~~~g~~p~~~ 372 (799)
.|||++|++++..+..+
T Consensus 259 ~L~L~~N~l~~~~~~~~ 275 (440)
T 3zyj_A 259 EINLAHNNLTLLPHDLF 275 (440)
T ss_dssp EEECTTSCCCCCCTTTT
T ss_pred EEECCCCCCCccChhHh
Confidence 99999999997665544
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-28 Score=263.12 Aligned_cols=246 Identities=20% Similarity=0.222 Sum_probs=207.4
Q ss_pred ccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcC-cCcCCcccC-------CCCCCCEEEeeCCcCCCCCCccc
Q 003737 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRL-SGPFPKVLT-------NITTLKNLSIEGNLFTGSIPPDI 183 (799)
Q Consensus 112 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l-~~~~p~~~~-------~L~~L~~L~Ls~N~l~~~~p~~~ 183 (799)
++..++|++|++++|.+ .+|..+... |++|+|++|.+ .+.+|..+. ++++|++|+|++|.+++.+|..+
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~-L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI-IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH-HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH-HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 55677899999999999 566655443 89999999999 456777766 79999999999999999999986
Q ss_pred --cCCCCCCEEEcccCcCCccCChhccCC-----CCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCC--Cchh
Q 003737 184 --RKLINLQKLILSSNSFTGELPAELTKL-----TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP--IPAS 254 (799)
Q Consensus 184 --~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~ 254 (799)
..+++|++|+|++|++++. |..+..+ ++|++|++++|++++..|..|+.+++|++|+|++|++.+. .|..
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 194 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence 8999999999999999977 8888877 9999999999999998889999999999999999998875 3445
Q ss_pred h--hcCCCCCeEEcCCCCCCCC-CCCc--cCC-CCccEEEccCCcCcccCC-ccccCCCCCCeeccccccCCCCCchhhh
Q 003737 255 I--SALTSLTDLRISDLKGSES-AFPK--LDK-MNLKTLILTKCLIHGEIP-DYIGDMTKLKNIDLSFNNLTGGIPTTFE 327 (799)
Q Consensus 255 ~--~~l~~L~~L~L~~n~~~~~-~~~~--l~~-~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 327 (799)
+ ..+++|++|++++|.+... .++. +.. .+|+.|+|++|++++.+| ..+..+++|++|+|++|+|+ .+|..+.
T Consensus 195 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~ 273 (312)
T 1wwl_A 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP 273 (312)
T ss_dssp SCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC
T ss_pred HHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc
Confidence 5 8899999999999765421 1221 223 689999999999998775 45677899999999999999 7787776
Q ss_pred ccCCCCEEeccCCcCCCcCChhh--hcCCCEEEeecCcCcc
Q 003737 328 KLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTW 366 (799)
Q Consensus 328 ~l~~L~~L~L~~N~l~g~~p~~~--~~~l~~l~ls~N~~~g 366 (799)
++|+.|+|++|++++. |. + ...++.|++++|.+++
T Consensus 274 --~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 274 --AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp --SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred --CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 8999999999999976 65 3 3457899999999875
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-25 Score=253.75 Aligned_cols=257 Identities=25% Similarity=0.351 Sum_probs=200.9
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.++++|+|++|.+++..+ +..+++|++|++++|.+.+..+ +..++ |++|++++|.+++..+ +.++++|++|++
T Consensus 68 ~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l 141 (466)
T 1o6v_A 68 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLEL 141 (466)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEE
T ss_pred cCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEEC
Confidence 578889999998886544 8888999999999998887765 77776 9999999998886543 888899999999
Q ss_pred eCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCC
Q 003737 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP 250 (799)
Q Consensus 171 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 250 (799)
++|.+++ ++ .+..+++|++|+++ |.+.+. + .+.++++|++|++++|.+++. ..+..+++|++|++++|.+++.
T Consensus 142 ~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~-~-~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~ 214 (466)
T 1o6v_A 142 SSNTISD-IS-ALSGLTSLQQLSFG-NQVTDL-K-PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDI 214 (466)
T ss_dssp EEEEECC-CG-GGTTCTTCSEEEEE-ESCCCC-G-GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC
T ss_pred CCCccCC-Ch-hhccCCcccEeecC-CcccCc-h-hhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccc
Confidence 9998875 33 47788888888886 445433 2 388888999999999988753 3478888999999999988876
Q ss_pred CchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhcc
Q 003737 251 IPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL 329 (799)
Q Consensus 251 ~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 329 (799)
.| +..+++|+.|++++|.... ++.+.. ++|+.|++++|.+++..| +..+++|+.|++++|++++..+ +..+
T Consensus 215 ~~--~~~l~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l 286 (466)
T 1o6v_A 215 TP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGL 286 (466)
T ss_dssp GG--GGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTC
T ss_pred cc--ccccCCCCEEECCCCCccc--chhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCC
Confidence 55 7778889999998865543 344555 788888998888886655 7788888888888888886544 7888
Q ss_pred CCCCEEeccCCcCCCcCChhhhcCCCEEEeecCcCcccCC
Q 003737 330 AKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESS 369 (799)
Q Consensus 330 ~~L~~L~L~~N~l~g~~p~~~~~~l~~l~ls~N~~~g~~p 369 (799)
++|+.|++++|++++..|-.-...++.|++++|++++..|
T Consensus 287 ~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~ 326 (466)
T 1o6v_A 287 TALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP 326 (466)
T ss_dssp TTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG
T ss_pred CccCeEEcCCCcccCchhhcCCCCCCEEECcCCcCCCchh
Confidence 8888888888888876554445678888888888887665
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-25 Score=253.45 Aligned_cols=257 Identities=25% Similarity=0.354 Sum_probs=218.4
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.+++.|++.++.++. +| .+..+++|++|+|++|.+++..+ +..++ |++|++++|.+++..| ++++++|++|++
T Consensus 46 ~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L 119 (466)
T 1o6v_A 46 DQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119 (466)
T ss_dssp HTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred ccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEEC
Confidence 578999999999884 55 48899999999999999998766 77777 9999999999997655 999999999999
Q ss_pred eCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCC
Q 003737 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP 250 (799)
Q Consensus 171 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 250 (799)
++|.+++. +. +.++++|++|++++|.+++ ++ .+..+++|++|+++ |.+.+.. .+.++++|++|++++|.+++.
T Consensus 120 ~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~ 192 (466)
T 1o6v_A 120 FNNQITDI-DP-LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSDI 192 (466)
T ss_dssp CSSCCCCC-GG-GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCCC
T ss_pred CCCCCCCC-hH-HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCCC
Confidence 99999864 33 9999999999999999985 44 48999999999997 5565433 389999999999999999864
Q ss_pred CchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhcc
Q 003737 251 IPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL 329 (799)
Q Consensus 251 ~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 329 (799)
..+..+++|++|++++|.... ..+ +.. .+|+.|++++|.+++. ..+..+++|+.|++++|++++..| +..+
T Consensus 193 --~~l~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l 264 (466)
T 1o6v_A 193 --SVLAKLTNLESLIATNNQISD-ITP-LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGL 264 (466)
T ss_dssp --GGGGGCTTCSEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTC
T ss_pred --hhhccCCCCCEEEecCCcccc-ccc-ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcC
Confidence 358899999999999965543 223 444 7899999999999864 468889999999999999997665 8999
Q ss_pred CCCCEEeccCCcCCCcCChhhhcCCCEEEeecCcCcccCC
Q 003737 330 AKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESS 369 (799)
Q Consensus 330 ~~L~~L~L~~N~l~g~~p~~~~~~l~~l~ls~N~~~g~~p 369 (799)
++|+.|++++|++++..|-.-...++.|++++|.+++..|
T Consensus 265 ~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~ 304 (466)
T 1o6v_A 265 TKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP 304 (466)
T ss_dssp TTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGG
T ss_pred CCCCEEECCCCccCccccccCCCccCeEEcCCCcccCchh
Confidence 9999999999999976553335678999999999998655
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.5e-26 Score=240.91 Aligned_cols=236 Identities=17% Similarity=0.172 Sum_probs=194.6
Q ss_pred cccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCc-CcCcCCcccCCCCCCCEE
Q 003737 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNR-LSGPFPKVLTNITTLKNL 168 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~-l~~~~p~~~~~L~~L~~L 168 (799)
..+++.|+++++.+++..+..|..+++|++|+|++|.+++..|..|..++ |++|++++|. ++...|..|..+++|++|
T Consensus 31 ~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 45799999999999988888899999999999999999999899999887 9999999997 887779999999999999
Q ss_pred EeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCC
Q 003737 169 SIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (799)
Q Consensus 169 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 248 (799)
++++|.+++..|..|.++++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|.++
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 190 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccc
Confidence 99999999888889999999999999999999777777999999999999999999777778999999999999999999
Q ss_pred CCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhc
Q 003737 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328 (799)
Q Consensus 249 ~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 328 (799)
+..|..+..+++|+.|++++ |.+++..+..+..+++|+.|++++|.+....+.. ..
T Consensus 191 ~~~~~~~~~l~~L~~L~l~~-----------------------n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~ 246 (285)
T 1ozn_A 191 HVHPHAFRDLGRLMTLYLFA-----------------------NNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PL 246 (285)
T ss_dssp EECTTTTTTCTTCCEEECCS-----------------------SCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HH
T ss_pred ccCHhHccCcccccEeeCCC-----------------------CcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HH
Confidence 88888888777766665554 5555444455666777777777777776433321 11
Q ss_pred cCCCCEEeccCCcCCCcCChhh
Q 003737 329 LAKTNFMYLTGNKLTGPVPKYI 350 (799)
Q Consensus 329 l~~L~~L~L~~N~l~g~~p~~~ 350 (799)
...++.+..+.+.+....|..+
T Consensus 247 ~~~l~~~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 247 WAWLQKFRGSSSEVPCSLPQRL 268 (285)
T ss_dssp HHHHHHCCSEECCCBEEESGGG
T ss_pred HHHHHhcccccCccccCCchHh
Confidence 1223334456666666666554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.2e-25 Score=247.95 Aligned_cols=251 Identities=19% Similarity=0.111 Sum_probs=208.8
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.+++.|+|++|++++. | ++.+++|++|+|++|.+++. + ++.++ |++|++++|++++. | ++.+++|++|++
T Consensus 64 ~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l 134 (457)
T 3bz5_A 64 TGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNC 134 (457)
T ss_dssp TTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEEC
Confidence 5799999999999974 4 89999999999999999986 3 77776 99999999999974 4 899999999999
Q ss_pred eCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCC
Q 003737 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP 250 (799)
Q Consensus 171 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 250 (799)
++|++++. + ++.+++|++|++++|+..+.+ .+..+++|++|++++|++++ +| ++.+++|++|++++|++++.
T Consensus 135 ~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~ 206 (457)
T 3bz5_A 135 ARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL 206 (457)
T ss_dssp TTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee
Confidence 99999874 3 889999999999999766666 47889999999999999986 45 88899999999999999875
Q ss_pred CchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCC-------CCCeeccccccCCCCC
Q 003737 251 IPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMT-------KLKNIDLSFNNLTGGI 322 (799)
Q Consensus 251 ~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~-------~L~~L~Ls~N~l~~~~ 322 (799)
.+..+++|+.|++++|.... +| +.. ++|+.|++++|++++..+..+.+++ +|+.|++++|.+.+.+
T Consensus 207 ---~l~~l~~L~~L~Ls~N~l~~--ip-~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~ 280 (457)
T 3bz5_A 207 ---DLNQNIQLTFLDCSSNKLTE--ID-VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYF 280 (457)
T ss_dssp ---CCTTCTTCSEEECCSSCCSC--CC-CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEE
T ss_pred ---ccccCCCCCEEECcCCcccc--cC-ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCcc
Confidence 38889999999999976655 45 444 7899999999999987666666555 6678888888888777
Q ss_pred chhhhccCCCCEEeccCCcCCCcCChhh----------hcCCCEEEeecCcCccc
Q 003737 323 PTTFEKLAKTNFMYLTGNKLTGPVPKYI----------FNSNKNVDISLNNFTWE 367 (799)
Q Consensus 323 p~~~~~l~~L~~L~L~~N~l~g~~p~~~----------~~~l~~l~ls~N~~~g~ 367 (799)
| ++.+++|+.|++++|.+.+.+|... ...++.|++++|++++.
T Consensus 281 ~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l 333 (457)
T 3bz5_A 281 Q--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL 333 (457)
T ss_dssp E--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC
T ss_pred c--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc
Confidence 7 5678899999999998888776432 13567899999999884
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-27 Score=253.71 Aligned_cols=264 Identities=17% Similarity=0.137 Sum_probs=214.3
Q ss_pred cEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEee
Q 003737 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (799)
Q Consensus 93 ~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls 171 (799)
+....+++.+++...+...+..+++|++|+|++|.+++..|..|..++ |++|+|++|.+++..| +..+++|++|+|+
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 466667888888766666677788999999999999999888999887 9999999999987665 8999999999999
Q ss_pred CCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCC
Q 003737 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251 (799)
Q Consensus 172 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 251 (799)
+|.+++. ...++|++|++++|++++..+. .+++|++|++++|++++..+..++.+++|++|+|++|.+++..
T Consensus 89 ~n~l~~l-----~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 160 (317)
T 3o53_A 89 NNYVQEL-----LVGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160 (317)
T ss_dssp SSEEEEE-----EECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEE
T ss_pred CCccccc-----cCCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCccc
Confidence 9998742 2448999999999999865544 3678999999999999888889999999999999999999877
Q ss_pred chhh-hcCCCCCeEEcCCCCCCCCCCCccC-CCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhcc
Q 003737 252 PASI-SALTSLTDLRISDLKGSESAFPKLD-KMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL 329 (799)
Q Consensus 252 p~~~-~~l~~L~~L~L~~n~~~~~~~~~l~-~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 329 (799)
+..+ ..+++|++|++++|.+... +... ..+|+.|+|++|++++. |..+..+++|+.|+|++|+++ .+|..+..+
T Consensus 161 ~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l 236 (317)
T 3o53_A 161 FAELAASSDTLEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFS 236 (317)
T ss_dssp GGGGGGGTTTCCEEECTTSCCCEE--ECCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCC
T ss_pred HHHHhhccCcCCEEECCCCcCccc--ccccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcC
Confidence 7776 4789999999998665433 3322 37899999999999864 445888999999999999999 578888899
Q ss_pred CCCCEEeccCCcCC-CcCChhhhc--CCCEEEee-cCcCcccCCC
Q 003737 330 AKTNFMYLTGNKLT-GPVPKYIFN--SNKNVDIS-LNNFTWESSD 370 (799)
Q Consensus 330 ~~L~~L~L~~N~l~-g~~p~~~~~--~l~~l~ls-~N~~~g~~p~ 370 (799)
++|+.|++++|+++ +.+|..+.. .++.++++ .+.++|..|.
T Consensus 237 ~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp TTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred CCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 99999999999998 555655433 35677777 4456555543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-25 Score=232.91 Aligned_cols=227 Identities=20% Similarity=0.245 Sum_probs=180.7
Q ss_pred EeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCC
Q 003737 98 ALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFT 176 (799)
Q Consensus 98 ~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~ 176 (799)
+..+.+++ .+|..+. ++|++|+|++|++++..+..|..++ |++|++++|++++..+..|.++++|++|+|++|.++
T Consensus 13 ~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 89 (276)
T 2z62_A 13 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89 (276)
T ss_dssp ECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred EecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccC
Confidence 33444454 5666554 5799999999999988877888877 999999999998877788889999999999999998
Q ss_pred CCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCc-CCccccCCCCCCEEEccCCCCCCCCchhh
Q 003737 177 GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK-IPEFIGKWKKIQKLHIQGSSLEGPIPASI 255 (799)
Q Consensus 177 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 255 (799)
+..+..|.++++|++|++++|.+++..+..+..+++|++|++++|++++. +|..|..+++|++|+|++|++++..+..+
T Consensus 90 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 169 (276)
T 2z62_A 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169 (276)
T ss_dssp EECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred ccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHh
Confidence 77778888999999999999998876666788899999999999998763 58888889999999999998887777777
Q ss_pred hcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEE
Q 003737 256 SALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335 (799)
Q Consensus 256 ~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 335 (799)
..+++|+.|++ .|++++|.+++..+..+. ..+|+.|+|++|++++..+..|..+++|+.|
T Consensus 170 ~~l~~L~~l~l-------------------~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 229 (276)
T 2z62_A 170 RVLHQMPLLNL-------------------SLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKI 229 (276)
T ss_dssp HHHHTCTTCCE-------------------EEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEE
T ss_pred hhhhhccccce-------------------eeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEE
Confidence 76666553221 567777888765555444 3489999999999997777778889999999
Q ss_pred eccCCcCCCcCC
Q 003737 336 YLTGNKLTGPVP 347 (799)
Q Consensus 336 ~L~~N~l~g~~p 347 (799)
++++|++++..|
T Consensus 230 ~l~~N~~~c~c~ 241 (276)
T 2z62_A 230 WLHTNPWDCSCP 241 (276)
T ss_dssp ECCSSCBCCCTT
T ss_pred EccCCcccccCC
Confidence 999998886544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=250.34 Aligned_cols=246 Identities=20% Similarity=0.254 Sum_probs=139.0
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-e-------------eEEEccCCcCcCcCCc
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-L-------------VELSVMGNRLSGPFPK 157 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L-------------~~L~Ls~N~l~~~~p~ 157 (799)
.++++|+++++++ |.+|++++++++|++|++++|.+.|.+|..++.+. | ++|++++|.+++ +|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC
Confidence 5788899999998 78999999999999999999999888888887765 4 788888888875 333
Q ss_pred ccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCC
Q 003737 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237 (799)
Q Consensus 158 ~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 237 (799)
. .++|++|++++|.+++ +|.. +++|++|++++|++++ +|.. .++|++|++++|++++ +| .|+++++|
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L 155 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFL 155 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTC
T ss_pred C---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCC
Confidence 2 3677788888877775 5543 3566677777666663 2221 1466666666666664 45 46666666
Q ss_pred CEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccc
Q 003737 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN 316 (799)
Q Consensus 238 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 316 (799)
++|++++|++++ +|..+ .+|++|++++|.... +|.+.. .+|+.|++++|++++ +|... ++|++|++++|
T Consensus 156 ~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~--l~~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n 225 (454)
T 1jl5_A 156 KIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNN 225 (454)
T ss_dssp CEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSS
T ss_pred CEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc--CccccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCC
Confidence 666666666664 34322 366666666644332 344444 566666666666664 33322 35666666666
Q ss_pred cCCCCCchhhhccCCCCEEeccCCcCCCcCChhhhcCCCEEEeecCcCcc
Q 003737 317 NLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTW 366 (799)
Q Consensus 317 ~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~l~~l~ls~N~~~g 366 (799)
+++ .+|. +..+++|+.|++++|++++ +|. ....++.|++++|.+++
T Consensus 226 ~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~-~~~~L~~L~l~~N~l~~ 271 (454)
T 1jl5_A 226 ILE-ELPE-LQNLPFLTTIYADNNLLKT-LPD-LPPSLEALNVRDNYLTD 271 (454)
T ss_dssp CCS-SCCC-CTTCTTCCEEECCSSCCSS-CCS-CCTTCCEEECCSSCCSC
T ss_pred cCC-cccc-cCCCCCCCEEECCCCcCCc-ccc-cccccCEEECCCCcccc
Confidence 666 4552 6666666666666666664 343 22455666666666655
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-24 Score=243.30 Aligned_cols=245 Identities=22% Similarity=0.328 Sum_probs=140.4
Q ss_pred cEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeC
Q 003737 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (799)
Q Consensus 93 ~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~ 172 (799)
++++|++++|.+++ +| +|.++++|++|++++|++++ +|..+ .+|++|++++|++++ +| .++++++|++|++++
T Consensus 132 ~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~--~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~ 204 (454)
T 1jl5_A 132 LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP--PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADN 204 (454)
T ss_dssp TCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC--TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCS
T ss_pred CCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc--ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCC
Confidence 45555555555553 44 35555555555555555554 22221 135555555555554 33 355555555555555
Q ss_pred CcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCc
Q 003737 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252 (799)
Q Consensus 173 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 252 (799)
|.+++ +|... ++|++|++++|.++ .+|. +..+++|++|++++|++++ +|.. +++|++|++++|++++ +|
T Consensus 205 N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~ 273 (454)
T 1jl5_A 205 NSLKK-LPDLP---LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LP 273 (454)
T ss_dssp SCCSS-CCCCC---TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CC
T ss_pred CcCCc-CCCCc---CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cC
Confidence 55553 33221 35555555555555 4442 5555555666665555553 3322 2455555555555554 33
Q ss_pred hhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCC-CCCCeeccccccCCCCCchhhhccCC
Q 003737 253 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDM-TKLKNIDLSFNNLTGGIPTTFEKLAK 331 (799)
Q Consensus 253 ~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~ 331 (799)
.. +++|+.|++++|.... +|.+. .+|+.|++++|++++. + .+ ++|+.|++++|++++ +|.. +++
T Consensus 274 ~~---~~~L~~L~ls~N~l~~--l~~~~-~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~ 338 (454)
T 1jl5_A 274 EL---PQSLTFLDVSENIFSG--LSELP-PNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPR 338 (454)
T ss_dssp CC---CTTCCEEECCSSCCSE--ESCCC-TTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTT
T ss_pred cc---cCcCCEEECcCCccCc--ccCcC-CcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---CCc
Confidence 22 2456666666543322 11110 3566666666666541 1 23 588999999999986 5654 588
Q ss_pred CCEEeccCCcCCCcCChhhhcCCCEEEeecCcCcc--cCCCCC
Q 003737 332 TNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTW--ESSDPI 372 (799)
Q Consensus 332 L~~L~L~~N~l~g~~p~~~~~~l~~l~ls~N~~~g--~~p~~~ 372 (799)
|+.|++++|+++ .+|. ....++.|++++|++++ .+|..+
T Consensus 339 L~~L~L~~N~l~-~lp~-~l~~L~~L~L~~N~l~~l~~ip~~l 379 (454)
T 1jl5_A 339 LERLIASFNHLA-EVPE-LPQNLKQLHVEYNPLREFPDIPESV 379 (454)
T ss_dssp CCEEECCSSCCS-CCCC-CCTTCCEEECCSSCCSSCCCCCTTC
T ss_pred CCEEECCCCccc-cccc-hhhhccEEECCCCCCCcCCCChHHH
Confidence 999999999998 4776 56788999999999998 677665
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=228.07 Aligned_cols=212 Identities=24% Similarity=0.324 Sum_probs=122.8
Q ss_pred CCeEecCCCCcccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCccc
Q 003737 81 SNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVL 159 (799)
Q Consensus 81 ~gv~c~~~~~~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~ 159 (799)
.|+.|.|. .+++.+++++++++ .+|..+. ++|++|+|++|++++..+..|..++ |++|++++|.++...+..|
T Consensus 8 ~~~~C~c~---~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~ 81 (270)
T 2o6q_A 8 DGGVCSCN---NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIF 81 (270)
T ss_dssp GTCSBEEE---TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTT
T ss_pred CCCCCEeC---CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhh
Confidence 67778764 34667888888888 4665543 5677777777766655444444443 5555555554443333334
Q ss_pred CCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCE
Q 003737 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK 239 (799)
Q Consensus 160 ~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 239 (799)
. ++++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++
T Consensus 82 ~------------------------~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 137 (270)
T 2o6q_A 82 K------------------------ELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTY 137 (270)
T ss_dssp S------------------------SCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred c------------------------CCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCE
Confidence 4 4455555555555544433344445555555555555555444444555555555
Q ss_pred EEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCC
Q 003737 240 LHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319 (799)
Q Consensus 240 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 319 (799)
|+|++|.+++..+..|..+++|++|+ |++|.+++..+..|..+++|+.|+|++|+++
T Consensus 138 L~Ls~n~l~~~~~~~~~~l~~L~~L~-----------------------L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 194 (270)
T 2o6q_A 138 LSLGYNELQSLPKGVFDKLTSLKELR-----------------------LYNNQLKRVPEGAFDKLTELKTLKLDNNQLK 194 (270)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEE-----------------------CCSSCCSCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred EECCCCcCCccCHhHccCCcccceeE-----------------------ecCCcCcEeChhHhccCCCcCEEECCCCcCC
Confidence 55555555544443444444333333 3334444444445666777777777778777
Q ss_pred CCCchhhhccCCCCEEeccCCcCCCc
Q 003737 320 GGIPTTFEKLAKTNFMYLTGNKLTGP 345 (799)
Q Consensus 320 ~~~p~~~~~l~~L~~L~L~~N~l~g~ 345 (799)
+..+..|..+++|+.|+|++|++...
T Consensus 195 ~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 195 RVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred cCCHHHhccccCCCEEEecCCCeeCC
Confidence 66666677788888888888887654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=254.38 Aligned_cols=216 Identities=19% Similarity=0.146 Sum_probs=147.4
Q ss_pred CCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEE
Q 003737 114 KLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKL 192 (799)
Q Consensus 114 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 192 (799)
.+++|++|+|++|.+++.+|..|..++ |++|+|++|.+++..| +..+++|++|+|++|.+++.. ..++|++|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEE
Confidence 334788888888888888788888777 8888888888887665 888888888888888887432 23788888
Q ss_pred EcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhh-cCCCCCeEEcCCCCC
Q 003737 193 ILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASIS-ALTSLTDLRISDLKG 271 (799)
Q Consensus 193 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~n~~ 271 (799)
++++|.+++..+. .+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++.+|..+. .+++|+.|+|++|.+
T Consensus 105 ~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l 181 (487)
T 3oja_A 105 HAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (487)
T ss_dssp ECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred ECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence 8888888865543 357788888888888888888888888888888888888887777765 677777777666443
Q ss_pred CCCCCCccC-CCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCC
Q 003737 272 SESAFPKLD-KMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343 (799)
Q Consensus 272 ~~~~~~~l~-~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 343 (799)
... +... .++|+.|+|++|.+++..| .+..+++|+.|+|++|++++ +|..+..+++|+.|++++|.++
T Consensus 182 ~~~--~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 182 YDV--KGQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250 (487)
T ss_dssp CEE--ECCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBC
T ss_pred ccc--cccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCc
Confidence 221 2111 2445555555555554322 24555555555555555553 4444555555555555555554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.91 E-value=8e-26 Score=243.59 Aligned_cols=244 Identities=17% Similarity=0.145 Sum_probs=209.4
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.++++|+|++|.+++..|..|..+++|++|+|++|.+++.++ +..++ |++|++++|++++.. ..++|++|++
T Consensus 34 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l 106 (317)
T 3o53_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHA 106 (317)
T ss_dssp GGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCEEEC
T ss_pred CCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCEEEC
Confidence 479999999999998888899999999999999999998765 77777 999999999998543 3489999999
Q ss_pred eCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccc-cCCCCCCEEEccCCCCCC
Q 003737 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI-GKWKKIQKLHIQGSSLEG 249 (799)
Q Consensus 171 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~ 249 (799)
++|++++..+. .+++|++|++++|++++..+..+..+++|++|++++|.+++..+..+ ..+++|++|+|++|.+++
T Consensus 107 ~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~ 183 (317)
T 3o53_A 107 ANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (317)
T ss_dssp CSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred CCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc
Confidence 99999865443 46889999999999998878889999999999999999998877777 479999999999999986
Q ss_pred CCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCC-CCCchhhh
Q 003737 250 PIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT-GGIPTTFE 327 (799)
Q Consensus 250 ~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~p~~~~ 327 (799)
. +. ...+++|++|++++|.+.. ..+.+.. ++|+.|+|++|.++ .+|..+..+++|+.|++++|.++ +.+|..+.
T Consensus 184 ~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~ 259 (317)
T 3o53_A 184 V-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259 (317)
T ss_dssp E-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHH
T ss_pred c-cc-ccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHh
Confidence 5 32 3358999999999966543 3334555 89999999999999 57888999999999999999999 78889999
Q ss_pred ccCCCCEEecc-CCcCCCcCChh
Q 003737 328 KLAKTNFMYLT-GNKLTGPVPKY 349 (799)
Q Consensus 328 ~l~~L~~L~L~-~N~l~g~~p~~ 349 (799)
.+++|+.|++. .+.++|..|..
T Consensus 260 ~~~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 260 KNQRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp TCHHHHHHHHHHHHHHHSSSSCC
T ss_pred ccccceEEECCCchhccCCchhc
Confidence 99999999998 45666665543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.8e-25 Score=252.39 Aligned_cols=234 Identities=16% Similarity=0.134 Sum_probs=203.7
Q ss_pred cccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEE
Q 003737 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 169 (799)
..+++.|+|++|.+++..|..|..+++|++|+|++|.+++.+| +..++ |++|+|++|.+++..+ .++|++|+
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~ 105 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLH 105 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEE
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEE
Confidence 3489999999999999888999999999999999999998776 77777 9999999999986443 38999999
Q ss_pred eeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCcccc-CCCCCCEEEccCCCCC
Q 003737 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIG-KWKKIQKLHIQGSSLE 248 (799)
Q Consensus 170 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~ 248 (799)
+++|.+++..+. .+++|++|+|++|.+++..|..+..+++|++|+|++|.+++..|..+. .+++|++|+|++|.++
T Consensus 106 L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~ 182 (487)
T 3oja_A 106 AANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182 (487)
T ss_dssp CCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred CcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc
Confidence 999999976554 468999999999999998899999999999999999999998888886 7999999999999999
Q ss_pred CCCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCC-CCCchhh
Q 003737 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT-GGIPTTF 326 (799)
Q Consensus 249 ~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~p~~~ 326 (799)
+..+ +..+++|+.|++++|.+. +..|.+.. ++|+.|+|++|.+++ +|..+..+++|+.|++++|.+. +.+|..+
T Consensus 183 ~~~~--~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~ 258 (487)
T 3oja_A 183 DVKG--QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFF 258 (487)
T ss_dssp EEEC--CCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHH
T ss_pred cccc--cccCCCCCEEECCCCCCC-CCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHH
Confidence 7632 346999999999996654 44445655 899999999999996 7888999999999999999998 7778888
Q ss_pred hccCCCCEEecc
Q 003737 327 EKLAKTNFMYLT 338 (799)
Q Consensus 327 ~~l~~L~~L~L~ 338 (799)
..++.|+.+++.
T Consensus 259 ~~l~~L~~l~~~ 270 (487)
T 3oja_A 259 SKNQRVQTVAKQ 270 (487)
T ss_dssp TTCHHHHHHHHH
T ss_pred HhCCCCcEEecc
Confidence 888777777665
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.8e-24 Score=222.78 Aligned_cols=208 Identities=20% Similarity=0.220 Sum_probs=182.3
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.+++.|++++|++++..+..|.++++|++|+|++|.+++..+..|..++ |++|+|++|.+++..+..|.++++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 4699999999999988888999999999999999999998888899887 999999999999988899999999999999
Q ss_pred eCCcCCCCCCccccCCCCCCEEEcccCcCCc-cCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCC----EEEccCC
Q 003737 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQ----KLHIQGS 245 (799)
Q Consensus 171 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~L~~N 245 (799)
++|.+++..+..+..+++|++|++++|.+++ .+|..+.++++|++|++++|++++..+..+..+++|+ +|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 9999998777789999999999999999986 3699999999999999999999988888887777777 8889998
Q ss_pred CCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCc
Q 003737 246 SLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323 (799)
Q Consensus 246 ~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 323 (799)
.+++..+..+. ..+|+.|+|++|++++..+..+..+++|+.|+|++|.+++..|
T Consensus 188 ~l~~~~~~~~~------------------------~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 188 PMNFIQPGAFK------------------------EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CCCEECTTSSC------------------------SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred cccccCccccC------------------------CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 88754433222 1257778888888887777778899999999999999996543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.91 E-value=4e-24 Score=249.28 Aligned_cols=233 Identities=27% Similarity=0.355 Sum_probs=140.6
Q ss_pred cEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEee
Q 003737 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (799)
Q Consensus 93 ~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls 171 (799)
.++.|++++++++ .+|..+. ++|++|+|++|.++..++ .++ |++|+|++|+|++ +|. .+++|++|+|+
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC----CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC----cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECc
Confidence 4778888888888 6777665 788888888888885433 234 8888888888874 554 66788888888
Q ss_pred CCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCC
Q 003737 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251 (799)
Q Consensus 172 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 251 (799)
+|.+++ +|. .+++|++|++++|++++ +|.. +++|++|++++|++++ +|.. +++|+.|++++|.+++ +
T Consensus 110 ~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l 176 (622)
T 3g06_A 110 SNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-L 176 (622)
T ss_dssp SCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-C
T ss_pred CCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCCc---cCCCCEEECCCCCCCC-C
Confidence 888874 444 56778888888888774 5543 3778888888888774 3432 3456666666666664 3
Q ss_pred chhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCC
Q 003737 252 PASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331 (799)
Q Consensus 252 p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 331 (799)
| ..+++|+.|++++|.+.. +|.. ..+|+.|++++|.++ .+|.. +++|+.|+|++|+|++ +| ..+++
T Consensus 177 ~---~~~~~L~~L~Ls~N~l~~--l~~~-~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~ 242 (622)
T 3g06_A 177 P---MLPSGLQELSVSDNQLAS--LPTL-PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSE 242 (622)
T ss_dssp C---CCCTTCCEEECCSSCCSC--CCCC-CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTT
T ss_pred c---ccCCCCcEEECCCCCCCC--CCCc-cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCc
Confidence 3 335566666666644332 2211 134555555555554 22221 2445555555555553 33 23344
Q ss_pred CCEEeccCCcCCCcCChhhhcCCCEEEeecCcCc
Q 003737 332 TNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365 (799)
Q Consensus 332 L~~L~L~~N~l~g~~p~~~~~~l~~l~ls~N~~~ 365 (799)
|+.|+|++|+|+ .+|. ....++.|+|++|+++
T Consensus 243 L~~L~Ls~N~L~-~lp~-~~~~L~~L~Ls~N~L~ 274 (622)
T 3g06_A 243 LKELMVSGNRLT-SLPM-LPSGLLSLSVYRNQLT 274 (622)
T ss_dssp CCEEECCSSCCS-CCCC-CCTTCCEEECCSSCCC
T ss_pred CcEEECCCCCCC-cCCc-ccccCcEEeCCCCCCC
Confidence 555555555554 2333 3334455555555554
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-22 Score=211.97 Aligned_cols=199 Identities=20% Similarity=0.249 Sum_probs=158.2
Q ss_pred eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccC
Q 003737 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220 (799)
Q Consensus 141 L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 220 (799)
.+++++++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|++++|.++...+..|.++++|++|++++
T Consensus 18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~ 94 (270)
T 2o6q_A 18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD 94 (270)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence 345555666655 3554443 5788888888888876666888899999999999998865566678899999999999
Q ss_pred CcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCc
Q 003737 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPD 300 (799)
Q Consensus 221 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~ 300 (799)
|++++..+..|..+++|++|+|++|.+++..+..|..+++|++ |+|++|.+++..+.
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-----------------------L~Ls~n~l~~~~~~ 151 (270)
T 2o6q_A 95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTY-----------------------LSLGYNELQSLPKG 151 (270)
T ss_dssp SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCE-----------------------EECCSSCCCCCCTT
T ss_pred CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCE-----------------------EECCCCcCCccCHh
Confidence 9998777778888999999999999988777766666665555 55556666666666
Q ss_pred cccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhh--cCCCEEEeecCcCc
Q 003737 301 YIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFT 365 (799)
Q Consensus 301 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~~l~~l~ls~N~~~ 365 (799)
.+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+. ..++.|+|++|.+.
T Consensus 152 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 152 VFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred HccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 788999999999999999988888899999999999999999964444342 46889999999875
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=220.36 Aligned_cols=200 Identities=19% Similarity=0.292 Sum_probs=135.9
Q ss_pred eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccC
Q 003737 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220 (799)
Q Consensus 141 L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 220 (799)
|++|++++|.++. + ..+..+++|++|+|++|.+++ + +.+..+++|++|++++|.+++..+..|.++++|++|++++
T Consensus 43 L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 118 (272)
T 3rfs_A 43 IDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVE 118 (272)
T ss_dssp CCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred eeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCC
Confidence 5556666655542 1 235555566666666665553 1 3455555566666665555554444455555555555555
Q ss_pred CcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCc
Q 003737 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPD 300 (799)
Q Consensus 221 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~ 300 (799)
|++++..+..|+.+++|++|+|++|++++..+..+..+ .+|+.|++++|++++..+.
T Consensus 119 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-----------------------~~L~~L~l~~n~l~~~~~~ 175 (272)
T 3rfs_A 119 NQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKL-----------------------TNLTELDLSYNQLQSLPEG 175 (272)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC-----------------------TTCCEEECCSSCCCCCCTT
T ss_pred CcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccC-----------------------ccCCEEECCCCCcCccCHH
Confidence 55555555555555555555555555554444444443 4566667777888877777
Q ss_pred cccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhhcCCCEEEeecCcCcccCCCCC
Q 003737 301 YIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPI 372 (799)
Q Consensus 301 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~l~~l~ls~N~~~g~~p~~~ 372 (799)
.+..+++|+.|++++|++++..|..|..+++|+.|++++|++++..| .++.++++.|.++|.+|..+
T Consensus 176 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~-----~l~~l~~~~n~~~g~ip~~~ 242 (272)
T 3rfs_A 176 VFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP-----GIRYLSEWINKHSGVVRNSA 242 (272)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT-----TTHHHHHHHHHTGGGBBCTT
T ss_pred HhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc-----HHHHHHHHHHhCCCcccCcc
Confidence 78899999999999999999888889999999999999999998766 46788899999999999775
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-22 Score=214.29 Aligned_cols=204 Identities=22% Similarity=0.193 Sum_probs=125.9
Q ss_pred cccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCC
Q 003737 111 ELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQ 190 (799)
Q Consensus 111 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 190 (799)
.+.++++++++++++|.++..++. +. -.+++|+|++|.+++..|..|..+++|++|+|++|.+++. +. ...+++|+
T Consensus 5 ~~~~l~~l~~l~~~~~~l~~ip~~-~~-~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~ 80 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLTALPPD-LP-KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QV-DGTLPVLG 80 (290)
T ss_dssp EEECSTTCCEEECTTSCCSSCCSC-CC-TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-EC-CSCCTTCC
T ss_pred cccccCCccEEECCCCCCCcCCCC-CC-CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cC-CCCCCcCC
Confidence 356667777777777777644332 21 1366777777777766667777777777777777777643 22 25677777
Q ss_pred EEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCC
Q 003737 191 KLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK 270 (799)
Q Consensus 191 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~ 270 (799)
+|++++|+++ .+|..+..+++|++|++++|++++..|..|..+++|++|+|++|++++..+..|..+++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-------- 151 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLE-------- 151 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC--------
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCC--------
Confidence 7777777776 5666667777777777777777766666677777777777777766654444444443333
Q ss_pred CCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCC
Q 003737 271 GSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343 (799)
Q Consensus 271 ~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 343 (799)
.|+|++|++++..+..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++.
T Consensus 152 ---------------~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 152 ---------------KLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp ---------------EEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ---------------EEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 3333344444333444555666666666666666 45555555556666666666554
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-22 Score=213.41 Aligned_cols=205 Identities=22% Similarity=0.236 Sum_probs=138.0
Q ss_pred ccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCC
Q 003737 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQ 190 (799)
Q Consensus 112 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 190 (799)
+..+++|+.|++++|.++.. ..+..++ |++|++++|.+++. ..+..+++|++|+|++|.+++..+..|.++++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112 (272)
T ss_dssp HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence 45566777777777776643 2345555 77777777777652 3677777777777777777766666677777788
Q ss_pred EEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCC
Q 003737 191 KLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK 270 (799)
Q Consensus 191 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~ 270 (799)
+|++++|++++..+..|..+++|++|++++|++++..+..|+.+++|++|++++|++++..+..+..+++|+.|+
T Consensus 113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~----- 187 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLR----- 187 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE-----
T ss_pred EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEE-----
Confidence 888887777766666677777788888888877766666677777888888888877766555555555544444
Q ss_pred CCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhh
Q 003737 271 GSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI 350 (799)
Q Consensus 271 ~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~ 350 (799)
+++|.+++..|..+..+++|+.|++++|.+.+. +++|+.|+++.|+++|.+|..+
T Consensus 188 ------------------L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~ 242 (272)
T 3rfs_A 188 ------------------LYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSA 242 (272)
T ss_dssp ------------------CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTT
T ss_pred ------------------CCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcc
Confidence 444555555555566666666666666666643 3356666666777777666543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-25 Score=252.75 Aligned_cols=275 Identities=19% Similarity=0.225 Sum_probs=208.0
Q ss_pred cEEEEEeCCCCCcc----cCCccccCCCCCCEEEccCCcCCCcCcccccc-----c-ceeEEEccCCcCcCc----CCcc
Q 003737 93 HVVTIALKAQNLTG----TLPTELSKLRYLKQLDLSRNCLTGSFSPQWAS-----L-QLVELSVMGNRLSGP----FPKV 158 (799)
Q Consensus 93 ~v~~L~L~~~~l~g----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l-~L~~L~Ls~N~l~~~----~p~~ 158 (799)
++++|+|++|.++. .++..+..+++|++|+|++|.+++..+..+.. . +|++|++++|++++. ++..
T Consensus 86 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 165 (461)
T 1z7x_W 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred ceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHH
Confidence 68899999998883 56888889999999999999887654443322 2 399999999988864 3566
Q ss_pred cCCCCCCCEEEeeCCcCCCCCCcccc-----CCCCCCEEEcccCcCCcc----CChhccCCCCCCEEEccCCcCCCcC--
Q 003737 159 LTNITTLKNLSIEGNLFTGSIPPDIR-----KLINLQKLILSSNSFTGE----LPAELTKLTNLNDLRISDNNFSGKI-- 227 (799)
Q Consensus 159 ~~~L~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~-- 227 (799)
+..+++|++|+|++|.++...+..+. .+++|++|++++|.++.. ++..+..+++|++|++++|.++...
T Consensus 166 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~ 245 (461)
T 1z7x_W 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMA 245 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred HhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHH
Confidence 67788999999999988654343343 366899999999988863 5777888899999999999887532
Q ss_pred ---CccccCCCCCCEEEccCCCCCCC----CchhhhcCCCCCeEEcCCCCCCCCCCCc----cC-C-CCccEEEccCCcC
Q 003737 228 ---PEFIGKWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESAFPK----LD-K-MNLKTLILTKCLI 294 (799)
Q Consensus 228 ---p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~n~~~~~~~~~----l~-~-~~L~~L~L~~N~l 294 (799)
+..+..+++|++|++++|.++.. ++..+..+++|++|++++|......... +. . ++|+.|++++|.+
T Consensus 246 ~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l 325 (461)
T 1z7x_W 246 ELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCC
Confidence 33334688999999999988864 5777888899999999986543221111 11 1 4899999999998
Q ss_pred ccc----CCccccCCCCCCeeccccccCCCCCchhhhc-----cCCCCEEeccCCcCCC----cCChhhh--cCCCEEEe
Q 003737 295 HGE----IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK-----LAKTNFMYLTGNKLTG----PVPKYIF--NSNKNVDI 359 (799)
Q Consensus 295 ~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~g----~~p~~~~--~~l~~l~l 359 (799)
++. ++..+..+++|++|+|++|++++..+..+.. .++|+.|++++|++++ .+|..+. +.++.||+
T Consensus 326 ~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l 405 (461)
T 1z7x_W 326 TAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDL 405 (461)
T ss_dssp BGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEEC
T ss_pred chHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEEC
Confidence 865 4666777899999999999988766665553 6789999999999986 6666653 57889999
Q ss_pred ecCcCccc
Q 003737 360 SLNNFTWE 367 (799)
Q Consensus 360 s~N~~~g~ 367 (799)
++|++++.
T Consensus 406 ~~N~i~~~ 413 (461)
T 1z7x_W 406 SNNCLGDA 413 (461)
T ss_dssp CSSSCCHH
T ss_pred CCCCCCHH
Confidence 99988754
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-22 Score=215.87 Aligned_cols=222 Identities=19% Similarity=0.228 Sum_probs=138.4
Q ss_pred CCCCEEEccCCcCCCcC----cccccccceeEEEccCCcCcCcCCccc--CCCCCCCEEEeeCCcCCCCCC----ccccC
Q 003737 116 RYLKQLDLSRNCLTGSF----SPQWASLQLVELSVMGNRLSGPFPKVL--TNITTLKNLSIEGNLFTGSIP----PDIRK 185 (799)
Q Consensus 116 ~~L~~L~Ls~N~l~~~~----p~~~~~l~L~~L~Ls~N~l~~~~p~~~--~~L~~L~~L~Ls~N~l~~~~p----~~~~~ 185 (799)
..++.|.+.++.+.... ...+...+|++|++++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 34677777777665321 111112238888888888887777777 778888888888888876555 33456
Q ss_pred CCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCc--C--CccccCCCCCCEEEccCCCCCCCCch----hhhc
Q 003737 186 LINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK--I--PEFIGKWKKIQKLHIQGSSLEGPIPA----SISA 257 (799)
Q Consensus 186 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~ 257 (799)
+++|++|+|++|++++..|..|..+++|++|+|++|++.+. + +..++.+++|++|+|++|+++. ++. .+.+
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhc
Confidence 77888888888888777777777888888888888876542 1 2234667778888888887763 222 2456
Q ss_pred CCCCCeEEcCCCCCCCCCCCccCC----CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCC
Q 003737 258 LTSLTDLRISDLKGSESAFPKLDK----MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN 333 (799)
Q Consensus 258 l~~L~~L~L~~n~~~~~~~~~l~~----~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 333 (799)
+++|++|++++|.+.....+.+.. ++|++|+|++|+++ .+|..+. ++|+.|+|++|++++. |. +..+++|+
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~ 297 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVD 297 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence 677777777664443321111221 35666666666665 4454443 5666666666666643 22 45556666
Q ss_pred EEeccCCcCC
Q 003737 334 FMYLTGNKLT 343 (799)
Q Consensus 334 ~L~L~~N~l~ 343 (799)
.|+|++|+++
T Consensus 298 ~L~L~~N~l~ 307 (310)
T 4glp_A 298 NLTLDGNPFL 307 (310)
T ss_dssp CEECSSTTTS
T ss_pred EEECcCCCCC
Confidence 6666666655
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-23 Score=228.13 Aligned_cols=253 Identities=18% Similarity=0.272 Sum_probs=156.0
Q ss_pred cEEEEEeCCCCCcccCCccccCC--CCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCc-CCcccCCCCCCCEEE
Q 003737 93 HVVTIALKAQNLTGTLPTELSKL--RYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGP-FPKVLTNITTLKNLS 169 (799)
Q Consensus 93 ~v~~L~L~~~~l~g~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~-~p~~~~~L~~L~~L~ 169 (799)
.++.++++++.+. +..+..+ ++++.|++++|.+.+.++..+...+|++|++++|.+++. +|..+..+++|++|+
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 4567777777665 3445555 677777777777776655543322366666666666544 555566666666666
Q ss_pred eeCCcCCCCCCccccCCCCCCEEEcccC-cCCc-cCChhccCCCCCCEEEccCC-cCCCc-CCccccCCC-CCCEEEccC
Q 003737 170 IEGNLFTGSIPPDIRKLINLQKLILSSN-SFTG-ELPAELTKLTNLNDLRISDN-NFSGK-IPEFIGKWK-KIQKLHIQG 244 (799)
Q Consensus 170 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~-~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~-~L~~L~L~~ 244 (799)
|++|.+++..|..+..+++|++|++++| .+++ .++..+..+++|++|++++| .+++. ++..+..++ +|++|++++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 6666655555555556666666666666 4543 24444555566666666666 55532 344455555 555555555
Q ss_pred C--CCC-CCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCc-CcccCCccccCCCCCCeecccccc-CC
Q 003737 245 S--SLE-GPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCL-IHGEIPDYIGDMTKLKNIDLSFNN-LT 319 (799)
Q Consensus 245 N--~l~-~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~Ls~N~-l~ 319 (799)
| .++ +.+|..+..++ +|+.|++++|. +++..+..+..+++|++|++++|. ++
T Consensus 205 ~~~~~~~~~l~~~~~~~~-----------------------~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~ 261 (336)
T 2ast_B 205 YRKNLQKSDLSTLVRRCP-----------------------NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDII 261 (336)
T ss_dssp CGGGSCHHHHHHHHHHCT-----------------------TCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCC
T ss_pred CcccCCHHHHHHHHhhCC-----------------------CCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCC
Confidence 5 333 23344444444 45555666666 555666677888899999999985 33
Q ss_pred CCCchhhhccCCCCEEeccCCcCCCcCChhhhcCCCEEEeecCcCcccCCCCC
Q 003737 320 GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPI 372 (799)
Q Consensus 320 ~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~l~~l~ls~N~~~g~~p~~~ 372 (799)
......+..+++|+.|++++| ++...-..+...++.|+++.|++++..|..+
T Consensus 262 ~~~~~~l~~~~~L~~L~l~~~-i~~~~~~~l~~~l~~L~l~~n~l~~~~~~~~ 313 (336)
T 2ast_B 262 PETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHLQINCSHFTTIARPTI 313 (336)
T ss_dssp GGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTSEESCCCSCCTTCSSC
T ss_pred HHHHHHHhcCCCCCEEeccCc-cCHHHHHHHHhhCcceEEecccCccccCCcc
Confidence 222235788999999999988 4432222334457888899999998888765
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=5.6e-22 Score=205.96 Aligned_cols=181 Identities=20% Similarity=0.278 Sum_probs=153.3
Q ss_pred CCeEecCCCCcccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCccc
Q 003737 81 SNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVL 159 (799)
Q Consensus 81 ~gv~c~~~~~~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~ 159 (799)
.|++|. ...+.+++++++++ .+|..+. +.|+.|+|++|.+++..+..|..++ |++|+|++|.+++..|..|
T Consensus 8 ~gC~C~-----~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 79 (251)
T 3m19_A 8 TGCTCN-----EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVF 79 (251)
T ss_dssp HSSEEE-----GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTT
T ss_pred CceEcC-----CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHh
Confidence 567774 23457899999998 6776665 6899999999999998888888887 9999999999998888889
Q ss_pred CCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCE
Q 003737 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK 239 (799)
Q Consensus 160 ~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 239 (799)
.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|+.+++|++
T Consensus 80 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 159 (251)
T 3m19_A 80 DDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQT 159 (251)
T ss_dssp TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred ccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCE
Confidence 99999999999999999777778889999999999999999766677888999999999999999777778899999999
Q ss_pred EEccCCCCCCCCchhhhcCCCCCeEEcCCC
Q 003737 240 LHIQGSSLEGPIPASISALTSLTDLRISDL 269 (799)
Q Consensus 240 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n 269 (799)
|+|++|++++..+..+..+++|+.|++++|
T Consensus 160 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 189 (251)
T 3m19_A 160 LSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189 (251)
T ss_dssp EECCSSCCSCCCTTTTTTCTTCCEEECCSC
T ss_pred EECCCCcCCccCHHHHhCCCCCCEEEeeCC
Confidence 999999998777777777777766666653
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-21 Score=207.53 Aligned_cols=200 Identities=22% Similarity=0.199 Sum_probs=172.6
Q ss_pred cccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEE
Q 003737 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 169 (799)
..+++++++++++++ .+|..+. +.+++|+|++|.+++..+..|..++ |++|+|++|.+++..+. +.+++|++|+
T Consensus 9 l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~ 83 (290)
T 1p9a_G 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLD 83 (290)
T ss_dssp STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEEE
T ss_pred cCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEEE
Confidence 357899999999998 6776664 7999999999999999999999987 99999999999965443 7899999999
Q ss_pred eeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCC
Q 003737 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (799)
Q Consensus 170 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 249 (799)
|++|.++ .+|..+..+++|++|++++|++++..|..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+++.
T Consensus 84 Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 162 (290)
T 1p9a_G 84 LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE 162 (290)
T ss_dssp CCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred CCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCc
Confidence 9999998 788899999999999999999998777889999999999999999998888889999999999999999997
Q ss_pred CCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCC
Q 003737 250 PIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG 320 (799)
Q Consensus 250 ~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 320 (799)
..+..|..+++|+.|+++ +|+++ .+|..+..+++|+.|+|++|.+..
T Consensus 163 l~~~~~~~l~~L~~L~L~-----------------------~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 163 LPAGLLNGLENLDTLLLQ-----------------------ENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CCTTTTTTCTTCCEEECC-----------------------SSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred cCHHHhcCcCCCCEEECC-----------------------CCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 666666767766665555 45555 566677777888899999888874
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.5e-22 Score=203.37 Aligned_cols=202 Identities=17% Similarity=0.206 Sum_probs=125.6
Q ss_pred cCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCc-CcCcCCcccCCCCCCCEEEeeC-CcCCCCCCccc
Q 003737 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNR-LSGPFPKVLTNITTLKNLSIEG-NLFTGSIPPDI 183 (799)
Q Consensus 107 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~-l~~~~p~~~~~L~~L~~L~Ls~-N~l~~~~p~~~ 183 (799)
.+|. +. ++|++|+|++|++++..+..|..++ |++|++++|+ +++..+..|.++++|++|++++ |.+++..+..|
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f 101 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL 101 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence 5565 33 3788888888888776666666665 7777777775 6655555666777777777776 66665555566
Q ss_pred cCCCCCCEEEcccCcCCccCChhccCCCCCC---EEEccCC-cCCCcCCccccCCCCCC-EEEccCCCCCCCCchhhhcC
Q 003737 184 RKLINLQKLILSSNSFTGELPAELTKLTNLN---DLRISDN-NFSGKIPEFIGKWKKIQ-KLHIQGSSLEGPIPASISAL 258 (799)
Q Consensus 184 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l 258 (799)
.++++|++|++++|++++ +|. |..+++|+ +|++++| ++++..+..|..+++|+ +|++++|+++ .+|...
T Consensus 102 ~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~--- 175 (239)
T 2xwt_C 102 KELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYA--- 175 (239)
T ss_dssp ECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTT---
T ss_pred CCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhh---
Confidence 667777777777776664 554 66666666 6666666 66655555566666666 6666666655 222211
Q ss_pred CCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCc-CcccCCccccCC-CCCCeeccccccCCCCCchhhhccCCCCEEe
Q 003737 259 TSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCL-IHGEIPDYIGDM-TKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 336 (799)
Q Consensus 259 ~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~-l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 336 (799)
+...+|+.|+|++|+ +++..+..|..+ ++|+.|++++|++++ +|.. .+++|+.|+
T Consensus 176 --------------------~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~ 232 (239)
T 2xwt_C 176 --------------------FNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELI 232 (239)
T ss_dssp --------------------TTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEE
T ss_pred --------------------cCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceee
Confidence 111245566666663 665555566666 777777777777764 3332 456666666
Q ss_pred ccCC
Q 003737 337 LTGN 340 (799)
Q Consensus 337 L~~N 340 (799)
++++
T Consensus 233 l~~~ 236 (239)
T 2xwt_C 233 ARNT 236 (239)
T ss_dssp CTTC
T ss_pred ccCc
Confidence 6654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.87 E-value=2.4e-24 Score=244.29 Aligned_cols=274 Identities=19% Similarity=0.225 Sum_probs=125.4
Q ss_pred cEEEEEeCCCCCcc----cCCccccCCCCCCEEEccCCcCCCcCccccc-cc-----ceeEEEccCCcCcC----cCCcc
Q 003737 93 HVVTIALKAQNLTG----TLPTELSKLRYLKQLDLSRNCLTGSFSPQWA-SL-----QLVELSVMGNRLSG----PFPKV 158 (799)
Q Consensus 93 ~v~~L~L~~~~l~g----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l-----~L~~L~Ls~N~l~~----~~p~~ 158 (799)
+++.|+|+++.++. .++..+..+++|++|+|++|.+.+..+..+. .+ +|++|+|++|+++. .+|..
T Consensus 29 ~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~ 108 (461)
T 1z7x_W 29 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 108 (461)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHH
Confidence 34555555555543 2344445555555555555555433222111 11 25555555555542 33455
Q ss_pred cCCCCCCCEEEeeCCcCCCCCCccc-----cCCCCCCEEEcccCcCCcc----CChhccCCCCCCEEEccCCcCCCcCCc
Q 003737 159 LTNITTLKNLSIEGNLFTGSIPPDI-----RKLINLQKLILSSNSFTGE----LPAELTKLTNLNDLRISDNNFSGKIPE 229 (799)
Q Consensus 159 ~~~L~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 229 (799)
+..+++|++|+|++|.+++..+..+ ...++|++|++++|++++. ++..+..+++|++|++++|.++...+.
T Consensus 109 l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 188 (461)
T 1z7x_W 109 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVR 188 (461)
T ss_dssp TTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred HccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHH
Confidence 5555555555555555443222211 1233455555555555532 233344455555555555555433222
Q ss_pred ccc-----CCCCCCEEEccCCCCCCC----CchhhhcCCCCCeEEcCCCCCCCCCC----CccC--CCCccEEEccCCcC
Q 003737 230 FIG-----KWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESAF----PKLD--KMNLKTLILTKCLI 294 (799)
Q Consensus 230 ~~~-----~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~n~~~~~~~----~~l~--~~~L~~L~L~~N~l 294 (799)
.+. ..++|++|+|++|.++.. ++..+..+++|++|++++|......+ +.+. ..+|+.|++++|.+
T Consensus 189 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l 268 (461)
T 1z7x_W 189 VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 268 (461)
T ss_dssp HHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCC
Confidence 222 134555555555555542 34444555555555555543322111 1111 14555555555555
Q ss_pred ccc----CCccccCCCCCCeeccccccCCCCCchhhhcc-----CCCCEEeccCCcCCCc----CChhhh--cCCCEEEe
Q 003737 295 HGE----IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL-----AKTNFMYLTGNKLTGP----VPKYIF--NSNKNVDI 359 (799)
Q Consensus 295 ~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~g~----~p~~~~--~~l~~l~l 359 (799)
+.. ++..+..+++|++|++++|.+++..+..+... ++|+.|++++|.+++. +|..+. ..++.||+
T Consensus 269 ~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L 348 (461)
T 1z7x_W 269 TAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQI 348 (461)
T ss_dssp CHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEEC
T ss_pred CHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEc
Confidence 532 34444445555555555555544333333322 4555555555555543 122211 34555555
Q ss_pred ecCcCcc
Q 003737 360 SLNNFTW 366 (799)
Q Consensus 360 s~N~~~g 366 (799)
++|.+++
T Consensus 349 s~n~i~~ 355 (461)
T 1z7x_W 349 SNNRLED 355 (461)
T ss_dssp CSSBCHH
T ss_pred cCCcccc
Confidence 5555543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.6e-21 Score=202.57 Aligned_cols=209 Identities=22% Similarity=0.275 Sum_probs=127.3
Q ss_pred eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccC
Q 003737 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220 (799)
Q Consensus 141 L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 220 (799)
.++++++++.++ .+|..+. ++|+.|+|++|.+++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 344555555554 3444333 4566666666666665555666666666666666666665566666666666667666
Q ss_pred CcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCc
Q 003737 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPD 300 (799)
Q Consensus 221 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~ 300 (799)
|++++..+..|..+++|++|+|++|++++..+..|..+++| +.|+|++|++++..+.
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-----------------------~~L~Ls~N~l~~~~~~ 149 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKL-----------------------KELRLNTNQLQSIPAG 149 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-----------------------CEEECCSSCCCCCCTT
T ss_pred CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcc-----------------------cEEECcCCcCCccCHH
Confidence 66666555666666677777777776665544444444443 4444555566655556
Q ss_pred cccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCCh------hhhc-CCCEEEeecCcCcccCCCCCc
Q 003737 301 YIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK------YIFN-SNKNVDISLNNFTWESSDPIE 373 (799)
Q Consensus 301 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~------~~~~-~l~~l~ls~N~~~g~~p~~~~ 373 (799)
.+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+. ++.. ..+..+..+|.+.+..+ ...
T Consensus 150 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 228 (251)
T 3m19_A 150 AFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCEILYLSQWIRENSNKVKDGTGQNLHESPD-GVT 228 (251)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTSTTHHHHHHHHHHSGGGBCC-------CCGG-GCB
T ss_pred HcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCccccHHHHHHHHhcccceeeccCcccccCCC-cCc
Confidence 677888888888888888877777888888899999999988876332 2221 22344555666654433 233
Q ss_pred CCC
Q 003737 374 CPR 376 (799)
Q Consensus 374 ~~~ 376 (799)
|..
T Consensus 229 C~~ 231 (251)
T 3m19_A 229 CSD 231 (251)
T ss_dssp BTT
T ss_pred cCC
Confidence 543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=4.6e-24 Score=231.46 Aligned_cols=233 Identities=19% Similarity=0.231 Sum_probs=183.4
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCc-Ccccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEE
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGS-FSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 169 (799)
.+++.++++++.+.+..+. +..+++|++|+|++|.+++. ++..+..++ |++|++++|.+++..|..++.+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 5789999999999987665 66899999999999999876 788888887 99999999999988999999999999999
Q ss_pred eeCC-cCCC-CCCccccCCCCCCEEEcccC-cCCcc-CChhccCCC-CCCEEEccCC--cCC-CcCCccccCCCCCCEEE
Q 003737 170 IEGN-LFTG-SIPPDIRKLINLQKLILSSN-SFTGE-LPAELTKLT-NLNDLRISDN--NFS-GKIPEFIGKWKKIQKLH 241 (799)
Q Consensus 170 Ls~N-~l~~-~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~l~~L~~L~ 241 (799)
|++| .+++ .++..+..+++|++|++++| .+++. ++..+..++ +|++|++++| .++ +.+|..+..+++|++|+
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~ 228 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEE
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEe
Confidence 9999 6765 36667889999999999999 99864 677889999 9999999999 555 46778888999999999
Q ss_pred ccCCC-CCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCC
Q 003737 242 IQGSS-LEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG 320 (799)
Q Consensus 242 L~~N~-l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 320 (799)
+++|. +++..+..+..+++|+.|++++|.... ......+..+++|+.|++++| ++.
T Consensus 229 l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~----------------------~~~~~~l~~~~~L~~L~l~~~-i~~ 285 (336)
T 2ast_B 229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDII----------------------PETLLELGEIPTLKTLQVFGI-VPD 285 (336)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCC----------------------GGGGGGGGGCTTCCEEECTTS-SCT
T ss_pred CCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCC----------------------HHHHHHHhcCCCCCEEeccCc-cCH
Confidence 99999 777778888888888888887753111 011123455677777777777 332
Q ss_pred CCchhhhcc-CCCCEEeccCCcCCCcCChhhh
Q 003737 321 GIPTTFEKL-AKTNFMYLTGNKLTGPVPKYIF 351 (799)
Q Consensus 321 ~~p~~~~~l-~~L~~L~L~~N~l~g~~p~~~~ 351 (799)
. .+..+ ..++.|++++|++++..|..+.
T Consensus 286 ~---~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 286 G---TLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp T---CHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred H---HHHHHHhhCcceEEecccCccccCCccc
Confidence 1 22222 1244555777777777766543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-23 Score=230.24 Aligned_cols=255 Identities=17% Similarity=0.236 Sum_probs=175.2
Q ss_pred EEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCc----ccccccc--eeEEEccCCcCcCcCCcccCCC-----CC
Q 003737 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFS----PQWASLQ--LVELSVMGNRLSGPFPKVLTNI-----TT 164 (799)
Q Consensus 96 ~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~--L~~L~Ls~N~l~~~~p~~~~~L-----~~ 164 (799)
..+++.++++|.+|..+...++|++|||++|.+++..+ ..+..++ |++|+|++|.+++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 35788888888888877777779999999999887776 5555553 8889999998887777777665 88
Q ss_pred CCEEEeeCCcCCCCCCcccc----CC-CCCCEEEcccCcCCccCChhc----cC-CCCCCEEEccCCcCCCcC----Ccc
Q 003737 165 LKNLSIEGNLFTGSIPPDIR----KL-INLQKLILSSNSFTGELPAEL----TK-LTNLNDLRISDNNFSGKI----PEF 230 (799)
Q Consensus 165 L~~L~Ls~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~~p~~~----~~-l~~L~~L~Ls~N~l~~~~----p~~ 230 (799)
|++|+|++|.+++..+..+. .+ ++|++|+|++|++++..+..+ .. .++|++|+|++|+++... +..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 89999999988866665443 34 788999999988886655443 33 358888999888887533 344
Q ss_pred ccCCC-CCCEEEccCCCCCCCCchhhhc----C-CCCCeEEcCCCCCCCCCC---Cc-cCC--CCccEEEccCCcCcccC
Q 003737 231 IGKWK-KIQKLHIQGSSLEGPIPASISA----L-TSLTDLRISDLKGSESAF---PK-LDK--MNLKTLILTKCLIHGEI 298 (799)
Q Consensus 231 ~~~l~-~L~~L~L~~N~l~~~~p~~~~~----l-~~L~~L~L~~n~~~~~~~---~~-l~~--~~L~~L~L~~N~l~~~~ 298 (799)
+..++ +|++|+|++|++++..+..+.. . ++|+.|++++|.+..... +. +.. .+|+.|+|++|.+++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 45555 8888888888888776654443 3 578888887765443221 11 222 36777777777776543
Q ss_pred C----ccccCCCCCCeeccccccCCCCCch-------hhhccCCCCEEeccCCcCCCcCChhh
Q 003737 299 P----DYIGDMTKLKNIDLSFNNLTGGIPT-------TFEKLAKTNFMYLTGNKLTGPVPKYI 350 (799)
Q Consensus 299 p----~~l~~l~~L~~L~Ls~N~l~~~~p~-------~~~~l~~L~~L~L~~N~l~g~~p~~~ 350 (799)
+ ..+..+++|+.|+|++|.+.+..+. .+..+++|+.|++++|++....|..+
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~~ 304 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPI 304 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHHH
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHHH
Confidence 3 2345567777777777775543332 34556667777777777765544433
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.86 E-value=6.3e-21 Score=222.36 Aligned_cols=240 Identities=28% Similarity=0.353 Sum_probs=198.2
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.+++.|+|++|+++ .+|. .+++|++|+|++|++++.++ .+. |++|+|++|++++ +|. .+++|+.|++
T Consensus 61 ~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L 128 (622)
T 3g06_A 61 AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSLPV----LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWI 128 (622)
T ss_dssp TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSCCCC----CCTTCCEEEECSCCCCC-CCC---CCTTCCEEEC
T ss_pred CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCcCCC----CCCCCCEEECcCCcCCC-CCC---CCCCcCEEEC
Confidence 57999999999999 5665 67999999999999986544 444 9999999999996 444 6789999999
Q ss_pred eCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCC
Q 003737 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP 250 (799)
Q Consensus 171 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 250 (799)
++|++++ +|.. +++|++|+|++|++++ +|. .+++|+.|++++|.+++ +| ..+++|+.|+|++|.+++
T Consensus 129 ~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~- 195 (622)
T 3g06_A 129 FGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS- 195 (622)
T ss_dssp CSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-
T ss_pred CCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-
Confidence 9999985 6654 4899999999999985 554 35789999999999985 56 457899999999999986
Q ss_pred CchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccC
Q 003737 251 IPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLA 330 (799)
Q Consensus 251 ~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 330 (799)
+|. .+++|+.|++++|.+.. +|.. ..+|+.|+|++|.|++ +| ..+++|+.|+|++|+|+ .+|. .++
T Consensus 196 l~~---~~~~L~~L~L~~N~l~~--l~~~-~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~ 261 (622)
T 3g06_A 196 LPT---LPSELYKLWAYNNRLTS--LPAL-PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPS 261 (622)
T ss_dssp CCC---CCTTCCEEECCSSCCSS--CCCC-CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCT
T ss_pred CCC---ccchhhEEECcCCcccc--cCCC-CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccc
Confidence 444 35789999999866543 3332 2689999999999996 55 45689999999999999 4665 678
Q ss_pred CCCEEeccCCcCCCcCChhhh--cCCCEEEeecCcCcccCCCC
Q 003737 331 KTNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESSDP 371 (799)
Q Consensus 331 ~L~~L~L~~N~l~g~~p~~~~--~~l~~l~ls~N~~~g~~p~~ 371 (799)
+|+.|+|++|+|+ .+|..+. ..++.|+|++|.+++.+|..
T Consensus 262 ~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~ 303 (622)
T 3g06_A 262 GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQA 303 (622)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHH
T ss_pred cCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHH
Confidence 9999999999999 7888764 46899999999999887754
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2.3e-23 Score=230.69 Aligned_cols=240 Identities=20% Similarity=0.270 Sum_probs=142.8
Q ss_pred cCCccccCCCCCCEEEccCCcCCCcCccc----ccccc-eeEEEccCC---cCcCcCCccc-------CCCCCCCEEEee
Q 003737 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQ----WASLQ-LVELSVMGN---RLSGPFPKVL-------TNITTLKNLSIE 171 (799)
Q Consensus 107 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~-L~~L~Ls~N---~l~~~~p~~~-------~~L~~L~~L~Ls 171 (799)
.++..+..+++|++|+|++|.+....+.. +..++ |++|+|++| ++++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 45666777788888888888887653333 44555 777777774 3444555544 677777778887
Q ss_pred CCcCCC----CCCccccCCCCCCEEEcccCcCCccCChh----ccCC---------CCCCEEEccCCcCC-CcCC---cc
Q 003737 172 GNLFTG----SIPPDIRKLINLQKLILSSNSFTGELPAE----LTKL---------TNLNDLRISDNNFS-GKIP---EF 230 (799)
Q Consensus 172 ~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l---------~~L~~L~Ls~N~l~-~~~p---~~ 230 (799)
+|.+++ .+|..+..+++|++|+|++|.++...+.. +..+ ++|++|++++|+++ +.+| ..
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 182 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence 777775 35666777777777777777776433332 3333 67777777777776 3334 35
Q ss_pred ccCCCCCCEEEccCCCCCC-----CCchhhhcCCCCCeEEcCCCCCCC---CCCCc-cCC-CCccEEEccCCcCccc---
Q 003737 231 IGKWKKIQKLHIQGSSLEG-----PIPASISALTSLTDLRISDLKGSE---SAFPK-LDK-MNLKTLILTKCLIHGE--- 297 (799)
Q Consensus 231 ~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~L~~n~~~~---~~~~~-l~~-~~L~~L~L~~N~l~~~--- 297 (799)
+..+++|++|+|++|.++. ..|..+..+++|+.|+|++|.+.. ..+|. +.. ++|+.|+|++|.+++.
T Consensus 183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 262 (386)
T 2ca6_A 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 262 (386)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHH
Confidence 5566777777777777662 223355666666666666544321 11221 222 4555555555555543
Q ss_pred -CCccc--cCCCCCCeeccccccCCC----CCchhh-hccCCCCEEeccCCcCCCcC
Q 003737 298 -IPDYI--GDMTKLKNIDLSFNNLTG----GIPTTF-EKLAKTNFMYLTGNKLTGPV 346 (799)
Q Consensus 298 -~p~~l--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~L~~N~l~g~~ 346 (799)
++..+ +.+++|+.|+|++|.+++ .+|..+ .++++|+.|++++|++++..
T Consensus 263 ~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 263 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 33444 225556666666666654 355544 44566666666666665544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=4.9e-23 Score=228.11 Aligned_cols=238 Identities=17% Similarity=0.179 Sum_probs=194.1
Q ss_pred Ccccccccc-eeEEEccCCcCcCcCC----cccCCCCCCCEEEeeCCc---CCCCCCccc-------cCCCCCCEEEccc
Q 003737 132 FSPQWASLQ-LVELSVMGNRLSGPFP----KVLTNITTLKNLSIEGNL---FTGSIPPDI-------RKLINLQKLILSS 196 (799)
Q Consensus 132 ~p~~~~~l~-L~~L~Ls~N~l~~~~p----~~~~~L~~L~~L~Ls~N~---l~~~~p~~~-------~~l~~L~~L~Ls~ 196 (799)
++..+..++ |++|+|++|.++...+ ..+..+++|++|+|++|. +++.+|..+ ..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 445555555 9999999999987644 457789999999999964 445666655 7899999999999
Q ss_pred CcCCc----cCChhccCCCCCCEEEccCCcCCCcCCcccc----CC---------CCCCEEEccCCCCC-CCCc---hhh
Q 003737 197 NSFTG----ELPAELTKLTNLNDLRISDNNFSGKIPEFIG----KW---------KKIQKLHIQGSSLE-GPIP---ASI 255 (799)
Q Consensus 197 N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l---------~~L~~L~L~~N~l~-~~~p---~~~ 255 (799)
|.+++ .+|..+..+++|++|+|++|.++...+..+. .+ ++|++|+|++|+++ +.++ ..+
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 183 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence 99997 4788899999999999999999754444443 34 89999999999998 4455 577
Q ss_pred hcCCCCCeEEcCCCCCCCC----CCC-ccCC-CCccEEEccCCcCc----ccCCccccCCCCCCeeccccccCCCC----
Q 003737 256 SALTSLTDLRISDLKGSES----AFP-KLDK-MNLKTLILTKCLIH----GEIPDYIGDMTKLKNIDLSFNNLTGG---- 321 (799)
Q Consensus 256 ~~l~~L~~L~L~~n~~~~~----~~~-~l~~-~~L~~L~L~~N~l~----~~~p~~l~~l~~L~~L~Ls~N~l~~~---- 321 (799)
..+++|+.|++++|.+... ..+ .+.. ++|+.|+|++|.++ +.+|..+..+++|+.|+|++|++++.
T Consensus 184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~ 263 (386)
T 2ca6_A 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 263 (386)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHH
Confidence 8899999999999765532 233 3444 78999999999997 67888899999999999999999976
Q ss_pred Cchhhhc--cCCCCEEeccCCcCCC----cCChhh---hcCCCEEEeecCcCcccCC
Q 003737 322 IPTTFEK--LAKTNFMYLTGNKLTG----PVPKYI---FNSNKNVDISLNNFTWESS 369 (799)
Q Consensus 322 ~p~~~~~--l~~L~~L~L~~N~l~g----~~p~~~---~~~l~~l~ls~N~~~g~~p 369 (799)
+|..+.. +++|+.|+|++|++++ .+|..+ .+.++.|++++|.+++..+
T Consensus 264 l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 264 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 5667744 9999999999999997 588776 3678999999999986653
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=1e-21 Score=210.72 Aligned_cols=223 Identities=20% Similarity=0.176 Sum_probs=182.1
Q ss_pred cEEEEEeCCCCCcccCCc---cccCCCCCCEEEccCCcCCCcCcccc--cccc-eeEEEccCCcCcCcCC----cccCCC
Q 003737 93 HVVTIALKAQNLTGTLPT---ELSKLRYLKQLDLSRNCLTGSFSPQW--ASLQ-LVELSVMGNRLSGPFP----KVLTNI 162 (799)
Q Consensus 93 ~v~~L~L~~~~l~g~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~l~-L~~L~Ls~N~l~~~~p----~~~~~L 162 (799)
+++.+.+.+..++...-. .+..+++|++|+|++|.+.+..|..+ ..+. |++|+|++|.+++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 467788888777532111 12345679999999999999999887 7776 9999999999998666 455679
Q ss_pred CCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCcc--C--ChhccCCCCCCEEEccCCcCCCcCCc----cccCC
Q 003737 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGE--L--PAELTKLTNLNDLRISDNNFSGKIPE----FIGKW 234 (799)
Q Consensus 163 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~--p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l 234 (799)
++|++|+|++|.+++..|..|..+++|++|+|++|++.+. + +..+..+++|++|+|++|+++. ++. .++.+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcC
Confidence 9999999999999988889999999999999999998753 2 2334789999999999999973 333 35788
Q ss_pred CCCCEEEccCCCCCCCCchhhhcC---CCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCee
Q 003737 235 KKIQKLHIQGSSLEGPIPASISAL---TSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNI 311 (799)
Q Consensus 235 ~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 311 (799)
++|++|+|++|++++..|..+..+ ++|++|++++|.+. .+|..-..+|+.|+|++|++++. |. +..+++|+.|
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~--~lp~~~~~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L 299 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE--QVPKGLPAKLRVLDLSSNRLNRA-PQ-PDELPEVDNL 299 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC--SCCSCCCSCCSCEECCSCCCCSC-CC-TTSCCCCSCE
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC--chhhhhcCCCCEEECCCCcCCCC-ch-hhhCCCccEE
Confidence 999999999999999888888777 69999999997665 34442227999999999999964 43 6788999999
Q ss_pred ccccccCCC
Q 003737 312 DLSFNNLTG 320 (799)
Q Consensus 312 ~Ls~N~l~~ 320 (799)
+|++|+++.
T Consensus 300 ~L~~N~l~~ 308 (310)
T 4glp_A 300 TLDGNPFLV 308 (310)
T ss_dssp ECSSTTTSC
T ss_pred ECcCCCCCC
Confidence 999999974
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.8e-21 Score=199.11 Aligned_cols=197 Identities=16% Similarity=0.155 Sum_probs=160.1
Q ss_pred ceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCc-CCCCCCccccCCCCCCEEEccc-CcCCccCChhccCCCCCCEEE
Q 003737 140 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL-FTGSIPPDIRKLINLQKLILSS-NSFTGELPAELTKLTNLNDLR 217 (799)
Q Consensus 140 ~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ 217 (799)
.+++|++++|++++..+..|.++++|++|++++|+ ++...+..|.++++|++|++++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 58899999999998877789999999999999997 7766666888999999999998 899876677888999999999
Q ss_pred ccCCcCCCcCCccccCCCCCC---EEEccCC-CCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCcc-EEEccCC
Q 003737 218 ISDNNFSGKIPEFIGKWKKIQ---KLHIQGS-SLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLK-TLILTKC 292 (799)
Q Consensus 218 Ls~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~-~L~L~~N 292 (799)
+++|++++ +|. |..+++|+ +|++++| .+++..+..|.++++| + .|++++|
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L-----------------------~~~L~l~~n 166 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE-----------------------TLTLKLYNN 166 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSS-----------------------EEEEECCSC
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcc-----------------------eeEEEcCCC
Confidence 99999986 666 88888888 8999998 8876655556655554 4 5556666
Q ss_pred cCcccCCccccCCCCCCeecccccc-CCCCCchhhhcc-CCCCEEeccCCcCCCcCChhhhcCCCEEEeecCc
Q 003737 293 LIHGEIPDYIGDMTKLKNIDLSFNN-LTGGIPTTFEKL-AKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNN 363 (799)
Q Consensus 293 ~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~L~~N~l~g~~p~~~~~~l~~l~ls~N~ 363 (799)
+++ .+|......++|+.|+|++|+ +++..+..|..+ ++|+.|++++|+++ .+|...+..++.|+++++.
T Consensus 167 ~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 167 GFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTW 237 (239)
T ss_dssp CCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCTTCTTCSEEECTTC-
T ss_pred CCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc-cCChhHhccCceeeccCcc
Confidence 776 444443333899999999995 997778889999 99999999999999 5676678889999998763
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=2.6e-21 Score=207.27 Aligned_cols=193 Identities=23% Similarity=0.341 Sum_probs=106.5
Q ss_pred cCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCE
Q 003737 113 SKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191 (799)
Q Consensus 113 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 191 (799)
..+++|++|++++|.++.. + .+..++ |++|++++|.+++..+ +..+++|++|+|++|.+++ + +.+..+++|++
T Consensus 38 ~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~-~~~~~l~~L~~ 111 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-V-SAIAGLQSIKT 111 (308)
T ss_dssp HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCE
T ss_pred HHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-c-hhhcCCCCCCE
Confidence 3455666666666655542 2 244443 5555555555554332 5566666666666666553 2 24556666666
Q ss_pred EEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCC
Q 003737 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG 271 (799)
Q Consensus 192 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~ 271 (799)
|++++|++++ ++. +..+++|++|++++|++++..+ +..+++|++|+|++|.+++..+ +..+++|
T Consensus 112 L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L---------- 175 (308)
T 1h6u_A 112 LDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKL---------- 175 (308)
T ss_dssp EECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTC----------
T ss_pred EECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCC----------
Confidence 6666666653 222 5566666666666666654322 5556666666666666554222 4444444
Q ss_pred CCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCC
Q 003737 272 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG 344 (799)
Q Consensus 272 ~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g 344 (799)
+.|++++|.+++..+ +..+++|++|+|++|++++..| +..+++|+.|++++|++++
T Consensus 176 -------------~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 176 -------------TTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp -------------CEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred -------------CEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 444444454443322 5556666666666666664432 5666667777777776663
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.85 E-value=7.5e-23 Score=224.60 Aligned_cols=250 Identities=16% Similarity=0.165 Sum_probs=194.2
Q ss_pred EEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCC----cccCCCC-CCCEEEeeCCcCCCCCCccccCC-----CC
Q 003737 120 QLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFP----KVLTNIT-TLKNLSIEGNLFTGSIPPDIRKL-----IN 188 (799)
Q Consensus 120 ~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p----~~~~~L~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~ 188 (799)
.++|++|.+++.+|..+...+ |++|+|++|.+++..+ ..+..++ +|++|+|++|.+++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 478999999999998888887 9999999999997777 7788898 89999999999998777777765 99
Q ss_pred CCEEEcccCcCCccCChhc----cCC-CCCCEEEccCCcCCCcCCcccc----C-CCCCCEEEccCCCCCCCCc----hh
Q 003737 189 LQKLILSSNSFTGELPAEL----TKL-TNLNDLRISDNNFSGKIPEFIG----K-WKKIQKLHIQGSSLEGPIP----AS 254 (799)
Q Consensus 189 L~~L~Ls~N~l~~~~p~~~----~~l-~~L~~L~Ls~N~l~~~~p~~~~----~-l~~L~~L~L~~N~l~~~~p----~~ 254 (799)
|++|+|++|.+++..+..+ ..+ ++|++|+|++|++++..+..+. . .++|++|+|++|.++...+ ..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 9999999999997766644 444 8999999999999877665543 3 3699999999999986444 44
Q ss_pred hhcCC-CCCeEEcCCCCCCCCCCCc----cCC--CCccEEEccCCcCccc----CCccccC-CCCCCeeccccccCCCCC
Q 003737 255 ISALT-SLTDLRISDLKGSESAFPK----LDK--MNLKTLILTKCLIHGE----IPDYIGD-MTKLKNIDLSFNNLTGGI 322 (799)
Q Consensus 255 ~~~l~-~L~~L~L~~n~~~~~~~~~----l~~--~~L~~L~L~~N~l~~~----~p~~l~~-l~~L~~L~Ls~N~l~~~~ 322 (799)
+..++ +|++|++++|.+....... +.. .+|+.|+|++|.++.. ++..+.. .++|++|+|++|++++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 45565 9999999997654433221 222 4899999999999863 4445555 459999999999999765
Q ss_pred ch----hhhccCCCCEEeccCCcCCCcCChhh---------hcCCCEEEeecCcCcccCC
Q 003737 323 PT----TFEKLAKTNFMYLTGNKLTGPVPKYI---------FNSNKNVDISLNNFTWESS 369 (799)
Q Consensus 323 p~----~~~~l~~L~~L~L~~N~l~g~~p~~~---------~~~l~~l~ls~N~~~g~~p 369 (799)
+. .+..+++|+.|+|++|.+.+..+..+ ...++.||+++|.+....+
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 53 34667899999999999765443321 1235789999999876543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=4.3e-21 Score=221.10 Aligned_cols=217 Identities=24% Similarity=0.345 Sum_probs=143.8
Q ss_pred CCCCCCCCCCCC-CCCcccCCCCCCCCCCe-EecCCCCcccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcC
Q 003737 55 DWNFGVDPCSQK-GNWELSSDDKKGFESNV-TCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSF 132 (799)
Q Consensus 55 ~W~~~~d~C~~~-~~W~~~~~~~~~~~~gv-~c~~~~~~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~ 132 (799)
+|..+.++|... ..| .++ .|.+ .+++.|+|+++++++ +|..+. ++|++|+|++|+|+. +
T Consensus 35 ~W~~~~~~~~~~~~~~-----------~~l~~C~~----~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~-i 95 (571)
T 3cvr_A 35 KWEKQALPGENRNEAV-----------SLLKECLI----NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALIS-L 95 (571)
T ss_dssp HHHTTCCTTCCHHHHH-----------HHHHHHHH----TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSC-C
T ss_pred HHhccCCccccccchh-----------hhcccccc----CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcc-c
Confidence 466566788421 136 566 5754 378899999999986 777663 789999999998884 4
Q ss_pred cccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCC
Q 003737 133 SPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLT 211 (799)
Q Consensus 133 p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 211 (799)
| ..++ |++|+|++|+|++ +|. +.. +|++|+|++|++++ +|. .+++|++|+|++|.+++ +|. .++
T Consensus 96 p---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~ 160 (571)
T 3cvr_A 96 P---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPT 160 (571)
T ss_dssp C---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCT
T ss_pred c---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCC
Confidence 4 2344 8888888888876 565 554 78888888888775 555 56778888888888775 555 467
Q ss_pred CCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccC
Q 003737 212 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTK 291 (799)
Q Consensus 212 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~ 291 (799)
+|++|+|++|++++ +|. |. ++|+.|+|++|+|+ .+|. +.. +| .. ....|+.|+|++
T Consensus 161 ~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L-----~~-----------~~~~L~~L~Ls~ 216 (571)
T 3cvr_A 161 SLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RN-----HH-----------SEETEIFFRCRE 216 (571)
T ss_dssp TCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC--------------------------CCEEEECCS
T ss_pred CcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hh-----hc-----------ccccceEEecCC
Confidence 77777777777775 555 54 67777777777776 3443 221 11 00 002346666666
Q ss_pred CcCcccCCccccCCCCCCeeccccccCCCCCchhhhccC
Q 003737 292 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLA 330 (799)
Q Consensus 292 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 330 (799)
|.|+ .+|..+..+++|+.|+|++|++++.+|..+..++
T Consensus 217 N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp SCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred Ccce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 6666 4566666677777777777777766666666543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-20 Score=204.96 Aligned_cols=238 Identities=14% Similarity=0.083 Sum_probs=158.5
Q ss_pred EEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCC-cccCCCCCCCE-EEeeC
Q 003737 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFP-KVLTNITTLKN-LSIEG 172 (799)
Q Consensus 96 ~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p-~~~~~L~~L~~-L~Ls~ 172 (799)
+++.++++++ .+|..+ .+++++|+|++|+|+.+.+..|..++ |++|+|++|++.+.+| ..|.++++|++ +.++.
T Consensus 13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 4677888888 677766 36889999999999877777788876 8888888888766554 46778887765 55667
Q ss_pred CcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccC-CcCCCcCCccccCCC-CCCEEEccCCCCCCC
Q 003737 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD-NNFSGKIPEFIGKWK-KIQKLHIQGSSLEGP 250 (799)
Q Consensus 173 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~ 250 (799)
|+++...|..|..+++|++|++++|+++...+..+....++..|++.+ |++....+..|..+. .++.|+|++|+++..
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i 169 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI 169 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred CcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCC
Confidence 888876677788888888888888888866666666667777888765 456655555666654 577788888877743
Q ss_pred CchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccC-CcCcccCCccccCCCCCCeeccccccCCCCCchhhhcc
Q 003737 251 IPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTK-CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL 329 (799)
Q Consensus 251 ~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 329 (799)
|.......+ |+.|++++ |.++...++.|..+++|++|||++|+|+...+.. +
T Consensus 170 -~~~~f~~~~-----------------------L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~---~ 222 (350)
T 4ay9_X 170 -HNSAFNGTQ-----------------------LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG---L 222 (350)
T ss_dssp -CTTSSTTEE-----------------------EEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSS---C
T ss_pred -Chhhccccc-----------------------hhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhh---h
Confidence 332222333 45555543 4444333345677777888888888777443333 3
Q ss_pred CCCCEEeccCCcCCCcCCh-hhhcCCCEEEeecCc
Q 003737 330 AKTNFMYLTGNKLTGPVPK-YIFNSNKNVDISLNN 363 (799)
Q Consensus 330 ~~L~~L~L~~N~l~g~~p~-~~~~~l~~l~ls~N~ 363 (799)
.+|+.|.+.++.-...+|. .-+.+++.++++++.
T Consensus 223 ~~L~~L~~l~~~~l~~lP~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 223 ENLKKLRARSTYNLKKLPTLEKLVALMEASLTYPS 257 (350)
T ss_dssp TTCCEEECTTCTTCCCCCCTTTCCSCCEEECSCHH
T ss_pred ccchHhhhccCCCcCcCCCchhCcChhhCcCCCCc
Confidence 4455555444433335553 224566777776553
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=8.4e-21 Score=201.42 Aligned_cols=124 Identities=27% Similarity=0.458 Sum_probs=102.5
Q ss_pred cCCCCCCeecccCCeeEEEEEeC------CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
++|...+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45667789999999999999853 478899999987776677899999999999999999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccc----cccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIF----HISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~----~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||||++|+|.++|+..+... .......+++.++..++.|||+||+|||+
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~ 146 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS 146 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999998653210 00112367888899999999999999994
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=6.3e-20 Score=184.64 Aligned_cols=147 Identities=24% Similarity=0.317 Sum_probs=71.6
Q ss_pred EEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCc
Q 003737 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL 174 (799)
Q Consensus 96 ~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~ 174 (799)
.+++++++++ .+|..+ .++|++|+|++|++++..+..|..++ |++|++++|++++..+..|..+++|++|+|++|.
T Consensus 11 ~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 87 (208)
T 2o6s_A 11 TVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87 (208)
T ss_dssp EEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCc
Confidence 3444455555 344433 35677777777777655544444444 5555555555554444444455555555555555
Q ss_pred CCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCC
Q 003737 175 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGS 245 (799)
Q Consensus 175 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 245 (799)
+++..+..|.++++|++|++++|++++..+..|.++++|++|++++|++++..+..|..+++|++|++++|
T Consensus 88 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 158 (208)
T 2o6s_A 88 LQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158 (208)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSC
T ss_pred CCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCC
Confidence 54333333444445555555554444333333444444444444444444333333344444444444444
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=5.5e-20 Score=197.02 Aligned_cols=189 Identities=18% Similarity=0.304 Sum_probs=132.8
Q ss_pred eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccC
Q 003737 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220 (799)
Q Consensus 141 L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 220 (799)
|++|++++|.++. +| .+..+++|++|+|++|.+++. +. +..+++|++|+|++|++++ ++ .+..+++|++|++++
T Consensus 43 L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~ 116 (308)
T 1h6u_A 43 ITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTS 116 (308)
T ss_dssp CCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTT
T ss_pred cCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCC
Confidence 6777777777663 33 466677777777777776643 33 6667777777777777664 22 466667777777777
Q ss_pred CcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCc
Q 003737 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPD 300 (799)
Q Consensus 221 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~ 300 (799)
|++++. +. +..+++|++|++++|.+++..+ +..++ +|+.|++++|.+++..+
T Consensus 117 n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~-----------------------~L~~L~l~~n~l~~~~~- 168 (308)
T 1h6u_A 117 TQITDV-TP-LAGLSNLQVLYLDLNQITNISP--LAGLT-----------------------NLQYLSIGNAQVSDLTP- 168 (308)
T ss_dssp SCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCT-----------------------TCCEEECCSSCCCCCGG-
T ss_pred CCCCCc-hh-hcCCCCCCEEECCCCccCcCcc--ccCCC-----------------------CccEEEccCCcCCCChh-
Confidence 776643 32 6666667777777666664322 44444 45666666677765433
Q ss_pred cccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhhcCCCEEEeecCcCcc
Q 003737 301 YIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTW 366 (799)
Q Consensus 301 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~l~~l~ls~N~~~g 366 (799)
+..+++|+.|++++|++++..+ +..+++|+.|+|++|++++..|-.-...++.|++++|.+++
T Consensus 169 -l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 169 -LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp -GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEEEEEEEC
T ss_pred -hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccccccCCCCCCEEEccCCeeec
Confidence 8899999999999999996554 89999999999999999976653334678999999999975
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.8e-20 Score=201.60 Aligned_cols=124 Identities=25% Similarity=0.428 Sum_probs=103.7
Q ss_pred cCCCCCCeecccCCeeEEEEEeC------CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
++|...+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34556788999999999999864 478999999987777777899999999999999999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCccccc------ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFH------ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~------~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||||++|+|.++|+....... ......+++.++..|+.|||+||+|||+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~ 176 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG 176 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 9999999999999986542211 0112257888899999999999999994
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.7e-19 Score=180.03 Aligned_cols=181 Identities=19% Similarity=0.184 Sum_probs=124.1
Q ss_pred CEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCc
Q 003737 119 KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS 198 (799)
Q Consensus 119 ~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 198 (799)
+.++.+++.++..+.... -+|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|++++|+
T Consensus 10 ~~v~c~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 87 (208)
T 2o6s_A 10 TTVECYSQGRTSVPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87 (208)
T ss_dssp TEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEecCCCccCCCCCCC--CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCc
Confidence 467777777765433221 137788888888876666677778888888888888776555567777888888888888
Q ss_pred CCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCc
Q 003737 199 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPK 278 (799)
Q Consensus 199 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~ 278 (799)
+++..+..|.++++|++|++++|++++..+..|..+++|++|+|++|.+++..+..+..+++|+.|++++
T Consensus 88 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~---------- 157 (208)
T 2o6s_A 88 LQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHD---------- 157 (208)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS----------
T ss_pred CCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecC----------
Confidence 7765555677777888888888877766666677777777777777777765555566666555555544
Q ss_pred cCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCC
Q 003737 279 LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331 (799)
Q Consensus 279 l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 331 (799)
|.+. +.+++|+.|+++.|+++|.+|..++.++.
T Consensus 158 -------------N~~~-------~~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 158 -------------NPWD-------CTCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp -------------CCBC-------CCTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred -------------CCee-------cCCCCHHHHHHHHHhCCceeeccCccccC
Confidence 4333 23456677777777777777766665554
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.1e-19 Score=207.07 Aligned_cols=185 Identities=21% Similarity=0.308 Sum_probs=126.2
Q ss_pred CCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEccc
Q 003737 117 YLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSS 196 (799)
Q Consensus 117 ~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 196 (799)
+|+.|+|++|.+++ +|..+. ..|++|+|++|+|+ .+| ..+++|++|+|++|.+++ +|. +.+ +|++|+|++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~-~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~ 129 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP-PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDN 129 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC-TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCS
T ss_pred CccEEEeCCCCCCc-cCHhHc-CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCC
Confidence 67777777777776 343332 23777777777776 455 345677777777777765 555 444 677777777
Q ss_pred CcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCC
Q 003737 197 NSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAF 276 (799)
Q Consensus 197 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~ 276 (799)
|++++ +|. .+++|++|+|++|.+++ +|. .+++|++|+|++|++++ +|. |.
T Consensus 130 N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~-------------------- 179 (571)
T 3cvr_A 130 NQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP-------------------- 179 (571)
T ss_dssp SCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--------------------
T ss_pred CcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--------------------
Confidence 77765 554 45667777777777664 444 45666666666666664 333 22
Q ss_pred CccCCCCccEEEccCCcCcccCCccccCCCCC-------CeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChh
Q 003737 277 PKLDKMNLKTLILTKCLIHGEIPDYIGDMTKL-------KNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY 349 (799)
Q Consensus 277 ~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 349 (799)
.+|+.|+|++|+|+ .+|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|..
T Consensus 180 -----~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~ 249 (571)
T 3cvr_A 180 -----ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRES 249 (571)
T ss_dssp -----TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHH
T ss_pred -----CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHH
Confidence 35666777777777 5555 543 66 99999999999 68888888999999999999999998887
Q ss_pred hh
Q 003737 350 IF 351 (799)
Q Consensus 350 ~~ 351 (799)
+.
T Consensus 250 l~ 251 (571)
T 3cvr_A 250 LS 251 (571)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.81 E-value=3.8e-20 Score=197.22 Aligned_cols=122 Identities=23% Similarity=0.362 Sum_probs=99.7
Q ss_pred CCCCCeecccCCeeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 678 FDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
++..+.||+|+||+||+|++. +++.||||+++... ....++|.+|++++++++|||||+++|+|.+++..+||
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 445678999999999999862 46899999997653 33457899999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCccccc-------ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFH-------ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~-------~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||++|+|.++|+.+..... ......+++.++..++.|||+||+|||+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~ 163 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS 163 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999976532111 1122357788888899999999999994
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=6.7e-20 Score=197.54 Aligned_cols=117 Identities=21% Similarity=0.339 Sum_probs=98.1
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
++|+..+.||+|+||+||+|+. .+|+.||||++... .....+.|.+|+++|++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5788899999999999999994 57999999999754 33446789999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||++|+|.++|+.++.. .++|.+++.|+.||+.||+|||+
T Consensus 104 y~~gg~L~~~i~~~~~~-------~~~e~~~~~~~~qi~~aL~ylH~ 143 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGV-------LFQEDQILDWFVQICLALKHVHD 143 (350)
T ss_dssp CCTTCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCcHHHHHHHcCCC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999765422 57888999999999999999994
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.8e-19 Score=195.06 Aligned_cols=205 Identities=16% Similarity=0.094 Sum_probs=122.3
Q ss_pred CCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCC-hhccCCCCCCE-EEccCCcCCCcCCccccCCCCCCEE
Q 003737 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELP-AELTKLTNLND-LRISDNNFSGKIPEFIGKWKKIQKL 240 (799)
Q Consensus 163 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L 240 (799)
+++++|+|++|+|+...+..|.++++|++|+|++|++.+.+| ..|.++++|+. +.++.|+++...|..|..+++|++|
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L 109 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 109 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence 345555555555543223345555555555555555443333 23445544443 3334455554445555555555555
Q ss_pred EccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCC-CCCccCC--CCccEEEccCCcCcccCCccccCCCCCCeecccc-c
Q 003737 241 HIQGSSLEGPIPASISALTSLTDLRISDLKGSES-AFPKLDK--MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSF-N 316 (799)
Q Consensus 241 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~-~~~~l~~--~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~-N 316 (799)
++++|+++...+..+....++..|++.+++.... ....+.. ..++.|+|++|+|+. +|.......+|++|++++ |
T Consensus 110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n 188 (350)
T 4ay9_X 110 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNN 188 (350)
T ss_dssp EEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCT
T ss_pred cccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC-CChhhccccchhHHhhccCC
Confidence 5555555544444444444455555544222221 1111222 368889999999985 455555667899999985 6
Q ss_pred cCCCCCchhhhccCCCCEEeccCCcCCCcCChhhhcCCCEEEeecCcCcccCC
Q 003737 317 NLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESS 369 (799)
Q Consensus 317 ~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~l~~l~ls~N~~~g~~p 369 (799)
.++...+..|..+++|++|+|++|+|+ .+|...+..++.|.+.+++--..+|
T Consensus 189 ~l~~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~~~~~L~~L~~l~~~~l~~lP 240 (350)
T 4ay9_X 189 NLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKLP 240 (350)
T ss_dssp TCCCCCTTTTTTEECCSEEECTTSCCC-CCCSSSCTTCCEEECTTCTTCCCCC
T ss_pred cccCCCHHHhccCcccchhhcCCCCcC-ccChhhhccchHhhhccCCCcCcCC
Confidence 676555567899999999999999999 6788888889999887765544555
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=6.5e-20 Score=197.36 Aligned_cols=114 Identities=23% Similarity=0.435 Sum_probs=103.0
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
+.|+..+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4577788999999999999995 579999999997665555667899999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.+++.+. .+++.+++.|+.||+.||+|||+
T Consensus 154 ~gg~L~~~l~~~----------~l~e~~~~~~~~qi~~aL~ylH~ 188 (346)
T 4fih_A 154 EGGALTDIVTHT----------RMNEEQIAAVCLAVLQALSVLHA 188 (346)
T ss_dssp TTEEHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCcHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999753 57899999999999999999994
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.79 E-value=6.8e-20 Score=194.26 Aligned_cols=115 Identities=21% Similarity=0.278 Sum_probs=103.4
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4588899999999999999994 579999999997542 234578999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||++|+|.++|.+.+ .++|.+++.|+.||+.||+|||+
T Consensus 112 Ey~~gG~L~~~i~~~~---------~l~e~~~~~~~~qi~~al~ylH~ 150 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG---------SFDETCTRFYTAEIVSALEYLHG 150 (311)
T ss_dssp CCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998654 68899999999999999999994
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.7e-19 Score=199.04 Aligned_cols=115 Identities=23% Similarity=0.431 Sum_probs=104.2
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
.+.|+..+.||+|+||.||+|.. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 45688889999999999999995 57999999999776555567799999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|++|+|.++++.. .+++.+++.|+.||+.||+|||+
T Consensus 230 ~~gG~L~~~i~~~----------~l~e~~~~~~~~qil~aL~ylH~ 265 (423)
T 4fie_A 230 LEGGALTDIVTHT----------RMNEEQIAAVCLAVLQALSVLHA 265 (423)
T ss_dssp CTTEEHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCcHHHHHhcc----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999753 57899999999999999999994
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.4e-18 Score=177.68 Aligned_cols=149 Identities=21% Similarity=0.289 Sum_probs=127.0
Q ss_pred CCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCC
Q 003737 100 KAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGS 178 (799)
Q Consensus 100 ~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~ 178 (799)
++++++ .+|..+. ++|++|+|++|.+++..|..|..+. |++|+|++|+|+...+..|..+++|++|+|++|++++.
T Consensus 27 ~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l 103 (229)
T 3e6j_A 27 RSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVL 103 (229)
T ss_dssp TTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred cCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCcc
Confidence 344454 5666554 8899999999999998888888887 99999999999877777789999999999999999877
Q ss_pred CCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCc
Q 003737 179 IPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252 (799)
Q Consensus 179 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 252 (799)
.+..|..+++|++|+|++|+++ .+|..+..+++|++|+|++|++++..+..|..+++|+.|+|++|.+....+
T Consensus 104 ~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 104 PSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred ChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 6777889999999999999998 788888999999999999999997777788889999999999998886543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=3.5e-19 Score=189.14 Aligned_cols=115 Identities=21% Similarity=0.389 Sum_probs=97.7
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
..+++...+.||+|+||+||+|++.+ .||||+++.. .....+.|.+|++++++++|||||+++|+|.+ +..+|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 34567778899999999999999753 5999999754 33445789999999999999999999999854 5689999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||++|+|.++|+.... .+++.++..++.|||+||+|||+
T Consensus 111 Ey~~gGsL~~~l~~~~~--------~l~~~~~~~i~~qia~gL~yLH~ 150 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQET--------KFQMFQLIDIARQTAQGMDYLHA 150 (307)
T ss_dssp ECCSSCBHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EcCCCCCHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999986532 57788888999999999999994
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.78 E-value=4.1e-19 Score=187.14 Aligned_cols=112 Identities=21% Similarity=0.349 Sum_probs=96.8
Q ss_pred CCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEE----CCEEEEEE
Q 003737 679 DPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLLVY 751 (799)
Q Consensus 679 ~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 751 (799)
...+.||+|+||+||+|.. .++..||||++... .....+.|.+|++++++++|||||+++++|.+ ++..||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 3456799999999999995 57899999999654 33445789999999999999999999999875 34589999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||++|+|.+++++.. .+++..++.|+.||++||+|||+
T Consensus 109 Ey~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~ylH~ 147 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLHT 147 (290)
T ss_dssp ECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred eCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998654 67888999999999999999995
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.5e-20 Score=222.23 Aligned_cols=194 Identities=22% Similarity=0.236 Sum_probs=83.0
Q ss_pred cCCCCHHHHHHHHHHHHhcCCCCCC------CCCCCCCCCCCCcccCCCCCCCCCCeEecCCCCcccEEEEEeCCCCCcc
Q 003737 33 ANKLHAEEVKALKQIGRKLGKKDWN------FGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTG 106 (799)
Q Consensus 33 ~~~~~~~~~~aL~~~~~~~~~~~W~------~~~d~C~~~~~W~~~~~~~~~~~~gv~c~~~~~~~~v~~L~L~~~~l~g 106 (799)
+.+..+.++++|.+++.++...+|. ....++. .| .++.+. .++++.|+|.++.+..
T Consensus 126 s~s~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-----------~~~~~s----~~~~~~l~L~~n~~~~ 187 (727)
T 4b8c_D 126 SKSLVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSG---TA-----------TNSAVS----TPLTPKIELFANGKDE 187 (727)
T ss_dssp ------CCCHHHHHHHHHHHHHHTTC------------------------------------------------------
T ss_pred hhhccccchhhhhhhhhhcccccCcccCCCcCCCCccc---cC-----------CCceec----CCccceEEeeCCCCCc
Confidence 3446677899999999887554443 2222221 45 444443 3679999999988875
Q ss_pred cCCccccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCC
Q 003737 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKL 186 (799)
Q Consensus 107 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l 186 (799)
++.. .|+.++|+.|.+.+ ++++.|.+. ..|+.+..++.|+.|+|++|.+. .+|..+..+
T Consensus 188 -~~~~-----~l~~l~Ls~~~i~~-------------~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l 246 (727)
T 4b8c_D 188 -ANQA-----LLQHKKLSQYSIDE-------------DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKY 246 (727)
T ss_dssp ------------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGC
T ss_pred -chhh-----HhhcCccCcccccC-------------cccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCC
Confidence 3332 34556666665543 344455554 55666666677777777777666 566666666
Q ss_pred CCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEc
Q 003737 187 INLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRI 266 (799)
Q Consensus 187 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 266 (799)
++|++|+|++|.|+ .+|..|.++++|++|+|++|.|+ .+|..|+.+++|++|+|++|.|+ .+|..|.++++|+.|+|
T Consensus 247 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L 323 (727)
T 4b8c_D 247 DFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGV 323 (727)
T ss_dssp CSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEEC
T ss_pred CCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeC
Confidence 77777777777766 66666666777777777777766 55666666677777777777665 45555666655555544
Q ss_pred CC
Q 003737 267 SD 268 (799)
Q Consensus 267 ~~ 268 (799)
++
T Consensus 324 ~~ 325 (727)
T 4b8c_D 324 EG 325 (727)
T ss_dssp TT
T ss_pred CC
Confidence 44
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=1e-18 Score=177.55 Aligned_cols=155 Identities=17% Similarity=0.238 Sum_probs=131.9
Q ss_pred EEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCc-ccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeC
Q 003737 95 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFS-PQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (799)
Q Consensus 95 ~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~ 172 (799)
+.++++++.++ .+|..+. ..+++|+|++|++++..+ ..|..++ |++|+|++|+|++..+..|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 37899999998 4776654 457899999999998855 4577776 99999999999988888899999999999999
Q ss_pred CcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCc
Q 003737 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252 (799)
Q Consensus 173 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 252 (799)
|.+++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|.+.+..+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99987777778899999999999999998888889999999999999999988888889899999999999998876544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.3e-18 Score=176.74 Aligned_cols=152 Identities=21% Similarity=0.307 Sum_probs=127.0
Q ss_pred EEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCC
Q 003737 95 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN 173 (799)
Q Consensus 95 ~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N 173 (799)
..+++++++++ .+|..+. ++|++|+|++|++++..+..|..++ |++|+|++|++++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 35788888888 5676654 7899999999999988887888876 899999999988888888888889999999999
Q ss_pred cCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCC
Q 003737 174 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (799)
Q Consensus 174 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 249 (799)
.++...+..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 8886555567888888888888888888778888888888888888888887777778888888888888888764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.5e-18 Score=190.26 Aligned_cols=171 Identities=22% Similarity=0.229 Sum_probs=143.0
Q ss_pred EEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCccccc-ccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeC
Q 003737 95 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWA-SLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (799)
Q Consensus 95 ~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~ 172 (799)
..+++++++++ .+|..+. +.++.|+|++|++++..+..|. .+. |++|+|++|+|++..|..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 36889999998 5776654 4689999999999998888886 776 99999999999988888999999999999999
Q ss_pred CcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccc---cCCCCCCEEEccCCCCCC
Q 003737 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI---GKWKKIQKLHIQGSSLEG 249 (799)
Q Consensus 173 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~ 249 (799)
|++++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+..| ..+++|+.|+|++|+++.
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 99987777789999999999999999998888899999999999999999996555555 568999999999999997
Q ss_pred CCchhhhcCCCC--CeEEcCC
Q 003737 250 PIPASISALTSL--TDLRISD 268 (799)
Q Consensus 250 ~~p~~~~~l~~L--~~L~L~~ 268 (799)
..+..+..++.+ +.|++.+
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~ 198 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHN 198 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCS
T ss_pred cCHHHhhhccHhhcceEEecC
Confidence 766777776653 4455544
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.77 E-value=8.8e-19 Score=183.05 Aligned_cols=114 Identities=21% Similarity=0.392 Sum_probs=97.7
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||+||+|.. .+|+.||||++++.. ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6799999999999999999994 579999999997542 233567999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+ +|+|.+++.+++ .+++.+++.++.||+.||+|||+
T Consensus 93 Ey~-~g~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~ylH~ 130 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD---------KMSEQEARRFFQQIISAVEYCHR 130 (275)
T ss_dssp ECC-CEEHHHHHHHSC---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eCC-CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 689999998765 68899999999999999999995
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=5.9e-19 Score=189.27 Aligned_cols=110 Identities=22% Similarity=0.309 Sum_probs=98.3
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
+.|...+.||+|+||+||+|+. .+|+.||||+++.... +.+|++++++++|||||++++++.+++..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4566778899999999999995 5799999999975432 247999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.++|++.+ .+++.+++.|+.||+.||+|||+
T Consensus 133 ~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~ylH~ 168 (336)
T 4g3f_A 133 EGGSLGQLIKQMG---------CLPEDRALYYLGQALEGLEYLHT 168 (336)
T ss_dssp TTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999998654 68899999999999999999996
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=8.8e-18 Score=170.60 Aligned_cols=149 Identities=15% Similarity=0.187 Sum_probs=128.8
Q ss_pred CEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCC-cccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccC
Q 003737 119 KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFP-KVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN 197 (799)
Q Consensus 119 ~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p-~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 197 (799)
+++++++|.++.. |..+.. .+++|+|++|++++..| ..|..+++|++|+|++|.+++..+..|.++++|++|+|++|
T Consensus 14 ~~l~~s~n~l~~i-P~~~~~-~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 14 TTVDCSNQKLNKI-PEHIPQ-YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp TEEECCSSCCSSC-CSCCCT-TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEeEeCCCCcccC-ccCCCC-CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 5899999999864 443321 27899999999998755 46889999999999999999877778999999999999999
Q ss_pred cCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCC
Q 003737 198 SFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDL 269 (799)
Q Consensus 198 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n 269 (799)
++++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|+.|++++|
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 163 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCc
Confidence 999888888999999999999999999888999999999999999999999888888888888777777664
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.4e-18 Score=187.36 Aligned_cols=128 Identities=20% Similarity=0.136 Sum_probs=77.4
Q ss_pred CEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccC-CCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccC
Q 003737 119 KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLT-NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN 197 (799)
Q Consensus 119 ~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~-~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 197 (799)
+.+++++|+++.. |..+.. .+++|+|++|+|++..+..+. ++++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 21 ~~l~c~~~~l~~i-P~~~~~-~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 21 NILSCSKQQLPNV-PQSLPS-YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp TEEECCSSCCSSC-CSSCCT-TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCcc-CccCCC-CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 4677777777753 322211 256666666666665555565 6666666666666666555555666666666666666
Q ss_pred cCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCC
Q 003737 198 SFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (799)
Q Consensus 198 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 248 (799)
++++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++|+++
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 149 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC
Confidence 666555555666666666666666666555555555555555555555555
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=3.2e-19 Score=188.96 Aligned_cols=115 Identities=18% Similarity=0.314 Sum_probs=96.1
Q ss_pred cCCCCCCeecccCCeeEEEEEe----CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~----~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
++|+..+.||+|+||+||+|+. .+++.||||+++... ......+.+|+++|++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4588899999999999999984 247899999997542 2234578899999999999999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||||++|+|.+++.+.+ .+++.+++.|+.||+.||+|||+
T Consensus 104 vmEy~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~ylH~ 144 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLHS 144 (304)
T ss_dssp EECCCTTCEEHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEcCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999998654 68899999999999999999995
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.75 E-value=6.1e-18 Score=179.47 Aligned_cols=173 Identities=20% Similarity=0.346 Sum_probs=106.3
Q ss_pred ccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCC
Q 003737 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQ 190 (799)
Q Consensus 112 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 190 (799)
+..+++|++|++++|.++.. + .+..++ |++|++++|++++..+ +.++++|++|+|++|.+++ + +.+..+++|+
T Consensus 42 ~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~ 115 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-L-SSLKDLKKLK 115 (291)
T ss_dssp HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-G-GGGTTCTTCC
T ss_pred hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-C-hhhccCCCCC
Confidence 34566677777777766644 2 244444 6666666666664433 6666666666666666653 2 2366666666
Q ss_pred EEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCC
Q 003737 191 KLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK 270 (799)
Q Consensus 191 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~ 270 (799)
+|++++|++++. ..+..+++|++|++++|++++. +.+..+++|++|+|++|++++..+ +..++
T Consensus 116 ~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~----------- 178 (291)
T 1h6t_A 116 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLT----------- 178 (291)
T ss_dssp EEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCT-----------
T ss_pred EEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCC-----------
Confidence 666666666642 3456666666666666666643 455666666666666666654333 44444
Q ss_pred CCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCC
Q 003737 271 GSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG 321 (799)
Q Consensus 271 ~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 321 (799)
+|+.|++++|.+++ +| .+..+++|+.|++++|+++..
T Consensus 179 ------------~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 179 ------------KLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp ------------TCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECC
T ss_pred ------------ccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCC
Confidence 45555556666664 33 377888899999999988753
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.75 E-value=6.4e-18 Score=179.35 Aligned_cols=169 Identities=22% Similarity=0.357 Sum_probs=81.0
Q ss_pred CCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEE
Q 003737 161 NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKL 240 (799)
Q Consensus 161 ~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 240 (799)
.+++|++|++++|.++. ++ .+..+++|++|++++|++++..+ +.++++|++|++++|++++ + +.+..+++|++|
T Consensus 44 ~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L 117 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-L-SSLKDLKKLKSL 117 (291)
T ss_dssp HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-G-GGGTTCTTCCEE
T ss_pred hcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-C-hhhccCCCCCEE
Confidence 34445555555555442 22 24445555555555555543222 4555555555555555543 1 224555555555
Q ss_pred EccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCC
Q 003737 241 HIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319 (799)
Q Consensus 241 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 319 (799)
+|++|++++. +.+..+++|+.|++++|..... +.+.. .+|+.|++++|.+++..| +..+++|+.|++++|+++
T Consensus 118 ~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~ 191 (291)
T 1h6t_A 118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191 (291)
T ss_dssp ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence 5555555432 2344444444444443222111 11222 344444555555554333 556666666666666666
Q ss_pred CCCchhhhccCCCCEEeccCCcCC
Q 003737 320 GGIPTTFEKLAKTNFMYLTGNKLT 343 (799)
Q Consensus 320 ~~~p~~~~~l~~L~~L~L~~N~l~ 343 (799)
+ +| .+..+++|+.|++++|+++
T Consensus 192 ~-l~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 192 D-LR-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp B-CG-GGTTCTTCSEEEEEEEEEE
T ss_pred C-Ch-hhccCCCCCEEECcCCccc
Confidence 4 23 2566666666666666655
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.4e-17 Score=169.17 Aligned_cols=149 Identities=15% Similarity=0.199 Sum_probs=127.1
Q ss_pred CEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCc
Q 003737 119 KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS 198 (799)
Q Consensus 119 ~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 198 (799)
+.++++++.++..+. .+. ..+++|+|++|+|++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus 14 ~~v~c~~~~l~~iP~-~l~-~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 14 NIVDCRGKGLTEIPT-NLP-ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp TEEECTTSCCSSCCS-SCC-TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCcCcCCC-ccC-cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 578999999886543 332 248999999999998888889999999999999999998888899999999999999999
Q ss_pred CCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCC
Q 003737 199 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDL 269 (799)
Q Consensus 199 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n 269 (799)
++...+..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+..|..+++|+.|++++|
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 162 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCC
Confidence 99665666888999999999999999888899999999999999999999877777887777777776664
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.75 E-value=9.8e-18 Score=195.16 Aligned_cols=158 Identities=22% Similarity=0.382 Sum_probs=92.2
Q ss_pred EEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcC
Q 003737 97 IALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLF 175 (799)
Q Consensus 97 L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l 175 (799)
+.+..+.+...++ +..|++|+.|++++|.+.... .+..++ |++|+|++|.+++..| +..+++|+.|+|++|.+
T Consensus 26 l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l 99 (605)
T 1m9s_A 26 DNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI 99 (605)
T ss_dssp HHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCCT--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred HhccCCCcccccc--hhcCCCCCEEECcCCCCCCCh--HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCC
Confidence 3344444443332 445666666666666665432 345554 6666666666665443 66666666666666666
Q ss_pred CCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhh
Q 003737 176 TGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI 255 (799)
Q Consensus 176 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 255 (799)
++ +| .+..+++|++|+|++|++++ + ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|.+++..| +
T Consensus 100 ~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l 171 (605)
T 1m9s_A 100 KD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--L 171 (605)
T ss_dssp CC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--G
T ss_pred CC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--h
Confidence 53 22 56666666666666666664 2 3466666666666666666643 456666666666666666665444 5
Q ss_pred hcCCCCCeEEcCC
Q 003737 256 SALTSLTDLRISD 268 (799)
Q Consensus 256 ~~l~~L~~L~L~~ 268 (799)
..+++|+.|+|++
T Consensus 172 ~~l~~L~~L~Ls~ 184 (605)
T 1m9s_A 172 AGLTKLQNLYLSK 184 (605)
T ss_dssp TTCTTCCEEECCS
T ss_pred ccCCCCCEEECcC
Confidence 5555555555544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.9e-18 Score=186.04 Aligned_cols=134 Identities=20% Similarity=0.314 Sum_probs=107.5
Q ss_pred ccHHHHHHhhcCCCCCCeecccCCeeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCC-Ccccce
Q 003737 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQH-PNLVKL 737 (799)
Q Consensus 666 ~~~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H-~niv~l 737 (799)
+...+++...++|+..+.||+|+||+||+|... .++.||||+++... ....+.|.+|+++|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 445566777888999999999999999999853 24689999997653 3345789999999999965 899999
Q ss_pred eEEEEEC-CEEEEEEecCCCCcHHHHHhcCccccc-------ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 738 YGCCVEG-NQLLLVYEYMKNNCLSRAIFGKLRIFH-------ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 738 ~g~~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~-------~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.++ +..++|||||++|+|.++|+....... ......+++.++..|+.|||+||+|||+
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~ 203 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 203 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh
Confidence 9999764 578999999999999999986543211 0112357788899999999999999994
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=3.8e-18 Score=181.16 Aligned_cols=118 Identities=19% Similarity=0.402 Sum_probs=96.0
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECC--------
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-------- 745 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-------- 745 (799)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 3588889999999999999995 579999999997543 334578999999999999999999999987544
Q ss_pred ----EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 ----QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ----~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..|+|||||++|+|.+++..+.... ..++..+..++.||++||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~------~~~~~~~~~i~~qi~~al~ylH~ 136 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIE------ERERSVCLHIFLQIAEAVEFLHS 136 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGG------GSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCC------hhHHHHHHHHHHHHHHHHHHHHH
Confidence 3699999999999999998664321 22345677889999999999995
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=4.8e-18 Score=181.10 Aligned_cols=111 Identities=24% Similarity=0.320 Sum_probs=89.8
Q ss_pred CCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECC----EEEEEEe
Q 003737 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----QLLLVYE 752 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~E 752 (799)
++...+.||+|+||+||+|++ +|+.||||+++.... ....+.+|+..+.+++|||||+++|+|.+++ ..|||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 355678999999999999998 589999999965422 1223345555667889999999999998754 6899999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||++|+|.++|+.+ .++++....++.|+|+||+|||+
T Consensus 82 y~~~gsL~~~l~~~----------~l~~~~~~~i~~~ia~gl~ylH~ 118 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY----------TVTVEGMIKLALSTASGLAHLHM 118 (303)
T ss_dssp CCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCcHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999864 34566777789999999999995
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.73 E-value=7.6e-18 Score=196.09 Aligned_cols=170 Identities=23% Similarity=0.349 Sum_probs=89.4
Q ss_pred CCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEE
Q 003737 161 NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKL 240 (799)
Q Consensus 161 ~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 240 (799)
.|++|+.|++++|.+.. +| .+..+++|++|+|++|++++..| +..+++|+.|+|++|.+++ +| .+..+++|++|
T Consensus 41 ~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L 114 (605)
T 1m9s_A 41 ELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSL 114 (605)
T ss_dssp HHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEE
T ss_pred cCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEE
Confidence 34444444444444432 22 24444444444444444443222 4444444444444444442 11 34444444555
Q ss_pred EccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCC
Q 003737 241 HIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319 (799)
Q Consensus 241 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 319 (799)
+|++|.+++. +.+..+++|+.|+|++|.+... +.+.. .+|+.|+|++|.+++..| +..+++|+.|+|++|+|+
T Consensus 115 ~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~ 188 (605)
T 1m9s_A 115 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 188 (605)
T ss_dssp ECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred EecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCC
Confidence 5544444431 2344444444444444332221 22333 456666666677766555 777778888888888777
Q ss_pred CCCchhhhccCCCCEEeccCCcCCC
Q 003737 320 GGIPTTFEKLAKTNFMYLTGNKLTG 344 (799)
Q Consensus 320 ~~~p~~~~~l~~L~~L~L~~N~l~g 344 (799)
+. ..+..+++|+.|+|++|++++
T Consensus 189 ~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 189 DL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp BC--GGGTTCTTCSEEECCSEEEEC
T ss_pred CC--hHHccCCCCCEEEccCCcCcC
Confidence 53 357777788888888887774
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.8e-19 Score=210.81 Aligned_cols=251 Identities=13% Similarity=0.073 Sum_probs=124.6
Q ss_pred ccEEEEEeCCCCCccc----CCccccCCCCCCEEEccCCcCCCc----Ccccccccc-eeEEEccCCcCcCcCCcccCCC
Q 003737 92 CHVVTIALKAQNLTGT----LPTELSKLRYLKQLDLSRNCLTGS----FSPQWASLQ-LVELSVMGNRLSGPFPKVLTNI 162 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L 162 (799)
.++++|+|+++.+++. ++..+..+++|++|+|++|.+++. ++..+..++ |++|++++|.+.+ +|..+.++
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~ 242 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAA 242 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHC
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhh
Confidence 3567777777766554 333445667777777777776632 233333444 7777777766553 33444444
Q ss_pred CCCCEEEe---------------------------eCCcCCCCCCccccCCCCCCEEEcccCcCCccCC-hhccCCCCCC
Q 003737 163 TTLKNLSI---------------------------EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELP-AELTKLTNLN 214 (799)
Q Consensus 163 ~~L~~L~L---------------------------s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~ 214 (799)
++|++|++ +++. .+.+|..+..+++|++|+|++|.+++... ..+..+++|+
T Consensus 243 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~ 321 (592)
T 3ogk_B 243 ANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLE 321 (592)
T ss_dssp TTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCC
T ss_pred hHHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCC
Confidence 44444444 3322 23455556677788888888887664332 3356667777
Q ss_pred EEEccCCcCCCcCCccccCCCCCCEEEcc-----------CCCCCCC-CchhhhcCCCCCeEEcCCCCCCCCCCCccCC-
Q 003737 215 DLRISDNNFSGKIPEFIGKWKKIQKLHIQ-----------GSSLEGP-IPASISALTSLTDLRISDLKGSESAFPKLDK- 281 (799)
Q Consensus 215 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~-----------~N~l~~~-~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~- 281 (799)
+|+++++...+.++..+..+++|++|+|+ .|.+++. ++.....+++|++|+++.++.....+..+..
T Consensus 322 ~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~ 401 (592)
T 3ogk_B 322 VLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTY 401 (592)
T ss_dssp EEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHH
T ss_pred EEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhh
Confidence 77776332222233333455666666666 2444432 1222334556666665443332221212211
Q ss_pred -CCccEEEcc----CCcCccc-----CCccccCCCCCCeeccccc--cCCCCCchhhhc-cCCCCEEeccCCcCCC
Q 003737 282 -MNLKTLILT----KCLIHGE-----IPDYIGDMTKLKNIDLSFN--NLTGGIPTTFEK-LAKTNFMYLTGNKLTG 344 (799)
Q Consensus 282 -~~L~~L~L~----~N~l~~~-----~p~~l~~l~~L~~L~Ls~N--~l~~~~p~~~~~-l~~L~~L~L~~N~l~g 344 (799)
++|+.|+++ .|.+++. ++..+..+++|+.|++++| .+++..+..+.. +++|+.|++++|++++
T Consensus 402 ~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~ 477 (592)
T 3ogk_B 402 LKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESD 477 (592)
T ss_dssp CCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSH
T ss_pred CCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCH
Confidence 345555553 3444432 2222334455555555432 244333333322 4445555555555443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.72 E-value=7.2e-17 Score=164.89 Aligned_cols=147 Identities=19% Similarity=0.212 Sum_probs=117.9
Q ss_pred CEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCc
Q 003737 119 KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS 198 (799)
Q Consensus 119 ~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 198 (799)
+.++.+++.++..+. .+. ..|++|+|++|++++..|..|.++++|++|+|++|+++...+..|..+++|++|+|++|+
T Consensus 22 ~~v~c~~~~l~~ip~-~~~-~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 99 (229)
T 3e6j_A 22 TTVDCRSKRHASVPA-GIP-TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99 (229)
T ss_dssp TEEECTTSCCSSCCS-CCC-TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEeEccCCCcCccCC-CCC-CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence 457888888875543 222 338899999999998888888899999999999999876555667889999999999999
Q ss_pred CCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCC
Q 003737 199 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268 (799)
Q Consensus 199 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 268 (799)
+++..+..|..+++|++|+|++|+++ .+|..+..+++|++|+|++|++++..+..+..+++|+.|++++
T Consensus 100 l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 168 (229)
T 3e6j_A 100 LTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFG 168 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeC
Confidence 98766777888899999999999988 6788888888999999999988876666677777766666655
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.71 E-value=5.5e-19 Score=206.64 Aligned_cols=273 Identities=15% Similarity=0.117 Sum_probs=191.6
Q ss_pred cEEEEEeCCCC-Ccc-cCCccccCCCCCCEEEccCCcCCCc----Ccccccccc-eeEEEccCCcCcC----cCCcccCC
Q 003737 93 HVVTIALKAQN-LTG-TLPTELSKLRYLKQLDLSRNCLTGS----FSPQWASLQ-LVELSVMGNRLSG----PFPKVLTN 161 (799)
Q Consensus 93 ~v~~L~L~~~~-l~g-~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~-L~~L~Ls~N~l~~----~~p~~~~~ 161 (799)
++++|+|+++. ++. .++..+..+++|++|+|++|.+++. ++.....++ |++|++++|.+++ .++..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 49999999876 221 2333345789999999999998766 333445555 9999999999973 44556678
Q ss_pred CCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCC---ccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCC
Q 003737 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFT---GELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQ 238 (799)
Q Consensus 162 L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 238 (799)
+++|++|+|++|.+.+ +|..+..+++|++|+++.+... +..+..+..+++|+.|+++++.. +.+|..+..+++|+
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~ 296 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIR 296 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCC
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCCc
Confidence 9999999999999885 6788889999999999864333 33445677788888888887643 46777888888899
Q ss_pred EEEccCCCCCCCCc-hhhhcCCCCCeEEcCCCCCCCCCCCcc-CC-CCccEEEccC-----------CcCccc-CCcccc
Q 003737 239 KLHIQGSSLEGPIP-ASISALTSLTDLRISDLKGSESAFPKL-DK-MNLKTLILTK-----------CLIHGE-IPDYIG 303 (799)
Q Consensus 239 ~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~n~~~~~~~~~l-~~-~~L~~L~L~~-----------N~l~~~-~p~~l~ 303 (799)
+|+|++|.+++... ..+..+++|+.|++++ +.....++.+ .. ++|+.|++++ |.++.. ++....
T Consensus 297 ~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~-~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~ 375 (592)
T 3ogk_B 297 KLDLLYALLETEDHCTLIQKCPNLEVLETRN-VIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQ 375 (592)
T ss_dssp EEEETTCCCCHHHHHHHHTTCTTCCEEEEEG-GGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHH
T ss_pred EEecCCCcCCHHHHHHHHHhCcCCCEEeccC-ccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHh
Confidence 99998888765443 3467788888888873 4433334433 22 5788888883 555543 222244
Q ss_pred CCCCCCeeccccccCCCCCchhhhc-cCCCCEEecc----CCcCCCc-----CChhh--hcCCCEEEeecC--cCcccC
Q 003737 304 DMTKLKNIDLSFNNLTGGIPTTFEK-LAKTNFMYLT----GNKLTGP-----VPKYI--FNSNKNVDISLN--NFTWES 368 (799)
Q Consensus 304 ~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~----~N~l~g~-----~p~~~--~~~l~~l~ls~N--~~~g~~ 368 (799)
.+++|++|+++.|++++..+..+.. +++|+.|+++ .|.+++. ++..+ ...++.|+++++ .+++..
T Consensus 376 ~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~ 454 (592)
T 3ogk_B 376 GCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLG 454 (592)
T ss_dssp HCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHH
T ss_pred hCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHH
Confidence 5788888888888888777766665 7888888885 6677753 22112 346778888743 355443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=4.5e-17 Score=162.30 Aligned_cols=155 Identities=19% Similarity=0.303 Sum_probs=99.8
Q ss_pred CCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCE
Q 003737 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK 239 (799)
Q Consensus 160 ~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 239 (799)
+.+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..+..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 45667777777777776 445 5677777777777777554 2345777777777777777777666777777777777
Q ss_pred EEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCC
Q 003737 240 LHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319 (799)
Q Consensus 240 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 319 (799)
|+|++|.+++..|..+..+++|++|++++|.. ++ .+| .+..+++|+.|++++|+++
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~----------------------i~-~~~-~l~~l~~L~~L~l~~n~i~ 172 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGA----------------------IT-DIM-PLKTLPELKSLNIQFDGVH 172 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTB----------------------CC-CCG-GGGGCSSCCEEECTTBCCC
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCC----------------------cc-ccH-hhcCCCCCCEEECCCCCCc
Confidence 77777777766666676666666555554321 11 223 3556667777777777776
Q ss_pred CCCchhhhccCCCCEEeccCCcCCC
Q 003737 320 GGIPTTFEKLAKTNFMYLTGNKLTG 344 (799)
Q Consensus 320 ~~~p~~~~~l~~L~~L~L~~N~l~g 344 (799)
+ ++ .+..+++|+.|++++|++.+
T Consensus 173 ~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 173 D-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp C-CT-TGGGCSSCCEEEECBC----
T ss_pred C-hH-HhccCCCCCEEEeeCcccCC
Confidence 4 33 56677777777777777653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.70 E-value=2.7e-17 Score=190.42 Aligned_cols=117 Identities=19% Similarity=0.339 Sum_probs=105.5
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
.++|+..+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+++|++++|||||++++++.+.+..|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 35788899999999999999995 57999999999876666677899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|++|+|.++|..+.. .+++.+++.|+.||+.||+|||+
T Consensus 236 ~~gg~L~~~i~~~~~--------~l~e~~~~~~~~qi~~al~ylH~ 273 (573)
T 3uto_A 236 MSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHE 273 (573)
T ss_dssp CCCCBHHHHHTCTTS--------CEEHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999975432 57788999999999999999994
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.6e-17 Score=181.54 Aligned_cols=114 Identities=12% Similarity=0.313 Sum_probs=99.3
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEEC------CE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------NQ 746 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~ 746 (799)
++|+..+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5688899999999999999995 579999999997542 33456789999999999999999999997643 57
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.|||||||+ |+|.+++...+ .+++.+++.|+.||+.||+|||+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~---------~l~~~~~~~~~~qil~al~ylH~ 176 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ---------PLTLEHVRYFLYQLLRGLKYMHS 176 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 899999996 78999998765 68899999999999999999994
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=7.1e-17 Score=160.84 Aligned_cols=149 Identities=17% Similarity=0.248 Sum_probs=88.7
Q ss_pred cCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCE
Q 003737 113 SKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191 (799)
Q Consensus 113 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 191 (799)
..+++|++|++++|.++. +| .+..++ |++|++++|.++ .+..+..+++|++|++++|.+++..|..+..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 445566666666666653 22 344444 666666666443 2235666666666666666666555666666666666
Q ss_pred EEcccCcCCccCChhccCCCCCCEEEccCCc-CCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCC
Q 003737 192 LILSSNSFTGELPAELTKLTNLNDLRISDNN-FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDL 269 (799)
Q Consensus 192 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n 269 (799)
|++++|++++..|..+..+++|++|++++|. ++ .+| .+..+++|++|++++|.+++. + .+..+++|+.|++++|
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCc
Confidence 6666666666566666666666666666666 43 344 466666666666666666542 2 4555555555555553
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=1e-19 Score=210.54 Aligned_cols=188 Identities=18% Similarity=0.229 Sum_probs=110.4
Q ss_pred cCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCc-------------CcCcCCcccCCCCCCCEEE-eeCCcCCC
Q 003737 113 SKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNR-------------LSGPFPKVLTNITTLKNLS-IEGNLFTG 177 (799)
Q Consensus 113 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~-------------l~~~~p~~~~~L~~L~~L~-Ls~N~l~~ 177 (799)
..+++|+.|+|++|+++ .+|..++.++ |++|++++|. +.+.+|..++++++|+.|+ ++.|.+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-- 422 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL-- 422 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence 56788888888888886 5677788776 8888887664 4455555666666666665 444432
Q ss_pred CCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhc
Q 003737 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISA 257 (799)
Q Consensus 178 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 257 (799)
.+|+.+.+++|.++. +|. ..|+.|+|++|++++ +|. |+.+++|+.|+|++|.++ .+|..++.
T Consensus 423 ---------~~L~~l~l~~n~i~~-l~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 423 ---------DDLRSKFLLENSVLK-MEY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ---------HHHHHHHHHHHHHHH-HHH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ---------chhhhhhhhcccccc-cCc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc
Confidence 123333344444442 111 136677777777764 454 667777777777777776 56666666
Q ss_pred CCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCC-chhhhccCCCCEEe
Q 003737 258 LTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI-PTTFEKLAKTNFMY 336 (799)
Q Consensus 258 l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ 336 (799)
+++|+.|+|++ |.|++ +| .++.+++|+.|+|++|+|++.. |..|..+++|+.|+
T Consensus 485 l~~L~~L~Ls~-----------------------N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~ 539 (567)
T 1dce_A 485 LRCLEVLQASD-----------------------NALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539 (567)
T ss_dssp CTTCCEEECCS-----------------------SCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred CCCCCEEECCC-----------------------CCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence 66655555544 33332 33 4445555555555555555444 55555555555555
Q ss_pred ccCCcCCCcC
Q 003737 337 LTGNKLTGPV 346 (799)
Q Consensus 337 L~~N~l~g~~ 346 (799)
|++|++++..
T Consensus 540 L~~N~l~~~~ 549 (567)
T 1dce_A 540 LQGNSLCQEE 549 (567)
T ss_dssp CTTSGGGGSS
T ss_pred ecCCcCCCCc
Confidence 5555555433
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.67 E-value=5.9e-17 Score=169.21 Aligned_cols=161 Identities=20% Similarity=0.322 Sum_probs=101.2
Q ss_pred cEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEee
Q 003737 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (799)
Q Consensus 93 ~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls 171 (799)
+++.++++++.+++.. .+..+++|++|++++|.++.. + .+..++ |++|+|++|++++..+ +..+++|++|+|+
T Consensus 20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~ 93 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVN 93 (263)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECC
T ss_pred HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECC
Confidence 3455666677766433 466777777777777777643 2 455555 7777777777765443 6777777777777
Q ss_pred CCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCC
Q 003737 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251 (799)
Q Consensus 172 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 251 (799)
+|++++ +|.. .. ++|++|++++|++++ ++ .+..+++|++|++++|++++. + .+..+++|++|+|++|++++.
T Consensus 94 ~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~- 165 (263)
T 1xeu_A 94 RNRLKN-LNGI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT- 165 (263)
T ss_dssp SSCCSC-CTTC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC-
T ss_pred CCccCC-cCcc-cc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch-
Confidence 777764 3332 22 667777777777764 22 466777777777777777643 3 566667777777777776654
Q ss_pred chhhhcCCCCCeEEcCC
Q 003737 252 PASISALTSLTDLRISD 268 (799)
Q Consensus 252 p~~~~~l~~L~~L~L~~ 268 (799)
..+..+++|+.|++++
T Consensus 166 -~~l~~l~~L~~L~l~~ 181 (263)
T 1xeu_A 166 -GGLTRLKKVNWIDLTG 181 (263)
T ss_dssp -TTSTTCCCCCEEEEEE
T ss_pred -HHhccCCCCCEEeCCC
Confidence 4455555555555544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=3.5e-16 Score=155.15 Aligned_cols=133 Identities=20% Similarity=0.265 Sum_probs=81.4
Q ss_pred EEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCc
Q 003737 95 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL 174 (799)
Q Consensus 95 ~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~ 174 (799)
+.+++++++++ .+|..+.. +|++|+|++|++++..+. ..|+.+++|++|+|++|.
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~----------------------~~~~~l~~L~~L~Ls~N~ 65 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSD----------------------GLFGRLPHLVKLELKRNQ 65 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCS----------------------CSGGGCTTCCEEECCSSC
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCc----------------------cccccCCCCCEEECCCCC
Confidence 45677777774 55554432 566666666555543332 135556666666666666
Q ss_pred CCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCc
Q 003737 175 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252 (799)
Q Consensus 175 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 252 (799)
+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|.+++..+
T Consensus 66 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 66 LTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 665556666666666666666666666555556666666666666666666666666666666666666666665443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.1e-16 Score=167.17 Aligned_cols=167 Identities=22% Similarity=0.331 Sum_probs=103.3
Q ss_pred eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccC
Q 003737 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220 (799)
Q Consensus 141 L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 220 (799)
++.+++++|.+++.. .+..+++|++|++++|.++ .+| .+..+++|++|+|++|++++..+ +.++++|++|++++
T Consensus 21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~ 94 (263)
T 1xeu_A 21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNR 94 (263)
T ss_dssp HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCS
T ss_pred HHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCC
Confidence 555566666665432 4566677777777777766 344 56667777777777777764333 66777777777777
Q ss_pred CcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCc
Q 003737 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPD 300 (799)
Q Consensus 221 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~ 300 (799)
|++++ +|... . ++|++|+|++|++++. + .+..+++|+. |+|++|++++. +
T Consensus 95 N~l~~-l~~~~-~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~-----------------------L~Ls~N~i~~~-~- 144 (263)
T 1xeu_A 95 NRLKN-LNGIP-S-ACLSRLFLDNNELRDT-D-SLIHLKNLEI-----------------------LSIRNNKLKSI-V- 144 (263)
T ss_dssp SCCSC-CTTCC-C-SSCCEEECCSSCCSBS-G-GGTTCTTCCE-----------------------EECTTSCCCBC-G-
T ss_pred CccCC-cCccc-c-CcccEEEccCCccCCC-h-hhcCcccccE-----------------------EECCCCcCCCC-h-
Confidence 77764 33322 2 6677777777776642 2 3444444444 44444555432 2
Q ss_pred cccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCc
Q 003737 301 YIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP 345 (799)
Q Consensus 301 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ 345 (799)
.+..+++|+.|+|++|++++. ..+..+++|+.|++++|++++.
T Consensus 145 ~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 145 MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 456667777777777777755 5567777777777777777744
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.5e-16 Score=183.53 Aligned_cols=115 Identities=20% Similarity=0.320 Sum_probs=98.3
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHH---HHHHHHHHhCCCCcccceeEEEEECCEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREF---VNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f---~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 748 (799)
++|+..++||+|+||+||+|+. .+|+.||||++++.. ....... ..++++++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 5688899999999999999995 579999999996532 1122233 34466778889999999999999999999
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|||||++|+|.++|.+.+ .++|..++.|+.||+.||+|||+
T Consensus 269 lVmEy~~GGdL~~~l~~~~---------~l~E~~a~~y~~qIl~aL~yLH~ 310 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG---------VFSEADMRFYAAEIILGLEHMHN 310 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999998654 68899999999999999999996
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.65 E-value=4.4e-16 Score=154.44 Aligned_cols=111 Identities=25% Similarity=0.342 Sum_probs=81.5
Q ss_pred ccEEEEEeCCCCCcccCCc-cccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEE
Q 003737 92 CHVVTIALKAQNLTGTLPT-ELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 169 (799)
.+++.|++++|.+++..+. .|..+++|++|+|++|++++..|..|..+. |++|+|++|+|++..|..|.++++|++|+
T Consensus 29 ~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 108 (192)
T 1w8a_A 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEE
Confidence 4799999999999977665 489999999999999998877776666665 66667666666666666666666666666
Q ss_pred eeCCcCCCCCCccccCCCCCCEEEcccCcCCcc
Q 003737 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGE 202 (799)
Q Consensus 170 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 202 (799)
|++|++++..|..|..+++|++|+|++|.+++.
T Consensus 109 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 666666666666666666666666666666544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=3.1e-16 Score=171.01 Aligned_cols=113 Identities=17% Similarity=0.314 Sum_probs=99.4
Q ss_pred HhhcCCCCCCeecccCCeeEEEEEe----CCCcEEEEEEccccChhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEE
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL 747 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~~----~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 747 (799)
...+.|+..+.||+|+||+||+|+. .+++.||||++.... ....+.+|++++.++ +|||||++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 3567899999999999999999974 246899999986543 345788999999998 699999999999999999
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|||||++|+|.+++. .+++.+++.|+.||+.||+|||+
T Consensus 96 ~lvmE~~~g~~L~~~~~------------~l~~~~~~~~~~qll~al~ylH~ 135 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------------SLSFQEVREYMLNLFKALKRIHQ 135 (361)
T ss_dssp EEEEECCCCCCHHHHHT------------TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcccHHHHHc------------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999984 46788999999999999999995
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.65 E-value=3.1e-17 Score=195.56 Aligned_cols=120 Identities=27% Similarity=0.328 Sum_probs=63.4
Q ss_pred cccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCC
Q 003737 133 SPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLT 211 (799)
Q Consensus 133 p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 211 (799)
+..+..+. |++|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+|..|++|+
T Consensus 217 ~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~ 293 (727)
T 4b8c_D 217 KDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCF 293 (727)
T ss_dssp -----CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGT
T ss_pred hhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCC
Confidence 33344333 444444444444 34444445555555555555555 55555555555555555555555 4555555555
Q ss_pred CCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhh
Q 003737 212 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASIS 256 (799)
Q Consensus 212 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 256 (799)
+|++|+|++|.|+ .+|..|+.+++|++|+|++|.+++.+|..+.
T Consensus 294 ~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 337 (727)
T 4b8c_D 294 QLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILT 337 (727)
T ss_dssp TCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHH
T ss_pred CCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHh
Confidence 5555555555554 4455555555666666666665555555543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=8.2e-16 Score=165.49 Aligned_cols=128 Identities=24% Similarity=0.385 Sum_probs=109.9
Q ss_pred ccccccHHHHHHhhcC----------CCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhCC
Q 003737 662 QTGLYTLRQIKAATNN----------FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ 730 (799)
Q Consensus 662 ~~~~~~~~~~~~~t~~----------f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~ 730 (799)
+.+.++++++..+++. |+..+.||+|+||.||+|... +|+.||||++........+.+.+|++++.+++
T Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 100 (321)
T 2c30_A 21 QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 100 (321)
T ss_dssp ----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC
T ss_pred cCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC
Confidence 3456788888777754 555678999999999999965 79999999997766666778999999999999
Q ss_pred CCcccceeEEEEECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 731 H~niv~l~g~~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+++++++...+..++||||+++|+|.+++... .+++..+..++.||++||+|||+
T Consensus 101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~l~~~~~~~i~~qi~~~L~~LH~ 159 (321)
T 2c30_A 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----------RLNEEQIATVCEAVLQALAYLHA 159 (321)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999998743 46788999999999999999994
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-15 Score=147.88 Aligned_cols=131 Identities=21% Similarity=0.173 Sum_probs=86.1
Q ss_pred CCCCEEEccCCcCC-CcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEE
Q 003737 116 RYLKQLDLSRNCLT-GSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLI 193 (799)
Q Consensus 116 ~~L~~L~Ls~N~l~-~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 193 (799)
++|++|+|++|.++ +.+|..+..++ |++|++++|.+++. ..+..+++|++|+|++|.+++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 56677777777666 45555555555 66666666666654 5666677777777777777665666666677777777
Q ss_pred cccCcCCccC-ChhccCCCCCCEEEccCCcCCCcCC---ccccCCCCCCEEEccCCCCC
Q 003737 194 LSSNSFTGEL-PAELTKLTNLNDLRISDNNFSGKIP---EFIGKWKKIQKLHIQGSSLE 248 (799)
Q Consensus 194 Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~ 248 (799)
+++|.+++.. +..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 7777776431 2566677777777777777765444 36666777777777776665
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=4e-18 Score=197.21 Aligned_cols=188 Identities=12% Similarity=0.113 Sum_probs=125.4
Q ss_pred CCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCc-------------CCccCChhccCCCCCCEEE-ccCCcCCC
Q 003737 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS-------------FTGELPAELTKLTNLNDLR-ISDNNFSG 225 (799)
Q Consensus 160 ~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-------------l~~~~p~~~~~l~~L~~L~-Ls~N~l~~ 225 (799)
..+++|+.|+|++|+++ .+|..++++++|+.|++++|. +.+.+|..+..+++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 44566666666666665 566666666666666665553 3444555555555555555 4444322
Q ss_pred cCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccC
Q 003737 226 KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGD 304 (799)
Q Consensus 226 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~ 304 (799)
+|+.+.+++|.++.. | ...|+.|++++|.+.. +|.+.. .+|+.|+|++|.|+ .+|..++.
T Consensus 424 ----------~L~~l~l~~n~i~~l-~-----~~~L~~L~Ls~n~l~~--lp~~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLKM-E-----YADVRVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ----------HHHHHHHHHHHHHHH-H-----HTTCSEEECTTSCCSS--CCCGGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ----------hhhhhhhhccccccc-C-----ccCceEEEecCCCCCC--CcCccccccCcEeecCccccc-ccchhhhc
Confidence 111112222222210 0 0135555555543322 333444 56777788888888 78999999
Q ss_pred CCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcC-Chhhh--cCCCEEEeecCcCcccCCC
Q 003737 305 MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPV-PKYIF--NSNKNVDISLNNFTWESSD 370 (799)
Q Consensus 305 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~-p~~~~--~~l~~l~ls~N~~~g~~p~ 370 (799)
+++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.. |..+. ..++.|+|++|.+++.+|.
T Consensus 485 l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 485 LRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred CCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 9999999999999997 67 8999999999999999999876 88775 4789999999999988764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=2.7e-16 Score=176.07 Aligned_cols=125 Identities=19% Similarity=0.234 Sum_probs=107.6
Q ss_pred cHHHHHHhhcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccCh---hhHHHHHHHHHHHHhCCCCcccceeEEEE
Q 003737 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCV 742 (799)
Q Consensus 667 ~~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~ 742 (799)
.+.+++..+++|+..+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|++++.+++|||||+++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 45566667889999999999999999999965 588999999965321 12335899999999999999999999999
Q ss_pred ECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 743 EGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 743 ~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+.+..|+|||||++|+|.++++.... .+++..++.|+.||+.||+|||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~--------~l~e~~~~~~~~qi~~aL~~LH~ 193 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFED--------RLPEEMARFYLAEMVIAIDSVHQ 193 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999999999986322 57899999999999999999994
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.3e-15 Score=162.79 Aligned_cols=116 Identities=22% Similarity=0.391 Sum_probs=103.9
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
++|...+.||+|+||.||+|.. .+++.||+|++........+.|.+|++++.+++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 4577789999999999999995 468999999997766667789999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.++++.... .+++..+..++.|+++||+|||+
T Consensus 90 ~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~ 126 (310)
T 3s95_A 90 KGGTLRGIIKSMDS--------QYPWSQRVSFAKDIASGMAYLHS 126 (310)
T ss_dssp TTCBHHHHHHHCCT--------TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999986432 57788888999999999999994
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.9e-15 Score=160.74 Aligned_cols=115 Identities=21% Similarity=0.485 Sum_probs=103.7
Q ss_pred hcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
.++|+..+.||+|+||.||+|. ..+|+.||||++........+.+.+|+.++.+++|||||++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 4578899999999999999999 467899999999766555567899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++... .+++..+..++.|++.||+|||+
T Consensus 99 ~~~~~L~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~ 134 (297)
T 3fxz_A 99 LAGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLHS 134 (297)
T ss_dssp CTTCBHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999754 46788999999999999999994
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=4.5e-16 Score=167.39 Aligned_cols=129 Identities=37% Similarity=0.615 Sum_probs=111.6
Q ss_pred ccHHHHHHhhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECC
Q 003737 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN 745 (799)
Q Consensus 666 ~~~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 745 (799)
+++.++..++++|+..+.||+|+||.||+|...+|+.||||++........+.+.+|++++.+++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 33445556788999999999999999999998889999999998766666788999999999999999999999999999
Q ss_pred EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++||||+++|+|.+++...... ...+++..+..++.||++||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~ 157 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLP-----TMSMSWEQRLEICIGAARGLHYLHT 157 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCC-----SCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEEcCCCCcHHHHHhccCCC-----ccccCHHHHHHHHHHHHHHHHHhcC
Confidence 999999999999999999754321 1247788888999999999999994
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.62 E-value=7.6e-16 Score=145.92 Aligned_cols=126 Identities=25% Similarity=0.263 Sum_probs=99.2
Q ss_pred eeEEEccCCcCc-CcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEcc
Q 003737 141 LVELSVMGNRLS-GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219 (799)
Q Consensus 141 L~~L~Ls~N~l~-~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 219 (799)
+++|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|++++|.+++.+|..+..+++|++|+++
T Consensus 19 l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls 96 (149)
T 2je0_A 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLS 96 (149)
T ss_dssp CSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECT
T ss_pred CeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECC
Confidence 677777777776 67777778888888888888888755 667888888888888888887777777778888888888
Q ss_pred CCcCCCc-CCccccCCCCCCEEEccCCCCCCCCc---hhhhcCCCCCeEEcCC
Q 003737 220 DNNFSGK-IPEFIGKWKKIQKLHIQGSSLEGPIP---ASISALTSLTDLRISD 268 (799)
Q Consensus 220 ~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~ 268 (799)
+|++++. .+..+..+++|++|++++|.+++..+ ..+..+++|+.|++++
T Consensus 97 ~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 97 GNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp TSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 8888763 34778888888888888888887665 5788888888887753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=8.5e-16 Score=165.47 Aligned_cols=131 Identities=34% Similarity=0.603 Sum_probs=113.3
Q ss_pred ccccHHHHHHhhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccCh-hhHHHHHHHHHHHHhCCCCcccceeEEEE
Q 003737 664 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCV 742 (799)
Q Consensus 664 ~~~~~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~ 742 (799)
..+++.++...+++|+..+.||+|+||.||+|...+|+.||||++..... .....|.+|++++.+++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 46888999999999999999999999999999987899999999976532 22347999999999999999999999999
Q ss_pred ECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 743 EGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 743 ~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..+..++||||+++|+|.++++..... ...+++..+..++.|++.||+|||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~ 149 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPES-----QPPLDWPKRQRIALGSARGLAYLHD 149 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTT-----CCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCceEEEEEeccCCCHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999999999999865421 1247788899999999999999994
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.4e-15 Score=164.02 Aligned_cols=116 Identities=16% Similarity=0.304 Sum_probs=103.7
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46788899999999999999995 68999999999654 3344567999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++...+ .+++..++.++.||++||+|||+
T Consensus 94 e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~al~~lH~ 132 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG---------RMKEKEARSKFRQIVSAVQYCHQ 132 (328)
T ss_dssp CCCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ECCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999997654 57888999999999999999994
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.7e-15 Score=146.65 Aligned_cols=129 Identities=24% Similarity=0.244 Sum_probs=113.4
Q ss_pred eeEEEccCCcCc-CcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEcc
Q 003737 141 LVELSVMGNRLS-GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219 (799)
Q Consensus 141 L~~L~Ls~N~l~-~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 219 (799)
|++|++++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|++++|++++.+|..+..+++|++|+++
T Consensus 26 L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 103 (168)
T 2ell_A 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLS 103 (168)
T ss_dssp CSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECB
T ss_pred CCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEecc
Confidence 999999999998 78898899999999999999999865 788999999999999999998788888889999999999
Q ss_pred CCcCCCcC-CccccCCCCCCEEEccCCCCCCCCc---hhhhcCCCCCeEEcCCCCC
Q 003737 220 DNNFSGKI-PEFIGKWKKIQKLHIQGSSLEGPIP---ASISALTSLTDLRISDLKG 271 (799)
Q Consensus 220 ~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~n~~ 271 (799)
+|++++.. +..+..+++|++|++++|.+++..+ ..+..+++|+.|++++|..
T Consensus 104 ~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~ 159 (168)
T 2ell_A 104 GNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED 159 (168)
T ss_dssp SSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred CCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence 99998643 2788999999999999999987665 5788888888888877544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=9.3e-16 Score=145.30 Aligned_cols=126 Identities=22% Similarity=0.213 Sum_probs=80.3
Q ss_pred CCCCEEEccCCcCC-CcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEE
Q 003737 116 RYLKQLDLSRNCLT-GSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLI 193 (799)
Q Consensus 116 ~~L~~L~Ls~N~l~-~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 193 (799)
++|++|++++|.++ +.+|..+..++ |++|++++|.+++. ..++.+++|++|+|++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 34455555555554 34444444444 55555555555544 5566677777777777777766666666677777777
Q ss_pred cccCcCCcc-CChhccCCCCCCEEEccCCcCCCcCC---ccccCCCCCCEEEcc
Q 003737 194 LSSNSFTGE-LPAELTKLTNLNDLRISDNNFSGKIP---EFIGKWKKIQKLHIQ 243 (799)
Q Consensus 194 Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~ 243 (799)
+++|.+++. .+..+..+++|++|++++|.+++..+ ..+..+++|++|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 777777752 33667777777777777777776554 467777777777765
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=2.8e-15 Score=163.84 Aligned_cols=117 Identities=18% Similarity=0.304 Sum_probs=103.1
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChh------hHHHHHHHHHHHHhCCCCcccceeEEEEECCE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQ------GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 746 (799)
..+.|...+.||+|+||.||+|.. .+|+.||||.++..... ..+.+.+|++++.+++|||||++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 345688889999999999999995 47899999999754321 35789999999999999999999999999999
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~ 133 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHT 133 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS---------CCBHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999997654 57888999999999999999994
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=6.4e-15 Score=157.08 Aligned_cols=129 Identities=36% Similarity=0.546 Sum_probs=112.0
Q ss_pred ccccHHHHHHhhcCCCCC------CeecccCCeeEEEEEeCCCcEEEEEEccccC----hhhHHHHHHHHHHHHhCCCCc
Q 003737 664 GLYTLRQIKAATNNFDPA------NKVGEGGFGSVYKGILSDGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQHPN 733 (799)
Q Consensus 664 ~~~~~~~~~~~t~~f~~~------~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l~H~n 733 (799)
..|++.++..++++|+.. +.||+|+||.||+|.. +++.||||++.... ....+.|.+|++++.+++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 468999999999999988 8999999999999986 58899999986532 234578999999999999999
Q ss_pred ccceeEEEEECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 734 iv~l~g~~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++++++.+.+..++||||+++|+|.+++...... ..+++..+..++.||++||+|||+
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~ 151 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT------PPLSWHMRCKIAQGAANGINFLHE 151 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGC------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHhc
Confidence 999999999999999999999999999999753221 146788888899999999999994
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=5.7e-15 Score=146.48 Aligned_cols=127 Identities=23% Similarity=0.278 Sum_probs=73.1
Q ss_pred EEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcC
Q 003737 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLF 175 (799)
Q Consensus 96 ~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l 175 (799)
.+++++++++ .+|..+. ++|++|+|++|+++ .+|..|.++++|++|+|++|.+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~------------------------~ip~~~~~l~~L~~L~Ls~N~i 66 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT------------------------LVPKELSNYKHLTLIDLSNNRI 66 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC------------------------SCCGGGGGCTTCCEEECCSSCC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc------------------------hhHHHhhcccCCCEEECCCCcC
Confidence 5677777776 5555442 45666666666655 3444555555555555555555
Q ss_pred CCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCC
Q 003737 176 TGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (799)
Q Consensus 176 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 249 (799)
++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++|+++...+..|..+++|+.|+|++|.+..
T Consensus 67 ~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 67 STLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 55444555555555555555555555555555555666666666666654444455556666666666665543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.59 E-value=2e-15 Score=165.92 Aligned_cols=116 Identities=24% Similarity=0.436 Sum_probs=101.0
Q ss_pred cCCCCCCeecccCCeeEEEEEeC----CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~----~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
++|+..+.||+|+||.||+|+.. ++..||||+++.. .....+.|.+|++++.+++|||||++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 46888999999999999999854 5778999999765 334457899999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.++++.... .+++..+..++.||++||+|||+
T Consensus 125 ~e~~~~~sL~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~ 165 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDA--------QFTVIQLVGMLRGIASGMKYLSD 165 (373)
T ss_dssp EECCTTCBHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999986532 46788888999999999999994
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.59 E-value=2.1e-15 Score=163.27 Aligned_cols=115 Identities=21% Similarity=0.286 Sum_probs=102.2
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||+||++.. .+|+.||+|+++.. .....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 5688889999999999999995 47899999999754 2234567899999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++...+ .+++..++.++.||+.||+|||+
T Consensus 85 E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~ 123 (337)
T 1o6l_A 85 EYANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYLHS 123 (337)
T ss_dssp ECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999997654 57888999999999999999994
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.59 E-value=9.3e-17 Score=187.72 Aligned_cols=275 Identities=17% Similarity=0.174 Sum_probs=173.9
Q ss_pred ccEEEEEeCCC-CCccc-CCccccCCCCCCEEEccCCcCCCcCccccc----ccc-eeEEEccCCc--CcC-cCCcccCC
Q 003737 92 CHVVTIALKAQ-NLTGT-LPTELSKLRYLKQLDLSRNCLTGSFSPQWA----SLQ-LVELSVMGNR--LSG-PFPKVLTN 161 (799)
Q Consensus 92 ~~v~~L~L~~~-~l~g~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l~-L~~L~Ls~N~--l~~-~~p~~~~~ 161 (799)
.++++|+|+++ .++.. ++..+..+++|++|+|++|.+++..+..+. .++ |++|++++|. ++. .++..+.+
T Consensus 130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~ 209 (594)
T 2p1m_B 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTR 209 (594)
T ss_dssp TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHH
T ss_pred CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHh
Confidence 47899999988 55433 444556889999999999998776554443 344 9999999987 221 12222345
Q ss_pred CCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCc--------------------------CC----ccCChhccCCC
Q 003737 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS--------------------------FT----GELPAELTKLT 211 (799)
Q Consensus 162 L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~--------------------------l~----~~~p~~~~~l~ 211 (799)
+++|++|+|++|...+.+|..+..+++|++|+++.+. +. +.++..+..++
T Consensus 210 ~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~ 289 (594)
T 2p1m_B 210 CPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCS 289 (594)
T ss_dssp CTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHHT
T ss_pred CCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHhhC
Confidence 7899999999883222356666677777777755442 11 12333344678
Q ss_pred CCCEEEccCCcCCCcC-CccccCCCCCCEEEccCCCCCC-CCchhhhcCCCCCeEEcCC--------CCCCC-CCCCccC
Q 003737 212 NLNDLRISDNNFSGKI-PEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTDLRISD--------LKGSE-SAFPKLD 280 (799)
Q Consensus 212 ~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~--------n~~~~-~~~~~l~ 280 (799)
+|++|++++|.+++.. +..+..+++|++|++++| +.. .++.....+++|++|++.+ ++... ..+..+.
T Consensus 290 ~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~ 368 (594)
T 2p1m_B 290 RLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVS 368 (594)
T ss_dssp TCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHH
T ss_pred CCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHH
Confidence 8999999988876432 233567888999999887 332 2233334578888888843 12111 1112221
Q ss_pred --CCCccEEEccCCcCcccCCcccc-CCCCCCeeccc--c----ccCCCC-----CchhhhccCCCCEEeccCCcCCCcC
Q 003737 281 --KMNLKTLILTKCLIHGEIPDYIG-DMTKLKNIDLS--F----NNLTGG-----IPTTFEKLAKTNFMYLTGNKLTGPV 346 (799)
Q Consensus 281 --~~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls--~----N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~g~~ 346 (799)
.++|+.|+++.|.+++..+..+. .+++|+.|+++ + |+++.. ++..+..+++|+.|++++ .+++..
T Consensus 369 ~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~ 447 (594)
T 2p1m_B 369 MGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKV 447 (594)
T ss_dssp HHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHH
T ss_pred HhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHH
Confidence 25788888888887765555554 47788888888 3 555522 222356677888888866 565544
Q ss_pred Chhh---hcCCCEEEeecCcCcccC
Q 003737 347 PKYI---FNSNKNVDISLNNFTWES 368 (799)
Q Consensus 347 p~~~---~~~l~~l~ls~N~~~g~~ 368 (799)
+..+ ...++.|+|++|.+++..
T Consensus 448 ~~~l~~~~~~L~~L~L~~~~i~~~~ 472 (594)
T 2p1m_B 448 FEYIGTYAKKMEMLSVAFAGDSDLG 472 (594)
T ss_dssp HHHHHHHCTTCCEEEEESCCSSHHH
T ss_pred HHHHHHhchhccEeeccCCCCcHHH
Confidence 4433 346778888888776543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.58 E-value=6.9e-17 Score=188.85 Aligned_cols=274 Identities=16% Similarity=0.133 Sum_probs=190.5
Q ss_pred ccEEEEEeCCCCCcccCCcccc-CCCCCCEEEccCC-cCCCc-Ccccccccc-eeEEEccCCcCcCcCCccc----CCCC
Q 003737 92 CHVVTIALKAQNLTGTLPTELS-KLRYLKQLDLSRN-CLTGS-FSPQWASLQ-LVELSVMGNRLSGPFPKVL----TNIT 163 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~-~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~----~~L~ 163 (799)
.++++|+|+++.+++..+..+. .+++|++|+|++| .++.. ++..+..++ |++|+|++|.+++..+..+ ..++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4688999999988877776665 6889999999998 55432 344444565 9999999999876554444 3677
Q ss_pred CCCEEEeeCCcCCCCCC-c----cccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCc----------------
Q 003737 164 TLKNLSIEGNLFTGSIP-P----DIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN---------------- 222 (799)
Q Consensus 164 ~L~~L~Ls~N~l~~~~p-~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~---------------- 222 (799)
+|++|++++|. +.+. . .+..+++|++|++++|...+.+|..+..+++|++|+++.+.
T Consensus 185 ~L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~ 262 (594)
T 2p1m_B 185 SLVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALS 262 (594)
T ss_dssp CCCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHH
T ss_pred cCcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHHHh
Confidence 99999999887 1222 2 23457999999999883333477777888888888865542
Q ss_pred ----------CC----CcCCccccCCCCCCEEEccCCCCCCCCc-hhhhcCCCCCeEEcCCCCCCCCCCCccCC--CCcc
Q 003737 223 ----------FS----GKIPEFIGKWKKIQKLHIQGSSLEGPIP-ASISALTSLTDLRISDLKGSESAFPKLDK--MNLK 285 (799)
Q Consensus 223 ----------l~----~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~n~~~~~~~~~l~~--~~L~ 285 (799)
+. +.++..+..+++|++|+|++|.+++... ..+..+++|+.|+++++ .....++.+.. ++|+
T Consensus 263 ~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~ 341 (594)
T 2p1m_B 263 GCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLR 341 (594)
T ss_dssp TCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCC
T ss_pred cCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCC
Confidence 11 1234444467899999999999775433 33668999999999985 33223333222 6899
Q ss_pred EEEccC---------CcCcccCCcccc-CCCCCCeeccccccCCCCCchhhh-ccCCCCEEecc--C----CcCCCcCCh
Q 003737 286 TLILTK---------CLIHGEIPDYIG-DMTKLKNIDLSFNNLTGGIPTTFE-KLAKTNFMYLT--G----NKLTGPVPK 348 (799)
Q Consensus 286 ~L~L~~---------N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~--~----N~l~g~~p~ 348 (799)
.|+++. +.+++.....+. .+++|+.|+++.|++++..+..+. .+++|+.|+++ + |.+++...+
T Consensus 342 ~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~ 421 (594)
T 2p1m_B 342 ELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLD 421 (594)
T ss_dssp EEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTH
T ss_pred EEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchh
Confidence 999943 455543333333 489999999999999987766665 68999999999 4 666632211
Q ss_pred -h----h--hcCCCEEEeecCcCcccCC
Q 003737 349 -Y----I--FNSNKNVDISLNNFTWESS 369 (799)
Q Consensus 349 -~----~--~~~l~~l~ls~N~~~g~~p 369 (799)
. + ...++.|++++ .++...+
T Consensus 422 ~~~~~l~~~~~~L~~L~L~~-~l~~~~~ 448 (594)
T 2p1m_B 422 IGFGAIVEHCKDLRRLSLSG-LLTDKVF 448 (594)
T ss_dssp HHHHHHHHHCTTCCEEECCS-SCCHHHH
T ss_pred hHHHHHHhhCCCccEEeecC-cccHHHH
Confidence 1 1 35789999987 6665443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.2e-14 Score=141.99 Aligned_cols=132 Identities=23% Similarity=0.304 Sum_probs=73.3
Q ss_pred EEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCc
Q 003737 95 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL 174 (799)
Q Consensus 95 ~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~ 174 (799)
+.+++++++++ .+|..+ .++|++|++++|++++.+ +..|..+++|++|+|++|.
T Consensus 10 ~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~-----------------------~~~~~~l~~L~~L~l~~n~ 63 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLP-----------------------HGVFDKLTQLTKLSLSQNQ 63 (177)
T ss_dssp TEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCC-----------------------TTTTTTCTTCSEEECCSSC
T ss_pred CEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeC-----------------------HHHhcCcccccEEECCCCc
Confidence 35666666666 344333 245666666666555443 3444555555555555555
Q ss_pred CCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCc
Q 003737 175 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252 (799)
Q Consensus 175 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 252 (799)
+++..+..|..+++|++|++++|++++..+..+..+++|++|++++|++++..+..+..+++|++|+|++|.+.+..|
T Consensus 64 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 64 IQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 554444445555556666666665554444445556666666666666654444445556666666666666655443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=8.2e-15 Score=143.11 Aligned_cols=111 Identities=23% Similarity=0.290 Sum_probs=74.5
Q ss_pred cccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEE
Q 003737 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 169 (799)
..+++.|++++|++++..+..|..+++|++|+|++|.+++.++..|..+. |++|++++|++++..+..+..+++|++|+
T Consensus 27 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 106 (177)
T 2o6r_A 27 PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELA 106 (177)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEE
Confidence 35799999999999977777789999999999999988866655555554 66666666666555555555555555555
Q ss_pred eeCCcCCCCCCccccCCCCCCEEEcccCcCCc
Q 003737 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTG 201 (799)
Q Consensus 170 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 201 (799)
|++|.+++..+..+..+++|++|++++|.+++
T Consensus 107 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 107 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 55555554333334555555555555555554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.1e-14 Score=144.47 Aligned_cols=126 Identities=21% Similarity=0.300 Sum_probs=110.8
Q ss_pred eEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCC
Q 003737 142 VELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221 (799)
Q Consensus 142 ~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 221 (799)
+++++++|.++ .+|..+. ++|++|+|++|.++ .+|..|.++++|++|+|++|.+++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 34555566655 4555443 58999999999998 78899999999999999999999888889999999999999999
Q ss_pred cCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCC
Q 003737 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG 271 (799)
Q Consensus 222 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~ 271 (799)
++++..|..|..+++|++|+|++|.++...+..|..+++|+.|++++|..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 138 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPL 138 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCe
Confidence 99998888999999999999999999987777899999999999998654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=1.2e-15 Score=169.36 Aligned_cols=122 Identities=20% Similarity=0.305 Sum_probs=105.3
Q ss_pred HHHHHHhhcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEE
Q 003737 668 LRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743 (799)
Q Consensus 668 ~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 743 (799)
+.+++...++|+..+.||+|+||+||+|+.. +++.||+|+++... ....+.+.+|++++..++|||||++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4455566788999999999999999999964 68999999996531 1223468899999999999999999999999
Q ss_pred CCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 744 GNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 744 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+..|+|||||++|+|.++++.. .+++..++.++.||+.||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~----------~~~e~~~~~~~~qi~~aL~~LH~ 186 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY----------DVPEKWARFYTAEVVLALDAIHS 186 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999753 47788999999999999999994
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=2.8e-15 Score=156.46 Aligned_cols=116 Identities=21% Similarity=0.356 Sum_probs=101.3
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEEC--CEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 751 (799)
++|...+.||+|+||.||+|+.. ++.||||++.... ....+.|.+|++++.+++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 45777899999999999999974 8899999997643 34457899999999999999999999999876 7789999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.++++..... .+++..+..++.||++||+|||+
T Consensus 89 e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~ 129 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNF-------VVDQSQAVKFALDMARGMAFLHT 129 (271)
T ss_dssp ECCTTCBHHHHHHSCSSC-------CCCHHHHHHHHHHHHHHHHHHTT
T ss_pred cccCCCcHHHHHhhcccC-------CCCHHHHHHHHHHHHHHHHHHhc
Confidence 999999999999865421 47888999999999999999995
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.4e-15 Score=169.00 Aligned_cols=126 Identities=19% Similarity=0.224 Sum_probs=107.9
Q ss_pred ccHHHHHHhhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEE
Q 003737 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCC 741 (799)
Q Consensus 666 ~~~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~ 741 (799)
+.+.+.....++|+..+.||+|+||+||+++. .+|+.||||++++.. ....+.+.+|.+++.+++|||||++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 34455556678899999999999999999996 479999999996532 12234688999999999999999999999
Q ss_pred EECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 742 VEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 742 ~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+.+..|+|||||++|+|.+++.+.+. .+++..++.|+.||+.||+|||+
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~ 180 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGE--------RIPAEMARFYLAEIVMAIDSVHR 180 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSS--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999976431 57888999999999999999994
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.57 E-value=7.8e-15 Score=157.79 Aligned_cols=116 Identities=16% Similarity=0.266 Sum_probs=102.4
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
.++|...+.||+|+||.||+|.. .+++.||+|.+.... .....+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 46788889999999999999995 468899999987543 3456789999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++..... .+++..+..++.||++||+|||+
T Consensus 83 ~~g~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~ 120 (321)
T 1tki_A 83 ISGLDIFERINTSAF--------ELNEREIVSYVHQVCEALQFLHS 120 (321)
T ss_dssp CCCCBHHHHHTSSSC--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999976432 57888999999999999999994
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.57 E-value=4.7e-15 Score=162.35 Aligned_cols=116 Identities=21% Similarity=0.354 Sum_probs=102.9
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
.++|...+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|++++.+++|||||++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45688899999999999999995 478999999996542 334568999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++..+. .+++..+..++.||++||+|||+
T Consensus 108 e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~ 146 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCHS 146 (362)
T ss_dssp CCCCSCBHHHHHTTCS---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999997654 57888999999999999999994
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.57 E-value=4.1e-15 Score=159.74 Aligned_cols=115 Identities=18% Similarity=0.334 Sum_probs=102.0
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||.||++.. .+|+.||+|+++... ....+.+.+|+.++.+++|||||++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 5678889999999999999995 479999999997542 233567889999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++.... .+++..++.++.||+.||+|||+
T Consensus 86 e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~ 124 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ---------RFPNPVAKFYAAEVCLALEYLHS 124 (318)
T ss_dssp CCCCSCBHHHHHHHTS---------SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred eCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998654 57888999999999999999995
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=5.3e-15 Score=154.63 Aligned_cols=115 Identities=23% Similarity=0.499 Sum_probs=101.8
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCC
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
++|+..+.||+|+||.||+|...+++.||+|++.... ...+++.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 4577789999999999999998888899999997643 234679999999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.+++..... .+++..+..++.|+++||+|||+
T Consensus 89 ~~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~ 124 (269)
T 4hcu_A 89 HGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEE 124 (269)
T ss_dssp TCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCcHHHHHHhcCc--------ccCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999976432 47788899999999999999994
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=5.1e-15 Score=159.61 Aligned_cols=115 Identities=18% Similarity=0.311 Sum_probs=101.5
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh------hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 748 (799)
+.|...+.||+|+||.||+|.. .+|+.||||.+..... ...+.+.+|++++.+++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4577889999999999999995 4789999999865422 13578999999999999999999999999999999
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~ 132 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE---------SLTEEEATEFLKQILNGVYYLHS 132 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS---------CCBHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEcCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999997654 57888999999999999999994
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.57 E-value=9.3e-15 Score=156.51 Aligned_cols=115 Identities=21% Similarity=0.338 Sum_probs=101.0
Q ss_pred cCCCC-CCeecccCCeeEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEEe
Q 003737 676 NNFDP-ANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 676 ~~f~~-~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 752 (799)
+.|.. .+.||+|+||.||+|. ..+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 34555 3789999999999999 457899999999766555567899999999985 79999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++|+|.+++.... .+++..+..++.||++||+|||+
T Consensus 92 ~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~ 129 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR---------HFNELEASVVVQDVASALDFLHN 129 (316)
T ss_dssp CCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999998654 57788999999999999999994
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.57 E-value=5.9e-15 Score=162.86 Aligned_cols=117 Identities=18% Similarity=0.334 Sum_probs=104.3
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
.+.|+..+.||+|+||.||+|.. .+|+.||+|.+..........+.+|++++.+++|||||++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 35688889999999999999995 47899999999776555667899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++..... .+++..+..++.||+.||+|||+
T Consensus 130 ~~gg~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~ 167 (387)
T 1kob_A 130 LSGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMHE 167 (387)
T ss_dssp CCCCBHHHHTTCTTC--------CBCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999976432 57788999999999999999994
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=3.3e-15 Score=159.83 Aligned_cols=124 Identities=21% Similarity=0.386 Sum_probs=104.3
Q ss_pred HHHHHhhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCE
Q 003737 669 RQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (799)
Q Consensus 669 ~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 746 (799)
.++....++|+..+.||+|+||.||+|+. +|+.||||++.... ....+.|.+|++++.+++||||+++++++.+.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 33344556788889999999999999987 58899999997653 3345689999999999999999999999999999
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++||||+++|+|.++++..... ..+++..+..++.||++||+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~ 155 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAR------EQLDERRRLSMAYDVAKGMNYLHN 155 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHH------HHSCHHHHHHHHHHHHHHHHHHHT
T ss_pred eEEEEecCCCCcHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHc
Confidence 99999999999999999865421 136788888999999999999995
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=4.2e-15 Score=163.34 Aligned_cols=112 Identities=23% Similarity=0.379 Sum_probs=94.9
Q ss_pred CCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCc
Q 003737 680 PANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 758 (799)
Q Consensus 680 ~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~Gs 758 (799)
..+.||+|+||.||+|.. .+|+.||+|+++.......+.|.+|++++.+++|||||++++++.+.+..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 356899999999999995 5789999999987666667889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 759 LSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 759 L~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|.+++..... .+++..+..++.||++||+|||+
T Consensus 173 L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~ 205 (373)
T 2x4f_A 173 LFDRIIDESY--------NLTELDTILFMKQICEGIRHMHQ 205 (373)
T ss_dssp EHHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999975432 46788888999999999999994
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=5e-15 Score=159.62 Aligned_cols=116 Identities=22% Similarity=0.394 Sum_probs=100.4
Q ss_pred cCCCCCCeecccCCeeEEEEEeC----CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~----~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
++|...+.||+|+||.||+|... .+..||||+++.. .....+.|.+|++++.+++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 45677899999999999999963 3456999999765 344457899999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.++++.... .+++..+..++.||+.||+|||+
T Consensus 129 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~ 169 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDG--------QFTIMQLVGMLRGVGAGMRYLSD 169 (325)
T ss_dssp EECCTTCBHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHH
T ss_pred eeCCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999975432 57788899999999999999994
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=4.8e-15 Score=161.55 Aligned_cols=116 Identities=22% Similarity=0.366 Sum_probs=102.0
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 749 (799)
.++|+..+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|.+++.++ +|||||++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 46788899999999999999995 46899999999754 223456788999999988 69999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+++|+|.+++...+ .+++..++.|+.||+.||+|||+
T Consensus 102 v~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~ 142 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR---------RFDEARARFYAAEIISALMFLHD 142 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999998654 67899999999999999999994
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.56 E-value=7.1e-15 Score=156.02 Aligned_cols=116 Identities=20% Similarity=0.230 Sum_probs=102.1
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
.++|+..+.||+|+||.||+|.. .+++.||+|.+... .....+.|.+|++++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 35688889999999999999994 57899999998543 233457899999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.+++...+ .+++..+..++.|+++||+|||+
T Consensus 90 ~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~ 129 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG---------PLSVDTAINFTNQILDGIKHAHD 129 (294)
T ss_dssp EECCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EeCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999997654 57788999999999999999994
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=2.5e-15 Score=165.51 Aligned_cols=118 Identities=21% Similarity=0.409 Sum_probs=102.1
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
..++|...+.||+|+||.||+|... +++.||||+++... ....+.|.+|++++.+++|||||+++++|...+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3456778899999999999999975 78999999997543 233457999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||++|+|.++++.... .+++..+..++.||++||+|||+
T Consensus 192 e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~ 231 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGA--------RLRVKTLLQMVGDAAAGMEYLES 231 (377)
T ss_dssp ECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999986432 46777888999999999999994
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=5.4e-15 Score=156.15 Aligned_cols=116 Identities=24% Similarity=0.342 Sum_probs=101.8
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CC-------cEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DG-------TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g-------~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 747 (799)
++|...+.||+|+||.||+|... ++ ..||+|.+........+.|.+|++++.+++||||+++++++.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 45777899999999999999843 33 57999999776666678899999999999999999999999999999
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||+++|+|.+++..... .+++..+..++.||++||+|||+
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~ 131 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKN--------CINILWKLEVAKQLAAAMHFLEE 131 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEECCCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHhh
Confidence 999999999999999986542 36788888999999999999994
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=5.7e-15 Score=155.00 Aligned_cols=116 Identities=18% Similarity=0.339 Sum_probs=103.4
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
.++|...+.||+|+||.||+|... ++..||+|++........+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 345788899999999999999954 5789999999776555678899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++.... .+++..+..++.|+++||+|||+
T Consensus 88 ~~~~~L~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lH~ 124 (277)
T 3f3z_A 88 CTGGELFERVVHKR---------VFRESDAARIMKDVLSAVAYCHK 124 (277)
T ss_dssp CCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999987654 57788999999999999999994
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=3.8e-15 Score=160.42 Aligned_cols=116 Identities=24% Similarity=0.351 Sum_probs=99.7
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
.++|+..+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++.+++|||||++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 357888999999999999999954 789999999965432 234678999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++|+|.+++.... .+++..+..++.||++||+|||+
T Consensus 86 ~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~ 123 (323)
T 3tki_A 86 YCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHG 123 (323)
T ss_dssp CCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999987654 57788999999999999999994
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=7.2e-15 Score=159.69 Aligned_cols=115 Identities=18% Similarity=0.299 Sum_probs=101.2
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 750 (799)
++|+..+.||+|+||.||+++. .+++.||+|+++... ....+.+.+|.+++.++ +|||||++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 4578889999999999999996 468999999997542 33456788999999988 899999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.+++...+ .+++..++.++.||+.||+|||+
T Consensus 89 ~e~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~ 128 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLHE 128 (345)
T ss_dssp ECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999997654 57888999999999999999994
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.56 E-value=9.9e-15 Score=161.37 Aligned_cols=117 Identities=15% Similarity=0.258 Sum_probs=102.7
Q ss_pred cCCCCCCeeccc--CCeeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 676 NNFDPANKVGEG--GFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~lG~G--~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
++|+..+.||+| +||.||+|... +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 457888999999 99999999964 79999999997542 33456788999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||++|+|.+++...... .+++..+..++.||++||+|||+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~ 146 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMD-------GMNELAIAYILQGVLKALDYIHH 146 (389)
T ss_dssp EECCTTCBHHHHHHHTCTT-------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEccCCCCHHHHHhhhccc-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999865322 57888999999999999999994
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.55 E-value=1.1e-14 Score=153.95 Aligned_cols=113 Identities=11% Similarity=0.032 Sum_probs=97.4
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|...+.||+|+||.||+|... +|+.||||++.... ....+.|.+|++.+.+++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56888899999999999999964 58999999997653 233478999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++... . .+.++..++.|+++||+|||+
T Consensus 111 e~~~g~~L~~~l~~~----------~-~~~~~~~i~~ql~~aL~~lH~ 147 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----------P-SPVGAIRAMQSLAAAADAAHR 147 (286)
T ss_dssp ECCCEEEHHHHHTTC----------C-CHHHHHHHHHHHHHHHHHHHH
T ss_pred EecCCCCHHHHHhcC----------C-ChHHHHHHHHHHHHHHHHHHH
Confidence 999999999999542 2 233567779999999999994
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=5.7e-15 Score=162.59 Aligned_cols=115 Identities=18% Similarity=0.376 Sum_probs=102.0
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|...+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|++++.+++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 4578889999999999999995 468999999986532 234568999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++.... .+++..++.|+.||+.||+|||+
T Consensus 95 e~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~ 133 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV---------HFKEETVKLFICELVMALDYLQN 133 (384)
T ss_dssp CCCTTEEHHHHHHTTC---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998654 57888999999999999999994
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.55 E-value=4.4e-15 Score=157.48 Aligned_cols=116 Identities=24% Similarity=0.403 Sum_probs=101.1
Q ss_pred cCCCCCCeecccCCeeEEEEEe-----CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC--CEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLL 748 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 748 (799)
++|+..+.||+|+||.||+|+. .+++.||||++........+.|.+|++++.+++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 4577889999999999999984 36889999999877666678899999999999999999999998653 5689
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||+++|+|.+++..... .+++..+..++.|++.||+|||+
T Consensus 90 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~ 132 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGT 132 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGG--------GCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCHHHHHHhccc--------ccCHHHHHHHHHHHHHHHHHHhc
Confidence 99999999999999986542 46788889999999999999994
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=6.1e-15 Score=159.06 Aligned_cols=115 Identities=19% Similarity=0.324 Sum_probs=95.8
Q ss_pred cCCCCCCeecccCCeeEEEEEe----CCCcEEEEEEccccC----hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 747 (799)
++|+..+.||+|+||.||++.. .+|+.||+|+++... ......+.+|++++.+++|||||++++++.+.+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5688889999999999999986 478999999997642 22345688999999999999999999999999999
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~ 139 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREG---------IFMEDTACFYLAEISMALGHLHQ 139 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999997654 57788999999999999999994
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.55 E-value=3.1e-15 Score=168.96 Aligned_cols=121 Identities=21% Similarity=0.305 Sum_probs=103.8
Q ss_pred HHHHhhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 670 QIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 670 ~~~~~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
+++...++|...+.||+|+||.||+|...++..||||+++... ...+.|.+|++++++++|||||++++++. .+..++
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 3445567788889999999999999998888999999997643 34678999999999999999999999986 667899
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||||++|+|.++++..... .+++..+..++.||++||+|||+
T Consensus 260 v~e~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~ 302 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGS-------KQPLPKLIDFSAQIAEGMAFIEQ 302 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHH-------TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeecCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999854321 46677888889999999999994
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.1e-14 Score=156.74 Aligned_cols=118 Identities=19% Similarity=0.387 Sum_probs=97.6
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECC--------
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-------- 745 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-------- 745 (799)
++|+..+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||+++++|.+.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 45788899999999999999965 79999999997543 335678999999999999999999999986643
Q ss_pred -------------------------------------------------EEEEEEecCCCCcHHHHHhcCcccccccccC
Q 003737 746 -------------------------------------------------QLLLVYEYMKNNCLSRAIFGKLRIFHISIYA 776 (799)
Q Consensus 746 -------------------------------------------------~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~ 776 (799)
..++||||+++|+|.+++.......
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~------ 159 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE------ 159 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG------
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc------
Confidence 3799999999999999998754321
Q ss_pred CCChHHHHHHHHHHHHHHhhhcC
Q 003737 777 TFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 777 ~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++..+..++.||++||+|||+
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH~ 182 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLHS 182 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHHHHHHHHh
Confidence 23455678889999999999994
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.55 E-value=9.6e-15 Score=153.78 Aligned_cols=116 Identities=22% Similarity=0.432 Sum_probs=99.7
Q ss_pred hcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
.++|+..+.||+|+||.||++...++..||||+++.... ..+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 356777899999999999999988888999999976432 3467999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.+++..... .+++..+..++.|+++||+|||+
T Consensus 102 ~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~ 138 (283)
T 3gen_A 102 ANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLES 138 (283)
T ss_dssp TTCBHHHHHHCGGG--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999986432 57788999999999999999994
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.55 E-value=6.9e-15 Score=160.15 Aligned_cols=115 Identities=21% Similarity=0.287 Sum_probs=102.0
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||.||+++. .+|+.||+|++.... ....+.+.+|++++.+++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 4678889999999999999995 478999999996542 234567899999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++...+ .+++..++.++.||+.||+|||+
T Consensus 121 e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~ 159 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG---------RFSEPHARFYAAQIVLTFEYLHS 159 (350)
T ss_dssp ECCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998654 57888999999999999999994
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.55 E-value=6.2e-15 Score=160.67 Aligned_cols=119 Identities=17% Similarity=0.286 Sum_probs=101.1
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-----hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
+.|+..+.||+|+||.||+|.. .+|+.||||+++... ....+.+.+|++++.+++|||||++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4577889999999999999985 578999999986431 1235789999999999999999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+++|+|.+++..+... ...+++..+..++.||++||+|||+
T Consensus 104 v~e~~~g~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~ 148 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQILEALRYCHD 148 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCCHHHHHHHhccc-----CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999888654311 1247888999999999999999994
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=6.3e-15 Score=160.03 Aligned_cols=117 Identities=19% Similarity=0.292 Sum_probs=102.1
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLL 748 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 748 (799)
..++|...+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|.+++.++ +||||+++++++.+.+..|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 457788999999999999999996 468999999997542 23456788999999886 9999999999999999999
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||+
T Consensus 95 lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~ 136 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCH---------KFDLSRATFYAAEIILGLQFLHS 136 (345)
T ss_dssp EEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999998654 57888999999999999999994
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=8.3e-15 Score=152.97 Aligned_cols=116 Identities=24% Similarity=0.422 Sum_probs=102.5
Q ss_pred hcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
.++|+..+.||+|+||.||+|...++..||||++.... ...+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 35677889999999999999998888899999997643 23567999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.+++..... .+++..+..++.|+++||+|||+
T Consensus 86 ~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~ 122 (268)
T 3sxs_A 86 SNGCLLNYLRSHGK--------GLEPSQLLEMCYDVCEGMAFLES 122 (268)
T ss_dssp TTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCcHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999976532 47788899999999999999994
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=8.1e-15 Score=159.61 Aligned_cols=115 Identities=19% Similarity=0.274 Sum_probs=95.4
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
..+.|...+.||+|+||.||+|... +++.||||+++... ..+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3466888899999999999999964 68899999997542 34678899999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++|+|.+++.... .+++..+..++.||++||+|||+
T Consensus 129 ~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~LH~ 166 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG---------YYSERDAADAVKQILEAVAYLHE 166 (349)
T ss_dssp CCCSCBHHHHHTTCS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999998654 57788999999999999999994
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.55 E-value=1.2e-14 Score=158.95 Aligned_cols=115 Identities=17% Similarity=0.287 Sum_probs=102.0
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
.++|...+.||+|+||.||++... +++.||||++..... ..+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 356888899999999999999954 789999999975432 346788999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++...+ .+++..++.++.|+++||+|||+
T Consensus 98 ~~~~~L~~~l~~~~---------~~~~~~~~~i~~ql~~~L~~LH~ 134 (361)
T 3uc3_A 98 ASGGELYERICNAG---------RFSEDEARFFFQQLLSGVSYCHS 134 (361)
T ss_dssp CCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999997654 57888999999999999999994
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.54 E-value=7.4e-15 Score=167.66 Aligned_cols=118 Identities=22% Similarity=0.409 Sum_probs=102.9
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
...+|...+.||+|+||.||+|... ++..||||+++... ...++|.+|+++|.+++|||||+++++|.+.+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 4556788899999999999999965 48899999997643 346789999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||++|+|.++++..... .+++..+..++.||++||+|||+
T Consensus 297 ~~~~g~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~ 336 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQ-------EVSAVVLLYMATQISSAMEYLEK 336 (495)
T ss_dssp CCTTCBHHHHHHHSCTT-------TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccCCCCHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999864322 56787888899999999999994
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.54 E-value=9.2e-15 Score=160.52 Aligned_cols=125 Identities=18% Similarity=0.319 Sum_probs=101.6
Q ss_pred hcCCCCCCeecccCCeeEEEEEe--------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccceeEEEEEC
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL--------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 744 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~--------~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 744 (799)
.++|...+.||+|+||.||+|+. .++..||||+++... ....+.+.+|++++.++ +|||||+++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 35677889999999999999984 235689999997653 33457899999999999 899999999999999
Q ss_pred CEEEEEEecCCCCcHHHHHhcCccccc-------ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFH-------ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~-------~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+..|+||||+++|+|.+++........ ......+++..+..++.||++||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 221 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999999999986542100 0011246778889999999999999994
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=4.4e-15 Score=162.07 Aligned_cols=135 Identities=20% Similarity=0.321 Sum_probs=108.2
Q ss_pred cccHHHHHHhhcCCCCCCeecccCCeeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccc
Q 003737 665 LYTLRQIKAATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVK 736 (799)
Q Consensus 665 ~~~~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~ 736 (799)
.+...+++...++|...+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++.++ +|||||+
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 345566667788899999999999999999973 246899999997653 33457899999999999 7899999
Q ss_pred eeEEEEECC-EEEEEEecCCCCcHHHHHhcCccccc--------------------------------------------
Q 003737 737 LYGCCVEGN-QLLLVYEYMKNNCLSRAIFGKLRIFH-------------------------------------------- 771 (799)
Q Consensus 737 l~g~~~~~~-~~~lV~Ey~~~GsL~~~L~~~~~~~~-------------------------------------------- 771 (799)
++++|.+.+ ..++||||+++|+|.++++.......
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998755 48999999999999999986542100
Q ss_pred -------------ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 772 -------------ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 772 -------------~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
......+++..+..++.||++||+|||+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~ 211 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 211 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH
Confidence 0001127888999999999999999994
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.2e-14 Score=163.87 Aligned_cols=116 Identities=23% Similarity=0.399 Sum_probs=100.6
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECC-EEEEEEe
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-QLLLVYE 752 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E 752 (799)
..++|...+.||+|+||.||+|... |+.||||+++... ..+.|.+|+++|.+++|||||++++++...+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3466778899999999999999975 7899999997643 4578999999999999999999999988765 7999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||++|+|.++++..+.. .+++..+..++.||++||+|||+
T Consensus 268 ~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~ 307 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEG 307 (450)
T ss_dssp CCTTCBHHHHHHHHCTT-------TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999865421 36788888999999999999994
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.5e-14 Score=152.26 Aligned_cols=120 Identities=24% Similarity=0.473 Sum_probs=103.1
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 750 (799)
+++|+..+.||+|+||.||+|... +++.||||++... .......+.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 456888899999999999999964 7899999999754 233457889999999999 999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.+++...... ...+++..+..++.||++||+|||+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~ 133 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRI-----MSYFKEAELKDLLLQVGRGLRYIHS 133 (289)
T ss_dssp EECCTTCBHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCCCcHHHHHHhhccc-----ccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999764311 1157888999999999999999994
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.54 E-value=9.2e-15 Score=158.42 Aligned_cols=127 Identities=23% Similarity=0.357 Sum_probs=104.0
Q ss_pred HhhcCCCCCCeecccCCeeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECC
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN 745 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 745 (799)
...++|...+.||+|+||.||+|... +++.||||+++... ....+.|.+|++++.+++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34577888999999999999999963 34899999997653 334578999999999999999999999999999
Q ss_pred EEEEEEecCCCCcHHHHHhcCccccc---------------ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFH---------------ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~---------------~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++||||+++|+|.+++........ ......+++..+..++.||++||+|||+
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~ 192 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 192 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999999986431100 0011367888899999999999999994
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.2e-14 Score=155.49 Aligned_cols=117 Identities=24% Similarity=0.414 Sum_probs=100.1
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
..++|+..+.||+|+||.||+|...+|+.||+|++.... ....+.+.+|++++.+++|||||++++++.+++..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 346788899999999999999998889999999996542 223467899999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++ +|.+++..... .+++..+..++.|+++||+|||+
T Consensus 99 e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~ 137 (311)
T 3niz_A 99 EFMEK-DLKKVLDENKT--------GLQDSQIKIYLYQLLRGVAHCHQ 137 (311)
T ss_dssp ECCSE-EHHHHHHTCTT--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCC-CHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99984 88888876432 57888999999999999999994
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.54 E-value=7.8e-15 Score=162.10 Aligned_cols=116 Identities=17% Similarity=0.291 Sum_probs=100.1
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 749 (799)
.++|+..+.||+|+||+||+++. .+++.||+|++++.. ....+.+.+|..++.++ +|||||++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 35688889999999999999995 468899999997642 22335688999999886 89999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+++|+|.+++...+ .+++..++.|+.||+.||+|||+
T Consensus 131 V~E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~ 171 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLHE 171 (396)
T ss_dssp EEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEcCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999998654 57899999999999999999994
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.5e-14 Score=155.35 Aligned_cols=118 Identities=17% Similarity=0.280 Sum_probs=100.8
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECC--EEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--QLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 751 (799)
++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++.+++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 45778899999999999999964 68999999997543 234577899999999999999999999998765 789999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++...... ..+++..+..++.||++||+|||+
T Consensus 89 e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~ 130 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLRE 130 (319)
T ss_dssp ECCTTCBHHHHHHSGGGT------TCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eCCCCCCHHHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999865421 137888999999999999999994
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=9.2e-15 Score=164.18 Aligned_cols=116 Identities=16% Similarity=0.287 Sum_probs=101.3
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
.++|+..+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|++++.+++|||||++++++.+++..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 45688899999999999999984 578999999997643 234567999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++..+. .+++..+..++.||++||+|||+
T Consensus 90 E~~~gg~L~~~i~~~~---------~~~e~~~~~i~~qil~aL~~lH~ 128 (444)
T 3soa_A 90 DLVTGGELFEDIVARE---------YYSEADASHCIQQILEAVLHCHQ 128 (444)
T ss_dssp CCCBCCBHHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EeCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998764 57888999999999999999994
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=3e-14 Score=150.80 Aligned_cols=117 Identities=19% Similarity=0.271 Sum_probs=99.5
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCC
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
+|.....||+|+||.||+|.. .+++.||||.+........+.+.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 455567999999999999994 5788999999977655556789999999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.+++...... ..+++..+..++.||+.||+|||+
T Consensus 103 ~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~ 140 (295)
T 2clq_A 103 GGSLSALLRSKWGP------LKDNEQTIGFYTKQILEGLKYLHD 140 (295)
T ss_dssp EEEHHHHHHHTTCC------CTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHhhccC------CCccHHHHHHHHHHHHHHHHHHHh
Confidence 99999999764321 245677888899999999999994
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.2e-14 Score=154.75 Aligned_cols=116 Identities=17% Similarity=0.284 Sum_probs=99.7
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
.++|...+.||+|+||.||++.. .+|+.||+|+++.......+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 34578889999999999999995 47899999999765544556799999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++.... .+++..+..++.|++.||+|||+
T Consensus 88 ~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~ 124 (304)
T 2jam_A 88 VSGGELFDRILERG---------VYTEKDASLVIQQVLSAVKYLHE 124 (304)
T ss_dssp CCSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCccHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999997654 57788999999999999999994
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=2.1e-14 Score=151.11 Aligned_cols=116 Identities=22% Similarity=0.360 Sum_probs=102.6
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
.++|+..+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46788899999999999999995 46899999998654 2334578899999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++..+. .+++..+..++.|++.||+|||+
T Consensus 85 e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~ 123 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCHS 123 (284)
T ss_dssp CCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999987654 57888999999999999999994
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=1.7e-14 Score=150.34 Aligned_cols=115 Identities=23% Similarity=0.477 Sum_probs=101.7
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCC
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
++|...+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 45777889999999999999988888999999976532 34689999999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.+++..... .+++..+..++.|+++||+|||+
T Consensus 87 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~ 122 (267)
T 3t9t_A 87 HGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEE 122 (267)
T ss_dssp TCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCcHHHHHhhCcc--------cCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999976532 46788889999999999999994
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=1.6e-14 Score=166.13 Aligned_cols=118 Identities=23% Similarity=0.315 Sum_probs=103.0
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++.+++|||||++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 35688889999999999999996 479999999996532 23356789999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||++|+|.+++...... .+++..++.|+.||+.||+|||+
T Consensus 263 mEy~~gg~L~~~l~~~~~~-------~l~e~~~~~i~~qIl~aL~yLH~ 304 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQA-------GFPEARAVFYAAEICCGLEDLHR 304 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSC-------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEcCCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999865422 58899999999999999999994
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.6e-14 Score=163.53 Aligned_cols=115 Identities=22% Similarity=0.329 Sum_probs=102.0
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccCh---hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56778899999999999999964 799999999965421 23467999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++...+ .+++..+..++.||+.||+|||+
T Consensus 96 E~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~ 134 (476)
T 2y94_A 96 EYVSGGELFDYICKNG---------RLDEKESRRLFQQILSGVDYCHR 134 (476)
T ss_dssp ECCSSEEHHHHTTSSS---------SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred eCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999997654 57888999999999999999995
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.53 E-value=1.1e-14 Score=164.24 Aligned_cols=119 Identities=22% Similarity=0.364 Sum_probs=101.9
Q ss_pred HHhhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 672 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 672 ~~~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
+...++|...+.||+|+||.||+|...++..||||+++... ...+.|.+|+++|.+++|||||++++++.+ +..++||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 34556788889999999999999998877889999997643 345789999999999999999999999865 6789999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||++|+|.++++..... .+++..+..++.||++||+|||+
T Consensus 258 e~~~~gsL~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~LH~ 298 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVER 298 (452)
T ss_dssp CCCTTCBHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhcCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999753211 46778888999999999999994
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.53 E-value=3.5e-14 Score=153.00 Aligned_cols=107 Identities=22% Similarity=0.293 Sum_probs=96.1
Q ss_pred CCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCC-CCcccceeEEEEECCEEEEEEecCCCCc
Q 003737 681 ANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYMKNNC 758 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~Gs 758 (799)
.+.||+|+||.||+|.. .+|+.||||++... ....+.+|++++.+++ |||||++++++.+.+..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 47899999999999996 47899999999643 3467889999999997 9999999999999999999999999999
Q ss_pred HHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 759 LSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 759 L~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|.+++.... .+++..+..++.||++||+|||+
T Consensus 93 L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~ 124 (325)
T 3kn6_A 93 LFERIKKKK---------HFSETEASYIMRKLVSAVSHMHD 124 (325)
T ss_dssp HHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999998754 57888999999999999999994
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=2e-14 Score=154.57 Aligned_cols=113 Identities=17% Similarity=0.273 Sum_probs=96.5
Q ss_pred hcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECC----EEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----QLLLV 750 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV 750 (799)
.++|+..+.||+|+||.||+|+.. ++.||||++.... .....+.+|+.++.+++|||||++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 356788899999999999999875 7899999996543 23446677999999999999999999998744 47999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.++++.+ .+++..+..++.|+++||+|||+
T Consensus 101 ~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~qi~~al~~LH~ 139 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN----------VVSWNELCHIAETMARGLAYLHE 139 (322)
T ss_dssp EECCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHTC
T ss_pred EecCCCCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999764 46677889999999999999995
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.53 E-value=2e-14 Score=151.24 Aligned_cols=115 Identities=16% Similarity=0.306 Sum_probs=101.1
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccCh------hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 748 (799)
++|...+.||+|+||.||++... +|+.||+|.+..... ...+.+.+|++++.+++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 45778899999999999999964 789999999865421 13578999999999999999999999999999999
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||+++|+|.+++.... .+++..+..++.||++||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~ 126 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE---------SLTEDEATQFLKQILDGVHYLHS 126 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999997543 57788999999999999999994
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.7e-14 Score=155.05 Aligned_cols=115 Identities=17% Similarity=0.280 Sum_probs=101.2
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh------hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 748 (799)
+.|...+.||+|+||.||+|.. .+|+.||||.+..... ...+.+.+|++++.+++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 4577889999999999999995 4789999999965422 13578999999999999999999999999999999
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||+++|+|.+++.... .+++..+..++.|+++||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~ 133 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHT 133 (321)
T ss_dssp EEECCCCSCBHHHHHHTCS---------CEEHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999997654 56788899999999999999994
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.8e-14 Score=152.43 Aligned_cols=115 Identities=23% Similarity=0.406 Sum_probs=101.3
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh--hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
++|+..+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 5688889999999999999996 4689999999865432 235678999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++|+|.+++.... .+++..+..++.|+++||+|||+
T Consensus 83 ~~~~~~l~~~~~~~~---------~~~~~~~~~i~~~l~~~l~~lH~ 120 (311)
T 4agu_A 83 YCDHTVLHELDRYQR---------GVPEHLVKSITWQTLQAVNFCHK 120 (311)
T ss_dssp CCSEEHHHHHHHTSS---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eCCCchHHHHHhhhc---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999887654 57788999999999999999994
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.52 E-value=2e-14 Score=151.72 Aligned_cols=119 Identities=20% Similarity=0.310 Sum_probs=102.0
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
++|...+.||+|+||.||++.. .++..||+|++.... ....+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 4577889999999999999995 568999999987653 33467899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++...... ...+++..+..++.|+++||+|||+
T Consensus 102 ~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~ 142 (285)
T 3is5_A 102 CEGGELLERIVSAQAR-----GKALSEGYVAELMKQMMNALAYFHS 142 (285)
T ss_dssp CSCCBHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCcHHHHHHhhhhc-----ccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999998643211 1157888999999999999999994
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.5e-14 Score=158.57 Aligned_cols=122 Identities=23% Similarity=0.282 Sum_probs=102.2
Q ss_pred cCCCCCCeecccCCeeEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 748 (799)
++|...+.||+|+||.||+|... +++.||||+++.. .......+.+|++++.+++|||||++++++.+.+..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 55778899999999999999843 4678999999754 3445568999999999999999999999999999999
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||+++|+|.+++....... .....+++..+..++.||++||+|||+
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~ 199 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEE 199 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCS--SSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCHHHHHHhhcccc--CccccccHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999998653211 112257788899999999999999994
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=2.8e-14 Score=151.07 Aligned_cols=115 Identities=18% Similarity=0.341 Sum_probs=97.9
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
++|+..+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|++++.+++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 4678889999999999999995 478999999996543 3335788999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++ ++.+.+..... .+++..+..++.|+++||+|||+
T Consensus 82 ~~~~-~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~ 119 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNG--------DLDPEIVKSFLFQLLKGLGFCHS 119 (292)
T ss_dssp CCSE-EHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCC-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9986 66666654322 57888999999999999999994
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.52 E-value=2.1e-14 Score=150.04 Aligned_cols=113 Identities=26% Similarity=0.486 Sum_probs=95.2
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccCh----hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR----QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||.||+|... |+.||||+++.... ...+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 56788899999999999999974 88999999865422 23468999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++..+ .+++..+..++.|+++||+|||+
T Consensus 86 e~~~~~~L~~~~~~~----------~~~~~~~~~i~~~l~~~l~~lH~ 123 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK----------RIPPDILVNWAVQIARGMNYLHD 123 (271)
T ss_dssp ECCTTEEHHHHHTSS----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EcCCCCCHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999998643 56788899999999999999994
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=1.3e-14 Score=158.08 Aligned_cols=116 Identities=21% Similarity=0.234 Sum_probs=102.0
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 749 (799)
.++|+..+.||+|+||.||+|... +|+.||||+++... ....+.+.+|.+++..+ +||+|+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467888999999999999999964 58899999997542 23456788999999988 89999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+++|+|.+++...+ .+++..++.++.||+.||+|||+
T Consensus 99 v~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~ 139 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG---------RFKEPHAVFYAAEIAIGLFFLQS 139 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999998654 57888999999999999999994
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.1e-14 Score=150.73 Aligned_cols=116 Identities=21% Similarity=0.416 Sum_probs=101.6
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|...+.||+|+||.||+|+. .+|+.||||.+.... ....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5688889999999999999995 578999999996532 123468999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++..... .+++..+..++.|+++||+|||+
T Consensus 91 e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~ 130 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVK--------PFSENEARHFMHQIITGMLYLHS 130 (278)
T ss_dssp ECCTTEEHHHHHHTCSS--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999986532 57788999999999999999994
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.52 E-value=9.1e-15 Score=154.29 Aligned_cols=119 Identities=22% Similarity=0.403 Sum_probs=103.4
Q ss_pred HhhcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
...++|...+.||+|+||.||+|... ++..||+|.+.... ...+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 34566888899999999999999964 58899999997543 34578999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++...... .+++..+..++.|++.||+|||+
T Consensus 89 e~~~~~~L~~~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lH~ 129 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQ-------EVSAVVLLYMATQISSAMEYLEK 129 (288)
T ss_dssp ECCTTEEHHHHHHHCCTT-------TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EcCCCCcHHHHHHhcccC-------CccHhHHHHHHHHHHHHHHHHHH
Confidence 999999999999864322 57788899999999999999994
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.52 E-value=1.9e-14 Score=151.15 Aligned_cols=117 Identities=23% Similarity=0.405 Sum_probs=101.7
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
+.++|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++.+++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 345688889999999999999985 467899999986532 2234679999999999999999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+
T Consensus 87 v~e~~~~~~l~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~LH~ 127 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS---------KFDEQRTATYITELANALSYCHS 127 (279)
T ss_dssp EECCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred EEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999997654 57788899999999999999995
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=2.7e-14 Score=151.76 Aligned_cols=118 Identities=22% Similarity=0.455 Sum_probs=101.1
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
..+.|+..+.||+|+||.||+|... +++.||+|.+........+.+.+|++++.+++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3466888899999999999999964 689999999977655667889999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++|+|.+++..... .+++..+..++.||++||+|||+
T Consensus 97 ~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~ 135 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDR--------GLTEPQIQVVCRQMLEALNFLHS 135 (302)
T ss_dssp CCTTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhc
Confidence 9999999999875332 57788999999999999999994
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=7.4e-15 Score=157.11 Aligned_cols=116 Identities=20% Similarity=0.240 Sum_probs=99.5
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECC----E
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----Q 746 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~ 746 (799)
.++|+..+.||+|+||.||++.. .+++.||||+++... ....+.|.+|++++.+++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35688889999999999999994 678999999997643 233467999999999999999999999987654 3
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++||||+++|+|.++++... .+++..+..++.|+++||+|||+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~ 134 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEVIADACQALNFSHQ 134 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 499999999999999998654 57788899999999999999994
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.9e-14 Score=164.75 Aligned_cols=117 Identities=20% Similarity=0.335 Sum_probs=100.3
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh-------------hhHHHHHHHHHHHHhCCCCcccceeE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR-------------QGNREFVNEIGMISAQQHPNLVKLYG 739 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~-------------~~~~~f~~E~~~l~~l~H~niv~l~g 739 (799)
..++|...+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++.+++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 456788999999999999999995 4688999999865421 23467999999999999999999999
Q ss_pred EEEECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 740 ~~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++.+.+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~ 164 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH---------KFDECDAANIMKQILSGICYLHK 164 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999997654 57888999999999999999994
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.52 E-value=2.5e-14 Score=151.22 Aligned_cols=115 Identities=23% Similarity=0.367 Sum_probs=100.3
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccCh--hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
++|...+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46778899999999999999988899999999965432 2346889999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++ +|.+++..... .+++..+..++.||++||+|||+
T Consensus 82 ~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~ 118 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEG--------GLESVTAKSFLLQLLNGIAYCHD 118 (288)
T ss_dssp CSE-EHHHHHHTSTT--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCC-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 985 99999876432 57788899999999999999994
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=3e-14 Score=153.53 Aligned_cols=116 Identities=23% Similarity=0.388 Sum_probs=101.2
Q ss_pred cCCCCCCeecccCCeeEEEEEe-----CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEE--CCEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLL 748 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 748 (799)
++|+..+.||+|+||.||+|+. .+++.||||++........+.+.+|++++.+++|+||+++++++.. .+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4577789999999999999984 4688999999987766667789999999999999999999999874 56789
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||+++|+|.+++..... .+++..+..++.|++.||+|||+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~ 145 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA--------RLDASRLLLYSSQICKGMEYLGS 145 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeecCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999976432 46788899999999999999994
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.5e-14 Score=156.48 Aligned_cols=114 Identities=20% Similarity=0.303 Sum_probs=100.1
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5688889999999999999995 678999999986532 122467999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+ +|+|.+++..+. .+++..+..++.||++||+|||+
T Consensus 89 E~~-~g~l~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~ 126 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK---------RMTEDEGRRFFQQIICAIEYCHR 126 (336)
T ss_dssp CCC-CEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ECC-CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 789999997654 57888999999999999999994
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=2.1e-14 Score=153.45 Aligned_cols=125 Identities=24% Similarity=0.415 Sum_probs=102.0
Q ss_pred hcCCCCCCeecccCCeeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 747 (799)
.++|...+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++.+++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45677889999999999999984 245789999997643 34457899999999999999999999999999999
Q ss_pred EEEEecCCCCcHHHHHhcCccccc---------------ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFH---------------ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~---------------~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||+++|+|.+++........ ......+++..+..++.||++||+|||+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 168 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE 168 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999986532100 0011236788899999999999999994
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.51 E-value=1.5e-14 Score=166.80 Aligned_cols=119 Identities=22% Similarity=0.364 Sum_probs=101.9
Q ss_pred HHhhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 672 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 672 ~~~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
+...++|...+.||+|+||.||+|...++..||||+++... ...++|.+|+++|.+++|+|||++++++.+ +..++||
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 34556688889999999999999998878889999997643 345789999999999999999999999865 6789999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||++|+|.++++..... .+++..+..++.||++||+|||+
T Consensus 341 e~~~~gsL~~~l~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~ 381 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVER 381 (535)
T ss_dssp CCCTTEEHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ehhcCCcHHHHHhhcCCC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999753211 46778888999999999999994
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=3.2e-14 Score=150.71 Aligned_cols=115 Identities=13% Similarity=0.209 Sum_probs=101.0
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|...+.||+|+||.||++... +++.||+|.+... .....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 45778899999999999999964 6889999998654 2334578999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++.... .+++..+..++.|+++||+|||+
T Consensus 95 e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~ 133 (294)
T 2rku_A 95 ELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLGCQYLHR 133 (294)
T ss_dssp ECCTTCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999987643 57788999999999999999994
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.5e-14 Score=153.64 Aligned_cols=115 Identities=22% Similarity=0.377 Sum_probs=94.4
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh--------------------------hhHHHHHHHHHHHH
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR--------------------------QGNREFVNEIGMIS 727 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~--------------------------~~~~~f~~E~~~l~ 727 (799)
.++|...+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 35688889999999999999985 5789999999865421 11356899999999
Q ss_pred hCCCCcccceeEEEEE--CCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 728 AQQHPNLVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 728 ~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++||||+++++++.+ .+..++||||+++|+|.+++... .+++..+..++.||++||+|||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~ 155 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----------PLSEDQARFYFQDLIKGIEYLHY 155 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999987 56899999999999998765432 57888999999999999999994
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.51 E-value=3.2e-14 Score=155.43 Aligned_cols=115 Identities=17% Similarity=0.329 Sum_probs=102.4
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
++|+..+.||+|+||.||++... +|+.||+|++... .....+.+.+|++++.+++||||+++++++.+++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 56888899999999999999964 7899999999765 334457899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++.... .+++..+..++.|++.||+|||+
T Consensus 113 ~~~~~L~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~lh~ 149 (360)
T 3eqc_A 113 MDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLRE 149 (360)
T ss_dssp CTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999998654 56788899999999999999994
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=3.9e-14 Score=148.41 Aligned_cols=116 Identities=22% Similarity=0.311 Sum_probs=101.8
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
.++|...+.||+|+||.||+|... +|+.||||.+.... ....+.+.+|++++.+++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 356888899999999999999964 78999999986542 22356899999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.+++.... .+++..+..++.||++||+|||+
T Consensus 90 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~ 129 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG---------RVEEMEARRLFQQILSAVDYCHR 129 (276)
T ss_dssp EECCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EeccCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999997654 56788899999999999999994
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=2.1e-14 Score=140.15 Aligned_cols=133 Identities=23% Similarity=0.220 Sum_probs=81.9
Q ss_pred cccCCCCCCEEEccCCcCCCcCccccccc-ceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCC
Q 003737 111 ELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINL 189 (799)
Q Consensus 111 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L 189 (799)
.+.++.+|++|++++|+++.. |...... +|++|++++|.+++. ..+..+++|++|+|++|.+++..+..|..+++|
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hcCCcCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 455666777777777777643 3333333 366666666666654 456667777777777777664433334666777
Q ss_pred CEEEcccCcCCccCCh--hccCCCCCCEEEccCCcCCCcCCcc----ccCCCCCCEEEccCCCCC
Q 003737 190 QKLILSSNSFTGELPA--ELTKLTNLNDLRISDNNFSGKIPEF----IGKWKKIQKLHIQGSSLE 248 (799)
Q Consensus 190 ~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~ 248 (799)
++|++++|+++ .+|. .+..+++|++|++++|.++ .+|.. +..+++|+.|+++.|.+.
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 77777777664 3444 5666666777777777665 33443 566666666666666543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=3.8e-14 Score=150.33 Aligned_cols=117 Identities=19% Similarity=0.276 Sum_probs=101.6
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---------hhhHHHHHHHHHHHHhCC-CCcccceeEEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---------RQGNREFVNEIGMISAQQ-HPNLVKLYGCCV 742 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---------~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~ 742 (799)
..++|...+.||+|+||.||+|.. .+|+.||||+++... ....+.+.+|++++.+++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 346788899999999999999996 478999999996542 122457889999999996 999999999999
Q ss_pred ECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 743 EGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 743 ~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..+..++||||+++|+|.+++..+. .+++..+..++.||+.||+|||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~ 142 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALLEVICALHK 142 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999997643 57788999999999999999994
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=1.2e-14 Score=163.89 Aligned_cols=116 Identities=20% Similarity=0.275 Sum_probs=93.5
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
.++|+..+.||+|+||.||+|.. .+|+.||||++... .......+.+|++++.+++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 35688889999999999999994 57899999999753 223346788999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||++|+|.+++.... .+++..++.++.||++||+|||+
T Consensus 227 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~ 266 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER---------VFSEDRARFYGAEIVSALDYLHS 266 (446)
T ss_dssp ECCCSSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EeeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHhh
Confidence 99999999999997654 57888999999999999999994
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.4e-14 Score=157.27 Aligned_cols=128 Identities=15% Similarity=0.233 Sum_probs=102.1
Q ss_pred HHhhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc-----ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECC
Q 003737 672 KAATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK-----SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN 745 (799)
Q Consensus 672 ~~~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 745 (799)
....++|...+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|++++.+++|||||++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 44566789999999999999999995 57889999998643 2334578999999999999999999999999999
Q ss_pred EEEEEEecCCCCcHHHHHhcCcccc-------------------------------cccccCCCChHHHHHHHHHHHHHH
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIF-------------------------------HISIYATFPQGNIQILIISAANNI 794 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~-------------------------------~~~~~~~~~~~~i~~~~~qi~~gL 794 (799)
..++||||+++|+|.+++....... .......+++..+..++.||++||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 9999999999999999996311100 000011235667888999999999
Q ss_pred hhhcC
Q 003737 795 DFFFF 799 (799)
Q Consensus 795 ~yLH~ 799 (799)
+|||+
T Consensus 182 ~~LH~ 186 (345)
T 3hko_A 182 HYLHN 186 (345)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99994
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.51 E-value=2.1e-14 Score=160.45 Aligned_cols=116 Identities=14% Similarity=0.265 Sum_probs=98.1
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh--------hhHHHHHHHHHHHHhCCCCcccceeEEEEEC
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQHPNLVKLYGCCVEG 744 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 744 (799)
..++|...+.||+|+||.||+|.. .+++.||||++..... .....+.+|++++.+++|||||++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 457788999999999999999985 5689999999865321 11235889999999999999999999974 5
Q ss_pred CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+..++|||||++|+|.+++.... .+++..+..++.|+++||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~ 257 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLHE 257 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSC---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CceEEEEEcCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 66899999999999999987654 57888999999999999999994
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=2.5e-14 Score=153.26 Aligned_cols=120 Identities=22% Similarity=0.308 Sum_probs=100.2
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEE----CCEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLL 749 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l 749 (799)
.++|...+.||+|+||.||+++. .+|+.||||++........+.+.+|++++.+++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35688889999999999999995 6789999999976666667889999999999999999999999873 347899
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+++|+|.+++...... ...+++..+..++.||++||+|||+
T Consensus 108 v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~ 152 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDK-----GNFLTEDQILWLLLGICRGLEAIHA 152 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCcHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999753211 1157888999999999999999994
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.51 E-value=1.6e-14 Score=151.67 Aligned_cols=117 Identities=24% Similarity=0.401 Sum_probs=100.2
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
..++|+..+.||+|+||.||+|...++..||||.+.... ...+.+.+|++++.+++||||+++++++. .+..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 445688889999999999999998888899999997543 34578999999999999999999999986 4568999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++...... .+++..+..++.|+++||+|||+
T Consensus 89 ~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~ 127 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGI-------KLTINKLLDMAAQIAEGMAFIEE 127 (279)
T ss_dssp CTTCBHHHHTTSHHHH-------TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHhcCCCC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999754311 46788889999999999999994
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=1.3e-14 Score=159.26 Aligned_cols=115 Identities=20% Similarity=0.338 Sum_probs=91.7
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHH-HHhCCCCcccceeEEEEECCEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGM-ISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
++|+..+.||+|+||.||+++. .+++.||||+++... ....+.+.+|..+ +..++|||||++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 4578889999999999999996 468899999997642 2234567778776 5678999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.+++...+ .+++..++.++.||+.||+|||+
T Consensus 118 ~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~ 157 (373)
T 2r5t_A 118 LDYINGGELFYHLQRER---------CFLEPRARFYAAEIASALGYLHS 157 (373)
T ss_dssp EECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999998654 57788999999999999999994
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=3.5e-14 Score=152.31 Aligned_cols=121 Identities=23% Similarity=0.404 Sum_probs=88.4
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh-hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
.++|+..+.||+|+||.||+|.. .+|+.||+|+++.... ...+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 35688899999999999999985 5789999999975432 334688999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|++ |+|.+++...... .....+++..++.++.||++||+|||+
T Consensus 84 ~~~-~~L~~~l~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~lH~ 126 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVG---NTPRGLELNLVKYFQWQLLQGLAFCHE 126 (317)
T ss_dssp CCC-CBHHHHHHHHHSS---SCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecC-CCHHHHHHhcccc---ccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 998 6999998754311 111257788999999999999999994
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.50 E-value=2.7e-14 Score=149.56 Aligned_cols=115 Identities=24% Similarity=0.350 Sum_probs=101.4
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
++|+..+.||+|+||.||+|... +++.||||.+.... ....+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 45788899999999999999964 78999999986543 33457899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++.... .+++..+..++.|+++||+|||+
T Consensus 87 ~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~ 123 (276)
T 2yex_A 87 CSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHG 123 (276)
T ss_dssp CTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999987543 57788899999999999999994
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=3.9e-14 Score=150.54 Aligned_cols=115 Identities=23% Similarity=0.344 Sum_probs=96.5
Q ss_pred CCCCCCeecccCCeeEEEEEe-----CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEEC--CEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLL 748 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 748 (799)
.|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++.+++||||+++++++... +..+
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 101 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 101 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence 467788999999999999983 368899999997543 33457899999999999999999999999876 6689
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||+++|+|.+++..... .+++..+..++.|++.||+|||+
T Consensus 102 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~ 144 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPKNKN--------KINLKQQLKYAVQICKGMDYLGS 144 (302)
T ss_dssp EEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCcHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHhhc
Confidence 99999999999999965432 57788899999999999999994
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=3.6e-14 Score=153.49 Aligned_cols=115 Identities=13% Similarity=0.209 Sum_probs=101.0
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|...+.||+|+||.||++... +++.||+|.+... .....+.+.+|++++.+++|+||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 45777899999999999999954 6889999998654 2334578999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++.... .+++..+..++.||++||+|||+
T Consensus 121 e~~~~~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~ 159 (335)
T 2owb_A 121 ELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLGCQYLHR 159 (335)
T ss_dssp CCCTTCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999987643 57788999999999999999994
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=2.6e-14 Score=154.26 Aligned_cols=116 Identities=22% Similarity=0.397 Sum_probs=98.6
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh--hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
..++|...+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|++++.+++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 345688899999999999999984 5789999999975532 2345788999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||++ |+|.+++.... .+++..++.++.||++||+|||+
T Consensus 112 ~e~~~-~~L~~~~~~~~---------~~~~~~~~~i~~ql~~~l~~LH~ 150 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP---------DVSMRVIKSFLYQLINGVNFCHS 150 (329)
T ss_dssp EECCS-EEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EecCC-CCHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99998 59999998654 57788999999999999999994
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.50 E-value=2.3e-14 Score=155.46 Aligned_cols=112 Identities=21% Similarity=0.393 Sum_probs=98.0
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEEe
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 752 (799)
.++|+..+.||+|+||.||+|.. .+|+.||||+++.... .+.+|++++.++ +|||||++++++.+.+..|+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 45688889999999999999995 4789999999975432 245788888887 79999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++|+|.+++...+ .+++..+..++.||+.||+|||+
T Consensus 97 ~~~gg~L~~~i~~~~---------~~~~~~~~~~~~qi~~al~~lH~ 134 (342)
T 2qr7_A 97 LMKGGELLDKILRQK---------FFSEREASAVLFTITKTVEYLHA 134 (342)
T ss_dssp CCCSCBHHHHHHTCT---------TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999998654 57888999999999999999994
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.50 E-value=4.6e-14 Score=150.80 Aligned_cols=116 Identities=16% Similarity=0.167 Sum_probs=102.0
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh---hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
.++|...+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|++++.+++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 36788899999999999999995 4789999999975422 2347899999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.+++.... .+++..+..++.|+++||+|||+
T Consensus 113 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~ 152 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG---------PLAPPRAVAIVRQIGSALDAAHA 152 (309)
T ss_dssp EECCCCEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999998653 57788899999999999999994
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.50 E-value=3.4e-14 Score=149.71 Aligned_cols=115 Identities=20% Similarity=0.382 Sum_probs=100.8
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46788899999999999999954 67899999986532 223467999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++.... .+++..+..++.|+++||+|||+
T Consensus 94 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~ 132 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG---------RFDEQRSATFMEELADALHYCHE 132 (284)
T ss_dssp CCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred EeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999997654 57788999999999999999995
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.50 E-value=6.3e-14 Score=148.10 Aligned_cols=113 Identities=21% Similarity=0.352 Sum_probs=97.1
Q ss_pred CCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEE----CCEEEEE
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLLV 750 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV 750 (799)
|...+.||+|+||.||+|.. .++..||+|.+... .....+.+.+|++++.+++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 55567899999999999985 56889999998654 33446789999999999999999999999875 3568999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.+++.... .+++..+..++.||++||+|||+
T Consensus 108 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~ 147 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLHT 147 (290)
T ss_dssp EECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred EEecCCCCHHHHHHHcc---------CCCHHHHHHHHHHHHHHHHHHHc
Confidence 99999999999997643 56788899999999999999995
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=2.7e-14 Score=162.79 Aligned_cols=115 Identities=19% Similarity=0.333 Sum_probs=102.0
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
++|...+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++.+++|||||++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 4588889999999999999995 47899999998643 23345789999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++|+|.+++.... .+++..+..++.||+.||+|||+
T Consensus 102 ~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~al~~lH~ 139 (486)
T 3mwu_A 102 LYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMHK 139 (486)
T ss_dssp CCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999987654 57888999999999999999994
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=2.6e-14 Score=163.28 Aligned_cols=115 Identities=21% Similarity=0.381 Sum_probs=97.5
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
+.|+..+.||+|+||.||+|.. .++..||||++.... ....+.+.+|++++.+++|||||+++++|.+.+..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4577889999999999999995 478999999997542 2345789999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++|+|.+++..+. .+++..+..++.||++||+|||+
T Consensus 117 ~~~~g~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~ 154 (494)
T 3lij_A 117 CYKGGELFDEIIHRM---------KFNEVDAAVIIKQVLSGVTYLHK 154 (494)
T ss_dssp CCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999987654 57788999999999999999994
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=2.5e-14 Score=153.01 Aligned_cols=115 Identities=23% Similarity=0.302 Sum_probs=96.9
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||+||+|... +|+.||||++... .......+.+|+..+.++ +|||||+++++|.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 56888999999999999999965 7999999998654 233345667777766665 8999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+ +|+|.+++..... .+++..+..++.||+.||+|||+
T Consensus 137 e~~-~~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~ 175 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGA--------SLPEAQVWGYLRDTLLALAHLHS 175 (311)
T ss_dssp ECC-CCBHHHHHHHHCS--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecc-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 6799999876532 57888999999999999999994
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=3.1e-14 Score=157.82 Aligned_cols=118 Identities=17% Similarity=0.280 Sum_probs=100.7
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECC--EEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--QLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 751 (799)
+.|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++.+++|||||++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 45778899999999999999964 68999999997543 234577899999999999999999999998765 789999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++...... ..+++..+..++.||+.||+|||+
T Consensus 89 e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~ 130 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLRE 130 (396)
T ss_dssp CCCTTEEHHHHTTSGGGT------TCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCHHHHHHhhhcc------cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999865421 137888999999999999999994
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=3.7e-14 Score=161.55 Aligned_cols=115 Identities=22% Similarity=0.371 Sum_probs=102.2
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++.+++|||||++++++.+.+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 45778899999999999999954 78999999986542 334678999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++..+. .+++..+..++.||+.||+|||+
T Consensus 106 e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~ 144 (484)
T 3nyv_A 106 EVYTGGELFDEIISRK---------RFSEVDAARIIRQVLSGITYMHK 144 (484)
T ss_dssp CCCCSCBHHHHHHTCS---------CCBHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998654 57788999999999999999994
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=2.2e-14 Score=153.25 Aligned_cols=126 Identities=21% Similarity=0.318 Sum_probs=103.3
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe------CCCcEEEEEEccccCh-hhHHHHHHHHHHHHhC-CCCcccceeEEEEECC
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN 745 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 745 (799)
..++|...+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|++++.++ +||||+++++++.+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 446688889999999999999984 3568999999976533 3457899999999999 9999999999999999
Q ss_pred EEEEEEecCCCCcHHHHHhcCccccc---------ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFH---------ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~---------~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++||||+++|+|.+++........ ......+++..+..++.||++||+|||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 163 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS 163 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999986542100 0111247888999999999999999994
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=3.7e-14 Score=156.41 Aligned_cols=125 Identities=19% Similarity=0.320 Sum_probs=102.4
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC--------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccceeEEEEEC
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 744 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 744 (799)
.++|...+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|++++.++ +|||||++++++.++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 456778899999999999999842 34689999997653 34457899999999999 999999999999999
Q ss_pred CEEEEEEecCCCCcHHHHHhcCcccc-------cccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIF-------HISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~-------~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+..++||||+++|+|.+++....... .......+++..+..++.||++||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 209 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999999998654210 00111257888999999999999999994
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.49 E-value=4.5e-14 Score=152.63 Aligned_cols=125 Identities=18% Similarity=0.325 Sum_probs=100.7
Q ss_pred hcCCCCCCeecccCCeeEEEEEe--------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccceeEEEEEC
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL--------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 744 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~--------~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 744 (799)
.++|...+.||+|+||.||+|.. .++..||||+++... ....+.+.+|++++.++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 45678889999999999999985 246789999997653 34457899999999999 899999999999999
Q ss_pred CEEEEEEecCCCCcHHHHHhcCcccccc-------cccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFHI-------SIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~-------~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+..++||||+++|+|.+++......... .....+++..+..++.||++||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 175 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999999999865421000 001247788899999999999999994
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=3.8e-14 Score=154.17 Aligned_cols=115 Identities=21% Similarity=0.413 Sum_probs=98.4
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh---hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
+.|...+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|++++.+++|||||++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3477788999999999999994 6789999999965422 23467999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||++ |+|.+++..... .+++..+..++.|+++||+|||+
T Consensus 134 e~~~-g~l~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~ 172 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHS 172 (348)
T ss_dssp ECCS-EEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCC-CCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9998 689888864322 57788899999999999999994
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=8.4e-14 Score=148.14 Aligned_cols=114 Identities=22% Similarity=0.437 Sum_probs=101.0
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
+.|...+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4577889999999999999985 578999999996543 33467899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++... .+++..+..++.|++.||+|||+
T Consensus 102 ~~~~~L~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~ 137 (303)
T 3a7i_A 102 LGGGSALDLLEPG----------PLDETQIATILREILKGLDYLHS 137 (303)
T ss_dssp CTTEEHHHHHTTS----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999998753 46788899999999999999994
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=5.8e-14 Score=148.08 Aligned_cols=115 Identities=30% Similarity=0.474 Sum_probs=97.3
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhh-------HHHHHHHHHHHHhCCCCcccceeEEEEECCE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQG-------NREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~-------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 746 (799)
.++|+..+.||+|+||.||+|.. .+++.||||++....... .+.+.+|++++.+++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 35677889999999999999995 578999999996542211 168999999999999999999999986554
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||+++|+|.+++..+.. .+++..+..++.|+++||+|||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~ 140 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAH--------PIKWSVKLRLMLDIALGIEYMQN 140 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHT
T ss_pred -eEEEEecCCCCHHHHHhcccC--------CccHHHHHHHHHHHHHHHHHHHh
Confidence 699999999999999876542 57788889999999999999995
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=1.1e-13 Score=148.48 Aligned_cols=112 Identities=22% Similarity=0.425 Sum_probs=97.1
Q ss_pred CCCCCeecccCCeeEEEEEeC-----CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEEC--CEEEE
Q 003737 678 FDPANKVGEGGFGSVYKGILS-----DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLL 749 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~-----~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 749 (799)
|...+.||+|+||.||++.+. +++.||||++.... ....+.+.+|++++.+++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 367789999999999998642 68899999997653 34467899999999999999999999999884 67899
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+++|+|.+++... .+++..+..++.|++.||+|||+
T Consensus 113 v~e~~~~~~L~~~l~~~----------~~~~~~~~~i~~~l~~~l~~LH~ 152 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH----------SIGLAQLLLFAQQICEGMAYLHA 152 (318)
T ss_dssp EECCCTTCBHHHHGGGS----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecccCCcHHHHHhhC----------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999754 36778899999999999999994
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=3.1e-14 Score=155.90 Aligned_cols=119 Identities=18% Similarity=0.185 Sum_probs=99.5
Q ss_pred hhcCCCCCCeecccCCeeEEEEE------eCCCcEEEEEEccccChhhHHHHHHHHHHHHhCC---CCcccceeEEEEEC
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGI------LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ---HPNLVKLYGCCVEG 744 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~------~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~ 744 (799)
..++|...+.||+|+||.||+|. ..+++.||||+++.. ...++.+|++++.+++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 44668888999999999999994 456889999999754 3457888888888887 99999999999999
Q ss_pred CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+..++|||||++|+|.++++....... ..+++..+..++.||++||+|||+
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~lH~ 190 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPE----KVMPQGLVISFAMRMLYMIEQVHD 190 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTT----CSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccc----cCCCHHHHHHHHHHHHHHHHHHhh
Confidence 999999999999999999975321111 168888999999999999999996
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.49 E-value=3.3e-14 Score=153.39 Aligned_cols=236 Identities=12% Similarity=0.053 Sum_probs=126.2
Q ss_pred ccEEEEEeCCCCCcccCCccccC-CCCCCEEEccCCcCC--CcCcccccccceeEEEccCCcCcCcCCcccCC-------
Q 003737 92 CHVVTIALKAQNLTGTLPTELSK-LRYLKQLDLSRNCLT--GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN------- 161 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~-l~~L~~L~Ls~N~l~--~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~------- 161 (799)
.+++.|.++++ +.+.--..+.. +++|++|||++|++. ...+..+.. ++.+.+..|.+ .+..|.+
T Consensus 25 ~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~--~~~~~~~~~~I---~~~aF~~~~~~~~~ 98 (329)
T 3sb4_A 25 NSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPN--GKFYIYMANFV---PAYAFSNVVNGVTK 98 (329)
T ss_dssp HHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGG--GCCEEECTTEE---CTTTTEEEETTEEE
T ss_pred CceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccccc--ccccccccccc---CHHHhccccccccc
Confidence 35777777643 11111122333 788999999999988 222222222 33444444422 2334555
Q ss_pred -CCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcC----CCcCCcccc----
Q 003737 162 -ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF----SGKIPEFIG---- 232 (799)
Q Consensus 162 -L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l----~~~~p~~~~---- 232 (799)
+++|+.|+|.+ .++..-+..|.++++|+.|++++|.++...+..|.++.++..+.+..+.. ...-...|.
T Consensus 99 g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~ 177 (329)
T 3sb4_A 99 GKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEP 177 (329)
T ss_dssp ECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCC
T ss_pred ccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccc
Confidence 88888888887 67655556688888888888888887766666777766666666554221 100111111
Q ss_pred ----------------------------------------------CCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEc
Q 003737 233 ----------------------------------------------KWKKIQKLHIQGSSLEGPIPASISALTSLTDLRI 266 (799)
Q Consensus 233 ----------------------------------------------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 266 (799)
.+++|+.|+|++|+++...+..|.++++|+.|++
T Consensus 178 L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l 257 (329)
T 3sb4_A 178 LETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKL 257 (329)
T ss_dssp CEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEEC
T ss_pred cceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEEC
Confidence 1445555555555555444445555555555555
Q ss_pred CCCCCCCCCCCccCC-CCcc-EEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEe
Q 003737 267 SDLKGSESAFPKLDK-MNLK-TLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 336 (799)
Q Consensus 267 ~~n~~~~~~~~~l~~-~~L~-~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 336 (799)
.+| .....-..|.. .+|+ .+++.+ .++...+..|.++++|+.++++.|+++...+.+|.++++|+.++
T Consensus 258 ~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 258 PHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp CTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred Ccc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 542 22211112333 3455 555554 44444444555555555555555555544444555555555554
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.49 E-value=4.8e-14 Score=161.58 Aligned_cols=119 Identities=19% Similarity=0.272 Sum_probs=102.4
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|...+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|++++.+++|||||++++++.+.+..|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 5678889999999999999996 479999999996542 223467899999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++...... ...+++..+..|+.||+.||+|||+
T Consensus 265 E~~~gg~L~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~aL~~LH~ 307 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDED-----NPGFQEPRAIFYTAQIVSGLEHLHQ 307 (543)
T ss_dssp CCCTTCBHHHHHHTSSTT-----SCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EeccCCCHHHHHHHhhcc-----cccccHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999764311 1157888999999999999999994
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=9.4e-14 Score=148.26 Aligned_cols=119 Identities=24% Similarity=0.430 Sum_probs=99.8
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++.+++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4578889999999999999995 57899999999753 2334578999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++...... ...+++..+..++.||++||+|||+
T Consensus 112 e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~ 154 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQ-----KRLIPERTVWKYFVQLCSALEHMHS 154 (310)
T ss_dssp ECCCSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCHHHHHHHhccc-----ccCCCHHHHHHHHHHHHHHHHHHhh
Confidence 999999999999742210 1157788899999999999999994
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.49 E-value=4.8e-14 Score=154.01 Aligned_cols=127 Identities=20% Similarity=0.237 Sum_probs=108.4
Q ss_pred ccccHHHHHHhhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCC-----CCcccce
Q 003737 664 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-----HPNLVKL 737 (799)
Q Consensus 664 ~~~~~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-----H~niv~l 737 (799)
..+++.+.....++|...+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|++++.+++ |||||++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 3455556566778899999999999999999995 57899999999643 334567888999999987 9999999
Q ss_pred eEEEEECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 738 ~g~~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++++...+..++||||+ +|+|.+++...... .+++..+..++.||+.||+|||+
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~ 155 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN-------GFHIEDIKLYCIEILKALNYLRK 155 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999 89999999865422 47788999999999999999994
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.49 E-value=9.4e-14 Score=146.58 Aligned_cols=114 Identities=25% Similarity=0.469 Sum_probs=96.7
Q ss_pred CCCCCC-eecccCCeeEEEEEeC---CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 677 NFDPAN-KVGEGGFGSVYKGILS---DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 677 ~f~~~~-~lG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
+|...+ .||+|+||.||+|... ++..||||+++... ....+.+.+|++++.+++||||+++++++ ..+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 344444 8999999999999853 67889999997653 34567899999999999999999999999 566789999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++..... .+++..+..++.|+++||+|||+
T Consensus 89 e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~ 128 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEE 128 (287)
T ss_dssp ECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EeCCCCCHHHHHHhCCc--------cCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999975432 57788999999999999999994
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.48 E-value=2.9e-14 Score=154.63 Aligned_cols=127 Identities=22% Similarity=0.380 Sum_probs=100.9
Q ss_pred HhhcCCCCCCeecccCCeeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccceeEEEEEC
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 744 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 744 (799)
...++|...+.||+|+||.||+|.. .++..||||++.... ....+.+.+|++++.++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3456788899999999999999985 245689999997542 33457899999999999 899999999999999
Q ss_pred CEEEEEEecCCCCcHHHHHhcCcccccc--------------cccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFHI--------------SIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~--------------~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+..++||||+++|+|.+++......... .....+++..+..++.||++||+|||+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 190 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF 190 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999999999865432110 001246788899999999999999994
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.48 E-value=3.1e-14 Score=153.02 Aligned_cols=124 Identities=20% Similarity=0.361 Sum_probs=94.3
Q ss_pred HhhcCCCCCCeecccCCeeEEEEEeC-CC---cEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCE
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGILS-DG---TVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~~~-~g---~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 746 (799)
...++|+..+.||+|+||.||+|... ++ ..||||+++.. .....+.|.+|++++.+++||||+++++++...+.
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 34567888999999999999999854 33 27999999764 33456789999999999999999999999987765
Q ss_pred E------EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 L------LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~------~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
. ++||||+++|+|.+++...... .....+++..+..++.||++||+|||+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~al~~LH~ 155 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIG---ENPFNLPLQTLVRFMVDIACGMEYLSS 155 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhcc---ccccccCHHHHHHHHHHHHHHHHHHHc
Confidence 5 9999999999999999754311 111257888999999999999999994
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=7.7e-14 Score=150.24 Aligned_cols=116 Identities=24% Similarity=0.403 Sum_probs=99.5
Q ss_pred cCCCCCCeecccCCeeEEEEEe-----CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECC--EEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--QLL 748 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~ 748 (799)
++|...+.||+|+||.||++.. .+|+.||||++........+.+.+|++++.+++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 3467788999999999999984 368899999998766666788999999999999999999999987644 689
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||+++|+|.+++..... .+++..+..++.||++||+|||+
T Consensus 121 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~ 163 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGT 163 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTT--------SSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEECCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999986532 46788888899999999999994
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.48 E-value=8.8e-14 Score=152.37 Aligned_cols=120 Identities=18% Similarity=0.314 Sum_probs=103.2
Q ss_pred HHHhhcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccCh--------hhHHHHHHHHHHHHhC-CCCcccceeEE
Q 003737 671 IKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQ-QHPNLVKLYGC 740 (799)
Q Consensus 671 ~~~~t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l-~H~niv~l~g~ 740 (799)
.....++|+..+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|++++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445567888999999999999999964 799999999865431 1135688999999999 79999999999
Q ss_pred EEECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 741 CVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 741 ~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+...+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH~ 218 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKV---------ALSEKETRSIMRSLLEAVSFLHA 218 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999999999999997543 57788999999999999999994
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=7.2e-14 Score=147.02 Aligned_cols=116 Identities=18% Similarity=0.303 Sum_probs=98.0
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC----CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
.++|+..+.||+|+||.||+|... .+..||+|.+.... ....+.|.+|++++.+++||||+++++++ .++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 456778899999999999999853 25679999987643 33457899999999999999999999998 4567899
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+++|+|.+++..+.. .+++..+..++.|+++||+|||+
T Consensus 93 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~ 134 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLES 134 (281)
T ss_dssp EEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999975532 47788899999999999999994
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=6.8e-14 Score=163.70 Aligned_cols=108 Identities=25% Similarity=0.472 Sum_probs=93.9
Q ss_pred eecccCCeeEEEEEeC---CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCCCc
Q 003737 683 KVGEGGFGSVYKGILS---DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 758 (799)
Q Consensus 683 ~lG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~Gs 758 (799)
.||+|+||.||+|... ++..||||+++... ....++|.+|+++|.+++|||||+++++|.+ +..++|||||++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999853 46689999997653 3356789999999999999999999999976 56899999999999
Q ss_pred HHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 759 LSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 759 L~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|.++++.... .+++..+..++.||++||+|||+
T Consensus 422 L~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~LH~ 454 (613)
T 2ozo_A 422 LHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEE 454 (613)
T ss_dssp HHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999976532 57788899999999999999994
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=6.6e-14 Score=153.01 Aligned_cols=124 Identities=20% Similarity=0.333 Sum_probs=105.1
Q ss_pred cHHHHHHhhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccCh-----------hhHHHHHHHHHHHHhCCCCccc
Q 003737 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR-----------QGNREFVNEIGMISAQQHPNLV 735 (799)
Q Consensus 667 ~~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~-----------~~~~~f~~E~~~l~~l~H~niv 735 (799)
...++....++|...+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++.+++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 45677788899999999999999999999987899999999854321 1237899999999999999999
Q ss_pred ceeEEEEEC-----CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 736 KLYGCCVEG-----NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 736 ~l~g~~~~~-----~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++++++... ...++||||++ |+|.+++..... .+++..+..++.||+.||+|||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~ 152 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI--------VISPQHIQYFMYHILLGLHVLHE 152 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999998653 36899999998 699998875432 57788999999999999999994
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=6.5e-14 Score=147.81 Aligned_cols=117 Identities=20% Similarity=0.333 Sum_probs=102.8
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
..++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++.+++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3456888999999999999999964 78999999986542 33467899999999999999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||+++|+|.+++.... .+++..+..++.||+.||+|||+
T Consensus 100 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~ 139 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMHK 139 (287)
T ss_dssp ECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999987543 57788999999999999999994
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.48 E-value=2.1e-14 Score=154.11 Aligned_cols=133 Identities=19% Similarity=0.316 Sum_probs=107.0
Q ss_pred cHHHHHHhhcCCCCCCeecccCCeeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeE
Q 003737 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYG 739 (799)
Q Consensus 667 ~~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g 739 (799)
..++++...++|...+.||+|+||.||+|... +++.||||.+.... ......|.+|++++.+++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 33445556778999999999999999999853 46789999997543 334567999999999999999999999
Q ss_pred EEEECCEEEEEEecCCCCcHHHHHhcCccccc-ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFH-ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 740 ~~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~-~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++.+.+..++||||+++|+|.++++....... ......+++..+..++.||+.||+|||+
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 156 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA 156 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999975432100 0111246778888899999999999994
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.48 E-value=5.4e-14 Score=149.13 Aligned_cols=116 Identities=19% Similarity=0.340 Sum_probs=98.5
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEE----------
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE---------- 743 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~---------- 743 (799)
.++|+..+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|++++.+++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 35688889999999999999995 57899999999643 3345789999999999999999999999865
Q ss_pred ---CCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 744 ---GNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 744 ---~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+..++||||+++|+|.+++..... .+++..+..++.|+++||+|||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~ 134 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENL--------NQQRDEYWRLFRQILEALSYIHS 134 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCG--------GGCHHHHHHHHHHHHHHHHHHHH
T ss_pred cccCCceEEEEecCCCCCHHHhhhcccc--------ccchHHHHHHHHHHHHHHHHHHh
Confidence 3568999999999999999985432 45667888889999999999994
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=7.1e-14 Score=146.67 Aligned_cols=120 Identities=19% Similarity=0.339 Sum_probs=101.0
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEE--CCEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLL 749 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 749 (799)
.++|+..+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|++++.+++||||+++++++.+ .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 35678889999999999999995 478999999997542 3345789999999999999999999998865 568999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+++|+|.+++...... ...+++..+..++.|++.||+|||+
T Consensus 85 v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~ 129 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHR 129 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCCHHHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 99999999999999754311 1147788999999999999999994
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=4.8e-14 Score=151.53 Aligned_cols=115 Identities=15% Similarity=0.269 Sum_probs=96.0
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh--------hhHHHHHHHHHHHHhCCCCcccceeEEEEECC
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGN 745 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 745 (799)
.++|...+.||+|+||.||+|.. .+++.||||.+..... .....+.+|++++.+++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 35688889999999999999995 4689999999865321 12346889999999999999999999987655
Q ss_pred EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++||||+++|+|.+++.... .+++..+..++.||++||+|||+
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~ 132 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLHE 132 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTC---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred -eEEEEecCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 899999999999999997654 57788999999999999999994
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.48 E-value=6.8e-14 Score=151.22 Aligned_cols=116 Identities=23% Similarity=0.437 Sum_probs=98.7
Q ss_pred cCCCCCCeecccCCeeEEEEEeCC-----CcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSD-----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~-----g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
.+|...+.||+|+||.||+|.... +..||||.++... ......|.+|++++.+++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 345667899999999999998532 2469999997653 3345689999999999999999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+++|+|.+++..... .+++..+..++.||++||+|||+
T Consensus 124 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~ 165 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLAN 165 (333)
T ss_dssp EEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999976432 57788899999999999999994
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.48 E-value=3.1e-14 Score=155.38 Aligned_cols=115 Identities=20% Similarity=0.299 Sum_probs=100.4
Q ss_pred cCCCCCCeecccCCeeEEEEEe----CCCcEEEEEEccccC----hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKS----RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ 746 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 746 (799)
++|...+.||+|+||.||+++. .+|+.||||+++... ....+.+.+|++++.++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5688889999999999999986 378999999996532 22345688899999999 69999999999999999
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++||||+++|+|.+++.... .+++..+..++.||++||+|||+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~ 177 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE---------RFTEHEVQIYVGEIVLALEHLHK 177 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999998654 57788999999999999999994
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=8.3e-14 Score=150.33 Aligned_cols=115 Identities=23% Similarity=0.385 Sum_probs=100.3
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
++|+..+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 45778899999999999999964 68999999986543 2334678899999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++++|.+++.... .+++..+..++.||+.||+|||+
T Consensus 105 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~LH~ 142 (331)
T 4aaa_A 105 FVDHTILDDLELFPN---------GLDYQVVQKYLFQIINGIGFCHS 142 (331)
T ss_dssp CCSEEHHHHHHHSTT---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCcchHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999998876544 57788999999999999999994
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=7.9e-14 Score=150.19 Aligned_cols=123 Identities=22% Similarity=0.273 Sum_probs=100.2
Q ss_pred hcCCCCCCeecccCCeeEEEEEe------CCCcEEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 747 (799)
.++|...+.||+|+||.||+|.. .+++.||||++... .......+.+|++++.+++||||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 45688889999999999999983 35778999999754 344567899999999999999999999999999999
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||+++|+|.+++....... .....+++..+..++.||++||+|||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~LH~ 158 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEE 158 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCS--SSTTSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEecCCCCcHHHHHHhhcccc--cccccccHHHHHHHHHHHHHHHHHHhh
Confidence 99999999999999998654211 112257788889999999999999994
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.47 E-value=7.1e-14 Score=150.63 Aligned_cols=115 Identities=22% Similarity=0.481 Sum_probs=92.7
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCc----EEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGT----VIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~----~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
++|+..+.||+|+||.||+|.. .+++ .||+|.++... ....+.|.+|++++.+++|||||+++++|.+.+ .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 4577889999999999999994 3444 36888886542 345678999999999999999999999998755 789
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+||+++|+|.++++.... .+++..+..++.||++||+|||+
T Consensus 94 v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~ 135 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLED 135 (327)
T ss_dssp EEECCTTCBHHHHHHHSTT--------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhh
Confidence 9999999999999986532 57788899999999999999994
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=7.2e-14 Score=149.18 Aligned_cols=113 Identities=27% Similarity=0.529 Sum_probs=95.8
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCC
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
++|+..+.||+|+||.||++... ++.||||++... ...+.|.+|++++.+++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 45677889999999999999974 788999999643 34578999999999999999999999876 45799999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.++++..... ..+++..+..++.|+++||+|||+
T Consensus 83 ~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~ 120 (307)
T 2eva_A 83 GGSLYNVLHGAEPL------PYYTAAHAMSWCLQCSQGVAYLHS 120 (307)
T ss_dssp TCBHHHHHHCSSSE------ECCCHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCHHHHHhccCCC------CccCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999865421 135677888889999999999995
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.47 E-value=3.6e-14 Score=154.09 Aligned_cols=117 Identities=18% Similarity=0.309 Sum_probs=100.8
Q ss_pred hcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhh-----------------HHHHHHHHHHHHhCCCCcccce
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG-----------------NREFVNEIGMISAQQHPNLVKL 737 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~-----------------~~~f~~E~~~l~~l~H~niv~l 737 (799)
.++|...+.||+|+||.||+|.. +|+.||||++....... .+.|.+|++++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 45788899999999999999998 89999999986532111 1789999999999999999999
Q ss_pred eEEEEECCEEEEEEecCCCCcHHHH------HhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 738 YGCCVEGNQLLLVYEYMKNNCLSRA------IFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 738 ~g~~~~~~~~~lV~Ey~~~GsL~~~------L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++++.+.+..++||||+++|+|.++ +.... ...+++..+..++.||+.||+|||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~ 169 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-------TCFIPIQVIKCIIKSVLNSFSYIHN 169 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-------CCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-------ccCCCHHHHHHHHHHHHHHHHHHhc
Confidence 9999999999999999999999998 44321 1267888999999999999999994
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=6.1e-14 Score=151.15 Aligned_cols=127 Identities=17% Similarity=0.298 Sum_probs=104.2
Q ss_pred ccHHHHHHhhcCCCCC-CeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCC-CCcccceeEE
Q 003737 666 YTLRQIKAATNNFDPA-NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQ-HPNLVKLYGC 740 (799)
Q Consensus 666 ~~~~~~~~~t~~f~~~-~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~-H~niv~l~g~ 740 (799)
..+...+...+.|... +.||+|+||.||+|.. .+|+.||||++.... ......+.+|++++.+++ ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3334444455556665 7899999999999995 468999999997542 234678999999999995 6999999999
Q ss_pred EEECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 741 CVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 741 ~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+.+.+..++||||+++|+|.+++...... .+++..+..++.|++.||+|||+
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~i~~ql~~~L~~LH~ 149 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAE-------MVSENDVIRLIKQILEGVYYLHQ 149 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-C-------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999998654322 57888999999999999999994
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.47 E-value=5.1e-14 Score=150.55 Aligned_cols=134 Identities=20% Similarity=0.332 Sum_probs=106.1
Q ss_pred ccHHHHHHhhcCCCCCCeecccCCeeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccce
Q 003737 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKL 737 (799)
Q Consensus 666 ~~~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l 737 (799)
+...++....++|...+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34455555677899999999999999999983 356899999997653 33456899999999999 79999999
Q ss_pred eEEEEECC-EEEEEEecCCCCcHHHHHhcCcccccc-------cccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 738 YGCCVEGN-QLLLVYEYMKNNCLSRAIFGKLRIFHI-------SIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 738 ~g~~~~~~-~~~lV~Ey~~~GsL~~~L~~~~~~~~~-------~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++++...+ ..++||||+++|+|.+++......... .....+++..+..++.||++||+|||+
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~ 166 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 166 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh
Confidence 99988754 589999999999999999865421100 001136788899999999999999994
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.47 E-value=7.5e-14 Score=146.73 Aligned_cols=113 Identities=20% Similarity=0.354 Sum_probs=96.7
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEE-----------
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE----------- 743 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----------- 743 (799)
.+|+..+.||+|+||.||+|... +|+.||+|++.... +.+.+|++++.+++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 45788899999999999999964 79999999997543 357789999999999999999998864
Q ss_pred -----CCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 744 -----GNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 744 -----~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
....++||||+++|+|.+++...... .+++..+..++.||++||+|||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~ 140 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-------KLDKVLALELFEQITKGVDYIHS 140 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 34579999999999999999754321 57788899999999999999994
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.47 E-value=2.7e-16 Score=156.79 Aligned_cols=146 Identities=22% Similarity=0.296 Sum_probs=82.2
Q ss_pred CCCCCEEEccCCcCCCcCcc------cccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCC
Q 003737 115 LRYLKQLDLSRNCLTGSFSP------QWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLI 187 (799)
Q Consensus 115 l~~L~~L~Ls~N~l~~~~p~------~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~ 187 (799)
...++.++++.+.+.+.+|. .+..++ |++|++++|.+++ +| .+..+++|++|++++|.++ .+|..+..++
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~ 93 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence 34444444444444444443 444444 5555555555554 44 5556666666666666665 4555555556
Q ss_pred CCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCC-ccccCCCCCCEEEccCCCCCCCCch----------hhh
Q 003737 188 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIP-EFIGKWKKIQKLHIQGSSLEGPIPA----------SIS 256 (799)
Q Consensus 188 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~----------~~~ 256 (799)
+|++|++++|++++ +| .+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++.+|. .+.
T Consensus 94 ~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~ 171 (198)
T 1ds9_A 94 TLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK 171 (198)
T ss_dssp HCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHH
T ss_pred cCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHH
Confidence 66666666666664 33 45566666666666666653222 3556666666666666666554443 256
Q ss_pred cCCCCCeEE
Q 003737 257 ALTSLTDLR 265 (799)
Q Consensus 257 ~l~~L~~L~ 265 (799)
.+++|+.||
T Consensus 172 ~l~~L~~Ld 180 (198)
T 1ds9_A 172 RLPNLKKLD 180 (198)
T ss_dssp HCSSCSEEC
T ss_pred hCCCcEEEC
Confidence 666666665
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.47 E-value=6.7e-14 Score=158.22 Aligned_cols=115 Identities=15% Similarity=0.312 Sum_probs=90.2
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC-----CE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQ 746 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 746 (799)
.++|...+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|++++.+++|||||++++++... +.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 35788899999999999999984 47899999999653 333457899999999999999999999998543 56
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.|+||||+. |+|.+++.... .+++..++.++.||+.||+|||+
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~ 174 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPV---------YLTELHIKTLLYNLLVGVKYVHS 174 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeccc-cchhhhcccCC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 899999985 79999997654 57888999999999999999994
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=7.4e-14 Score=150.18 Aligned_cols=124 Identities=23% Similarity=0.405 Sum_probs=105.0
Q ss_pred HHHHHHhhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhC-CCCcccceeEEEEE--
Q 003737 668 LRQIKAATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE-- 743 (799)
Q Consensus 668 ~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~-- 743 (799)
..++....++|+..+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|++++.++ +||||+++++++..
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 334445678899999999999999999995 578999999986543 2356899999999998 89999999999987
Q ss_pred ----CCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 744 ----GNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 744 ----~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+..++||||+++|+|.+++...... .+++..+..++.||+.||+|||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~ 147 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-------TLKEEWIAYICREILRGLSHLHQ 147 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGG-------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 46789999999999999999865321 57888899999999999999994
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.1e-13 Score=150.13 Aligned_cols=114 Identities=16% Similarity=0.231 Sum_probs=100.2
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCC--CcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQH--PNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~ 751 (799)
+.|+..+.||+|+||.||++...+++.||||++... .....+.+.+|++++.+++| +||+++++++.+++..++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 457788999999999999999888999999998654 33445789999999999987 99999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
| +.+|+|.+++.... .+++..+..++.||++||+|||+
T Consensus 89 e-~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~ 126 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIHQ 126 (343)
T ss_dssp C-CCSEEHHHHHHHSC---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred e-CCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9 56889999998754 57788899999999999999994
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=2.2e-13 Score=144.58 Aligned_cols=110 Identities=21% Similarity=0.369 Sum_probs=93.6
Q ss_pred hcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHh--CCCCcccceeEEEEEC----CEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA--QQHPNLVKLYGCCVEG----NQLL 748 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~----~~~~ 748 (799)
.++|+..+.||+|+||.||+|.. +|+.||||++... ..+.+.+|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 45788899999999999999987 6899999998653 34567777777776 7999999999997653 4589
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhc
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFF 798 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH 798 (799)
+||||+++|+|.++++.. .+++..+..++.||++||+|||
T Consensus 83 lv~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~~i~~~l~~lH 122 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT----------TLDTVSCLRIVLSIASGLAHLH 122 (301)
T ss_dssp EEECCCTTCBHHHHHTTC----------CBCHHHHHHHHHHHHHHHHHHH
T ss_pred EehhhccCCCHHHHHhhc----------ccCHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999643 4678888899999999999999
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=8.9e-14 Score=155.97 Aligned_cols=115 Identities=16% Similarity=0.317 Sum_probs=100.0
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC-----CE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQ 746 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 746 (799)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++.+++|+|||++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46788899999999999999995 57889999999754 333457899999999999999999999999776 57
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.|+||||++ |+|.++++... .+++..++.++.||++||+|||+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~i~~qil~aL~~LH~ 147 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI---------FLTEEHIKTILYNLLLGENFIHE 147 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEecCC-cCHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 899999997 59999998654 57888999999999999999994
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.46 E-value=1.3e-13 Score=146.21 Aligned_cols=116 Identities=27% Similarity=0.459 Sum_probs=97.6
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
++|+..+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++.+++||||+++++++..++..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 46788899999999999999964 789999999965432 234678999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|++ |+|.+++...... .+++..+..++.||++||+|||+
T Consensus 83 ~~~-~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~ 121 (299)
T 2r3i_A 83 FLH-QDLKKFMDASALT-------GIPLPLIKSYLFQLLQGLAFCHS 121 (299)
T ss_dssp CCS-EEHHHHHHHTTTT-------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccc-CCHHHHHHhhhcc-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 998 6999999765321 56788899999999999999994
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.5e-13 Score=161.35 Aligned_cols=108 Identities=22% Similarity=0.366 Sum_probs=93.2
Q ss_pred CeecccCCeeEEEEEe---CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCC
Q 003737 682 NKVGEGGFGSVYKGIL---SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~---~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+.||+|+||.||+|.. ..++.||||+++... ....++|.+|++++.+++|||||+++++|. .+..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 4799999999999974 346789999997643 234578999999999999999999999996 4568899999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.++++... .+++..+..++.||+.||+|||+
T Consensus 454 g~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~yLH~ 487 (635)
T 4fl3_A 454 GPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLEE 487 (635)
T ss_dssp EEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999997654 57788899999999999999994
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.3e-13 Score=147.64 Aligned_cols=114 Identities=19% Similarity=0.327 Sum_probs=94.1
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEE-----------
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV----------- 742 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~----------- 742 (799)
.++|...+.||+|+||.||+|... +|+.||||++........+.+.+|++++.+++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 356788899999999999999964 58999999998766666788999999999999999999999873
Q ss_pred ---ECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 743 ---EGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 743 ---~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+.+..++||||++ |+|.+++... .+++..+..++.|+++||+|||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~ 138 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG----------PLLEEHARLFMYQLLRGLKYIHS 138 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC----------CccHHHHHHHHHHHHHHHHHHHh
Confidence 3467899999998 6999998643 46788899999999999999994
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.2e-13 Score=147.67 Aligned_cols=116 Identities=30% Similarity=0.576 Sum_probs=96.3
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
..+.|+..+.||+|+||.||+|... +|+.||||.+.... ..+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567888999999999999999964 68999999997543 34679999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++|+|.+++..... .+++..+..++.||+.||+|||+
T Consensus 105 ~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~ 143 (314)
T 3com_A 105 YCGAGSVSDIIRLRNK--------TLTEDEIATILQSTLKGLEYLHF 143 (314)
T ss_dssp CCTTEEHHHHHHHHTC--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999974321 57788999999999999999994
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=3.6e-14 Score=153.54 Aligned_cols=116 Identities=16% Similarity=0.234 Sum_probs=100.9
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh--------hhHHHHHHHHHHHHhCCCCcccceeEEEEECC
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGN 745 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 745 (799)
.++|...+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++.+++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 45688899999999999999984 5789999999975421 12346788999999999999999999999999
Q ss_pred EEEEEEecCCCC-cHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNN-CLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~G-sL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++||||+.+| +|.+++.... .+++..+..++.||+.||+|||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH~ 148 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP---------RLDEPLASYIFRQLVSAVGYLRL 148 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEEEeCCCCccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999887 9999998654 57888999999999999999994
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=9.8e-14 Score=149.68 Aligned_cols=114 Identities=20% Similarity=0.237 Sum_probs=98.8
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEEe
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 752 (799)
.++|...+.||+|+||.||+|.. .+|+.||||.+..... .+.+.+|++++.++ +|+||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 35688889999999999999994 6789999999865422 34688999999999 99999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+ +|+|.+++..... .+++..+..++.||++||+|||+
T Consensus 86 ~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~ 123 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDR--------TFSLKTVLMIAIQLISRMEYVHS 123 (330)
T ss_dssp CC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eC-CCCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99 9999999986422 57888999999999999999994
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.2e-13 Score=146.00 Aligned_cols=114 Identities=22% Similarity=0.359 Sum_probs=95.6
Q ss_pred cCCCCCC-eecccCCeeEEEEEe---CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 676 NNFDPAN-KVGEGGFGSVYKGIL---SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 676 ~~f~~~~-~lG~G~~g~Vy~~~~---~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
++|...+ .||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++.+++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4466666 899999999999963 346899999997543 22357899999999999999999999999 6677899
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+++|+|.+++.... .+++..+..++.||++||+|||+
T Consensus 95 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~ 135 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLEE 135 (291)
T ss_dssp EEECCTTEEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCHHHHHHhCc---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999998654 57788899999999999999994
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.46 E-value=1.1e-13 Score=135.10 Aligned_cols=126 Identities=14% Similarity=0.200 Sum_probs=100.6
Q ss_pred ceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEcc
Q 003737 140 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219 (799)
Q Consensus 140 ~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 219 (799)
+|++|++++|+++. +|......++|++|+|++|.+++. ..|..+++|++|++++|++++..+..+..+++|++|+++
T Consensus 20 ~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 96 (176)
T 1a9n_A 20 RDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 96 (176)
T ss_dssp SCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred CceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECC
Confidence 38999999999984 455333344999999999999864 678889999999999999986555556889999999999
Q ss_pred CCcCCCcCCc--cccCCCCCCEEEccCCCCCCCCch----hhhcCCCCCeEEcCCCC
Q 003737 220 DNNFSGKIPE--FIGKWKKIQKLHIQGSSLEGPIPA----SISALTSLTDLRISDLK 270 (799)
Q Consensus 220 ~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~L~~n~ 270 (799)
+|+++ .+|. .+..+++|++|++++|.++. +|. .+..+++|+.|++++|.
T Consensus 97 ~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~ 151 (176)
T 1a9n_A 97 NNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVK 151 (176)
T ss_dssp SCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECC
T ss_pred CCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCC
Confidence 99996 4565 78889999999999999874 455 37888888888887644
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=6.8e-14 Score=148.57 Aligned_cols=125 Identities=16% Similarity=0.294 Sum_probs=87.8
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
..++|...+.||+|+||.||+|.. .+++.||||++.... ....+++.+|++++.+++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 456788899999999999999984 578999999986543 234567899999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++...... .......+++..+..++.||++||+|||+
T Consensus 93 e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 139 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAK-GEHKSGVLDESTIATILREVLEGLEYLHK 139 (303)
T ss_dssp ECCTTCBHHHHHHHHHHT-TTTTTCSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred hhccCCchHHHHHHHhhc-cccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999742110 00011157788999999999999999994
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=2.2e-13 Score=146.73 Aligned_cols=124 Identities=25% Similarity=0.438 Sum_probs=98.9
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcE--EEEEEcccc-ChhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTV--IAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~--vAvK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 750 (799)
++|...+.||+|+||.||+|.. .+|.. ||||.+... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 4577889999999999999995 45664 499998653 233456799999999999 899999999999999999999
Q ss_pred EecCCCCcHHHHHhcCccccc-------ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFH-------ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~-------~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.+++........ ......+++..+..++.||++||+|||+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 160 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 160 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999986531000 0111257888999999999999999994
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.45 E-value=1.6e-13 Score=145.36 Aligned_cols=114 Identities=23% Similarity=0.329 Sum_probs=95.4
Q ss_pred CCCCCeecccCCeeEEEEEe-CCC---cEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEE-EEEE
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SDG---TVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL-LLVY 751 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~g---~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV~ 751 (799)
|...+.||+|+||.||+|.. .++ ..||+|.+.... ....+.|.+|++++++++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 44568899999999999984 233 379999997643 34457899999999999999999999999876655 9999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+.+|+|.+++..... .+++..+..++.|+++||+|||+
T Consensus 103 e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~ 142 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQR--------NPTVKDLISFGLQVARGMEYLAE 142 (298)
T ss_dssp CCCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHH
T ss_pred ecccCCCHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999986432 46777888999999999999994
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=1.1e-13 Score=147.89 Aligned_cols=124 Identities=23% Similarity=0.380 Sum_probs=95.8
Q ss_pred HhhcCCCCCCeecccCCeeEEEEEeC----CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCE
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~~~----~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 746 (799)
...++|...+.||+|+||.||+|... ++..||||+++.. .....+.+.+|++++.+++||||+++++++.+.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34566788899999999999999853 3458999999754 23345789999999999999999999999987553
Q ss_pred -----EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 -----LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 -----~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++||||+++|+|.+++...... .....+++..+..++.||++||+|||+
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~ 165 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLE---TGPKHIPLQTLLKFMVDIALGMEYLSN 165 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBT---TSCCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhh---cCCccCCHHHHHHHHHHHHHHHHHHHh
Confidence 59999999999999999543211 011257888999999999999999995
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.45 E-value=8.1e-14 Score=153.06 Aligned_cols=114 Identities=27% Similarity=0.402 Sum_probs=94.9
Q ss_pred CCCCCeecccCCeeEEEEEeC--CC--cEEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEEEE-CCEEEEEE
Q 003737 678 FDPANKVGEGGFGSVYKGILS--DG--TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLLVY 751 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~--~g--~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~ 751 (799)
|...+.||+|+||.||+|... ++ ..||||.++.. .....+.|.+|++++++++|||||+++++|.+ ++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 455678999999999999853 22 46899999754 33456789999999999999999999999865 45789999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.++++.... .+++..+..++.||++||+|||+
T Consensus 171 e~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~ 210 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLAS 210 (373)
T ss_dssp ECCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHH
T ss_pred ECCCCCCHHHHHhhccc--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999986542 45677888889999999999994
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=7.6e-14 Score=150.63 Aligned_cols=129 Identities=25% Similarity=0.379 Sum_probs=104.1
Q ss_pred HHHhhcCCCCCCeecccCCeeEEEEEeC-CC-----cEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccceeEEEE
Q 003737 671 IKAATNNFDPANKVGEGGFGSVYKGILS-DG-----TVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCV 742 (799)
Q Consensus 671 ~~~~t~~f~~~~~lG~G~~g~Vy~~~~~-~g-----~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~ 742 (799)
++...++|...+.||+|+||.||+|... ++ ..||+|.+.... ....+.+.+|++++.++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3445678888999999999999999853 22 489999997653 33457899999999999 8999999999999
Q ss_pred ECCEEEEEEecCCCCcHHHHHhcCccccccc-----ccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 743 EGNQLLLVYEYMKNNCLSRAIFGKLRIFHIS-----IYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 743 ~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~-----~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..+..++||||+++|+|.+++.......... ....+++..+..++.||+.||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 182 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS 182 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 9999999999999999999997543211000 01246788899999999999999994
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.44 E-value=1.6e-13 Score=145.49 Aligned_cols=115 Identities=25% Similarity=0.366 Sum_probs=95.8
Q ss_pred CCCCCCeecccCCeeEEEEEeCC----CcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEE-CCEEEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLLV 750 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV 750 (799)
.|+..+.||+|+||.||+|...+ +..||+|.+.... ....+.+.+|++++++++||||++++++|.+ ++..++|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence 46677899999999999998532 2368999987643 3445789999999999999999999999754 5578999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.++++.... .+++..+..++.|+++||+|||+
T Consensus 106 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~ql~~~l~~lH~ 146 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKYLAS 146 (298)
T ss_dssp EECCTTCBHHHHHHCTTC--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EeCCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999976432 46777888899999999999994
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=2.1e-13 Score=150.73 Aligned_cols=114 Identities=16% Similarity=0.227 Sum_probs=99.3
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCC--CCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQ--HPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 751 (799)
..|...+.||+|+||.||++...+++.||||++... .....+.+.+|++++.+++ |+|||++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 347888999999999999999877999999998654 3344578999999999996 599999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
| +.+|+|.+++.... .+++..+..++.||+.||+|||+
T Consensus 136 E-~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~ 173 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIHQ 173 (390)
T ss_dssp E-CCSEEHHHHHHHCS---------SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred e-cCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9 56889999998654 56677888899999999999995
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.1e-13 Score=145.05 Aligned_cols=117 Identities=19% Similarity=0.294 Sum_probs=96.2
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC----hhhHHHHHHHHHHHHhCCCCcccceeEEEE--ECCEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQHPNLVKLYGCCV--EGNQL 747 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~ 747 (799)
.++|...+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|++++.+++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46799999999999999999995 578999999997542 234578999999999999999999999985 34578
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||+++| |.+++...... .+++..+..++.||++||+|||+
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH~ 127 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEK-------RFPVCQAHGYFCQLIDGLEYLHS 127 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTC-------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEehhccCC-HHHHHHhCccc-------ccCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999986 77777653321 57888999999999999999994
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.44 E-value=1.5e-14 Score=156.49 Aligned_cols=112 Identities=19% Similarity=0.276 Sum_probs=92.2
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccC--------hhhHHHHHHHHHHHHhCC---------CCccccee
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--------RQGNREFVNEIGMISAQQ---------HPNLVKLY 738 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~--------~~~~~~f~~E~~~l~~l~---------H~niv~l~ 738 (799)
++|+..+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|++++++++ |||||++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4577789999999999999997 68999999997542 123478999999998886 88888887
Q ss_pred EEEE------------------------------ECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHH
Q 003737 739 GCCV------------------------------EGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILII 788 (799)
Q Consensus 739 g~~~------------------------------~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~ 788 (799)
+++. +.+..++||||+++|++.+.+.++ .+++..++.++.
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~----------~~~~~~~~~i~~ 168 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK----------LSSLATAKSILH 168 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT----------CCCHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc----------CCCHHHHHHHHH
Confidence 7643 267899999999999877766432 467889999999
Q ss_pred HHHHHHhhhc
Q 003737 789 SAANNIDFFF 798 (799)
Q Consensus 789 qi~~gL~yLH 798 (799)
||+.||+|||
T Consensus 169 qi~~aL~~lH 178 (336)
T 2vuw_A 169 QLTASLAVAE 178 (336)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999999999
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=5e-14 Score=151.64 Aligned_cols=115 Identities=19% Similarity=0.377 Sum_probs=96.5
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChh-hHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
++|...+.||+|+||.||+|... +++.||||++...... ....+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46778899999999999999964 7899999999754322 223566899999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++ |+|.+++..... .+++..++.++.||+.||+|||+
T Consensus 82 ~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~ 118 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN--------IINMHNVKLFLFQLLRGLAYCHR 118 (324)
T ss_dssp CS-EEHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cc-cCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 98 599999876542 47788899999999999999994
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.44 E-value=1.6e-13 Score=152.24 Aligned_cols=112 Identities=18% Similarity=0.230 Sum_probs=92.2
Q ss_pred cCCCCC-CeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHh-CCCCcccceeEEEEE----CCEEE
Q 003737 676 NNFDPA-NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGCCVE----GNQLL 748 (799)
Q Consensus 676 ~~f~~~-~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~----~~~~~ 748 (799)
++|... +.||+|+||+||++.. .+|+.||||+++.. ..+.+|++++.+ .+||||+++++++.. .+..|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 345544 6899999999999995 47899999999632 457788888754 589999999999876 56789
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|||||++|+|.+++...... .+++..+..++.||+.||+|||+
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~ 179 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLHS 179 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----------CCBHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCcHHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999865422 57888999999999999999994
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.44 E-value=1.4e-13 Score=149.63 Aligned_cols=117 Identities=21% Similarity=0.418 Sum_probs=93.9
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChh-----hHHHHHHHHHHHHhCCCCcccceeEEEEECCEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQ-----GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 747 (799)
..++|...+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|++++.+++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 456788999999999999999995 46899999999754221 124788999999999999999999999999999
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||+++ +|.+++..... .+++..+..++.|+++||+|||+
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~ 130 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSL--------VLTPSHIKAYMLMTLQGLEYLHQ 130 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCS--------SCCSSHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEcCCC-CHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999986 89998876532 46677889999999999999994
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=9.1e-14 Score=145.91 Aligned_cols=115 Identities=23% Similarity=0.402 Sum_probs=96.6
Q ss_pred hcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC-CEEEEEEec
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-NQLLLVYEY 753 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey 753 (799)
.++|+..+.||+|+||.||++.. +|+.||||+++... ..+.|.+|++++.+++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 35677889999999999999987 48899999997543 456899999999999999999999997654 468999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++...... .+++..+..++.|+++||+|||+
T Consensus 97 ~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~ 135 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEG 135 (278)
T ss_dssp CTTEEHHHHHHHHHHH-------HCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHhcccc-------cCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999764321 36777888999999999999994
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=2.2e-13 Score=143.15 Aligned_cols=117 Identities=20% Similarity=0.334 Sum_probs=97.7
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~~----g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 748 (799)
..++|...+.||+|+||.||+|.... +..||||.+... .....+.|.+|++++.+++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34567888999999999999998532 346999999765 33456789999999999999999999999764 4568
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||+++|+|.+++..... .+++..+..++.|+++||+|||+
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~ 131 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKN--------SLKVLTLVLYSLQICKAMAYLES 131 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999975432 47788899999999999999994
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.43 E-value=4.4e-13 Score=144.63 Aligned_cols=114 Identities=19% Similarity=0.374 Sum_probs=96.4
Q ss_pred HHhhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhC--CCCcccceeEEEEEC----C
Q 003737 672 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ--QHPNLVKLYGCCVEG----N 745 (799)
Q Consensus 672 ~~~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l--~H~niv~l~g~~~~~----~ 745 (799)
....++|+..+.||+|+||.||+|+.. |+.||||++... ....+.+|.+++... +||||+++++++... +
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 344567999999999999999999975 899999998543 234566677766655 899999999999987 7
Q ss_pred EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++||||+++|+|.++++.. .+++..+..++.|++.||+|||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~~i~~~l~~lH~ 152 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST----------TLDAKSMLKLAYSSVSGLCHLHT 152 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHHS
T ss_pred ceEEEEeccCCCcHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 899999999999999999754 46778899999999999999995
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.43 E-value=6.5e-13 Score=128.75 Aligned_cols=88 Identities=23% Similarity=0.261 Sum_probs=51.5
Q ss_pred CCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEc
Q 003737 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHI 242 (799)
Q Consensus 163 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 242 (799)
++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 45555666666555555555555666666666666665444444556666666666666666554555666666666666
Q ss_pred cCCCCCCC
Q 003737 243 QGSSLEGP 250 (799)
Q Consensus 243 ~~N~l~~~ 250 (799)
++|.++..
T Consensus 110 ~~N~~~c~ 117 (170)
T 3g39_A 110 LNNPWDCA 117 (170)
T ss_dssp CSSCBCTT
T ss_pred CCCCCCCC
Confidence 66666543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.43 E-value=1.3e-13 Score=151.20 Aligned_cols=114 Identities=18% Similarity=0.352 Sum_probs=91.9
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECC------
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------ 745 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 745 (799)
.+.|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 45688889999999999999995 57999999999653 2334568999999999999999999999997653
Q ss_pred EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..|+||||| +++|.+++... .+++..++.++.||++||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----------~l~~~~~~~~~~qi~~~L~~LH~ 146 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----------KLGEDRIQFLVYQMLKGLRYIHA 146 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 469999999 78999998753 46788999999999999999994
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=3.2e-13 Score=144.05 Aligned_cols=118 Identities=25% Similarity=0.442 Sum_probs=95.5
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-----hhhHHHHHHHHHHHHhCC---CCcccceeEEEEEC
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQ---HPNLVKLYGCCVEG 744 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-----~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~ 744 (799)
.+++|+..+.||+|+||.||+|.. .+|+.||||++.... ......+.+|++++.+++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999994 578999999986432 112356778888777664 99999999999876
Q ss_pred C-----EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 N-----QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~-----~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
. ..++||||++ |+|.+++...... .+++..+..++.||++||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~ 138 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP-------GLPAETIKDLMRQFLRGLDFLHA 138 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTT-------CSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 5 5799999998 5999999865422 47888999999999999999994
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.9e-13 Score=149.54 Aligned_cols=115 Identities=23% Similarity=0.418 Sum_probs=91.2
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCC-CCcccceeEEEEECC--EE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGN--QL 747 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~--~~ 747 (799)
..++|+..+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.++.+++ |||||++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 456788999999999999999984 57899999998653 3344567889999999997 999999999998654 68
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|||||+ |+|.++++.. .+++..++.++.||++||+|||+
T Consensus 87 ~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~i~~qi~~~L~~LH~ 127 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN----------ILEPVHKQYVVYQLIKVIKYLHS 127 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecccC-cCHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999998 6999998753 46778889999999999999994
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.42 E-value=2.5e-13 Score=143.48 Aligned_cols=115 Identities=23% Similarity=0.433 Sum_probs=95.9
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
..++|...+.||+|+||.||+|+.. ..||||.++... ....+.|.+|++++.+++|+||+++++++ ..+..++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 4466888899999999999999854 359999996543 34457899999999999999999999965 556689999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.++++.... .+++..+..++.|+++||+|||+
T Consensus 99 e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~lH~ 138 (289)
T 3og7_A 99 QWCEGSSLYHHLHASET--------KFEMKKLIDIARQTARGMDYLHA 138 (289)
T ss_dssp ECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred EecCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999975432 57788899999999999999994
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=3.1e-13 Score=143.55 Aligned_cols=112 Identities=19% Similarity=0.251 Sum_probs=94.6
Q ss_pred cCCCCC-CeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHH-HhCCCCcccceeEEEEE----CCEEE
Q 003737 676 NNFDPA-NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMI-SAQQHPNLVKLYGCCVE----GNQLL 748 (799)
Q Consensus 676 ~~f~~~-~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~ 748 (799)
++|... +.||+|+||.||++.. .+++.||+|+++. ...+.+|++++ ...+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 445555 7799999999999995 5789999999864 24677888887 55699999999999987 66789
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||+++|+|.+++...... .+++..+..++.|++.||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~ 135 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLHS 135 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTC-------CCBHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeecCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999999865422 57888999999999999999994
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.42 E-value=1.7e-13 Score=162.01 Aligned_cols=117 Identities=21% Similarity=0.236 Sum_probs=101.9
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLL 748 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 748 (799)
..++|+..+.||+|+||.||+|+. .+++.||||+++.. .....+.+.+|.+++..+ +|++|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 346788899999999999999995 46889999999753 223456788999999987 7999999999999999999
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||+++|+|.++++..+ .+++..++.|+.||+.||+|||+
T Consensus 419 lV~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~ 460 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG---------RFKEPHAVFYAAEIAIGLFFLQS 460 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCcCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999998654 57888999999999999999994
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.42 E-value=1.6e-15 Score=151.21 Aligned_cols=155 Identities=21% Similarity=0.282 Sum_probs=100.7
Q ss_pred cCCCCCCCEEEeeCCcCCCCCCc------cccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCcccc
Q 003737 159 LTNITTLKNLSIEGNLFTGSIPP------DIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIG 232 (799)
Q Consensus 159 ~~~L~~L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 232 (799)
+.....++.++++.+.+++.+|. .+..+++|++|++++|.+++ +| .+..+++|++|++++|.++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 34455667777777777766665 67777777777777777775 56 6777777777777777776 5666666
Q ss_pred CCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCC-ccccCCCCCCee
Q 003737 233 KWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIP-DYIGDMTKLKNI 311 (799)
Q Consensus 233 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L 311 (799)
.+++|++|+|++|++++ +| .+..+++|+ .|++++|.+++..+ ..+..+++|++|
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~-----------------------~L~l~~N~i~~~~~~~~l~~l~~L~~L 145 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLR-----------------------VLYMSNNKITNWGEIDKLAALDKLEDL 145 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSS-----------------------EEEESEEECCCHHHHHHHTTTTTCSEE
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCC-----------------------EEECCCCcCCchhHHHHHhcCCCCCEE
Confidence 66777777777777764 33 344444444 44444455543221 356667777777
Q ss_pred ccccccCCCCCch----------hhhccCCCCEEeccCCcCC
Q 003737 312 DLSFNNLTGGIPT----------TFEKLAKTNFMYLTGNKLT 343 (799)
Q Consensus 312 ~Ls~N~l~~~~p~----------~~~~l~~L~~L~L~~N~l~ 343 (799)
++++|.+++.+|. .+..+++|+.|+ +|.++
T Consensus 146 ~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 146 LLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp EECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred EecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 7777777665554 266777777765 55554
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=9.8e-14 Score=149.38 Aligned_cols=115 Identities=23% Similarity=0.378 Sum_probs=94.3
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcE----EEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTV----IAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~----vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
++|...+.||+|+||.||+|.. .+++. ||+|.+.... ....+.+.+|+.++.+++||||++++++|. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 4577789999999999999995 44543 7888875432 233457889999999999999999999986 456899
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+++|+|.+++..... .+++..+..++.||++||+|||+
T Consensus 92 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~ 133 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRG--------ALGPQLLLNWGVQIAKGMYYLEE 133 (325)
T ss_dssp EEECCTTCBSHHHHHSSGG--------GSCTTHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCHHHHHHHccc--------cCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999986532 45677888899999999999994
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=8.1e-13 Score=142.94 Aligned_cols=113 Identities=24% Similarity=0.390 Sum_probs=98.4
Q ss_pred HHhhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHh--CCCCcccceeEEEEECC----
Q 003737 672 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA--QQHPNLVKLYGCCVEGN---- 745 (799)
Q Consensus 672 ~~~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~~---- 745 (799)
....++|...+.||+|+||.||+|+. +|+.||||++... ..+.+.+|++++.. ++||||+++++++...+
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 34556799999999999999999997 5899999999643 34678899999887 79999999999998876
Q ss_pred EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhc
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFF 798 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH 798 (799)
..++||||+++|+|.+++.+. .+++..+..++.|++.||+|||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~~i~~~l~~lH 156 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY----------TVTVEGMIKLALSTASGLAHLH 156 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHH
T ss_pred eeEEEEeecCCCcHHHHHhcc----------CccHHHHHHHHHHHHHHHHHHH
Confidence 789999999999999999753 4667788889999999999999
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.42 E-value=6.2e-14 Score=151.31 Aligned_cols=259 Identities=16% Similarity=0.089 Sum_probs=174.7
Q ss_pred ccCCcccc--CCCCCCEEEccCCcCCCcCcccccc-cc-eeEEEccCCcCc--CcCCcccCCCCCCCEEEeeCCcCCCCC
Q 003737 106 GTLPTELS--KLRYLKQLDLSRNCLTGSFSPQWAS-LQ-LVELSVMGNRLS--GPFPKVLTNITTLKNLSIEGNLFTGSI 179 (799)
Q Consensus 106 g~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~-l~-L~~L~Ls~N~l~--~~~p~~~~~L~~L~~L~Ls~N~l~~~~ 179 (799)
|.++..+. .+.+|+.|+++++ +....-..+.. +. |++|||++|++. ...+..+ +.++.+.+..|.+.
T Consensus 13 g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I~--- 85 (329)
T 3sb4_A 13 GTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFVP--- 85 (329)
T ss_dssp TCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEEC---
T ss_pred CcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---cccccccccccccC---
Confidence 33444333 3678999999875 22111122333 44 999999999987 3332222 33566777776432
Q ss_pred CccccC--------CCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCC----C
Q 003737 180 PPDIRK--------LINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSS----L 247 (799)
Q Consensus 180 p~~~~~--------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~----l 247 (799)
+..|.+ +++|+.|+|.+ .++..-+.+|.++++|+.|++++|.+....+..|..+.++..+.+..+. .
T Consensus 86 ~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~ 164 (329)
T 3sb4_A 86 AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFK 164 (329)
T ss_dssp TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTS
T ss_pred HHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcc
Confidence 346777 99999999999 8886667789999999999999999987888889888888777765521 1
Q ss_pred CCCCchhhhcCCCCC--------------------------eEEcCCCCCCCCCCCccC--CCCccEEEccCCcCcccCC
Q 003737 248 EGPIPASISALTSLT--------------------------DLRISDLKGSESAFPKLD--KMNLKTLILTKCLIHGEIP 299 (799)
Q Consensus 248 ~~~~p~~~~~l~~L~--------------------------~L~L~~n~~~~~~~~~l~--~~~L~~L~L~~N~l~~~~p 299 (799)
.......|.++..|+ .+.+.+ ......+..+. ..+|+.++|++|+++...+
T Consensus 165 ~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~-~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~ 243 (329)
T 3sb4_A 165 NRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEG-KLDNADFKLIRDYMPNLVSLDISKTNATTIPD 243 (329)
T ss_dssp TTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEE-CCCHHHHHHHHHHCTTCCEEECTTBCCCEECT
T ss_pred ccccccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEee-eecHHHHHHHHHhcCCCeEEECCCCCcceecH
Confidence 222223344444444 222222 11111111111 2589999999999997777
Q ss_pred ccccCCCCCCeeccccccCCCCCchhhhccCCCC-EEeccCCcCCCcCChhhhc---CCCEEEeecCcCcccCCCCC-cC
Q 003737 300 DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN-FMYLTGNKLTGPVPKYIFN---SNKNVDISLNNFTWESSDPI-EC 374 (799)
Q Consensus 300 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~g~~p~~~~~---~l~~l~ls~N~~~g~~p~~~-~~ 374 (799)
..|.++++|+.|+|.+| ++...+.+|.++++|+ .+++.+ +++ .|++..|. .++.++++.|+++...+..+ .|
T Consensus 244 ~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~ 320 (329)
T 3sb4_A 244 FTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLRYVLATGDKITTLGDELFGNG 320 (329)
T ss_dssp TTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEEEEEECSSCCCEECTTTTCTT
T ss_pred hhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCCEEEeCCCccCccchhhhcCC
Confidence 78999999999999998 8777778899999999 999988 776 45554443 56899999998886655544 45
Q ss_pred CC
Q 003737 375 PR 376 (799)
Q Consensus 375 ~~ 376 (799)
..
T Consensus 321 ~~ 322 (329)
T 3sb4_A 321 VP 322 (329)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.41 E-value=4.2e-12 Score=140.39 Aligned_cols=238 Identities=11% Similarity=0.072 Sum_probs=103.3
Q ss_pred CCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcc
Q 003737 116 RYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILS 195 (799)
Q Consensus 116 ~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 195 (799)
..++.+.+.. .++.+....|...+|+.+.+..+ ++.+-...|.+. +|+.+.+.. .++..-+..|.++++|+.++++
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~ 188 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNSQIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLS 188 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTCCCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECT
T ss_pred CCccEEEECC-ccCEehHhhcccCCccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecC
Confidence 3444444432 23333344444434445544433 333333444442 355555443 3332333344455555555555
Q ss_pred cCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCC
Q 003737 196 SNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA 275 (799)
Q Consensus 196 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~ 275 (799)
+|.++..-...|. ..+|+.+.+..+ ++..-...|.++++|+.+++..| ++..-...|.+ .+|+.+.+.+ +.....
T Consensus 189 ~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp~-~i~~I~ 263 (401)
T 4fdw_A 189 KTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLPN-GVTNIA 263 (401)
T ss_dssp TSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEET-TCCEEC
T ss_pred CCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeCC-CccEEC
Confidence 5444422222222 344555555422 33333444444555555555432 23223333333 4455544432 221111
Q ss_pred CCccCC-CCccEEEccCCcCc-----ccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChh
Q 003737 276 FPKLDK-MNLKTLILTKCLIH-----GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY 349 (799)
Q Consensus 276 ~~~l~~-~~L~~L~L~~N~l~-----~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 349 (799)
-..|.. .+|+.+++.+|.+. ...+..|.++++|+.++|. |.++..-..+|.++++|+.++|..| ++ .++..
T Consensus 264 ~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~-~I~~~ 340 (401)
T 4fdw_A 264 SRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VT-QINFS 340 (401)
T ss_dssp TTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CC-EECTT
T ss_pred hhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-cc-EEcHH
Confidence 112333 34555555444433 2333445556666666665 3355444455556666666666433 33 23332
Q ss_pred hhc--CCCEEEeecCcCc
Q 003737 350 IFN--SNKNVDISLNNFT 365 (799)
Q Consensus 350 ~~~--~l~~l~ls~N~~~ 365 (799)
.|. .++.++++.|.+.
T Consensus 341 aF~~~~L~~l~l~~n~~~ 358 (401)
T 4fdw_A 341 AFNNTGIKEVKVEGTTPP 358 (401)
T ss_dssp SSSSSCCCEEEECCSSCC
T ss_pred hCCCCCCCEEEEcCCCCc
Confidence 221 3555666655443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.41 E-value=4e-13 Score=144.71 Aligned_cols=109 Identities=18% Similarity=0.374 Sum_probs=96.1
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCC-CCcccceeEEEEE--CCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVE--GNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~ 751 (799)
++|+..+.||+|+||.||+|.. .+++.||||+++.. ..+.+.+|++++.+++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5678889999999999999984 67899999999743 3467999999999997 9999999999988 66789999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++. .+++..+..++.||++||+|||+
T Consensus 113 e~~~~~~l~~~~~------------~~~~~~~~~~~~qi~~~l~~lH~ 148 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------------TLTDYDIRFYMYEILKALDYCHS 148 (330)
T ss_dssp ECCCCCCHHHHGG------------GCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eccCchhHHHHHH------------hCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999874 35677899999999999999994
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.41 E-value=3.4e-13 Score=148.65 Aligned_cols=118 Identities=20% Similarity=0.347 Sum_probs=92.9
Q ss_pred HHhhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC------
Q 003737 672 KAATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------ 744 (799)
Q Consensus 672 ~~~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 744 (799)
+...++|...+.||+|+||.||+|.. .+|+.||||++..... ...+|++++++++|||||++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567889999999999999999984 6799999999865422 234799999999999999999998543
Q ss_pred --------------------------------CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHH
Q 003737 745 --------------------------------NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAAN 792 (799)
Q Consensus 745 --------------------------------~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~ 792 (799)
...++||||++ |+|.+.+...... ...+++..++.++.||++
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~ 152 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-----GRSIPMNLISIYIYQLFR 152 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHH
Confidence 34889999998 5888887642110 116788899999999999
Q ss_pred HHhhhcC
Q 003737 793 NIDFFFF 799 (799)
Q Consensus 793 gL~yLH~ 799 (799)
||+|||+
T Consensus 153 aL~~LH~ 159 (383)
T 3eb0_A 153 AVGFIHS 159 (383)
T ss_dssp HHHHHHT
T ss_pred HHHHHHH
Confidence 9999995
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=3.4e-13 Score=145.29 Aligned_cols=115 Identities=23% Similarity=0.483 Sum_probs=96.9
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCc----EEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGT----VIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~----~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
++|+..+.||+|+||.||+|.. .+++ .||+|.+... .....+.+.+|++++.+++||||+++++++...+ .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 5688889999999999999994 3454 3578877544 3345678999999999999999999999998755 789
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+||+++|+|.+++..... .+++..+..++.||++||+|||+
T Consensus 94 v~~~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~ 135 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLED 135 (327)
T ss_dssp EECCCSSCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhh
Confidence 9999999999999986532 57788899999999999999994
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=4.6e-13 Score=145.66 Aligned_cols=115 Identities=21% Similarity=0.390 Sum_probs=96.9
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEE--------C
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE--------G 744 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--------~ 744 (799)
++|+..+.||+|+||.||+|.. .+|+.||||++.... ......+.+|++++.+++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5688889999999999999996 578999999986543 2234678899999999999999999999987 3
Q ss_pred CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+..++||||+++ +|.+.+..... .+++..+..++.||+.||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~ 142 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLV--------KFTLSEIKRVMQMLLNGLYYIHR 142 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ceEEEEEeccCC-CHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 468999999985 88888765432 57888999999999999999994
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=5.4e-13 Score=141.25 Aligned_cols=114 Identities=16% Similarity=0.234 Sum_probs=99.5
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEEe
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 752 (799)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|++++.++ +|++++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35688889999999999999994 678999999986432 234688999999999 79999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+ +|+|.+++..... .+++..+..++.||++||+|||+
T Consensus 87 ~~-~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~ 124 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHE 124 (298)
T ss_dssp CC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ec-CCCHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99 9999999986532 47788999999999999999995
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.41 E-value=6.8e-13 Score=128.61 Aligned_cols=105 Identities=23% Similarity=0.310 Sum_probs=58.2
Q ss_pred EEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCc
Q 003737 95 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL 174 (799)
Q Consensus 95 ~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~ 174 (799)
+.++++++.++ .+|..+. ++|++|+|++|++++. .|..|.++++|++|+|++|+
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~-----------------------~~~~~~~l~~L~~L~Ls~N~ 65 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKL-----------------------EPGVFDRLTQLTRLDLDNNQ 65 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCC-----------------------CTTTTTTCTTCSEEECCSSC
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCcc-----------------------ChhhhcCcccCCEEECCCCC
Confidence 45677777766 3554442 5555666555555544 44555555555555555555
Q ss_pred CCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCC
Q 003737 175 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG 225 (799)
Q Consensus 175 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 225 (799)
+++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+..
T Consensus 66 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 66 LTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred cCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 554444445555555555555555554444445555555566666555543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.2e-13 Score=147.50 Aligned_cols=119 Identities=19% Similarity=0.285 Sum_probs=92.7
Q ss_pred HHhhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChh------hHHHHHHHHHHHHhC----CCCcccceeEE
Q 003737 672 KAATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQ------GNREFVNEIGMISAQ----QHPNLVKLYGC 740 (799)
Q Consensus 672 ~~~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~------~~~~f~~E~~~l~~l----~H~niv~l~g~ 740 (799)
....++|...+.||+|+||.||+|.. .+++.||||++...... ....+.+|++++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 33456799999999999999999984 57899999999654321 223567899999988 89999999999
Q ss_pred EEECCEEEEEEec-CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 741 CVEGNQLLLVYEY-MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 741 ~~~~~~~~lV~Ey-~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+...+..++|+|| +++|+|.+++..+. .+++..+..++.||++||+|||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~ 157 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG---------PLGEGPSRCFFGQVVAAIQHCHS 157 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999 89999999998654 57788999999999999999994
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.4e-12 Score=126.85 Aligned_cols=86 Identities=24% Similarity=0.324 Sum_probs=42.8
Q ss_pred CCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEc
Q 003737 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHI 242 (799)
Q Consensus 163 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 242 (799)
++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 44445555555554444444555555555555555554433333445555555555555555443334555555555555
Q ss_pred cCCCCC
Q 003737 243 QGSSLE 248 (799)
Q Consensus 243 ~~N~l~ 248 (799)
++|.+.
T Consensus 113 ~~N~~~ 118 (174)
T 2r9u_A 113 YNNPWD 118 (174)
T ss_dssp CSSCBC
T ss_pred CCCCcc
Confidence 555554
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=4.4e-13 Score=145.80 Aligned_cols=115 Identities=19% Similarity=0.361 Sum_probs=98.6
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEEC-----CE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQ 746 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 746 (799)
..++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+|++++.+++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 346788899999999999999995 478999999997543 33456789999999999999999999998764 67
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++||||++ |+|.+++..+ .+++..+..++.||++||+|||+
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~~~~qi~~~L~~LH~ 130 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ----------MLSDDHIQYFIYQTLRAVKVLHG 130 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeccC-ccHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 899999998 6999998753 47788999999999999999994
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=2e-13 Score=145.99 Aligned_cols=122 Identities=15% Similarity=0.226 Sum_probs=103.5
Q ss_pred HHHHHHhhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCC--CCcccceeEEEEE
Q 003737 668 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQ--HPNLVKLYGCCVE 743 (799)
Q Consensus 668 ~~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~ 743 (799)
++.+....++|...+.||+|+||.||++...+++.||||++... .....+.+.+|++++.+++ |+||+++++++..
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 33334445668889999999999999999888999999999654 3344578999999999997 5999999999999
Q ss_pred CCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 744 GNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 744 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+..++||| +.+|+|.+++.... .+++..+..++.||++||+|||+
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~ 145 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIHQ 145 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHCS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCEEEEEEe-cCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999 66889999998654 56777888999999999999994
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=3.9e-13 Score=144.94 Aligned_cols=117 Identities=20% Similarity=0.299 Sum_probs=98.1
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCC-CCcccceeEEEEE--------CC
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVE--------GN 745 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~--------~~ 745 (799)
.+|+..+.||+|+||.||+|.. .+|+.||||++........+.+.+|++++.++. ||||+++++++.. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 4677889999999999999995 578999999997666666778999999999996 9999999999953 34
Q ss_pred EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++||||++ |+|.+++...... ..+++..+..++.||+.||+|||+
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~ 154 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESR------GPLSCDTVLKIFYQTCRAVQHMHR 154 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTT------CSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred eEEEEEEecC-CCHHHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 5899999996 7999998752211 157888999999999999999995
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.39 E-value=5.3e-13 Score=140.75 Aligned_cols=119 Identities=18% Similarity=0.326 Sum_probs=94.0
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHH-HHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNRE-FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~-f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
.++|+..+.||+|+||.||+|.. .+|+.||||+++... .....+ +..+...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 45688889999999999999995 578999999997652 222333 444555678889999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||++ |+|.+++...... ...+++..+..++.|++.||+|||+
T Consensus 86 e~~~-~~l~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~ 127 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDK-----GQTIPEDILGKIAVSIVKALEHLHS 127 (290)
T ss_dssp ECCS-EEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ehhc-cchHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 9998 5998887642110 1167888999999999999999994
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.39 E-value=9.2e-14 Score=152.93 Aligned_cols=122 Identities=8% Similarity=0.037 Sum_probs=92.7
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHH---HHHHhCCCCccccee-------EE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEI---GMISAQQHPNLVKLY-------GC 740 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~---~~l~~l~H~niv~l~-------g~ 740 (799)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.|.+|+ +.+++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45677889999999999999994 67999999999743 334457899999 556667899999998 66
Q ss_pred EEECC-----------------EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 741 CVEGN-----------------QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 741 ~~~~~-----------------~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+.+.+ ..++||||+ +|+|.+++...+..... ...+++..+..++.||++||+|||+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~ 224 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSST--HKSLVHHARLQLTLQVIRLLASLHH 224 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTT--THHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccc--cccccHHHHHHHHHHHHHHHHHHHh
Confidence 65543 278999999 68999999865321000 0022235677789999999999994
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=3.5e-13 Score=152.33 Aligned_cols=113 Identities=18% Similarity=0.267 Sum_probs=95.3
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC------C
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------N 745 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~ 745 (799)
.++|+..+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++|||||++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46788899999999999999984 57899999999754 334457899999999999999999999999654 4
Q ss_pred EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..|+|||||++ +|.+.+.. .+++..++.++.||++||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~-----------~l~~~~~~~~~~qil~aL~~lH~ 182 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHS 182 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS-----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCC-CHHHHHhh-----------cCCHHHHHHHHHHHHHHHHHHHH
Confidence 67999999986 56666643 36688899999999999999994
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.39 E-value=3.5e-13 Score=142.19 Aligned_cols=115 Identities=23% Similarity=0.416 Sum_probs=89.8
Q ss_pred cCCCCCCeecccCCeeEEEEEeC--CCc--EEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS--DGT--VIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~--~g~--~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 748 (799)
++|+..+.||+|+||.||+|... +++ .||||+++... ....+.+.+|++++.+++||||+++++++...+ .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 45778899999999999999852 333 68999987542 334578999999999999999999999997655 88
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+||+++|+|.+++..... .+++..+..++.|+++||+|||+
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~ 139 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLES 139 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHH
T ss_pred eeEecccCCCHHHHHHhccC--------CcCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999986432 46788899999999999999994
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.38 E-value=6.6e-13 Score=145.28 Aligned_cols=114 Identities=14% Similarity=0.262 Sum_probs=97.9
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEEC-----CEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQL 747 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 747 (799)
.++|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 45788899999999999999985 478899999997543 33457899999999999999999999999765 368
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||++ |+|.+++... .+++..+..++.||+.||+|||+
T Consensus 106 ~iv~e~~~-~~L~~~l~~~----------~~~~~~~~~i~~qi~~aL~~LH~ 146 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ----------HLSNDHICYFLYQILRGLKYIHS 146 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEcccC-cCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999998 5999998754 47788999999999999999994
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.38 E-value=6.3e-12 Score=138.98 Aligned_cols=251 Identities=10% Similarity=0.095 Sum_probs=195.8
Q ss_pred CCcccCCccccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCcc
Q 003737 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPD 182 (799)
Q Consensus 103 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~ 182 (799)
+++..-...|.+. +|+.++|..+ ++.+...+|...+|+.+.+.. .++.+-+..|.++++|+.++|++|+++......
T Consensus 123 ~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~a 199 (401)
T 4fdw_A 123 SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNSTVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPAST 199 (401)
T ss_dssp TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTCCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTT
T ss_pred ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCCCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhh
Confidence 3454445567774 7999999877 777778888887899999986 777777889999999999999999998544445
Q ss_pred ccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCC
Q 003737 183 IRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT 262 (799)
Q Consensus 183 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 262 (799)
|. ..+|+.+.|..+ ++..-..+|.++++|+.+++..| ++..-...|.+ .+|+.+.+ .+.++......|.++++|+
T Consensus 200 F~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~ 274 (401)
T 4fdw_A 200 FV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELA 274 (401)
T ss_dssp TT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCC
T ss_pred Ee-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCC
Confidence 65 689999999855 77566778999999999999875 55555667777 79999999 4567766688999999999
Q ss_pred eEEcCCCCCCCC---CCC--ccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEe
Q 003737 263 DLRISDLKGSES---AFP--KLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 336 (799)
Q Consensus 263 ~L~L~~n~~~~~---~~~--~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 336 (799)
.+++.++..... .++ .|.. .+|+.++|. +.++..-...|.++++|+.++|..| ++..-+.+|.++ +|+.++
T Consensus 275 ~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~ 351 (401)
T 4fdw_A 275 EVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVK 351 (401)
T ss_dssp EEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEE
T ss_pred EEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEE
Confidence 999987544311 122 2555 689999999 5587677788999999999999665 776777899999 999999
Q ss_pred ccCCcCCCcCChhhh----cCCCEEEeecCcCc
Q 003737 337 LTGNKLTGPVPKYIF----NSNKNVDISLNNFT 365 (799)
Q Consensus 337 L~~N~l~g~~p~~~~----~~l~~l~ls~N~~~ 365 (799)
+.+|.+.. ++...+ ..+..+.+..|.+.
T Consensus 352 l~~n~~~~-l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 352 VEGTTPPQ-VFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp ECCSSCCB-CCCSSCCCSCTTCCEEEECGGGHH
T ss_pred EcCCCCcc-cccccccCCCCCccEEEeCHHHHH
Confidence 99998874 443332 24567888776543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=5.9e-13 Score=156.83 Aligned_cols=118 Identities=18% Similarity=0.293 Sum_probs=98.8
Q ss_pred HhhcCCCCCCeecccCCeeEEEEEeC----CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEE
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 747 (799)
...++|...+.||+|+||.||+|... .+..||||+++... ....+.|.+|+.++.+++|||||++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 34456777889999999999999863 25679999987643 334578999999999999999999999984 5678
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||+++|+|.+++..+.. .+++..+..++.||++||+|||+
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~ 509 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKF--------SLDLASLILYAYQLSTALAYLES 509 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTT--------TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEcCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999999975432 46788888999999999999994
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.38 E-value=8.9e-13 Score=144.67 Aligned_cols=113 Identities=17% Similarity=0.255 Sum_probs=96.3
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECC------
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------ 745 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 745 (799)
.++|...+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46788899999999999999984 47899999999653 2334567899999999999999999999997654
Q ss_pred EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++||||+++ +|.+++.. .+++..+..++.||+.||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~i~~qi~~al~~lH~ 145 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHS 145 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS-----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ceEEEEEcCCC-CHHHHHhh-----------ccCHHHHHHHHHHHHHHHHHHHH
Confidence 78999999984 88888753 46678899999999999999994
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=3.6e-13 Score=146.26 Aligned_cols=114 Identities=17% Similarity=0.230 Sum_probs=90.8
Q ss_pred cCCCCCCeecccCCeeEEEEEeC----CCcEEEEEEccccChh-----------hHHHHHHHHHHHHhCCCCcccceeEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQ-----------GNREFVNEIGMISAQQHPNLVKLYGC 740 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~----~g~~vAvK~l~~~~~~-----------~~~~f~~E~~~l~~l~H~niv~l~g~ 740 (799)
++|...+.||+|+||.||+|... ++..||||+....... ..+.+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 45778899999999999999964 5788999998654321 12357789999999999999999999
Q ss_pred EEE----CCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 741 CVE----GNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 741 ~~~----~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+.. ....++||||+ +|+|.+++...+ .+++..+..++.||+.||+|||+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~ 169 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG---------TFKKSTVLQLGIRMLDVLEYIHE 169 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG---------BCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 988 67899999999 999999997654 57788999999999999999994
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.1e-13 Score=148.14 Aligned_cols=120 Identities=15% Similarity=0.315 Sum_probs=101.3
Q ss_pred HHHHhhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEE
Q 003737 670 QIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (799)
Q Consensus 670 ~~~~~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 747 (799)
+.....++|...+.||+|+||.||+|...+ .||+|.++... ....+.|.+|++++.+++|+||+++++++.+.+..
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 334455778889999999999999998753 49999986542 22345688999999999999999999999999999
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||+++|+|.+++..... .+++..+..++.||++||+|||+
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~ 148 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKI--------VLDVNKTRQIAQEIVKGMGYLHA 148 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCC--------CCCSHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeecccCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999999976532 46777899999999999999994
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=8.9e-13 Score=146.47 Aligned_cols=119 Identities=23% Similarity=0.366 Sum_probs=87.8
Q ss_pred CCC-CCeecccCCeeEEEEEeC---CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEE--CCEEEEEE
Q 003737 678 FDP-ANKVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLVY 751 (799)
Q Consensus 678 f~~-~~~lG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 751 (799)
|+. .++||+|+||.||+|... +++.||||++.... ..+.+.+|++++.+++|||||++++++.. ....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 443 458999999999999964 57899999997542 23578899999999999999999999965 67899999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||++ |+|.+++..............+++..++.++.||+.||+|||+
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~ 146 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 146 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9997 5888888643221111122258888999999999999999994
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.37 E-value=4.4e-13 Score=159.18 Aligned_cols=114 Identities=15% Similarity=0.344 Sum_probs=95.5
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC--CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCE-----
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS--DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ----- 746 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~--~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~----- 746 (799)
.++|...+.||+|+||.||+|... +|+.||||++.... ....+.|.+|++++.+++|||||++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 367888999999999999999964 68999999986543 3445689999999999999999999999987654
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.|+|||||++|+|.+++.. .+++..+..++.||++||+|||+
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----------~l~~~~~~~~~~qi~~aL~~lH~ 200 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----------KLPVAEAIAYLLEILPALSYLHS 200 (681)
T ss_dssp EEEEEECCCCEECC----C-----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCcHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 7999999999999987653 46778899999999999999994
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.37 E-value=3.7e-13 Score=147.43 Aligned_cols=114 Identities=22% Similarity=0.363 Sum_probs=90.0
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC------C
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------N 745 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~ 745 (799)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36788899999999999999984 57899999999653 233457889999999999999999999998754 5
Q ss_pred EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++|+||+ +++|.+++... .+++..++.++.||++||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH~ 150 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIHS 150 (367)
T ss_dssp CCEEEEECC-CEECC-----C----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEeccc-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 679999999 68999988653 57788999999999999999994
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=3.3e-13 Score=146.94 Aligned_cols=111 Identities=13% Similarity=0.167 Sum_probs=93.8
Q ss_pred cCCCCCCeecccCCeeEEEEEeC---------CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccc----------
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS---------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK---------- 736 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~---------~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~---------- 736 (799)
++|...+.||+|+||.||+|... +++.||||.+... +.+.+|++++.+++|||||+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 56888899999999999999964 3789999998653 36889999999999999998
Q ss_pred -----eeEEEEE-CCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 737 -----LYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 737 -----l~g~~~~-~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++++.. .+..++||||+ +|+|.+++...... .+++..+..++.||++||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~ 177 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKH-------VLSERSVLQVACRLLDALEFLHE 177 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGG-------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 6788876 77899999999 99999999865211 67888999999999999999994
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.37 E-value=5.9e-13 Score=143.04 Aligned_cols=118 Identities=22% Similarity=0.452 Sum_probs=96.0
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe--CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhC---CCCcccceeEEEE----
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL--SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQ---QHPNLVKLYGCCV---- 742 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~--~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~---- 742 (799)
+.++|...+.||+|+||.||+|.. .+|+.||||+++... ......+.+|++++.++ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 456788999999999999999996 468899999986532 22234577788777665 8999999999987
Q ss_pred -ECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 743 -EGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 743 -~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.....++||||++ |+|.+++...... .+++..+..++.||++||+|||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~ 138 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLHS 138 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTT-------CSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 4567899999998 6999999765422 47788999999999999999994
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.37 E-value=5.4e-13 Score=145.98 Aligned_cols=117 Identities=14% Similarity=0.236 Sum_probs=94.1
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeCC------CcEEEEEEccccChhh-----------HHHHHHHHHHHHhCCCCcccc
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQG-----------NREFVNEIGMISAQQHPNLVK 736 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~~------g~~vAvK~l~~~~~~~-----------~~~f~~E~~~l~~l~H~niv~ 736 (799)
..++|...+.||+|+||.||+|.... ++.||||++....... ...+..|+..+.+++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34578889999999999999998653 4789999986543211 123556777788899999999
Q ss_pred eeEEEEEC----CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 737 LYGCCVEG----NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 737 l~g~~~~~----~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++++... ...++||||+ +|+|.+++..... .+++..+..++.||+.||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~~l~~lH~ 170 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--------RFSRKTVLQLSLRILDILEYIHE 170 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99998764 4589999999 9999999986532 57888999999999999999994
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.9e-12 Score=125.93 Aligned_cols=104 Identities=19% Similarity=0.261 Sum_probs=57.5
Q ss_pred EEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCc
Q 003737 95 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL 174 (799)
Q Consensus 95 ~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~ 174 (799)
+.++++++.++ .+|..+. ++|++|+|++|++++.+| ..|.++++|++|+|++|+
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~-----------------------~~~~~l~~L~~L~Ls~N~ 68 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEP-----------------------GVFDHLVNLQQLYFNSNK 68 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCT-----------------------TTTTTCTTCCEEECCSSC
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCH-----------------------HHhcCCcCCCEEECCCCC
Confidence 46777777775 5565443 566666666666655444 445555555555555555
Q ss_pred CCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCC
Q 003737 175 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS 224 (799)
Q Consensus 175 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 224 (799)
|++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+.
T Consensus 69 l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 69 LTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred CCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcc
Confidence 55433334455555555555555555433334555555555555555554
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.2e-12 Score=146.65 Aligned_cols=117 Identities=16% Similarity=0.218 Sum_probs=98.4
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhC------CCCcccceeEEEEECCE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ------QHPNLVKLYGCCVEGNQ 746 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l------~H~niv~l~g~~~~~~~ 746 (799)
...+|+..+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|++++..+ .|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 345688899999999999999985 46899999999753 33346778888888776 57799999999999999
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++||||+. |+|.+++...... .+++..++.++.||++||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~ 218 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQ-------GFSLPLVRKFAHSILQCLDALHK 218 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeccC-CCHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999996 6999999865422 47788999999999999999994
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=1.8e-12 Score=139.43 Aligned_cols=120 Identities=15% Similarity=0.372 Sum_probs=96.0
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHH-HHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
.++|...+.||+|+||.||+|.. .+|+.||||++.... .....++.+|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 35688889999999999999996 478999999997653 334456777776 677789999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++ +|.+++....... ...+++..+..++.|+++||+|||+
T Consensus 101 e~~~~-~l~~~~~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~ 143 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVL----DDVIPEEILGKITLATVKALNHLKE 143 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTT----CCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eecCC-ChHHHHHHHHhhh----cccCcHHHHHHHHHHHHHHHHHHhc
Confidence 99985 8888876321110 1157788899999999999999994
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1e-12 Score=144.15 Aligned_cols=113 Identities=24% Similarity=0.389 Sum_probs=96.5
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEE----
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL---- 747 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~---- 747 (799)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++.+++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 35688889999999999999985 57899999999764 233357899999999999999999999999876654
Q ss_pred --EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 --LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 --~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||++ |+|.+++.. .+++..+..++.||+.||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~ 162 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM-----------EFSEEKIQYLVYQMLKGLKYIHS 162 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS-----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEcccc-ccHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999998 699888742 46788999999999999999994
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=1.8e-12 Score=140.25 Aligned_cols=114 Identities=19% Similarity=0.251 Sum_probs=90.5
Q ss_pred hhcCCCCC-CeecccCCeeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHH-HHHHhCCCCcccceeEEEEE----CCE
Q 003737 674 ATNNFDPA-NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEI-GMISAQQHPNLVKLYGCCVE----GNQ 746 (799)
Q Consensus 674 ~t~~f~~~-~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~-~~l~~l~H~niv~l~g~~~~----~~~ 746 (799)
..++|... ++||+|+||.||+|... +|+.||||++.... ...+|+ ..+..++||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 34567774 46999999999999964 78999999986531 222333 34566799999999999876 445
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++||||+++|+|.+++...... .+++..+..++.||+.||+|||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~-------~l~~~~~~~i~~ql~~~l~~LH~ 146 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQ-------AFTEREAAEIMRDIGTAIQFLHS 146 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CC-------CCBHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeccCCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 89999999999999999865422 57888999999999999999994
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=1.9e-12 Score=139.79 Aligned_cols=111 Identities=25% Similarity=0.348 Sum_probs=89.2
Q ss_pred hcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHH--HhCCCCcccceeEEEEE-----CCEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMI--SAQQHPNLVKLYGCCVE-----GNQL 747 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l--~~l~H~niv~l~g~~~~-----~~~~ 747 (799)
.++|...+.||+|+||.||+|+. +++.||||++... ....+..|.++. ..++|+||+++++++.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 35688889999999999999986 6899999999643 234455555554 45899999999987653 2357
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||+++|+|.+++.... .++..+..++.||++||+|||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~~L~~LH~ 129 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT----------SDWVSSCRLAHSVTRGLAYLHT 129 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHC
T ss_pred EEEEecCCCCcHHHHHhhcc----------cchhHHHHHHHHHHHHHHHHHh
Confidence 89999999999999997653 3566788889999999999995
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=1.1e-12 Score=144.74 Aligned_cols=116 Identities=17% Similarity=0.298 Sum_probs=95.3
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCC--------CCcccceeEEEE---
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ--------HPNLVKLYGCCV--- 742 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~--------H~niv~l~g~~~--- 742 (799)
.++|...+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|++++.+++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 36788899999999999999984 57899999999753 334567899999999886 788999999987
Q ss_pred -ECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 743 -EGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 743 -~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.....++||||+ +|+|.+++...... .+++..++.++.||++||+|||+
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~ 164 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQ-------GLPLPCVKKIIQQVLQGLDYLHT 164 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 445789999999 56777766544321 57888999999999999999994
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=1.9e-12 Score=139.51 Aligned_cols=116 Identities=17% Similarity=0.279 Sum_probs=98.7
Q ss_pred hcCCCCCCeecccCCeeEEEEEe--CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCc------ccceeEEEEECCE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL--SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN------LVKLYGCCVEGNQ 746 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~--~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 746 (799)
.++|+..+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|++++.+++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35688899999999999999985 36889999999653 334567889999998887654 9999999999999
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++||||+ +|+|.+++...... .+++..+..++.||++||+|||+
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~ 136 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFL-------PFRLDHIRKMAYQICKSVNFLHS 136 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEcCC-CCCHHHHHHhcCCC-------CCcHHHHHHHHHHHHHHHHHHHH
Confidence 99999999 88999999865422 57788899999999999999994
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=9.9e-13 Score=143.21 Aligned_cols=113 Identities=23% Similarity=0.381 Sum_probs=95.5
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCE-----
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ----- 746 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~----- 746 (799)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++.+++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 35678889999999999999995 57899999999654 23335689999999999999999999999987653
Q ss_pred -EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 -LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 -~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++||||++ |+|.+++.. .+++..+..++.||++||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~i~~qi~~al~~LH~ 144 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----------KFSEEKIQYLVYQMLKGLKYIHS 144 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEecccc-CCHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 499999998 688877642 46788999999999999999994
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=3.5e-13 Score=156.66 Aligned_cols=118 Identities=22% Similarity=0.363 Sum_probs=98.4
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEEEE------CCEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE------GNQL 747 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~~~ 747 (799)
++|...+.||+|+||.||+|.. .+|+.||||++... .....+.|.+|++++.+++|||||++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6789999999999999999985 57899999998764 34446789999999999999999999998765 5678
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||||+++|+|.+++...... ..+++..+..++.|++.||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~------~~lse~~i~~I~~QLl~aL~yLHs 139 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENC------CGLKEGPIRTLLSDISSALRYLHE 139 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCT------TCCCSSHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCHHHHHHhcccC------CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999864321 146677888999999999999994
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.32 E-value=3.9e-12 Score=134.51 Aligned_cols=115 Identities=21% Similarity=0.319 Sum_probs=96.3
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEE-EECCEEEEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC-VEGNQLLLVY 751 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 751 (799)
..++|...+.||+|+||.||+|.. .+|+.||||++..... .+.+.+|++++.+++|++++..+.++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 346788899999999999999995 6799999999865432 34689999999999998877666655 5677889999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+ +|+|.+++..... .+++..+..++.||++||+|||+
T Consensus 85 e~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~ 123 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHS 123 (296)
T ss_dssp ECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred Eec-CCCHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 9999999974332 57888999999999999999994
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.31 E-value=8.5e-13 Score=141.70 Aligned_cols=119 Identities=17% Similarity=0.274 Sum_probs=100.4
Q ss_pred HHhhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChh------hHHHHHHHHHHHHhCC--CCcccceeEEEE
Q 003737 672 KAATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQ------GNREFVNEIGMISAQQ--HPNLVKLYGCCV 742 (799)
Q Consensus 672 ~~~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~------~~~~f~~E~~~l~~l~--H~niv~l~g~~~ 742 (799)
....++|+..+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|++++.+++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 33456788899999999999999984 57899999999654211 2246788999999996 599999999999
Q ss_pred ECCEEEEEEecCCC-CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 743 EGNQLLLVYEYMKN-NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 743 ~~~~~~lV~Ey~~~-GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..+..++|+||+.+ |+|.+++.... .+++..+..++.||++||+|||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH~ 167 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG---------ALQEELARSFFWQVLEAVRHCHN 167 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999986 89999998644 57788899999999999999994
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.31 E-value=4e-12 Score=138.57 Aligned_cols=123 Identities=21% Similarity=0.324 Sum_probs=85.6
Q ss_pred HHHHHhhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCE-
Q 003737 669 RQIKAATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ- 746 (799)
Q Consensus 669 ~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~- 746 (799)
.+.....++|...+.||+|+||.||+|.. .+|+.||||++.... .....+.+|++.+.+++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 34455678899999999999999999996 478999999985532 223467788888999999999999999976433
Q ss_pred ------EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhc
Q 003737 747 ------LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFF 798 (799)
Q Consensus 747 ------~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH 798 (799)
.++||||+++ +|.+.+..... ....+++..+..++.|++.||+|||
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH 146 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYR-----RQVAPPPILIKVFLFQLIRSIGCLH 146 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHT-----TTCCCCHHHHHHHHHHHHHHHHHHT
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhh-----cccCCCHHHHHHHHHHHHHHHHHHh
Confidence 7899999986 55544432110 0115678889999999999999999
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=2.3e-12 Score=144.23 Aligned_cols=112 Identities=15% Similarity=0.186 Sum_probs=91.9
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEEecC
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
.+|...+.||+|+||+||.....+|+.||||++..... ..+.+|++++.++ +|||||++++++.+.+..++||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 45778899999999997655556789999999965432 2356899999999 7999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+ |+|.+++..... ...+..+..++.||++||+|||+
T Consensus 101 ~-g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~ 136 (432)
T 3p23_A 101 A-ATLQEYVEQKDF--------AHLGLEPITLLQQTTSGLAHLHS 136 (432)
T ss_dssp S-EEHHHHHHSSSC--------CCCSSCHHHHHHHHHHHHHHHHH
T ss_pred C-CCHHHHHHhcCC--------CccchhHHHHHHHHHHHHHHHHH
Confidence 7 699999986542 23333566779999999999994
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.30 E-value=4.7e-12 Score=133.80 Aligned_cols=115 Identities=21% Similarity=0.319 Sum_probs=92.6
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEE-EECCEEEEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC-VEGNQLLLVY 751 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 751 (799)
..++|+..+.||+|+||.||+|.. .+++.||||.+..... .+.+.+|++++.+++|++++..++++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 456799999999999999999995 6789999998754322 23588999999999998877776655 6678899999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+ +|+|.+++..... .+++..+..++.||+.||+|||+
T Consensus 85 e~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~ 123 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHS 123 (296)
T ss_dssp ECC-CCBHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred Ecc-CCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 9999999975432 57788999999999999999994
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.30 E-value=3.2e-12 Score=142.64 Aligned_cols=113 Identities=21% Similarity=0.369 Sum_probs=89.2
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC----C--EEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG----N--QLLL 749 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~----~--~~~l 749 (799)
.|...+.||+|+||.||+|+. .+|+.||||++..... .+.+|++++++++|+|||++++++... + ..++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 467788999999999999996 4689999999865422 234799999999999999999988642 2 3679
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||+++ ++.+.+...... ...+++..++.++.||++||+|||+
T Consensus 131 v~e~~~~-~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~ 174 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRA-----KQTLPVIYVKLYMYQLFRSLAYIHS 174 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ehhcccc-cHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999986 676666431100 1167888999999999999999995
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=5.9e-12 Score=134.59 Aligned_cols=116 Identities=18% Similarity=0.380 Sum_probs=85.7
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccCh-hhHHH-HHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNRE-FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~-f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
.++|+..+.||+|+||.||+|... +|+.||||++..... ....+ +..+..++..++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356777889999999999999964 789999999976532 22233 444455788889999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+ ++.+..+...... .+++..+..++.|+++||+|||+
T Consensus 104 e~~-~~~~~~l~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~ 142 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQG--------PIPERILGKMTVAIVKALYYLKE 142 (318)
T ss_dssp CCC-SEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecc-CCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 4455555443221 57888999999999999999994
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.28 E-value=3.7e-12 Score=139.51 Aligned_cols=115 Identities=16% Similarity=0.202 Sum_probs=97.1
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCC-----------CCcccceeEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-----------HPNLVKLYGCCVE 743 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g~~~~ 743 (799)
++|...+.||+|+||.||+|+. .+++.||||++... ....+.+.+|++++.+++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5688889999999999999995 57899999999753 334567889999999886 8999999999886
Q ss_pred CC----EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 744 GN----QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 744 ~~----~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+ ..++||||+ +|+|.+++...... .+++..+..++.||+.||+|||+
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~ 149 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHR-------GIPLIYVKQISKQLLLGLDYMHR 149 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhcc-------CCcHHHHHHHHHHHHHHHHHHHh
Confidence 54 789999999 89999999764322 47788899999999999999994
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.28 E-value=3.5e-12 Score=141.11 Aligned_cols=114 Identities=20% Similarity=0.339 Sum_probs=88.1
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECC------EEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------QLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~l 749 (799)
.+|...+.||+|+||.||+|....+..||+|++..... ...+|++++++++|||||++++++...+ ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 34777899999999999999987666799998854322 1237999999999999999999986543 3789
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||++++.+....+... ....+++..++.++.||++||+|||+
T Consensus 116 v~e~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~qi~~aL~~LH~ 159 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAK------LKQTMPMLLIKLYMYQLLRSLAYIHS 159 (394)
T ss_dssp EEECCSEEHHHHHHHHHH------TTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EeeccCccHHHHHHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999754443332111 01167888999999999999999994
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=5.9e-12 Score=141.18 Aligned_cols=116 Identities=18% Similarity=0.134 Sum_probs=88.6
Q ss_pred CCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEEecCCC
Q 003737 678 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +|||||++++++.+.+..++||||+.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 3445789999999998776678999999998653 235678999999876 89999999999999999999999996
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.+++......... .....+..+..++.||+.||+|||+
T Consensus 93 gsL~~~l~~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~ 133 (434)
T 2rio_A 93 LNLQDLVESKNVSDEN--LKLQKEYNPISLLRQIASGVAHLHS 133 (434)
T ss_dssp EEHHHHHHTC--------------CCHHHHHHHHHHHHHHHHH
T ss_pred CCHHHHHhccCCCchh--hhhccchhHHHHHHHHHHHHHHHHH
Confidence 6999999865421110 0011233456679999999999994
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.27 E-value=1.2e-11 Score=139.97 Aligned_cols=114 Identities=21% Similarity=0.311 Sum_probs=95.6
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCC-CcccceeEEEEECCEEEEEEe
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 752 (799)
.++|...+.||+|+||.||+|+. .+++.||||++..... ..++.+|++++..++| ++++.+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46788999999999999999995 6789999998765432 2358899999999987 556666677788899999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+ +|+|.+++..... .+++..+..++.||+.||+|||+
T Consensus 84 ~~-g~sL~~ll~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~ 121 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSR--------KLSLKTVLMLADQMINRVEFVHS 121 (483)
T ss_dssp CC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CC-CCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99 9999999975432 57888999999999999999994
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=9.6e-12 Score=134.98 Aligned_cols=116 Identities=13% Similarity=0.218 Sum_probs=96.5
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC-CC-cEEEEEEccccChhhHHHHHHHHHHHHhCCCCc------ccceeEEEEECCE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS-DG-TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN------LVKLYGCCVEGNQ 746 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~-~g-~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 746 (799)
.++|...+.||+|+||.||+|... ++ +.||||+++.. ....+.+.+|++++.+++|++ ++.+.+++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 467888999999999999999853 44 78999999753 334567889999999988766 8999999999999
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++||||+ +|++.+++...... .+++..+..++.||++||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~-------~~~~~~~~~i~~qi~~~L~~lH~ 141 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQ-------PYPLPHVRHMAYQLCHALRFLHE 141 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEecc-CCChHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999 66777777654321 57888999999999999999996
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=9e-12 Score=137.19 Aligned_cols=119 Identities=17% Similarity=0.188 Sum_probs=99.2
Q ss_pred HHHhhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCC-CC-----cccceeEEEEE
Q 003737 671 IKAATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HP-----NLVKLYGCCVE 743 (799)
Q Consensus 671 ~~~~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~-----niv~l~g~~~~ 743 (799)
.....++|...+.||+|+||.||+|.. .+++.||||+++.. ....+++.+|++++..++ |+ +|+++++++..
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 344567899999999999999999995 47889999999753 333567888998888875 55 49999999999
Q ss_pred CCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhc
Q 003737 744 GNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFF 798 (799)
Q Consensus 744 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH 798 (799)
.+..++||||++ |+|.+++...... .+++..++.++.|++.||+|||
T Consensus 128 ~~~~~lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH 174 (382)
T 2vx3_A 128 RNHLCLVFEMLS-YNLYDLLRNTNFR-------GVSLNLTRKFAQQMCTALLFLA 174 (382)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHT
T ss_pred CCceEEEEecCC-CCHHHHHhhcCcC-------CCCHHHHHHHHHHHHHHHHHhc
Confidence 999999999996 5999999865422 4778889999999999999999
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=8.1e-12 Score=136.96 Aligned_cols=114 Identities=9% Similarity=-0.046 Sum_probs=77.6
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh---hhHHHHHHHH---HHHHhCCCCccccee-------EEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR---QGNREFVNEI---GMISAQQHPNLVKLY-------GCC 741 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~f~~E~---~~l~~l~H~niv~l~-------g~~ 741 (799)
..|...+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+ +.+.+ +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 3477889999999999999995 4789999999977532 2345677885 45555 799988754 444
Q ss_pred EEC-----------------CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHH------HHHHHHHHHHHhhhc
Q 003737 742 VEG-----------------NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNI------QILIISAANNIDFFF 798 (799)
Q Consensus 742 ~~~-----------------~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i------~~~~~qi~~gL~yLH 798 (799)
... ...++|||||+ |+|.++++..+. .+++... ..++.||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--------~~~~~~~~~~~vk~~i~~qi~~aL~~LH 211 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--------VYVFRGDEGILALHILTAQLIRLAANLQ 211 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--------SCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--------ccchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence 433 33799999999 899999986532 2233233 455699999999999
Q ss_pred C
Q 003737 799 F 799 (799)
Q Consensus 799 ~ 799 (799)
+
T Consensus 212 ~ 212 (371)
T 3q60_A 212 S 212 (371)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.20 E-value=3e-11 Score=131.05 Aligned_cols=103 Identities=20% Similarity=0.233 Sum_probs=71.0
Q ss_pred EEccCC-cCcCcCCcccCCCCCCCEEEeeC-CcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCC
Q 003737 144 LSVMGN-RLSGPFPKVLTNITTLKNLSIEG-NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221 (799)
Q Consensus 144 L~Ls~N-~l~~~~p~~~~~L~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 221 (799)
++++++ +++ .+|. +..+++|++|+|++ |.|++..+..|.+|++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 455555 555 3565 77777777777775 7777665566777777777777777777777777777777777777777
Q ss_pred cCCCcCCccccCCCCCCEEEccCCCCCC
Q 003737 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (799)
Q Consensus 222 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 249 (799)
+|++..+..|..++ |+.|+|++|.+..
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 77765555555554 7777777777664
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=3.4e-11 Score=138.37 Aligned_cols=103 Identities=10% Similarity=0.064 Sum_probs=77.8
Q ss_pred CCCCeecccCCeeEEEEEeCCCcEEEEEEccccCh--------hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 679 DPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 679 ~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
...+.||+|+||.||+|.. .++.+|+|+...... ...+.|.+|++++.+++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3467899999999999954 578889988643211 1135689999999999999999888888888888999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.++++. +..++.|+++||+|||+
T Consensus 418 mE~~~ggsL~~~l~~-----------------~~~i~~qi~~aL~~LH~ 449 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------------NLDIAYKIGEIVGKLHK 449 (540)
T ss_dssp EECCCSEEHHHHSTT-----------------CTHHHHHHHHHHHHHHH
T ss_pred EECCCCCCHHHHHHH-----------------HHHHHHHHHHHHHHHHH
Confidence 999999999999874 22469999999999994
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.15 E-value=6.5e-11 Score=128.41 Aligned_cols=101 Identities=21% Similarity=0.215 Sum_probs=62.3
Q ss_pred EEeCCC-CCcccCCccccCCCCCCEEEccC-CcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCC
Q 003737 97 IALKAQ-NLTGTLPTELSKLRYLKQLDLSR-NCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN 173 (799)
Q Consensus 97 L~L~~~-~l~g~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N 173 (799)
++++++ +|+ .+|. |..+++|++|+|++ |.|++.++..|..+. |++|+|++|+|++..|..|.+|++|++|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 456666 677 4777 88888888888885 888776666665554 666666666666555555566666666666666
Q ss_pred cCCCCCCccccCCCCCCEEEcccCcCC
Q 003737 174 LFTGSIPPDIRKLINLQKLILSSNSFT 200 (799)
Q Consensus 174 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 200 (799)
+|++..+..|..++ |++|+|++|.+.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 55543333333333 555555555544
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.12 E-value=3.5e-12 Score=139.62 Aligned_cols=134 Identities=18% Similarity=0.213 Sum_probs=76.6
Q ss_pred CCCCEEEccCCcCCCcCccccccc------ceeEEEccCCcCcCcCCccc-CCCCCCCEEEeeCCcCCCCCCccc-----
Q 003737 116 RYLKQLDLSRNCLTGSFSPQWASL------QLVELSVMGNRLSGPFPKVL-TNITTLKNLSIEGNLFTGSIPPDI----- 183 (799)
Q Consensus 116 ~~L~~L~Ls~N~l~~~~p~~~~~l------~L~~L~Ls~N~l~~~~p~~~-~~L~~L~~L~Ls~N~l~~~~p~~~----- 183 (799)
+.|+.|+|++|.++......+... .|++|+|++|.++......+ ..+++|++|+|++|.++......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 567777777777765433333221 37777777777654322222 234566777777776653322222
Q ss_pred cCCCCCCEEEcccCcCCc----cCChhccCCCCCCEEEccCCcCCCc----CCccccCCCCCCEEEccCCCCCC
Q 003737 184 RKLINLQKLILSSNSFTG----ELPAELTKLTNLNDLRISDNNFSGK----IPEFIGKWKKIQKLHIQGSSLEG 249 (799)
Q Consensus 184 ~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~ 249 (799)
...++|++|+|++|.++. .++..+..+++|++|+|++|.++.. ++..+...++|++|+|++|.++.
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~ 225 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD 225 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence 234667777777777653 2344445666677777777766532 23445555666666666666653
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.11 E-value=2e-12 Score=141.67 Aligned_cols=167 Identities=16% Similarity=0.155 Sum_probs=126.2
Q ss_pred ccEEEEEeCCCCCcccCCccccC-----CCCCCEEEccCCcCCCcCccccc-ccc-eeEEEccCCcCcCcCCccc-----
Q 003737 92 CHVVTIALKAQNLTGTLPTELSK-----LRYLKQLDLSRNCLTGSFSPQWA-SLQ-LVELSVMGNRLSGPFPKVL----- 159 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~-----l~~L~~L~Ls~N~l~~~~p~~~~-~l~-L~~L~Ls~N~l~~~~p~~~----- 159 (799)
.+++.|+|++|.++......+.. .++|++|+|++|.++......+. .+. |++|+|++|.++......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 46889999999998644333332 27999999999999764433333 344 9999999999975544444
Q ss_pred CCCCCCCEEEeeCCcCCC----CCCccccCCCCCCEEEcccCcCCcc----CChhccCCCCCCEEEccCCcCCCc----C
Q 003737 160 TNITTLKNLSIEGNLFTG----SIPPDIRKLINLQKLILSSNSFTGE----LPAELTKLTNLNDLRISDNNFSGK----I 227 (799)
Q Consensus 160 ~~L~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~ 227 (799)
...++|++|+|++|.++. .++..+..+++|++|+|++|.++.. ++..+...++|++|+|++|.++.. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 356899999999999864 2344557889999999999999842 456678888999999999999753 3
Q ss_pred CccccCCCCCCEEEccCCCCCCCCchhhhcC
Q 003737 228 PEFIGKWKKIQKLHIQGSSLEGPIPASISAL 258 (799)
Q Consensus 228 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 258 (799)
...+...++|++|+|++|.++......+..+
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 262 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSSEGRQVLRDL 262 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCHHHHHHHHHC
T ss_pred HHHHHhCCCCCEEeccCCCCCHHHHHHHHHH
Confidence 4455667899999999999886555555443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=8.8e-11 Score=135.76 Aligned_cols=104 Identities=13% Similarity=0.005 Sum_probs=77.8
Q ss_pred ecccCCeeEEEEE-eCCCcEEEEEEccccC----------hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEEE
Q 003737 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKS----------RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 684 lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~----------~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 751 (799)
.+.|+.|.++++. .-.|+.+|||.+.... ....++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4555555555443 2348889999996531 22346799999999999 7999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||++||+|.++|.+.+ .+++. .++.||+.||+|+|+
T Consensus 322 Eyv~G~~L~d~i~~~~---------~l~~~---~I~~QIl~AL~ylH~ 357 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE---------EIDRE---KILGSLLRSLAALEK 357 (569)
T ss_dssp ECCCSEEHHHHHHTTC---------CCCHH---HHHHHHHHHHHHHHH
T ss_pred ecCCCCcHHHHHHhCC---------CCCHH---HHHHHHHHHHHHHHH
Confidence 9999999999998765 34453 358999999999994
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=1.5e-10 Score=121.59 Aligned_cols=108 Identities=14% Similarity=0.053 Sum_probs=82.8
Q ss_pred HHhhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccCh------------------hhHHHHHHHHHHHHhCCCCc
Q 003737 672 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR------------------QGNREFVNEIGMISAQQHPN 733 (799)
Q Consensus 672 ~~~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~------------------~~~~~f~~E~~~l~~l~H~n 733 (799)
......|...+.||+|+||.||+|...+|+.||||.++.... .....+.+|++++.+++ |
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 333445666789999999999999987799999999964321 13467999999999999 4
Q ss_pred ccceeEEEEECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 734 iv~l~g~~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++.+++.. +..++||||+++|+|.+ +.. .....++.||++||+|||+
T Consensus 164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------------~~~~~i~~qi~~~l~~lH~ 211 (282)
T 1zar_A 164 -LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------------ENPDEVLDMILEEVAKFYH 211 (282)
T ss_dssp -SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------------SCHHHHHHHHHHHHHHHHH
T ss_pred -CCcCeEEec-cceEEEEEecCCCcHHH-cch---------------hhHHHHHHHHHHHHHHHHH
Confidence 666665543 55699999999999988 421 1234579999999999994
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.86 E-value=1.8e-09 Score=117.24 Aligned_cols=155 Identities=21% Similarity=0.259 Sum_probs=88.9
Q ss_pred hccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhh--cCCCCCeEEcCC--CC-CCCCCC----
Q 003737 206 ELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASIS--ALTSLTDLRISD--LK-GSESAF---- 276 (799)
Q Consensus 206 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~--n~-~~~~~~---- 276 (799)
.+..+++|+.|+|++|.-. .++. +. +++|++|+|..+.+.......+. .+++|+.|+|+. ++ .....+
T Consensus 167 ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~ 243 (362)
T 2ra8_A 167 VLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFR 243 (362)
T ss_dssp HHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTG
T ss_pred HHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHH
Confidence 3444555555555554211 1222 22 45566666655555433222332 456666666542 11 001001
Q ss_pred CccC---CCCccEEEccCCcCcccCCccc---cCCCCCCeeccccccCCCC----CchhhhccCCCCEEeccCCcCCCcC
Q 003737 277 PKLD---KMNLKTLILTKCLIHGEIPDYI---GDMTKLKNIDLSFNNLTGG----IPTTFEKLAKTNFMYLTGNKLTGPV 346 (799)
Q Consensus 277 ~~l~---~~~L~~L~L~~N~l~~~~p~~l---~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~~ 346 (799)
+.+. .++|+.|+|.+|.+....+..+ ..+++|++|+|+.|.+++. ++..+..+++|+.|+|++|.++...
T Consensus 244 ~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~ 323 (362)
T 2ra8_A 244 PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEM 323 (362)
T ss_dssp GGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHH
T ss_pred HHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHH
Confidence 1111 2689999999998875443333 2578999999999999864 3444567899999999999887543
Q ss_pred Chhhhc-CCCEEEeecCc
Q 003737 347 PKYIFN-SNKNVDISLNN 363 (799)
Q Consensus 347 p~~~~~-~l~~l~ls~N~ 363 (799)
-..+.. ....+|++.|.
T Consensus 324 ~~~l~~alg~~~~~~~~~ 341 (362)
T 2ra8_A 324 KKELQKSLPMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHHCCSEEECCSBC
T ss_pred HHHHHHHcCCEEEecCCc
Confidence 333333 23678888876
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.77 E-value=1.2e-07 Score=104.42 Aligned_cols=169 Identities=9% Similarity=0.061 Sum_probs=89.1
Q ss_pred cEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCC---------------------c
Q 003737 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGN---------------------R 150 (799)
Q Consensus 93 ~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N---------------------~ 150 (799)
+++++.+.. +++..-..+|.++++|+.++|..+ ++.+....|..+. |+.+.+..+ .
T Consensus 72 ~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~~~~~~~~~~ 149 (394)
T 4fs7_A 72 KVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCDFKEITIPEG 149 (394)
T ss_dssp TEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCCCSEEECCTT
T ss_pred CceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeecccccccccCcc
Confidence 577777753 466444567888888888888654 4444444555543 444443322 1
Q ss_pred CcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCcc
Q 003737 151 LSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEF 230 (799)
Q Consensus 151 l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 230 (799)
....-...|.++++|+.+.+.++. ...-...|.++.+|+.+++..| ++..-...|.++..|+.+.+..+... +.+.
T Consensus 150 ~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~ 225 (394)
T 4fs7_A 150 VTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDF 225 (394)
T ss_dssp CCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTT
T ss_pred ccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehh
Confidence 111223456666777777776543 2233345666677777776655 33333445666666666665544321 2222
Q ss_pred ccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCC
Q 003737 231 IGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268 (799)
Q Consensus 231 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 268 (799)
.....+|+.+.+..+ ++......+..+..|+.+.+..
T Consensus 226 ~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~ 262 (394)
T 4fs7_A 226 ALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQN 262 (394)
T ss_dssp TTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECC
T ss_pred hcccCCCceEEECCC-ceecccccccccccceeEEcCC
Confidence 333345555555432 2222234455566666666654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=4.9e-09 Score=108.60 Aligned_cols=105 Identities=12% Similarity=0.107 Sum_probs=76.6
Q ss_pred CCCCCeecccCCeeEEEEEe-CCCcE--EEEEEccccChh------------------------hHHHHHHHHHHHHhCC
Q 003737 678 FDPANKVGEGGFGSVYKGIL-SDGTV--IAVKQLSSKSRQ------------------------GNREFVNEIGMISAQQ 730 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~-~~g~~--vAvK~l~~~~~~------------------------~~~~f~~E~~~l~~l~ 730 (799)
|+..+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|++.+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 44568899999999999996 78988 999987543111 1236889999999998
Q ss_pred CCcc--cceeEEEEECCEEEEEEecCCC-C----cHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhc
Q 003737 731 HPNL--VKLYGCCVEGNQLLLVYEYMKN-N----CLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFF 798 (799)
Q Consensus 731 H~ni--v~l~g~~~~~~~~~lV~Ey~~~-G----sL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH 798 (799)
|+++ +.++++ +..++||||+.+ | +|.++.... ++..+..++.|++.||+|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~------------~~~~~~~i~~qi~~~l~~lH 187 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGREL------------KELDVEGIFNDVVENVKRLY 187 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGG------------GGSCHHHHHHHHHHHHHHHH
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhcc------------ChHHHHHHHHHHHHHHHHHH
Confidence 8865 333332 356899999942 4 677664321 13356778999999999999
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=98.72 E-value=5.9e-09 Score=115.84 Aligned_cols=122 Identities=9% Similarity=0.004 Sum_probs=80.6
Q ss_pred hcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccCh---hhHHHHHHHHHHHHhCCC-Cccccee-----------
Q 003737 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQH-PNLVKLY----------- 738 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H-~niv~l~----------- 738 (799)
+..|...+.||+|+||.||+|. ..+|+.||||++..... ...+.|.+|+.++..++| +|.....
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3446677899999999999999 56799999999874322 235789999999999987 3221111
Q ss_pred ----------EEEEE-----CCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 739 ----------GCCVE-----GNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 739 ----------g~~~~-----~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++.. ....+++|+++ +|+|.+++........ ....+++..+..++.||++||+|||+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~ 229 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS--THKSLVHHARLQLTLQVIRLLASLHH 229 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTT--TSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccc--cCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 11111 12346666655 6899999852110000 00135566777778999999999994
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.69 E-value=2.8e-09 Score=115.69 Aligned_cols=208 Identities=17% Similarity=0.170 Sum_probs=93.3
Q ss_pred cccEEEEEeCCCCCcc-cC-------CccccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCC
Q 003737 91 TCHVVTIALKAQNLTG-TL-------PTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g-~~-------p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L 162 (799)
..+|+.|.+......| .. ..++..+++|+.|.+..+...... +++.. .+.+...+..+
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~-------------is~~~-~~~L~~ll~~~ 171 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQE-------------ISWIE-QVDLSPVLDAM 171 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCC-------------GGGCB-CCBCHHHHHTC
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcc-------------ccccc-ccCHHHHHhcC
Confidence 4578888888776553 21 334566789999988765332100 00000 01122333444
Q ss_pred CCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhcc--CCCCCCEEEccC--CcCCCc-----CCccc--
Q 003737 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELT--KLTNLNDLRISD--NNFSGK-----IPEFI-- 231 (799)
Q Consensus 163 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~--N~l~~~-----~p~~~-- 231 (799)
++|+.|+|++|.-. .++. +. +++|++|+|..|.++......+. .+++|++|+|+. |...+. +...+
T Consensus 172 P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~ 248 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSK 248 (362)
T ss_dssp TTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCT
T ss_pred CCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhc
Confidence 55555555554211 1222 22 45555555555544422222222 455555555532 111110 00111
Q ss_pred cCCCCCCEEEccCCCCCCCCchhhh---cCCCCCeEEcCCCCCCCCC---CCc-cCC-CCccEEEccCCcCcccCCcccc
Q 003737 232 GKWKKIQKLHIQGSSLEGPIPASIS---ALTSLTDLRISDLKGSESA---FPK-LDK-MNLKTLILTKCLIHGEIPDYIG 303 (799)
Q Consensus 232 ~~l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~L~~n~~~~~~---~~~-l~~-~~L~~L~L~~N~l~~~~p~~l~ 303 (799)
..+++|++|+|.+|.+....+..+. .+++|+.|+|+.|.+.... ++. +.. ++|+.|+|++|.++...-..+.
T Consensus 249 ~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~ 328 (362)
T 2ra8_A 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQ 328 (362)
T ss_dssp TTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHH
T ss_pred CCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHH
Confidence 1345566666655555432222222 2455666666553332211 111 122 4667777777766533222222
Q ss_pred C-CCCCCeecccccc
Q 003737 304 D-MTKLKNIDLSFNN 317 (799)
Q Consensus 304 ~-l~~L~~L~Ls~N~ 317 (799)
. + ...++++.|+
T Consensus 329 ~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 329 KSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHC--CSEEECCSBC
T ss_pred HHc--CCEEEecCCc
Confidence 1 1 3457777776
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.55 E-value=9.4e-07 Score=97.30 Aligned_cols=261 Identities=12% Similarity=0.135 Sum_probs=150.3
Q ss_pred EEEEEeCCCCCcccCCccccCCCCCCEEEccCCc---CCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEE
Q 003737 94 VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNC---LTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (799)
Q Consensus 94 v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 169 (799)
++++.+.. .++..-..+|.++++|+.+.+..|. ++.+-..+|.... |+.+.+..+ ++......|.++.+|+.+.
T Consensus 66 L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~ 143 (394)
T 4gt6_A 66 LTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVT 143 (394)
T ss_dssp CCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEE
T ss_pred CEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccccc
Confidence 55555543 2444445567788888888877653 4444455666554 666655443 4434455677777777777
Q ss_pred eeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCC---
Q 003737 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSS--- 246 (799)
Q Consensus 170 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~--- 246 (799)
+..+ +.......|..+.+|+.+.+..+ ++..-...|. ..+|+.+.+..+-.. .-...|..+.++.......+.
T Consensus 144 lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~-~~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~ 219 (394)
T 4gt6_A 144 IPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFT-GTALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPA 219 (394)
T ss_dssp CCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT-TCCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCB
T ss_pred ccce-eeeecccceecccccccccccce-eeEecccccc-ccceeEEEECCcccc-cccchhhhccccceeccccccccc
Confidence 7644 23233445667777777777544 2212222332 245666655443221 223334444444443322211
Q ss_pred ---------------------------------CCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCC
Q 003737 247 ---------------------------------LEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKC 292 (799)
Q Consensus 247 ---------------------------------l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N 292 (799)
++..-...|.++.+|+.+.+.+ ......-..+.. .+|+.+.+. +
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~-~~~~I~~~aF~~c~~L~~i~l~-~ 297 (394)
T 4gt6_A 220 IDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPD-SVVSIGTGAFMNCPALQDIEFS-S 297 (394)
T ss_dssp SSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCT-TCCEECTTTTTTCTTCCEEECC-T
T ss_pred ccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEeccc-ccceecCcccccccccccccCC-C
Confidence 1111234567778888888765 222222222444 678888885 4
Q ss_pred cCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhhc---CCCEEEeecCcCc
Q 003737 293 LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN---SNKNVDISLNNFT 365 (799)
Q Consensus 293 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~---~l~~l~ls~N~~~ 365 (799)
.++..-...|.++.+|+.++|..+ ++..-..+|.++.+|+.+.+..+ ++ .|....|. +|+.+++..|...
T Consensus 298 ~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~~ 370 (394)
T 4gt6_A 298 RITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSRSQ 370 (394)
T ss_dssp TCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCHHH
T ss_pred cccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCceee
Confidence 555455567888888888888765 66555678888888988888654 55 56655443 5788888877544
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.46 E-value=1.7e-06 Score=95.19 Aligned_cols=217 Identities=14% Similarity=0.113 Sum_probs=140.2
Q ss_pred cccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCC
Q 003737 133 SPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLT 211 (799)
Q Consensus 133 p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 211 (799)
...|..+. |+.+.+.++. .......|.++++|+.+++..| ++..-...|.++..|+.+.+..+... +.+.+....
T Consensus 155 ~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~ 230 (394)
T 4fs7_A 155 DEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKT 230 (394)
T ss_dssp TTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTC
T ss_pred hhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccC
Confidence 45566665 8888876553 3355567778888888888766 44344456777888888877665433 333444556
Q ss_pred CCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEcc
Q 003737 212 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILT 290 (799)
Q Consensus 212 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~ 290 (799)
+|+.+.+..+ ++..-...|..+..|+.+.+..+..+ .....|..+..++.+.......... .+.. .+|+.+.+.
T Consensus 231 ~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~~---~F~~~~~L~~i~l~ 305 (394)
T 4fs7_A 231 GVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPEK---TFYGCSSLTEVKLL 305 (394)
T ss_dssp CCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECTT---TTTTCTTCCEEEEC
T ss_pred CCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeeccc---cccccccccccccc
Confidence 7777777543 23234456677788888888766443 4455667777777776654221111 1222 577788776
Q ss_pred CCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhh---cCCCEEEeecC
Q 003737 291 KCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLN 362 (799)
Q Consensus 291 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~---~~l~~l~ls~N 362 (799)
.+ ++..-...|.++++|+.++|..+ ++..-..+|.++.+|+.+.+..| ++ .++...| .+|+.+++..+
T Consensus 306 ~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 306 DS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp TT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCCEEEEEGG
T ss_pred cc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCCEEEECCC
Confidence 54 55455667888888888888754 66556678888888888888776 55 4555444 25778888765
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.44 E-value=4.1e-08 Score=106.44 Aligned_cols=105 Identities=9% Similarity=-0.010 Sum_probs=70.3
Q ss_pred CCCCCeecccCCeeEEEEEeCCCcEEEEEEccccCh--------------hhHHH--------HHHHHHHHHhCCCCccc
Q 003737 678 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--------------QGNRE--------FVNEIGMISAQQHPNLV 735 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~--------------~~~~~--------f~~E~~~l~~l~H~niv 735 (799)
|+....||+|+||.||+|..++|+.||||+++.... ..... ..+|...|.++.+..+.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 677889999999999999988899999998754210 00111 23456666666554443
Q ss_pred ceeEEEEECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 736 ~l~g~~~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
...-+.... .+|||||+++++|.++.. . ++...++.|++.+|.|||+
T Consensus 177 vp~p~~~~~--~~LVME~i~G~~L~~l~~-------------~--~~~~~l~~qll~~l~~lH~ 223 (397)
T 4gyi_A 177 VPEPIAQSR--HTIVMSLVDALPMRQVSS-------------V--PDPASLYADLIALILRLAK 223 (397)
T ss_dssp CCCEEEEET--TEEEEECCSCEEGGGCCC-------------C--SCHHHHHHHHHHHHHHHHH
T ss_pred CCeeeeccC--ceEEEEecCCccHhhhcc-------------c--HHHHHHHHHHHHHHHHHHH
Confidence 222222222 379999999988865421 1 1345568999999999994
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.37 E-value=8.8e-06 Score=89.47 Aligned_cols=257 Identities=11% Similarity=0.144 Sum_probs=172.7
Q ss_pred CccccCCC-CCCEEEccCCcCCCcCcccccccc-eeEEEccCCc---CcCcCCcccCCCCCCCEEEeeCCcCCCCCCccc
Q 003737 109 PTELSKLR-YLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNR---LSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI 183 (799)
Q Consensus 109 p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~---l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~ 183 (799)
..+|.+.+ .|+.+.+..+ ++.+-..+|..+. |+.+.+..|. ++.+-...|.++.+|+.+.+..+ ++..-...|
T Consensus 56 ~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF 133 (394)
T 4gt6_A 56 DRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAF 133 (394)
T ss_dssp TTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTT
T ss_pred HhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhh
Confidence 44677774 5999999754 7767778888877 9999998774 55555678888999998877655 443445578
Q ss_pred cCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCe
Q 003737 184 RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTD 263 (799)
Q Consensus 184 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 263 (799)
..+.+|+.+.+..+ +...-...|..+.+|+.+.+..+ ++..-...|. ..+|+.+.+..+-.. .....|..+.+++.
T Consensus 134 ~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~-~~~l~~i~ip~~~~~-i~~~af~~c~~l~~ 209 (394)
T 4gt6_A 134 HHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFT-GTALTQIHIPAKVTR-IGTNAFSECFALST 209 (394)
T ss_dssp TTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT-TCCCSEEEECTTCCE-ECTTTTTTCTTCCE
T ss_pred hhhcccccccccce-eeeecccceecccccccccccce-eeEecccccc-ccceeEEEECCcccc-cccchhhhccccce
Confidence 88999999999754 33344567888999999999765 4433344554 467898888755332 33455666666666
Q ss_pred EEcCCCCCC---------------------------CCCCC---------ccCC-CCccEEEccCCcCcccCCccccCCC
Q 003737 264 LRISDLKGS---------------------------ESAFP---------KLDK-MNLKTLILTKCLIHGEIPDYIGDMT 306 (799)
Q Consensus 264 L~L~~n~~~---------------------------~~~~~---------~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~ 306 (799)
......... ...+| .+.. ..|+.+.+..+..+ .....|.+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~ 288 (394)
T 4gt6_A 210 ITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCP 288 (394)
T ss_dssp EEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCT
T ss_pred ecccccccccccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEecccccce-ecCccccccc
Confidence 554321110 00112 1333 57888888765433 4556788999
Q ss_pred CCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhh---cCCCEEEeecCcCcccCCC-CC-cCCCC
Q 003737 307 KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLNNFTWESSD-PI-ECPRG 377 (799)
Q Consensus 307 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~---~~l~~l~ls~N~~~g~~p~-~~-~~~~~ 377 (799)
+|+.+.+. +.++.....+|.++.+|+.+.+..+ ++ .|.+..| .+|+.+.+..+ ++ .|.. .+ .|..+
T Consensus 289 ~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L 359 (394)
T 4gt6_A 289 ALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTAL 359 (394)
T ss_dssp TCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTC
T ss_pred ccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCC
Confidence 99999996 5676666778999999999999865 55 4555444 35889999755 43 3332 23 56554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.31 E-value=8.4e-08 Score=98.93 Aligned_cols=78 Identities=27% Similarity=0.322 Sum_probs=35.1
Q ss_pred CCCCEEEcccCcCCc--cCChhccCCCCCCEEEccCCcCCCcCCccccCCC--CCCEEEccCCCCCCCCc-------hhh
Q 003737 187 INLQKLILSSNSFTG--ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWK--KIQKLHIQGSSLEGPIP-------ASI 255 (799)
Q Consensus 187 ~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p-------~~~ 255 (799)
++|++|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+.+| ..+
T Consensus 170 ~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il 247 (267)
T 3rw6_A 170 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIR 247 (267)
T ss_dssp TTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHH
T ss_pred CCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHH
Confidence 334444444444433 2233334444444444444444432 1122222 55555555555554333 235
Q ss_pred hcCCCCCeEEc
Q 003737 256 SALTSLTDLRI 266 (799)
Q Consensus 256 ~~l~~L~~L~L 266 (799)
..+++|+.||-
T Consensus 248 ~~~P~L~~LDg 258 (267)
T 3rw6_A 248 ERFPKLLRLDG 258 (267)
T ss_dssp HHCTTCCEESS
T ss_pred HHCcccCeECC
Confidence 56677776653
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.28 E-value=1.9e-05 Score=86.23 Aligned_cols=257 Identities=14% Similarity=0.130 Sum_probs=152.9
Q ss_pred cEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeC
Q 003737 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (799)
Q Consensus 93 ~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~ 172 (799)
+++++.+. .+++..-..+|.++.+|+.++|..+ ++.+-..+|...+|+.+.+..+ ++..-...|.. .+|+.+.+..
T Consensus 47 ~i~~v~ip-~~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~lp~ 122 (379)
T 4h09_A 47 RISEVRVN-SGITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADTKLQSYTGMER-VKKFGDYVFQG-TDLDDFEFPG 122 (379)
T ss_dssp GCSEEEEC-TTEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCCCCEEEECTT-CCEECTTTTTT-CCCSEEECCT
T ss_pred CCEEEEeC-CCccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCCCCceEECCce-eeEeccceecc-CCcccccCCC
Confidence 46666664 3455445567888889999988654 6666667777777777776543 44344445554 3677777765
Q ss_pred CcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCc------------------------------
Q 003737 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN------------------------------ 222 (799)
Q Consensus 173 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~------------------------------ 222 (799)
+. +..-...|.+ .+|+.+.+..+ ++..-...|..+.+++.+.+..+.
T Consensus 123 ~~-~~i~~~~F~~-~~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (379)
T 4h09_A 123 AT-TEIGNYIFYN-SSVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEF 199 (379)
T ss_dssp TC-CEECTTTTTT-CCCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEE
T ss_pred cc-cccccccccc-ceeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceecccccccccccc
Confidence 42 2111222322 23444443322 222223334444444444433221
Q ss_pred -----CCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcc
Q 003737 223 -----FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHG 296 (799)
Q Consensus 223 -----l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~ 296 (799)
........+....+|+.+.+..+ +.......|.++..|+.+.+.+ +.....-..+.. .+|+.+.+..+ ++.
T Consensus 200 ~~~~~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~-~v~~I~~~aF~~~~~l~~i~l~~~-i~~ 276 (379)
T 4h09_A 200 TIPSTVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPK-NVTSIGSFLLQNCTALKTLNFYAK-VKT 276 (379)
T ss_dssp ECCTTCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECT-TCCEECTTTTTTCTTCCEEEECCC-CSE
T ss_pred ccccceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCC-CccEeCccccceeehhcccccccc-cee
Confidence 11122344556778888888654 3434456677888888888865 332222223444 67888888644 554
Q ss_pred cCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhhc---CCCEEEeec
Q 003737 297 EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN---SNKNVDISL 361 (799)
Q Consensus 297 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~---~l~~l~ls~ 361 (799)
.....|.++++|+.+++.++.++..-..+|.++.+|+.+.|..+ ++ .|....|. +|+.+++..
T Consensus 277 i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 277 VPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp ECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCCCCCCT
T ss_pred ccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCCCEEEECC
Confidence 55567888899999999988888777788999999999999754 55 45554432 456666543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.19 E-value=3.6e-07 Score=89.31 Aligned_cols=64 Identities=20% Similarity=0.245 Sum_probs=27.9
Q ss_pred CCCCCCEEEcccCcCCcc----CChhccCCCCCCEEEccCCcCCCc----CCccccCCCCCCEEEc--cCCCCC
Q 003737 185 KLINLQKLILSSNSFTGE----LPAELTKLTNLNDLRISDNNFSGK----IPEFIGKWKKIQKLHI--QGSSLE 248 (799)
Q Consensus 185 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--~~N~l~ 248 (799)
..++|++|+|++|.+... +...+...++|++|+|++|.|... +...+...++|++|+| ++|.+.
T Consensus 63 ~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 63 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred hCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCC
Confidence 334445555555544321 222333334455555555554421 2333344444555555 445444
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.18 E-value=2.2e-07 Score=90.84 Aligned_cols=24 Identities=17% Similarity=0.093 Sum_probs=16.9
Q ss_pred cCCccccCCCCCCEEEccCC-cCCC
Q 003737 107 TLPTELSKLRYLKQLDLSRN-CLTG 130 (799)
Q Consensus 107 ~~p~~~~~l~~L~~L~Ls~N-~l~~ 130 (799)
.+...+...+.|++|+|++| .+..
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~ 51 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPV 51 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCH
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCH
Confidence 34455677788888888887 7763
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.16 E-value=1.5e-06 Score=89.54 Aligned_cols=96 Identities=26% Similarity=0.394 Sum_probs=73.8
Q ss_pred EEccCCcCc---CcCCcccCCCCCCCEEEeeCCcCCC--CCCccccCCCCCCEEEcccCcCCccCChhccCCC--CCCEE
Q 003737 144 LSVMGNRLS---GPFPKVLTNITTLKNLSIEGNLFTG--SIPPDIRKLINLQKLILSSNSFTGELPAELTKLT--NLNDL 216 (799)
Q Consensus 144 L~Ls~N~l~---~~~p~~~~~L~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L 216 (799)
++++.|... +.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|++++. ..+..++ +|++|
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L 225 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL 225 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence 667777432 2222233568999999999999997 4567778999999999999999965 3344444 99999
Q ss_pred EccCCcCCCcCCc-------cccCCCCCCEEE
Q 003737 217 RISDNNFSGKIPE-------FIGKWKKIQKLH 241 (799)
Q Consensus 217 ~Ls~N~l~~~~p~-------~~~~l~~L~~L~ 241 (799)
+|++|.+.+.+|+ .+..+++|+.||
T Consensus 226 ~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 226 WLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp ECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred EccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 9999999887763 467889999886
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=2.2e-05 Score=80.79 Aligned_cols=112 Identities=13% Similarity=0.020 Sum_probs=85.5
Q ss_pred HhhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCC-CCcccceeEEEEECCEEEEEE
Q 003737 673 AATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 673 ~~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 751 (799)
....+|......+.|+.+.||+.... +..+++|............+.+|++++..+. |..+.++++++...+..|+||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 34456777777888888999999854 6789999986532223346889999999884 677889999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||++|.+|.+.+.. ......++.+++++++.||.
T Consensus 90 e~i~G~~l~~~~~~--------------~~~~~~~~~~l~~~l~~LH~ 123 (263)
T 3tm0_A 90 SEADGVLCSEEYED--------------EQSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp ECCSSEEHHHHCCT--------------TTCHHHHHHHHHHHHHHHHH
T ss_pred EecCCeehhhccCC--------------cccHHHHHHHHHHHHHHHhC
Confidence 99999999876321 11223458899999999983
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.84 E-value=0.00056 Score=74.39 Aligned_cols=240 Identities=15% Similarity=0.098 Sum_probs=151.5
Q ss_pred cEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeC
Q 003737 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (799)
Q Consensus 93 ~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~ 172 (799)
++++++|.. +++..-..+|.+. .|+.+.+..+ ++.+....|...+|+.+.+..+- ...-...|.+. +|+.+.+..
T Consensus 70 ~L~~I~lp~-~v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~~L~~i~lp~~~-~~i~~~~F~~~-~l~~~~~~~ 144 (379)
T 4h09_A 70 NMTKVTVAS-TVTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGTDLDDFEFPGAT-TEIGNYIFYNS-SVKRIVIPK 144 (379)
T ss_dssp TCCEEEECT-TCCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTCCCSEEECCTTC-CEECTTTTTTC-CCCEEEECT
T ss_pred CCCEEEeCC-cceEechhhhcCC-CCceEECCce-eeEeccceeccCCcccccCCCcc-ccccccccccc-eeeeeeccc
Confidence 578888864 3664445566665 5777776543 44444555655567777775442 21222233322 344443332
Q ss_pred CcCCCCCCccccCCCCCCEEEcccCc-----------------------------------CCccCChhccCCCCCCEEE
Q 003737 173 NLFTGSIPPDIRKLINLQKLILSSNS-----------------------------------FTGELPAELTKLTNLNDLR 217 (799)
Q Consensus 173 N~l~~~~p~~~~~l~~L~~L~Ls~N~-----------------------------------l~~~~p~~~~~l~~L~~L~ 217 (799)
+ ++..-...|....+++.+.+..+. ........+....+|+.+.
T Consensus 145 ~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~f~~~~~l~~i~ 223 (379)
T 4h09_A 145 S-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKTVTAYGFSYGKNLKKIT 223 (379)
T ss_dssp T-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCEECTTTTTTCSSCSEEE
T ss_pred e-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeEEeecccccccccceee
Confidence 2 221222233334444433332211 1112334566778899998
Q ss_pred ccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcc
Q 003737 218 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHG 296 (799)
Q Consensus 218 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~ 296 (799)
+..+ +.......|.++..|+.+.+..+ ++..-...|.++.+|+.+.+.. +........+.. .+|+.+.+.++.++.
T Consensus 224 ~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~-~i~~i~~~aF~~c~~L~~i~l~~~~i~~ 300 (379)
T 4h09_A 224 ITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYA-KVKTVPYLLCSGCSNLTKVVMDNSAIET 300 (379)
T ss_dssp CCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECC-CCSEECTTTTTTCTTCCEEEECCTTCCE
T ss_pred eccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccccccc-cceeccccccccccccccccccccccce
Confidence 8665 44355667888999999999766 5555567788899999999875 333322333555 789999999998887
Q ss_pred cCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCC
Q 003737 297 EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343 (799)
Q Consensus 297 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 343 (799)
.-...|.++.+|+.++|..+ ++..-..+|.++++|+.+.+..+ ++
T Consensus 301 I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~ 345 (379)
T 4h09_A 301 LEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-IT 345 (379)
T ss_dssp ECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CC
T ss_pred ehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cC
Confidence 77788999999999999765 76566778999999999988654 44
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.46 E-value=6.8e-05 Score=71.70 Aligned_cols=84 Identities=10% Similarity=0.127 Sum_probs=44.5
Q ss_pred CCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCc-CCccCChhccCC----CCCCEEEccCCc-CCCcCCccccCCCC
Q 003737 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS-FTGELPAELTKL----TNLNDLRISDNN-FSGKIPEFIGKWKK 236 (799)
Q Consensus 163 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~ 236 (799)
-+|+.||++++.++..--..+..+++|++|+|++|. ++..--..+..+ ++|++|+|++|. ++..--..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 357777777776654333445666677777776664 443222223332 246666666653 44322233445555
Q ss_pred CCEEEccCCC
Q 003737 237 IQKLHIQGSS 246 (799)
Q Consensus 237 L~~L~L~~N~ 246 (799)
|++|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 5555555553
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00013 Score=74.54 Aligned_cols=103 Identities=14% Similarity=0.017 Sum_probs=73.7
Q ss_pred CCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCc--ccceeEEEEECCEEEEEEecC
Q 003737 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN--LVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~ 754 (799)
++....+.+.|..+.||+....+|..+++|..... ....+.+|++++..+++.+ +.+++++...++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34333333456679999998777888999997653 2245788999999886545 456888888777899999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++.++. .... ....++.++++.|+.||.
T Consensus 98 ~G~~l~--~~~~---------------~~~~~~~~l~~~l~~lh~ 125 (264)
T 1nd4_A 98 PGQDLL--SSHL---------------APAEKVSIMADAMRRLHT 125 (264)
T ss_dssp SSEETT--TSCC---------------CHHHHHHHHHHHHHHHTT
T ss_pred CCcccC--cCcC---------------CHhHHHHHHHHHHHHHhC
Confidence 998884 2110 112357889999999984
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.43 E-value=4.9e-05 Score=72.71 Aligned_cols=87 Identities=10% Similarity=0.081 Sum_probs=63.4
Q ss_pred ccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCc-CCCCCCccccCC----CCCCEEEcccCc-CCccCChhccC
Q 003737 136 WASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL-FTGSIPPDIRKL----INLQKLILSSNS-FTGELPAELTK 209 (799)
Q Consensus 136 ~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~ 209 (799)
.....|++||++++.++..--..+..+++|+.|+|++|. ++..--..+..+ ++|++|+|++|. ++..--..+.+
T Consensus 58 ~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~ 137 (176)
T 3e4g_A 58 LDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHH 137 (176)
T ss_dssp TTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGG
T ss_pred CCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhc
Confidence 355679999999998876555667889999999999985 553222345554 369999999985 76433345678
Q ss_pred CCCCCEEEccCCc
Q 003737 210 LTNLNDLRISDNN 222 (799)
Q Consensus 210 l~~L~~L~Ls~N~ 222 (799)
+++|++|+++++.
T Consensus 138 ~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 138 FRNLKYLFLSDLP 150 (176)
T ss_dssp CTTCCEEEEESCT
T ss_pred CCCCCEEECCCCC
Confidence 8999999999885
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0011 Score=71.45 Aligned_cols=107 Identities=9% Similarity=0.164 Sum_probs=75.3
Q ss_pred CCeecccCCeeEEEEEeCCCcEEEEEEcc--ccC-hhhHHHHHHHHHHHHhCCC--CcccceeEEEEEC---CEEEEEEe
Q 003737 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLS--SKS-RQGNREFVNEIGMISAQQH--PNLVKLYGCCVEG---NQLLLVYE 752 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~--~~~-~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~---~~~~lV~E 752 (799)
.+.++.|.++.||+....+ ..+++|+.. ... ......+.+|.+++..+++ ..++++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4578899999999988754 578888876 332 1224578899999998874 5578889888766 34899999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+++..+.+... ..+++++...++.++++.|+.||.
T Consensus 122 ~v~G~~l~~~~~-----------~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 122 FVSGRVLWDQSL-----------PGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp CCCCBCCCCTTC-----------TTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCeecCCCcc-----------ccCCHHHHHHHHHHHHHHHHHHhC
Confidence 999877643111 134455667779999999999993
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0014 Score=63.89 Aligned_cols=15 Identities=20% Similarity=0.282 Sum_probs=6.9
Q ss_pred CCCCCEEEccCCcCC
Q 003737 210 LTNLNDLRISDNNFS 224 (799)
Q Consensus 210 l~~L~~L~Ls~N~l~ 224 (799)
-+.|++|+|+.|.|.
T Consensus 97 N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 97 SPSLRVLNVESNFLT 111 (197)
T ss_dssp CSSCCEEECCSSBCC
T ss_pred CCccCeEecCCCcCC
Confidence 344444444444443
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.19 E-value=0.0011 Score=64.41 Aligned_cols=20 Identities=10% Similarity=0.074 Sum_probs=12.5
Q ss_pred ccccCCCCCCEEEccCC-cCC
Q 003737 110 TELSKLRYLKQLDLSRN-CLT 129 (799)
Q Consensus 110 ~~~~~l~~L~~L~Ls~N-~l~ 129 (799)
..+.+-+.|++|+|++| .+.
T Consensus 35 ~ll~~n~~L~~L~L~~nn~ig 55 (197)
T 1pgv_A 35 RLREDDTDLKEVNINNMKRVS 55 (197)
T ss_dssp HHHTTCSSCCEEECTTCCSSC
T ss_pred HHHhcCCCccEEECCCCCCCC
Confidence 33455567777777764 554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.19 E-value=0.0071 Score=54.77 Aligned_cols=56 Identities=18% Similarity=0.133 Sum_probs=36.2
Q ss_pred EEEccCCcCc-ccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCC
Q 003737 286 TLILTKCLIH-GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343 (799)
Q Consensus 286 ~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 343 (799)
.++.+++.++ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|.+|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5666666665 24454332 35777777777777666666777777777777766554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=95.97 E-value=0.0097 Score=53.87 Aligned_cols=36 Identities=25% Similarity=0.314 Sum_probs=17.3
Q ss_pred CCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcC
Q 003737 164 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSF 199 (799)
Q Consensus 164 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 199 (799)
+|++|+|++|+|+...+..|..+++|++|+|++|.+
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 345555555555433333444455555555555544
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=95.53 E-value=0.068 Score=54.51 Aligned_cols=101 Identities=8% Similarity=0.007 Sum_probs=72.5
Q ss_pred eecccCCe-eEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhCC-CCcccceeEEEEECCEEEEEEecCCCCcH
Q 003737 683 KVGEGGFG-SVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (799)
Q Consensus 683 ~lG~G~~g-~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~GsL 759 (799)
.+..|..| .||+.... ++..+.+|+-... ....+.+|.+.|..+. +--+.++++++.+++..++||||+++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445555 68987754 5667889986533 3457888999988774 32366889999999999999999999998
Q ss_pred HHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 760 SRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 760 ~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+...... + ....++.+++..|+-||.
T Consensus 108 ~~~~~~~~------------~-~~~~~~~~l~~~L~~Lh~ 134 (272)
T 4gkh_A 108 FQVLEEYP------------D-SGENIVDALAVFLRRLHS 134 (272)
T ss_dssp HHHHHHCG------------G-GHHHHHHHHHHHHHHHHT
T ss_pred cccccCCH------------H-HHHHHHHHHHHHHHHhcC
Confidence 87654321 2 233457788888888884
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=95.51 E-value=0.047 Score=57.21 Aligned_cols=102 Identities=15% Similarity=0.113 Sum_probs=74.0
Q ss_pred CCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCC---cccceeEEEE-ECCEEEEEEecCCC
Q 003737 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHP---NLVKLYGCCV-EGNQLLLVYEYMKN 756 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~Ey~~~ 756 (799)
.+.++.|....||+. |..+++|.-. .......+.+|.+++..+.+. -+.+.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456788888899987 5667888743 223456789999999998753 3556777764 34557899999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..+.+.... .++.++...++.|+++.|+.||.
T Consensus 98 ~~l~~~~~~-----------~l~~~~~~~~~~~lg~~La~LH~ 129 (306)
T 3tdw_A 98 QILGEDGMA-----------VLPDDAKDRLALQLAEFMNELSA 129 (306)
T ss_dssp EECHHHHHT-----------TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred eECchhhhh-----------hCCHHHHHHHHHHHHHHHHHHhc
Confidence 888764322 23455666778999999999983
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=95.05 E-value=0.023 Score=54.19 Aligned_cols=86 Identities=28% Similarity=0.435 Sum_probs=69.7
Q ss_pred CHHHHhhhccCCcceeeeeeeecCCceEEEeccccceecCCCccccCCceEEEEEeCCeeeecccccchhcCCCCccEEe
Q 003737 484 DLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVK 563 (799)
Q Consensus 484 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~ 563 (799)
+..++++++..+.++++...|..+|.|.++|++.+..+.. .+.++|++++++...+.++|+...+|+ ..++.+
T Consensus 53 ~~~lY~TaR~~~~~~tY~f~v~~~G~Y~VrLhF~ei~~~~------~~~rvFdV~ing~~~l~~fdi~~~ag~-~~~~~~ 125 (174)
T 2jwp_A 53 DQVLYQTERYNEDSFGYDIPIKEEGEYVLVLKFAEVYFAQ------SQQKVFDVRVNGHTVVKDLDIFDRVGH-STAHDE 125 (174)
T ss_dssp HHHTTTCCCCCCSCEEEEEECCSCEEEEEEEEEECCSCCC------SSSSCEEEEETTEEEEEEECHHHHHSS-SSCEEE
T ss_pred CchhhhhhccCCCCeEEEEEeCCCeEEEEEEEEeccccCC------CCCeEeEEEECCEEeecCcCHHHhhCC-CeeEEE
Confidence 4567788888888998888888889999999999987642 578999999999999999999988876 456667
Q ss_pred eeeeeecCcccEE
Q 003737 564 NFPAEVTSHTLKI 576 (799)
Q Consensus 564 ~~~~~~s~n~l~~ 576 (799)
.+.+++..+.++.
T Consensus 126 ~~~~~v~~~~l~i 138 (174)
T 2jwp_A 126 IIPISIKKGKLSV 138 (174)
T ss_dssp EEEEEEETTEEEE
T ss_pred EEEEEEecCceee
Confidence 6777776665544
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=94.47 E-value=0.046 Score=57.07 Aligned_cols=102 Identities=12% Similarity=0.111 Sum_probs=71.3
Q ss_pred CCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCC-CCc--ccceeEEEEECC---EEEEEEecC
Q 003737 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPN--LVKLYGCCVEGN---QLLLVYEYM 754 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~Ey~ 754 (799)
.+.++.|....||+.. ..+++|..... .....+.+|.+++..+. +.. +.+++++....+ ..|+||||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 45788886432 34567899999998874 433 334444433333 348899999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|.++.+.... .++.++...++.|+++.++.||.
T Consensus 99 ~G~~l~~~~~~-----------~l~~~~~~~~~~~l~~~la~LH~ 132 (304)
T 3sg8_A 99 KGVPLTPLLLN-----------NLPKQSQNQAAKDLARFLSELHS 132 (304)
T ss_dssp CCEECCHHHHH-----------TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCeECCccccc-----------cCCHHHHHHHHHHHHHHHHHHHc
Confidence 99888754331 34555677779999999999983
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=94.28 E-value=0.11 Score=53.81 Aligned_cols=77 Identities=18% Similarity=0.184 Sum_probs=55.4
Q ss_pred CCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCC---cccceeEEEEECCEEEEEEecC
Q 003737 678 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHP---NLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
....+.+|.|..+.||+.++.+|+.|.||+-..........|.+|.+.|..+.-. -+.+++++ +. -++||||+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEee
Confidence 3345678999999999999999999999987654433345688999998887422 23444443 33 37899999
Q ss_pred CCCc
Q 003737 755 KNNC 758 (799)
Q Consensus 755 ~~Gs 758 (799)
+.+.
T Consensus 93 ~~~~ 96 (288)
T 3f7w_A 93 DERP 96 (288)
T ss_dssp CCCC
T ss_pred cccC
Confidence 8654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=94.26 E-value=0.09 Score=57.15 Aligned_cols=76 Identities=14% Similarity=0.199 Sum_probs=50.2
Q ss_pred CCeecccCCeeEEEEEeC-CCcEEEEEEccccCh-------hhHHHHHHHHHHHHhCCC--Ccc-cceeEEEEECCEEEE
Q 003737 681 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-------QGNREFVNEIGMISAQQH--PNL-VKLYGCCVEGNQLLL 749 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-------~~~~~f~~E~~~l~~l~H--~ni-v~l~g~~~~~~~~~l 749 (799)
.+.+|.|.++.||++... +++.++||....... .....+.+|.+++..+.. +.. .+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999753 467899998653211 123457788888887642 333 355543 4556789
Q ss_pred EEecCCCCc
Q 003737 750 VYEYMKNNC 758 (799)
Q Consensus 750 V~Ey~~~Gs 758 (799)
||||+++..
T Consensus 113 vmE~l~g~~ 121 (397)
T 2olc_A 113 VMEDLSHLK 121 (397)
T ss_dssp EECCCTTSE
T ss_pred EEEeCCCcc
Confidence 999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=93.41 E-value=0.14 Score=53.72 Aligned_cols=74 Identities=15% Similarity=0.125 Sum_probs=59.0
Q ss_pred CCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCC---CCcccceeEEEEECCEEEEEEecCCCC
Q 003737 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ---HPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~~G 757 (799)
.+.++.|....+|+... ++..+++|+.... ....|.+|.+.|..+. ...++++++++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 45689999999999886 4667888887542 3567889998888774 356788999888888899999999987
Q ss_pred c
Q 003737 758 C 758 (799)
Q Consensus 758 s 758 (799)
.
T Consensus 117 ~ 117 (312)
T 3jr1_A 117 K 117 (312)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=92.40 E-value=0.075 Score=56.75 Aligned_cols=115 Identities=7% Similarity=0.006 Sum_probs=72.6
Q ss_pred Cee-cccCCeeEEEEEeC-------CCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCC---CcccceeEEEEEC---
Q 003737 682 NKV-GEGGFGSVYKGILS-------DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQH---PNLVKLYGCCVEG--- 744 (799)
Q Consensus 682 ~~l-G~G~~g~Vy~~~~~-------~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H---~niv~l~g~~~~~--- 744 (799)
+.| +.|....+|+.... ++..+++|...... ......+.+|++++..+.. -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78889999988754 26678888865432 1112457788888887743 2466788877654
Q ss_pred CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+..++||||+++..+.+.+...- ...+...++.++...++.++++.|+-||.
T Consensus 106 g~~~~v~e~l~G~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~~La~LH~ 157 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPDVMPYTF---GDNWFADAPAERQRQLQDATVAALATLHS 157 (357)
T ss_dssp SSCEEEEECCCCBCCCBTTBGGG---SCSTTTTSCHHHHHHHHHHHHHHHHHHTT
T ss_pred CCceEEEEecCCCChhhcCcccc---cccccCCCCHHHHHHHHHHHHHHHHHHhC
Confidence 34689999999877654321000 00000023344445568899999999984
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.05 E-value=0.27 Score=54.62 Aligned_cols=60 Identities=12% Similarity=0.141 Sum_probs=17.8
Q ss_pred CCeecccCCeeEEEEEeCC-CcEEEE------EEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEE
Q 003737 681 ANKVGEGGFGSVYKGILSD-GTVIAV------KQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~~~-g~~vAv------K~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 743 (799)
.+.+| ||.||+|.+.. ...||| |+.+... ......|.+|..++.+.+|+|+++.+++...
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 45566 99999999753 367888 7765432 2234579999999999999999999988654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 799 | ||||
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-24 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-07 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-22 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-22 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-21 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-21 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-21 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-20 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-20 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-20 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-20 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-20 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-20 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-19 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-19 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-19 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-19 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-19 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-19 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-18 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-18 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-18 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-18 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-18 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-18 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-18 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-17 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-17 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-17 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-17 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-17 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-17 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-17 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-17 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-16 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-16 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-16 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-16 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-14 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-16 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-16 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-16 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-05 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-15 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-14 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-14 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-14 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-13 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-13 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-13 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-13 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-13 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-13 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-13 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-13 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-13 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-12 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-12 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-12 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-11 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-06 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-09 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 5e-24
Identities = 26/86 (30%), Positives = 46/86 (53%), Gaps = 1/86 (1%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
+ ++G G FG V+ G + +A+K + + +F+ E ++ HP LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSR 761
+LYG C+E + LV+E+M++ CLS
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD 89
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.6 bits (245), Expect = 2e-23
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 1/95 (1%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
+ ++G G FG V G +A+K + + EF+ E ++ H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIF 770
+LYG C + + ++ EYM N CL + F
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRF 97
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 99.4 bits (246), Expect = 2e-23
Identities = 73/318 (22%), Positives = 116/318 (36%), Gaps = 23/318 (7%)
Query: 37 HAEEVKALKQIGRKLGK----KDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATC 92
+ ++ +AL QI + LG W D C+ W V CD + T
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN--RTWL-----------GVLCDTDTQTY 50
Query: 93 HVVTIALKAQNLTG--TLPTELSKLRYLKQLDLS--RNCLTGSFSPQWASLQLVELSVMG 148
V + L NL +P+ L+ L YL L + N + QL L +
Sbjct: 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110
Query: 149 NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELT 208
+SG P L+ I TL L N +G++PP I L NL + N +G +P
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170
Query: 209 KLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
+ L N + + + + LEG + + + ++
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230
Query: 269 LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328
+ NL L L I+G +P + + L ++++SFNNL G IP
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGN 289
Query: 329 LAKTNFMYLTGNK-LTGP 345
L + + NK L G
Sbjct: 290 LQRFDVSAYANNKCLCGS 307
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.5 bits (137), Expect = 2e-09
Identities = 20/62 (32%), Positives = 30/62 (48%), Gaps = 3/62 (4%)
Query: 194 LSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL--EGPI 251
L +N G LP LT+L L+ L +S NN G+IP+ G ++ + P+
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPL 309
Query: 252 PA 253
PA
Sbjct: 310 PA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 50.9 bits (120), Expect = 2e-07
Identities = 19/58 (32%), Positives = 29/58 (50%), Gaps = 4/58 (6%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRL--SGPFPK 157
+ GTLP L++L++L L++S N L G PQ +LQ + N+ P P
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.1 bits (236), Expect = 3e-22
Identities = 24/91 (26%), Positives = 40/91 (43%), Gaps = 2/91 (2%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
++G G FG V+ G + T +AVK L + F+ E ++ QH LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK 766
+LY + + ++ EYM+N L +
Sbjct: 72 RLYAVVTQEP-IYIITEYMENGSLVDFLKTP 101
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.1 bits (236), Expect = 8e-22
Identities = 21/98 (21%), Positives = 43/98 (43%), Gaps = 2/98 (2%)
Query: 674 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQH 731
++F+ +++G G G V+K G V+A K + + + R + E+ ++
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRI 769
P +V YG ++ + E+M L + + RI
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI 101
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 93.3 bits (231), Expect = 2e-21
Identities = 26/108 (24%), Positives = 46/108 (42%), Gaps = 14/108 (12%)
Query: 666 YTLRQIKAATNNFDPA---------NKVGEGGFGSVYKGIL----SDGTVIAVKQL-SSK 711
+T A F +G G FG V G L +A+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 712 SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759
+ + R+F++E ++ HPN++ L G + ++++ E+M+N L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL 114
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 92.0 bits (228), Expect = 7e-21
Identities = 26/107 (24%), Positives = 49/107 (45%), Gaps = 4/107 (3%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPN 733
F ++G G FG+VY + + V+A+K++S +Q N ++ + E+ + +HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQ 780
++ GC + + LV EY + K + + I A
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHG 123
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.6 bits (227), Expect = 7e-21
Identities = 24/107 (22%), Positives = 55/107 (51%), Gaps = 7/107 (6%)
Query: 667 TLRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF 719
L ++++ + DP K+G+G G+VY + ++ G +A++Q++ + +
Sbjct: 5 ILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI 64
Query: 720 VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK 766
+NEI ++ ++PN+V + G++L +V EY+ L+ +
Sbjct: 65 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 111
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.3 bits (221), Expect = 3e-20
Identities = 27/94 (28%), Positives = 43/94 (45%), Gaps = 4/94 (4%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
+G+G FG V G G +AVK + + + + F+ E +++ +H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 736 KLYGCCVEG-NQLLLVYEYMKNNCLSRAIFGKLR 768
+L G VE L +V EYM L + + R
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 97
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.9 bits (220), Expect = 4e-20
Identities = 20/91 (21%), Positives = 42/91 (46%), Gaps = 1/91 (1%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
++G G FG+VYKG + + +++ + Q + F NE+G++ +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK 766
G QL +V ++ + + L +
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHII 97
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.0 bits (220), Expect = 4e-20
Identities = 26/103 (25%), Positives = 50/103 (48%), Gaps = 6/103 (5%)
Query: 669 RQIKAATNNFDPAN-KVGEGGFGSVYKGIL---SDGTVIAVKQLSSKSRQGNRE-FVNEI 723
+++ +N A+ ++G G FGSV +G+ +A+K L + + + E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 724 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK 766
++ +P +V+L G C + L+LV E L + + GK
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK 102
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 7e-20
Identities = 28/120 (23%), Positives = 46/120 (38%), Gaps = 8/120 (6%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNRE-FVNEIGMISA 728
N +G G FG V + +AVK L + RE ++E+ ++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 729 -QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILI 787
H N+V L G C G L++ EY L + K F S + + ++ +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 89.7 bits (222), Expect = 7e-20
Identities = 22/96 (22%), Positives = 44/96 (45%), Gaps = 1/96 (1%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
+++D ++G G FG V++ + G A K + + EI +S +HP L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIF 770
V L+ + N+++++YE+M L + +
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM 121
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 88.2 bits (218), Expect = 8e-20
Identities = 26/94 (27%), Positives = 44/94 (46%), Gaps = 2/94 (2%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
+ +K+G G +G VY+G+ +AVK L + + EF+ E ++ +HPNL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLR 768
V+L G C ++ E+M L + R
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 109
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.7 bits (217), Expect = 1e-19
Identities = 23/90 (25%), Positives = 43/90 (47%), Gaps = 1/90 (1%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
++G+G FG VYK + A K + +KS + +++ EI ++++ HPN+VKL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKLRIF 770
N L ++ E+ + + R
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPL 107
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.5 bits (216), Expect = 2e-19
Identities = 24/96 (25%), Positives = 41/96 (42%), Gaps = 2/96 (2%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
+ K+G+G FG V+ G + T +A+K L F+ E ++ +H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFH 771
+LY + +V EYM L + G+ +
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL 110
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 87.8 bits (217), Expect = 3e-19
Identities = 20/89 (22%), Positives = 43/89 (48%), Gaps = 1/89 (1%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
+ +D ++G G FG V++ + + G V K +++ NEI +++ HP L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAI 763
+ L+ + +++L+ E++ L I
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI 117
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.8 bits (214), Expect = 5e-19
Identities = 27/103 (26%), Positives = 41/103 (39%), Gaps = 8/103 (7%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNRE-FVNEIGMISA 728
N + +G G FG V +AVK L K+ RE ++E+ M++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 729 -QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIF 770
H N+V L G C + L++EY L + K F
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKF 139
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 85.9 bits (212), Expect = 7e-19
Identities = 24/103 (23%), Positives = 44/103 (42%), Gaps = 2/103 (1%)
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMI 726
+Q + + +D + +G G F V ++A+K ++ K+ +G NEI ++
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRI 769
+HPN+V L G L L+ + + L I K
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY 104
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 86.7 bits (214), Expect = 9e-19
Identities = 26/95 (27%), Positives = 41/95 (43%), Gaps = 7/95 (7%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQ- 730
N+F +G GGFG VY +D G + A+K L K +QG +NE M+S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 731 --HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI 763
P +V + ++L + + M L +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL 98
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 85.3 bits (210), Expect = 1e-18
Identities = 29/106 (27%), Positives = 51/106 (48%), Gaps = 7/106 (6%)
Query: 668 LRQIKAATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNR-EFV 720
L ++ NN + +GEG FG V++ T++AVK L ++ + +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK 766
E +++ +PN+VKL G C G + L++EYM L+ +
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSM 110
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.4 bits (208), Expect = 2e-18
Identities = 32/124 (25%), Positives = 51/124 (41%), Gaps = 8/124 (6%)
Query: 677 NFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISAQQH 731
+F+ +G G FG VY G L D AVK L+ + G +F+ E ++ H
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 732 PNLVKLYGCCVEG-NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISA 790
PN++ L G C+ L+V YMK+ L I + + F + + A
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 791 ANNI 794
+
Sbjct: 148 SKKF 151
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.5 bits (206), Expect = 3e-18
Identities = 27/96 (28%), Positives = 38/96 (39%), Gaps = 2/96 (2%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPN 733
++D +GEG +G V + +AVK + K E EI + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRI 769
+VK YG EGN L EY L I + +
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 100
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.6 bits (206), Expect = 3e-18
Identities = 22/93 (23%), Positives = 42/93 (45%), Gaps = 6/93 (6%)
Query: 682 NKVGEGGFGSVYKGILSD---GTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVK 736
++G G FG+V KG +AVK L +++ E + E ++ +P +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRI 769
+ G C E +LV E + L++ + +
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV 104
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.7 bits (204), Expect = 5e-18
Identities = 23/97 (23%), Positives = 46/97 (47%), Gaps = 5/97 (5%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPN 733
+++ +G G +G K SDG ++ K+L S + + V+E+ ++ +HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 734 LVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKLR 768
+V+ Y ++ L +V EY + L+ I +
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK 101
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 82.6 bits (203), Expect = 7e-18
Identities = 24/107 (22%), Positives = 48/107 (44%), Gaps = 2/107 (1%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPN 733
+ K+GEG +G VYK + G A+K++ + + EI ++ +H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQ 780
+VKLY +L+LV+E++ + + + ++ + Q
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ 108
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (204), Expect = 7e-18
Identities = 25/96 (26%), Positives = 42/96 (43%), Gaps = 5/96 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDG---TVIAVKQLS-SKSRQGNREFVNEIGMISA-QQ 730
N+ + +GEG FG V K + A+K++ S+ +R+F E+ ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK 766
HPN++ L G C L L EY + L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS 105
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (203), Expect = 1e-17
Identities = 23/96 (23%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLS-SKSRQGNREFVNEIGMISA 728
+ ++G+G FG VY+G+ T +A+K ++ + S + EF+NE ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF 764
++V+L G +G L++ E M L +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 115
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.0 bits (202), Expect = 1e-17
Identities = 27/111 (24%), Positives = 38/111 (34%), Gaps = 6/111 (5%)
Query: 672 KAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK---SRQGNREFVNEIGMIS 727
K +F +GEG F +V L+ A+K L + E ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKLRIFHISIYA 776
HP VKLY + +L Y KN L + I G Y
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT 114
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.3 bits (200), Expect = 1e-17
Identities = 23/102 (22%), Positives = 40/102 (39%), Gaps = 8/102 (7%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSK---SRQGNREFVNEIGMISA 728
+ K+G+G FG V +G +AVK L + +F+ E+ + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIF 770
H NL++LYG + + +V E L + F
Sbjct: 68 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHF 108
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.4 bits (200), Expect = 2e-17
Identities = 27/103 (26%), Positives = 51/103 (49%), Gaps = 6/103 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGT-----VIAVKQLSSKSRQGNR-EFVNEIGMISAQ 729
+ +G G FG VYKG+L + +A+K L + + R +F+ E G++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHI 772
H N+++L G + ++++ EYM+N L + + K F +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV 109
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (199), Expect = 3e-17
Identities = 23/85 (27%), Positives = 39/85 (45%), Gaps = 6/85 (7%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
+G+G FG V++G G +AVK SS+ + + EI +H N++
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 743 EGN----QLLLVYEYMKNNCLSRAI 763
+ N QL LV +Y ++ L +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL 92
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.6 bits (198), Expect = 7e-17
Identities = 17/101 (16%), Positives = 42/101 (41%), Gaps = 2/101 (1%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHP 732
+ + +GEG +G V + +A+K++S Q + + EI ++ +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHIS 773
N++ + + Y+ + + ++ L+ H+S
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLS 107
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 7e-17
Identities = 30/121 (24%), Positives = 56/121 (46%), Gaps = 3/121 (2%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPN 733
NF K+GEG +G VYK G V+A+K++ +++ + EI ++ HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANN 793
+VKL N+L LV+E++ + L + + ++ +Q L ++
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 794 I 794
+
Sbjct: 123 V 123
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.4 bits (195), Expect = 8e-17
Identities = 27/121 (22%), Positives = 48/121 (39%), Gaps = 14/121 (11%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQ 730
+ +GEG FG V++GI +A+K + + RE F+ E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISA 790
HP++VKL G E N + ++ E G+LR F + ++ +
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTL--------GELRSFLQVRKYSLDLASLILYAYQL 117
Query: 791 A 791
+
Sbjct: 118 S 118
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.1 bits (194), Expect = 1e-16
Identities = 24/105 (22%), Positives = 46/105 (43%), Gaps = 6/105 (5%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQG-----NREFVNEIGMISAQQHPNLV 735
+ +GEG F +VYK + ++A+K++ R NR + EI ++ HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQ 780
L + + LV+++M+ + L + I A
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM 108
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.0 bits (194), Expect = 1e-16
Identities = 21/106 (19%), Positives = 42/106 (39%), Gaps = 7/106 (6%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNR------EFVNEIGMISA 728
+ +D ++G G F V K S G A K + + + +R + E+ ++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISI 774
QHPN++ L+ ++L+ E + L + K +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 115
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.9 bits (194), Expect = 1e-16
Identities = 25/104 (24%), Positives = 48/104 (46%), Gaps = 9/104 (8%)
Query: 682 NKVGEGGFGSVYKGILSD-GTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLY 738
++G G F +VYKG+ ++ +A +L + ++ + F E M+ QHPN+V+ Y
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 739 GCCVE----GNQLLLVYEYMKNNCLSRAI--FGKLRIFHISIYA 776
++LV E M + L + F ++I + +
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWC 118
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 79.0 bits (194), Expect = 2e-16
Identities = 19/90 (21%), Positives = 40/90 (44%), Gaps = 4/90 (4%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 731
+F +G G FG V+ +G A+K L + + +E M+S H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSR 761
P +++++G + Q+ ++ +Y++ L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFS 93
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.9 bits (191), Expect = 4e-16
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 668 LRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTV----IAVKQLS-SKSRQGNREFVN 721
LR +K F +G G FG+VYKG+ + +G +A+K+L + S + N+E ++
Sbjct: 3 LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60
Query: 722 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759
E ++++ +P++ +L G C+ + L+ + M CL
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCL 97
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.8 bits (190), Expect = 4e-16
Identities = 39/189 (20%), Positives = 69/189 (36%), Gaps = 5/189 (2%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
+P D+ + L L +N T + L NL+ L + +N S P K+
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGE 297
++L++ + L+ L L K +S F L++M + L G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141
Query: 298 IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV 357
M KL I ++ N+T L + ++L GNK+T + N
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTE---LHLDGNKITKVDAASLKGLNNLA 198
Query: 358 DISLNNFTW 366
+ L+ +
Sbjct: 199 KLGLSFNSI 207
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 74.3 bits (181), Expect = 5e-15
Identities = 52/293 (17%), Positives = 101/293 (34%), Gaps = 28/293 (9%)
Query: 85 CDCSSATCH----------------VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCL 128
C C + L+ +T + L+ L L L N +
Sbjct: 8 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 129 TGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLI 187
+ +A L +L L + N+L K+ + L+ E S+ + ++I
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 188 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL 247
++ L + +G + L+ +RI+D N + IP+ G + +LH+ G+ +
Sbjct: 128 VVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKI 183
Query: 248 EGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTK 307
AS+ L +L L +S S L + ++P + D
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKY 243
Query: 308 LKNIDLSFNNLTGGIPTTF------EKLAKTNFMYLTGNKLT-GPVPKYIFNS 353
++ + L NN++ F K A + + L N + + F
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 296
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 72.4 bits (176), Expect = 2e-14
Identities = 43/247 (17%), Positives = 88/247 (35%), Gaps = 15/247 (6%)
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 152
++ T+ L ++ P + L L++L LS+N L P+ L EL V N ++
Sbjct: 56 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKEL--PEKMPKTLQELRVHENEIT 113
Query: 153 GPFPKVLTNIT--TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKL 210
V + + L +G + + L + ++ + T +P L
Sbjct: 114 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--P 170
Query: 211 TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK 270
+L +L + N + + + KL + +S+ S++ L +L +++ K
Sbjct: 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230
Query: 271 GSESAFPKLDKMNLKTLILTKCLIHG------EIPDYIGDMTKLKNIDLSFNNLTGG--I 322
+ D ++ + L I P Y + L N +
Sbjct: 231 LVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 290
Query: 323 PTTFEKL 329
P+TF +
Sbjct: 291 PSTFRCV 297
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 77.1 bits (189), Expect = 5e-16
Identities = 21/97 (21%), Positives = 36/97 (37%), Gaps = 8/97 (8%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS---SKSRQGNREFVNEIGMISAQQ 730
++ ++ +G GG V+ L +AVK L ++ F E +A
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 731 HPNLVKLYGCCVE----GNQLLLVYEYMKNNCLSRAI 763
HP +V +Y G +V EY+ L +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV 102
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.8 bits (188), Expect = 8e-16
Identities = 23/101 (22%), Positives = 43/101 (42%), Gaps = 10/101 (9%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL--------SDGTVIAVKQLSSKSRQGN-REFVNEIGMI 726
+ +GEG FG V + T +AVK L S + + + + ++E+ M+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 727 SA-QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK 766
+H N++ L G C + L ++ EY L + +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR 113
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.8 bits (186), Expect = 9e-16
Identities = 24/107 (22%), Positives = 46/107 (42%), Gaps = 6/107 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 731
+F+ +G+G FG+VY ++A+K L + E+ + S +H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKLRIFHISIYA 776
PN+++LYG + ++ L+ EY + R + K + Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 112
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.1 bits (184), Expect = 4e-15
Identities = 16/82 (19%), Positives = 36/82 (43%), Gaps = 2/82 (2%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
+G G FG V++ + S K + K EI +++ +H N++ L+
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 742 VEGNQLLLVYEYMKNNCLSRAI 763
+L++++E++ + I
Sbjct: 71 ESMEELVMIFEFISGLDIFERI 92
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 75.8 bits (185), Expect = 4e-15
Identities = 39/195 (20%), Positives = 73/195 (37%), Gaps = 13/195 (6%)
Query: 168 LSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKI 227
L N + P I NL +L L+ N L LTNL DL +++N S
Sbjct: 202 LIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA 257
Query: 228 PEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTL 287
P + K+ +L + + + P + + +L + E P + NL L
Sbjct: 258 P--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQ---LEDISPISNLKNLTYL 312
Query: 288 ILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 347
L I P + +TKL+ + + N ++ ++ L N++ N+++ P
Sbjct: 313 TLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368
Query: 348 KYIFNSNKNVDISLN 362
+ ++
Sbjct: 369 LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.0 bits (175), Expect = 6e-14
Identities = 44/177 (24%), Positives = 73/177 (41%), Gaps = 13/177 (7%)
Query: 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRL 151
++ ++L L L+ L L LDL+ N ++ +P +L EL + N++
Sbjct: 219 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQI 275
Query: 152 SGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLT 211
S P L +T L NL + N I L NL L L N+ + P ++ LT
Sbjct: 276 SNISP--LAGLTALTNLELNENQLE--DISPISNLKNLTYLTLYFNNISDISP--VSSLT 329
Query: 212 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
L L ++N S + I L + + P ++ LT +T L ++D
Sbjct: 330 KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 70.4 bits (171), Expect = 2e-13
Identities = 39/198 (19%), Positives = 70/198 (35%), Gaps = 15/198 (7%)
Query: 143 ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGE 202
L N++S P +T L LS+ GN + L NL L L++N +
Sbjct: 201 SLIATNNQISDITPL--GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNL 256
Query: 203 LPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT 262
P L+ LT L +L++ N S I G + + +++ LT L
Sbjct: 257 AP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDISPISNLKNLTYL- 312
Query: 263 DLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 322
L +++ S L L+ L + + ++T + + N ++
Sbjct: 313 TLYFNNISDI-SPVSSLT--KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT 367
Query: 323 PTTFEKLAKTNFMYLTGN 340
P L + + L
Sbjct: 368 P--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 2e-05
Identities = 20/90 (22%), Positives = 38/90 (42%), Gaps = 7/90 (7%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVE 143
S ++ + L N++ P +S L L++L + N ++ A+L +
Sbjct: 300 ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINW 355
Query: 144 LSVMGNRLSGPFPKVLTNITTLKNLSIEGN 173
LS N++S P L N+T + L +
Sbjct: 356 LSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 6e-05
Identities = 38/157 (24%), Positives = 68/157 (43%), Gaps = 9/157 (5%)
Query: 209 KLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
KLTNL L ++N S P I + +L + G+ L+ ++++LT+LTDL +++
Sbjct: 195 KLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLAN 250
Query: 269 LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328
+ S A P L L L I P + +T L N++L+ N L +
Sbjct: 251 NQISNLA-PLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE--DISPISN 305
Query: 329 LAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
L ++ L N ++ P + + + N +
Sbjct: 306 LKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVS 342
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.0 bits (181), Expect = 9e-15
Identities = 20/99 (20%), Positives = 35/99 (35%), Gaps = 5/99 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQ-Q 730
+F +G+G FG V+ A+K L + + + E ++S +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRI 769
HP L ++ L V EY+ L I +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF 100
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.7 bits (180), Expect = 1e-14
Identities = 21/124 (16%), Positives = 42/124 (33%), Gaps = 13/124 (10%)
Query: 666 YTLRQIKAAT----NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL--SSKSRQGNRE 718
+ +++ + VG G +G+V + G +A+K+L +S +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 719 FVNEIGMISAQQHPNLVKLYGCCVEGNQL------LLVYEYMKNNCLSRAIFGKLRIFHI 772
E+ ++ +H N++ L L LV +M + KL I
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 773 SIYA 776
Sbjct: 124 QFLV 127
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.7 bits (180), Expect = 1e-14
Identities = 24/127 (18%), Positives = 51/127 (40%), Gaps = 17/127 (13%)
Query: 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
++ +G G FG VY+ L G ++A+K++ R NRE + ++ H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76
Query: 736 KLYGCCVEGNQ------LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIIS 789
+L + L LV +Y+ ++ + T P +++ +
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVY------RVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 790 AANNIDF 796
++ +
Sbjct: 131 LFRSLAY 137
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.8 bits (175), Expect = 3e-14
Identities = 25/104 (24%), Positives = 44/104 (42%), Gaps = 9/104 (8%)
Query: 676 NNFDPANKVGEGGFGSVYKGI------LSDGTVIAVKQLSSKSRQG-NREFVNEIGMISA 728
+ +G G FG V + + +AVK L + +R ++E+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 729 QQH-PNLVKLYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKLRIF 770
H N+V L G C + G L+++ E+ K LS + K F
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 116
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 70.1 bits (171), Expect = 1e-13
Identities = 20/104 (19%), Positives = 40/104 (38%), Gaps = 11/104 (10%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS---------SKSRQGNREFVNEIGMI 726
N++P +G G V + I AVK + + ++ + E+ ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 727 SA-QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRI 769
HPN+++L LV++ MK L + K+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 107
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.3 bits (171), Expect = 1e-13
Identities = 21/130 (16%), Positives = 49/130 (37%), Gaps = 10/130 (7%)
Query: 674 ATNNFDPANKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGNRE-----FVNEIGMI 726
A ++ ++GEG +G V+K + + G +A+K++ ++ + V + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQIL 786
+HPN+V+L+ C + + + P I+ +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTETIKDM 121
Query: 787 IISAANNIDF 796
+ +DF
Sbjct: 122 MFQLLRGLDF 131
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 69.9 bits (170), Expect = 1e-13
Identities = 21/107 (19%), Positives = 41/107 (38%), Gaps = 4/107 (3%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
N + K+G G FG +Y G ++ G +A+K K++ + E + Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 735 VKLYG-CCVEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQ 780
+ C EG+ ++V E + + F + ++ Q
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQ 111
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.2 bits (171), Expect = 1e-13
Identities = 23/92 (25%), Positives = 37/92 (40%), Gaps = 4/92 (4%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 731
N+FD +G+G FG V + G A+K L + ++ V E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI 763
P L L ++L V EY L +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL 96
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.3 bits (171), Expect = 2e-13
Identities = 25/110 (22%), Positives = 42/110 (38%), Gaps = 9/110 (8%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQH 731
+ + VG G +GSV G +AVK+LS +S + E+ ++ +H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 732 PNLVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIY 775
N++ L E N + LV M + + KL H+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.5 bits (169), Expect = 3e-13
Identities = 19/107 (17%), Positives = 46/107 (42%), Gaps = 11/107 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHP 732
+ ++ K+G+G FG V+K G +A+K++ ++ + + EI ++ +H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 733 NLVKLYGCCVEG--------NQLLLVYEYMKNNCLSRAIFGKLRIFH 771
N+V L C + LV+++ +++ ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL 116
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 69.5 bits (169), Expect = 3e-13
Identities = 20/105 (19%), Positives = 47/105 (44%), Gaps = 8/105 (7%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPN 733
+++ K+G G + V++ I +++ + VK L ++ + EI + + + PN
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91
Query: 734 LVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYA 776
++ L + LV+E++ N + ++ L + I Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIRFYM 135
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.8 bits (165), Expect = 5e-13
Identities = 19/97 (19%), Positives = 35/97 (36%), Gaps = 9/97 (9%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE------FVNEIGMISA--QQHPN 733
+G GGFGSVY GI +SD +A+K + E E+ ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKLRIF 770
+++L + +L+ E + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL 107
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.1 bits (165), Expect = 6e-13
Identities = 19/87 (21%), Positives = 41/87 (47%), Gaps = 3/87 (3%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHP 732
++ K+GEG +G+V+K ++A+K++ + EI ++ +H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCL 759
N+V+L+ +L LV+E+ +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLK 88
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.9 bits (162), Expect = 2e-12
Identities = 18/95 (18%), Positives = 33/95 (34%), Gaps = 9/95 (9%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQHP 732
+ +G G G V +A+K+LS +++ + E+ ++ H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 733 NLVKLYGCCV------EGNQLLLVYEYMKNNCLSR 761
N++ L E + LV E M N
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV 111
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 66.4 bits (161), Expect = 3e-12
Identities = 27/107 (25%), Positives = 43/107 (40%), Gaps = 6/107 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQH 731
+ FD +G G FG V G A+K L + ++ +NE ++ A
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKLRIFHISIYA 776
P LVKL + + L +V EY+ + + G+ H YA
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYA 147
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 64.8 bits (157), Expect = 7e-12
Identities = 16/87 (18%), Positives = 35/87 (40%), Gaps = 4/87 (4%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMIS-AQQHPN 733
++ ++GEG FG +++G L + +A+K +S + +E
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLS 760
+ +Y EG +LV + + +
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLED 89
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.1 bits (155), Expect = 1e-11
Identities = 26/140 (18%), Positives = 49/140 (35%), Gaps = 14/140 (10%)
Query: 650 VSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGIL----SDGTVIAV 705
++ ELR +L T K NF+ +G G +G V+ G + A+
Sbjct: 3 LTVKHELRTANL-----TGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAM 57
Query: 706 KQLS----SKSRQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQLLLVYEYMKNNCLS 760
K L + + E ++ + P LV L+ +L L+ +Y+ L
Sbjct: 58 KVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF 117
Query: 761 RAIFGKLRIFHISIYATFPQ 780
+ + R + +
Sbjct: 118 THLSQRERFTEHEVQIYVGE 137
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.3 bits (156), Expect = 1e-11
Identities = 20/85 (23%), Positives = 31/85 (36%), Gaps = 9/85 (10%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC- 741
+G G G V + A+K L + RE E+ A Q P++V++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-QDCPKARREV--EL-HWRASQCPHIVRIVDVYE 75
Query: 742 ---VEGNQLLLVYEYMKNNCLSRAI 763
LL+V E + L I
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRI 100
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.1 bits (149), Expect = 5e-11
Identities = 30/177 (16%), Positives = 58/177 (32%), Gaps = 4/177 (2%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
++P I Q++ L N + A NL L + N + +
Sbjct: 25 AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 238 QKLHIQGSSLEGPI-PASISALTSLTDLRISDLKGSESAFP-KLDKMNLKTLILTKCLIH 295
++L + ++ + PA+ L L L + E L+ L L +
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 296 GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN 352
D D+ L ++ L N ++ F L + + L N++ P +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.0 bits (146), Expect = 1e-10
Identities = 32/285 (11%), Positives = 82/285 (28%), Gaps = 12/285 (4%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVEL 144
C C + VT + Q L +P + +++ L N ++ + + + + + +
Sbjct: 6 CVCYNEP--KVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTI 60
Query: 145 SV--MGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGE 202
+ + P L L L L
Sbjct: 61 LWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL 120
Query: 203 LPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT 262
P L L L + DN + + L + G+ + + L SL
Sbjct: 121 GPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD 180
Query: 263 DLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEI-PDYIGDMTKLKNIDLSFNNLTGG 321
L + + + + + + + + + L+ + L+ N
Sbjct: 181 RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240
Query: 322 IPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV-DISLNNFT 365
A + +++ +P+ + + +++ ++ N+
Sbjct: 241 CRAR-PLWAWLQKFRGSSSEVPCSLPQRL--AGRDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.7 bits (140), Expect = 7e-10
Identities = 42/254 (16%), Positives = 66/254 (25%), Gaps = 28/254 (11%)
Query: 68 NWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNC 127
N + + L P L L L L R
Sbjct: 57 NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116
Query: 128 LTGSF-SPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKL 186
L L L + N L ++ L +L + GN + R L
Sbjct: 117 LQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176
Query: 187 INLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSS 246
+L +L+L N P L L L + NN S E + + +Q L + +
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236
Query: 247 LEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMT 306
D R L L+ + + +P +
Sbjct: 237 WVC-------------DCRARPLWA-----------WLQKFRGSSSEVPCSLPQRLAGRD 272
Query: 307 KLKNIDLSFNNLTG 320
L+ N+L G
Sbjct: 273 LK---RLAANDLQG 283
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.3 bits (142), Expect = 4e-10
Identities = 30/257 (11%), Positives = 83/257 (32%), Gaps = 14/257 (5%)
Query: 121 LDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIP 180
LDL+ L + + S ++ + + P + + ++++ + ++ S
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEVSTL 63
Query: 181 PDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE---------- 229
I + LQ L L + + L K +NL L +S + +
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123
Query: 230 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLIL 289
+ + + +L+ R + K S + + +
Sbjct: 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 183
Query: 290 TKCLIHGEIPDYIGDMTKLKNIDLSF-NNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK 348
++ + + L+++ LS ++ ++ + + G G +
Sbjct: 184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL 243
Query: 349 YIFNSNKNVDISLNNFT 365
+ + ++ I+ ++FT
Sbjct: 244 -LKEALPHLQINCSHFT 259
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 8e-06
Identities = 38/258 (14%), Positives = 72/258 (27%), Gaps = 24/258 (9%)
Query: 101 AQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL--QLVELSVMGNRLSGPFPKV 158
++ E ++ +DLS + + S S +L LS+ G RLS P
Sbjct: 31 PRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT 90
Query: 159 LTNITTLKNLSIE--GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDL 216
L + L L++ ++ + L + L+ D
Sbjct: 91 LAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE----------------LNLSWCFDF 134
Query: 217 RISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAF 276
+ + + DL S + ++
Sbjct: 135 TEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ 194
Query: 277 PKLDKMNLKTLILTKC-LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335
L+ L L++C I E +G++ LK + + G + E L
Sbjct: 195 EFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ-- 252
Query: 336 YLTGNKLTGPVPKYIFNS 353
+ + T I N
Sbjct: 253 -INCSHFTTIARPTIGNK 269
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 55.9 bits (134), Expect = 2e-09
Identities = 14/91 (15%), Positives = 23/91 (25%), Gaps = 14/91 (15%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR----------QGNREFVNEIGMISAQQH 731
+GEG +V+ VK G+ F + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 732 PNLVKLYGCCV----EGNQLLLVYEYMKNNC 758
L KL G V ++ E +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKE 96
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 56.2 bits (134), Expect = 7e-09
Identities = 14/79 (17%), Positives = 31/79 (39%), Gaps = 3/79 (3%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+G G F +V+ + + T +A+K + + +EI ++ + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 742 VEG-NQLLLVYEYMKNNCL 759
+LL + + N +
Sbjct: 79 ANHILKLLDHFNHKGPNGV 97
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.1 bits (118), Expect = 4e-07
Identities = 39/207 (18%), Positives = 68/207 (32%), Gaps = 6/207 (2%)
Query: 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219
+ + + ++ + T ++PPD+ K + L LS N A L T L L +
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL 279
+ G + L + + L+ + + S
Sbjct: 64 --RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 280 DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG 339
L+ L L + P + KL+ + L+ NNLT L + + L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 340 NKLTGPVPKYIFNSNKNVDISLNNFTW 366
N L +PK F S+ L+ W
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.6 bits (109), Expect = 5e-06
Identities = 48/240 (20%), Positives = 73/240 (30%), Gaps = 36/240 (15%)
Query: 82 NVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-Q 140
+ C+ S H+ + +NLT LP +L K L LS N L +
Sbjct: 1 HPICEVSKVASHL-EVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTR 56
Query: 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSI--EGNLFTGSIPPDIRKLINLQKLILSSNS 198
L +L L L TL L + S+P + L L L +S N
Sbjct: 57 LTQL-----NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNR 111
Query: 199 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 258
T L L L +L + N P + K++KL + ++L ++ L
Sbjct: 112 LTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL 171
Query: 259 TSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNL 318
+L L + + IP L L N
Sbjct: 172 ENLDTLLLQENSLY------------------------TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 5e-07
Identities = 24/113 (21%), Positives = 35/113 (30%), Gaps = 4/113 (3%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 166
T+ L +L + LDLS N L A L L N L
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQEL 70
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGE--LPAELTK-LTNLNDL 216
L L + + L L L NS E + L + L +++ +
Sbjct: 71 LLC-NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.9 bits (103), Expect = 6e-06
Identities = 22/117 (18%), Positives = 37/117 (31%), Gaps = 8/117 (6%)
Query: 119 KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE-GNLFTG 177
+ L L+ LT L + L + NRL P + L+ L + +
Sbjct: 1 RVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNAL 55
Query: 178 SIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSGKIPEFIGK 233
+ L LQ+L+L +N L L L + N+ +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQER 111
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.8 bits (87), Expect = 0.001
Identities = 17/131 (12%), Positives = 35/131 (26%), Gaps = 27/131 (20%)
Query: 190 QKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249
+ L L+ T L +L + L +S N P ++
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALR------CLEVLQASD 52
Query: 250 PIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLK 309
++ + +L L+ L + L + +L
Sbjct: 53 NALENVDGVANLPRLQELLLCNN-------------------RLQQSAAIQPLVSCPRLV 93
Query: 310 NIDLSFNNLTG 320
++L N+L
Sbjct: 94 LLNLQGNSLCQ 104
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 1e-06
Identities = 14/85 (16%), Positives = 33/85 (38%), Gaps = 9/85 (10%)
Query: 161 NITTLKNLSIEGNLFTG----SIPPDIRKLINLQKLILSSNSFTGELPAELTK-----LT 211
+ L+ L + + S+ + +L++L LS+N +L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 212 NLNDLRISDNNFSGKIPEFIGKWKK 236
L L + D +S ++ + + +K
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 2e-06
Identities = 14/90 (15%), Positives = 31/90 (34%), Gaps = 5/90 (5%)
Query: 165 LKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGE----LPAELTKLTNLNDLRIS 219
+++L I+ + + ++ L Q + L T + + L L +L +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249
N + + + IQ SL+
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 1e-05
Identities = 15/89 (16%), Positives = 32/89 (35%), Gaps = 10/89 (11%)
Query: 140 QLVELSVMGNRLSG----PFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLI-----NLQ 190
L L + +S L +L+ L + N + + + + L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 191 KLILSSNSFTGELPAELTKL-TNLNDLRI 218
+L+L ++ E+ L L + LR+
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEKDKPSLRV 458
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 12/92 (13%), Positives = 31/92 (33%), Gaps = 10/92 (10%)
Query: 187 INLQKLILSSNSFTGELPAELTK-LTNLNDLRISDNNFSGK----IPEFIGKWKKIQKLH 241
+++Q L + + AEL L +R+ D + I + + +L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 242 IQGSSLEGPIPASISAL-----TSLTDLRISD 268
++ + L + + L + +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 8e-05
Identities = 17/167 (10%), Positives = 40/167 (23%), Gaps = 6/167 (3%)
Query: 260 SLTDLRISDLKGSESAFPKLDKM--NLKTLILTKCLIHGE----IPDYIGDMTKLKNIDL 313
+ L I + S++ + +L + + + L C + I + L ++L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 314 SFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIE 373
N L + +T + L + + E
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122
Query: 374 CPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINC 420
+ + + L +A + L
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKP 169
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.1 bits (115), Expect = 1e-06
Identities = 18/96 (18%), Positives = 34/96 (35%), Gaps = 12/96 (12%)
Query: 147 MGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE 206
N S + +L+ L++ N +P L++LI S N E+P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPEL 322
Query: 207 LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHI 242
L L+ + N + P+ ++ L +
Sbjct: 323 PQNLKQLH---VEYNPLR-EFPDIPE---SVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 2e-05
Identities = 21/135 (15%), Positives = 44/135 (32%), Gaps = 8/135 (5%)
Query: 56 WNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKL 115
+ +L + +V+ + S + + + +
Sbjct: 224 PSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLP 283
Query: 116 RYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLF 175
L++L++S N L L+ + S N L+ P++ N LK L +E N
Sbjct: 284 PSLEELNVSNNKLI-ELPALPPRLERLIAS--FNHLAE-VPELPQN---LKQLHVEYNPL 336
Query: 176 TGSIPPDIRKLINLQ 190
P + +L+
Sbjct: 337 R-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.002
Identities = 13/65 (20%), Positives = 25/65 (38%), Gaps = 5/65 (7%)
Query: 188 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL 247
+L L++ + LP L +L S N+ + ++PE K + + +L
Sbjct: 39 QAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
Query: 248 EGPIP 252
P
Sbjct: 94 SDLPP 98
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 0.001
Identities = 13/92 (14%), Positives = 36/92 (39%), Gaps = 8/92 (8%)
Query: 164 TLKNLSIEGNLFTG----SIPPDIRKLINLQKLILSSNSFTGE----LPAELTKLTNLND 215
+++ S++ + T S+ + + ++++++LS N+ E L + +L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 216 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL 247
SD E + + + ++ L
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 0.001
Identities = 30/152 (19%), Positives = 56/152 (36%), Gaps = 5/152 (3%)
Query: 108 LPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKN 167
L +SK Q L L P + + + + ++ + NI L +
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLS 69
Query: 168 LSIEGNLFTG--SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG 225
L++ N + ++K NL+ L LS N E + K L +L + N+ S
Sbjct: 70 LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129
Query: 226 KIPEFIGKWKKIQKLHIQGSSLEG-PIPASIS 256
+ I++ + L+G +P I+
Sbjct: 130 TFRDQSTYISAIRERFPKLLRLDGHELPPPIA 161
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 32/203 (15%), Positives = 68/203 (33%), Gaps = 23/203 (11%)
Query: 156 PKVLTNITTLKNLS--IEGNLFTGSI--PPDIRKLINLQKLILSSNSFTGELPAELTKLT 211
P + I + + I+ NL S+ +L ++ ++I +++ + L
Sbjct: 11 PTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG--IQYLP 68
Query: 212 NLNDLRISDNNFSGKIP---------------EFIGKWKKIQKLHIQGSSLEGPIPASIS 256
N+ L ++ N + P + ++ SLE + I+
Sbjct: 69 NVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDIN 128
Query: 257 ALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN 316
L L L L ++ + K L+ + +TKL+N+ LS N
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKN 188
Query: 317 NLTGGIPTTFEKLAKTNFMYLTG 339
+++ L + + L
Sbjct: 189 HISD--LRALAGLKNLDVLELFS 209
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 799 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.89 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.89 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.87 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.86 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.84 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.79 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.78 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.78 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.78 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.78 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.78 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.77 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.77 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.77 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.77 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.77 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.76 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.76 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.76 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.75 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.75 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.75 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.75 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.75 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.75 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.75 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.74 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.74 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.73 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.73 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.72 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.71 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.71 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.71 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.7 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.7 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.69 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.69 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.69 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.69 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.69 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.68 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.68 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.68 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.68 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.67 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.67 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.67 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.67 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.67 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.67 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.66 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.66 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.66 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.66 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.65 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.63 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.63 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.63 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.62 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.62 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.6 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.59 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.59 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.58 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.58 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.58 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.57 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.57 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.57 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.57 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.55 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.54 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.51 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.5 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.48 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.46 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.45 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.44 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.42 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.42 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.41 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.37 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.37 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.29 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.17 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.14 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.12 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.09 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.08 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 98.95 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.18 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.15 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.34 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.16 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.24 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.22 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.12 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 90.09 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.2e-40 Score=356.49 Aligned_cols=291 Identities=28% Similarity=0.462 Sum_probs=224.5
Q ss_pred CCCHHHHHHHHHHHHhcCC----CCCCCCCCCCCCCCCCcccCCCCCCCCCCeEecCCCCcccEEEEEeCCCCCcc--cC
Q 003737 35 KLHAEEVKALKQIGRKLGK----KDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTG--TL 108 (799)
Q Consensus 35 ~~~~~~~~aL~~~~~~~~~----~~W~~~~d~C~~~~~W~~~~~~~~~~~~gv~c~~~~~~~~v~~L~L~~~~l~g--~~ 108 (799)
-|.++|++||++||+++.+ ++|..++|||. +.| .||+|+..+...||++|+|++++++| .+
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~--~~w-----------~gv~C~~~~~~~~v~~L~L~~~~l~g~~~l 68 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN--RTW-----------LGVLCDTDTQTYRVNNLDLSGLNLPKPYPI 68 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTT--TCS-----------TTEEECCSSSCCCEEEEEEECCCCSSCEEC
T ss_pred CCCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCC--CcC-----------CCeEEeCCCCcEEEEEEECCCCCCCCCCCC
Confidence 3899999999999999975 78998899993 248 79999976666799999999999998 58
Q ss_pred CccccCCCCCCEEEccC-CcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCC
Q 003737 109 PTELSKLRYLKQLDLSR-NCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKL 186 (799)
Q Consensus 109 p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l 186 (799)
|+++++|++|++|+|++ |++.|.+|..++.++ |++|+|++|++.+..|..+..+.+|+++++++|.+.+.+|..+.++
T Consensus 69 p~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l 148 (313)
T d1ogqa_ 69 PSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148 (313)
T ss_dssp CGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGC
T ss_pred ChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccC
Confidence 99999999999999997 899999999999887 9999999999999899999999999999999999988999999999
Q ss_pred CCCCEEEcccCcCCccCChhccCCCCC-CEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEE
Q 003737 187 INLQKLILSSNSFTGELPAELTKLTNL-NDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLR 265 (799)
Q Consensus 187 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 265 (799)
++|+++++++|.+++.+|..+..+.++ +.+++++|++++..|..+..+..+ .++++.+.+.+.+|..+..+++|+.|+
T Consensus 149 ~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~ 227 (313)
T d1ogqa_ 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIH 227 (313)
T ss_dssp TTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEE
T ss_pred cccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccc
Confidence 999999999999999999988888776 889999999998888888877654 688998888888888887777777776
Q ss_pred cCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCc
Q 003737 266 ISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 341 (799)
Q Consensus 266 L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 341 (799)
++++.. .+.++.+.. .+|+.|+|++|+++|.+|+.++++++|++|+|++|+|+|.+|. ++++++|+.+++++|+
T Consensus 228 ~~~~~l-~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 228 LAKNSL-AFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp CCSSEE-CCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred cccccc-cccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 665332 223333333 3444444444444444444444444444444444444444442 3344444444444443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=1.3e-29 Score=270.19 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=216.1
Q ss_pred CCCCEEEccCCcCCCc--Ccccccccc-eeEEEccC-CcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCE
Q 003737 116 RYLKQLDLSRNCLTGS--FSPQWASLQ-LVELSVMG-NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191 (799)
Q Consensus 116 ~~L~~L~Ls~N~l~~~--~p~~~~~l~-L~~L~Ls~-N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 191 (799)
.+++.|||++|.+.+. +|..++.++ |++|+|++ |+++|.+|..|++|++|++|+|++|++.+..+..+..+.+|++
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 4688999999999984 788999998 99999986 8999999999999999999999999999988889999999999
Q ss_pred EEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCC-CEEEccCCCCCCCCchhhhcCCCCCeEEcCCCC
Q 003737 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI-QKLHIQGSSLEGPIPASISALTSLTDLRISDLK 270 (799)
Q Consensus 192 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~ 270 (799)
+++++|.+.+.+|..+.++++|+++++++|.+.+.+|+.+..+.++ +.+++++|++++..|..+..+..+ .+++..+.
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~ 208 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSE
T ss_pred cccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 9999999999999999999999999999999999999999988876 889999999999999998887655 68888743
Q ss_pred CCCCCCCc-cCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCCh
Q 003737 271 GSESAFPK-LDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK 348 (799)
Q Consensus 271 ~~~~~~~~-l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~ 348 (799)
..+.+|. +.. .+++.+++++|.+++.+| .++.+++|+.|+|++|+++|.+|..|+++++|++|+|++|+|+|.+|.
T Consensus 209 -~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~ 286 (313)
T d1ogqa_ 209 -LEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp -EEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred -cccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC
Confidence 3444554 333 789999999999987765 578889999999999999999999999999999999999999999986
Q ss_pred hh-hcCCCEEEeecCc-Cccc
Q 003737 349 YI-FNSNKNVDISLNN-FTWE 367 (799)
Q Consensus 349 ~~-~~~l~~l~ls~N~-~~g~ 367 (799)
.. ...++.+++++|+ ++|.
T Consensus 287 ~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 287 GGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp STTGGGSCGGGTCSSSEEEST
T ss_pred cccCCCCCHHHhCCCccccCC
Confidence 42 3567788899987 4553
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=4e-24 Score=226.30 Aligned_cols=267 Identities=21% Similarity=0.302 Sum_probs=221.8
Q ss_pred cEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEee
Q 003737 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (799)
Q Consensus 93 ~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls 171 (799)
+.+.++.++.+++ .+|..+. +++++|+|++|+++...+..|..+. |++|++++|.+....|..|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 3456788888888 6787764 6899999999999988888898887 9999999999998889999999999999999
Q ss_pred CCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCC--CcCCccccCCCCCCEEEccCCCCCC
Q 003737 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS--GKIPEFIGKWKKIQKLHIQGSSLEG 249 (799)
Q Consensus 172 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~ 249 (799)
+|+++ .+|..+ ...|+.|++++|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++++|.++.
T Consensus 88 ~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~ 164 (305)
T d1xkua_ 88 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 164 (305)
T ss_dssp SSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc
Confidence 99998 566543 468999999999999777777888889999999888643 3446678889999999999999874
Q ss_pred CCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhc
Q 003737 250 PIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328 (799)
Q Consensus 250 ~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 328 (799)
+|..+ +++|+.|++++|.........+.. ..++.|++++|.+++..+..+..+++|++|+|++|+|+ .+|..|..
T Consensus 165 -l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~ 240 (305)
T d1xkua_ 165 -IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 240 (305)
T ss_dssp -CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred -cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cccccccc
Confidence 44433 678999999986665554445665 78999999999999988999999999999999999999 67889999
Q ss_pred cCCCCEEeccCCcCCCcCChhhh---------cCCCEEEeecCcCc-ccCCC
Q 003737 329 LAKTNFMYLTGNKLTGPVPKYIF---------NSNKNVDISLNNFT-WESSD 370 (799)
Q Consensus 329 l~~L~~L~L~~N~l~g~~p~~~~---------~~l~~l~ls~N~~~-g~~p~ 370 (799)
+++|++|+|++|+|+ .++...+ ..++.++|++|.+. +.+++
T Consensus 241 l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~ 291 (305)
T d1xkua_ 241 HKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 291 (305)
T ss_dssp CSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCG
T ss_pred ccCCCEEECCCCccC-ccChhhccCcchhcccCCCCEEECCCCcCccCcCCH
Confidence 999999999999999 4554322 34689999999885 44443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=2e-24 Score=226.27 Aligned_cols=249 Identities=17% Similarity=0.194 Sum_probs=195.3
Q ss_pred EEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEee-CC
Q 003737 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIE-GN 173 (799)
Q Consensus 96 ~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls-~N 173 (799)
.+++++.+++ ++|..+. +.+++|+|++|+|+...+..|..++ |++|++++|++....+..+.+++.++.++.. .|
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 3466777777 6776654 6789999999999988888888887 9999999999988888888888888888765 55
Q ss_pred cCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCch
Q 003737 174 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA 253 (799)
Q Consensus 174 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 253 (799)
.++...|..|.++++|++|++++|.+....+..+..+++|+.+++++|++++..+..|..+++|++|++++|++++..+.
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 66666677888889999999999988876777788888899999999988877777888888888888888888876666
Q ss_pred hhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCC
Q 003737 254 SISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN 333 (799)
Q Consensus 254 ~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 333 (799)
.|.++++|+ .+++++|++++..|..|..+++|++||+++|++++..|..|..+++|+
T Consensus 172 ~f~~l~~L~-----------------------~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~ 228 (284)
T d1ozna_ 172 AFRGLHSLD-----------------------RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228 (284)
T ss_dssp TTTTCTTCC-----------------------EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCC
T ss_pred hhccccccc-----------------------hhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccC
Confidence 666666554 455666777778888999999999999999999988888999999999
Q ss_pred EEeccCCcCCCcCCh-hhhcCCCEEEeecCcCcccCCC
Q 003737 334 FMYLTGNKLTGPVPK-YIFNSNKNVDISLNNFTWESSD 370 (799)
Q Consensus 334 ~L~L~~N~l~g~~p~-~~~~~l~~l~ls~N~~~g~~p~ 370 (799)
.|++++|++...-+. .+...++.+....+.+....|.
T Consensus 229 ~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p~ 266 (284)
T d1ozna_ 229 YLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQ 266 (284)
T ss_dssp EEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESG
T ss_pred EEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCCch
Confidence 999999999865442 2223344444445555444443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.89 E-value=2.8e-22 Score=211.98 Aligned_cols=257 Identities=21% Similarity=0.252 Sum_probs=215.9
Q ss_pred cccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEE
Q 003737 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 169 (799)
+..++.|+|++|+++...+..|.++++|++|++++|.+....|..|..++ |++|++++|+++. +|..+ ...|+.|+
T Consensus 30 ~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~ 106 (305)
T d1xkua_ 30 PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELR 106 (305)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEEE
T ss_pred CCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCc-Cccch--hhhhhhhh
Confidence 35799999999999966666899999999999999999999899999987 9999999999984 55443 46899999
Q ss_pred eeCCcCCCCCCccccCCCCCCEEEcccCcCC--ccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCC
Q 003737 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFT--GELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL 247 (799)
Q Consensus 170 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 247 (799)
+++|.+.+..+..+.....++.++...|... ...+..+..+++|+.+++++|.+. .+|..+ +++|++|++++|..
T Consensus 107 ~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~ 183 (305)
T d1xkua_ 107 VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKI 183 (305)
T ss_dssp CCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCC
T ss_pred ccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcC
Confidence 9999998766667888889999999988644 345667889999999999999998 455543 68999999999999
Q ss_pred CCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhh
Q 003737 248 EGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTF 326 (799)
Q Consensus 248 ~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 326 (799)
++..+..+.+++.++.|++++|.+.......+.. ++|++|+|++|+|+ .+|..+..+++|++|+|++|+|+......|
T Consensus 184 ~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f 262 (305)
T d1xkua_ 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 262 (305)
T ss_dssp CEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSS
T ss_pred CCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhc
Confidence 9999999999999999999997665544444555 89999999999998 568899999999999999999996544343
Q ss_pred ------hccCCCCEEeccCCcCC-CcCChhhhcCC
Q 003737 327 ------EKLAKTNFMYLTGNKLT-GPVPKYIFNSN 354 (799)
Q Consensus 327 ------~~l~~L~~L~L~~N~l~-g~~p~~~~~~l 354 (799)
..+.+|+.|+|++|+++ ..++...+..+
T Consensus 263 ~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~ 297 (305)
T d1xkua_ 263 CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 297 (305)
T ss_dssp SCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTC
T ss_pred cCcchhcccCCCCEEECCCCcCccCcCCHhHhccc
Confidence 46788999999999996 56777666543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=1.6e-23 Score=219.25 Aligned_cols=250 Identities=16% Similarity=0.161 Sum_probs=196.0
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEcc-CCcCcCcCCcccCCCCCCCEEE
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVM-GNRLSGPFPKVLTNITTLKNLS 169 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls-~N~l~~~~p~~~~~L~~L~~L~ 169 (799)
..+++|+|++|+|+...+..|.++++|++|++++|++....+..+..+. ++.++.. .|.++...|..|.++++|++|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence 4678999999999977777899999999999999999999888888877 8888764 6777777789999999999999
Q ss_pred eeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCC
Q 003737 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (799)
Q Consensus 170 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 249 (799)
+++|.+....+..+..+++|+.+++++|++++..+..|..+++|++|++++|++++..+..|.++++|+++++++|++++
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~ 191 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence 99999987777789999999999999999997777889999999999999999998889999999999999999999999
Q ss_pred CCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhcc
Q 003737 250 PIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL 329 (799)
Q Consensus 250 ~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 329 (799)
..|..|.++++|++|++++ |.+++..+..|.++++|++|+|++|.+...-+.. .-.
T Consensus 192 i~~~~f~~l~~L~~L~l~~-----------------------N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~-~l~ 247 (284)
T d1ozna_ 192 VHPHAFRDLGRLMTLYLFA-----------------------NNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLW 247 (284)
T ss_dssp ECTTTTTTCTTCCEEECCS-----------------------SCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHH
T ss_pred cChhHhhhhhhcccccccc-----------------------cccccccccccccccccCEEEecCCCCCCCccch-HHH
Confidence 8899988887776666554 5555555566666777777777777666432211 111
Q ss_pred CCCCEEeccCCcCCCcCChhhhcCCCEEEeecCcCcc
Q 003737 330 AKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTW 366 (799)
Q Consensus 330 ~~L~~L~L~~N~l~g~~p~~~~~~l~~l~ls~N~~~g 366 (799)
..++.+....++++...|..+. .....+++.+.|+|
T Consensus 248 ~~l~~~~~~~~~~~C~~p~~l~-g~~l~~l~~~~l~g 283 (284)
T d1ozna_ 248 AWLQKFRGSSSEVPCSLPQRLA-GRDLKRLAANDLQG 283 (284)
T ss_dssp HHHHHCCSEECCCBEEESGGGT-TCBGGGSCGGGSCC
T ss_pred HHHHhCcCCCCceEeCCchHHc-CCccccCCHHHCCC
Confidence 2233444455566555555442 23344455555543
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.89 E-value=3.2e-22 Score=218.04 Aligned_cols=258 Identities=23% Similarity=0.331 Sum_probs=187.5
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.++++|++++++++. + +.+..+++|++|||++|++++..+ ++.++ |++|++++|++++.. .++++++|+.|++
T Consensus 44 ~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~ 117 (384)
T d2omza2 44 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTL 117 (384)
T ss_dssp TTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccccc--ccccccccccccc
Confidence 468888898888874 3 457788899999999998887643 77776 999999999888643 3788888998888
Q ss_pred eCCcCCCCC---------------------------------------------------------------CccccCCC
Q 003737 171 EGNLFTGSI---------------------------------------------------------------PPDIRKLI 187 (799)
Q Consensus 171 s~N~l~~~~---------------------------------------------------------------p~~~~~l~ 187 (799)
++|.+++.. +..+..++
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 197 (384)
T d2omza2 118 FNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLT 197 (384)
T ss_dssp CSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccccccccccccccc
Confidence 877765311 12345567
Q ss_pred CCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcC
Q 003737 188 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRIS 267 (799)
Q Consensus 188 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 267 (799)
+++.+++++|.+++..| +...++|++|++++|+++. ++.+..+++|+.|++++|.+++..+ +..+++|+.|+++
T Consensus 198 ~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~ 271 (384)
T d2omza2 198 NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG 271 (384)
T ss_dssp TCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred ccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC--cchhhcccccchhccccCccCCCCc--ccccccCCEeecc
Confidence 78888888888886544 4566788888888888874 2467788888888888888886443 6778888888888
Q ss_pred CCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcC
Q 003737 268 DLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPV 346 (799)
Q Consensus 268 ~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~ 346 (799)
.+.... ++.+.. ..++.+++..|.+++. ..+..+++++.|++++|++++.. .+..+++|+.|++++|++++ +
T Consensus 272 ~~~l~~--~~~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l 344 (384)
T d2omza2 272 ANQISN--ISPLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-V 344 (384)
T ss_dssp SSCCCC--CGGGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-C
T ss_pred CcccCC--CCccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-C
Confidence 754432 233333 6677778887777642 34667788888888888888643 27778888888888888874 4
Q ss_pred Chhh--hcCCCEEEeecCcCcccCC
Q 003737 347 PKYI--FNSNKNVDISLNNFTWESS 369 (799)
Q Consensus 347 p~~~--~~~l~~l~ls~N~~~g~~p 369 (799)
| .+ .+.++.||+++|++++.+|
T Consensus 345 ~-~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 345 S-SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp G-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred h-hHcCCCCCCEEECCCCcCCCChh
Confidence 4 23 2467888888888886554
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.1e-21 Score=203.12 Aligned_cols=197 Identities=23% Similarity=0.259 Sum_probs=113.0
Q ss_pred cEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEee
Q 003737 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (799)
Q Consensus 93 ~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls 171 (799)
...++++++++|+ .+|+.+. ++|++|+|++|+|++..+..|..++ |++|+|++|+|+.. | .++.+++|++|+|+
T Consensus 11 ~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLS 85 (266)
T ss_dssp TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECC
T ss_pred CCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccccccc
Confidence 3445688888888 5676654 5677888877777766555555554 66666666655522 2 23445555555555
Q ss_pred CCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCC
Q 003737 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251 (799)
Q Consensus 172 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 251 (799)
+|+++ ..+..+..+++|++|++++|.+.+..+..+..+.++++|++++|.++...+..+..+++|+.|++
T Consensus 86 ~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l--------- 155 (266)
T d1p9ag_ 86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL--------- 155 (266)
T ss_dssp SSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC---------
T ss_pred ccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccc---------
Confidence 55554 23444455555555555555544444444444444444444444444333333333333333333
Q ss_pred chhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCC
Q 003737 252 PASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331 (799)
Q Consensus 252 p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 331 (799)
++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++
T Consensus 156 --------------------------------------~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~ 196 (266)
T d1p9ag_ 156 --------------------------------------ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHL 196 (266)
T ss_dssp --------------------------------------TTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCC
T ss_pred --------------------------------------ccccccccCccccccccccceeecccCCCc-ccChhHCCCCC
Confidence 344444445555666777777777777777 66766777777
Q ss_pred CCEEeccCCcCC
Q 003737 332 TNFMYLTGNKLT 343 (799)
Q Consensus 332 L~~L~L~~N~l~ 343 (799)
|+.|+|++|++.
T Consensus 197 L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 197 LPFAFLHGNPWL 208 (266)
T ss_dssp CSEEECCSCCBC
T ss_pred CCEEEecCCCCC
Confidence 777777777775
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=2.9e-21 Score=199.87 Aligned_cols=203 Identities=20% Similarity=0.208 Sum_probs=134.2
Q ss_pred EEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcC
Q 003737 144 LSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 223 (799)
Q Consensus 144 L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 223 (799)
.+.++++++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+++ .+| .+..+++|++|+|++|++
T Consensus 15 v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l 89 (266)
T d1p9ag_ 15 VNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQL 89 (266)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCC
T ss_pred EEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccccccccccc
Confidence 344444444 2343332 34556666666665444445566666666666666665 233 245566666666666666
Q ss_pred CCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCcccc
Q 003737 224 SGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIG 303 (799)
Q Consensus 224 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~ 303 (799)
+. .+..+..+++|+.|++++|.+....+..+..+.++ +.|++++|.++...+..+.
T Consensus 90 ~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l-----------------------~~L~l~~n~l~~l~~~~~~ 145 (266)
T d1p9ag_ 90 QS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGEL-----------------------QELYLKGNELKTLPPGLLT 145 (266)
T ss_dssp SS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTC-----------------------CEEECTTSCCCCCCTTTTT
T ss_pred cc-cccccccccccccccccccccceeecccccccccc-----------------------ccccccccccceecccccc
Confidence 53 45556666677777777776665555555444443 3444555556655666778
Q ss_pred CCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhhc--CCCEEEeecCcCcccCCCCCcCCCCCccc
Q 003737 304 DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN--SNKNVDISLNNFTWESSDPIECPRGSVNL 381 (799)
Q Consensus 304 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~--~l~~l~ls~N~~~g~~p~~~~~~~~~~~~ 381 (799)
.+++|+.+++++|++++..+..|..+++|+.|+|++|+|+ .+|+.++. .++.|+|++|.+. |++....+
T Consensus 146 ~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~--------CdC~~~~l 216 (266)
T d1p9ag_ 146 PTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL--------CNCEILYF 216 (266)
T ss_dssp TCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC--------CSGGGHHH
T ss_pred ccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC--------CCcchHHH
Confidence 8999999999999999988899999999999999999999 88988764 6789999999654 77654444
Q ss_pred eec
Q 003737 382 VES 384 (799)
Q Consensus 382 ~~~ 384 (799)
..|
T Consensus 217 ~~w 219 (266)
T d1p9ag_ 217 RRW 219 (266)
T ss_dssp HHH
T ss_pred HHH
Confidence 333
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.84 E-value=4.3e-20 Score=200.90 Aligned_cols=252 Identities=24% Similarity=0.307 Sum_probs=200.5
Q ss_pred EEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcC
Q 003737 97 IALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLF 175 (799)
Q Consensus 97 L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l 175 (799)
..+...++++.++ ...+.+|++|++++|.++.. ..+..++ |++|+|++|+|++.. .++++++|++|++++|++
T Consensus 27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i 100 (384)
T d2omza2 27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQI 100 (384)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccc
Confidence 3456666776654 35678999999999999864 3466777 999999999999654 399999999999999999
Q ss_pred CCCCCccccCCCCCCEEEcccCcCCccC----------------------------------------------------
Q 003737 176 TGSIPPDIRKLINLQKLILSSNSFTGEL---------------------------------------------------- 203 (799)
Q Consensus 176 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~---------------------------------------------------- 203 (799)
++. + .++++++|+.|++++|.+++..
T Consensus 101 ~~i-~-~l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (384)
T d2omza2 101 ADI-T-PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLE 178 (384)
T ss_dssp CCC-G-GGTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCC
T ss_pred ccc-c-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhccccccc
Confidence 854 3 4899999999999988776321
Q ss_pred -----------ChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCC
Q 003737 204 -----------PAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 272 (799)
Q Consensus 204 -----------p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~ 272 (799)
...+..+++++.+++++|.+++..| +..+++|++|++++|.++. ++.+..+++|+.|++++|...
T Consensus 179 ~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~ 254 (384)
T d2omza2 179 RLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQIS 254 (384)
T ss_dssp EEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCC
T ss_pred cccccccccccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC--cchhhcccccchhccccCccC
Confidence 1234556788899999999886554 4567899999999999885 346788999999999986543
Q ss_pred CCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhh
Q 003737 273 ESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351 (799)
Q Consensus 273 ~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~ 351 (799)
. ++.+.. ++|+.|++++|.+++.. .+..++.++.++++.|++++ ...+..+++++.|++++|++++..|-.-+
T Consensus 255 ~--~~~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~~l~~l 328 (384)
T d2omza2 255 N--LAPLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISPVSSL 328 (384)
T ss_dssp C--CGGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCGGGGGC
T ss_pred C--CCcccccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCcccccC
Confidence 2 334444 78999999999998654 37788999999999999986 34588999999999999999986554456
Q ss_pred cCCCEEEeecCcCcc
Q 003737 352 NSNKNVDISLNNFTW 366 (799)
Q Consensus 352 ~~l~~l~ls~N~~~g 366 (799)
+.++.|++++|++++
T Consensus 329 ~~L~~L~L~~n~l~~ 343 (384)
T d2omza2 329 TKLQRLFFANNKVSD 343 (384)
T ss_dssp TTCCEEECCSSCCCC
T ss_pred CCCCEEECCCCCCCC
Confidence 789999999999985
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=1.9e-19 Score=188.11 Aligned_cols=115 Identities=21% Similarity=0.468 Sum_probs=104.0
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
.++|+..+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 34689999999999999999994 57999999999766555567899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++.++ .+++..++.++.||+.||+|||+
T Consensus 99 ~~gg~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~yLH~ 134 (293)
T d1yhwa1 99 LAGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLHS 134 (293)
T ss_dssp CTTCBHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCcHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999987653 57888999999999999999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=1.2e-19 Score=189.48 Aligned_cols=116 Identities=22% Similarity=0.447 Sum_probs=104.2
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
+.|+..+.||+|+||+||+|+. .+|+.||||+++.......+.|.+|++++++++|||||++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4577788999999999999995 578999999998766666778999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.+++.+... .+++.+++.++.||++||+|||+
T Consensus 92 ~~g~L~~~~~~~~~--------~l~e~~~~~i~~qi~~gL~ylH~ 128 (288)
T d2jfla1 92 AGGAVDAVMLELER--------PLTESQIQVVCKQTLDALNYLHD 128 (288)
T ss_dssp TTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999875432 57899999999999999999995
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=2.4e-19 Score=184.08 Aligned_cols=115 Identities=23% Similarity=0.436 Sum_probs=103.2
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCC
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
++|+..+.||+|+||+||+|+.++++.||||+++.... ..++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57888999999999999999998888999999976533 45789999999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.+++..... .+++..+..++.||++||+|||+
T Consensus 83 ~g~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~~LH~ 118 (258)
T d1k2pa_ 83 NGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLES 118 (258)
T ss_dssp TEEHHHHHHSGGG--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCcHHHhhhcccc--------CCcHHHHHHHHHHHHHHHHHHhh
Confidence 9999999876543 56777888899999999999994
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=1.5e-19 Score=186.33 Aligned_cols=115 Identities=23% Similarity=0.499 Sum_probs=102.0
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCC
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 755 (799)
++|+..+.||+|+||+||+|...+++.||||+++... ...++|.+|++++++++|||||+++|+|..++..++|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 3577788999999999999999888999999997643 345789999999999999999999999999999999999999
Q ss_pred CCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 756 NNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 756 ~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|+|.++++.... .++++.+..++.|||+||+|||+
T Consensus 84 ~g~L~~~l~~~~~--------~~~~~~~~~i~~qia~gl~~lH~ 119 (263)
T d1sm2a_ 84 HGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEE 119 (263)
T ss_dssp TCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHhhhc
Confidence 9999999876542 56777888889999999999994
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=9.7e-20 Score=188.28 Aligned_cols=115 Identities=24% Similarity=0.348 Sum_probs=100.3
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5688889999999999999995 579999999997543 23346799999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.+++..+. .+++.+++.++.||++||+|||+
T Consensus 85 ~~gg~L~~~l~~~~---------~l~e~~~~~i~~qi~~al~ylH~ 121 (271)
T d1nvra_ 85 CSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHG 121 (271)
T ss_dssp CTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCcHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999997654 57899999999999999999994
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.78 E-value=7.3e-20 Score=191.09 Aligned_cols=121 Identities=21% Similarity=0.395 Sum_probs=105.0
Q ss_pred HHHhhcCCCCCCeecccCCeeEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 671 IKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 671 ~~~~t~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
++...++|+..+.||+|+||+||+|... +|+.||||+++... ...++|.+|+++|++++|||||+++|+|.+++..++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 3344567888899999999999999964 68899999997543 346789999999999999999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||||++|+|.++++..... .+++..+..++.|||+||+|||+
T Consensus 91 v~E~~~~g~l~~~l~~~~~~-------~~~~~~~~~i~~qi~~gL~yLH~ 133 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQ-------EVSAVVLLYMATQISSAMEYLEK 133 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTT-------TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EeecccCcchHHHhhhcccc-------chHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999765422 67888889999999999999994
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.77 E-value=2.1e-19 Score=188.73 Aligned_cols=114 Identities=23% Similarity=0.440 Sum_probs=97.2
Q ss_pred CCCCCeecccCCeeEEEEEeC-CC---cEEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 678 FDPANKVGEGGFGSVYKGILS-DG---TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 678 f~~~~~lG~G~~g~Vy~~~~~-~g---~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
|+..+.||+|+||+||+|... ++ ..||||++... .....+.|.+|+++|++++|||||+++|+|.+++..++|||
T Consensus 28 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~E 107 (299)
T d1jpaa_ 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITE 107 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 444579999999999999964 33 36899998764 34456789999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||++|+|.++++.... .+++.++..++.|||+||+|||+
T Consensus 108 y~~~g~L~~~~~~~~~--------~l~~~~~~~i~~qia~gl~yLH~ 146 (299)
T d1jpaa_ 108 FMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLAD 146 (299)
T ss_dssp CCTTEEHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCcceeeeccccC--------CCCHHHHHHHHHHHHHHHHHHhh
Confidence 9999999999886542 46788888999999999999994
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=4.1e-19 Score=186.18 Aligned_cols=115 Identities=18% Similarity=0.308 Sum_probs=102.8
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC------hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS------RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 748 (799)
+.|+..+.||+|+||+||+|.. .+|+.||||+++... ....+.|.+|+++|++++|||||++++++.+++..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5688889999999999999995 579999999986532 123578999999999999999999999999999999
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|||||++|+|.+++...+ .+++..++.++.||+.||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~~~~---------~l~~~~~~~~~~qi~~al~yLH~ 131 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE---------SLTEEEATEFLKQILNGVYYLHS 131 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEcCCCccccchhcccc---------ccchhHHHHHHHHHHHHHHhhhh
Confidence 9999999999999998654 67899999999999999999994
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.77 E-value=4.9e-19 Score=189.76 Aligned_cols=117 Identities=19% Similarity=0.339 Sum_probs=105.7
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
.++|+..+.||+|+||.||+|+. .+|+.||||++........+.+.+|++++.+++|||||++++++.+++..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35788899999999999999995 57999999999877666678899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|++|+|.+++..+.. .+++..++.++.||+.||+|||+
T Consensus 105 ~~gg~L~~~l~~~~~--------~l~e~~~~~i~~qi~~aL~ylH~ 142 (350)
T d1koaa2 105 MSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHE 142 (350)
T ss_dssp CCSCBHHHHHTCTTS--------CBCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999975432 57899999999999999999994
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=3.2e-19 Score=183.60 Aligned_cols=115 Identities=23% Similarity=0.408 Sum_probs=102.4
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||+||+|+. .+|+.||+|++.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4578889999999999999996 578999999986532 233568999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||++|+|.+++.... .+++..++.++.||++||+|||+
T Consensus 86 Ey~~~g~L~~~l~~~~---------~l~e~~~~~i~~qi~~al~~lH~ 124 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---------KFDEQRTATYITELANALSYCHS 124 (263)
T ss_dssp ECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eecCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998654 67899999999999999999995
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.3e-19 Score=192.69 Aligned_cols=117 Identities=17% Similarity=0.317 Sum_probs=104.6
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
..++|+..+.||+|+||+||+|.. .+|+.||+|+++... ....+.+.+|+++|++++|||||+++++|.+++..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 356788899999999999999995 579999999997653 334578999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||++|+|.+++++.+ .+++..++.++.|+++||+|||+
T Consensus 84 Ey~~gg~L~~~l~~~~---------~l~~~~~~~~~~qil~aL~yLH~ 122 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLRE 122 (322)
T ss_dssp ECCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EcCCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998654 57888999999999999999994
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=2.7e-19 Score=185.34 Aligned_cols=117 Identities=24% Similarity=0.401 Sum_probs=100.7
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
..++|+..+.||+|+||+||+|..++++.||||+++... ...++|.+|++++++++|||||+++|+|. ++..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEe
Confidence 445677889999999999999999888999999997543 34578999999999999999999999885 4567999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++|+|.++++..... .+++..+..++.|||+||+|||+
T Consensus 89 ~~~g~L~~~~~~~~~~-------~l~~~~~~~i~~qi~~gl~~lH~ 127 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGI-------KLTINKLLDMAAQIAEGMAFIEE 127 (272)
T ss_dssp CTTCBHHHHTTSHHHH-------TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCcHHHHHhhcCCC-------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999988755422 57788888999999999999994
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.76 E-value=4.1e-19 Score=187.08 Aligned_cols=116 Identities=21% Similarity=0.338 Sum_probs=98.8
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
.+.|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 45688889999999999999995 478999999997543 2234578899999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||++|+|.+++..++ .+++..++.++.||+.||+|||+
T Consensus 88 ~~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~ylH~ 125 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG---------FYTERDASRLIFQVLDAVKYLHD 125 (307)
T ss_dssp CCCSCBHHHHHHTCS---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccCCCcHHHhhhccc---------CCCHHHHHHHHHHHHHHHHhhhh
Confidence 999999999998654 68899999999999999999994
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=9.8e-19 Score=182.08 Aligned_cols=115 Identities=25% Similarity=0.451 Sum_probs=96.3
Q ss_pred cCCCCCCe-ecccCCeeEEEEEeC---CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEE
Q 003737 676 NNFDPANK-VGEGGFGSVYKGILS---DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~-lG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 750 (799)
++|...+. ||+|+||+||+|..+ ++..||||+++... ....++|.+|+++|++++|||||+++|+|.+ +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34555554 999999999999853 45689999997653 3456789999999999999999999999864 568999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||++|+|.+++...+. .+++..+..++.|||+||+|||+
T Consensus 87 mE~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~gL~ylH~ 127 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEE 127 (285)
T ss_dssp EECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999875432 57888899999999999999995
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=4.9e-19 Score=183.58 Aligned_cols=115 Identities=23% Similarity=0.405 Sum_probs=98.7
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
..++|...+.||+|+||+||+|+.. ..||||+++.. .....+.|.+|++++.+++|||||+++|++. .+..++||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEE
Confidence 4567888999999999999999864 35999999754 3445678999999999999999999999875 45689999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||++|+|.++++.... .+++..+..++.|||+||+|||+
T Consensus 83 Ey~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~ 122 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIET--------KFEMIKLIDIARQTAQGMDYLHA 122 (276)
T ss_dssp ECCCEEEHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHhc
Confidence 99999999999976532 57788899999999999999994
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.75 E-value=1e-18 Score=187.51 Aligned_cols=116 Identities=18% Similarity=0.342 Sum_probs=104.6
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
++|+..+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4688899999999999999995 579999999998766566678999999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.+++..+.. .+++.+++.++.||+.||+|||+
T Consensus 109 ~gg~L~~~~~~~~~--------~l~e~~~~~i~~qi~~aL~ylH~ 145 (352)
T d1koba_ 109 SGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMHE 145 (352)
T ss_dssp CCCBHHHHTTCTTC--------CBCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCChHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999998875532 57899999999999999999994
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=1.5e-18 Score=179.27 Aligned_cols=112 Identities=21% Similarity=0.349 Sum_probs=96.4
Q ss_pred CCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEE----CCEEEEEE
Q 003737 679 DPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLLVY 751 (799)
Q Consensus 679 ~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 751 (799)
+..+.||+|+||+||+|.. .+++.||+|++... .....+.|.+|+++|++++|||||++++++.+ .+..++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 3456799999999999995 47889999998654 33445789999999999999999999999875 34689999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++.+.. .++++.++.++.||++||+|||+
T Consensus 92 E~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~gl~yLH~ 130 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLHT 130 (270)
T ss_dssp ECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred eCCCCCcHHHHHhccc---------cccHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998654 57888999999999999999995
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=6.2e-19 Score=183.83 Aligned_cols=115 Identities=21% Similarity=0.278 Sum_probs=102.8
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4588889999999999999995 579999999996532 234568999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++...+ .+++..++.++.|++.||+|||+
T Consensus 88 Ey~~gg~L~~~~~~~~---------~l~e~~~~~~~~qi~~al~ylH~ 126 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---------SFDETCTRFYTAEIVSALEYLHG 126 (288)
T ss_dssp CCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EccCCCCHHHhhhccC---------CCCHHHHHHHHHHHHHHHHhhcc
Confidence 9999999999988665 68899999999999999999994
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=1.8e-18 Score=183.31 Aligned_cols=116 Identities=16% Similarity=0.266 Sum_probs=103.1
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
.++|...+.||+|+||+||+|.. .+|+.||||.++... .....+.+|+++|.+++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 35688889999999999999995 578999999997653 2345788999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|++|+|.++++..+. .+++++++.|+.||++||+|||+
T Consensus 83 ~~gg~L~~~i~~~~~--------~l~e~~~~~i~~qi~~al~yLH~ 120 (321)
T d1tkia_ 83 ISGLDIFERINTSAF--------ELNEREIVSYVHQVCEALQFLHS 120 (321)
T ss_dssp CCCCBHHHHHTSSSC--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 999999999976532 57899999999999999999994
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=6.3e-19 Score=182.02 Aligned_cols=119 Identities=19% Similarity=0.340 Sum_probs=100.0
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEE--CCEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 750 (799)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.|.+|++++++++|||||++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5688899999999999999985 579999999997653 3345679999999999999999999999865 4568999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.+++.+.... ...+++..+..++.||++||+|||+
T Consensus 84 mEy~~~g~L~~~i~~~~~~-----~~~l~e~~~~~i~~qi~~al~ylH~ 127 (269)
T d2java1 84 MEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHR 127 (269)
T ss_dssp EECCTTEEHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EecCCCCcHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999743211 1168899999999999999999994
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.75 E-value=1.2e-18 Score=180.71 Aligned_cols=115 Identities=19% Similarity=0.286 Sum_probs=101.9
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh---------hhHHHHHHHHHHHHhCC-CCcccceeEEEEEC
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR---------QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEG 744 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~---------~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~ 744 (799)
++|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|++++++++ |||||++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5688899999999999999995 5799999999865421 12346899999999997 99999999999999
Q ss_pred CEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+..|+|||||++|+|.++|+.++ .+++..++.|+.||++||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~~lH~ 128 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALLEVICALHK 128 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cceEEEEEcCCCchHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999998654 68899999999999999999994
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.74 E-value=8.9e-19 Score=184.53 Aligned_cols=114 Identities=21% Similarity=0.406 Sum_probs=100.6
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh---hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
.|+..+.||+|+||+||+|+. .+|+.||||++..... ...+.|.+|+++|++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 478889999999999999984 5789999999976532 234679999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||++|+|..++..+. .+++.+++.++.||++||+|||+
T Consensus 96 ~~~~g~l~~~~~~~~---------~l~e~~~~~i~~qi~~aL~yLH~ 133 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK---------PLQEVEIAAVTHGALQGLAYLHS 133 (309)
T ss_dssp CCSEEHHHHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCchHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999987766544 67899999999999999999994
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=3.1e-18 Score=177.66 Aligned_cols=108 Identities=22% Similarity=0.365 Sum_probs=91.6
Q ss_pred CeecccCCeeEEEEEeC---CCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecCCC
Q 003737 682 NKVGEGGFGSVYKGILS---DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (799)
Q Consensus 682 ~~lG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 756 (799)
+.||+|+||+||+|..+ .++.||||+++... ....++|.+|+++|++++|||||+++|+|.+ +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999854 35689999996542 2335689999999999999999999999964 567899999999
Q ss_pred CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 757 NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 757 GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|.++++... .+++..+..++.|||+||+|||+
T Consensus 92 g~L~~~l~~~~---------~l~~~~~~~i~~qi~~gl~ylH~ 125 (277)
T d1xbba_ 92 GPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLEE 125 (277)
T ss_dssp EEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHhhHHh
Confidence 99999998654 57788899999999999999995
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=2e-18 Score=183.86 Aligned_cols=115 Identities=21% Similarity=0.280 Sum_probs=103.6
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|+++|++++|||||++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5688899999999999999995 689999999997542 234578999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||++|+|.+++...+ .++|+.++.|+.||+.||+|||+
T Consensus 85 ey~~gg~L~~~~~~~~---------~~~e~~~~~~~~qil~al~ylH~ 123 (337)
T d1o6la_ 85 EYANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYLHS 123 (337)
T ss_dssp ECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eccCCCchhhhhhccc---------CCcHHHHHHHHHHHhhhhhhhhh
Confidence 9999999999998765 68899999999999999999994
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=1.3e-18 Score=180.95 Aligned_cols=116 Identities=22% Similarity=0.354 Sum_probs=100.8
Q ss_pred hcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
.++|+..+.||+|+||.||+|..++++.||||+++.. ....+.|.+|++++++++|||||+++|+|. ++..++|||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 3568888999999999999999988889999999754 334578999999999999999999999985 56689999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|..+++..... .+++.++..++.|||+||+|||+
T Consensus 94 ~~g~l~~~~~~~~~~-------~l~~~~~~~i~~~i~~gl~~LH~ 131 (285)
T d1fmka3 94 SKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVER 131 (285)
T ss_dssp TTCBHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCchhhhhhhcccc-------cchHHHHHHHHHHHHHHHHHHhh
Confidence 999999998865322 57788899999999999999994
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=4.2e-18 Score=180.30 Aligned_cols=115 Identities=20% Similarity=0.303 Sum_probs=100.7
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHH-hCCCCcccceeEEEEECCEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMIS-AQQHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 750 (799)
++|...+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|+.++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5688889999999999999995 579999999996532 234567888888776 68999999999999999999999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||++|+|.++++... .+++.+++.++.||+.||+|||+
T Consensus 82 mEy~~~g~L~~~i~~~~---------~~~e~~~~~~~~qi~~al~ylH~ 121 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---------KFDLSRATFYAAEIILGLQFLHS 121 (320)
T ss_dssp EECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EeecCCCcHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999998654 57888999999999999999995
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=2.6e-18 Score=176.58 Aligned_cols=114 Identities=24% Similarity=0.403 Sum_probs=95.6
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEE-CCEEEEEEecC
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLLVYEYM 754 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~ 754 (799)
++|+..+.||+|+||.||+|.. .|+.||||+++.. ...++|.+|++++++++|||||+++|+|.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 4566778999999999999998 4789999999654 345789999999999999999999999965 45689999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.++|+.+... .++++.+..++.||++||+|||+
T Consensus 84 ~~g~L~~~l~~~~~~-------~l~~~~~~~i~~~i~~al~ylH~ 121 (262)
T d1byga_ 84 AKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEG 121 (262)
T ss_dssp TTEEHHHHHHHHHHH-------HCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHhhcccccc
Confidence 999999999765321 46777888899999999999994
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.71 E-value=7.2e-18 Score=178.16 Aligned_cols=115 Identities=18% Similarity=0.339 Sum_probs=102.4
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688889999999999999995 57999999999653 2234578999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||++|+|.+++..+. .+++..++.++.||+.||+|||+
T Consensus 84 E~~~gg~l~~~~~~~~---------~~~~~~~~~~~~qi~~al~~lH~ 122 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---------RFPNPVAKFYAAEVCLALEYLHS 122 (316)
T ss_dssp CCCCSCBHHHHHHHTS---------SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred eecCCccccccccccc---------cccccHHHHHHHHHHHhhhhhcc
Confidence 9999999999988765 56788899999999999999996
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.71 E-value=7e-18 Score=175.19 Aligned_cols=116 Identities=19% Similarity=0.215 Sum_probs=100.9
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECC----E
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----Q 746 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~ 746 (799)
.++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.|.+|++++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35688889999999999999994 679999999997643 233467999999999999999999999987654 4
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.|+||||+++|+|.+++...+ .+++.+++.++.||++||+|||+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---------~l~~~~~~~i~~qi~~al~~lH~ 129 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEVIADACQALNFSHQ 129 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEECCCCCEehhhhcccC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 799999999999999987654 57888999999999999999994
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.70 E-value=7.6e-18 Score=177.06 Aligned_cols=131 Identities=22% Similarity=0.352 Sum_probs=107.3
Q ss_pred HHHHHhhcCCCCCCeecccCCeeEEEEEeC------CCcEEEEEEccccCh-hhHHHHHHHHHHHHhCCCCcccceeEEE
Q 003737 669 RQIKAATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCC 741 (799)
Q Consensus 669 ~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~ 741 (799)
.+++.++++|+..+.||+|+||+||+|+.. +++.||||+++.... ...++|.+|++++++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 455667888999999999999999999853 457899999976533 3457899999999999999999999999
Q ss_pred EECCEEEEEEecCCCCcHHHHHhcCccccc---------------ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 742 VEGNQLLLVYEYMKNNCLSRAIFGKLRIFH---------------ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 742 ~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~---------------~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+.+..++||||+++|+|.++++....... ......+++..+..++.|+++||+|||+
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~ 158 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 158 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc
Confidence 999999999999999999999975432111 0112247788899999999999999994
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=1.1e-17 Score=174.12 Aligned_cols=116 Identities=23% Similarity=0.440 Sum_probs=99.4
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCC-----cEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDG-----TVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g-----~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
+.|+..++||+|+||.||+|+++.. ..||||+++... ....++|.+|++++++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577889999999999999986432 479999997653 3345689999999999999999999999999999999
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||||++|++.+++..... .+++.++..++.||++||+|||+
T Consensus 87 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~~i~~gl~~lH~ 128 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLAN 128 (283)
T ss_dssp EEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecccCcchhhhhcccc--------cccHHHHHHHHHHHHHhhhhccc
Confidence 9999999999998875532 56777888899999999999994
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=1e-16 Score=161.13 Aligned_cols=202 Identities=16% Similarity=0.265 Sum_probs=105.5
Q ss_pred EEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCc
Q 003737 120 QLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS 198 (799)
Q Consensus 120 ~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 198 (799)
.++++.+.+++.. .+..++ |++|++.+|.++. ++ .+..+++|++|++++|.+++.. .+.++++|+++++++|.
T Consensus 23 ~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~ 96 (227)
T d1h6ua2 23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNP 96 (227)
T ss_dssp HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCC
T ss_pred HHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeeccc--ccccccccccccccccc
Confidence 3455555555432 223343 6666666666653 22 3556666666666666665332 25566666666666665
Q ss_pred CCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCc
Q 003737 199 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPK 278 (799)
Q Consensus 199 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~ 278 (799)
++ .++ .+.++++|+.+++++|...+. ..+...+.++.+.++.+.+.... .+.+.++
T Consensus 97 ~~-~i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~------------------ 152 (227)
T d1h6ua2 97 LK-NVS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTN------------------ 152 (227)
T ss_dssp CS-CCG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTT------------------
T ss_pred cc-ccc-ccccccccccccccccccccc--chhccccchhhhhchhhhhchhh--hhccccc------------------
Confidence 55 222 355566666666666555432 22444555555555555554321 2334444
Q ss_pred cCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhhcCCCEEE
Q 003737 279 LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVD 358 (799)
Q Consensus 279 l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~l~~l~ 358 (799)
|+.|++++|.++... .+.++++|+.|+|++|++++ ++ .+..+++|++|+|++|++++..|-.-.+.++.|+
T Consensus 153 -----L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~l~~l~~L~~L~ 223 (227)
T d1h6ua2 153 -----LQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSPLANTSNLFIVT 223 (227)
T ss_dssp -----CCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEE
T ss_pred -----cccccccccccccch--hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcccccCCCCCEEE
Confidence 455555555544222 25556666666666666654 22 2566666666666666666432222234556666
Q ss_pred ee
Q 003737 359 IS 360 (799)
Q Consensus 359 ls 360 (799)
++
T Consensus 224 ls 225 (227)
T d1h6ua2 224 LT 225 (227)
T ss_dssp EE
T ss_pred ee
Confidence 55
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=1.6e-16 Score=159.61 Aligned_cols=206 Identities=22% Similarity=0.305 Sum_probs=157.9
Q ss_pred cEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEee
Q 003737 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (799)
Q Consensus 93 ~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls 171 (799)
+++.+++..+.+++.+ .+..+.+|+.|++.+|.++.. + .+..++ |++|++++|++++..| +..+++|++|+++
T Consensus 20 ~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~ 93 (227)
T d1h6ua2 20 NAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELS 93 (227)
T ss_dssp HHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECC
T ss_pred HHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc-h-hHhcCCCCcEeecCCceeecccc--ccccccccccccc
Confidence 3455677777777654 457789999999999999865 3 477777 9999999999986544 8999999999999
Q ss_pred CCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCC
Q 003737 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251 (799)
Q Consensus 172 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 251 (799)
+|.++ .+ +.+.++++|+++++++|...+. ..+...+.++.+.++.+.+... ..+..+++|++|++++|.+....
T Consensus 94 ~n~~~-~i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~ 167 (227)
T d1h6ua2 94 GNPLK-NV-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT 167 (227)
T ss_dssp SCCCS-CC-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG
T ss_pred ccccc-cc-cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccch
Confidence 99987 34 4688999999999999988743 3477888999999999998743 34778899999999999987432
Q ss_pred chhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCC
Q 003737 252 PASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331 (799)
Q Consensus 252 p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 331 (799)
.+.++++|++|+++ +|++++ ++ .+..+++|++|+|++|++++. + .+.++++
T Consensus 168 --~l~~l~~L~~L~Ls-----------------------~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~ 218 (227)
T d1h6ua2 168 --PLANLSKLTTLKAD-----------------------DNKISD-IS-PLASLPNLIEVHLKNNQISDV-S-PLANTSN 218 (227)
T ss_dssp --GGTTCTTCCEEECC-----------------------SSCCCC-CG-GGGGCTTCCEEECTTSCCCBC-G-GGTTCTT
T ss_pred --hhcccccceecccC-----------------------CCccCC-Ch-hhcCCCCCCEEECcCCcCCCC-c-ccccCCC
Confidence 36666665555554 455543 22 266777888888888888753 3 2778888
Q ss_pred CCEEeccC
Q 003737 332 TNFMYLTG 339 (799)
Q Consensus 332 L~~L~L~~ 339 (799)
|+.|++++
T Consensus 219 L~~L~lsn 226 (227)
T d1h6ua2 219 LFIVTLTN 226 (227)
T ss_dssp CCEEEEEE
T ss_pred CCEEEeeC
Confidence 88888763
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=1.8e-17 Score=174.77 Aligned_cols=124 Identities=25% Similarity=0.447 Sum_probs=98.9
Q ss_pred cCCCCCCeecccCCeeEEEEEeC-CCc--EEEEEEcccc-ChhhHHHHHHHHHHHHhC-CCCcccceeEEEEECCEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS-DGT--VIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 750 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~--~vAvK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 750 (799)
++|+..+.||+|+||+||+|+.. +|. .||||+++.. .....++|.+|+++|.++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 45777889999999999999964 454 5788888644 333456899999999998 799999999999999999999
Q ss_pred EecCCCCcHHHHHhcCccc-------ccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRI-------FHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~-------~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||+++|+|.++|+.+... ........+++..+..++.|||+||+|||+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~ 145 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 145 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc
Confidence 9999999999999865210 001122368888999999999999999994
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.69 E-value=1.9e-15 Score=161.32 Aligned_cols=250 Identities=21% Similarity=0.252 Sum_probs=149.0
Q ss_pred cEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeC
Q 003737 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (799)
Q Consensus 93 ~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~ 172 (799)
+++.|+|++++++ .+|+. +++|++|+|++|+|+. +|..+. +|++|++++|+++. +++. .+.|++|++++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~-lp~~~~--~L~~L~l~~n~l~~-l~~l---p~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTE-LPELPQ--SLKSLLVDNNNLKA-LSDL---PPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSS-CCCCCT--TCCEEECCSSCCSC-CCSC---CTTCCEEECCS
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcc-cccchh--hhhhhhhhhcccch-hhhh---ccccccccccc
Confidence 5778899999987 57753 4688999999999984 454432 38888999998873 3321 24689999999
Q ss_pred CcCCCCCCccccCCCCCCEEEcccCcCCccCC------------------hhccCCCCCCEEEccCCcCCCcC-------
Q 003737 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELP------------------AELTKLTNLNDLRISDNNFSGKI------- 227 (799)
Q Consensus 173 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p------------------~~~~~l~~L~~L~Ls~N~l~~~~------- 227 (799)
|.++ .+|. ++.+++|++|++++|.+....+ ..+..++.++.|++++|.+....
T Consensus 108 n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~ 185 (353)
T d1jl5a_ 108 NQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLE 185 (353)
T ss_dssp SCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCC
T ss_pred cccc-cccc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceeccccccccccccccccccc
Confidence 9887 5564 6788999999998887763221 12334455566666655543211
Q ss_pred -----------CccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcc
Q 003737 228 -----------PEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHG 296 (799)
Q Consensus 228 -----------p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~ 296 (799)
...+..++.|+.+++++|.... ++. ...++..+.+.++..... +.. ...+...++..+.+.+
T Consensus 186 ~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~--~~~-~~~l~~~~~~~~~~~~ 258 (353)
T d1jl5a_ 186 SIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDL--PEL-PQSLTFLDVSENIFSG 258 (353)
T ss_dssp EEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCC--CCC-CTTCCEEECCSSCCSE
T ss_pred ccccccccccccccccccccccccccccccccc-ccc---cccccccccccccccccc--ccc-cccccccccccccccc
Confidence 1112334445555555544432 121 122333444433222110 000 0123333333332221
Q ss_pred ----------------cCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhhcCCCEEEee
Q 003737 297 ----------------EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDIS 360 (799)
Q Consensus 297 ----------------~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~l~~l~ls 360 (799)
.++.....+++|++|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|. ...+++.|+++
T Consensus 259 l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~-~~~~L~~L~L~ 332 (353)
T d1jl5a_ 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPE-LPQNLKQLHVE 332 (353)
T ss_dssp ESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCC-CCTTCCEEECC
T ss_pred cccccchhcccccccCccccccccCCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCC-cccc-ccCCCCEEECc
Confidence 11112233578899999999888 5664 3578888999999988 5665 34578889999
Q ss_pred cCcCcccCC
Q 003737 361 LNNFTWESS 369 (799)
Q Consensus 361 ~N~~~g~~p 369 (799)
+|+++ .+|
T Consensus 333 ~N~L~-~lp 340 (353)
T d1jl5a_ 333 YNPLR-EFP 340 (353)
T ss_dssp SSCCS-SCC
T ss_pred CCcCC-CCC
Confidence 99887 344
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.69 E-value=2.6e-17 Score=161.02 Aligned_cols=130 Identities=19% Similarity=0.247 Sum_probs=96.4
Q ss_pred CEEEccCCcCCCcCcccccccceeEEEccCCcCcCc-CCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccC
Q 003737 119 KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGP-FPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN 197 (799)
Q Consensus 119 ~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~-~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 197 (799)
++++.++++++.+ |..+. ..+++|+|++|+|++. .+..|.++++|++|+|++|++....+..|..+++|++|+|++|
T Consensus 11 ~~v~Cs~~~L~~i-P~~lp-~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 11 TTVDCTGRGLKEI-PRDIP-LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp TEEECTTSCCSSC-CSCCC-TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred CEEEEeCCCcCcc-CCCCC-CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 4678888888854 33321 2377888888888753 3556677888888888888887777777778888888888888
Q ss_pred cCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCC
Q 003737 198 SFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP 250 (799)
Q Consensus 198 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 250 (799)
+++...|..|.++++|++|+|++|+|++..|+.|..+++|++|+|++|.+...
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 88766677777888888888888888777777777777888888877777644
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=2.4e-16 Score=159.75 Aligned_cols=214 Identities=16% Similarity=0.111 Sum_probs=118.8
Q ss_pred CEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCC-ccccCCCCCCEEEccc-
Q 003737 119 KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIP-PDIRKLINLQKLILSS- 196 (799)
Q Consensus 119 ~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~- 196 (799)
+.++.+++.++.. |..+. ..+++|++++|+|+...+..|.++++|++|+|++|.+...++ ..|.+++++++|++..
T Consensus 11 ~~i~c~~~~l~~i-P~~l~-~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 11 RVFLCQESKVTEI-PSDLP-RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp SEEEEESCSCSSC-CSCSC-SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred CEEEEeCCCCCCc-CCCCC-CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 4566666666633 32221 125666666666665444556666666666666666554333 3455666666666543
Q ss_pred CcCCccCChhccCCCCCCEEEccCCcCCCcCCc-cccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCC
Q 003737 197 NSFTGELPAELTKLTNLNDLRISDNNFSGKIPE-FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA 275 (799)
Q Consensus 197 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~ 275 (799)
|.+....+..|.++++|++|++++|++....+. .+..++.+..+...++.+....+..+..++
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~---------------- 152 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS---------------- 152 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSB----------------
T ss_pred ccccccccccccccccccccccchhhhccccccccccccccccccccccccccccccccccccc----------------
Confidence 455545555566666666666666665432111 122233333333334333322222221111
Q ss_pred CCccCCCCccEEEccCCcCcccCCccccCCCCCC-eeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhhcCC
Q 003737 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLK-NIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSN 354 (799)
Q Consensus 276 ~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~l 354 (799)
..++.|++++|+++...+..+ ..++++ .+++++|+++...+..|.++++|++|++++|+++ .+|...+..+
T Consensus 153 ------~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~l 224 (242)
T d1xwdc1 153 ------FESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENL 224 (242)
T ss_dssp ------SSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC-CCCSSSCTTC
T ss_pred ------ccceeeecccccccccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC-ccCHHHHcCC
Confidence 356777788888875444433 344444 4466777888655566788888888888888887 5666666666
Q ss_pred CEEE
Q 003737 355 KNVD 358 (799)
Q Consensus 355 ~~l~ 358 (799)
..|.
T Consensus 225 ~~L~ 228 (242)
T d1xwdc1 225 KKLR 228 (242)
T ss_dssp CEEE
T ss_pred cccc
Confidence 5554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=7.6e-17 Score=163.54 Aligned_cols=226 Identities=16% Similarity=0.141 Sum_probs=164.5
Q ss_pred eEecCCCCcccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcC-CcccC
Q 003737 83 VTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPF-PKVLT 160 (799)
Q Consensus 83 v~c~~~~~~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~-p~~~~ 160 (799)
..|+|.+ +.+++++.+++ .+|..+. +++++|||++|+++...+..|..++ |++|++++|.+...+ +..|.
T Consensus 4 ~~C~C~~-----~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~ 75 (242)
T d1xwdc1 4 RICHCSN-----RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFS 75 (242)
T ss_dssp SSEEECS-----SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEE
T ss_pred CcCCCcC-----CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccc
Confidence 3466542 35778888888 7887664 6899999999999988888898887 999999999987654 55789
Q ss_pred CCCCCCEEEeeC-CcCCCCCCccccCCCCCCEEEcccCcCCccCCh-hccCCCCCCEEEccCCcCCCcCCccccCCC-CC
Q 003737 161 NITTLKNLSIEG-NLFTGSIPPDIRKLINLQKLILSSNSFTGELPA-ELTKLTNLNDLRISDNNFSGKIPEFIGKWK-KI 237 (799)
Q Consensus 161 ~L~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L 237 (799)
+++++++|++.. |++....+..|.++++|++|++++|.+....+. .+..++.+..+..+++.+....+..|..++ .+
T Consensus 76 ~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l 155 (242)
T d1xwdc1 76 NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFES 155 (242)
T ss_dssp SCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSC
T ss_pred cccccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccc
Confidence 999999999875 678777778899999999999999999743322 234556666777788888766667777765 78
Q ss_pred CEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCCCCccEEEccCCcCcccCCccccCCCCCCeecccccc
Q 003737 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNN 317 (799)
Q Consensus 238 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 317 (799)
+.|++++|+++...+.. ....+++.+ +++++|+++...+..|.++++|++|+|++|+
T Consensus 156 ~~L~l~~n~l~~i~~~~-~~~~~l~~~----------------------~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~ 212 (242)
T d1xwdc1 156 VILWLNKNGIQEIHNCA-FNGTQLDEL----------------------NLSDNNNLEELPNDVFHGASGPVILDISRTR 212 (242)
T ss_dssp EEEECCSSCCCEECTTT-TTTCCEEEE----------------------ECTTCTTCCCCCTTTTTTSCCCSEEECTTSC
T ss_pred eeeeccccccccccccc-ccchhhhcc----------------------ccccccccccccHHHhcCCCCCCEEECCCCc
Confidence 99999999998543333 233333332 2345566664444557777888888888888
Q ss_pred CCCCCchhhhccCCCCEEeccC
Q 003737 318 LTGGIPTTFEKLAKTNFMYLTG 339 (799)
Q Consensus 318 l~~~~p~~~~~l~~L~~L~L~~ 339 (799)
|+...+..|.++++|+.+++.+
T Consensus 213 l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 213 IHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp CCCCCSSSCTTCCEEESSSEES
T ss_pred CCccCHHHHcCCcccccCcCCC
Confidence 8755555566666666655543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=1.6e-17 Score=172.07 Aligned_cols=117 Identities=18% Similarity=0.300 Sum_probs=98.7
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeC----CCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEE
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 748 (799)
..++|+..+.||+|+||.||+|+.. .+..||||+++... ....+.|.+|++++++++|||||+++|++. ++..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 3456888899999999999999853 24578999986543 334578999999999999999999999985 56789
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||+++|+|.+++..... .+++..+..++.||++||+|||+
T Consensus 84 iv~E~~~~g~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~ 126 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLES 126 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeccCCcHHhhhhccCC--------CCCHHHHHHHHHHHHHHhhhhcc
Confidence 99999999999998875432 57788999999999999999995
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=2.8e-17 Score=172.38 Aligned_cols=116 Identities=27% Similarity=0.468 Sum_probs=96.5
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh--hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
++|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788899999999999999995 6799999999965432 235789999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+.++ +.+++...... .+++..++.|+.||+.||+|||+
T Consensus 82 ~~~~~-~~~~~~~~~~~-------~l~e~~~~~~~~qil~~L~yLH~ 120 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASALT-------GIPLPLIKSYLFQLLQGLAFCHS 120 (298)
T ss_dssp CCSEE-HHHHHHHTTTT-------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCc-hhhhhhhhccc-------CCCHHHHHHHHHHHHHHHHHhhc
Confidence 99764 44454433221 68899999999999999999995
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.68 E-value=1.6e-17 Score=162.53 Aligned_cols=157 Identities=20% Similarity=0.270 Sum_probs=130.5
Q ss_pred EEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCc-Ccccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeC
Q 003737 95 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGS-FSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (799)
Q Consensus 95 ~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~ 172 (799)
+.+++++++++ .+|..+. +++++|+|++|+|++. .+..|..+. |++|+|++|++.+..+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 36889999998 7887764 7899999999999874 466778887 99999999999999999999999999999999
Q ss_pred CcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCc
Q 003737 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252 (799)
Q Consensus 173 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 252 (799)
|+++...|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....+.. .-...++.+.+..|.++...|
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCSS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeCCC
Confidence 9999887888999999999999999999888889999999999999999987543221 112235555666677665555
Q ss_pred hhh
Q 003737 253 ASI 255 (799)
Q Consensus 253 ~~~ 255 (799)
..+
T Consensus 167 ~~l 169 (192)
T d1w8aa_ 167 SKV 169 (192)
T ss_dssp TTT
T ss_pred hhh
Confidence 443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=2.5e-17 Score=174.87 Aligned_cols=126 Identities=22% Similarity=0.379 Sum_probs=99.1
Q ss_pred hhcCCCCCCeecccCCeeEEEEEeC-CC-----cEEEEEEcccc-ChhhHHHHHHHHHHHHhC-CCCcccceeEEEEECC
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGILS-DG-----TVIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN 745 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~~-~g-----~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 745 (799)
..++|+..+.||+|+||+||+|+.. .+ ..||||++... .....+.|.+|++++.++ +|||||+++++|.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 4467888899999999999999853 22 36999998654 333456899999999998 8999999999999999
Q ss_pred EEEEEEecCCCCcHHHHHhcCcccccc--------------cccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFHI--------------SIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~--------------~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++|||||++|+|.++|+.+...... .....+++..+..|+.||++||+|||+
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~ 182 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF 182 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999999999865432111 111247888899999999999999995
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=9e-17 Score=169.29 Aligned_cols=111 Identities=27% Similarity=0.403 Sum_probs=93.7
Q ss_pred CCeecccCCeeEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC-CEEEEEEecC
Q 003737 681 ANKVGEGGFGSVYKGILSD----GTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-NQLLLVYEYM 754 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~~~----g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~ 754 (799)
.++||+|+||+||+|.+.+ ...||||+++.. .....++|.+|+++|++++|||||+++|+|.+. ...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999999643 236899999754 444567899999999999999999999998864 5899999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|+|.++++.... .+++..+..++.|+|+||+|||+
T Consensus 112 ~~g~l~~~~~~~~~--------~~~~~~~~~i~~qia~gL~~lH~ 148 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLAS 148 (311)
T ss_dssp TTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCchhhhhccccc--------cchHHHHHHHHHHHHHhhhhhcc
Confidence 99999999986543 45566777889999999999994
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.67 E-value=3.2e-17 Score=175.55 Aligned_cols=115 Identities=21% Similarity=0.287 Sum_probs=102.7
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 751 (799)
++|+..+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4688889999999999999995 579999999986532 233567999999999999999999999999999999999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||+++|+|.+++...+ .+++..++.|+.||+.||+|||+
T Consensus 121 e~~~~g~l~~~l~~~~---------~l~e~~~~~i~~qi~~aL~yLH~ 159 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---------RFSEPHARFYAAQIVLTFEYLHS 159 (350)
T ss_dssp ECCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccchhhhHhhcC---------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999998654 67899999999999999999994
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.67 E-value=3.1e-17 Score=176.62 Aligned_cols=115 Identities=21% Similarity=0.350 Sum_probs=97.5
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC---hhhHHHHHH---HHHHHHhCCCCcccceeEEEEECCEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVN---EIGMISAQQHPNLVKLYGCCVEGNQLL 748 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~---E~~~l~~l~H~niv~l~g~~~~~~~~~ 748 (799)
++|+..+.||+|+||.||+|+. .+|+.||||++.... ......+.+ |+++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5788899999999999999995 579999999986432 122233444 467778889999999999999999999
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|||||++|+|.++|.... .+++..++.|+.||+.||+|||+
T Consensus 84 ivmE~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~aL~ylH~ 125 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---------VFSEADMRFYAAEIILGLEHMHN 125 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEecCCCcHHHHHHhcc---------cccHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999998654 57788999999999999999994
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.67 E-value=4.1e-17 Score=170.12 Aligned_cols=115 Identities=22% Similarity=0.354 Sum_probs=102.0
Q ss_pred cCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccCh--hhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEec
Q 003737 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 753 (799)
++|+..+.||+|+||+||+|+.++|+.||||+++.... ...+.|.+|+.+|++++|||||++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 56888899999999999999988999999999976532 2357899999999999999999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+.++.+..+....+ .+++..++.++.||+.||+|||+
T Consensus 82 ~~~~~~~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH~ 118 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG---------GLESVTAKSFLLQLLNGIAYCHD 118 (286)
T ss_dssp CSEEHHHHHHTSTT---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ehhhhHHHHHhhcC---------CcchhhhHHHHHHHHHHHHHhcc
Confidence 99887777765543 68899999999999999999994
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=3.9e-17 Score=172.32 Aligned_cols=126 Identities=21% Similarity=0.310 Sum_probs=103.2
Q ss_pred hhcCCCCCCeecccCCeeEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccceeEEEEECC
Q 003737 674 ATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN 745 (799)
Q Consensus 674 ~t~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 745 (799)
..++|+..+.||+|+||.||+|+. .+++.||||+++... .....+|.+|++++.++ +|||||+++|+|.+.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 446677889999999999999985 246789999997653 34456899999999998 6999999999999999
Q ss_pred EEEEEEecCCCCcHHHHHhcCccccc---------ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFH---------ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~---------~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++|||||++|+|.++++....... ......+++..+..|+.||++||+|||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~ 163 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS 163 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999999986542110 1122357888999999999999999994
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=7.4e-17 Score=170.67 Aligned_cols=115 Identities=23% Similarity=0.482 Sum_probs=94.8
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCc----EEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGT----VIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~----~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 749 (799)
.+|+..+.||+|+||+||+|.. .+|+ .||||+++.. .....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 3588899999999999999985 3454 6899998654 344567899999999999999999999999764 5678
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++||+.+|+|.+++..+.. .+++..+..++.|||+||+|||+
T Consensus 88 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~ 129 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLED 129 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS--------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeccCCccccccccccc--------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 8999999999998876543 57788899999999999999994
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=3.3e-16 Score=155.34 Aligned_cols=163 Identities=22% Similarity=0.328 Sum_probs=80.3
Q ss_pred CCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEc
Q 003737 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHI 242 (799)
Q Consensus 163 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 242 (799)
.+|++|++++|.++.. + .+..+++|++|++++|++++ ++ .+..+++|++|++++|++++ +| .+..+++|+.|++
T Consensus 46 ~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (210)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred cCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-cc-ccccccccccccc
Confidence 3444444444444321 1 23444444444444444442 22 13444444444444444442 22 2444444444444
Q ss_pred cCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCC
Q 003737 243 QGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG 321 (799)
Q Consensus 243 ~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 321 (799)
++|.+.. ...+.++++|+.+++++|.... .+.+.. ++|+.+++++|++++. + .+.++++|++|+|++|+++.
T Consensus 120 ~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~- 192 (210)
T d1h6ta2 120 EHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD- 192 (210)
T ss_dssp TTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB-
T ss_pred ccccccc--cccccccccccccccccccccc--ccccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCC-
Confidence 4444431 1234444444444444432211 111112 3566666666766643 2 26777888888888888874
Q ss_pred CchhhhccCCCCEEeccC
Q 003737 322 IPTTFEKLAKTNFMYLTG 339 (799)
Q Consensus 322 ~p~~~~~l~~L~~L~L~~ 339 (799)
+| .+..+++|++|+|++
T Consensus 193 l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 193 LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CG-GGTTCTTCSEEEEEE
T ss_pred Ch-hhcCCCCCCEEEccC
Confidence 44 477888888888764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=3.7e-17 Score=171.58 Aligned_cols=110 Identities=21% Similarity=0.408 Sum_probs=92.0
Q ss_pred CCeecccCCeeEEEEEe-CCCcEEEEEEccccChh-----hHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEecC
Q 003737 681 ANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQ-----GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (799)
Q Consensus 681 ~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 754 (799)
.++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 46899999999999995 57999999999654321 1346899999999999999999999999999999999999
Q ss_pred CCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 755 KNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 755 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
++|++..+...+. .+++..++.++.||++||+|||+
T Consensus 83 ~~~~~~~~~~~~~---------~l~~~~~~~~~~qil~aL~~lH~ 118 (299)
T d1ua2a_ 83 ETDLEVIIKDNSL---------VLTPSHIKAYMLMTLQGLEYLHQ 118 (299)
T ss_dssp SEEHHHHHTTCCS---------SCCSSHHHHHHHHHHHHHHHHHH
T ss_pred cchHHhhhhhccc---------CCCHHHHHHHHHHHHHHHHHhhc
Confidence 9988877665443 57788999999999999999994
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=1.8e-17 Score=174.58 Aligned_cols=128 Identities=20% Similarity=0.338 Sum_probs=103.5
Q ss_pred HHhhcCCCCCCeecccCCeeEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC
Q 003737 672 KAATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG 744 (799)
Q Consensus 672 ~~~t~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 744 (799)
+...++|...+.||+|+||+||+|... +++.||||+++.. .......|.+|++++++++|||||+++|+|..+
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 334467778899999999999999853 3578999999754 334456799999999999999999999999999
Q ss_pred CEEEEEEecCCCCcHHHHHhcCccccc-ccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIFH-ISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~~-~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+..++|||||++|+|.++++....... ......+++..+..++.|+|+||+|||+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~ 151 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA 151 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 999999999999999999975432111 1112245677888899999999999994
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.66 E-value=7.1e-16 Score=151.48 Aligned_cols=161 Identities=20% Similarity=0.317 Sum_probs=87.0
Q ss_pred CCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEE
Q 003737 161 NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKL 240 (799)
Q Consensus 161 ~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 240 (799)
.+.+|++|++++|.++. + +.+..+++|++|++++|++++. +. +.++++|++|++++|.+.. ++ .+.++++|+.|
T Consensus 38 ~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L 111 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGL 111 (199)
T ss_dssp HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEE
T ss_pred HhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCc-cc-ccCCccccccccccccccc-cc-ccccccccccc
Confidence 34455555555555542 2 2344555555555555555532 21 5555555555555555542 22 24555555555
Q ss_pred EccCCCCCCCCchhhhcCCCCCeEEcCCCCCCCCCCCccCC-CCccEEEccCCcCcccCCccccCCCCCCeeccccccCC
Q 003737 241 HIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319 (799)
Q Consensus 241 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~~~~~~~~l~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 319 (799)
++++|.+... ..+..+++|+.|++++|... .++.+.. .+|+.|++.+|++++. + .++++++|++|++++|+++
T Consensus 112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~--~~~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 112 TLFNNQITDI--DPLKNLTNLNRLELSSNTIS--DISALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp ECCSSCCCCC--GGGTTCTTCSEEECCSSCCC--CCGGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred cccccccccc--cccchhhhhHHhhhhhhhhc--ccccccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCC
Confidence 5555555432 22444555555555543322 1222333 4566666667776643 2 3677888888888888887
Q ss_pred CCCchhhhccCCCCEE
Q 003737 320 GGIPTTFEKLAKTNFM 335 (799)
Q Consensus 320 ~~~p~~~~~l~~L~~L 335 (799)
. ++ .+..+++|+.|
T Consensus 186 ~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 186 D-IS-VLAKLTNLESL 199 (199)
T ss_dssp C-CG-GGGGCTTCSEE
T ss_pred C-Cc-cccCCCCCCcC
Confidence 4 33 47777877765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=3.9e-17 Score=168.84 Aligned_cols=115 Identities=23% Similarity=0.424 Sum_probs=89.4
Q ss_pred cCCCCCCeecccCCeeEEEEEeC--CC--cEEEEEEcccc---ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGILS--DG--TVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~~--~g--~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 748 (799)
++|+..+.||+|+||.||+|+.. ++ ..||||+++.. .....++|.+|++++++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 45777889999999999999853 23 37899998754 23345789999999999999999999999965 4678
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+||||+++|++.+++..+.. .+++..+..++.|||+||+|||+
T Consensus 87 lv~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~ 129 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLES 129 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHH
T ss_pred eeeeeecCcchhhhhhcccC--------CCCHHHHHHHHHHHHHHHHHhhh
Confidence 99999999999998876532 46788899999999999999994
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=6.4e-17 Score=172.18 Aligned_cols=113 Identities=18% Similarity=0.228 Sum_probs=95.1
Q ss_pred hcCCCCC-CeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhC-CCCcccceeEEEEE----CCEE
Q 003737 675 TNNFDPA-NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE----GNQL 747 (799)
Q Consensus 675 t~~f~~~-~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~----~~~~ 747 (799)
.++|... ++||+|+||+||+|.. .+|+.||||+++. ...+.+|++++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 3567765 4699999999999994 6799999999864 24577899987654 89999999999875 3568
Q ss_pred EEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 748 LLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 748 ~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+|||||++|+|.++|..+... .+++.+++.|+.||+.||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~-------~l~e~~~~~i~~qi~~al~ylH~ 129 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLHS 129 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCC-------CEEHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEECCCCCcHHHHHHhcCCC-------CcCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999865422 57899999999999999999994
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=2.5e-16 Score=164.52 Aligned_cols=115 Identities=17% Similarity=0.315 Sum_probs=102.2
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEECCEEEEEEe
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 752 (799)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4688889999999999999994 678999999986543 3345789999999999999999999999999999999999
Q ss_pred cCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 753 YMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 753 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|+.++++..++...+ .+++..++.++.|+++||+|||+
T Consensus 82 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~q~~~aL~~lH~ 119 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---------DLDPEIVKSFLFQLLKGLGFCHS 119 (292)
T ss_dssp CCSEEHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecccccccccccccc---------ccchhHHHHHHHHHHHHHHHhhc
Confidence 999999998887654 67788999999999999999994
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.63 E-value=1.8e-15 Score=149.79 Aligned_cols=161 Identities=24% Similarity=0.315 Sum_probs=110.6
Q ss_pred cEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEee
Q 003737 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (799)
Q Consensus 93 ~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls 171 (799)
.++.|+++++.++.. + .+..+++|++|+|++|++++..+ ++.++ |++|++++|++++ +| .+.++++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECT
T ss_pred CccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCccc--cccCccccccccccccccc-cc-cccccccccccccc
Confidence 567777777777643 2 36777788888888887776443 45555 7777777777764 33 46777777777777
Q ss_pred CCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCC
Q 003737 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251 (799)
Q Consensus 172 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 251 (799)
+|.+.. ...+..+++|+.+++++|.+++ +..+..+++|+++++++|++++. + .+.++++|++|+|++|+++. +
T Consensus 121 ~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~-l 193 (210)
T d1h6ta2 121 HNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD-L 193 (210)
T ss_dssp TSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB-C
T ss_pred cccccc--cccccccccccccccccccccc--ccccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCC-C
Confidence 777652 2356777777777777777763 33466677777777777777643 3 26777777777777777764 3
Q ss_pred chhhhcCCCCCeEEcC
Q 003737 252 PASISALTSLTDLRIS 267 (799)
Q Consensus 252 p~~~~~l~~L~~L~L~ 267 (799)
| .+.++++|++|+|+
T Consensus 194 ~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 194 R-ALAGLKNLDVLELF 208 (210)
T ss_dssp G-GGTTCTTCSEEEEE
T ss_pred h-hhcCCCCCCEEEcc
Confidence 4 46777777777765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=1.6e-16 Score=166.49 Aligned_cols=125 Identities=19% Similarity=0.320 Sum_probs=96.7
Q ss_pred hcCCCCCCeecccCCeeEEEEEeC--------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccceeEEEEEC
Q 003737 675 TNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 744 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 744 (799)
.++|...+.||+|+||.||+|+.. ++..||||+++... .....++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 456777889999999999999842 23579999997654 34457899999999888 899999999999999
Q ss_pred CEEEEEEecCCCCcHHHHHhcCcccc-------cccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 745 NQLLLVYEYMKNNCLSRAIFGKLRIF-------HISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 745 ~~~~lV~Ey~~~GsL~~~L~~~~~~~-------~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+..++|||||++|+|.++|+.+.... .......+++..+..++.|||+||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~ 153 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 153 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh
Confidence 99999999999999999998654211 01112357888999999999999999995
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.62 E-value=2.9e-15 Score=147.01 Aligned_cols=159 Identities=26% Similarity=0.402 Sum_probs=115.7
Q ss_pred ccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.++++|++++++++. + +.+..+++|++|++++|++++..+ +..++ |++|++++|.+... + .+.++++|+.|++
T Consensus 40 ~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEEEC
T ss_pred cCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccccccccccc-c-ccccccccccccc
Confidence 467788888888773 3 247778888888888888876544 66665 88888888877643 3 3778888888888
Q ss_pred eCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCC
Q 003737 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP 250 (799)
Q Consensus 171 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 250 (799)
++|.+... ..+..+++|+.|++++|++.. + +.+..+++|++|++++|++++. + .++++++|++|++++|+++.
T Consensus 114 ~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~- 186 (199)
T d2omxa2 114 FNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD- 186 (199)
T ss_dssp CSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-
T ss_pred cccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC-
Confidence 88877642 347778888888888888763 3 3577788888888888888753 2 37788888888888888774
Q ss_pred CchhhhcCCCCCeE
Q 003737 251 IPASISALTSLTDL 264 (799)
Q Consensus 251 ~p~~~~~l~~L~~L 264 (799)
++ .+..+++|+.|
T Consensus 187 i~-~l~~L~~L~~L 199 (199)
T d2omxa2 187 IS-VLAKLTNLESL 199 (199)
T ss_dssp CG-GGGGCTTCSEE
T ss_pred Cc-cccCCCCCCcC
Confidence 33 46777777765
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=4.9e-16 Score=163.04 Aligned_cols=109 Identities=25% Similarity=0.383 Sum_probs=88.5
Q ss_pred CCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHH--HHHhCCCCcccceeEEEEECC----EEEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIG--MISAQQHPNLVKLYGCCVEGN----QLLLV 750 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~--~l~~l~H~niv~l~g~~~~~~----~~~lV 750 (799)
+|...+.||+|+||.||+|+. +|+.||||+++... .+++.+|.+ .+.+++|||||+++|+|.+.+ ..++|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 455677899999999999997 58899999996532 334444544 556789999999999998754 68999
Q ss_pred EecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 751 YEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 751 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
||||++|+|.++|++. .++++....++.|+|.||+|+|+
T Consensus 80 ~Ey~~~g~L~~~l~~~----------~l~~~~~~~~~~~ia~gl~~lH~ 118 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY----------TVTVEGMIKLALSTASGLAHLHM 118 (303)
T ss_dssp EECCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHHC
T ss_pred EecccCCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999864 34566777789999999999994
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=1.7e-16 Score=164.04 Aligned_cols=115 Identities=17% Similarity=0.282 Sum_probs=98.3
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccCh------hhHHHHHHHHHHHHhCC--CCcccceeEEEEECCE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR------QGNREFVNEIGMISAQQ--HPNLVKLYGCCVEGNQ 746 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~------~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~ 746 (799)
++|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|++++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4688889999999999999995 5799999999865321 12245779999999986 8999999999999999
Q ss_pred EEEEEecCCC-CcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKN-NCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~-GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++||||+.+ +++.+++..+. .++++.++.++.||++||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~---------~l~e~~~~~~~~qi~~al~~lH~ 128 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG---------ALQEELARSFFWQVLEAVRHCHN 128 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEEeccCcchHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999986 68888887654 67899999999999999999994
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=5.8e-16 Score=162.33 Aligned_cols=131 Identities=20% Similarity=0.313 Sum_probs=100.1
Q ss_pred HHHHHhhcCCCCCCeecccCCeeEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhC-CCCcccceeEE
Q 003737 669 RQIKAATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGC 740 (799)
Q Consensus 669 ~~~~~~t~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~ 740 (799)
.+++...++|+..+.||+|+||.||+|... +++.||||+++... ....+.+.+|++.+.++ +|+|||+++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 444445577888999999999999999842 35689999997643 34457889999888887 68999999999
Q ss_pred EEEC-CEEEEEEecCCCCcHHHHHhcCcccccc-------cccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 741 CVEG-NQLLLVYEYMKNNCLSRAIFGKLRIFHI-------SIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 741 ~~~~-~~~~lV~Ey~~~GsL~~~L~~~~~~~~~-------~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+..+ +..++|||||++|+|.++++.+...... .....+++.++..++.||++||+|||+
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~ 152 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 152 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh
Confidence 8765 4689999999999999999865432110 112357888999999999999999994
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.59 E-value=7.9e-16 Score=163.53 Aligned_cols=109 Identities=18% Similarity=0.368 Sum_probs=94.9
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCC-CCcccceeEEEEEC--CEEEEEE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEG--NQLLLVY 751 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~ 751 (799)
++|+..+.||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+++|.+++ ||||+++++++... +..++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 4688899999999999999995 67999999999754 3467899999999995 99999999999854 5689999
Q ss_pred ecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 752 EYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 752 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||++|+|.++.+ .+++..++.++.||+.||+|||+
T Consensus 112 e~~~~~~L~~~~~------------~l~e~~i~~i~~qil~aL~~LH~ 147 (328)
T d3bqca1 112 EHVNNTDFKQLYQ------------TLTDYDIRFYMYEILKALDYCHS 147 (328)
T ss_dssp ECCCSCBGGGTTT------------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eecCCCcHHHHhc------------CCCHHHHHHHHHHHHHHHHHHhh
Confidence 9999999976532 57889999999999999999994
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=6.9e-16 Score=165.46 Aligned_cols=115 Identities=17% Similarity=0.291 Sum_probs=98.0
Q ss_pred hcCCCCCCeecccCCeeEEEEE-eCCCcEEEEEEccccC--hhhHHHHHHHHHHHHhCCCCcccceeEEEEEC-----CE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQ 746 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 746 (799)
.++|+..+.||+|+||+||+|. ..+|+.||||+++... ....+.+.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4578889999999999999999 4689999999997543 33456789999999999999999999998643 33
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++++||+.+|+|.++++.+ .+++..++.++.||+.||+|||+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----------~l~e~~~~~i~~qil~aL~~LH~ 139 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIHS 139 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeecCCchhhhcccc----------cccHHHHHHHHHHHHHHHHHHHh
Confidence 46677888999999999653 57899999999999999999994
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=7.5e-16 Score=165.00 Aligned_cols=114 Identities=18% Similarity=0.352 Sum_probs=91.5
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEECC------
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------ 745 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 745 (799)
.++|+..+.||+|+||+||+|.. .+|+.||||+++.. .....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46788889999999999999994 57999999999754 3334568999999999999999999999997654
Q ss_pred EEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 746 QLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 746 ~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
..++||||+ +++|.++++.. .+++..++.++.||+.||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH~ 139 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE----------KLGEDRIQFLVYQMLKGLRYIHA 139 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEecc-cccHHHHHHhc----------cccHHHHHHHHHHHHHHHHHHHh
Confidence 579999999 55788776543 58899999999999999999994
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=4.9e-16 Score=164.38 Aligned_cols=115 Identities=19% Similarity=0.300 Sum_probs=100.2
Q ss_pred cCCCCCCeecccCCeeEEEEEe----CCCcEEEEEEccccC----hhhHHHHHHHHHHHHhCCC-CcccceeEEEEECCE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQ 746 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~ 746 (799)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++.+++| |||+++++++.+.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5688899999999999999984 258899999986532 2234678899999999977 899999999999999
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.++|||||.+|+|.+++...+ .+++..+..++.||+.||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---------~~~e~~~~~~~~Qi~~al~~lH~ 147 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---------RFTEHEVQIYVGEIVLALEHLHK 147 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eeeeeecccccHHHHHHHhcc---------cccHHHHHHHHHHHHHHHHHhhc
Confidence 999999999999999998665 56788999999999999999994
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=9.9e-16 Score=163.89 Aligned_cols=115 Identities=12% Similarity=0.214 Sum_probs=93.9
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhCCCCcccceeEEEEECC----EEE
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----QLL 748 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 748 (799)
+++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|.+++|||||++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45688889999999999999984 689999999997543 344568999999999999999999999997643 234
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+++||+.+|+|.+++..+ .+++..++.++.||+.||+|||+
T Consensus 87 ~l~~~~~~g~L~~~l~~~----------~l~~~~i~~i~~qil~al~yLH~ 127 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----------HLSNDHICYFLYQILRGLKYIHS 127 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeecCCchhhhhhcC----------CCCHHHHHHHHHHHHHHHHHHHH
Confidence 555677899999999754 57899999999999999999995
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=1.7e-15 Score=162.45 Aligned_cols=113 Identities=20% Similarity=0.336 Sum_probs=90.0
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccceeEEEEEC------CEEEE
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------NQLLL 749 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 749 (799)
+|...++||+|+||+||+|+. .+|+.||||++..... .+.+|+++|++++|||||++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 366778999999999999995 5799999999965432 234799999999999999999998653 24789
Q ss_pred EEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 750 VYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 750 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
|||||++|.+..+.+.... ...+++.+++.++.||++||+|||+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~------~~~l~~~~~~~i~~qil~aL~yLH~ 140 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRA------KQTLPVIYVKLYMYQLFRSLAYIHS 140 (350)
T ss_dssp EEECCSEEHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred EEeccCCccHHHHHhhhhc------cCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999987654444331111 1268899999999999999999996
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=1.5e-15 Score=160.52 Aligned_cols=116 Identities=19% Similarity=0.349 Sum_probs=95.0
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEE--------
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE-------- 743 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-------- 743 (799)
.++|+..+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36788899999999999999995 58999999998654 23345789999999999999999999999865
Q ss_pred CCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 744 GNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 744 ~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.+..++||||+++|.+........ .+++..++.+++||++||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~---------~~~~~~~~~i~~qil~~l~~lH~ 135 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV---------KFTLSEIKRVMQMLLNGLYYIHR 135 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC---------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CceEEEEEeccCCCccchhhhccc---------ccccHHHHHHHHHHHHHHHHhcc
Confidence 345799999999887765544433 67888999999999999999994
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.57 E-value=8.4e-14 Score=148.20 Aligned_cols=242 Identities=24% Similarity=0.287 Sum_probs=169.1
Q ss_pred cccEEEEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCcCCcccCCCCCCCEEEe
Q 003737 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (799)
Q Consensus 91 ~~~v~~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 170 (799)
.+++++|+|++|+|+ .+|.. +.+|+.|++++|+++.. +... -.|++|++++|.+. .+|. ++.+++|+.|++
T Consensus 57 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l-~~lp--~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l 127 (353)
T d1jl5a_ 57 PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKAL-SDLP--PLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDV 127 (353)
T ss_dssp CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCC-CSCC--TTCCEEECCSSCCS-SCCC-CTTCTTCCEEEC
T ss_pred CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchh-hhhc--cccccccccccccc-cccc-hhhhccceeecc
Confidence 357999999999999 77765 46899999999998854 2110 12999999999998 4564 688999999999
Q ss_pred eCCcCCCCCC------------------ccccCCCCCCEEEcccCcCCcc------------------CChhccCCCCCC
Q 003737 171 EGNLFTGSIP------------------PDIRKLINLQKLILSSNSFTGE------------------LPAELTKLTNLN 214 (799)
Q Consensus 171 s~N~l~~~~p------------------~~~~~l~~L~~L~Ls~N~l~~~------------------~p~~~~~l~~L~ 214 (799)
++|.+....+ ..+..++.++.|++++|.+... ....+..++.|+
T Consensus 128 ~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~ 207 (353)
T d1jl5a_ 128 DNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLT 207 (353)
T ss_dssp CSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCC
T ss_pred ccccccccccccccccchhhccccccccccccccccceeccccccccccccccccccccccccccccccccccccccccc
Confidence 9988753221 2355677889999988876531 112345678999
Q ss_pred EEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCchhhhcCCCCCeEEcCCCCC---------------CCCCCCcc
Q 003737 215 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG---------------SESAFPKL 279 (799)
Q Consensus 215 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~~---------------~~~~~~~l 279 (799)
.+++++|.... +|. ...++..+.+..|.+... +.. ...+...++..+.. ....++.+
T Consensus 208 ~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~-~~~---~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~ 279 (353)
T d1jl5a_ 208 TIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDL-PEL---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSL 279 (353)
T ss_dssp EEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEE
T ss_pred ccccccccccc-ccc---cccccccccccccccccc-ccc---cccccccccccccccccccccchhcccccccCccccc
Confidence 99999998763 443 345688888888887642 221 23333444332111 11112222
Q ss_pred CC--CCccEEEccCCcCcccCCccccCCCCCCeeccccccCCCCCchhhhccCCCCEEeccCCcCCCcCChhhhcCCCEE
Q 003737 280 DK--MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV 357 (799)
Q Consensus 280 ~~--~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~l~~l 357 (799)
.. ++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|+.|++++|+++ .+|. +...++.|
T Consensus 280 ~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~-~~~~L~~L 349 (353)
T d1jl5a_ 280 CDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD-IPESVEDL 349 (353)
T ss_dssp CCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC-CCTTCCEE
T ss_pred cccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCc-cccccCee
Confidence 22 58999999999998 56653 678999999999999 56653 568999999999998 6775 33456666
Q ss_pred Ee
Q 003737 358 DI 359 (799)
Q Consensus 358 ~l 359 (799)
.+
T Consensus 350 ~~ 351 (353)
T d1jl5a_ 350 RM 351 (353)
T ss_dssp EC
T ss_pred EC
Confidence 54
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=2.3e-15 Score=161.64 Aligned_cols=112 Identities=18% Similarity=0.256 Sum_probs=92.3
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhCCCCcccceeEEEEE------CCE
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE------GNQ 746 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~~ 746 (799)
++|+..+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|++++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 5688899999999999999995 57999999999754 23345678999999999999999999999964 367
Q ss_pred EEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 747 LLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 747 ~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
.|+||||+.+|.+ +.++. .+++..++.+++||+.||+|||+
T Consensus 97 ~~iv~Ey~~~~l~-~~~~~-----------~~~~~~i~~~~~qil~gl~~LH~ 137 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQM-----------ELDHERMSYLLYQMLCGIKHLHS 137 (355)
T ss_dssp EEEEEECCSEEHH-HHHTS-----------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEeccchHHH-Hhhhc-----------CCCHHHHHHHHHHHHHHHHHhhh
Confidence 8999999976544 44432 46788999999999999999994
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=8e-16 Score=159.95 Aligned_cols=209 Identities=14% Similarity=0.218 Sum_probs=114.9
Q ss_pred CCCCCEEEeeCCcCCCC-CCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCC-cCCCc-CCccccCCCCCC
Q 003737 162 ITTLKNLSIEGNLFTGS-IPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN-NFSGK-IPEFIGKWKKIQ 238 (799)
Q Consensus 162 L~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~ 238 (799)
..+|++|||+++.++.. ++..+..+++|++|+|++|.++...+..+..+++|++|+++++ .++.. +...+..+++|+
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~ 124 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcc
Confidence 34555555555554422 2223445556666666666555555555555566666666553 23311 111223455666
Q ss_pred EEEccCC-CCCCC-Cchhhhc-CCCCCeEEcCCCC--CCCCCCCcc-CC-CCccEEEccCC-cCcccCCccccCCCCCCe
Q 003737 239 KLHIQGS-SLEGP-IPASISA-LTSLTDLRISDLK--GSESAFPKL-DK-MNLKTLILTKC-LIHGEIPDYIGDMTKLKN 310 (799)
Q Consensus 239 ~L~L~~N-~l~~~-~p~~~~~-l~~L~~L~L~~n~--~~~~~~~~l-~~-~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~ 310 (799)
+|+++++ .++.. +...+.. .++|+.|+++++. .....+..+ .. ++|++|++++| .+++.....+..+++|++
T Consensus 125 ~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~ 204 (284)
T d2astb2 125 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH 204 (284)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred ccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCE
Confidence 6666654 23211 1122222 3456666665431 122222222 12 56777777765 466666667778888999
Q ss_pred eccccc-cCCCCCchhhhccCCCCEEeccCCcCCCcCChhhhcCCCEEEeecCcCcccCCCC
Q 003737 311 IDLSFN-NLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDP 371 (799)
Q Consensus 311 L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~l~~l~ls~N~~~g~~p~~ 371 (799)
|+|++| .+++.....+.++++|+.|+++++ ++...-..+...+..|++..++++...++.
T Consensus 205 L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L~i~~~~ls~~~~~~ 265 (284)
T d2astb2 205 LSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHLQINCSHFTTIARPT 265 (284)
T ss_dssp EECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred EECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCccccccCccCCCCCCCc
Confidence 999884 677666677888899999999887 332211223344555667777777655443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=7.3e-15 Score=154.25 Aligned_cols=117 Identities=21% Similarity=0.425 Sum_probs=91.9
Q ss_pred hcCCCCCCeecccCCeeEEEEEe-CC-CcEEEEEEccccC--hhhHHHHHHHHHHHHhC---CCCcccceeEEEEE----
Q 003737 675 TNNFDPANKVGEGGFGSVYKGIL-SD-GTVIAVKQLSSKS--RQGNREFVNEIGMISAQ---QHPNLVKLYGCCVE---- 743 (799)
Q Consensus 675 t~~f~~~~~lG~G~~g~Vy~~~~-~~-g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~---- 743 (799)
.++|+..+.||+|+||+||+|+. .+ ++.||||+++... ......+.+|+++++++ +|||||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46788899999999999999985 44 6789999986542 22234567787776655 89999999999864
Q ss_pred -CCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 744 -GNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 744 -~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
....+++|||+++|.+......... .++++.++.++.||++||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~yLH~ 134 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEP--------GVPTETIKDMMFQLLRGLDFLHS 134 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTT--------CSCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCceEEEEEEeccCCchhhhhhccCC--------CCCHHHHHHHHHHHHHHHHHHHh
Confidence 2468999999999887655543322 57888999999999999999994
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=2.8e-15 Score=155.74 Aligned_cols=251 Identities=20% Similarity=0.283 Sum_probs=166.2
Q ss_pred EEEeCCCCCcccCCccccCCCCCCEEEccCCcCCCcCcccccccceeEEEccCCcCcCc-CCcccCCCCCCCEEEeeCCc
Q 003737 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGP-FPKVLTNITTLKNLSIEGNL 174 (799)
Q Consensus 96 ~L~L~~~~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~L~~L~Ls~N~l~~~-~p~~~~~L~~L~~L~Ls~N~ 174 (799)
.+||+++.+.......+.. ..+..+.++...+.......+...+|++||++++.++.. ++..+..+++|++|+|+++.
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~ 82 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCB
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccC
Confidence 5677777665332222221 245566777666655444555555688888888887643 44557788899999999888
Q ss_pred CCCCCCccccCCCCCCEEEcccC-cCCcc-CChhccCCCCCCEEEccCCc-CCCc-CCccccC-CCCCCEEEccCC--CC
Q 003737 175 FTGSIPPDIRKLINLQKLILSSN-SFTGE-LPAELTKLTNLNDLRISDNN-FSGK-IPEFIGK-WKKIQKLHIQGS--SL 247 (799)
Q Consensus 175 l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~Ls~N~-l~~~-~p~~~~~-l~~L~~L~L~~N--~l 247 (799)
+++..+..+..+++|++|++++| .++.. +..-+..+++|++|+++++. ++.. +...+.. .++|+.|+++++ .+
T Consensus 83 l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i 162 (284)
T d2astb2 83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNL 162 (284)
T ss_dssp CCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGS
T ss_pred CCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccc
Confidence 87766777888889999999885 45421 22224567889999998863 4321 2222333 468899998865 34
Q ss_pred CCC-CchhhhcCCCCCeEEcCCCCCCC-CCCCccCC-CCccEEEccCC-cCcccCCccccCCCCCCeeccccccCCCCCc
Q 003737 248 EGP-IPASISALTSLTDLRISDLKGSE-SAFPKLDK-MNLKTLILTKC-LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323 (799)
Q Consensus 248 ~~~-~p~~~~~l~~L~~L~L~~n~~~~-~~~~~l~~-~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 323 (799)
+.. +.....++++|++|+++++...+ ..+..+.. ++|++|+|++| .++......++++++|+.|+++++--.+.++
T Consensus 163 ~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~ 242 (284)
T d2astb2 163 QKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242 (284)
T ss_dssp CHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHH
T ss_pred ccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHH
Confidence 322 33344678899999998865444 34444555 78999999985 6776666678889999999999983333444
Q ss_pred hhhhccCCCCEEeccCCcCCCcCChhh
Q 003737 324 TTFEKLAKTNFMYLTGNKLTGPVPKYI 350 (799)
Q Consensus 324 ~~~~~l~~L~~L~L~~N~l~g~~p~~~ 350 (799)
.....+|+|+ +..++++...++.+
T Consensus 243 ~l~~~lp~L~---i~~~~ls~~~~~~~ 266 (284)
T d2astb2 243 LLKEALPHLQ---INCSHFTTIARPTI 266 (284)
T ss_dssp HHHHHSTTSE---ESCCCSCCTTCSSC
T ss_pred HHHHhCcccc---ccCccCCCCCCCcc
Confidence 4445677765 47788887655544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.48 E-value=8.8e-14 Score=124.97 Aligned_cols=118 Identities=19% Similarity=0.289 Sum_probs=76.6
Q ss_pred eEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCC
Q 003737 142 VELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221 (799)
Q Consensus 142 ~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 221 (799)
|+|+|++|+++ .++ .+..+++|++|++++|+++ .+|+.++.+++|++|++++|.++. +| .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 35666666666 333 3667777777777777776 466667777777777777777763 34 3777777777777777
Q ss_pred cCCCcC-CccccCCCCCCEEEccCCCCCCC---CchhhhcCCCCCeE
Q 003737 222 NFSGKI-PEFIGKWKKIQKLHIQGSSLEGP---IPASISALTSLTDL 264 (799)
Q Consensus 222 ~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~---~p~~~~~l~~L~~L 264 (799)
+++... ...+..+++|++|++++|+++.. .......+++|+.|
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 776432 24567777777777777776532 23334456666654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=1.9e-15 Score=167.12 Aligned_cols=157 Identities=15% Similarity=0.223 Sum_probs=100.9
Q ss_pred CCCCCEEEccCCcCCC-----cCCccccCCCCCCEEEccCCCCCCC----CchhhhcCCCCCeEEcCCCCCCCCCCCc--
Q 003737 210 LTNLNDLRISDNNFSG-----KIPEFIGKWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESAFPK-- 278 (799)
Q Consensus 210 l~~L~~L~Ls~N~l~~-----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~n~~~~~~~~~-- 278 (799)
.+.++.+++++|.+.. ..+........++.|++++|.+... ....+...+.++.+++++|......+..
T Consensus 225 ~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~ 304 (460)
T d1z7xw1 225 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLC 304 (460)
T ss_dssp CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHH
T ss_pred cccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhh
Confidence 3455566666655421 1222334466899999999988643 2334566788999999886653322211
Q ss_pred --c--CCCCccEEEccCCcCcccCCc----cccCCCCCCeeccccccCCCC----Cchhhh-ccCCCCEEeccCCcCCCc
Q 003737 279 --L--DKMNLKTLILTKCLIHGEIPD----YIGDMTKLKNIDLSFNNLTGG----IPTTFE-KLAKTNFMYLTGNKLTGP 345 (799)
Q Consensus 279 --l--~~~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~L~~N~l~g~ 345 (799)
+ ....|+.+++++|.++..... .+...++|++|+|++|+++.. ++..+. ..+.|+.|+|++|+|+..
T Consensus 305 ~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~ 384 (460)
T d1z7xw1 305 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 384 (460)
T ss_dssp HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHH
T ss_pred ccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChH
Confidence 1 125788999999988754333 234556899999999988743 233333 356799999999998742
Q ss_pred ----CChhhh--cCCCEEEeecCcCcc
Q 003737 346 ----VPKYIF--NSNKNVDISLNNFTW 366 (799)
Q Consensus 346 ----~p~~~~--~~l~~l~ls~N~~~g 366 (799)
++..+. +.++.|||++|+++.
T Consensus 385 ~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 385 SCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred HHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 233332 568899999998875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.45 E-value=1.1e-13 Score=144.00 Aligned_cols=113 Identities=16% Similarity=0.241 Sum_probs=96.5
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCC-CcccceeEEEEECCEEEEEEec
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQLLLVYEY 753 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey 753 (799)
++|+..+.||+|+||+||+|+. .+|+.||||.+.... ....+.+|++.+..++| +|++.+++++......++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 5688889999999999999994 578999999986542 23457788999999976 8999999999999999999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+ +|+|.++++.... .+++..+..++.|++.||+|||+
T Consensus 83 ~-~~~l~~~~~~~~~--------~~~~~~~~~i~~q~~~~l~~lH~ 119 (293)
T d1csna_ 83 L-GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHE 119 (293)
T ss_dssp C-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHT
T ss_pred c-CCCHHHHHHhhcc--------chhhHHHHHHHHHHHHHHHHHHH
Confidence 9 6899999876543 57788889999999999999996
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=8.2e-14 Score=131.48 Aligned_cols=123 Identities=14% Similarity=0.163 Sum_probs=74.1
Q ss_pred eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccC
Q 003737 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220 (799)
Q Consensus 141 L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 220 (799)
+++|+|++|+|+. +|..+..+++|+.|+|++|.++ .++ .|..+++|++|++++|+++...+..+..+++|++|++++
T Consensus 20 lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~ 96 (162)
T d1a9na_ 20 DRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN 96 (162)
T ss_dssp CEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCS
T ss_pred CcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecc
Confidence 5555555555553 3445555666667777766665 332 366666777777777776644444455667777777777
Q ss_pred CcCCCcCC-ccccCCCCCCEEEccCCCCCCCC---chhhhcCCCCCeEEc
Q 003737 221 NNFSGKIP-EFIGKWKKIQKLHIQGSSLEGPI---PASISALTSLTDLRI 266 (799)
Q Consensus 221 N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~---p~~~~~l~~L~~L~L 266 (799)
|+++.... ..+..+++|++|++++|.++... +..+..+++|+.||-
T Consensus 97 N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 97 NSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp CCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred ccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence 77653211 34666677777777777665322 234666777777753
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.42 E-value=3.4e-13 Score=121.05 Aligned_cols=117 Identities=21% Similarity=0.296 Sum_probs=80.9
Q ss_pred CEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccC
Q 003737 119 KQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN 197 (799)
Q Consensus 119 ~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 197 (799)
|+|||++|+++.. + .+..+. |++|++++|.|+ .+|..++.+++|++|++++|.++. +| .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 4677777777644 2 255565 777777777776 466677888888888888888874 44 4788888888888888
Q ss_pred cCCccC-ChhccCCCCCCEEEccCCcCCCc---CCccccCCCCCCEE
Q 003737 198 SFTGEL-PAELTKLTNLNDLRISDNNFSGK---IPEFIGKWKKIQKL 240 (799)
Q Consensus 198 ~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L 240 (799)
+++... ...+..+++|++|++++|.++.. ....+..+++|+.|
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 887432 24677888888888888887632 22233446666654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=9.9e-14 Score=130.91 Aligned_cols=127 Identities=21% Similarity=0.173 Sum_probs=98.4
Q ss_pred cccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCC
Q 003737 111 ELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINL 189 (799)
Q Consensus 111 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L 189 (799)
.+.+...|++|||++|+|+.. +..+..++ |++|+|++|.|+.. + .|..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l-~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL-D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE-C-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc-C-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 466777888888888888865 45555565 88888888888844 3 47888999999999999985545556788999
Q ss_pred CEEEcccCcCCccCC--hhccCCCCCCEEEccCCcCCCcCC----ccccCCCCCCEEEc
Q 003737 190 QKLILSSNSFTGELP--AELTKLTNLNDLRISDNNFSGKIP----EFIGKWKKIQKLHI 242 (799)
Q Consensus 190 ~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L 242 (799)
++|++++|+++. ++ ..+..+++|++|++++|.++. .| ..+..+++|+.||-
T Consensus 90 ~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 90 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETT
T ss_pred ccceeccccccc-cccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeCC
Confidence 999999999874 33 457888999999999998874 34 35778899998873
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.41 E-value=2.2e-13 Score=142.31 Aligned_cols=113 Identities=21% Similarity=0.308 Sum_probs=90.6
Q ss_pred cCCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCCCCcccce-eEEEEECCEEEEEEec
Q 003737 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL-YGCCVEGNQLLLVYEY 753 (799)
Q Consensus 676 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l-~g~~~~~~~~~lV~Ey 753 (799)
++|+..+.||+|+||+||+|.. .+|+.||||++..... .+++.+|++++++++|+|+|.. .++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4588889999999999999984 5789999999865432 2458899999999988776655 4555778889999999
Q ss_pred CCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 754 MKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 754 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+. |++.+.+..... .+++..+..++.|+++||+|||+
T Consensus 85 ~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~ 121 (299)
T d1ckia_ 85 LG-PSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHS 121 (299)
T ss_dssp CC-CBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cC-CchhhhhhhccC--------CCcHHHHHHHHHHHHHHHHHHHH
Confidence 95 566666654332 57888999999999999999994
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=1e-14 Score=161.16 Aligned_cols=275 Identities=16% Similarity=0.177 Sum_probs=185.7
Q ss_pred ccEEEEEeCCCCCccc-CCccccCCCCCCEEEccCCcCCC----cCcccccccc-eeEEEccCCcCcCc----CCcccC-
Q 003737 92 CHVVTIALKAQNLTGT-LPTELSKLRYLKQLDLSRNCLTG----SFSPQWASLQ-LVELSVMGNRLSGP----FPKVLT- 160 (799)
Q Consensus 92 ~~v~~L~L~~~~l~g~-~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~-L~~L~Ls~N~l~~~----~p~~~~- 160 (799)
.++++||++++++++. +..-+..++++++|+|++|.++. .+...+...+ |++|||++|.|+.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 3689999999999863 23446678999999999999874 2344455565 99999999998632 222332
Q ss_pred CCCCCCEEEeeCCcCCCC----CCccccCCCCCCEEEcccCcCCccC----C----------------------------
Q 003737 161 NITTLKNLSIEGNLFTGS----IPPDIRKLINLQKLILSSNSFTGEL----P---------------------------- 204 (799)
Q Consensus 161 ~L~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p---------------------------- 204 (799)
...+|++|+|++|.++.. ++..+..+++|++|++++|.++..- .
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 161 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence 235899999999998743 3456788999999999999875310 0
Q ss_pred -hhccCCCCCCEEEccCCcCCCc---------------------------------CCccccCCCCCCEEEccCCCCCC-
Q 003737 205 -AELTKLTNLNDLRISDNNFSGK---------------------------------IPEFIGKWKKIQKLHIQGSSLEG- 249 (799)
Q Consensus 205 -~~~~~l~~L~~L~Ls~N~l~~~---------------------------------~p~~~~~l~~L~~L~L~~N~l~~- 249 (799)
..+.....++.++++.+..... ....+.....++.++++.|.+..
T Consensus 162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~ 241 (460)
T d1z7xw1 162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 241 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccccc
Confidence 0012234566666665543210 00112345677888888887642
Q ss_pred ----CCchhhhcCCCCCeEEcCCCCCCCCCCCc----cCC-CCccEEEccCCcCcccCCccc-----cCCCCCCeecccc
Q 003737 250 ----PIPASISALTSLTDLRISDLKGSESAFPK----LDK-MNLKTLILTKCLIHGEIPDYI-----GDMTKLKNIDLSF 315 (799)
Q Consensus 250 ----~~p~~~~~l~~L~~L~L~~n~~~~~~~~~----l~~-~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~Ls~ 315 (799)
..+........++.|++++|......... +.. ..++.+++++|.++......+ .....|+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~ 321 (460)
T d1z7xw1 242 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 321 (460)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred ccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccc
Confidence 12333445678999999986654332211 222 689999999999874322221 2346899999999
Q ss_pred ccCCCCCchh----hhccCCCCEEeccCCcCCCc----CChhhh---cCCCEEEeecCcCcc
Q 003737 316 NNLTGGIPTT----FEKLAKTNFMYLTGNKLTGP----VPKYIF---NSNKNVDISLNNFTW 366 (799)
Q Consensus 316 N~l~~~~p~~----~~~l~~L~~L~L~~N~l~g~----~p~~~~---~~l~~l~ls~N~~~g 366 (799)
|.++...... +...++|++|+|++|+++.. ++..+. ..++.|+|++|+++.
T Consensus 322 ~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~ 383 (460)
T d1z7xw1 322 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 383 (460)
T ss_dssp SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred cchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCCh
Confidence 9998654443 34567899999999999753 333333 248899999999985
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.37 E-value=4.3e-14 Score=150.89 Aligned_cols=141 Identities=13% Similarity=0.114 Sum_probs=73.9
Q ss_pred CCccccCCCCCCEEEccCCcCCCcCc----ccccccc-eeEEEccCCcCcCc----------CCcccCCCCCCCEEEeeC
Q 003737 108 LPTELSKLRYLKQLDLSRNCLTGSFS----PQWASLQ-LVELSVMGNRLSGP----------FPKVLTNITTLKNLSIEG 172 (799)
Q Consensus 108 ~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~-L~~L~Ls~N~l~~~----------~p~~~~~L~~L~~L~Ls~ 172 (799)
+...+.....|+.|+|++|.+...-. ..+...+ |+.|+++++..... +...+...++|+.|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 34456667778888888777654322 2233333 66777666544311 112344566677777777
Q ss_pred CcCCCCC----CccccCCCCCCEEEcccCcCCccCC----h---------hccCCCCCCEEEccCCcCCCc----CCccc
Q 003737 173 NLFTGSI----PPDIRKLINLQKLILSSNSFTGELP----A---------ELTKLTNLNDLRISDNNFSGK----IPEFI 231 (799)
Q Consensus 173 N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~p----~---------~~~~l~~L~~L~Ls~N~l~~~----~p~~~ 231 (799)
|.+...- ...+...++|++|++++|.+...-. . .....+.|+.|++++|.++.. +...+
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l 182 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchh
Confidence 7665431 2223445667777777666542100 0 012345566666666655421 22223
Q ss_pred cCCCCCCEEEccCCCCC
Q 003737 232 GKWKKIQKLHIQGSSLE 248 (799)
Q Consensus 232 ~~l~~L~~L~L~~N~l~ 248 (799)
...+.|++|+|++|.+.
T Consensus 183 ~~~~~L~~L~L~~n~i~ 199 (344)
T d2ca6a1 183 QSHRLLHTVKMVQNGIR 199 (344)
T ss_dssp HHCTTCCEEECCSSCCC
T ss_pred hhhhhhccccccccccc
Confidence 44556666666666554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.29 E-value=2.9e-13 Score=144.29 Aligned_cols=231 Identities=15% Similarity=0.127 Sum_probs=163.2
Q ss_pred cccccc-eeEEEccCCcCcCc----CCcccCCCCCCCEEEeeCCcCCCCC---C-------ccccCCCCCCEEEcccCcC
Q 003737 135 QWASLQ-LVELSVMGNRLSGP----FPKVLTNITTLKNLSIEGNLFTGSI---P-------PDIRKLINLQKLILSSNSF 199 (799)
Q Consensus 135 ~~~~l~-L~~L~Ls~N~l~~~----~p~~~~~L~~L~~L~Ls~N~l~~~~---p-------~~~~~l~~L~~L~Ls~N~l 199 (799)
.+.... +++|+|++|.+... +-..+...++|+.|+++++...... | ..+...++|++|+|++|.+
T Consensus 26 ~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i 105 (344)
T d2ca6a1 26 VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF 105 (344)
T ss_dssp HHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCC
T ss_pred HHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccc
Confidence 344444 99999999988642 3345677899999999987654221 1 2345678999999999998
Q ss_pred Ccc----CChhccCCCCCCEEEccCCcCCCcCCc-------------cccCCCCCCEEEccCCCCCCC----CchhhhcC
Q 003737 200 TGE----LPAELTKLTNLNDLRISDNNFSGKIPE-------------FIGKWKKIQKLHIQGSSLEGP----IPASISAL 258 (799)
Q Consensus 200 ~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~-------------~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l 258 (799)
+.. +...+...++|++|++++|.+...-.. .....+.|+.|++++|.++.. +...+...
T Consensus 106 ~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~ 185 (344)
T d2ca6a1 106 GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH 185 (344)
T ss_dssp CTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHC
T ss_pred ccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhh
Confidence 754 334456788999999999987521111 123567899999999988743 33446678
Q ss_pred CCCCeEEcCCCCCCCCC----C-CccCC-CCccEEEccCCcCccc----CCccccCCCCCCeeccccccCCCCCchhh--
Q 003737 259 TSLTDLRISDLKGSESA----F-PKLDK-MNLKTLILTKCLIHGE----IPDYIGDMTKLKNIDLSFNNLTGGIPTTF-- 326 (799)
Q Consensus 259 ~~L~~L~L~~n~~~~~~----~-~~l~~-~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~-- 326 (799)
+.|+.|+++.|.+.... + ..+.. ++|+.|+|++|.++.. +...+..+++|++|+|++|.+++.-...+
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 89999999987654321 1 12333 6899999999998643 34556788999999999999986433333
Q ss_pred --hc--cCCCCEEeccCCcCCCc----CChhh---hcCCCEEEeecCcCc
Q 003737 327 --EK--LAKTNFMYLTGNKLTGP----VPKYI---FNSNKNVDISLNNFT 365 (799)
Q Consensus 327 --~~--l~~L~~L~L~~N~l~g~----~p~~~---~~~l~~l~ls~N~~~ 365 (799)
.. .+.|+.|++++|+++.. +...+ ...++.|+|++|.|.
T Consensus 266 ~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred HhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 32 36799999999998742 22222 235889999999885
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.17 E-value=2.2e-13 Score=133.04 Aligned_cols=112 Identities=29% Similarity=0.342 Sum_probs=54.3
Q ss_pred CCccccCCCCCCEEEccCCcCCCcCcccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCC
Q 003737 108 LPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKL 186 (799)
Q Consensus 108 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l 186 (799)
++.++..+++|++|+|++|+++.. + .+..++ |++|+|++|.|+ .+|..+..+++|++|++++|+++. + +.+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred hhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccc
Confidence 445666677777777777766643 2 244443 555555555554 233333333445555555555442 1 224444
Q ss_pred CCCCEEEcccCcCCccCC-hhccCCCCCCEEEccCCcCC
Q 003737 187 INLQKLILSSNSFTGELP-AELTKLTNLNDLRISDNNFS 224 (799)
Q Consensus 187 ~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 224 (799)
++|++|++++|+++.... ..+..+++|++|++++|.+.
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 455555555555442111 23444444555555444443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.14 E-value=2.2e-13 Score=133.03 Aligned_cols=131 Identities=22% Similarity=0.287 Sum_probs=103.2
Q ss_pred Ccccccccc-eeEEEccCCcCcCcCCcccCCCCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCcCCccCChhccCC
Q 003737 132 FSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKL 210 (799)
Q Consensus 132 ~p~~~~~l~-L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 210 (799)
++..+..+. |++|+|++|+|+. ++ .+..+++|++|+|++|.++ .+|..+..+++|++|++++|+++. + +.+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred hhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccc
Confidence 345667776 9999999999984 44 5888999999999999997 566666667789999999999984 3 357888
Q ss_pred CCCCEEEccCCcCCCcCC-ccccCCCCCCEEEccCCCCCCCCch----------hhhcCCCCCeEEcC
Q 003737 211 TNLNDLRISDNNFSGKIP-EFIGKWKKIQKLHIQGSSLEGPIPA----------SISALTSLTDLRIS 267 (799)
Q Consensus 211 ~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~----------~~~~l~~L~~L~L~ 267 (799)
++|++|++++|+++.... ..+..+++|+.|+|++|++....+. .+..+++|+.||-.
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD~~ 182 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLDGM 182 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEESSG
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeCCc
Confidence 999999999999975322 4688999999999999987643322 26778999998743
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.12 E-value=1.1e-10 Score=108.80 Aligned_cols=104 Identities=19% Similarity=0.176 Sum_probs=65.8
Q ss_pred EEEccCCcCcCcCCcccCCCCCCCEEEeeCCc-CCCCCCccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCC
Q 003737 143 ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL-FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221 (799)
Q Consensus 143 ~L~Ls~N~l~~~~p~~~~~L~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 221 (799)
.++.+++.+. ..|..+..+++|++|++++|+ ++...+..|.++++|+.|+|++|+|+...|..|..+++|++|+|++|
T Consensus 12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence 3455555554 345556666777777776553 65444456777777777777777777655666777777777777777
Q ss_pred cCCCcCCccccCCCCCCEEEccCCCCC
Q 003737 222 NFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (799)
Q Consensus 222 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 248 (799)
+|+...+..|.. .+|++|+|++|.+.
T Consensus 91 ~l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 91 ALESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp CCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred CCcccChhhhcc-ccccccccCCCccc
Confidence 776443444433 35777777777664
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.09 E-value=7.1e-11 Score=126.31 Aligned_cols=115 Identities=15% Similarity=0.124 Sum_probs=88.2
Q ss_pred CCCCCCeecccCCeeEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhCC-----------CCcccceeEEEEE-
Q 003737 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-----------HPNLVKLYGCCVE- 743 (799)
Q Consensus 677 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g~~~~- 743 (799)
+|+..+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++.+++ |+|||++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 478889999999999999995 679999999997542 23467888998888775 5789999988764
Q ss_pred -CCEEEEEEecCCCCcHHHHH-hcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 744 -GNQLLLVYEYMKNNCLSRAI-FGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 744 -~~~~~lV~Ey~~~GsL~~~L-~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
....+++++++..+...... ..... ..+++..++.++.||++||+|||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~i~~i~~qil~al~~lh~ 143 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEH-------RGIPLIYVKQISKQLLLGLDYMHR 143 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cccceeeeeeecccccccccccccccc-------cCCcHHHHHHHHHHHHHHHHHHhh
Confidence 45677777777665443332 22211 267888999999999999999994
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.08 E-value=1.9e-10 Score=107.22 Aligned_cols=106 Identities=17% Similarity=0.143 Sum_probs=79.4
Q ss_pred CCCCCEEEeeCCcCCCCCCccccCCCCCCEEEcccCc-CCccCChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEE
Q 003737 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS-FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKL 240 (799)
Q Consensus 162 L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 240 (799)
....+.++.+++.+. ..|..+..+++|++|++++|+ ++...+.+|.++++|+.|+|++|+|+...|..|..+++|++|
T Consensus 7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 345567888888876 567778888889999987664 776556778888889999999888887778888888888888
Q ss_pred EccCCCCCCCCchhhhcCCCCCeEEcCCC
Q 003737 241 HIQGSSLEGPIPASISALTSLTDLRISDL 269 (799)
Q Consensus 241 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~n 269 (799)
+|++|+++...+..|..+ +|+.|+|++|
T Consensus 86 ~Ls~N~l~~l~~~~~~~~-~l~~L~L~~N 113 (156)
T d2ifga3 86 NLSFNALESLSWKTVQGL-SLQELVLSGN 113 (156)
T ss_dssp ECCSSCCSCCCSTTTCSC-CCCEEECCSS
T ss_pred eccCCCCcccChhhhccc-cccccccCCC
Confidence 888888885444444333 4556655553
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=98.95 E-value=5.8e-10 Score=107.65 Aligned_cols=100 Identities=18% Similarity=0.146 Sum_probs=75.6
Q ss_pred CCCeecccCCeeEEEEEeCCCcEEEEEEccccCh------------------hhHHHHHHHHHHHHhCCCCcccceeEEE
Q 003737 680 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR------------------QGNREFVNEIGMISAQQHPNLVKLYGCC 741 (799)
Q Consensus 680 ~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~------------------~~~~~f~~E~~~l~~l~H~niv~l~g~~ 741 (799)
..+.||+|+||.||+|...+|+.||||.++.... .....+.+|.+.+.+++|.++++.+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 3578999999999999988899999998754210 0123456788999999999999887653
Q ss_pred EECCEEEEEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 742 VEGNQLLLVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 742 ~~~~~~~lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
. .++||||++++.+.+ +++..+..++.|+++|++|||+
T Consensus 84 --~--~~lvme~~~~~~~~~----------------l~~~~~~~i~~ql~~~l~~lH~ 121 (191)
T d1zara2 84 --G--NAVLMELIDAKELYR----------------VRVENPDEVLDMILEEVAKFYH 121 (191)
T ss_dssp --T--TEEEEECCCCEEGGG----------------CCCSCHHHHHHHHHHHHHHHHH
T ss_pred --C--CEEEEEeeccccccc----------------hhhHHHHHHHHHHHHHHHHHhh
Confidence 2 379999999865432 2233566779999999999994
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.18 E-value=2e-08 Score=93.69 Aligned_cols=81 Identities=25% Similarity=0.237 Sum_probs=38.5
Q ss_pred CCCCCCEEEcccCcCCcc--CChhccCCCCCCEEEccCCcCCCcCCccccCCCCCCEEEccCCCCCCCCc-------hhh
Q 003737 185 KLINLQKLILSSNSFTGE--LPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP-------ASI 255 (799)
Q Consensus 185 ~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-------~~~ 255 (799)
.+++|++|+|++|+++.. ++..+..+++|+.|+|++|.++...+-.+....+|++|++++|.+..... ..+
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~ 142 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIR 142 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHH
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHH
Confidence 445555555555555432 12334455555555555555553222222233345555566665554332 124
Q ss_pred hcCCCCCeEE
Q 003737 256 SALTSLTDLR 265 (799)
Q Consensus 256 ~~l~~L~~L~ 265 (799)
..+++|+.||
T Consensus 143 ~~~P~L~~LD 152 (162)
T d1koha1 143 ERFPKLLRLD 152 (162)
T ss_dssp TTSTTCCEET
T ss_pred HHCCCCCEEC
Confidence 4456666554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.15 E-value=3e-08 Score=92.52 Aligned_cols=84 Identities=24% Similarity=0.298 Sum_probs=51.2
Q ss_pred ccCCCCCCCEEEeeCCcCCCCC--CccccCCCCCCEEEcccCcCCccCChhccCCCCCCEEEccCCcCCCcCCc------
Q 003737 158 VLTNITTLKNLSIEGNLFTGSI--PPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE------ 229 (799)
Q Consensus 158 ~~~~L~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~------ 229 (799)
.+..+++|++|+|++|+++..- +..+..+++|+.|+|++|.++..-+-.+....+|+.|++++|.+.....+
T Consensus 60 ~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~ 139 (162)
T d1koha1 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYIS 139 (162)
T ss_dssp HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHH
T ss_pred HHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHH
Confidence 3445667777777777776432 23355677777777777777743332333445677777777777654432
Q ss_pred -cccCCCCCCEEE
Q 003737 230 -FIGKWKKIQKLH 241 (799)
Q Consensus 230 -~~~~l~~L~~L~ 241 (799)
.+..+++|+.||
T Consensus 140 ~i~~~~P~L~~LD 152 (162)
T d1koha1 140 AIRERFPKLLRLD 152 (162)
T ss_dssp HHHTTSTTCCEET
T ss_pred HHHHHCCCCCEEC
Confidence 245677777665
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.34 E-value=5.2e-05 Score=70.15 Aligned_cols=64 Identities=11% Similarity=0.113 Sum_probs=30.1
Q ss_pred cCCCCCCEEEcccCcCCc----cCChhccCCCCCCEEEccCCcCCCc----CCccccCCCCCCEEEccCCCC
Q 003737 184 RKLINLQKLILSSNSFTG----ELPAELTKLTNLNDLRISDNNFSGK----IPEFIGKWKKIQKLHIQGSSL 247 (799)
Q Consensus 184 ~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l 247 (799)
...+.|++|+|++|.+.. .+...+...+.|++|+|++|.++.. +-..+...++|++|+|++|.+
T Consensus 41 ~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 41 CNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp TTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSS
T ss_pred hhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcC
Confidence 344455555555555542 1222333445555555555555421 112234445555555555543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.16 E-value=5.4e-05 Score=70.01 Aligned_cols=87 Identities=15% Similarity=0.124 Sum_probs=45.4
Q ss_pred cCCCCCCCEEEeeCCcCCC----CCCccccCCCCCCEEEcccCcCCcc----CChhccCCCCCCEEEccCCcCCCc----
Q 003737 159 LTNITTLKNLSIEGNLFTG----SIPPDIRKLINLQKLILSSNSFTGE----LPAELTKLTNLNDLRISDNNFSGK---- 226 (799)
Q Consensus 159 ~~~L~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~---- 226 (799)
+...+.|++|+|++|.+.. .+...+...+.|++|+|++|.++.. +...+...++|++|++++|.+...
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~ 119 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQV 119 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHH
T ss_pred HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHH
Confidence 3444556666666655542 1112233445666677766666532 233455566777777777654421
Q ss_pred ---CCccccCCCCCCEEEccCC
Q 003737 227 ---IPEFIGKWKKIQKLHIQGS 245 (799)
Q Consensus 227 ---~p~~~~~l~~L~~L~L~~N 245 (799)
+...+...++|+.|+++.+
T Consensus 120 ~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 120 EMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHHHHHHHhCCCccEeeCcCC
Confidence 2233334456666666544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.24 E-value=0.00073 Score=61.91 Aligned_cols=15 Identities=13% Similarity=0.096 Sum_probs=6.4
Q ss_pred CCCCCCEEEccCCcC
Q 003737 209 KLTNLNDLRISDNNF 223 (799)
Q Consensus 209 ~l~~L~~L~Ls~N~l 223 (799)
..++|++|++++|.+
T Consensus 44 ~n~~L~~L~Ls~n~l 58 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRS 58 (166)
T ss_dssp TCCSCCEEECTTSCC
T ss_pred cCCccCeeeccCCcc
Confidence 334444444444443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.22 E-value=0.00053 Score=62.91 Aligned_cols=108 Identities=16% Similarity=0.202 Sum_probs=54.2
Q ss_pred CCCCCCCEEEeeC-CcCCCC----CCccccCCCCCCEEEcccCcCCcc----CChhccCCCCCCEEEccCCcCCCc----
Q 003737 160 TNITTLKNLSIEG-NLFTGS----IPPDIRKLINLQKLILSSNSFTGE----LPAELTKLTNLNDLRISDNNFSGK---- 226 (799)
Q Consensus 160 ~~L~~L~~L~Ls~-N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~---- 226 (799)
.+.++|++|+|++ +.++.. +-..+...++|++|++++|.++.. +...+...++++.+++++|.+...
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3455666666665 334311 112334556677777777666532 223344556677777776666422
Q ss_pred CCccccCCCCCCEEEcc--CCCCCC----CCchhhhcCCCCCeEEcC
Q 003737 227 IPEFIGKWKKIQKLHIQ--GSSLEG----PIPASISALTSLTDLRIS 267 (799)
Q Consensus 227 ~p~~~~~l~~L~~L~L~--~N~l~~----~~p~~~~~l~~L~~L~L~ 267 (799)
+-..+...++|+.++|+ +|.+.. .+...+...++|+.|++.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~ 140 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYH 140 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECC
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCc
Confidence 22344555666654443 444432 123334445555555554
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.12 E-value=0.01 Score=58.00 Aligned_cols=115 Identities=13% Similarity=0.046 Sum_probs=76.1
Q ss_pred HHHHhhcCCCCCCeecccCCeeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCC-CCcccceeEEEEECCEEE
Q 003737 670 QIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLL 748 (799)
Q Consensus 670 ~~~~~t~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 748 (799)
++....+.|+..+..+-++...||+... +++.+.+|+...........+.+|...+..+. +--+.+++++...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4444445565544433344568998875 45667788876544334446778888877663 333567888888889999
Q ss_pred EEEecCCCCcHHHHHhcCcccccccccCCCChHHHHHHHHHHHHHHhhhcC
Q 003737 749 LVYEYMKNNCLSRAIFGKLRIFHISIYATFPQGNIQILIISAANNIDFFFF 799 (799)
Q Consensus 749 lV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~~~i~~~~~qi~~gL~yLH~ 799 (799)
+|||++++..+.+...... ....++.++++.++.||.
T Consensus 87 lv~~~l~G~~~~~~~~~~~--------------~~~~~~~~l~~~l~~lH~ 123 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQ--------------SPEKIIELYAECIRLFHS 123 (263)
T ss_dssp EEEECCSSEEHHHHTTTCS--------------CHHHHHHHHHHHHHHHHT
T ss_pred EEEEecccccccccccccc--------------cHHHHHHHHHHHHHHHhc
Confidence 9999999988876543211 222346778888888874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=90.09 E-value=0.42 Score=45.40 Aligned_cols=74 Identities=16% Similarity=0.070 Sum_probs=52.5
Q ss_pred ecccCC-eeEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhCCC--CcccceeEEEEECCEEEEEEecCCCCcHH
Q 003737 684 VGEGGF-GSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH--PNLVKLYGCCVEGNQLLLVYEYMKNNCLS 760 (799)
Q Consensus 684 lG~G~~-g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~GsL~ 760 (799)
+..|.. +.||+....+|..+.+|.-..... ..+.+|.+.+..+.. --+.++++++.+++..++||||+++-++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 344443 578999887888889998755432 246677777766533 33567888888888899999999986653
|